Clustering O 0 2.1387263586802874e-06
of O 0 9.313326998494631e-09
missense O 0 0.004201196599751711
mutations O 0 0.002974787726998329
in O 0 8.073633495087051e-08
the O 0 1.6275639609375503e-06
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999983310699463
telangiectasia I-Disease 1 0.9999998807907104
gene O 0 0.000717447604984045
in O 0 5.661708435411583e-09
a O 0 2.3316681918572613e-08
sporadic B-Disease 0 0.0017370334826409817
T I-Disease 1 0.9997047781944275
- I-Disease 1 0.5783984065055847
cell I-Disease 1 0.8894933462142944
leukaemia I-Disease 1 0.8314555883407593
. O 0 4.292768096547661e-08

Ataxia B-Disease 1 0.999998927116394
- I-Disease 1 0.9999955892562866
telangiectasia I-Disease 1 0.9999997615814209
( O 0 0.00013968294661026448
A B-Disease 1 0.9999983310699463
- I-Disease 1 0.9999988079071045
T I-Disease 1 0.9999998807907104
) O 0 6.53488041457706e-10
is O 0 3.9814089525247454e-11
a O 0 6.797209461950615e-10
recessive B-Disease 0 0.00026644536410458386
multi I-Disease 1 0.7536363005638123
- I-Disease 1 0.9998787641525269
system I-Disease 0 0.23958556354045868
disorder I-Disease 1 0.5947356820106506
caused O 0 2.599607284992089e-07
by O 0 4.6413012322332747e-10
mutations O 0 1.9792412331298692e-07
in O 0 6.115645490023525e-11
the O 0 1.422537001388724e-11
ATM O 0 2.0808266754102078e-07
gene O 0 4.67720617791656e-09
at O 0 7.996934781040466e-10
11q22 O 0 2.9375037513545976e-08
- O 0 1.2331870493653696e-06
q23 O 0 3.486802597763017e-07
( O 0 2.625666073452493e-10
ref O 0 4.224089934723452e-06
. O 0 5.751431969569509e-11
3 O 0 5.830916305349376e-11
) O 0 2.97260167869684e-11
. O 0 1.2109871994070431e-09

The O 0 4.8327532198300105e-08
risk O 0 4.5813789029125473e-07
of O 0 1.0270853056937312e-09
cancer B-Disease 0 1.833834539866075e-05
, O 0 4.0178760318809736e-10
especially O 0 2.901629381213411e-09
lymphoid B-Disease 0 1.141096845458378e-06
neoplasias I-Disease 0 4.4982312829233706e-05
, O 0 3.6614800080769783e-10
is O 0 1.0824656448971126e-10
substantially O 0 1.9734034850671378e-08
elevated O 0 5.908622142669628e-07
in O 0 2.5058701780267256e-08
A B-Disease 1 0.9999988079071045
- I-Disease 1 0.9999997615814209
T I-Disease 1 1.0
patients O 0 8.895592145563569e-06
and O 0 1.336343444791055e-07
has O 0 4.133262621053291e-08
long O 0 7.41648475965917e-09
been O 0 1.452905529220061e-08
associated O 0 1.3496462614170923e-08
with O 0 3.951396010393182e-08
chromosomal O 1 0.9999992847442627
instability O 1 0.9999874830245972
. O 0 9.231374065166165e-07

By O 0 2.524137165949014e-08
analysing O 0 3.441596345510334e-05
tumour B-Disease 1 0.9999502897262573
DNA O 0 2.206077624578029e-05
from O 0 2.160148726559896e-09
patients O 0 2.5504527378927833e-09
with O 0 2.156084893956134e-10
sporadic B-Disease 0 1.2211970897624269e-05
T I-Disease 1 0.9820368885993958
- I-Disease 0 0.0016468233661726117
cell I-Disease 0 0.0050895558670163155
prolymphocytic I-Disease 0 0.1139962449669838
leukaemia I-Disease 0 0.1995752453804016
( O 0 4.369275163895736e-09
T B-Disease 0 0.0034960035700351
- I-Disease 0 4.2545507312752306e-05
PLL I-Disease 0 4.4196985982125625e-05
) O 0 1.0372332853725297e-10
, O 0 2.6519663201551857e-12
a O 0 3.40354446015656e-11
rare O 0 1.3572669210759614e-08
clonal B-Disease 0 1.1310297622912913e-06
malignancy I-Disease 0 6.905127520440146e-05
with O 0 2.3192688047846133e-10
similarities O 0 1.7689778530893818e-08
to O 0 3.284277294568483e-10
a O 0 4.256860108853289e-08
mature B-Disease 0 3.813340299529955e-06
T I-Disease 0 0.0002526297466829419
- I-Disease 0 9.099927410716191e-06
cell I-Disease 0 0.0007593788905069232
leukaemia I-Disease 0 0.01014154963195324
seen O 0 4.433431968209334e-06
in O 0 2.095107198840651e-08
A B-Disease 1 0.9999973773956299
- I-Disease 1 0.999996542930603
T I-Disease 1 0.9999998807907104
, O 0 2.22155094320442e-09
we O 0 4.688618937542799e-10
demonstrate O 0 1.5882394011068612e-10
a O 0 1.4477311016669603e-10
high O 0 2.9296407522139134e-09
frequency O 0 2.225946182932148e-08
of O 0 1.0739797939862683e-11
ATM O 0 3.828243734460557e-06
mutations O 0 1.732659825393057e-06
in O 0 6.381508654840218e-08
T B-Disease 0 0.16340163350105286
- I-Disease 0 0.0005729319527745247
PLL I-Disease 0 0.0005695994477719069
. O 0 8.675996809870412e-08

In O 0 4.605658965317616e-09
marked O 0 1.543804195591747e-08
contrast O 0 8.739171164506843e-09
to O 0 1.215285164168911e-11
the O 0 1.0216603604784602e-11
ATM O 0 3.231943537684856e-06
mutation O 0 6.721985528201913e-07
pattern O 0 3.4237091313116252e-06
in O 0 3.587070551702709e-08
A B-Disease 1 0.9999967813491821
- I-Disease 1 0.9999985694885254
T I-Disease 1 1.0
, O 0 2.535879839449251e-10
the O 0 4.949651365854235e-12
most O 0 1.5135830956636287e-12
frequent O 0 1.3342722759990266e-10
nucleotide O 0 1.8232271248308507e-09
changes O 0 7.495961490411318e-11
in O 0 7.85841183792435e-11
this O 0 1.5742580572464249e-09
leukaemia B-Disease 0 6.25635584583506e-05
were O 0 4.0595075745386566e-08
missense O 0 0.0007534378673881292
mutations O 0 0.0001630011829547584
. O 0 3.7032947375337244e-08

These O 0 2.6075208658937754e-09
clustered O 0 2.10737880479428e-08
in O 0 1.7638043803280823e-10
the O 0 2.6673689298983838e-11
region O 0 1.840524954666023e-10
corresponding O 0 3.3061367532560837e-10
to O 0 1.8517591973687964e-12
the O 0 4.3014476529268375e-12
kinase O 0 6.623476878075962e-09
domain O 0 1.0209055822940627e-09
, O 0 1.9571995066303138e-11
which O 0 7.380113187238635e-11
is O 0 1.6324342919094015e-11
highly O 0 1.2417965267186304e-10
conserved O 0 1.4424893501896463e-09
in O 0 1.1184255604979043e-10
ATM O 0 1.6882815998542355e-06
- O 0 1.805272518140555e-07
related O 0 4.57676962994924e-09
proteins O 0 2.1280048556615583e-10
in O 0 8.999769679496339e-11
mouse O 0 2.1848798326118413e-07
, O 0 1.5268880604324409e-10
yeast O 0 2.5751390353434545e-08
and O 0 2.0683841306379236e-09
Drosophila O 0 1.533988935875641e-08
. O 0 3.264991832452324e-09

The O 0 2.3621160138986852e-08
resulting O 0 6.56965397638487e-08
amino O 0 8.119928729399817e-09
- O 0 7.411581037786164e-08
acid O 0 1.5742491754622279e-09
substitutions O 0 3.498805245527592e-09
are O 0 8.574808918471177e-11
predicted O 0 8.074889090714521e-10
to O 0 6.440533436430362e-12
interfere O 0 1.2768490709191838e-09
with O 0 1.3337429771720366e-10
ATP O 0 1.0949177919883368e-07
binding O 0 4.0512002641435174e-08
or O 0 5.585649276440563e-09
substrate O 0 3.9864153222879395e-06
recognition O 0 1.0697620922428541e-07
. O 0 4.6573479295375364e-08

Two O 0 7.780013855374079e-10
of O 0 5.488871510084259e-11
seventeen O 0 6.7681438231659286e-09
mutated O 0 1.5809140450073755e-06
T B-Disease 0 0.0004342726606409997
- I-Disease 0 7.096499302861048e-06
PLL I-Disease 0 1.2463173334253952e-05
samples O 0 1.0754023094250442e-07
had O 0 4.278828846793203e-09
a O 0 6.359340831707527e-10
previously O 0 4.4484784211817896e-07
reported O 0 1.7545407899888232e-05
A B-Disease 1 0.9999850988388062
- I-Disease 1 0.9999889135360718
T I-Disease 1 0.9999992847442627
allele O 0 6.849480996606871e-05
. O 0 3.080169008740086e-08

In O 0 2.6328700997169108e-08
contrast O 0 5.46512353594153e-07
, O 0 4.423416632981514e-10
no O 0 2.38862796209105e-09
mutations O 0 1.4160346495373233e-07
were O 0 5.710207862108518e-09
detected O 0 3.148248651996255e-06
in O 0 2.47453793567054e-11
the O 0 1.4672398712667345e-11
p53 O 0 2.6250651652404144e-10
gene O 0 5.280451076394854e-10
, O 0 4.447022611264728e-12
suggesting O 0 1.9107766480175314e-09
that O 0 1.5863925451053973e-10
this O 0 1.0930846228163205e-09
tumour B-Disease 1 0.9999886751174927
suppressor O 0 0.0003237492637708783
is O 0 2.2693035006682294e-08
not O 0 1.1474761141272438e-09
frequently O 0 6.02000982397044e-09
altered O 0 3.4474485488544815e-08
in O 0 5.076543074800099e-10
this O 0 8.249545935257174e-09
leukaemia B-Disease 0 0.0003230669826734811
. O 0 2.1701726637957108e-08

Occasional O 0 2.533794713599491e-06
missense O 0 0.00046310145989991724
mutations O 0 7.68484387663193e-05
in O 0 1.9858703570463376e-09
ATM O 0 9.786113878362812e-06
were O 0 6.177730682566107e-08
also O 0 2.6129973740296464e-09
found O 0 3.384683422424928e-09
in O 0 3.670564963087486e-09
tumour B-Disease 1 0.999988317489624
DNA O 0 8.268750661954982e-07
from O 0 3.615062693640425e-10
patients O 0 8.121133210359233e-10
with O 0 8.720983379895131e-10
B B-Disease 0 1.5522139165113913e-06
- I-Disease 0 3.3784594961616676e-06
cell I-Disease 0 0.00013606071297544986
non I-Disease 0 3.4636470900295535e-06
- I-Disease 1 0.9541535377502441
Hodgkins I-Disease 1 0.9995726943016052
lymphomas I-Disease 1 0.6412917375564575
( O 0 8.611427682048145e-10
B B-Disease 0 3.246457822569937e-07
- I-Disease 0 1.1048822443626705e-06
NHL I-Disease 0 2.2391125398257827e-08
) O 0 1.2478115329200845e-12
and O 0 3.03846114935169e-11
a O 0 3.90772081360069e-09
B B-Disease 0 7.263938073265308e-07
- I-Disease 0 2.7153796509082895e-06
NHL I-Disease 0 1.6669125102453108e-07
cell O 0 2.654004163105128e-07
line O 0 1.2223021883528418e-07
. O 0 2.9462274842018132e-09

The O 0 9.550599200380816e-10
evidence O 0 7.26107118875774e-10
of O 0 2.8205222445815137e-12
a O 0 2.044877461804262e-11
significant O 0 6.742933295056375e-11
proportion O 0 1.333247734436327e-09
of O 0 1.2668146913419331e-11
loss O 0 1.74422840615307e-08
- O 0 5.446268858122494e-08
of O 0 2.387151032401391e-10
- O 0 7.588116659462685e-06
function O 0 1.64341557251646e-07
mutations O 0 8.619619507044263e-08
and O 0 6.195363666527953e-11
a O 0 3.8690867176782717e-10
complete O 0 1.6654395640358644e-09
absence O 0 7.075721675242619e-10
of O 0 1.0886429561637878e-12
the O 0 1.7507184937870512e-11
normal O 0 1.3825682265711237e-10
copy O 0 5.064271224597405e-10
of O 0 7.433066748913086e-13
ATM O 0 3.619730648551922e-08
in O 0 3.7803440933181776e-11
the O 0 7.912674855614643e-12
majority O 0 9.78721131916771e-11
of O 0 4.789180163555784e-10
mutated O 0 0.00023499059898313135
tumours B-Disease 1 0.999983549118042
establishes O 0 1.8769179632727173e-07
somatic O 0 1.783223524398636e-07
inactivation O 0 8.202524668377009e-07
of O 0 6.9070218294831065e-12
this O 0 9.98389652201448e-12
gene O 0 1.136043037419654e-09
in O 0 2.77551939764642e-11
the O 0 1.8670242435403495e-11
pathogenesis O 0 5.279537695912495e-09
of O 0 1.699799155596704e-11
sporadic B-Disease 0 1.5933625036268495e-05
T I-Disease 1 0.848858654499054
- I-Disease 0 4.5351567678153515e-05
PLL I-Disease 0 3.8740781747037545e-05
and O 0 5.3617479345291486e-09
suggests O 0 1.1540454147862533e-09
that O 0 1.7908483723738655e-11
ATM O 0 4.315212365213483e-08
acts O 0 4.280452881033625e-09
as O 0 1.8858507810914915e-10
a O 0 9.38023703156432e-08
tumour B-Disease 1 0.9999918937683105
suppressor O 0 0.0012038780841976404
. O 0 4.762331329288827e-08

As O 0 5.2128865668521485e-09
constitutional O 0 1.017605111286457e-08
DNA O 0 1.1238388424317236e-06
was O 0 8.963481690216213e-08
not O 0 1.3209175420136887e-10
available O 0 3.5612145177221777e-11
, O 0 8.074491596177236e-13
a O 0 5.3901248048271455e-11
putative O 0 3.3460315762567916e-07
hereditary O 0 0.0032355464063584805
predisposition O 0 0.0005452692857943475
to O 0 1.9246152760388213e-07
T B-Disease 0 0.052953604608774185
- I-Disease 0 2.0136028979322873e-05
PLL I-Disease 0 1.0477434443600941e-05
will O 0 1.3024847866915934e-09
require O 0 8.864298184363406e-11
further O 0 9.466203862440459e-12
investigation O 0 2.0572652470463026e-09
. O 0 3.221699851341242e-10
. O 0 1.825638640262639e-09

Myotonic B-Disease 1 0.9999933242797852
dystrophy I-Disease 1 0.9999945163726807
protein O 0 6.04228516749572e-05
kinase O 0 1.7905451386468485e-05
is O 0 2.0195147776291833e-09
involved O 0 1.4334761155865294e-10
in O 0 1.2340042182534816e-11
the O 0 7.376900305888778e-12
modulation O 0 7.408718638579614e-10
of O 0 2.7803607940274366e-12
the O 0 4.350618129644879e-11
Ca2 O 0 2.1885836076762644e-07
+ O 0 1.802612281665006e-08
homeostasis O 0 2.9055493087071227e-06
in O 0 2.302279256127804e-09
skeletal O 0 0.00017937773372977972
muscle O 0 4.240511043462902e-05
cells O 0 1.638956291571958e-06
. O 0 1.5593110802569754e-08

Myotonic B-Disease 1 0.999993085861206
dystrophy I-Disease 1 0.9999990463256836
( O 0 0.00019016856094822288
DM B-Disease 1 0.9999991655349731
) O 0 5.503920430527387e-09
, O 0 4.111139206841585e-11
the O 0 1.4469658110582984e-11
most O 0 2.6458960022957e-10
prevalent O 0 2.144637392120785e-06
muscular B-Disease 1 0.8792760968208313
disorder I-Disease 0 0.16888733208179474
in O 0 2.1404434846772347e-07
adults O 0 8.11756081020576e-07
, O 0 6.677089992024321e-10
is O 0 1.7264237817116168e-09
caused O 0 1.4831025296757616e-08
by O 0 6.124426521481041e-10
( O 0 1.9703362552636605e-10
CTG O 0 8.638777870828562e-08
) O 0 1.194943363008738e-11
n O 0 8.660848038744007e-09
- O 0 3.4173922358604614e-08
repeat O 0 1.49793404347065e-08
expansion O 0 1.2293416284947511e-10
in O 0 3.908423064358235e-12
a O 0 1.305139416679646e-11
gene O 0 7.779891314507736e-11
encoding O 0 1.5386435181508062e-10
a O 0 9.195992300981004e-10
protein O 0 1.238297198113969e-08
kinase O 0 5.005045295547461e-06
( O 0 8.929332828699899e-09
DM B-Disease 1 0.9999994039535522
protein O 0 2.398321896635025e-07
kinase O 0 4.16807552028331e-06
; O 0 2.0350781060329837e-09
DMPK O 0 1.8864639059756882e-05
) O 0 7.930003875777913e-12
and O 0 1.0059592048250465e-11
involves O 0 2.561497194908391e-11
changes O 0 9.789227067846795e-11
in O 0 7.460729256614229e-11
cytoarchitecture O 0 2.8568425136654696e-07
and O 0 6.75578792908027e-09
ion O 0 7.620116230100393e-05
homeostasis O 0 0.0025639517698436975
. O 0 7.209148833453582e-08

To O 0 1.2351309974789615e-09
obtain O 0 2.8818838426758475e-09
clues O 0 1.2144637651090306e-07
to O 0 1.7942579366714284e-10
the O 0 6.451331135970406e-11
normal O 0 1.122212656134991e-09
biological O 0 4.417303745007928e-10
role O 0 8.310588328619417e-12
of O 0 8.509140657711467e-13
DMPK O 0 2.6524378426984185e-07
in O 0 1.0764577423882926e-10
cellular O 0 1.0098867164742842e-07
ion O 0 8.004074516065884e-06
homeostasis O 0 0.0005710706464014947
, O 0 4.2126099830674946e-10
we O 0 5.779950962292446e-10
have O 0 6.170679939243584e-11
compared O 0 8.481991498054953e-11
the O 0 7.498273703332448e-12
resting O 0 2.3478815336375192e-08
[ O 0 1.983681136019655e-10
Ca2 O 0 6.892250103973652e-10
+ O 0 6.408557573500673e-10
] O 0 4.14558520844821e-09
i O 0 7.835087245666728e-09
, O 0 4.0980844477449263e-13
the O 0 3.8450387080009307e-13
amplitude O 0 3.5736139047948257e-10
and O 0 1.7526228732189786e-11
shape O 0 4.298583267114964e-09
of O 0 1.0006812219132133e-11
depolarization O 0 6.947399810997013e-08
- O 0 9.613560905563645e-06
induced O 0 1.732380951580126e-05
Ca2 O 0 4.78159108752152e-07
+ O 0 1.7460656920320616e-08
transients O 0 8.196128078452602e-07
, O 0 1.6164345903457722e-11
and O 0 2.2354295064336283e-12
the O 0 5.331123997115439e-13
content O 0 1.0614675804987428e-11
of O 0 1.7766871958022068e-12
ATP O 0 4.351776272670804e-09
- O 0 5.2121137628091674e-08
driven O 0 1.3421559685866669e-07
ion O 0 9.544394288241165e-07
pumps O 0 3.704673190441099e-07
in O 0 9.32711796686192e-10
cultured O 0 7.870481226746051e-07
skeletal O 0 3.178613042109646e-06
muscle O 0 4.952995169560381e-08
cells O 0 1.0186823606872508e-09
of O 0 3.825107765254021e-12
wild O 0 2.1186139509410395e-09
- O 0 3.4718518691079225e-06
type O 0 8.677709956828039e-06
and O 0 1.1061263016642897e-08
DMPK O 0 8.144972525769845e-06
[ O 0 7.730818651907612e-09
- O 0 4.0511315546609694e-07
/ O 0 1.966104150596948e-07
- O 0 1.9289384454168612e-06
] O 0 8.627646508330145e-08
knockout O 0 5.768475148215657e-06
mice O 0 3.167838804074563e-05
. O 0 1.715196518148332e-08

In O 0 3.640266044158125e-08
vitro O 0 2.677573547771317e-06
- O 0 3.45173612004146e-05
differentiated O 0 2.3397017230308848e-06
DMPK O 0 0.00011197465937584639
[ O 0 7.203197327498856e-08
- O 0 1.2479496263040346e-06
/ O 0 2.838733053067699e-07
- O 0 5.340083362170844e-07
] O 0 1.1427284896114998e-08
myotubes O 0 1.8365886589322145e-08
exhibit O 0 2.627851491965316e-09
a O 0 4.2759301654982096e-10
higher O 0 5.323696594672356e-09
resting O 0 8.2437608739383e-08
[ O 0 3.5649133645065945e-10
Ca2 O 0 2.235684526397108e-09
+ O 0 9.437746140150693e-10
] O 0 3.582077523489602e-09
i O 0 4.827536148610534e-09
than O 0 1.3614859240007604e-11
do O 0 6.778626965298074e-11
wild O 0 1.445231712082773e-10
- O 0 3.7093386140441e-08
type O 0 4.763267327234644e-07
myotubes O 0 8.293975497508654e-07
because O 0 3.385333957606207e-10
of O 0 4.559760772085419e-13
an O 0 1.6624062152900687e-12
altered O 0 6.575966438049363e-10
open O 0 1.5290330113160167e-10
probability O 0 2.351760453045415e-10
of O 0 1.3240649028578577e-11
voltage O 0 4.779585196956759e-06
- O 0 4.815170541405678e-06
dependent O 0 1.5830912047931633e-07
l O 0 1.5050597994559212e-06
- O 0 1.1860627324722373e-07
type O 0 3.834956316950411e-07
Ca2 O 0 3.308304030724685e-08
+ O 0 2.787480246624341e-09
and O 0 2.3746810073888014e-10
Na O 0 5.8273005976161585e-08
+ O 0 6.486329695576387e-09
channels O 0 1.133273563880266e-08
. O 0 1.2875713828464086e-08

The O 0 8.701448450665339e-09
mutant O 0 1.561289337814742e-07
myotubes O 0 7.67163271575555e-07
exhibit O 0 2.6660606167183687e-08
smaller O 0 2.2895536577749453e-09
and O 0 2.944332833099139e-10
slower O 0 5.444105610763472e-09
Ca2 O 0 1.904170510158565e-08
+ O 0 1.606005772814001e-09
responses O 0 5.338458008985469e-10
upon O 0 2.72151398639231e-11
triggering O 0 1.1325295146136227e-09
by O 0 6.607772662370337e-11
acetylcholine O 0 5.129942337589455e-07
or O 0 2.6749031434292192e-08
high O 0 4.9672618018803405e-08
external O 0 3.5036232475249562e-06
K O 0 4.596398866851814e-06
+ O 0 1.3753839844810045e-08
. O 0 4.552469956564664e-09

In O 0 8.206153978562725e-09
addition O 0 1.5213190707186186e-09
, O 0 5.971606542587438e-11
we O 0 2.392657738603532e-10
observed O 0 3.149783767142367e-10
that O 0 1.4332784091519724e-11
these O 0 4.039109758463555e-12
Ca2 O 0 8.492846426122469e-09
+ O 0 2.9437952075994644e-09
transients O 0 4.0920187416304543e-07
partially O 0 2.0442475090476364e-07
result O 0 1.161502671820358e-09
from O 0 1.668616633754283e-12
an O 0 4.2375204365417696e-13
influx O 0 1.2790123127270903e-11
of O 0 1.830475441361168e-12
extracellular O 0 2.3519264313875965e-10
Ca2 O 0 3.2813110006912893e-09
+ O 0 7.827880010857768e-11
through O 0 1.862467211705132e-12
the O 0 6.88387818970071e-11
l O 0 3.3668888477222936e-07
- O 0 9.960558600141667e-08
type O 0 2.0590641724993475e-06
Ca2 O 0 2.1084690615680302e-07
+ O 0 1.7675342078860012e-08
channel O 0 6.608789959727801e-08
. O 0 8.108383298122135e-09

Neither O 0 1.5904986412351718e-06
the O 0 7.187230810501433e-10
content O 0 1.2782087610574422e-09
nor O 0 8.27600654673688e-09
the O 0 8.365631971873899e-12
activity O 0 1.046282019356859e-10
of O 0 5.800387080368008e-12
Na O 0 2.386762076866944e-08
+ O 0 1.31219457522036e-09
/ O 0 4.556622634765972e-09
K O 0 2.9642041710076228e-08
+ O 0 2.3751531852411745e-09
ATPase O 0 2.5597525876719374e-08
and O 0 3.3129166077117134e-10
sarcoplasmic O 0 4.061638207986107e-07
reticulum O 0 5.13316251726792e-07
Ca2 O 0 7.880486236899742e-07
+ O 0 7.410888258618797e-08
- O 0 1.4471219174083672e-06
ATPase O 0 2.4819639747875044e-06
are O 0 1.7297430154883386e-09
affected O 0 1.8964709802560265e-09
by O 0 4.5904580137090534e-10
DMPK O 0 0.0001018159746308811
absence O 0 1.6619711118437408e-07
. O 0 8.999847089796731e-09

In O 0 2.6131385055805367e-08
conclusion O 0 9.89020687569564e-09
, O 0 7.425805109706474e-11
our O 0 1.9259971395513276e-10
data O 0 2.958981670797556e-10
suggest O 0 5.576874517743136e-10
that O 0 4.782030327277198e-11
DMPK O 0 4.306566552259028e-07
is O 0 1.1565386669187827e-11
involved O 0 1.3808175956808721e-11
in O 0 7.64053664087383e-12
modulating O 0 7.21892945421132e-09
the O 0 1.8006474783449633e-11
initial O 0 6.292817655850769e-11
events O 0 1.4073806356429408e-11
of O 0 4.542332655843584e-12
excitation O 0 5.387130954659369e-07
- O 0 2.132247027475387e-05
contraction O 0 6.737749572494067e-06
coupling O 0 1.3940705230197636e-06
in O 0 1.195795018560375e-09
skeletal O 0 3.331698098918423e-05
muscle O 0 4.8323104238079395e-06
. O 0 3.33509553307465e-09
. O 0 5.662291968633326e-09

Constitutional O 0 1.4933154488971923e-05
RB1 O 0 0.006328492891043425
- O 0 2.9885819458286278e-05
gene O 0 2.237022272311151e-06
mutations O 0 2.6156521926168352e-05
in O 0 7.306113491978294e-09
patients O 0 9.451298410567688e-09
with O 0 1.3423775424570294e-09
isolated O 0 2.744177663771552e-06
unilateral B-Disease 0 0.00012835471716243774
retinoblastoma I-Disease 0 0.009329784661531448
. O 0 2.3827531947517855e-07

In O 0 3.373335388801024e-08
most O 0 1.517594938604816e-09
patients O 0 1.6358333576604878e-09
with O 0 2.413434174730611e-10
isolated O 0 1.9855727373396803e-07
unilateral B-Disease 0 1.8526183339417912e-05
retinoblastoma I-Disease 0 0.00048734029405750334
, O 0 1.1462117921468007e-09
tumor B-Disease 0 1.675934413469804e-07
development O 0 2.9100733975329085e-11
is O 0 6.7448594452679256e-12
initiated O 0 2.5760879540648318e-11
by O 0 1.958024714587836e-11
somatic O 0 1.882287925525361e-08
inactivation O 0 4.859859927819343e-07
of O 0 7.45796566864465e-12
both O 0 3.190596398194856e-11
alleles O 0 5.834279170890966e-10
of O 0 3.084691529986472e-11
the O 0 3.777709700614196e-09
RB1 O 0 1.939704452524893e-05
gene O 0 1.800774356297552e-07
. O 0 1.5316617307803426e-08

However O 0 1.0928313542990509e-07
, O 0 5.000878183780699e-11
some O 0 6.996438476312983e-13
of O 0 1.7076460688200679e-12
these O 0 1.8593350470386127e-10
patients O 0 1.983031516772371e-09
can O 0 1.5402424224930655e-08
transmit O 0 3.4749748010654e-05
retinoblastoma B-Disease 0 2.2778414859203622e-05
predisposition O 0 2.3834061721572652e-05
to O 0 5.058683694159072e-09
their O 0 2.5103288336936203e-08
offspring O 0 1.2878952020400902e-06
. O 0 1.38547333605743e-08

To O 0 2.2299140312043164e-09
determine O 0 1.3312893010208882e-08
the O 0 1.3175005530996486e-10
frequency O 0 6.035833166606608e-07
and O 0 1.0035795111607015e-10
nature O 0 7.278848079828037e-10
of O 0 5.8172498935971095e-12
constitutional O 0 3.160559103321248e-08
RB1 O 0 3.021071279363241e-05
- O 0 5.319573688211676e-07
gene O 0 5.454793239323408e-08
mutations O 0 3.047526320187899e-07
in O 0 8.886207325531359e-10
patients O 0 1.610595101730894e-09
with O 0 2.3218670042179923e-10
isolated O 0 3.411912246065185e-07
unilateral B-Disease 0 5.085307748231571e-06
retinoblastoma I-Disease 0 7.005484076216817e-05
, O 0 8.363342240969018e-10
we O 0 7.343328722875242e-10
analyzed O 0 1.7394665707826107e-09
DNA O 0 7.044376637566074e-09
from O 0 5.0740529833337433e-11
peripheral O 0 1.42562271321367e-07
blood O 0 2.9757529773632996e-07
and O 0 2.878642657577757e-09
from O 0 3.406704474073763e-09
tumor B-Disease 0 4.639035614673048e-05
tissue O 0 0.0003329202299937606
. O 0 8.194457734589378e-08

The O 0 9.969881586968654e-10
analysis O 0 2.7722419915221508e-09
of O 0 5.368201994038202e-10
tumors B-Disease 1 0.9999908208847046
from O 0 5.472107211801358e-10
54 O 0 1.7984619349320496e-10
( O 0 4.37487242613277e-12
71 O 0 3.723247404829877e-11
% O 0 3.3942204515774455e-12
) O 0 2.768917636408047e-13
of O 0 2.435113308912884e-12
76 O 0 1.4136551651500184e-10
informative O 0 2.1426123453238688e-07
patients O 0 1.8729872763856292e-08
showed O 0 1.9860169686580775e-06
loss O 0 4.736513758984984e-08
of O 0 1.606103028350958e-10
constitutional O 0 1.979036369448295e-06
heterozygosity O 0 0.22002579271793365
( O 0 1.6748353459661303e-07
LOH O 1 0.9998263716697693
) O 0 2.908837337667336e-10
at O 0 2.0918478060849566e-09
intragenic O 0 1.0902057283601607e-06
loci O 0 1.4992407670888497e-07
. O 0 1.5590078561444898e-08

Three O 0 1.9680610474637206e-09
of O 0 1.8633042331295258e-10
13 O 0 6.351340009480566e-10
uninformative O 0 0.0002726766688283533
patients O 0 6.179204774525715e-07
had O 0 3.437750351054092e-08
constitutional O 0 5.658947799247471e-08
deletions O 0 6.138883327366784e-05
. O 0 1.1306992320214704e-07

For O 0 2.2317392378568e-09
39 O 0 1.5318069035430426e-09
randomly O 0 1.4407523174497783e-08
selected O 0 2.2926252540855785e-07
tumors B-Disease 1 0.999998927116394
, O 0 2.9800812928471032e-09
SSCP O 0 3.5418212064541876e-05
, O 0 2.7305313565761935e-10
hetero O 0 1.2708504755210015e-06
- O 0 2.7416245984568377e-07
duplex O 0 1.6907436020119349e-06
analysis O 0 2.249659347697275e-09
, O 0 1.0449028794989879e-12
sequencing O 0 1.1237471890523931e-11
, O 0 7.472798963827076e-13
and O 0 2.1252726141451905e-12
Southern O 0 5.227076150388088e-12
blot O 0 2.854097544968681e-07
analysis O 0 8.507531346069186e-10
were O 0 7.405183410913452e-11
used O 0 9.076417395448289e-10
to O 0 1.939984978216458e-10
identify O 0 5.647043508361094e-07
mutations O 0 3.302174945929437e-06
. O 0 1.4182477414692585e-08

Mutations O 0 0.0013003707863390446
were O 0 2.6172985556627282e-08
detected O 0 5.986858013784513e-07
in O 0 1.302364882604934e-10
21 O 0 7.97615307135402e-11
( O 0 1.43231032503216e-12
91 O 0 7.455391339006301e-12
% O 0 1.037792247970959e-12
) O 0 7.395211287959669e-13
of O 0 1.1628987356404608e-10
23 O 0 1.7988982108363416e-06
tumors B-Disease 1 0.9999997615814209
with O 0 0.00021653248404618353
LOH O 1 0.9999958276748657
. O 0 2.1081764316477347e-06

In O 0 1.3086161487763093e-08
6 O 0 7.178968530752172e-10
( O 0 9.523775865161177e-12
38 O 0 1.776352676063908e-11
% O 0 2.1024364974669973e-12
) O 0 3.568499933482433e-13
of O 0 3.6949495546556577e-11
16 O 0 8.721904691810778e-07
tumors B-Disease 1 0.9999998807907104
without O 0 4.457565228221938e-05
LOH O 1 0.9999433755874634
, O 0 1.860239601247926e-10
one O 0 2.755718431224352e-10
mutation O 0 1.6214384856994002e-07
was O 0 1.2399615911817818e-07
detected O 0 2.874660822271835e-06
, O 0 1.2657278870842337e-11
and O 0 1.930637767710852e-11
in O 0 1.2665585594207052e-11
9 O 0 7.524179890250338e-11
( O 0 1.0353209175389955e-12
56 O 0 2.7066970626626885e-12
% O 0 1.129809462131759e-12
) O 0 1.366380560129457e-13
of O 0 4.462282540002027e-12
the O 0 2.1445555375976255e-06
tumors B-Disease 1 1.0
without O 0 0.0004886469687335193
LOH O 1 0.9999814033508301
, O 0 7.319653771986623e-10
both O 0 3.0249719396024943e-10
mutations O 0 2.052761232107514e-07
were O 0 2.552736688699042e-08
found O 0 7.114146427511514e-08
. O 0 2.546351396404134e-08

Thus O 0 3.807071990991062e-08
, O 0 1.537574755017257e-11
a O 0 7.14729143924675e-12
total O 0 2.29820437853967e-12
of O 0 1.2336246390728944e-12
45 O 0 3.076254181944016e-11
mutations O 0 4.4683382327548316e-08
were O 0 1.709829788865136e-08
identified O 0 4.103878382011317e-06
in O 0 4.331167815507797e-07
tumors B-Disease 1 0.9999983310699463
of O 0 1.4160089767401018e-09
36 O 0 1.5401983688434484e-08
patients O 0 6.835634280832892e-08
. O 0 2.9020183589523185e-08

Thirty O 0 1.3664809728197724e-07
- O 0 5.3669072741513446e-08
nine O 0 3.7484432224843545e-11
of O 0 3.670195224125816e-12
the O 0 1.79945697231787e-10
mutations O 0 5.2570118924677445e-08
- O 0 1.0605909039895778e-08
including O 0 9.129506872707083e-11
34 O 0 2.0701542910450677e-11
small O 0 2.734137638515932e-10
mutations O 0 2.98136797027837e-07
, O 0 2.720403589895337e-11
2 O 0 1.0973911883371823e-11
large O 0 4.724102775632844e-10
structural O 0 6.738778029102832e-05
alterations O 0 1.711737581899797e-06
, O 0 6.995431317546874e-11
and O 0 1.359213713802987e-10
hypermethylation O 0 3.509726639094879e-06
in O 0 7.000219426345211e-08
3 O 0 2.451691671012668e-06
tumors O 1 1.0
- O 0 0.08324150741100311
were O 0 2.9601946152979508e-05
not O 0 8.821063488539949e-07
detected O 0 5.10366476191848e-07
in O 0 1.677341598949056e-11
the O 0 8.407444879177106e-12
corresponding O 0 3.759961231253328e-09
peripheral O 0 5.036552508386194e-08
blood O 0 1.4208612242327945e-07
DNA O 0 7.948961524562037e-07
. O 0 2.4792280228780328e-08

In O 0 1.8105065890949845e-08
6 O 0 1.4303769280132883e-09
( O 0 1.2063982625376557e-11
17 O 0 2.221031691895803e-11
% O 0 1.339495680173497e-12
) O 0 2.346000184481195e-13
of O 0 2.0992539304098834e-13
the O 0 4.597053640531534e-11
36 O 0 1.1758931328653688e-10
patients O 0 2.0384531562722685e-10
, O 0 5.337088843787585e-12
a O 0 1.4202449216682567e-09
mutation O 0 3.3275473469984718e-06
was O 0 4.760651250990122e-08
detected O 0 1.9588051713981258e-07
in O 0 9.160166548893844e-12
constitutional O 0 3.6261255109693025e-10
DNA O 0 6.417321429807998e-08
, O 0 8.10784599181158e-12
and O 0 4.31552450025352e-12
1 O 0 4.9583822291088264e-12
of O 0 9.532966863817771e-13
these O 0 2.34535502130484e-10
mutations O 0 2.5893532651366513e-08
is O 0 1.1419777623533633e-10
known O 0 3.054365926846714e-10
to O 0 1.2923628833760858e-10
be O 0 1.21416103837646e-08
associated O 0 8.557236697015469e-09
with O 0 1.2216356815031304e-09
reduced O 0 8.204339678741235e-07
expressivity O 0 0.0028146461118012667
. O 0 5.904881916762861e-08

The O 0 2.507006824359337e-09
presence O 0 1.2804292071066925e-09
of O 0 3.4926456258382865e-12
a O 0 4.3168377206193043e-10
constitutional O 0 8.327455702783482e-08
mutation O 0 4.6500645112246275e-05
was O 0 5.343048314898624e-07
not O 0 2.880887750578154e-10
associated O 0 8.960443498295945e-11
with O 0 4.107680775383704e-12
an O 0 2.1523857349214914e-11
early O 0 1.8252181988032135e-08
age O 0 8.326101585964807e-09
at O 0 1.1249191578244222e-09
treatment O 0 5.087295473771292e-09
. O 0 5.390078605671533e-09

In O 0 6.90303210149068e-08
1 O 0 5.958812998585472e-09
patient O 0 1.3625316341858706e-07
, O 0 4.7595271474021317e-11
somatic O 0 4.0784055244103e-08
mosaicism O 0 6.550179386977106e-05
was O 0 1.0201065947512689e-07
demonstrated O 0 4.9587494110880925e-09
by O 0 8.444085708436688e-12
molecular O 0 1.6965982396754953e-08
analysis O 0 3.691089447976914e-11
of O 0 1.45336271229618e-12
DNA O 0 4.4748546201844874e-08
and O 0 5.89713222698407e-10
RNA O 0 2.023570866427349e-09
from O 0 1.0012430468053779e-10
peripheral O 0 3.8025220305826224e-07
blood O 0 2.330600409550243e-06
. O 0 3.095753342563512e-08

In O 0 2.28110721423036e-08
2 O 0 6.598233071031245e-09
patients O 0 4.090923599875396e-09
without O 0 6.619128578577715e-10
a O 0 8.384141381156951e-09
detectable O 0 0.0009845457971096039
mutation O 0 2.1515738808375318e-06
in O 0 4.0742417772854367e-10
peripheral O 0 1.0594827699605958e-06
blood O 0 2.3462530407414306e-06
, O 0 2.213555588825855e-10
mosaicism O 0 6.946047506062314e-07
was O 0 1.3975895107876113e-08
suggested O 0 4.21243484538536e-09
because O 0 9.587626526030846e-11
1 O 0 4.069407137652359e-12
of O 0 1.2143856883625737e-12
the O 0 8.922961258761575e-10
patients O 0 1.2891618439425656e-07
showed O 0 0.0013321450678631663
multifocal O 1 0.9999514818191528
tumors B-Disease 1 1.0
and O 0 3.036400642031367e-07
the O 0 1.2994369469332412e-10
other O 0 3.479156893138047e-11
later O 0 7.61546159466775e-10
developed O 0 3.6591569774202526e-09
bilateral B-Disease 0 1.5549014165117114e-07
retinoblastoma I-Disease 0 1.7169437342090532e-05
. O 0 4.677922049722838e-08

In O 0 5.861721330546743e-09
conclusion O 0 2.2900952245663575e-09
, O 0 2.6013587117734716e-11
our O 0 3.684351435051525e-11
results O 0 3.7674665470666113e-11
emphasize O 0 2.2953285105931087e-10
that O 0 3.88372389803493e-11
the O 0 4.83147116064897e-12
manifestation O 0 2.0477131101870327e-09
and O 0 1.3953639632635628e-10
transmissibility O 0 8.918915384015236e-09
of O 0 4.156560512447172e-12
retinoblastoma B-Disease 0 2.652710406891856e-08
depend O 0 1.290757278837873e-09
on O 0 9.400324962882678e-10
the O 0 3.5836389411514347e-11
nature O 0 1.1394457599678276e-09
of O 0 2.0828388926780184e-12
the O 0 1.6181651504854067e-11
first O 0 2.637652318782102e-10
mutation O 0 6.99149049765424e-09
, O 0 1.574988512005604e-12
its O 0 1.1728858986467805e-12
time O 0 1.0966427071990026e-10
in O 0 1.523204826159308e-11
development O 0 3.1898281759035196e-12
, O 0 1.5889953198719442e-12
and O 0 1.1942006411524986e-11
the O 0 1.0281362350025858e-12
number O 0 1.520966512458255e-11
and O 0 2.3229333387386752e-11
types O 0 3.038450879788712e-10
of O 0 5.1168613617036396e-12
cells O 0 2.7406135139074195e-09
that O 0 4.875578274443626e-10
are O 0 3.384501012781982e-10
affected O 0 5.690872773023159e-10
. O 0 1.5578380252456725e-10
. O 0 1.988993858503818e-09

Hereditary B-Disease 1 0.9998176693916321
deficiency I-Disease 1 0.9995492100715637
of I-Disease 0 1.2908411006762321e-09
the I-Disease 0 1.9338523837841848e-10
fifth I-Disease 0 1.789825621045793e-09
component I-Disease 0 1.690318218727782e-09
of I-Disease 0 8.401642229149964e-12
complement I-Disease 0 5.297624117162059e-09
in O 0 3.756406297128478e-09
man O 0 1.922056617331691e-05
. O 0 1.8992011519003427e-08

I O 0 0.0008641559979878366
. O 0 4.7586726736881246e-07

Clinical O 0 6.16584875388071e-05
, O 0 6.9882375441920885e-09
immunochemical O 0 1.9168361177435145e-05
, O 0 8.082408076148795e-10
and O 0 1.3329324310973334e-09
family O 0 1.3646129559674591e-08
studies O 0 4.023829269783619e-09
. O 0 5.2327098210014356e-09

The O 0 3.896801992198107e-09
first O 0 9.237021703079051e-10
recognized O 0 6.1395990513801735e-09
human O 0 2.5397535186044706e-09
kindred O 0 1.21965717880812e-06
with O 0 1.1749128248084162e-07
hereditary B-Disease 1 0.999431312084198
deficiency I-Disease 1 0.9768765568733215
of I-Disease 0 1.7954047970558662e-10
the I-Disease 0 4.865823854949269e-10
fifth I-Disease 0 1.2153241968348993e-08
component I-Disease 0 1.1615122197383698e-08
of I-Disease 0 7.567876880720803e-11
complement I-Disease 0 7.953771330448944e-08
( O 0 2.124586950813523e-09
C5 O 0 5.270774636301212e-06
) O 0 3.301673864863908e-11
is O 0 4.1856351717939333e-10
described O 0 1.7543956687404716e-07
. O 0 1.905994650996945e-08

The O 0 1.4066313447358425e-08
proband O 0 1.350879529127269e-06
, O 0 4.418970397934707e-11
a O 0 6.003102875906663e-11
20 O 0 3.743999207883597e-11
- O 0 4.149685040033546e-08
year O 0 1.8324448625151035e-09
- O 0 7.911404509286513e-07
old O 0 2.9343398182390956e-06
black O 0 9.2472947699207e-07
female O 0 1.1956869911955437e-06
with O 0 3.3276805879722815e-06
systemic B-Disease 1 0.9999997615814209
lupus I-Disease 1 0.9994445443153381
erythematosus I-Disease 1 0.9999868869781494
since O 0 0.00032074167393147945
age O 0 1.170722896404186e-07
11 O 0 2.6057844770832617e-10
, O 0 2.9480737295806136e-11
lacked O 0 1.6540460592295858e-06
serum O 0 2.8878370358143002e-05
hemolytic O 0 8.654246812511701e-06
complement O 0 6.577650424333115e-09
activity O 0 2.3117323166843562e-08
, O 0 3.0321564703506e-11
even O 0 4.0247025157036376e-10
during O 0 3.082635924300803e-09
remission O 0 2.1436710540001513e-07
. O 0 3.219975175383638e-09

C5 O 0 0.01850677654147148
was O 0 4.477518587009399e-07
undetectable O 0 1.88276737844717e-06
in O 0 5.360742960647258e-10
her O 0 2.2658435128164456e-08
serum O 0 1.8212682562079863e-07
by O 0 3.611421925397984e-11
both O 0 7.068856056058337e-10
immunodiffusion O 0 9.917457646224648e-06
and O 0 1.6788067824791142e-08
hemolytic O 0 9.383721771882847e-05
assays O 0 2.620788109197747e-05
. O 0 5.0144201679813705e-08

Other O 0 6.405844743540001e-10
complement O 0 2.1487414070264776e-09
components O 0 4.532957564862272e-09
were O 0 3.0574201503874576e-10
normal O 0 1.2513289293636376e-09
during O 0 6.116674944323108e-10
remission O 0 4.455273039383201e-09
of O 0 3.158372868794501e-11
lupus O 0 3.0837139775030664e-07
, O 0 2.0739453210349978e-10
but O 0 1.60508193403075e-08
C1 O 0 6.072409087209962e-05
, O 0 5.507863609643948e-11
C4 O 0 3.0195531053323066e-06
, O 0 2.6680635478726344e-09
C2 O 0 1.0807134458445944e-05
, O 0 4.384263785350839e-11
and O 0 3.648048974014273e-09
C3 O 0 0.0024027307517826557
levels O 0 1.5261492762874695e-06
fell O 0 9.96577227851958e-07
during O 0 4.815803933411189e-08
exacerbations O 0 0.0005127910990267992
. O 0 7.945613589299683e-08

A O 0 3.8649164935122826e-07
younger O 0 7.639123111857771e-08
half O 0 1.5106955686405854e-09
- O 0 1.303132421526243e-06
sister O 0 4.739830274047563e-06
, O 0 6.166235855253888e-10
who O 0 2.0643335929548812e-08
had O 0 1.4783738322421414e-07
no O 0 9.694697382656159e-07
underlying O 0 0.4968865215778351
disease O 0 0.0001507817505626008
, O 0 2.155813444426613e-10
was O 0 2.3239250523943156e-08
also O 0 5.108928280428415e-10
found O 0 2.686373901106265e-10
to O 0 1.1091124546558362e-10
lack O 0 4.371494810584409e-08
immunochemically O 0 0.0003226871194783598
detectable O 0 0.03178824484348297
C5 O 0 9.926890197675675e-05
. O 0 1.474547506319368e-08

By O 0 7.394537959726222e-08
hemolytic O 0 0.0018056400585919619
assay O 0 0.00011732129496522248
, O 0 1.7297957510820083e-09
she O 0 4.669433284476554e-09
exhibited O 0 2.127089793191317e-08
1 O 0 3.0012638208010145e-11
- O 0 1.2725560161186422e-08
2 O 0 4.147202373183667e-11
% O 0 7.793666428369816e-13
of O 0 6.652938833520694e-13
the O 0 1.8288336123273297e-10
normal O 0 7.280271319132225e-08
serum O 0 1.3216771321822307e-06
C5 O 0 4.15903599559897e-07
level O 0 3.6219454102592863e-09
and O 0 2.441598867530814e-10
normal O 0 1.3834393630673958e-09
concentrations O 0 1.4869744546786023e-08
of O 0 4.024521601392328e-12
other O 0 1.6349333345488937e-11
complement O 0 2.0363790653732394e-09
components O 0 6.539349328704702e-08
. O 0 6.102018890175032e-09

C5 O 0 0.012575839646160603
levels O 0 5.596069740931853e-07
of O 0 3.0567364611711056e-11
other O 0 2.104977650518869e-11
family O 0 1.3709483548396406e-10
members O 0 4.18119445316778e-12
were O 0 2.2344727457213054e-10
either O 0 8.922144689726963e-10
normal O 0 7.8562578664787e-10
or O 0 2.67484298599463e-11
approximately O 0 2.2168618937085105e-12
half O 0 8.764870079724929e-11
- O 0 2.352253204662702e-06
normal O 0 1.3862055503466308e-08
, O 0 7.0041060624970175e-12
consistent O 0 1.827565210277271e-09
with O 0 1.509784519626578e-10
autosomal O 0 2.1707373889512382e-05
codominant O 0 4.016860202682437e-06
inheritance O 0 2.569982484601496e-07
of O 0 8.584200711370116e-11
the O 0 1.2787355618826268e-09
gene O 0 9.377530659548938e-06
determining O 0 0.01852545328438282
C5 B-Disease 1 0.9999990463256836
deficiency I-Disease 1 0.9999973773956299
. O 0 4.6505573436661507e-07

Normal O 0 0.00014544051373377442
hemolytic O 0 0.18020372092723846
titers O 0 0.003009348874911666
were O 0 1.1502156560538879e-08
restored O 0 1.334199026814531e-07
to O 0 7.160452786258986e-10
both O 0 2.834306656041008e-08
homozygous O 1 0.9988910555839539
C5 B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999991655349731
deficient I-Disease 1 0.9999997615814209
( O 0 9.456726388634706e-07
C5D B-Disease 1 0.9999997615814209
) O 0 4.439433543002025e-10
sera O 0 1.6254771750823238e-08
by O 0 6.223666547400253e-12
addition O 0 6.328168544733614e-11
of O 0 3.095890557802683e-11
highly O 0 2.5351956978170165e-08
purified O 0 1.338331827582806e-07
human O 0 1.3727348857628385e-07
C5 O 0 2.35751795116812e-05
. O 0 5.811957581869365e-09

In O 0 1.2248561276351211e-08
specific O 0 2.798343601284614e-08
C5 O 0 6.659785140072927e-05
titrations O 0 0.00014839379582554102
, O 0 2.3007911131855963e-09
however O 0 1.2445950936523786e-09
, O 0 2.940885382440861e-11
it O 0 9.567038827817953e-11
was O 0 4.213390969454167e-09
noted O 0 2.051015052240146e-10
that O 0 3.2921405185293295e-11
when O 0 2.2251702216924407e-11
limited O 0 2.2265275560762188e-12
amounts O 0 4.9584981953731955e-11
of O 0 7.415469280291909e-12
C5 O 0 1.2828090234506817e-07
were O 0 5.450555007335822e-10
assayed O 0 1.7523856854495534e-07
in O 0 2.479129575239103e-11
the O 0 4.438159041664225e-12
presence O 0 6.253453310733903e-11
of O 0 5.5089431280630485e-12
low O 0 6.688220643980003e-09
dilutions O 0 1.7123657158890637e-08
of O 0 4.882983253851059e-11
either O 0 1.127699533753912e-06
C5D B-Disease 1 0.9999997615814209
serum O 0 1.1966296369791962e-05
, O 0 2.19310832515196e-12
curving O 0 1.2246539893290276e-10
rather O 0 3.9264622803125704e-11
than O 0 7.6279850491634e-12
linear O 0 6.467634205975514e-10
dose O 0 2.0570942638187262e-07
- O 0 3.0173515597198275e-07
response O 0 6.056657841924107e-09
plots O 0 1.43176066558226e-07
were O 0 1.0354849422355983e-08
consistently O 0 2.440675643811119e-07
obtained O 0 3.2711753306102764e-09
, O 0 1.9415970567426832e-12
suggesting O 0 1.203230015622836e-10
some O 0 1.360348248977128e-12
inhibitory O 0 3.5744198711995523e-09
effect O 0 6.175926436924328e-09
. O 0 2.6943647313260044e-09

Further O 0 1.3972696777386773e-08
studies O 0 7.42320693802867e-09
suggested O 0 4.3140415684206346e-09
that O 0 1.1631205026896296e-10
low O 0 1.207378552692262e-08
dilutions O 0 6.659702194156125e-07
of O 0 7.348222030856277e-09
C5D B-Disease 1 0.9999994039535522
serum O 0 0.00010475393355591223
contain O 0 1.2166182727924024e-08
a O 0 8.83965178832824e-10
factor O 0 1.1938693367241626e-09
( O 0 4.725071896249933e-12
or O 0 3.7158284782456974e-10
factors O 0 4.3639428182196127e-10
) O 0 2.3285971675196526e-12
interfering O 0 4.2503978114893926e-10
at O 0 5.061912000670077e-11
some O 0 6.247068834452918e-13
step O 0 2.588763092781221e-10
in O 0 3.742457038713454e-11
the O 0 1.5010728771081006e-10
hemolytic O 0 1.7114405181928305e-06
assay O 0 4.196246834453632e-07
of O 0 5.856689022643025e-10
C5 O 0 7.47808808228001e-05
, O 0 4.1017168828094697e-11
rather O 0 1.4575560203233806e-10
than O 0 3.016466243455085e-11
a O 0 1.1944842892575025e-09
true O 0 2.0165217051726358e-07
C5 O 0 1.1085636515417718e-06
inhibitor O 0 1.0955983675842162e-08
or O 0 1.1214257966685182e-08
inactivator O 0 1.1384585377527401e-05
. O 0 3.165246553749057e-08

Of O 0 3.572429907450214e-09
clinical O 0 1.661502011529592e-07
interest O 0 2.6537989583630406e-07
are O 0 2.6577684497652854e-09
( O 0 2.8213039543478757e-11
a O 0 2.9023808356676284e-10
) O 0 6.2889871262072905e-12
the O 0 4.079852341382084e-12
documentation O 0 2.1633110858232385e-09
of O 0 9.016165591901881e-10
membranous O 1 0.9894747734069824
glomerulonephritis B-Disease 1 0.9999997615814209
, O 0 1.1088745850429405e-05
vasculitis B-Disease 1 0.9999995231628418
, O 0 5.2541150097340505e-08
and O 0 2.1767842554254457e-05
arthritis B-Disease 1 0.9999985694885254
in O 0 1.4698657846423657e-09
an O 0 5.894632698622004e-11
individual O 0 1.0822771656648911e-07
lacking O 0 4.9261860112892464e-05
C5 O 0 3.680496956803836e-05
( O 0 1.778342577363201e-11
and O 0 1.351712925617976e-11
its O 0 4.994298377636319e-12
biologic O 0 1.8914352306609317e-09
functions O 0 4.9967977672205066e-11
) O 0 1.259555394012013e-11
, O 0 1.566519830520363e-11
and O 0 2.43825293289035e-10
( O 0 1.3511433291646391e-11
b O 0 1.623492451585662e-10
) O 0 9.886409995784468e-14
a O 0 4.3113941236572195e-12
remarkable O 0 1.6611916286990436e-09
propensity O 0 1.2864848031313159e-06
to O 0 1.1110126933999709e-06
bacterial B-Disease 1 0.9999998807907104
infections I-Disease 1 0.9999998807907104
in O 0 4.411833121054087e-09
the O 0 9.809637824265138e-11
proband O 0 1.4501572422886966e-06
, O 0 1.0339834891071042e-11
even O 0 2.5830252867176107e-11
during O 0 2.289726047655094e-11
periods O 0 2.644442720356466e-10
of O 0 2.862650221036045e-12
low O 0 3.3822200151689685e-08
- O 0 9.513227894331067e-08
dose O 0 4.246876983415859e-08
or O 0 2.513560193317943e-10
alternate O 0 6.357566556536298e-11
- O 0 4.236222039821769e-08
day O 0 3.803310555383632e-09
corticosteroid O 0 0.00014984612062107772
therapy O 0 1.559420297780889e-06
. O 0 6.732672197529155e-09

Other O 0 1.940467342365082e-09
observations O 0 8.64926406052291e-08
indicate O 0 7.933574863727699e-08
that O 0 1.7551395059545172e-10
the O 0 5.149086712563644e-10
C5D B-Disease 1 0.9999988079071045
state O 0 4.730983382827958e-10
is O 0 3.140711649085581e-11
compatible O 0 1.0694138630196193e-10
with O 0 6.495013554763673e-11
normal O 0 8.015778596437428e-10
coagulation O 0 9.861307326275437e-10
function O 0 1.0034517661239306e-09
and O 0 6.82285963837792e-11
the O 0 1.1179429777741223e-11
capacity O 0 1.6175918937655354e-10
to O 0 6.745477006825373e-12
mount O 0 1.583897528689704e-07
a O 0 1.193833867318972e-07
neutrophilic O 0 0.0076800924725830555
leukocytosis O 0 0.0018934402614831924
during O 0 1.8100665784004377e-06
pyogenic B-Disease 1 0.7830595970153809
infection I-Disease 0 0.15056228637695312
. O 0 3.5454741365015252e-09
. O 0 5.261794555622146e-09

Susceptibility O 1 0.9856902956962585
to O 0 0.00029342572088353336
ankylosing B-Disease 1 0.9999997615814209
spondylitis I-Disease 1 1.0
in O 0 0.0002653671253938228
twins O 0 0.0032618138939142227
: O 0 7.951515140769416e-11
the O 0 2.3999864595669607e-12
role O 0 7.248890376843065e-11
of O 0 5.916933176058903e-12
genes O 0 1.7148160669222534e-09
, O 0 3.567578177321451e-11
HLA O 0 3.407960136314614e-08
, O 0 3.623164615551566e-11
and O 0 1.0748492373924279e-10
the O 0 4.974386458300728e-10
environment O 0 1.3804094578517834e-07
. O 0 3.743445997628214e-09

OBJECTIVE O 0 8.178770940503455e-07
To O 0 8.50856940459721e-10
determine O 0 2.9237012810767737e-09
the O 0 2.8923325540164413e-11
relative O 0 1.5801672859083737e-08
effects O 0 2.5661858416015093e-08
of O 0 1.8637971374579898e-11
genetic O 0 7.972011673018642e-08
and O 0 9.761804697916432e-10
environmental O 0 2.813976385240835e-09
factors O 0 4.290095501069402e-10
in O 0 6.317052436699555e-10
susceptibility O 0 0.008884681388735771
to O 0 0.0008257742738351226
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 0 8.954697113949805e-05
AS B-Disease 1 0.9999397993087769
) O 0 2.6963080657083083e-09
. O 0 8.499069004130888e-09

METHODS O 0 0.0002989064669236541
Twins O 0 0.0008562134462408721
with O 0 1.6982946604571225e-08
AS B-Disease 1 0.9950130581855774
were O 0 2.1636340719055625e-08
identified O 0 2.4379531282647804e-08
from O 0 1.599718621458912e-11
the O 0 7.707783716837113e-11
Royal O 0 8.357910132872348e-07
National O 0 8.872413559402048e-08
Hospital O 0 2.3625987921604974e-07
for O 0 1.9958427799338097e-08
Rheumatic B-Disease 1 0.8665924668312073
Diseases I-Disease 0 5.169961877982132e-05
database O 0 1.9835134423829004e-07
. O 0 3.1981869597075274e-08

Clinical O 0 1.4386235307028983e-05
and O 0 1.1219135842566175e-08
radiographic O 0 4.940851067658514e-05
examinations O 0 3.93081791116856e-06
were O 0 5.893312060578637e-09
performed O 0 1.5560835953110086e-09
to O 0 1.931875319438614e-11
establish O 0 7.88729703771196e-09
diagnoses O 0 0.0004023128130938858
, O 0 1.1170127045545541e-09
and O 0 4.387771923575201e-07
disease O 0 0.00010864632349694148
severity O 0 0.003274244023486972
was O 0 9.469616202295583e-08
assessed O 0 1.2797121584640081e-08
using O 0 1.9686870189605798e-10
a O 0 5.715053430499495e-10
combination O 0 8.452736288688811e-09
of O 0 6.750989350878811e-11
validated O 0 2.0885285323402059e-07
scoring O 0 1.7402340901639946e-08
systems O 0 7.08981886532456e-08
. O 0 5.00256236435348e-09

HLA O 0 4.325669942772947e-05
typing O 0 9.538080121274106e-07
for O 0 4.483735327465155e-10
HLA O 0 1.105280603042047e-06
- O 0 7.626834985785536e-07
B27 O 0 1.1789602893941264e-07
, O 0 4.3826001855373775e-11
HLA O 0 1.1495007612438712e-08
- O 0 2.0297411751357686e-08
B60 O 0 7.182629602198176e-09
, O 0 1.2934374925277492e-11
and O 0 3.249272517713564e-10
HLA O 0 1.8060491129290313e-06
- O 0 0.0005794291500933468
DR1 O 1 0.9994286894798279
was O 0 5.301604915075586e-07
performed O 0 1.7245570249624365e-10
by O 0 2.0604113033784177e-12
polymerase O 0 5.508234424134173e-10
chain O 0 1.3735383497248677e-08
reaction O 0 3.4281999461427404e-10
with O 0 5.701905527594198e-12
sequence O 0 2.0378505827256532e-10
- O 0 3.0478670698386168e-09
specific O 0 8.37184488400311e-11
primers O 0 1.1873301986042861e-07
, O 0 1.9136414675102742e-11
and O 0 8.062418788146175e-11
zygosity O 0 2.0239623665929685e-07
was O 0 1.3636866746935539e-08
assessed O 0 2.9777815768738947e-08
using O 0 5.483477671930359e-09
microsatellite O 0 1.0700059647206217e-05
markers O 0 4.2089017370017245e-05
. O 0 7.104966215365494e-08

Genetic O 0 6.32721494184807e-05
and O 0 5.256898916172759e-09
environmental O 0 6.10646644361168e-09
variance O 0 3.821022609429292e-09
components O 0 3.2953494155663066e-08
were O 0 1.8278091262757812e-09
assessed O 0 6.736772206750175e-08
with O 0 1.0796696175985332e-10
the O 0 4.527019592526216e-10
program O 0 1.4079780674691733e-09
Mx O 0 3.813423532506022e-08
, O 0 2.0210441935460122e-13
using O 0 2.7055406526255155e-12
data O 0 9.162547803809318e-11
from O 0 9.475918313905929e-13
this O 0 2.8061520121469563e-12
and O 0 3.785878208151239e-11
previous O 0 3.3933694743026876e-10
studies O 0 4.176254828069936e-11
of O 0 1.5088165092325134e-11
twins O 0 1.3187813237891532e-05
with O 0 1.935772431238547e-09
AS B-Disease 1 0.9972721934318542
. O 0 5.639380518118742e-08

RESULTS O 0 4.377629466034705e-06
Six O 0 1.3430614398401985e-09
of O 0 2.5153923388643307e-10
8 O 0 2.8815611230470495e-08
monozygotic O 0 0.08524249494075775
( O 0 8.513834082179983e-09
MZ O 1 0.9904098510742188
) O 0 4.668168962496111e-09
twin O 0 0.011425724253058434
pairs O 0 4.2668048990890384e-05
were O 0 2.8274494070501532e-06
disease O 0 1.2730703247143538e-06
concordant O 0 5.099718691781163e-07
, O 0 1.0962076385512276e-10
compared O 0 4.0161904357738365e-10
with O 0 1.3136482353293122e-11
4 O 0 3.4301145257487065e-11
of O 0 4.8888892066611955e-12
15 O 0 1.8569108750643437e-10
B27 O 0 4.714269863370646e-08
- O 0 8.800898285699077e-06
positive O 0 4.3902204538426304e-08
dizygotic O 0 3.685287811094895e-05
( O 0 2.3099668011727914e-10
DZ O 0 0.0002074541844194755
) O 0 5.637694477922395e-11
twin O 0 9.692449793874403e-07
pairs O 0 1.6565444127536466e-08
( O 0 5.7236108214064885e-12
27 O 0 1.0572445696688249e-11
% O 0 4.070693706160339e-13
) O 0 2.532907965400316e-13
and O 0 7.114377229694435e-12
4 O 0 2.9317661579680854e-12
of O 0 6.2257798742748616e-12
32 O 0 5.880172460059896e-10
DZ O 0 0.48623764514923096
twin O 0 0.00013307237531989813
pairs O 0 1.0748322409881439e-07
overall O 0 1.2265206628114811e-08
( O 0 9.24051894030109e-12
12 O 0 6.819603475677338e-12
. O 0 4.7746728445985376e-12
5 O 0 2.0082425306044982e-11
% O 0 2.1296155811034723e-11
) O 0 5.035622960281039e-11
. O 0 1.7321134526682158e-09

Nonsignificant O 0 2.7229074476053938e-05
increases O 0 1.4335711284729769e-07
in O 0 4.16271149494829e-11
similarity O 0 2.912012575517764e-10
with O 0 3.4224161699070166e-11
regard O 0 1.214211398092857e-09
to O 0 1.349645617487738e-09
age O 0 7.092266685049253e-08
at O 0 4.4741376825641055e-08
disease O 0 2.630742415021814e-07
onset O 0 3.784988678035006e-08
and O 0 1.8606405305376938e-10
all O 0 1.9011112128985985e-12
of O 0 1.4869091201352713e-12
the O 0 1.7065089341627981e-09
disease O 0 9.958713462765445e-07
severity O 0 1.8477343473932706e-05
scores O 0 1.761419099466366e-08
assessed O 0 1.0134024108765516e-07
were O 0 2.7981235106722124e-09
noted O 0 1.1206816807884934e-08
in O 0 1.0129246774681633e-08
disease O 0 4.40935536971665e-06
- O 0 0.0012201669160276651
concordant O 1 0.541687548160553
MZ O 1 0.9999752044677734
twins O 0 0.012063492089509964
compared O 0 2.2617156147930473e-08
with O 0 7.077439967417831e-09
concordant O 0 0.028252238407731056
DZ O 1 0.999886155128479
twins O 0 0.01354200579226017
. O 0 2.378409291736716e-08

HLA O 0 0.0007636942318640649
- O 0 1.9205321223125793e-05
B27 O 0 3.124059730907902e-07
and O 0 4.6311141033150705e-10
B60 O 0 1.0781848303054176e-08
were O 0 8.556677033588755e-10
associated O 0 2.24007679072713e-09
with O 0 2.0216177343268527e-10
the O 0 3.1000904954225916e-08
disease O 0 2.207791112596169e-06
in O 0 1.3132404885762838e-10
probands O 0 1.5549770751022152e-06
, O 0 2.96637714392034e-11
and O 0 3.2976454900079943e-11
the O 0 6.013232967116977e-11
rate O 0 8.404558826669017e-08
of O 0 2.172695877378228e-11
disease O 0 2.495144002523375e-08
concordance O 0 2.1597500676762138e-08
was O 0 6.716319056465636e-09
significantly O 0 2.6542574804722108e-09
increased O 0 6.76607492255954e-10
among O 0 4.656082186471622e-10
DZ O 1 0.6210020184516907
twin O 0 0.002348943380638957
pairs O 0 2.6859981971938396e-07
in O 0 2.874109283901305e-10
which O 0 1.5283187215775484e-10
the O 0 1.7336264368505994e-10
co O 0 5.329324721969897e-06
- O 0 0.00137245818041265
twin O 0 0.21479475498199463
was O 0 5.879381959061902e-08
positive O 0 3.131738618433744e-11
for O 0 1.4409802561246576e-12
both O 0 8.559839642652278e-11
B27 O 0 6.054961687596006e-08
and O 0 1.9946972074080804e-08
DR1 O 1 0.7361530065536499
. O 0 5.623205012739163e-08

Additive O 0 2.4105236207105918e-06
genetic O 0 8.618987521913368e-06
effects O 0 2.890489668061491e-06
were O 0 2.8708784238773433e-09
estimated O 0 3.325698882949979e-10
to O 0 7.41651618590966e-12
contribute O 0 3.484163998979106e-11
97 O 0 1.5711997675138534e-11
% O 0 1.886374086448872e-12
of O 0 1.4398153893105392e-12
the O 0 7.866975820780553e-11
population O 0 6.71582511824198e-11
variance O 0 1.7893478920782968e-09
. O 0 1.743929090025631e-08

CONCLUSION O 0 4.798071699951834e-07
Susceptibility O 0 0.00014415370242204517
to O 0 1.0202520606128473e-08
AS B-Disease 1 0.8579453825950623
is O 0 1.4056455999167383e-10
largely O 0 1.3043387203648393e-10
genetically O 0 1.553847495117111e-09
determined O 0 2.9486980679394037e-07
, O 0 2.5943473064282685e-11
and O 0 1.0572325133406668e-11
the O 0 9.734092004665129e-12
environmental O 0 8.73000394197021e-10
trigger O 0 7.416994129982868e-09
for O 0 3.88771133341681e-11
the O 0 8.794184047644649e-09
disease O 0 1.3998004533277708e-06
is O 0 9.384416577162824e-10
probably O 0 1.98920719896023e-08
ubiquitous O 0 4.5140563997847494e-07
. O 0 1.4809766746282094e-08

HLA O 0 0.0002732591237872839
- O 0 2.7646585749607766e-06
B27 O 0 6.893085213732775e-08
accounts O 0 1.5553003329671355e-09
for O 0 6.347143730739413e-12
a O 0 1.0649154474906553e-10
minority O 0 3.4394256887004815e-10
of O 0 4.386821201435298e-12
the O 0 3.6214444637527876e-11
overall O 0 1.9088250979848453e-08
genetic O 0 5.276571073409286e-07
susceptibility O 0 0.000630932510830462
to O 0 1.0667120164953303e-07
AS B-Disease 1 0.9999023675918579
. O 0 3.124029603895906e-07

Cell O 0 4.294940663385205e-05
cycle O 0 2.046130930466461e-06
- O 0 5.275712737784488e-06
dependent O 0 4.672215325740581e-08
colocalization O 0 2.3994198272703215e-07
of O 0 1.3223745709556312e-10
BARD1 O 0 3.496035424177535e-05
and O 0 1.6126245228065272e-08
BRCA1 O 0 6.054425512047601e-07
proteins O 0 6.370254324039593e-10
in O 0 8.405011409085006e-11
discrete O 0 2.4658282882228377e-07
nuclear O 0 0.0001321732415817678
domains O 0 9.86518784884538e-07
. O 0 2.9323983241624774e-08

Germ O 0 0.08277539908885956
- O 0 0.001266823266632855
line O 0 1.2653720204980345e-06
mutations O 0 7.46837116594179e-08
of O 0 7.693048455215123e-12
the O 0 7.166843507544485e-11
BRCA1 O 0 3.352790542976436e-07
gene O 0 1.3653314923089965e-08
predispose O 0 2.194083492668142e-08
women O 0 3.1060712335495566e-10
to O 0 4.984327880985795e-11
early O 0 2.035533519517685e-08
- O 0 0.37354451417922974
onset O 1 0.5785462260246277
breast B-Disease 1 0.9999897480010986
and I-Disease 1 0.9999269247055054
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999992847442627
by O 0 1.497531165739474e-08
compromising O 0 5.71077544009313e-05
the O 0 4.6449322166353113e-10
genes O 0 8.781193550078115e-09
presumptive O 0 6.788059545215219e-05
function O 0 4.852510215869188e-08
as O 0 1.21781043582736e-10
a O 0 6.398691798636946e-09
tumor B-Disease 0 2.612438765936531e-05
suppressor O 0 0.0001521633967058733
. O 0 4.459288049929455e-08

Although O 0 2.4467855297416463e-08
the O 0 9.376074916467303e-11
biochemical O 0 2.8370001459165906e-08
properties O 0 1.1573745517523548e-08
of O 0 1.208716043921143e-10
BRCA1 O 0 1.847720159275923e-05
polypeptides O 0 2.48243225087208e-07
are O 0 3.165963491369439e-09
not O 0 4.022601807207593e-09
understood O 0 2.5584933283084865e-08
, O 0 4.334671510619614e-12
their O 0 8.42601856343439e-12
expression O 0 7.039004490394518e-09
pattern O 0 1.6618474774077185e-07
and O 0 1.5694484600814462e-10
subcellular O 0 4.38488960696759e-08
localization O 0 1.0550746054605042e-08
suggest O 0 8.232298731591925e-10
a O 0 5.461677290985456e-11
role O 0 1.1248999509660962e-09
in O 0 5.575354067310911e-10
cell O 0 2.0766981378983473e-06
- O 0 6.9964680733392015e-06
cycle O 0 2.9669769219253794e-07
regulation O 0 9.917544474546958e-08
. O 0 6.525541884627728e-09

When O 0 5.056313625573239e-07
resting O 0 1.6794044768175809e-06
cells O 0 2.2172171654233352e-08
are O 0 9.704602399462914e-11
induced O 0 1.0840497566277918e-07
to O 0 5.151903556543935e-11
proliferate O 0 1.7511954553128817e-08
, O 0 2.734906918988589e-12
the O 0 2.1249768437925365e-12
steady O 0 5.9986335898543075e-09
- O 0 2.3893310441280846e-08
state O 0 1.2310991115427328e-10
levels O 0 2.3039607721653255e-10
of O 0 4.899211461864561e-13
BRCA1 O 0 4.978213841155821e-09
increase O 0 5.790839335828579e-11
in O 0 2.6969895067230354e-11
late O 0 7.648651156877406e-10
G1 O 0 6.034289867784537e-08
and O 0 2.282828509558854e-10
reach O 0 3.1854401061348625e-11
a O 0 1.0836802288860525e-10
maximum O 0 4.97990448877772e-09
during O 0 7.96196353292089e-09
S O 0 7.2997345341718756e-06
phase O 0 2.2871279981018233e-08
. O 0 5.6765223632737616e-09

Moreover O 0 1.3713756743527483e-06
, O 0 2.3436599883019937e-10
in O 0 2.2645794961473342e-10
S O 0 1.3175166486689704e-06
phase O 0 3.4262946257967997e-08
cells O 0 2.103234741923643e-08
, O 0 4.2752430068349057e-11
BRCA1 O 0 1.0116392701320365e-07
polypeptides O 0 1.1324782889232665e-08
are O 0 6.702580851447593e-11
hyperphosphorylated O 0 5.920128387515433e-08
and O 0 2.1030521768494737e-10
accumulate O 0 1.0201814948374022e-09
into O 0 1.4143556117951483e-11
discrete O 0 2.6965203403506166e-08
subnuclear O 0 7.979814654390793e-06
foci O 0 1.331556723016547e-05
termed O 0 2.611086529213935e-06
" O 0 8.58536068903959e-08
BRCA1 O 0 3.0228173272917047e-05
nuclear O 0 3.450953227002174e-05
dots O 0 0.0006050002411939204
. O 0 1.1110428488336765e-07

" O 0 2.7019727895094547e-06
BRCA1 O 0 0.0007032147841528058
associates O 0 4.4281500777287874e-06
in O 0 1.4514035528989666e-09
vivo O 0 6.126161338215752e-07
with O 0 4.138583364898807e-10
a O 0 8.954133789984553e-08
structurally O 0 0.00023548716853838414
related O 0 1.376372580352836e-07
protein O 0 6.353914727696974e-08
termed O 0 4.089228241355158e-06
BARD1 O 0 0.0019507338292896748
. O 0 4.786792118238736e-08

Here O 0 1.0540371420120209e-07
we O 0 6.244921801901171e-10
show O 0 6.673512298327466e-10
that O 0 1.6038063238577038e-11
the O 0 2.608785583391171e-12
steady O 0 1.823352246965726e-09
- O 0 1.2307904029285055e-08
state O 0 1.565699098149409e-10
levels O 0 4.88507290175022e-10
of O 0 4.817573748781834e-13
BARD1 O 0 1.0586207821461358e-07
, O 0 3.0087766045988618e-12
unlike O 0 2.8160673445909445e-11
those O 0 6.895964268366361e-12
of O 0 4.413071904435517e-12
BRCA1 O 0 8.615130013822636e-07
, O 0 3.4434821660767057e-10
remain O 0 6.59168830630108e-10
relatively O 0 2.962940726103369e-10
constant O 0 1.0513465298345182e-07
during O 0 3.026567441111183e-08
cell O 0 1.1476578947622329e-05
cycle O 0 2.923606245985866e-07
progression O 0 2.7816668080049567e-07
. O 0 4.556579558112617e-09

However O 0 9.173857051791856e-08
, O 0 4.282753596207556e-10
immunostaining O 0 7.064413694024552e-07
revealed O 0 2.9915071309005725e-07
that O 0 9.691401015032852e-10
BARD1 O 0 1.2853655789513141e-05
resides O 0 4.1017468532800194e-08
within O 0 1.6723684936881256e-10
BRCA1 O 0 1.0591008958726889e-06
nuclear O 0 7.310019327633199e-07
dots O 0 1.3866255130778882e-06
during O 0 5.940281599947639e-09
S O 0 7.933435881568585e-07
phase O 0 2.2366344887281286e-10
of O 0 4.204346072678167e-12
the O 0 3.757169228513213e-11
cell O 0 1.543310332863257e-07
cycle O 0 1.6082259080008043e-08
, O 0 8.695992710638922e-12
but O 0 9.394566374831825e-11
not O 0 1.6152818665959856e-11
during O 0 5.950685777467157e-11
the O 0 1.7956855447032183e-10
G1 O 0 2.5347904397676757e-07
phase O 0 9.735424910672918e-09
. O 0 4.901763439590923e-09

Nevertheless O 0 1.3101769582135603e-05
, O 0 2.0774779674326282e-09
BARD1 O 0 9.788303714231006e-07
polypeptides O 0 1.8999115170004188e-08
are O 0 6.485902093178453e-11
found O 0 5.686811785365897e-11
exclusively O 0 8.937844214740309e-11
in O 0 5.330743138576288e-11
the O 0 8.48580580803393e-12
nuclear O 0 3.3115157282992413e-09
fractions O 0 1.897029928976668e-11
of O 0 5.950838780077738e-13
both O 0 2.2500517074530713e-11
G1 O 0 6.638529157498851e-07
- O 0 9.963786169464584e-07
and O 0 1.404805427540623e-08
S O 0 4.336659003456589e-06
- O 0 1.0917542425659121e-07
phase O 0 7.964090720236072e-09
cells O 0 2.233090157233164e-08
. O 0 1.0881961998165934e-09

Therefore O 0 1.3487795058608754e-07
, O 0 1.4973268458451372e-10
progression O 0 2.6910418338133013e-09
to O 0 6.035467264853267e-11
S O 0 1.494505681876035e-06
phase O 0 5.933046054451552e-09
is O 0 1.0817762657877594e-10
accompanied O 0 2.3777266267011044e-10
by O 0 1.008737537944171e-11
the O 0 1.0002843171819098e-11
aggregation O 0 8.516164162752915e-11
of O 0 2.8975119178986652e-11
nuclear O 0 4.3387748860368447e-07
BARD1 O 0 5.783054461971915e-07
polypeptides O 0 1.2435444673997154e-08
into O 0 1.5806487230207722e-09
BRCA1 O 0 2.7592997867031954e-05
nuclear O 0 2.1899853891227394e-05
dots O 0 0.0003839930868707597
. O 0 6.504221516934194e-08

This O 0 1.5882440251857588e-08
cell O 0 3.9765129145052924e-07
cycle O 0 1.576914741008295e-07
- O 0 1.206439151246741e-06
dependent O 0 1.5232767935913216e-08
colocalization O 0 1.2909629276691703e-07
of O 0 3.9508851051861527e-11
BARD1 O 0 1.024232551571913e-05
and O 0 4.323547297957475e-09
BRCA1 O 0 2.0431707525858656e-06
indicates O 0 7.697742887557979e-09
a O 0 2.2953843686890352e-11
role O 0 8.365188403081092e-11
for O 0 2.373176308245739e-11
BARD1 O 0 2.5266188004025025e-06
in O 0 2.2334980531724113e-09
BRCA1 O 0 2.717387178563513e-05
- O 0 4.7764653572812676e-05
mediated O 0 0.00021867571922484785
tumor B-Disease 0 0.0006517854635603726
suppression O 0 1.0611517609504517e-05
. O 0 4.745457360399996e-08

Ethnic O 0 2.582131060080428e-07
differences O 0 1.2215266451676143e-06
in O 0 2.1475898837053364e-09
the O 0 1.1110566910943476e-09
HFE O 0 8.029967284528539e-05
codon O 0 1.8585360805900564e-07
282 O 0 2.518865827028094e-08
( O 0 2.1460586641097734e-09
Cys O 0 0.0065986113622784615
/ O 0 2.990663233504165e-05
Tyr O 0 4.730632099381182e-06
) O 0 1.2490564138545324e-09
polymorphism O 0 1.7396918110534898e-06
. O 0 1.6636910515899217e-08

Recent O 0 3.1609576467417355e-07
studies O 0 6.87572594415542e-08
have O 0 1.4362216971264274e-09
shown O 0 1.1460979720823161e-07
that O 0 6.745561222487595e-06
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
( O 0 0.0010807408252730966
HH B-Disease 1 0.9999845027923584
) O 0 3.170771978311393e-10
is O 0 5.376963874148544e-10
likely O 0 2.9892182062951633e-09
to O 0 1.422038597986841e-10
be O 0 9.15389275490952e-09
caused O 0 3.970932027641538e-09
by O 0 3.2887890327737423e-11
homozygosity O 0 2.2139617783523136e-07
for O 0 1.2195159812544709e-11
a O 0 1.4748280374732303e-09
Cys282Tyr O 0 2.522795284676249e-06
mutation O 0 6.694017429254018e-08
in O 0 5.943766312466181e-11
the O 0 2.4829832634409854e-10
HFE O 0 7.824904059816618e-06
gene O 0 1.5650796214572438e-08
located O 0 9.076300599986098e-09
4 O 0 7.009462787976872e-09
. O 0 1.7999600032680974e-08

5 O 0 1.2355751266568404e-07
Mb O 0 7.802394065947738e-06
telomeric O 0 6.535716238431633e-05
to O 0 3.391367187077776e-08
HLA O 0 0.00017609179485589266
- O 0 8.645659545436502e-05
A O 0 8.418659831477271e-07
. O 0 2.8852459976747014e-08

Population O 0 2.99301916584227e-08
studies O 0 1.7070623803405738e-09
of O 0 1.811280986308006e-11
this O 0 3.734798234567016e-11
polymorphism O 0 3.983933822837571e-07
are O 0 2.633388299089212e-11
facilitated O 0 1.7602956592366326e-10
by O 0 2.08206160645652e-11
the O 0 3.173856663596375e-11
fact O 0 1.7197776536193032e-10
that O 0 1.1671823230141598e-11
the O 0 9.934356288987534e-12
Cys282Tyr O 0 2.7217888032282644e-07
mutation O 0 1.5452771506829777e-08
creates O 0 8.358622127779824e-10
a O 0 1.0218874635370412e-09
Rsal O 0 3.509541670609906e-07
restriction O 0 7.299998827647869e-09
site O 0 3.606801612932031e-08
. O 0 1.0830078167600732e-08

We O 0 1.0294550065736985e-06
have O 0 1.0397711580623081e-09
studied O 0 8.835589482281136e-10
the O 0 2.2664540383354748e-11
codon O 0 5.63198199188264e-09
282 O 0 1.7827254117364078e-09
( O 0 5.529940949600132e-10
Cys O 0 0.00040285236900672317
/ O 0 3.2358666430809535e-06
Tyr O 0 7.872200171732402e-07
) O 0 2.4960873645785142e-11
polymorphism O 0 8.99290171219036e-08
in O 0 5.485637638580343e-11
different O 0 3.5723989738611905e-11
ethnic O 0 2.2214353967431322e-10
groups O 0 2.579355395937455e-09
. O 0 1.9629522896025264e-08

In O 0 1.6632561994356365e-08
agreement O 0 5.12777986738655e-10
with O 0 1.6338486119593654e-11
previous O 0 6.959555709507015e-10
observations O 0 2.0258347888102435e-08
the O 0 2.5788227109302397e-10
Tyr O 0 2.8043982069902995e-07
allele O 0 9.145031043544805e-08
appeared O 0 3.137888393567323e-09
to O 0 3.547547325344347e-11
be O 0 6.836879951066521e-10
rare O 0 1.5691888899382889e-09
or O 0 3.851461372050835e-09
absent O 0 4.015076271457474e-08
in O 0 8.538482698661198e-10
Asiatic O 0 9.631166975054839e-09
( O 0 1.7474490604518778e-11
Indian O 0 2.002302663950406e-11
, O 0 9.935115230508273e-12
Chinese O 0 1.4753722549221138e-11
) O 0 1.3936663455227372e-11
populations O 0 1.4703285255990295e-09
. O 0 2.715605740277738e-09

The O 0 9.770322328961356e-09
highest O 0 1.013027457474891e-07
allele O 0 1.4231882516924088e-07
frequency O 0 5.276148158372962e-07
( O 0 5.288772024492072e-12
7 O 0 7.020745096397718e-12
. O 0 5.007077109701885e-13
5 O 0 4.702917309057364e-12
% O 0 2.040870944464146e-12
) O 0 1.3807905556786904e-12
was O 0 7.573068394606253e-09
found O 0 1.8442156690667844e-09
in O 0 3.807869131122743e-09
Swedes O 0 7.260757411131635e-05
. O 0 1.622515100052624e-07

Saamis O 0 2.135771865141578e-05
( O 0 8.202424850445311e-10
2 O 0 1.62580116036537e-10
% O 0 1.388068826546629e-11
) O 0 2.1276656651803005e-12
and O 0 2.8169699212154953e-11
Mordvinians O 0 4.6144190690711184e-08
( O 0 9.410715479454823e-13
1 O 0 1.500467285142637e-12
. O 0 3.4509875426053105e-12
8 O 0 1.2121276204979381e-11
% O 0 2.5743578276060664e-12
) O 0 1.0593353451382459e-12
had O 0 7.2801809025691e-10
significantly O 0 1.2766183665746667e-08
lower O 0 9.302870473959501e-09
frequencies O 0 1.9193503675296597e-08
of O 0 5.6005578646933785e-11
the O 0 1.8812029711767764e-09
Tyr O 0 2.6460152184881736e-06
allele O 0 5.734997898798611e-07
. O 0 1.115544190355422e-08

Comparisons O 0 3.2535618288420665e-07
with O 0 1.41323797109294e-09
allele O 0 1.0486689205890798e-07
frequencies O 0 2.256717124282659e-08
based O 0 2.24503318713154e-10
on O 0 2.3458168740830843e-09
prevalence O 0 2.884349214582471e-06
estimates O 0 1.2718063047145733e-08
of O 0 3.1744754047657864e-10
HH B-Disease 1 0.9999817609786987
showed O 0 3.4737565783871105e-06
some O 0 1.2187741267599694e-11
disagreements O 0 2.0453056137625936e-08
with O 0 3.097396644724526e-11
the O 0 4.140744691571996e-11
RFLP O 0 4.862859626086902e-08
data O 0 1.1351859008357224e-08
, O 0 8.560979182503647e-12
particularly O 0 2.976597579529283e-10
in O 0 4.481503779185658e-10
Finns O 0 3.9031524465826806e-06
. O 0 1.8821513236844112e-08

The O 0 2.892690176281576e-08
newly O 0 2.0650786325404624e-07
described O 0 1.7183178613322525e-07
HFE O 0 1.3468477845890447e-05
marker O 0 4.56456263009386e-07
provides O 0 8.952243807369697e-11
a O 0 6.665647200865266e-11
new O 0 6.157508964516056e-12
approach O 0 6.67572386259252e-11
to O 0 2.620985026235978e-12
the O 0 1.0270249277757881e-12
screening O 0 1.0347810108779498e-10
of O 0 4.973255141038635e-11
HH B-Disease 1 0.9991727471351624
as O 0 1.142509975515793e-09
well O 0 4.7025366933795e-10
as O 0 2.506731627827108e-11
studies O 0 3.491839629943261e-12
of O 0 9.119294945916789e-14
the O 0 4.860197747730277e-12
relationship O 0 2.333322202119348e-09
between O 0 1.1401148081180423e-10
the O 0 1.086988943299616e-09
HFE O 0 0.00019328392227180302
Tyr O 0 2.4743399080762174e-06
allele O 0 1.7804502761009644e-07
and O 0 1.393502868651808e-09
different O 0 6.5034746477010685e-09
disorders O 0 0.00023961647821124643
including O 0 4.6227879124671745e-07
cancer B-Disease 0 0.005151058547198772

Autosomal B-Disease 1 0.9994426369667053
dominant I-Disease 1 0.9688655138015747
neurohypophyseal I-Disease 1 0.999627947807312
diabetes I-Disease 1 0.999880313873291
insipidus I-Disease 1 0.9989967942237854
associated O 0 1.1963283213844988e-05
with O 0 1.953516681751921e-09
a O 0 1.165924778945282e-08
missense O 0 0.00013989355647936463
mutation O 0 1.8298250097359414e-06
encoding O 0 4.418842181053151e-08
Gly23 O 0 1.8205320884590037e-05
- O 0 8.564815652789548e-05
- O 0 0.00016026879893615842
> O 0 1.2419916401995579e-06
Val O 0 1.7752123312675394e-05
in O 0 6.192061530185811e-09
neurophysin O 0 6.180164200486615e-05
II O 0 0.00012529951345641166
. O 0 2.886440420013514e-08

Autosomal B-Disease 1 0.9991744160652161
dominant I-Disease 1 0.889348030090332
neurohypophyseal I-Disease 1 0.9995809197425842
diabetes I-Disease 1 0.9998759031295776
insipidus I-Disease 1 0.9977304339408875
( O 0 1.892228880251423e-07
ADNDI B-Disease 0 0.0009794712532311678
) O 0 1.026760232392121e-09
is O 0 6.037154332005912e-09
an O 0 3.2598836696706712e-06
inherited B-Disease 1 1.0
disease I-Disease 1 1.0
caused O 0 0.05887024849653244
by O 0 1.3474476645569666e-07
progressive O 0 0.00010661972919479012
degeneration O 0 6.562558701261878e-05
of O 0 1.964512302832233e-10
the O 0 9.731113692623694e-10
magnocellular O 0 2.251881596748717e-06
neurons O 0 1.3827126110754762e-07
of O 0 2.130367236785613e-11
the O 0 1.0313859488686461e-10
hypothalamus O 0 4.13384597663935e-08
leading O 0 1.1209846384474531e-09
to O 0 2.1436682984266042e-10
decreased O 0 5.5830000178502814e-08
ability O 0 1.6776311451138781e-09
to O 0 2.3309488020317737e-11
produce O 0 2.1359546076293867e-10
the O 0 2.997872783350175e-10
hormone O 0 5.480761444687232e-08
arginine O 0 2.7422304427204836e-08
vasopressin O 0 7.435935600597077e-08
( O 0 1.1890055606755823e-10
AVP O 0 9.776139009431972e-09
) O 0 1.2485962264108252e-10
. O 0 2.7130326873958666e-09

Affected O 0 2.47326397584402e-06
individuals O 0 7.735597939984018e-09
are O 0 3.639331891402975e-10
not O 0 2.828665635057348e-10
symptomatic O 0 2.140651211846034e-08
at O 0 2.193535486583187e-08
birth O 0 1.5309276477637468e-06
, O 0 1.2253549563912003e-10
but O 0 6.536275964919014e-10
usually O 0 5.797932089990354e-08
develop O 0 2.911811236572248e-07
diabetes B-Disease 0 6.0827776906080544e-05
insipidus I-Disease 0 1.3008467249164823e-05
at O 0 4.4332612247899306e-08
1 O 0 7.4073098765836676e-09
- O 0 2.0112287529627793e-05
6 O 0 3.4747060340123426e-08
yr O 0 1.5143424207053613e-05
of O 0 3.9303979515459275e-10
age O 0 4.7352763488106575e-08
. O 0 3.422295558053179e-09

The O 0 2.138095478443347e-09
genetic O 0 5.7114306173389195e-08
locus O 0 1.8076603680583503e-07
of O 0 5.038411909907836e-10
the O 0 1.0137813433175324e-07
disease O 0 1.2132662050134968e-05
is O 0 6.121226303612559e-10
the O 0 7.278122549081445e-11
AVP O 0 1.4036488948931947e-07
- O 0 2.187901918659918e-05
neurophysin O 0 0.0001233257498824969
II O 0 0.00017213638057000935
( O 0 1.0873408423650588e-10
NPII O 0 9.702432635094738e-08
) O 0 1.4702926376397585e-12
gene O 0 1.667931071036577e-10
, O 0 3.6258105892694736e-12
and O 0 8.931130140998889e-11
mutations O 0 3.852580476859657e-08
that O 0 3.5038538737097724e-09
cause O 0 5.197193218009488e-07
ADNDI B-Disease 0 0.017315488308668137
have O 0 1.271430818405861e-07
been O 0 1.674805716334049e-08
found O 0 3.268911141773856e-09
in O 0 3.157138092624301e-11
both O 0 1.1366140667545821e-11
the O 0 1.359360801006515e-11
signal O 0 7.966263204650659e-09
peptide O 0 1.8457665951210345e-10
of O 0 5.328287724232217e-13
the O 0 8.215381500087382e-12
prepro O 0 1.0049484444607515e-07
- O 0 5.164519620848296e-07
AVP O 0 4.844861933861466e-08
- O 0 1.2145151231379714e-06
NPII O 0 1.4356633073475678e-06
precursor O 0 1.3293550704673862e-09
and O 0 1.4667088377162685e-10
within O 0 1.5244379369949712e-10
NPII O 0 5.58547753826133e-06
itself O 0 3.573671847334481e-08
. O 0 8.161510578474918e-09

An O 0 2.6047386469940648e-08
affected O 0 5.5142319155265795e-08
girl O 0 1.9308714399812743e-05
who O 0 2.8284135034084557e-09
presented O 0 9.861231831109762e-10
at O 0 1.8472599838670334e-10
9 O 0 4.043304580036988e-11
months O 0 1.908378143011813e-11
of O 0 3.298858148453876e-12
age O 0 3.681594140658717e-09
and O 0 1.8029028270305503e-10
her O 0 7.222014541952149e-09
similarly O 0 6.326536095002666e-08
affected O 0 2.1473032241203782e-09
younger O 0 2.744065419335584e-09
brother O 0 2.0945318368603694e-08
and O 0 2.5415127780092917e-09
father O 0 1.3778789309526474e-07
were O 0 1.026254969893614e-09
all O 0 7.310033654783776e-12
found O 0 2.836726686883395e-10
to O 0 5.1721564531259645e-11
have O 0 5.481613496449711e-10
a O 0 1.3833754974879042e-10
novel O 0 1.1783634068507354e-09
missense O 0 1.7364877749059815e-06
mutation O 0 1.1132511446021454e-07
( O 0 1.4797519112819124e-11
G1758 O 0 7.0703425336660075e-09
- O 0 3.7090851492393995e-06
- O 0 6.761016993550584e-05
> O 0 2.726158356836095e-07
T O 0 8.098508601506182e-07
) O 0 5.502198631608668e-13
encoding O 0 1.7652776809762294e-11
the O 0 4.781836385192584e-12
amino O 0 2.542145313699784e-11
acid O 0 1.8509480406714296e-11
substitution O 0 1.292249501849696e-10
Gly23 O 0 1.636295223761408e-07
- O 0 4.200789589958731e-06
- O 0 1.6343410607078113e-05
> O 0 1.7570194188465393e-07
Val O 0 4.058520062244497e-06
within O 0 1.0814554585181213e-08
NPII O 0 0.00010708527406677604
. O 0 4.494433980539725e-08

The O 0 8.816356711349727e-08
mutation O 0 1.5057725249789655e-05
was O 0 1.880134981036008e-08
confirmed O 0 2.3580815078361184e-09
by O 0 5.913506490040632e-11
restriction O 0 2.410137200925533e-09
endonuclease O 0 6.02503860136494e-07
analysis O 0 3.491347300155212e-08
. O 0 8.497869075085873e-09

A O 0 2.0484269498410868e-06
T1 O 0 0.0009398663532920182
- O 0 1.2443107380022411e-06
weighted O 0 3.003198045803401e-08
magnetic O 0 1.8516483351049828e-06
resonance O 0 6.089480848459061e-06
imaging O 0 5.662063358613523e-06
of O 0 2.1689702811578115e-10
the O 0 1.1038206793045902e-08
fathers O 0 4.402154445415363e-05
pituitary O 0 2.611937998153735e-05
gland O 0 1.1745872825486003e-06
demonstrates O 0 2.2333798810336702e-08
an O 0 2.689162503788367e-10
attenuated O 0 1.5227113181026652e-05
posterior O 0 0.000337352481437847
pituitary O 0 0.0022047688253223896
bright O 0 0.00012642572983168066
spot O 0 2.2986681869952008e-05
. O 0 6.825901976981186e-08

This O 0 5.874012742879131e-08
mutation O 0 3.233133611502126e-05
may O 0 6.833131749317545e-08
be O 0 6.475716490816907e-11
valuable O 0 6.311461769881177e-11
for O 0 2.04106545033389e-12
developing O 0 2.8773386451241834e-11
models O 0 2.185215786099093e-09
of O 0 1.2773843094393555e-10
dominantly B-Disease 1 0.8350249528884888
inherited I-Disease 1 0.9999505281448364
neurodegeneration I-Disease 1 1.0
, O 0 1.6840430161479958e-09
as O 0 5.163499402355276e-12
the O 0 2.0737495921852034e-12
early O 0 1.524368131722298e-10
age O 0 3.0687427599040973e-10
of O 0 2.4873792262014582e-12
onset O 0 1.512195346720091e-08
of O 0 3.8204817087716947e-10
symptoms O 0 2.4971157586151094e-07
suggests O 0 1.3021419498215892e-09
that O 0 9.952189072848228e-11
this O 0 1.9594192934846433e-10
mutation O 0 3.6573942452378105e-07
may O 0 2.018706801720782e-08
be O 0 2.244283925367796e-10
particularly O 0 2.1677379336004776e-10
deleterious O 0 1.7306192034993728e-07
to O 0 3.971445117212369e-10
the O 0 2.6748609993632044e-09
magnocellular O 0 2.2391724996850826e-05
neuron O 0 1.0438199751661159e-05
. O 0 1.127662518918271e-09
. O 0 4.303045919584747e-09

Frequent O 0 1.9438599338172935e-05
inactivation O 0 5.6526390835642815e-05
of O 0 8.700419940055326e-09
PTEN O 0 0.0016356559935957193
/ O 0 2.0705558199551888e-05
MMAC1 O 0 0.0002765958197414875
in O 0 1.9480076218769682e-07
primary O 1 0.9616732001304626
prostate B-Disease 1 1.0
cancer I-Disease 1 0.9999992847442627
. O 0 6.593783837161027e-06

Sporadic B-Disease 1 0.8966807723045349
prostate I-Disease 1 0.9999872446060181
carcinoma I-Disease 1 1.0
is O 0 6.991239160925034e-07
the O 0 3.2297658991709e-10
most O 0 6.722848666651515e-11
common O 0 9.762367803034522e-09
male B-Disease 0 4.9134382607007865e-06
cancer I-Disease 0 1.6007641079340829e-07
in O 0 4.713003945444605e-11
the O 0 5.516979581510206e-11
Western O 0 2.8689281506011355e-10
world O 0 1.9399204020942307e-08
, O 0 1.0623162072231906e-11
yet O 0 3.4851409952407764e-11
many O 0 6.608418239711922e-14
of O 0 5.3845569360699494e-14
the O 0 1.0368820602471573e-12
major O 0 1.3630709408407604e-11
genetic O 0 3.075293630860898e-10
events O 0 2.389583808604101e-10
involved O 0 4.3481065969963595e-10
in O 0 1.591059228811531e-10
the O 0 5.0333567175320226e-11
progression O 0 1.2123415604747834e-09
of O 0 9.930468990518304e-13
this O 0 1.1165030705528878e-10
often O 0 7.915631385913002e-07
fatal O 1 0.8530475497245789
cancer B-Disease 0 0.0034265443682670593
remain O 0 1.5057059954415308e-07
to O 0 1.1672147692820545e-09
be O 0 5.154024762532572e-08
elucidated O 0 1.0109588401974179e-05
. O 0 1.2106876390305388e-08

Numerous O 0 2.005031376484112e-07
cytogenetic O 0 0.003325195051729679
and O 0 4.205244152899468e-08
allelotype O 0 4.78846013720613e-05
studies O 0 4.0938211043339834e-08
have O 0 4.512995310790302e-09
reported O 0 1.871462274039004e-08
frequent O 0 5.270998215678446e-08
loss O 0 1.6353654075373925e-07
of O 0 4.7985771606251504e-11
heterozygosity O 0 1.1714790161931887e-05
on O 0 9.727743588427984e-08
chromosomal O 0 0.041186925023794174
arm O 0 4.5600234443554655e-05
10q O 0 6.105270244916028e-07
in O 0 2.052069625335662e-08
sporadic B-Disease 1 0.9296878576278687
prostate I-Disease 1 1.0
cancer I-Disease 1 0.9999986886978149
. O 0 2.6987536330125295e-06

Deletion O 0 0.0001389586686855182
mapping O 0 6.02997861278709e-05
studies O 0 2.9245293831081653e-07
have O 0 2.0533851952109217e-08
unambiguously O 0 1.683257141849026e-05
identified O 0 8.882928170805826e-08
a O 0 1.7249920380990602e-09
region O 0 6.606780678097834e-10
of O 0 4.1929522354156035e-11
chromosome O 0 2.3977736418601125e-06
10q23 O 0 6.704085819819738e-08
to O 0 2.4362772910180297e-10
be O 0 8.096835424353799e-10
the O 0 2.532823603629275e-11
minimal O 0 1.17461823379017e-07
area O 0 1.6409770209335761e-09
of O 0 4.202145298393134e-10
loss O 0 8.271629212686094e-07
. O 0 2.1258202309581975e-08

A O 0 1.0546987283532872e-07
new O 0 8.589582378704108e-09
tumor B-Disease 0 3.324717908981256e-06
suppressor O 0 9.44707790040411e-06
gene O 0 8.06723562618572e-07
, O 0 2.436431723040755e-09
PTEN O 0 0.0001551787427160889
/ O 0 1.049429556587711e-05
MMAC1 O 0 0.003386020427569747
, O 0 3.1290833812924745e-10
was O 0 4.373093442922027e-09
isolated O 0 2.0856576909977775e-08
recently O 0 7.004520341524767e-08
at O 0 8.897604875102161e-10
this O 0 3.4553363642553236e-11
region O 0 3.150815719443756e-11
of O 0 6.5024478856923196e-12
chromosome O 0 1.1847760816863229e-07
10q23 O 0 7.124817624770685e-09
and O 0 1.12259312956553e-10
found O 0 7.542140523231211e-11
to O 0 2.7141219827164775e-11
be O 0 2.2918125175408477e-09
inactivated O 0 8.0750774955618e-09
by O 0 1.989522956102885e-11
mutation O 0 4.1505163750343854e-08
in O 0 3.0874138801095796e-09
three O 0 7.043934601824731e-06
prostate B-Disease 1 1.0
cancer I-Disease 1 0.9999991655349731
cell O 0 0.02528582513332367
lines O 0 0.00010248653416056186
. O 0 4.777160711455508e-08

We O 0 1.4677310389288323e-07
screened O 0 2.3770273855916457e-06
80 O 0 7.763478038214089e-08
prostate B-Disease 1 0.9956423044204712
tumors I-Disease 1 0.9999980926513672
by O 0 1.5284010723704e-09
microsatellite O 0 3.8336951547535136e-05
analysis O 0 1.4326950292797846e-07
and O 0 5.327818186628974e-10
found O 0 4.071967651952946e-09
chromosome O 0 9.096422672882909e-07
10q23 O 0 3.613315158190744e-08
to O 0 1.000071206402886e-10
be O 0 6.386361439680854e-10
deleted O 0 2.899108331178013e-08
in O 0 1.2180991770804894e-09
23 O 0 3.347100097084166e-10
cases O 0 9.549487867133166e-10
. O 0 9.555832569674294e-09

We O 0 1.0216837864618356e-07
then O 0 2.1576399000799995e-10
proceeded O 0 2.259698678175326e-11
with O 0 7.950096744119284e-13
sequence O 0 1.717380578025729e-11
analysis O 0 9.743472521861474e-12
of O 0 5.836451656172914e-13
the O 0 1.0290098634291311e-11
entire O 0 2.4164708012364144e-09
PTEN O 0 9.213289558829274e-06
/ O 0 1.22258668966424e-07
MMAC1 O 0 4.723639449366601e-06
coding O 0 7.295205932678073e-07
region O 0 2.5353310562081788e-08
and O 0 2.1313406595169226e-09
tested O 0 5.5927202424754796e-08
for O 0 4.923269257550711e-12
homozygous O 0 4.427768374171137e-08
deletion O 0 3.2703784569321215e-08
with O 0 5.790087853618786e-11
new O 0 9.887103635808359e-11
intragenic O 0 2.3060739806624042e-07
markers O 0 3.373609729351301e-07
in O 0 4.1962183727761726e-10
these O 0 3.598811179617023e-11
23 O 0 1.676369286440771e-11
cases O 0 1.6368241831377084e-11
with O 0 9.221597097042178e-11
10q23 O 0 2.9227336995063524e-07
loss O 0 8.366477288745955e-08
of O 0 3.700819650731546e-10
heterozygosity O 0 5.7418794312980026e-05
. O 0 8.896917336187471e-08

The O 0 7.301039217644245e-10
identification O 0 1.3188639069738883e-09
of O 0 2.8192528606779677e-12
the O 0 2.6405039179472345e-12
second O 0 4.901347036567749e-11
mutational O 0 2.681779847080179e-07
event O 0 5.438639050225902e-08
in O 0 3.749875687741877e-10
10 O 0 2.4705765211407993e-11
( O 0 1.1015180954865311e-11
43 O 0 1.2276663019505918e-10
% O 0 2.4057544845135226e-10
) O 0 5.269417346909222e-09
tumors B-Disease 1 0.9999969005584717
establishes O 0 7.202416600193828e-05
PTEN O 0 0.009057206101715565
/ O 0 2.06840695682331e-06
MMAC1 O 0 7.156715582823381e-06
as O 0 6.523070972264122e-11
a O 0 9.179252496993584e-11
main O 0 2.955456435138615e-10
inactivation O 0 2.210174443462165e-08
target O 0 4.2174011505302644e-10
of O 0 1.904177553482822e-12
10q O 0 2.0818024637492272e-08
loss O 0 2.601293225268364e-08
in O 0 3.863955377880757e-09
sporadic B-Disease 1 0.9323321580886841
prostate I-Disease 1 1.0
cancer I-Disease 1 0.9999995231628418
. O 0 1.5594203262025985e-07
. O 0 2.1529475091597305e-08

Risk O 0 1.0859679605346173e-05
reversals O 0 3.2924569381975743e-07
in O 0 1.0832468255728145e-09
predictive O 0 2.1016313667132636e-07
testing O 0 4.509327879986813e-07
for O 0 9.761521369000548e-07
Huntington B-Disease 1 0.9999954700469971
disease I-Disease 1 0.9999963045120239
. O 0 1.392907734043547e-06

The O 0 1.9076666912809515e-09
first O 0 2.7475835495671674e-10
predictive O 0 5.320583440493465e-08
testing O 0 1.9130791883981146e-07
for O 0 2.0358174879220314e-07
Huntington B-Disease 1 0.9999994039535522
disease I-Disease 1 0.9999997615814209
( O 0 4.420207488919914e-08
HD B-Disease 0 0.0006747442530468106
) O 0 1.2611306443588433e-10
was O 0 9.94111992724811e-09
based O 0 4.058696434494635e-11
on O 0 1.8138575363924048e-10
analysis O 0 1.0086571855527637e-10
of O 0 1.5934081311341775e-12
linked O 0 3.082437416424e-08
polymorphic O 0 3.8322795603562554e-08
DNA O 0 2.0872255035442322e-08
markers O 0 4.103507222907865e-08
to O 0 3.7004083824898615e-11
estimate O 0 6.897905580061092e-10
the O 0 3.7963616625336094e-12
likelihood O 0 1.0483820478413008e-09
of O 0 8.457738849554364e-12
inheriting O 0 2.2876953664763278e-08
the O 0 2.2678084410365784e-10
mutation O 0 1.0740657785390795e-07
for O 0 2.248697339446437e-10
HD B-Disease 0 1.0443775863677729e-05
. O 0 2.2836323054775676e-08

Limits O 0 1.1727544801942713e-07
to O 0 1.5393039620725801e-10
accuracy O 0 3.7976852773624614e-09
included O 0 7.707633142839398e-12
recombination O 0 8.224639302945036e-10
between O 0 5.395206156832977e-11
the O 0 2.0346802367954275e-11
DNA O 0 2.912765495466374e-08
markers O 0 1.4728784947237727e-07
and O 0 7.86768081240119e-11
the O 0 7.98348886998923e-11
mutation O 0 2.775228153950593e-07
, O 0 9.875682216442527e-11
pedigree O 0 9.827805342865759e-07
structure O 0 3.6138428072263196e-07
, O 0 7.893575550144138e-12
and O 0 1.1093868879097357e-11
whether O 0 1.945346661536007e-10
DNA O 0 6.625703008467099e-08
samples O 0 8.950511443117648e-09
were O 0 3.4607067211922526e-10
available O 0 1.5400969388679187e-10
from O 0 2.8664653983767607e-11
family O 0 5.705740879768939e-10
members O 0 1.16859980026085e-10
. O 0 2.2618482642400295e-09

With O 0 9.644230969385603e-10
direct O 0 1.2405186877728624e-09
tests O 0 2.0704049585873463e-09
for O 0 2.8758284816021717e-12
the O 0 5.256732896197214e-11
HD B-Disease 0 2.9812608772772364e-05
mutation O 0 6.783783419450629e-07
, O 0 5.4390353332323116e-11
we O 0 2.3307678009842903e-10
have O 0 1.584933920217857e-11
assessed O 0 2.493633077804702e-10
the O 0 7.362576694147638e-12
accuracy O 0 1.1078978623402236e-08
of O 0 1.8864100819609986e-12
results O 0 2.714366509337651e-10
obtained O 0 7.516520739159205e-11
by O 0 3.842086371275144e-12
linkage O 0 1.2721356190681377e-09
approaches O 0 1.4521892022223426e-10
when O 0 3.5524898994721e-11
requested O 0 1.0907343604704689e-11
to O 0 2.44865846349418e-11
do O 0 6.341002722898281e-10
so O 0 5.634122075132142e-12
by O 0 2.052860268927925e-12
the O 0 2.722874356542171e-11
test O 0 3.6131736491640254e-10
individuals O 0 8.700095505131955e-11
. O 0 6.423866993898741e-10

For O 0 1.429302454170056e-09
six O 0 1.168345697966089e-10
such O 0 2.267236572095488e-11
individuals O 0 1.5127073205167818e-10
, O 0 8.654366806526426e-11
there O 0 9.512923782040161e-11
was O 0 5.793173163404219e-10
significant O 0 5.1155368135935575e-11
disparity O 0 3.324096109480479e-09
between O 0 1.5665385655339037e-10
the O 0 4.436640221872068e-10
tests O 0 2.553335498589604e-08
. O 0 3.032760931276357e-09

Three O 0 5.067896768906621e-09
went O 0 2.118476727375196e-09
from O 0 8.52018802732779e-12
a O 0 8.303610021798136e-10
decreased O 0 7.751419417445504e-08
risk O 0 5.701707994631988e-09
to O 0 1.3753398593607802e-11
an O 0 1.1201264742133343e-11
increased O 0 2.7011479275529382e-08
risk O 0 5.631468411593232e-07
, O 0 1.669597966824643e-11
while O 0 2.408057954428333e-11
in O 0 1.7355071373070796e-12
another O 0 7.302202245651479e-12
three O 0 2.4384888205886135e-11
the O 0 4.249741114570327e-10
risk O 0 3.6464129493651853e-07
was O 0 2.691711245006445e-07
decreased O 0 4.0485517160959716e-07
. O 0 2.0589649984970038e-09

Knowledge O 0 1.982673225597864e-08
of O 0 2.837959034440729e-11
the O 0 6.146045478105933e-12
potential O 0 4.087021832077653e-10
reasons O 0 6.24476373389804e-11
for O 0 2.081241402092024e-13
these O 0 3.5008007235291794e-13
changes O 0 1.7935418775150147e-11
in O 0 2.3766733373009608e-11
results O 0 3.946797333398422e-10
and O 0 8.388068017950445e-11
impact O 0 3.7442010603072617e-10
of O 0 1.1317677480957022e-12
these O 0 3.4988085345633024e-11
risk O 0 4.844163958850345e-10
reversals O 0 8.592854761069191e-10
on O 0 3.3755975792360005e-10
both O 0 3.4778185886708e-10
patients O 0 4.450226021024406e-10
and O 0 9.459819039214779e-11
the O 0 6.697353782669779e-11
counseling O 0 3.081136901172954e-09
team O 0 2.9727109662758266e-10
can O 0 8.386244476632498e-11
assist O 0 1.6694260557281737e-11
in O 0 9.614320624351524e-12
the O 0 1.9610810371439857e-12
development O 0 4.822704193462035e-13
of O 0 3.3932218471664777e-13
strategies O 0 4.5921544344906806e-11
for O 0 1.1176268244206256e-12
the O 0 1.8616832034301645e-11
prevention O 0 2.7840372229803734e-09
and O 0 1.8497843534692748e-10
, O 0 8.46385461716892e-12
where O 0 1.6122785051475574e-10
necessary O 0 1.079791589475576e-09
, O 0 6.8375383480145935e-12
management O 0 2.6373933419143736e-12
of O 0 1.1515606719060545e-13
a O 0 1.9465269673890617e-10
risk O 0 3.423379357769818e-09
reversal O 0 8.950677421459829e-10
in O 0 1.7530307067081807e-11
any O 0 6.682896597220989e-11
predictive O 0 1.2272178828709457e-08
testing O 0 3.506073653625208e-09
program O 0 4.283668697535603e-10
. O 0 3.681218524453911e-11
. O 0 5.058594654272497e-10

A O 0 1.2015621564387402e-07
novel O 0 2.81308167870975e-08
common O 0 2.0444591797286193e-08
missense O 0 2.5604331312933937e-05
mutation O 0 2.911499223046121e-06
G301C O 0 1.9389037220207683e-07
in O 0 1.8488215125511687e-10
the O 0 1.1490217111109757e-10
N O 0 1.8989206864716834e-06
- O 0 1.1820691270258976e-06
acetylgalactosamine O 0 9.504106128588319e-05
- O 0 3.242576349293813e-05
6 O 0 1.6934039948068857e-08
- O 0 1.335248180112103e-05
sulfate O 0 7.276477117557079e-05
sulfatase O 0 2.52411155088339e-06
gene O 0 1.9896701175525777e-08
in O 0 2.190774672783391e-09
mucopolysaccharidosis B-Disease 0 6.525104254251346e-06
IVA I-Disease 0 0.0005764790112152696
. O 0 3.5198118553125823e-07

Mucopolysaccharidosis B-Disease 0 0.003768806578591466
IVA I-Disease 1 0.7059335708618164
( O 0 5.431006684375461e-06
MPS B-Disease 1 0.9999417066574097
IVA I-Disease 1 0.9999963045120239
) O 0 5.230018729207586e-08
is O 0 6.5088356926423785e-09
an O 0 1.9404089002250657e-08
autosomal B-Disease 1 0.9999613761901855
recessive I-Disease 1 0.9999853372573853
lysosomal I-Disease 1 0.9999881982803345
storage I-Disease 1 0.9999905824661255
disorder I-Disease 1 0.9999618530273438
caused O 0 2.9953900593682192e-05
by O 0 7.156742753977596e-09
a O 0 3.414665115997195e-05
genetic B-Disease 1 0.9999997615814209
defect I-Disease 1 0.9999996423721313
in O 0 1.5482014248391351e-07
N O 0 0.00023938399681355804
- O 0 1.218688612425467e-05
acetylgalactosamine O 0 0.0021681871730834246
- O 0 0.0006567153614014387
6 O 0 3.0753821533835435e-07
- O 0 0.002697370247915387
sulfate O 0 0.010919648222625256
sulfatase O 0 3.908556391252205e-05
( O 0 6.079246550605433e-10
GALNS O 0 2.230201516795205e-06
) O 0 3.6460295893547823e-10
. O 0 2.391258080436387e-09

In O 0 8.42762215569337e-09
previous O 0 8.783555216496097e-09
studies O 0 7.255675615880364e-09
, O 0 1.0482815310242088e-10
we O 0 1.3176646440626882e-09
have O 0 5.1013988172643465e-11
found O 0 3.801377268519701e-11
two O 0 1.3861796259451165e-11
common O 0 1.972943364236812e-09
mutations O 0 8.2341280460696e-08
in O 0 2.3383464609061377e-10
Caucasians O 0 2.1584982690114884e-08
and O 0 1.3882157645639381e-09
Japanese O 0 7.995890172196596e-08
, O 0 9.109851067945485e-11
respectively O 0 5.472245767634831e-09
. O 0 1.6711290129478584e-09

To O 0 3.060525832765393e-09
characterize O 0 3.682411033878452e-07
the O 0 8.005297535973455e-10
mutational O 0 6.970288723096019e-06
spectrum O 0 2.1729316301843937e-07
in O 0 3.0641673226528e-11
various O 0 2.1272031445335182e-12
ethnic O 0 2.7576836647558167e-11
groups O 0 2.1423848806101375e-10
, O 0 3.597548300926512e-11
mutations O 0 1.965438922724161e-09
in O 0 9.159205512088153e-12
the O 0 8.914752616662192e-12
GALNS O 0 1.5887870574715635e-07
gene O 0 7.26046167631722e-10
in O 0 2.0378156107003775e-10
Colombian O 0 6.15455689967348e-07
MPS B-Disease 1 0.9996809959411621
IVA I-Disease 1 0.9999959468841553
patients O 0 1.1731560334737878e-05
were O 0 4.106608031406722e-08
investigated O 0 1.035712739394512e-05
, O 0 7.315616168401817e-11
and O 0 3.756803548804477e-11
genetic O 0 6.348848113901795e-09
backgrounds O 0 1.3533841602964003e-08
were O 0 3.072807563953006e-10
extensively O 0 2.0671142575423573e-09
analyzed O 0 1.2747522148970347e-08
to O 0 1.782053844767706e-11
identify O 0 8.574583265641422e-10
racial O 0 3.2399047888986843e-09
origin O 0 1.0465324606911963e-08
, O 0 6.0130698163740615e-12
based O 0 5.4469432436698995e-12
on O 0 4.0458836281231925e-10
mitochondrial O 0 3.5915141438636056e-07
DNA O 0 1.2281614090170478e-06
( O 0 4.0485390040423397e-10
mtDNA O 0 1.4635665124274055e-08
) O 0 2.386149611233179e-10
lineages O 0 8.773107573745165e-09
. O 0 4.237108885973839e-09

Three O 0 7.963133263899635e-09
novel O 0 2.758729600316201e-08
missense O 0 0.00020646814664360136
mutations O 0 0.0009954727720469236
never O 0 2.3246149794431403e-05
identified O 0 1.764775987567191e-07
previously O 0 3.1751310469729788e-09
in O 0 3.028757800116466e-11
other O 0 1.4686061394764138e-11
populations O 0 2.9213420571494453e-10
and O 0 4.1560893615510963e-10
found O 0 3.73706088296899e-09
in O 0 1.7665718887727166e-10
16 O 0 1.0232186625769302e-11
out O 0 1.2982670494210424e-11
of O 0 7.060399574015941e-12
19 O 0 7.037510574292583e-10
Colombian O 0 2.572589323790453e-07
MPS B-Disease 1 0.9967195391654968
IVA I-Disease 1 0.9999213218688965
unrelated O 0 6.3464449340244755e-06
alleles O 0 6.857167988982837e-08
account O 0 2.0625584795652685e-08
for O 0 1.1454594217585878e-10
84 O 0 1.4283022542471713e-09
. O 0 7.760484699304016e-09

2 O 0 1.9298084907859447e-08
% O 0 3.9571695920059824e-10
of O 0 9.498831408938369e-12
the O 0 9.204937506668287e-11
alleles O 0 3.09985237478827e-09
in O 0 6.108047401198746e-10
this O 0 5.796676472158424e-10
study O 0 3.697138595271099e-09
. O 0 8.302473375465524e-09

The O 0 1.0345531542554909e-08
G301C O 0 1.4253072322389926e-07
and O 0 5.127916979930092e-10
S162F O 0 3.660911218617002e-08
mutations O 0 5.040992334670591e-08
account O 0 1.4840751960676357e-09
for O 0 9.170012665871141e-11
68 O 0 1.0041927289705654e-09
. O 0 4.1956602636616935e-09

4 O 0 5.549535941895556e-08
% O 0 3.4346023802811487e-09
and O 0 1.0818510531862557e-09
10 O 0 1.0716767473439859e-09
. O 0 6.180286060697426e-09

5 O 0 4.483139193212082e-09
% O 0 9.97689639237187e-11
of O 0 2.546153565763376e-11
mutations O 0 2.0872928416793e-06
, O 0 4.4266662557745917e-10
respectively O 0 1.2915461589102506e-08
, O 0 2.31202852002399e-11
whereas O 0 1.467794635834352e-10
the O 0 1.1769201932465556e-11
remaining O 0 1.895471973822893e-10
F69V O 0 2.820323743435438e-06
is O 0 1.335331289986641e-10
limited O 0 1.12136844948596e-11
to O 0 8.649675593830342e-12
a O 0 6.403584329461864e-10
single O 0 3.4732354947664135e-07
allele O 0 3.5803518017019087e-07
. O 0 9.083851892910388e-09

The O 0 7.537257928902363e-09
skewed O 0 2.592877592633158e-07
prevalence O 0 3.7357625615186407e-07
of O 0 1.0067269934355139e-11
G301C O 0 4.539221443167207e-09
in O 0 1.2504710808491915e-11
only O 0 2.3141993529818272e-11
Colombian O 0 1.4782983726036036e-08
patients O 0 4.519591090268449e-10
and O 0 3.5024472905265114e-11
haplotype O 0 1.1581938963445282e-08
analysis O 0 4.7720806473083854e-11
by O 0 4.332968445847074e-12
restriction O 0 2.4642102247618425e-10
fragment O 0 1.8333722096031124e-08
length O 0 2.1122279036944747e-08
polymorphisms O 0 8.042861168178206e-07
in O 0 1.349073491807573e-10
the O 0 7.426173564972771e-11
GALNS O 0 4.625328529073158e-06
gene O 0 1.1672197430812048e-08
suggest O 0 7.2148829133311665e-09
that O 0 2.087390815752599e-10
G301C O 0 2.293460976687811e-09
originated O 0 4.692340405121342e-10
from O 0 7.9518449117022e-12
a O 0 4.233423056554386e-10
common O 0 3.142740068184935e-09
ancestor O 0 1.9194241929199052e-07
. O 0 3.125656533597976e-08

Investigation O 0 5.684141513029317e-08
of O 0 1.5190451674307326e-10
the O 0 5.838305533467647e-11
genetic O 0 2.2786981190847655e-08
background O 0 4.211617721239236e-08
by O 0 1.8788273020708957e-11
means O 0 4.988055801735669e-11
of O 0 1.6585708501049012e-12
mtDNA O 0 8.683670449372016e-10
lineages O 0 2.4027599354603524e-10
indicate O 0 4.942328768464677e-09
that O 0 2.4883532734332192e-11
all O 0 8.57531060050043e-12
our O 0 3.220571143103257e-09
patients O 0 1.338641419934561e-10
are O 0 3.802856640700014e-11
probably O 0 5.226921673262552e-10
of O 0 5.0806646216539075e-12
native O 0 9.392726596502143e-10
American O 0 5.743372710753647e-08
descent O 0 7.901800017862115e-06

Low O 0 9.399932423548307e-06
frequency O 0 2.063567990262527e-06
of O 0 6.012043640701847e-10
BRCA1 O 0 1.2204123777337372e-05
germline O 0 1.317494115937734e-05
mutations O 0 5.655905169987818e-06
in O 0 8.006336149612991e-10
45 O 0 5.249704670973188e-09
German O 1 0.999394416809082
breast B-Disease 1 0.9999995231628418
/ I-Disease 1 0.9999997615814209
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
families O 0 2.3244576368597336e-05
. O 0 1.0624094670674822e-07

In O 0 6.781582850834411e-09
this O 0 4.348519461183642e-11
study O 0 7.280552549726593e-11
we O 0 1.983567615715387e-10
investigated O 0 1.6138800518206153e-08
45 O 0 1.4105935308705853e-09
German O 1 0.9985049962997437
breast B-Disease 1 0.9999985694885254
/ I-Disease 1 0.9999991655349731
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999992847442627
families O 0 3.8642522071086205e-08
for O 0 4.728727964753432e-10
germline O 0 9.117544323089533e-06
mutations O 0 1.3339258657651953e-06
in O 0 4.0215022978351556e-10
the O 0 1.241148184227825e-09
BRCA1 O 0 5.294869697536342e-05
gene O 0 1.514109612799075e-06
. O 0 6.103697103299055e-08

We O 0 1.4519712010496733e-07
identified O 0 8.765129067000998e-09
four O 0 6.090443427364534e-11
germline O 0 2.647726944360329e-07
mutations O 0 5.125243092152232e-07
in O 0 3.234722489864339e-10
three O 0 1.645193137278511e-08
breast B-Disease 1 0.9836349487304688
cancer I-Disease 0 0.0011589238420128822
families O 0 1.1369274410810704e-09
and O 0 3.8047523465145616e-10
in O 0 1.0798102412223898e-09
one O 0 1.5449932107003406e-05
breast B-Disease 1 0.9999990463256836
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 3.1040897283673985e-06
. O 0 3.471024162537972e-11
among O 0 4.550952930476582e-12
these O 0 7.952420839896224e-12
were O 0 2.8386859529661024e-10
one O 0 8.478081570117979e-10
frameshift O 0 0.0002629047376103699
mutation O 0 2.254868604723015e-06
, O 0 3.9499504361772964e-11
one O 0 4.0418418612020446e-10
nonsense O 0 4.11290875490522e-06
mutation O 0 1.482191350987705e-06
, O 0 8.746227700417997e-12
one O 0 1.0746232029235081e-11
novel O 0 1.7391373063890825e-10
splice O 0 6.832219412444829e-08
site O 0 2.669715115644067e-07
mutation O 0 8.864681149134412e-06
, O 0 7.409562546856208e-11
and O 0 6.762046478314687e-11
one O 0 1.1542348188342544e-09
missense O 0 0.00045615938142873347
mutation O 0 0.0004337789141573012
. O 0 6.128708918140546e-08

The O 0 7.600043971933701e-08
missense O 0 0.0019047344103455544
mutation O 0 0.029156699776649475
was O 0 3.3798957588260237e-07
also O 0 3.436192996808529e-10
found O 0 1.6289960491633337e-09
in O 0 6.054760026685813e-10
2 O 0 5.166521432897753e-09
. O 0 3.365206069361193e-08

8 O 0 1.5744841874720805e-08
% O 0 1.1654700815544317e-10
of O 0 1.8601418148855853e-12
the O 0 1.1338382489844978e-11
general O 0 6.719567263724358e-11
population O 0 1.1541411056026352e-11
, O 0 3.737532852654546e-12
suggesting O 0 7.210562813497745e-09
that O 0 8.151239683229505e-10
it O 0 3.2745070543960253e-10
is O 0 1.2280602090797288e-09
not O 0 7.51600026660526e-08
disease O 0 1.0051514891529223e-06
associated O 0 1.920775645203321e-07
. O 0 2.870956627987198e-08

The O 0 1.5911547635028e-08
average O 0 2.2922776565792446e-07
age O 0 2.2089596818375412e-09
of O 0 1.6570736449672552e-10
disease O 0 1.00443855899357e-06
onset O 0 5.882443474547472e-07
in O 0 6.708761879359315e-10
those O 0 2.3365098744676516e-10
families O 0 6.66079580380341e-10
harbouring O 0 4.493822416407056e-06
causative O 0 1.7705830032355152e-05
mutations O 0 3.183484977853368e-06
was O 0 6.715575651128347e-09
between O 0 2.5984142615342876e-10
32 O 0 9.121279287427342e-10
. O 0 3.4471638876709676e-09

3 O 0 1.0281171824999547e-07
and O 0 6.884541381424469e-09
37 O 0 1.1437271574266106e-08
. O 0 7.346386166062757e-09

4 O 0 5.440683281676684e-08
years O 0 3.908295020949026e-09
, O 0 1.5000131345366263e-11
whereas O 0 5.398790858812674e-10
the O 0 3.0774275489031666e-11
family O 0 1.2405021454497955e-09
harbouring O 0 1.9381532467832585e-07
the O 0 4.362126285184509e-11
missense O 0 2.5209026262018597e-06
mutation O 0 1.0195633421972161e-06
had O 0 2.8253077655193692e-09
an O 0 2.513765064160456e-11
average O 0 5.538084479894678e-08
age O 0 3.8389330603294525e-10
of O 0 9.873116213476862e-12
onset O 0 1.2151897266221567e-08
of O 0 1.545888694831632e-10
51 O 0 6.629113702416589e-09
. O 0 1.3185426972484038e-08

2 O 0 2.821454359036579e-07
years O 0 8.234363235715136e-08
. O 0 3.4184612474064124e-08

These O 0 2.4923316743752366e-09
findings O 0 2.0016632795716305e-09
show O 0 1.0032800368264816e-08
that O 0 3.092800904269666e-09
BRCA1 O 0 2.96757866635744e-06
is O 0 1.7680795716401576e-09
implicated O 0 1.0817158369036406e-07
in O 0 5.509492168043195e-11
a O 0 6.529967538915216e-11
small O 0 1.1575168601396513e-10
fraction O 0 1.2987247721696349e-08
of O 0 3.3177323643940326e-07
breast B-Disease 1 0.999997615814209
/ I-Disease 1 0.9999991655349731
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
families O 0 1.2766530232966034e-07
suggesting O 0 8.982255650380466e-08
the O 0 4.935362535318788e-11
involvement O 0 1.402446048182071e-09
of O 0 1.0335063534150368e-11
another O 0 1.945470229358648e-09
susceptibility O 0 0.0008951463387347758
gene O 0 4.2477945498831104e-06
( O 0 8.387980088286895e-09
s O 0 5.881059041712433e-05
) O 0 3.22033955058032e-08

Paternal O 0 0.10911543667316437
transmission O 0 0.011457229033112526
of O 0 9.08175661606947e-06
congenital B-Disease 1 0.9999969005584717
myotonic I-Disease 1 0.9999996423721313
dystrophy I-Disease 1 0.9999994039535522
. O 0 0.0005568391061387956

We O 0 7.988357424437709e-07
report O 0 2.8731463874720475e-09
a O 0 1.5889181637085414e-10
rare O 0 3.245941737617386e-09
case O 0 1.9738777723432577e-08
of O 0 1.5701806077572655e-08
paternally O 1 0.9950138926506042
transmitted O 1 0.9999583959579468
congenital B-Disease 1 0.9999991655349731
myotonic I-Disease 1 0.9999998807907104
dystrophy I-Disease 1 0.9999998807907104
( O 0 0.011661926284432411
DM B-Disease 1 0.9999983310699463
) O 0 2.814171864429227e-07
. O 0 1.2153270745329792e-07

The O 0 9.363716912957898e-09
proband O 0 1.5816046925465344e-06
is O 0 3.0745897494632857e-10
a O 0 2.402668342060821e-10
23 O 0 9.205007589496716e-11
year O 0 2.356587425200729e-10
old O 0 1.2498536307248287e-05
, O 0 7.423266197292833e-07
mentally B-Disease 1 0.9999995231628418
retarded I-Disease 1 0.9999990463256836
male O 0 0.09684450924396515
who O 0 6.905147893121466e-05
suffers O 1 0.6300026178359985
severe O 0 0.20738573372364044
muscular B-Disease 1 0.9859035611152649
weakness I-Disease 1 0.9086927175521851
. O 0 1.1438414730946533e-06

He O 0 3.1681463497079676e-07
presented O 0 1.33245563915807e-07
with O 0 3.0840141107546515e-07
respiratory O 1 0.5755156874656677
and O 0 1.0219722668125542e-07
feeding O 0 2.1932023628323805e-06
difficulties O 0 2.3681034235778498e-06
at O 0 1.727390497308079e-07
birth O 0 3.6493427160166902e-06
. O 0 1.152161122064399e-08

His O 0 5.819103421345062e-07
two O 0 9.914555931800351e-08
sibs O 1 0.6213940382003784
suffer O 0 0.0005070932093076408
from O 0 3.7024328491952474e-08
childhood O 0 0.010699661448597908
onset O 1 0.8728355765342712
DM B-Disease 1 0.9999982118606567
. O 0 2.0866978047706652e-06

Their O 0 1.4927346470017255e-08
late O 0 2.058318138153936e-08
father O 0 1.1122493503989972e-07
had O 0 1.503856261741987e-09
the O 0 1.4778395521219956e-11
adult O 0 9.930880562336597e-10
type O 0 1.5656864604807197e-07
of O 0 7.865183171418266e-09
DM B-Disease 1 0.9999998807907104
, O 0 5.876931719051015e-10
with O 0 2.5329313646516027e-10
onset O 0 6.733252178037219e-08
around O 0 2.521604702820923e-09
30 O 0 1.660962617444639e-10
years O 0 9.714793414161704e-10
. O 0 3.3771900831425228e-09

Only O 0 1.9629664560483207e-09
six O 0 8.109504040509918e-11
other O 0 7.931728190913034e-12
cases O 0 5.0206141327668874e-11
of O 0 4.612036447193546e-11
paternal O 0 0.004443534184247255
transmission O 0 0.00931861437857151
of O 0 6.935655392226181e-07
congenital B-Disease 1 0.9999992847442627
DM I-Disease 1 1.0
have O 0 0.015798775479197502
been O 0 3.98295287595829e-06
reported O 0 1.2844104730902473e-06
recently O 0 6.892026362947945e-07
. O 0 1.661068793623599e-08

We O 0 2.319656111637869e-08
review O 0 4.277300458266353e-10
the O 0 3.455850536293603e-11
sex O 0 1.323541720665844e-08
related O 0 9.611531126552109e-09
effects O 0 5.622158028018021e-07
on O 0 2.402964867087576e-07
transmission O 0 0.000646275351755321
of O 0 7.140035336306028e-07
congenital B-Disease 1 0.9999966621398926
DM I-Disease 1 0.9999996423721313
. O 0 6.952542662475025e-06

Decreased O 0 3.319905590615235e-05
fertility O 0 1.946610836967011e-06
of O 0 3.535835235712881e-10
males O 0 1.938577831595012e-08
with O 0 1.057967824458217e-09
adult O 0 2.433489726172411e-06
onset O 0 0.0006265661213546991
DM B-Disease 1 0.9999997615814209
and O 0 1.07857204056927e-07
contraction O 0 1.3087414174606238e-07
of O 0 4.307605053904817e-12
the O 0 1.5160629696087113e-11
repeat O 0 4.06928934992834e-09
upon O 0 1.8151691261181213e-10
male O 0 5.810563763475329e-08
transmission O 0 4.022803423708865e-08
contribute O 0 1.9218276275934087e-11
to O 0 5.557628142416338e-12
the O 0 1.9661720168651087e-11
almost O 0 2.0328697059035505e-10
absent O 0 3.930767267235069e-09
occurrence O 0 4.307178258500244e-08
of O 0 4.585415033786511e-11
paternal O 0 0.00010083613597089425
transmission O 0 0.0003375723899807781
of O 0 1.9081048208136053e-07
congenital B-Disease 1 0.9999940395355225
DM I-Disease 1 0.9999994039535522
. O 0 1.4147068213787861e-05

Also O 0 1.2398096771448763e-08
the O 0 8.624540664969871e-11
fathers O 0 6.853069223211605e-10
of O 0 2.9236634814522322e-12
the O 0 1.3399263643076864e-10
reported O 0 7.849732241993479e-07
congenitally O 0 0.0006429547211155295
affected O 0 1.5160363631139262e-08
children O 0 4.502385131388564e-09
showed O 0 1.3538846133087645e-06
, O 0 1.3508392321393003e-11
on O 0 7.829914494550394e-10
average O 0 1.070619060072886e-08
, O 0 1.0428925084626783e-11
shorter O 0 3.15778558857005e-09
CTG O 0 2.075165994597228e-08
repeat O 0 1.9655223226777707e-08
lengths O 0 1.169847337223473e-06
and O 0 4.850913559728554e-10
hence O 0 5.6040998508422035e-09
less O 0 1.2713818442477987e-08
severe O 0 3.670837031677365e-05
clinical O 0 8.060713298618793e-06
symptoms O 0 6.441703135351418e-06
than O 0 1.3292333900238873e-09
the O 0 1.7806863761293812e-09
mothers O 0 3.670111681230992e-08
of O 0 4.59290765142395e-11
children O 0 3.8399914359388276e-08
with O 0 1.108813285100041e-05
congenital B-Disease 1 0.9999938011169434
DM I-Disease 1 0.9999996423721313
. O 0 1.3177756045479327e-05

We O 0 1.713194563990328e-07
conclude O 0 1.5263422525890746e-08
that O 0 5.915269385425859e-10
paternal O 0 3.865037797368132e-06
transmission O 0 1.0154084520763718e-05
of O 0 7.393565226720966e-08
congenital B-Disease 1 0.9999994039535522
DM I-Disease 1 1.0
is O 0 5.897368282603566e-07
rare O 0 7.523990319668883e-08
and O 0 9.599487871270185e-10
preferentially O 0 9.608692863594115e-08
occurs O 0 3.3207359084741483e-10
with O 0 2.0945125842053436e-11
onset O 0 1.3561800571437743e-08
of O 0 6.019754694719381e-10
DM B-Disease 1 0.9999994039535522
past O 0 4.4845438651464065e-07
30 O 0 3.2340932709651327e-10
years O 0 3.02658759165908e-10
in O 0 4.8561044074801885e-11
the O 0 1.2072944033381106e-10
father O 0 3.5590716152000823e-07
. O 0 4.354547278317966e-10
. O 0 2.3105499735720514e-09

The O 0 9.668311662380802e-08
RB1 O 0 0.00018596049631014466
gene O 0 9.377229162055301e-07
mutation O 0 3.0988958314992487e-06
in O 0 6.033548105577324e-10
a O 0 1.6914478706553382e-08
child O 0 2.1346151697798632e-05
with O 0 2.32006459555123e-06
ectopic B-Disease 1 0.9999433755874634
intracranial I-Disease 1 0.9999890327453613
retinoblastoma I-Disease 1 0.998840868473053
. O 0 1.3476726053340826e-05

The O 0 5.700438521216711e-08
RB1 O 0 9.118305024458095e-05
gene O 0 9.180943720821233e-07
mutation O 0 1.0454078619659413e-05
was O 0 7.21736048703292e-09
investigated O 0 1.5627044547272817e-07
in O 0 2.4026178269132004e-10
a O 0 1.1835673774385214e-08
child O 0 4.135574272368103e-05
with O 0 3.0905269454706286e-07
ectopic B-Disease 1 0.9993434548377991
intracranial I-Disease 1 0.9998102784156799
retinoblastoma I-Disease 0 5.682429036824033e-05
using O 0 1.1150186551844854e-08
DNA O 0 1.1403418511690688e-06
obtained O 0 7.986268535375984e-09
from O 0 1.1352707836309595e-11
both O 0 1.0354063960382742e-11
the O 0 5.501448602229786e-11
pineal B-Disease 0 4.7196593300213863e-07
and I-Disease 0 1.0286212415167029e-07
retinal I-Disease 0 0.00016353235696442425
tumours I-Disease 1 0.9999961853027344
of O 0 6.081217751585655e-10
the O 0 1.2473096333565081e-08
patient O 0 6.4295632000721525e-06
. O 0 2.2952301392820118e-08

A O 0 4.290783408578136e-07
nonsense O 0 1.7388727428624406e-05
mutation O 0 1.515893814030278e-06
in O 0 7.329782336640278e-10
exon O 0 3.392620783415623e-06
17 O 0 9.822416657812028e-09
( O 0 1.4431428274619407e-11
codon O 0 2.316700165039265e-10
556 O 0 1.2735139331976342e-10
) O 0 4.126163115607956e-13
of O 0 1.2993414937739756e-12
the O 0 3.8531347557047013e-10
RB1 O 0 2.313932782271877e-06
gene O 0 1.0709295672484132e-08
was O 0 9.722769256370611e-09
found O 0 1.9919921268041207e-10
to O 0 6.418793274676204e-11
be O 0 3.4466511866781957e-09
present O 0 3.5864375358407585e-10
homozygously O 0 7.589322876810911e-07
in O 0 1.336620675251865e-10
both O 0 8.422471747815408e-11
the O 0 2.2792348564060205e-10
retinal B-Disease 0 8.383119620702928e-07
and I-Disease 0 1.6732029095578582e-08
the I-Disease 0 2.6461510316266867e-08
pineal I-Disease 0 0.0011929514585062861
tumours I-Disease 1 0.9999814033508301
. O 0 2.3727143627638725e-07

The O 0 6.48975762018722e-09
same O 0 4.436845557620472e-09
mutation O 0 2.404051144822006e-07
was O 0 1.0786616044811126e-09
present O 0 5.763434868244488e-11
heterozygously O 0 6.83245389154763e-08
in O 0 1.236157357031864e-11
the O 0 2.51654144571567e-12
DNA O 0 2.126082865316903e-09
from O 0 2.589293579893792e-12
the O 0 1.7739917607811906e-12
constitutional O 0 1.8392720679827335e-10
cells O 0 5.7669646835734056e-11
of O 0 1.2418851754250615e-12
the O 0 1.3036423329726432e-10
patient O 0 3.592328567947334e-08
, O 0 1.2649797008490449e-11
proving O 0 5.738463926263648e-09
it O 0 4.670087927483024e-11
to O 0 1.4030520668895097e-11
be O 0 5.869011943104852e-10
of O 0 4.210149590067047e-11
germline O 0 7.40749555916409e-07
origin O 0 8.107768678655702e-08
. O 0 9.929711275447062e-09

The O 0 3.854173424855389e-09
initial O 0 1.662913717837e-08
mutation O 0 8.68412428189913e-07
was O 0 7.172293869928126e-09
shown O 0 4.874111336761189e-09
to O 0 8.12701711483399e-11
have O 0 4.733513137011869e-09
occurred O 0 8.557028507993891e-08
in O 0 7.480136648974067e-11
the O 0 2.876171523169546e-10
paternally O 0 1.1406225439714035e-06
derived O 0 9.207460749394158e-08
RB1 O 0 1.1229453775740694e-05
allele O 0 5.800143867418228e-07
. O 0 9.601745176723853e-09

The O 0 2.4083048444367705e-08
mutation O 0 9.085446436074562e-06
is O 0 1.6274369629698526e-09
in O 0 4.363649025451721e-11
an O 0 3.4808148117321247e-12
area O 0 1.8190925155092685e-10
of O 0 4.272827751339303e-12
the O 0 2.7193658783120078e-11
gene O 0 3.778968804546423e-10
that O 0 1.0657765468768954e-11
encodes O 0 1.9264517064909725e-11
the O 0 7.224483598161635e-12
protein O 0 1.0431481234363105e-09
- O 0 3.069662568577769e-07
binding O 0 1.0033262753950112e-07
region O 0 4.124501018498705e-10
known O 0 2.0502172182190748e-10
as O 0 2.3823011272017247e-11
the O 0 2.7898072740839552e-11
pocket O 0 5.0657952670007944e-05
region O 0 1.1135267818929151e-08
and O 0 9.946695023188568e-09
has O 0 1.0745305978332453e-08
been O 0 1.762535006832877e-08
detected O 0 1.1130287020932883e-06
in O 0 3.1552298968007264e-11
other O 0 1.5416360896192138e-11
cases O 0 1.0659843840965522e-10
of O 0 5.56443016663799e-11
retinoblastoma B-Disease 0 1.8342068415222457e-06
. O 0 1.9794190730948458e-09
. O 0 1.1133694854947862e-08

Low O 0 0.0003033913380932063
levels O 0 2.5451140572840814e-07
of O 0 3.696683584242244e-11
beta O 0 4.307477985410202e-10
hexosaminidase O 0 6.646334327342629e-08
A O 0 3.533592307647382e-09
in O 0 2.424229983422066e-10
healthy O 0 2.7092681431639676e-09
individuals O 0 6.235004873511585e-11
with O 0 1.6466709107376687e-09
apparent O 0 0.06995287537574768
deficiency O 0 0.08462321013212204
of O 0 3.285133970409859e-11
this O 0 9.447598259271217e-10
enzyme O 0 2.210233418509233e-08
. O 0 6.005628438998656e-09

Appreciable O 0 0.00010480649507371709
beta O 0 6.102918064243568e-07
hexosaminidase O 0 2.602229142212309e-05
A O 0 1.0585985421585065e-07
( O 0 2.7437488045456426e-11
hex O 0 1.2178627883940862e-08
A O 0 5.470075503666294e-09
) O 0 1.1924388559902965e-11
activity O 0 8.747755853022454e-10
has O 0 1.093421950204565e-10
been O 0 2.5954236537728548e-09
detected O 0 1.8974313320541114e-07
in O 0 1.8055354433776927e-10
cultured O 0 6.41439282844658e-06
skin O 0 0.00039284105878323317
fibroblasts O 0 2.129777811887834e-07
and O 0 6.558385621246998e-07
melanoma B-Disease 0 0.1318480521440506
tissue O 0 1.3195160136092454e-05
from O 0 1.9403414430740895e-09
healthy O 0 9.939530798419582e-08
individuals O 0 1.5683241372244083e-09
previously O 0 2.481063354764501e-08
reported O 0 1.3264637743759522e-07
as O 0 2.8547975094994626e-09
having O 0 7.794191333232448e-06
deficiency B-Disease 0 1.826796869863756e-05
of I-Disease 0 8.995165723391096e-12
hex I-Disease 0 1.9183000077305223e-08
A I-Disease 0 1.2322226572436534e-09
activity O 0 5.735419361663219e-10
indistinguishable O 0 1.2473185817540866e-09
from O 0 2.7711910457334232e-12
that O 0 8.377990141916758e-12
of O 0 2.5548710716472023e-11
patients O 0 3.073056831226495e-08
with O 0 0.0002491645864211023
Tay B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
Sachs I-Disease 1 0.9999998807907104
disease I-Disease 1 0.9496592283248901
( O 0 8.309348764612423e-09
TSD B-Disease 0 1.2532721484603826e-05
) O 0 7.637251386860555e-10
. O 0 1.971844909576248e-09

Identification O 0 1.0220204558208934e-06
and O 0 2.9343438789908305e-09
quantitation O 0 5.774892997578718e-06
of O 0 3.966206529870675e-10
hex O 0 2.4629656536490074e-07
A O 0 2.154303047063877e-08
, O 0 5.1826043456770776e-11
amounting O 0 5.736294772518136e-10
to O 0 6.950093972557525e-11
3 O 0 2.1627335478058285e-09
. O 0 4.764854732997037e-09

5 O 0 8.950890162395808e-08
% O 0 4.6688275467943186e-09
- O 0 3.878868938045343e-06
6 O 0 4.869987790812047e-08
. O 0 2.4638602269533294e-08

9 O 0 1.4811151416438406e-08
% O 0 5.6539543880074206e-11
of O 0 3.5679096396096233e-12
total O 0 8.364582637643281e-11
beta O 0 6.5365007850815e-10
hexosaminidase O 0 3.455098180893401e-07
activity O 0 1.7447009170723504e-08
, O 0 1.7112464223423274e-11
has O 0 3.6703511757663065e-11
been O 0 3.4319009439842674e-11
obtained O 0 1.0151014750992005e-10
by O 0 7.47968006975519e-11
cellulose O 0 3.8023297292966163e-06
acetate O 0 4.088983871497476e-07
gel O 0 1.692798946351104e-06
electrophoresis O 0 6.072333746942604e-08
, O 0 6.739706015501667e-11
DEAE O 0 4.2660332155719516e-07
- O 0 6.930127938176156e-08
cellulose O 0 1.8534681203163927e-06
ion O 0 1.1973168511758558e-05
- O 0 7.99297595222015e-06
exchange O 0 5.893202725815172e-08
chromatography O 0 4.061068921146216e-07
, O 0 2.3645916821801727e-11
radial O 0 7.57692575348301e-09
immunodiffusion O 0 9.827907661019708e-07
, O 0 9.929512073680868e-11
and O 0 3.188930786102162e-10
radioimmunoassay O 0 2.009232048294507e-06
. O 0 6.058402224340398e-09

Previous O 0 2.1368619229633623e-07
family O 0 5.272556791169336e-08
studies O 0 2.4211626037384804e-09
suggested O 0 5.90627546870337e-09
that O 0 7.297750598267427e-11
these O 0 1.6479038619787723e-11
individuals O 0 1.5976703293674177e-10
may O 0 1.3669104959035394e-08
be O 0 1.9602863776668755e-10
compound O 0 6.356624671077782e-10
heterozygotes O 0 9.398931410942168e-09
for O 0 1.228630652078122e-11
the O 0 2.757020826915646e-11
common O 0 9.82923409331704e-10
mutant O 0 2.310687463591421e-08
TSD B-Disease 0 7.425007879646728e-07
gene O 0 2.008038890721764e-08
and O 0 3.2289218521164287e-10
a O 0 1.7785887207466544e-09
rare O 0 2.456072252243757e-07
( O 0 5.342695730270464e-10
allelic O 0 5.146018793311669e-07
) O 0 9.739841155820272e-10
mutant O 0 7.672328194985312e-08
gene O 0 3.8523089074260497e-07
. O 0 2.626459938426251e-08

Thus O 0 3.4165424267484923e-07
, O 0 1.3329698456132633e-10
the O 0 3.965387740390014e-11
postulated O 0 1.039462773633204e-07
rate O 0 8.391840822241647e-08
mutant O 0 3.3489409023701455e-09
gene O 0 2.0732897620945323e-09
appears O 0 8.608636026252725e-10
to O 0 2.06518786446952e-12
code O 0 4.481918308707478e-12
for O 0 5.522764320517459e-13
the O 0 3.76005606858576e-12
expression O 0 1.0392476879061974e-09
of O 0 6.447293653816244e-12
low O 0 6.8298713351566676e-09
amounts O 0 1.3359835460136082e-10
of O 0 2.0883057436082986e-11
hex O 0 3.9832077192158977e-08
A O 0 2.1652482473655255e-08
. O 0 5.125944113615333e-09

Heterozygotes O 0 7.588753760501277e-06
for O 0 4.8745085745594e-10
the O 0 1.366200208519075e-10
rare O 0 1.0349872958670403e-08
mutant O 0 1.4962827208364615e-06
may O 0 3.792682150560722e-07
be O 0 1.0210458034620729e-09
indistinguishable O 0 2.120644815306605e-08
from O 0 1.205304189788592e-10
heterozygotes O 0 3.6723665886029266e-08
for O 0 3.751719421241084e-11
the O 0 2.541438726133549e-10
common O 0 2.5292068883686625e-08
TSD B-Disease 0 9.614001100999303e-06
mutant O 0 7.011684601820889e-07
. O 0 2.5796076386086497e-08

However O 0 1.2375774360862124e-07
, O 0 4.8098296179244215e-11
direct O 0 6.283402964601947e-11
visualization O 0 8.880451041193282e-09
and O 0 4.3544640115911193e-10
quantitation O 0 1.1217913424843573e-06
of O 0 5.183137946618288e-11
hex O 0 2.8985775557544002e-08
A O 0 4.867308778244706e-10
by O 0 1.3969557281778844e-11
the O 0 1.6660225282683072e-11
methods O 0 1.5266101272004562e-08
described O 0 1.767616026882024e-07
may O 0 1.0277912743106299e-08
prevent O 0 1.7457452150537733e-09
false O 0 1.3602050330518978e-07
- O 0 8.77351112649194e-07
positive O 0 4.229518957288292e-09
prenatal O 0 3.092841507168487e-05
diagnosis O 0 2.8257593385205837e-06
of O 0 1.0471803979505978e-10
TSD B-Disease 0 1.401057670591399e-05
in O 0 2.930486253660547e-08
fetuses O 0 2.1914879653195385e-06
having O 0 1.751608857958331e-09
the O 0 1.5328524560764833e-10
incomplete O 0 1.728767529129982e-08
hex B-Disease 0 2.9470842832779454e-07
A I-Disease 0 1.2863742995250504e-06
deficiency I-Disease 0 3.1147450499702245e-05
of O 0 1.1241824311725157e-11
the O 0 6.927954876445597e-10
type O 0 0.0001514945615781471
described O 0 3.828090029855957e-06
in O 0 1.742511801516855e-09
the O 0 5.433469785209866e-10
four O 0 4.084857341268844e-09
healthy O 0 2.1216689560787927e-07
individuals O 0 7.469225948852909e-08

The O 0 4.8335827784740104e-08
tumor B-Disease 0 1.557562245579902e-05
suppressor O 0 1.1175649888173211e-05
gene O 0 7.568897331111657e-07
Smad4 O 0 1.0464831575518474e-05
/ O 0 1.52620464177744e-06
Dpc4 O 0 1.97913641386549e-06
is O 0 2.0307461268131988e-10
required O 0 2.979555491222641e-11
for O 0 3.0666333188100747e-12
gastrulation O 0 1.0699984898110415e-08
and O 0 7.217246245083686e-10
later O 0 2.4431315304163093e-10
for O 0 9.507822480714356e-12
anterior O 0 1.558009010693695e-08
development O 0 2.0636534148188446e-11
of O 0 7.411241759180953e-12
the O 0 2.0320246874039327e-10
mouse O 0 4.602267438258423e-07
embryo O 0 2.6584851298139256e-07
. O 0 1.4117111923894754e-08

Mutations O 0 0.00023016543127596378
in O 0 4.847336310120909e-09
the O 0 2.492445583257563e-09
SMAD4 O 0 0.0021181772463023663
/ O 0 3.385221498319879e-05
DPC4 O 0 0.0002809859870467335
tumor B-Disease 0 1.2604216863110196e-05
suppressor O 0 2.4050632418948226e-06
gene O 0 3.999728193093688e-08
, O 0 2.4526877057118313e-11
a O 0 8.376396798404073e-11
key O 0 1.2237603153053556e-09
signal O 0 2.2149855283259967e-08
transducer O 0 8.221931580010278e-07
in O 0 2.126905040977789e-10
most O 0 1.564036677947911e-10
TGFbeta O 0 2.7604248771240236e-06
- O 0 3.5435264180705417e-06
related O 0 1.668766458351456e-08
pathways O 0 1.6745174136190144e-09
, O 0 7.502423161886984e-12
are O 0 2.0996954175345195e-12
involved O 0 1.2805427725137708e-11
in O 0 1.7700957019584074e-11
50 O 0 3.079518237636414e-11
% O 0 3.362141121066031e-11
of O 0 2.5869277830992132e-09
pancreatic B-Disease 1 0.6998035311698914
cancers I-Disease 1 0.9976298809051514
. O 0 4.236836730342475e-07

Homozygous O 0 0.0002799946814775467
Smad4 O 0 0.0004034907906316221
mutant O 0 7.758167339488864e-05
mice O 0 0.024632900953292847
die O 0 0.0005857922369614244
before O 0 4.468105885280238e-09
day O 0 1.9904435877293736e-09
7 O 0 1.3117391617356589e-09
. O 0 2.3061865750406696e-09

5 O 0 3.804016301955926e-08
of O 0 2.3015329642106508e-09
embryogenesis O 0 5.848562977917027e-06
. O 0 3.9739200019539567e-07

Mutant O 0 1.5799388393133995e-06
embryos O 0 2.967548482502025e-07
have O 0 5.3856084036851826e-09
reduced O 0 2.8570252830206755e-09
size O 0 2.3396522408347664e-07
, O 0 3.123877267974251e-10
fail O 0 5.656066548453964e-08
to O 0 9.826791463884987e-11
gastrulate O 0 1.7969999817069038e-06
or O 0 2.086014694313576e-09
express O 0 1.1610636063696944e-10
a O 0 7.590732209461493e-11
mesodermal O 0 4.719271728959029e-08
marker O 0 8.69759276156401e-07
, O 0 1.947919742173454e-10
and O 0 4.0022726799371355e-10
show O 0 2.845845870069752e-07
abnormal O 0 2.52791528509988e-06
visceral O 0 1.8488342902855948e-05
endoderm O 0 0.0002468835446052253
development O 0 1.7005376662382332e-08
. O 0 1.4389233804479318e-08

Growth B-Disease 1 0.9998414516448975
retardation I-Disease 1 0.9999676942825317
of O 0 7.010742542057358e-10
the O 0 1.5675525322222938e-09
Smad4 O 0 0.00010757438576547429
- O 0 0.00018868784536607563
deficient O 0 3.007193299708888e-06
embryos O 0 3.8665062263021355e-09
results O 0 2.746002758513555e-09
from O 0 5.989676116202602e-11
reduced O 0 4.421234489626613e-09
cell O 0 1.556512643219321e-07
proliferation O 0 3.041451890339886e-08
rather O 0 1.5259389585242644e-10
than O 0 2.5035444203846957e-11
increased O 0 6.106090633117844e-10
apoptosis O 0 1.6990982842912672e-08
. O 0 4.159160127414907e-09

Aggregation O 0 4.28519314255027e-07
of O 0 2.125170484035266e-09
mutant O 0 3.670014336876193e-07
Smad4 O 0 1.410159620718332e-05
ES O 0 3.8551206671399996e-07
cells O 0 1.6746067865724967e-09
with O 0 3.463306724738047e-11
wild O 0 1.5565060351718785e-08
- O 0 9.058489013114013e-06
type O 0 1.5058199096529279e-05
tetraploid O 0 8.227554644690827e-06
morulae O 0 1.614438406249974e-05
rescues O 0 3.400893774596625e-06
the O 0 3.298315842670263e-09
gastrulation B-Disease 0 5.857225460204063e-06
defect I-Disease 0 6.446212501032278e-05
. O 0 1.2885024602837802e-08

These O 0 5.833313831971054e-09
results O 0 1.4140072224222422e-08
indicate O 0 3.379433977102053e-08
that O 0 5.894062460320981e-10
Smad4 O 0 5.538960294870776e-07
is O 0 1.0942481643017032e-10
initially O 0 7.778110794331994e-11
required O 0 6.8578090255122515e-12
for O 0 4.4440867002018547e-13
the O 0 5.245560387966142e-13
differentiation O 0 3.6345557639927417e-12
of O 0 1.1792655610701197e-12
the O 0 7.56784392097476e-12
visceral O 0 9.793274813318931e-08
endoderm O 0 2.469361106705037e-06
and O 0 2.3465718257398294e-10
that O 0 2.7752970060967996e-11
the O 0 1.5764800923023792e-11
gastrulation B-Disease 0 2.565099421758532e-08
defect I-Disease 0 1.994260543369819e-07
in O 0 7.24144147423722e-11
the O 0 1.0368515074299367e-10
epiblast O 0 1.427656911801023e-06
is O 0 2.9835789394638823e-09
secondary O 0 1.466234023084212e-09
and O 0 8.426203623734807e-10
non O 0 8.116801453184053e-09
- O 0 7.0302171479852404e-06
cell O 0 1.168173457699595e-05
autonomous O 0 2.7865938889704012e-08
. O 0 1.3766988438135286e-08

Rescued O 0 6.664969987468794e-05
embryos O 0 6.412270522559993e-06
show O 0 5.926531594013795e-05
severe O 0 0.0017046746797859669
anterior O 0 0.0008368993876501918
truncations O 0 0.0003247335262130946
, O 0 1.915904945803959e-08
indicating O 0 4.1750348600544385e-07
a O 0 1.018641615502247e-09
second O 0 2.5999807862220337e-10
important O 0 1.7721260223146906e-11
role O 0 8.751205315959965e-11
for O 0 3.192191302958669e-11
Smad4 O 0 1.3522583230951568e-07
in O 0 6.050442369343045e-10
anterior O 0 2.2594447273149854e-06
patterning O 0 4.44313591287937e-05
during O 0 4.141358900255909e-08
embryogenesis O 0 1.5033542695164215e-06
. O 0 2.5631528899339173e-08

Prevalence O 0 0.0008588882628828287
of O 0 3.7353293791397846e-09
p16 O 0 5.406988066170015e-07
and O 0 4.083579696612105e-09
CDK4 O 0 1.882686046883464e-05
germline O 0 8.062189408519771e-06
mutations O 0 1.1727829587471206e-06
in O 0 2.8086675207816825e-09
48 O 0 2.994309866721778e-08
melanoma B-Disease 1 0.9963778853416443
- O 1 0.9982604384422302
prone O 1 0.9997531771659851
families O 0 1.350696607005375e-06
in O 0 5.8236782507492535e-08
France O 0 4.7662233555456623e-05
. O 0 7.892356279626256e-08

The O 0 1.6008205250273022e-07
French O 0 2.8752596335834824e-05
Familial B-Disease 1 0.9776471853256226
Melanoma I-Disease 1 0.9995879530906677
Study O 0 2.3242503175424645e-06
Group O 0 1.195713963397793e-07
. O 0 1.9049261723580457e-08

Germline O 0 0.002194410189986229
mutations O 0 0.0002743387594819069
in O 0 1.984643560604127e-09
the O 0 1.1320775566980856e-10
p16 O 0 2.7285350867600755e-08
and O 0 1.0741653122536832e-09
CDK4 O 0 3.78667791665066e-05
genes O 0 6.177860711886751e-08
have O 0 4.2726711058094224e-09
been O 0 4.5192227737800295e-09
reported O 0 3.860655350962361e-09
in O 0 3.908751360776064e-12
a O 0 2.3314336572433092e-11
subset O 0 1.5950434306688521e-09
of O 0 1.0217900969777816e-09
melanoma B-Disease 0 0.4011709988117218
pedigrees O 0 6.520029273815453e-05
, O 0 3.229802814086469e-10
but O 0 5.641999645256135e-10
their O 0 2.0866672834074507e-09
prevalence O 0 9.192822290060576e-06
is O 0 1.291599605046656e-09
not O 0 3.9944103580324963e-10
well O 0 6.385034168054915e-10
known O 0 6.2137601730682945e-09
. O 0 6.641085459335727e-09

We O 0 5.230098309993991e-08
searched O 0 6.301712485168309e-09
for O 0 6.949918071597061e-12
such O 0 1.97893004066918e-11
germline O 0 1.2667966586832335e-07
mutations O 0 1.0770588687591953e-07
in O 0 3.1064442684858307e-10
48 O 0 3.7329342394976095e-10
French O 0 3.003980418725405e-05
melanoma B-Disease 1 0.9996058344841003
- O 1 0.9555283188819885
prone O 1 0.9849313497543335
families O 0 9.750323881618783e-10
selected O 0 3.67727445715893e-11
according O 0 1.1809678235330523e-11
to O 0 2.5500304992598366e-12
two O 0 2.36817423310276e-12
major O 0 9.389496818945631e-11
criteria O 0 1.5769389127839872e-09
families O 0 5.128958022182495e-12
with O 0 5.2924852000924005e-12
at O 0 9.649714360904227e-10
least O 0 1.8183111266667495e-11
three O 0 1.2188043109484514e-11
affected O 0 1.7947782149363434e-10
members O 0 2.5223078833902512e-12
( O 0 2.8666279419664598e-12
n O 0 2.4745322235730782e-08
= O 0 5.74921132923123e-09
20 O 0 3.5636248726239605e-12
) O 0 4.4428152021040723e-13
or O 0 3.958420397021101e-11
families O 0 6.613796749849188e-12
with O 0 1.1398401320028562e-11
two O 0 8.249143729210928e-11
affected O 0 3.4379302182863114e-10
members O 0 2.5800108577334058e-12
, O 0 1.1040457827474204e-12
one O 0 2.0633609838088818e-12
of O 0 1.6415872567537848e-13
them O 0 3.57664462283247e-12
affected O 0 2.0876763859312142e-11
before O 0 1.2152945316756814e-11
the O 0 7.564525394965216e-12
age O 0 2.16500966460087e-11
of O 0 2.2386628141524145e-13
50 O 0 2.2182279884458422e-12
( O 0 1.8147380299871063e-12
n O 0 3.342248433568784e-08
= O 0 2.606179982933554e-08
28 O 0 3.6382338114426815e-11
) O 0 4.732347868609266e-13
, O 0 7.781575405742258e-13
and O 0 1.013218762363488e-11
one O 0 1.1210925417171058e-11
additional O 0 4.1292379238111465e-11
minor O 0 8.416538577193933e-09
criterion O 0 7.421228076509578e-08
. O 0 1.0809976913606079e-08

Sixteen O 0 1.6124900525937846e-07
different O 0 3.2145508477299245e-09
p16 O 0 1.402970468689091e-07
germline O 0 7.451618785125902e-06
mutations O 0 9.944449629983865e-06
were O 0 3.838115159027211e-09
found O 0 2.4121884489858303e-09
in O 0 4.675134168685702e-10
21 O 0 2.050533770558971e-10
families O 0 1.0829158403335981e-10
, O 0 1.9587605842863454e-11
while O 0 1.1306900554730603e-10
one O 0 3.233655287981918e-10
germline O 0 3.6162322203381336e-07
mutation O 0 1.0554427944953204e-06
, O 0 4.2154852525344566e-11
Arg24His O 0 1.2532672144516255e-07
, O 0 1.2438303165218656e-10
was O 0 2.273874599723058e-08
detected O 0 9.689446187621797e-07
in O 0 7.92305318575437e-11
the O 0 4.033770817368776e-10
CDK4 O 0 2.3593578589498065e-05
gene O 0 1.0089375734878558e-07
. O 0 8.742071955225583e-09

The O 0 5.863376451031854e-09
frequency O 0 6.776154748422414e-08
of O 0 3.0052221128284984e-11
p16 O 0 1.9722820709944244e-08
gene O 0 2.2142673472558272e-08
mutation O 0 9.493234642832249e-08
in O 0 3.9824268882604485e-11
our O 0 3.0086287627906216e-11
sample O 0 7.43220970877978e-11
( O 0 1.253852382164522e-12
44 O 0 7.577459710042533e-13
% O 0 4.310545247566272e-13
) O 0 1.8658726365188005e-13
is O 0 2.154586188282681e-12
among O 0 1.6004594568033714e-12
the O 0 3.6090394561760775e-11
highest O 0 2.4065241177595453e-07
rates O 0 1.603124530902278e-07
yet O 0 4.515862350729094e-09
reported O 0 2.754364292201217e-09
and O 0 1.089981490481895e-11
the O 0 1.5604987788075952e-11
CDK4 O 0 5.866584160685306e-06
mutation O 0 3.202844567340435e-08
is O 0 1.2519937343802301e-11
the O 0 1.4250073560387322e-12
second O 0 1.154446205298143e-09
mutation O 0 3.4281976013517124e-07
detected O 0 1.8414839360048063e-06
in O 0 4.043536339093379e-11
this O 0 3.721330882333618e-11
gene O 0 2.4711255264264764e-09
worldwide O 0 9.058430672226336e-10
. O 0 2.829454892605554e-09

In O 0 9.011218438104152e-09
summary O 0 1.532415616622984e-08
, O 0 6.910636646262347e-11
our O 0 1.9838702902674754e-10
results O 0 1.297388863008564e-10
show O 0 1.3562000411582176e-09
frequent O 0 1.8316551608776876e-09
involvement O 0 1.6993826346123342e-09
of O 0 2.329285635899181e-12
the O 0 8.332253290110891e-12
p16 O 0 1.9767101289147604e-09
gene O 0 2.0896304686601752e-09
in O 0 3.363483103147047e-10
familial B-Disease 0 0.0009469141368754208
melanoma I-Disease 1 0.9911468625068665
and O 0 5.395358115833915e-08
confirm O 0 3.140414150948345e-07
the O 0 8.38798388386186e-12
role O 0 4.9094121129522605e-11
of O 0 1.2468242584218192e-12
the O 0 1.5926189186887818e-11
CDK4 O 0 3.5190129210604937e-07
gene O 0 4.2841916125802015e-10
as O 0 3.798043476943569e-11
a O 0 1.825740447713997e-08
melanoma B-Disease 0 0.33211398124694824
- O 0 0.00013152076280675828
predisposing O 0 2.4493451746820938e-06
gene O 0 4.023586370749399e-07
. O 0 1.367452262535096e-09
. O 0 5.059735297407997e-09

Progression O 0 7.849367648304906e-06
of O 0 8.968398801378896e-10
somatic O 0 8.048538688854023e-07
CTG O 0 1.4747515706403647e-05
repeat O 0 2.014310666709207e-06
length O 0 3.5192471159462e-08
heterogeneity O 0 2.959268101676571e-07
in O 0 1.7046254408015216e-09
the O 0 7.029568593885926e-10
blood O 0 6.34126877230301e-07
cells O 0 3.935533641197253e-07
of O 0 1.636182815900611e-07
myotonic B-Disease 1 0.9999994039535522
dystrophy I-Disease 1 0.9999998807907104
patients O 0 0.0008039578679017723
. O 0 2.3346595412476745e-07

The O 0 4.147870935611309e-09
genetic O 0 5.545853554167479e-08
basis O 0 9.030660663711387e-09
of O 0 5.45356613201875e-08
myotonic B-Disease 1 0.9999998807907104
dystrophy I-Disease 1 1.0
( O 0 0.005225211847573519
DM B-Disease 1 1.0
) O 0 3.6226432964525657e-09
is O 0 1.0834942665294278e-10
the O 0 5.924081104141665e-12
expansion O 0 1.199687155173379e-10
of O 0 4.769775720225855e-12
an O 0 2.086188860550564e-10
unstable O 0 2.4730170480324887e-05
CTG O 0 9.719340141600696e-07
repeat O 0 2.0933460120886593e-07
in O 0 5.99995469974246e-11
the O 0 2.116592318079924e-11
34 O 0 3.661052017100985e-11
UTR O 0 2.8459954393156295e-09
of O 0 6.689281940863712e-12
the O 0 3.791229552518871e-09
DM B-Disease 1 0.9999977350234985
protein O 0 5.094551625006716e-08
kinase O 0 3.496782881029503e-07
gene O 0 1.8856979977499577e-08
on O 0 5.347003551037233e-08
chromosome O 0 6.700988888042048e-05
19 O 0 1.8635974541325595e-08
. O 0 9.292265623628282e-09

One O 0 8.408997054232259e-09
of O 0 2.6351369003529967e-11
the O 0 1.3485378612398957e-11
principal O 0 1.4129274139573766e-10
features O 0 2.503412199761357e-10
of O 0 2.22558620838198e-11
the O 0 7.94906966916642e-08
DM B-Disease 1 1.0
mutation O 0 0.00010100291547132656
is O 0 5.952754955629302e-10
an O 0 2.298990338378548e-11
extraordinarily O 0 5.096892891742755e-06
high O 0 2.6724553237045257e-08
level O 0 1.3172348767298558e-09
of O 0 2.412451315103592e-12
somatic O 0 1.537474680901596e-08
mosaicism O 0 7.5177445069130044e-06
, O 0 1.589087889053431e-10
due O 0 4.265454656149359e-10
to O 0 2.1649477349727775e-11
an O 0 1.2750767108826722e-10
extremely O 0 5.05066509504104e-07
high O 0 2.006507493490517e-08
degree O 0 2.691021405709648e-09
of O 0 6.295300218617239e-12
somatic O 0 5.8358541110692386e-08
instability O 0 4.742534827073541e-07
both O 0 2.2758638029696243e-10
within O 0 1.417797407254895e-10
and O 0 7.328860296418327e-10
between O 0 7.471498975064605e-10
different O 0 1.886549583218766e-09
tissues O 0 2.346127985219937e-06
. O 0 1.1095663055016303e-08

This O 0 2.1624458668156876e-08
instability O 0 5.965547984487785e-07
appears O 0 2.24899547873747e-08
to O 0 4.416501539483697e-11
be O 0 3.184692787261412e-11
biased O 0 9.486651048051797e-11
towards O 0 1.802117049337637e-12
further O 0 1.04256176174794e-12
expansion O 0 1.3621196184865347e-11
and O 0 2.0931776277544056e-12
continuous O 0 6.183534240200572e-11
throughout O 0 7.468527532528135e-12
the O 0 1.0536451919285206e-11
life O 0 9.731293548753683e-11
of O 0 1.7687336784002333e-13
an O 0 1.5025750825861661e-12
individual O 0 3.484071017800794e-11
, O 0 2.8765798337077042e-12
features O 0 4.806735010021157e-09
that O 0 4.523959518110132e-08
could O 0 9.130022817771533e-07
be O 0 5.742065933844742e-09
associated O 0 1.5877494874416698e-09
with O 0 1.8587206426778913e-11
the O 0 6.80435291444681e-11
progressive O 0 1.8439035187611807e-08
nature O 0 6.234846949837447e-08
of O 0 8.134615897548159e-11
the O 0 3.351907551518707e-08
disease O 0 7.498211743950378e-06
. O 0 1.396334514680575e-08

Although O 0 4.112220253205123e-08
increasing O 0 8.700618892021339e-09
measured O 0 9.310822974839539e-07
allele O 0 1.6238726630035671e-07
size O 0 5.4492819145934845e-08
between O 0 4.307151524329811e-09
patients O 0 6.234606608757076e-09
clearly O 0 7.401505630610927e-09
correlates O 0 4.592544566861534e-09
with O 0 1.813016056728678e-11
an O 0 2.492543151044746e-11
increased O 0 1.7748075009649256e-08
severity O 0 6.941803439985961e-05
of O 0 2.058371917357249e-09
symptoms O 0 2.7901151042897254e-06
and O 0 3.242227319955049e-10
an O 0 1.8653016631287045e-11
earlier O 0 1.5925484930789935e-08
age O 0 6.16435458233866e-10
of O 0 2.279041321981423e-12
onset O 0 8.799015738247817e-09
, O 0 7.826786094233817e-12
this O 0 2.666747031532246e-12
correlation O 0 7.044967720304385e-09
is O 0 1.2090112244678153e-10
not O 0 7.358214038077904e-11
precise O 0 1.6034699967804045e-07
and O 0 8.888428326692122e-10
measured O 0 7.875528353906702e-06
allele O 0 3.2957139239897515e-08
length O 0 3.491587960979814e-07
cannot O 0 3.349715882450255e-07
be O 0 2.590501702037784e-10
used O 0 1.6402315616836916e-10
as O 0 5.574646647077408e-12
an O 0 2.917469217600388e-12
accurate O 0 2.1153812213015044e-07
predictor O 0 2.5433093924220884e-06
of O 0 1.9654904093169279e-10
age O 0 1.0797509553128748e-08
of O 0 3.811391202646064e-10
onset O 0 2.386968162682024e-06
. O 0 9.047077043078389e-08

In O 0 1.4447837592967971e-08
order O 0 4.024149624637374e-10
to O 0 1.5364461439237864e-11
further O 0 2.7326765850155255e-11
characterize O 0 2.101831242384833e-08
the O 0 3.2610192324256104e-10
dynamics O 0 1.3834775813847955e-07
of O 0 1.4751656562950188e-09
DM B-Disease 1 0.9999966621398926
CTG O 0 6.362188742059516e-06
repeat O 0 1.6666709257151524e-07
somatic O 0 2.3195130438580236e-07
instability O 0 4.578990683512529e-06
, O 0 1.586979714307546e-10
we O 0 2.648804509064462e-10
have O 0 6.851235551108559e-11
studied O 0 9.089878294510356e-10
repeat O 0 1.265338767098001e-08
length O 0 1.1419477585761229e-09
changes O 0 6.069048041901226e-11
over O 0 1.736305890731593e-11
time O 0 1.61737276349605e-10
in O 0 1.0297529495773006e-09
111 O 0 7.527779644078691e-08
myotonic B-Disease 1 0.999998927116394
dystrophy I-Disease 1 0.9999998807907104
patients O 0 4.140935288887704e-06
with O 0 8.65404081729082e-10
varying O 0 1.8941047130738298e-07
clinical O 0 2.2210535917110974e-06
severity O 0 0.0003493368567433208
and O 0 2.542036359187705e-09
CTG O 0 1.3741323812155315e-07
repeat O 0 7.043372107773394e-08
size O 0 5.073267317357022e-08
over O 0 2.743153482143157e-10
time O 0 1.8659181144631276e-10
intervals O 0 7.068936547227622e-10
of O 0 2.238040482105408e-12
1 O 0 1.1996208193476576e-10
- O 0 6.6282427724218e-07
7 O 0 1.2138362537328362e-09
years O 0 1.394699467027749e-09
. O 0 2.3334245646822183e-09

We O 0 1.5180885384324938e-06
have O 0 2.8716545807938587e-10
found O 0 3.9317531869142996e-11
a O 0 1.4293527299258368e-11
direct O 0 1.6581201689458425e-10
progression O 0 3.164888795481602e-09
of O 0 8.662780237068957e-13
the O 0 3.667690283426506e-12
size O 0 3.002268655905027e-09
heterogeneity O 0 1.759611789609039e-09
over O 0 2.873797033675629e-10
time O 0 2.8354393832863423e-10
related O 0 1.1357608603601577e-10
to O 0 7.799589099577453e-12
initial O 0 2.68285615945274e-10
CTG O 0 2.2726908355252817e-08
repeat O 0 2.4970434608917458e-08
size O 0 6.112260564350436e-08
and O 0 7.765273840609765e-11
the O 0 1.3105625092102446e-11
time O 0 1.725708603794729e-10
interval O 0 4.656936614111373e-09
and O 0 8.640940046822365e-11
always O 0 3.9908992777171193e-10
biased O 0 2.156824024934778e-11
towards O 0 1.913071047063286e-12
further O 0 6.853114430105389e-12
expansion O 0 6.661723395140484e-10
. O 0 1.136277072433245e-09

Attempts O 0 9.202000939012578e-08
to O 0 1.4215593147071104e-09
mathematically O 0 4.910674533675774e-07
model O 0 1.2102767676935855e-08
the O 0 3.2374566916182346e-10
dynamics O 0 4.229467322147684e-06
have O 0 8.404955842422623e-09
proved O 0 2.6012036968836583e-08
only O 0 5.93051718844606e-11
partially O 0 3.695956252158794e-08
successful O 0 4.5943121529390396e-10
suggesting O 0 5.575909955979341e-09
that O 0 1.245548456041412e-11
individual O 0 7.250670550074112e-12
specific O 0 4.063235164997181e-11
genetic O 0 1.0281088869135147e-08
and O 0 2.2724728765410873e-09
/ O 0 3.412962712445733e-08
or O 0 6.161712473584657e-09
environmental O 0 4.763966643395179e-08
factors O 0 1.6712820016806518e-09
also O 0 1.0156301494257391e-10
play O 0 7.963596448945509e-11
a O 0 2.1260695981517586e-10
role O 0 9.786151888846462e-10
in O 0 1.6427331717139282e-10
somatic O 0 7.593103390490796e-08
mosaicism O 0 8.32320347399218e-06
. O 0 1.7202016477924076e-09
. O 0 4.315571899837778e-09

Aspartylglucosaminuria B-Disease 1 0.9996390342712402
among O 0 1.4876388831908116e-07
Palestinian O 0 2.085035021082149e-06
Arabs O 0 8.838293297230848e-07
. O 0 8.040377963425271e-08

Aspartylglucosaminuria B-Disease 1 0.9999887943267822
( O 0 1.5182612514763605e-05
AGU B-Disease 1 0.9999736547470093
) O 0 1.2800971394000271e-09
is O 0 1.276634076230465e-10
a O 0 1.5499372896243813e-09
rare O 0 4.3128525248903316e-06
disorder B-Disease 0 0.001700366148725152
of I-Disease 0 2.803197896028564e-09
glycoprotein I-Disease 1 0.983146607875824
metabolism I-Disease 0 0.013700658455491066
caused O 0 2.76027236623122e-07
by O 0 8.235314097326807e-10
the O 0 4.381570590794581e-07
deficiency B-Disease 0 0.0002917803649324924
of I-Disease 0 1.57048367366297e-11
the I-Disease 0 8.787891525585678e-10
lysosomal I-Disease 0 0.0001682210568105802
enzyme I-Disease 0 4.499563601711998e-07
aspartylglucosaminidase I-Disease 0 1.1861890925501939e-05
( O 0 1.0329653798990535e-09
AGA O 0 1.5934911345993896e-07
) O 0 5.441714856502244e-10
. O 0 4.104194317733345e-09

AGU B-Disease 1 0.999948263168335
is O 0 8.062581855483586e-07
inherited O 0 0.00013024438521824777
as O 0 7.267111912234725e-10
an O 0 7.278236902052981e-10
autosomal O 1 0.9924800395965576
recessive O 1 0.9991521835327148
trait O 1 0.9219900965690613
and O 0 1.5617003157331055e-07
occurs O 0 6.5242726776659765e-09
with O 0 7.15181906751905e-12
a O 0 2.4842634616106807e-09
high O 0 1.22032332683375e-07
frequency O 0 1.7642252714722417e-05
in O 0 7.510051247550109e-09
Finland O 0 2.5754939997568727e-05
because O 0 3.205476772905058e-09
of O 0 4.514124751081594e-12
a O 0 2.172722668447591e-09
founder O 0 1.9760662439693988e-08
effect O 0 3.19440083274003e-08
. O 0 3.547699689576689e-09

While O 0 4.87705271723371e-08
very O 0 1.8045241967357128e-09
few O 0 1.141686412076126e-09
patients O 0 1.3176193469632835e-09
with O 0 1.1973315672264562e-08
AGU B-Disease 1 0.9999990463256836
have O 0 1.686201329675896e-07
been O 0 8.72291749942633e-09
reported O 0 9.352217889002645e-10
from O 0 5.7083474232222375e-12
non O 0 2.4222379657601323e-10
- O 0 1.7029275056756887e-07
Finnish O 0 1.549133230582811e-05
origin O 0 2.173984015030328e-08
, O 0 6.080533299090973e-10
we O 0 1.5428716437781986e-07
diagnosed O 0 7.435229235852603e-06
the O 0 1.9995300970521157e-09
disorder O 0 1.2981997315364424e-05
in O 0 1.2571589325105492e-09
8 O 0 9.246470256130124e-10
patients O 0 1.5287997257029673e-10
originating O 0 1.39809733235019e-10
from O 0 2.227701183243891e-11
3 O 0 5.114512632853341e-11
unrelated O 0 1.5028792432758564e-08
families O 0 3.7602321256713367e-10
, O 0 3.1369141225562336e-12
all O 0 2.776672338236641e-12
Palestinian O 0 1.3120694530854848e-09
Arabs O 0 5.093234722863826e-10
from O 0 1.133213401588451e-11
the O 0 3.372770812637427e-11
region O 0 2.454242642446758e-10
of O 0 1.0102514658161255e-10
Jerusalem O 0 8.492354481859365e-07
. O 0 9.76086056425629e-09

The O 0 9.727965988304277e-08
clinical O 0 7.441401066898834e-06
diagnosis O 0 0.01752009429037571
of O 0 5.908746203431292e-08
AGU B-Disease 1 0.9999992847442627
is O 0 9.600721568858717e-07
often O 0 1.1718601200527701e-07
difficult O 0 1.2487896583479596e-07
, O 0 4.1695032843014346e-12
in O 0 1.981062666342459e-12
particular O 0 1.85029162130812e-11
early O 0 3.41174033469116e-11
in O 0 1.0394627866783246e-11
the O 0 1.0688464002761577e-11
course O 0 1.8774106713692618e-09
of O 0 5.498592466762764e-12
the O 0 3.791952973841717e-09
disease O 0 6.350552439471358e-07
, O 0 1.1429621138425716e-11
and O 0 2.5366816286398475e-11
most O 0 1.7271029441670582e-12
of O 0 9.697043515388692e-13
the O 0 8.322700306706565e-10
patients O 0 4.724051816396013e-09
are O 0 1.136797944667478e-08
diagnosed O 0 8.786306352703832e-06
after O 0 5.628327803819388e-10
the O 0 2.0435761416415232e-10
age O 0 8.918588090267576e-10
of O 0 2.980935160171172e-12
5 O 0 1.1899811691584716e-10
years O 0 1.2462412213309904e-09
. O 0 3.5138796317113474e-09

However O 0 1.543835708162078e-07
, O 0 1.920652248355026e-10
since O 0 1.8433389536998135e-10
these O 0 9.652980671737144e-12
patients O 0 4.739000511455593e-11
excrete O 0 2.7482335851480855e-10
early O 0 7.666872345324371e-12
large O 0 5.996553947840155e-12
amounts O 0 5.275375275504146e-11
of O 0 5.3476047374989566e-12
aspartylglucosamine O 0 7.09195546733099e-08
in O 0 2.7538898939027945e-10
urine O 0 6.539446761877343e-09
, O 0 8.295622001830427e-12
biochemical O 0 9.190592176189227e-10
screening O 0 2.3849847097245913e-10
is O 0 4.5032397949507086e-11
easy O 0 1.0886155310529944e-09
by O 0 1.3407374099827507e-09
urine O 0 5.315562248142669e-07
chromatography O 0 3.650010967248818e-06
. O 0 1.3827429201640484e-09
. O 0 3.9861847156430485e-09

Detection O 0 2.718447603911045e-06
of O 0 6.191987478310068e-10
heterozygous O 0 1.6072792163868144e-07
carriers O 0 3.118867297757788e-08
of O 0 4.934216923935253e-10
the O 0 1.883950858427852e-06
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999992847442627
telangiectasia I-Disease 1 0.9999998807907104
( O 0 1.5925818885875742e-08
ATM O 0 3.5275850223115413e-06
) O 0 2.7881049899369792e-11
gene O 0 5.282849158128045e-10
by O 0 1.6835798033465466e-10
G2 O 0 1.929544168888242e-07
phase O 0 1.4758811950343897e-08
chromosomal O 0 7.038952026050538e-05
radiosensitivity O 0 7.723637281742413e-06
of O 0 1.021384754551491e-09
peripheral O 0 1.5574240023852326e-05
blood O 0 0.00019377921125851572
lymphocytes O 0 9.496061102254316e-05
. O 0 3.5133314923996295e-08

In O 0 0.00011045306746382266
ataxia B-Disease 1 0.9999990463256836
- I-Disease 1 0.999997615814209
telangiectasia I-Disease 1 0.9999998807907104
( O 0 0.00016949202108662575
A B-Disease 1 0.9999991655349731
- I-Disease 1 0.9999990463256836
T I-Disease 1 1.0
) O 0 2.0564895564234575e-08
patients O 0 5.3944497757640875e-09
, O 0 3.0407509843399794e-11
mutations O 0 1.6871945618390782e-08
in O 0 4.730349445480897e-11
a O 0 3.291388550596963e-10
single O 0 5.158427907048235e-09
gene O 0 1.3368254281331815e-09
, O 0 5.0060194704826255e-12
ATM O 0 3.989495311884639e-08
, O 0 6.928026728691972e-12
result O 0 1.1392414789312966e-09
in O 0 4.720800195201491e-09
an O 0 0.0031809438951313496
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 0 1.4980703326727962e-06
embraces O 0 4.6418545451842874e-08
a O 0 9.030173830915089e-10
variety O 0 1.5074078096866117e-10
of O 0 1.0629222328695231e-11
clinical O 0 2.6542881226276904e-09
features O 0 1.6592456120179122e-07
and O 0 7.072827656884328e-08
manifests O 0 1.1610075745238646e-07
extreme O 0 1.011813537843409e-06
radiosensitivity O 0 9.332940862805117e-06
and O 0 8.380380278616428e-10
a O 0 4.884299631413569e-10
strong O 0 1.0623765867023849e-08
pre O 0 8.943549801188055e-06
- O 0 6.0628095525316894e-05
disposition O 0 3.7818031159986276e-06
to O 0 1.3587795777425526e-08
malignancy B-Disease 0 0.0006683782557956874
. O 0 1.1581496650592271e-08

Heterozygotes O 0 1.300759868172463e-05
for O 0 3.62472191151042e-10
the O 0 4.857123384049977e-11
ATM O 0 4.364171957149665e-07
gene O 0 5.458811358494131e-08
have O 0 1.6343052466893937e-09
no O 0 1.1009142486528845e-09
clinical O 0 9.971156123000924e-10
expression O 0 2.246119024107429e-08
of O 0 1.2665019033519798e-09
A B-Disease 1 0.9999969005584717
- I-Disease 1 0.9999985694885254
T I-Disease 1 1.0
but O 0 0.00023515263455919921
may O 0 5.281210178509355e-06
be O 0 4.064334007125581e-06
cancer B-Disease 0 9.985903488995973e-06
prone O 0 5.1751212595263496e-05
with O 0 8.451082889049388e-11
a O 0 4.266799358276785e-09
moderate O 0 2.0970105651940685e-07
increase O 0 2.1809281491869115e-08
in O 0 6.646886374639394e-10
in O 0 9.572228565346563e-10
vitro O 0 1.7511906662548427e-06
radiosensitivity O 0 5.2901905291946605e-05
. O 0 4.5780030433206775e-08

We O 0 5.559218152484391e-07
performed O 0 7.045532601779314e-09
a O 0 7.44565020749377e-10
blind O 0 2.5542611581386154e-08
chromosomal O 0 3.929592367057921e-06
analysis O 0 5.309742867609657e-09
on O 0 1.6909760258698725e-09
G2 O 0 1.5130110853078804e-07
- O 0 1.1468524263591462e-07
phase O 0 1.1589716741866596e-08
lymphocytes O 0 1.9428938458077027e-08
from O 0 2.882166727502522e-11
7 O 0 3.157386574415e-10
unrelated O 0 2.3448880881460354e-07
A B-Disease 1 0.9999960660934448
- I-Disease 1 0.9999985694885254
T I-Disease 1 1.0
patients O 0 7.509322585974587e-07
, O 0 4.018732568944472e-11
13 O 0 4.5128012438055976e-11
obligate O 0 1.6542669811769883e-07
A B-Disease 1 0.999995231628418
- I-Disease 1 0.9999978542327881
T I-Disease 1 0.9999998807907104
heterozygotes O 0 0.0004213603388052434
( O 0 8.77463865456285e-11
parents O 0 1.615584610537013e-10
of O 0 2.405687845111193e-12
the O 0 2.428029166612333e-10
patients O 0 1.0547058781895657e-09
) O 0 4.419153411261423e-12
, O 0 5.512926920525629e-12
and O 0 7.514729116753216e-11
14 O 0 1.8945239474432718e-11
normal O 0 1.570586438681687e-10
controls O 0 1.5813664822061924e-09
following O 0 2.0740323347645528e-10
X O 0 2.4458765892632073e-06
- O 0 2.7836245308776597e-08
irradiation O 0 1.1203075800381157e-08
with O 0 9.174036530446017e-11
1 O 0 3.2827743301488965e-10
Gy O 0 8.631470791442553e-07
in O 0 2.2949159933505214e-11
order O 0 3.02522265051286e-12
to O 0 2.398979452589156e-12
evaluate O 0 4.887160121036516e-10
this O 0 1.3635155504676533e-11
cytogenetic O 0 7.103950139253357e-08
method O 0 4.0610836915533355e-10
as O 0 9.072426837564151e-12
a O 0 4.6293455180368426e-11
tool O 0 2.4926309905026756e-09
for O 0 7.138014138097226e-12
detection O 0 8.22630674690572e-09
of O 0 3.900865741535142e-11
ATM O 0 3.56260352418758e-05
carriers O 0 2.5034296413650736e-07
. O 0 1.0159566521394936e-08

Both O 0 1.458610995541676e-06
A B-Disease 1 0.9998714923858643
- I-Disease 1 0.9999740123748779
T I-Disease 1 0.999998927116394
homozygotes O 0 0.0022057066671550274
and O 0 2.528260267808946e-09
heterozygotes O 0 3.708306621774682e-07
showed O 0 1.3375024821016268e-07
significantly O 0 6.3657998872201915e-09
increased O 0 1.469543486898317e-09
levels O 0 1.0526825633405679e-08
of O 0 6.76048939052265e-10
radiation O 1 0.9999847412109375
- O 0 0.07437778264284134
induced O 0 0.014037666842341423
chromatid O 0 0.0232935082167387
damage O 0 0.002538764849305153
relative O 0 1.0995654520229436e-06
to O 0 2.001742382962135e-10
that O 0 2.2712628999776996e-10
of O 0 5.7428600069853175e-11
normal O 0 4.300537170820462e-08
controls O 0 8.950358392212365e-07
. O 0 4.174620471530943e-08

These O 0 3.6672760383993364e-09
results O 0 4.899706862460107e-09
show O 0 4.5453902863812345e-09
that O 0 2.7556118845084576e-11
the O 0 1.5451511597985856e-11
G2 O 0 8.17825025478669e-08
- O 0 5.195161278948035e-08
phase O 0 3.2449267717282737e-09
chromosomal O 0 7.895268936408684e-06
radiosensitivity O 0 8.569962233195838e-07
assay O 0 1.3184518365960685e-06
can O 0 3.729493514015303e-08
be O 0 7.468161505874704e-11
used O 0 1.0433267444431849e-10
for O 0 2.356090799890409e-12
the O 0 1.4243505680466839e-11
detection O 0 1.3980472601815563e-07
of O 0 2.8912543470482888e-09
A B-Disease 1 0.9999971389770508
- I-Disease 1 0.999995231628418
T I-Disease 1 0.999998927116394
heterozygotes O 0 0.0014933461789041758
. O 0 1.0330746391673529e-07

In O 0 1.437074725885168e-08
combination O 0 3.402842096988934e-08
with O 0 5.170915917673824e-10
molecular O 0 1.7415244428775623e-06
genetic O 0 6.025803145348618e-07
analyses O 0 1.0988442227244377e-06
, O 0 8.85926124127856e-11
this O 0 1.642974367666028e-10
test O 0 1.509855174219865e-08
may O 0 4.824608712539202e-09
be O 0 4.277918297379557e-11
of O 0 5.87360618042182e-13
value O 0 6.345382552730428e-10
in O 0 3.503836804030769e-11
studies O 0 1.8560035452974688e-11
of O 0 1.7208487239350756e-12
familial B-Disease 0 9.696000233816449e-07
and I-Disease 0 5.216728737877929e-08
sporadic I-Disease 0 1.7074324205168523e-05
cancers I-Disease 0 0.011587215587496758
aimed O 0 1.285559125818736e-08
at O 0 2.090599249271463e-09
determination O 0 1.0626926894019562e-08
of O 0 1.8725726264740006e-12
the O 0 2.401818327557592e-12
potential O 0 3.709439352905797e-11
involvement O 0 2.0571386261103441e-10
of O 0 1.1093954747909418e-11
ATM O 0 1.2981872714590281e-05
mutations O 0 3.317686150694499e-06
in O 0 1.093348078740064e-08
tumor B-Disease 0 0.00034219390363432467
risk O 0 6.427129392250208e-06
or O 0 4.35599467607517e-09
development O 0 5.924098989140703e-10
. O 0 8.728106570821126e-10
. O 0 2.413007349488794e-09

Ataxia B-Disease 1 0.9999985694885254
- I-Disease 1 0.9999861717224121
telangiectasia I-Disease 1 0.999998927116394
: O 0 3.556916183811154e-08
identification O 0 2.3749008093432167e-08
and O 0 1.8284776470700592e-10
detection O 0 2.6680039511006726e-08
of O 0 3.556178268526722e-11
founder O 0 4.9108805910691444e-08
- O 0 1.3148018297215458e-05
effect O 0 1.7625525572384504e-07
mutations O 0 2.2581342307148589e-07
in O 0 5.8397314761649e-11
the O 0 1.050857404566452e-11
ATM O 0 5.401453506692633e-08
gene O 0 1.2950827077418126e-09
in O 0 8.6488878558999e-11
ethnic O 0 5.666372371315731e-10
populations O 0 5.1473438844595876e-08
. O 0 2.341709581799023e-08

To O 0 2.0301971215275216e-09
facilitate O 0 8.531238493425519e-10
the O 0 1.0359561125605765e-10
evaluation O 0 1.499207286093096e-10
of O 0 3.1303575183383447e-12
ATM O 0 7.373679267175248e-08
heterozygotes O 0 5.497806654375381e-08
for O 0 3.9454401551397567e-11
susceptibility O 0 1.9326798792462796e-06
to O 0 3.156049588337595e-10
other O 0 2.4067701165364497e-09
diseases O 0 2.965951580335968e-06
, O 0 6.893755098019705e-12
such O 0 3.609845061758321e-11
as O 0 1.0648194859186333e-07
breast B-Disease 1 0.9905120730400085
cancer I-Disease 0 0.00432113092392683
, O 0 1.898222468099675e-09
we O 0 1.9100185877363174e-09
have O 0 3.381608534858138e-11
attempted O 0 8.698490261416225e-10
to O 0 3.6386779006525316e-11
define O 0 5.071406850021276e-09
the O 0 3.995680869506302e-11
most O 0 4.332590883282528e-11
common O 0 9.148057866781301e-10
mutations O 0 1.5386186547061698e-08
and O 0 5.323386870204061e-11
their O 0 2.1609429523561374e-10
frequencies O 0 2.7264597974863136e-06
in O 0 4.005210030300077e-07
ataxia B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999991655349731
telangiectasia I-Disease 1 1.0
( O 0 0.00013801422028336674
A B-Disease 1 0.9999997615814209
- I-Disease 1 0.9999996423721313
T I-Disease 1 0.9999998807907104
) O 0 3.612059540358814e-09
homozygotes O 0 3.977924052378512e-07
from O 0 6.272554697872579e-11
10 O 0 8.765304454483314e-11
ethnic O 0 1.1499913243895321e-09
populations O 0 3.945055127019259e-08
. O 0 1.501017088401113e-08

Both O 0 1.587411269099448e-08
genomic O 0 9.484707561568939e-07
mutations O 0 7.857220043661073e-05
and O 0 2.815629729369107e-09
their O 0 3.524805725074742e-10
effects O 0 8.644909854638172e-08
on O 0 4.604613579317629e-09
cDNA O 0 7.320732464677349e-09
were O 0 2.085327466261333e-08
characterized O 0 8.068951729001128e-07
. O 0 2.902594253839652e-08

Protein O 0 4.888955231763248e-07
- O 0 2.2806119659435353e-07
truncation O 0 4.3381540137943375e-08
testing O 0 9.45831235554806e-09
of O 0 6.905191262535082e-12
the O 0 1.6386329793061094e-11
entire O 0 7.444496408215429e-11
ATM O 0 7.710291072271502e-09
cDNA O 0 1.929748583151536e-09
detected O 0 8.173228849273073e-08
92 O 0 4.17875664626699e-11
( O 0 2.2858720125085163e-12
66 O 0 2.3047506611528767e-11
% O 0 6.657765484752165e-12
) O 0 2.995880236597581e-12
truncating O 0 9.672715961528411e-09
mutations O 0 5.699199334685545e-08
in O 0 1.2298317919601232e-10
140 O 0 2.32069807815094e-10
mutant O 0 3.697845940564548e-08
alleles O 0 2.2413264844090008e-07
screened O 0 6.512975232908502e-06
. O 0 7.81977291808289e-08

The O 0 8.782416571762042e-09
haplotyping O 0 1.0547324791332358e-06
of O 0 1.9737553258458718e-10
patients O 0 1.9592856226324784e-09
with O 0 2.3223808987005157e-10
identical O 0 0.0010597581276670098
mutations O 0 7.33712886358262e-06
indicates O 0 2.1333005406631855e-07
that O 0 4.6119771890396066e-10
almost O 0 3.2168719077407815e-11
all O 0 1.0081580752510644e-12
of O 0 4.893850624222706e-13
these O 0 5.798462404671412e-12
represent O 0 5.961250937325246e-11
common O 0 2.0667278999297878e-09
ancestry O 0 9.476627127469328e-08
and O 0 2.197868775866141e-09
that O 0 7.790170730714863e-10
very O 0 3.789087932304369e-10
few O 0 5.464951824407649e-10
spontaneously O 0 9.277248302907992e-09
recurring O 0 1.0170310815738048e-07
ATM O 0 0.00013529405987355858
mutations O 0 3.233978713979013e-05
exist O 0 3.6182811413709715e-07
. O 0 8.319434918746538e-09

Assays O 0 4.170349711785093e-06
requiring O 0 4.986988599853248e-08
minimal O 0 3.726208674947884e-08
amounts O 0 5.158778959568622e-10
of O 0 3.912182210130677e-12
genomic O 0 2.7921842615796777e-09
DNA O 0 4.2333954297646414e-07
were O 0 1.4446370766307837e-09
designed O 0 4.547838017288086e-08
to O 0 2.967435325240686e-11
allow O 0 5.689111334805652e-11
rapid O 0 4.2129794097789386e-10
screening O 0 2.69498534599677e-10
for O 0 1.2355302544952984e-11
common O 0 2.760042472349511e-10
ethnic O 0 1.4400071135511894e-09
mutations O 0 2.4432822556264e-06
. O 0 1.872508548217411e-08

These O 0 1.636569879615024e-09
rapid O 0 8.312930788179074e-09
assays O 0 1.4142655118121183e-06
detected O 0 6.304152520897333e-06
mutations O 0 1.2061624943271454e-07
in O 0 6.264853913418023e-11
76 O 0 1.4955800486937676e-10
% O 0 6.091624600579326e-12
of O 0 1.2547907157767213e-11
Costa O 0 2.1754695467279817e-07
Rican O 0 9.543830401526066e-07
patients O 0 2.9997502259959674e-09
( O 0 2.4570506219900867e-12
3 O 0 2.7796820834674607e-12
) O 0 1.0357035731432471e-13
, O 0 2.9336776063981773e-13
50 O 0 1.0784625146045834e-12
% O 0 2.289370136607932e-13
of O 0 6.6806881207637225e-12
Norwegian O 0 0.011221833527088165
patients O 0 2.1047195986056977e-08
( O 0 3.1487353956832775e-12
1 O 0 1.721302614332565e-11
) O 0 4.283776838028691e-13
, O 0 5.277614283094589e-13
25 O 0 4.4055511734357455e-13
% O 0 2.543714208453479e-13
of O 0 6.212517913301019e-12
Polish O 0 0.0037622060626745224
patients O 0 3.334257669962426e-08
( O 0 2.3516740638163114e-11
4 O 0 1.6381861145386978e-11
) O 0 5.356912287889093e-13
, O 0 6.523064965784087e-13
and O 0 5.112773919513369e-12
14 O 0 1.0544689036870447e-12
% O 0 1.3149328631154034e-13
of O 0 1.5759201669324208e-12
Italian O 0 1.0540326229602215e-06
patients O 0 2.7647820033394055e-08
( O 0 1.3764001223492972e-11
1 O 0 6.475296687735721e-11
) O 0 5.472958024277386e-12
, O 0 1.5037735596676316e-12
as O 0 6.043551076251319e-12
well O 0 1.1545313316485561e-10
as O 0 5.289157653520782e-11
in O 0 1.6170643990509603e-10
patients O 0 1.396074783555079e-10
of O 0 1.1148000925165213e-11
Amish O 0 2.768838157862774e-06
/ O 0 5.488470833370229e-07
Mennonite O 0 9.340602247220886e-08
and O 0 1.2157322260009096e-08
Irish O 0 6.223928039617022e-07
English O 0 8.390335892727308e-08
backgrounds O 0 2.705139365843934e-07
. O 0 1.4304950113341874e-08

Additional O 0 1.7567588272981993e-08
mutations O 0 4.037561211589491e-06
were O 0 3.894639721835347e-09
observed O 0 2.878633154068666e-08
in O 0 6.524191603629603e-11
Japanese O 0 9.926700350604278e-09
, O 0 3.784670927348133e-12
Utah O 0 4.874738807059131e-11
Mormon O 0 2.3384344807753088e-11
, O 0 5.2631614344544886e-12
and O 0 3.673404636028721e-11
African O 0 6.5391032866291e-11
American O 0 1.599995691492495e-08
patients O 0 1.0187645393955336e-08
. O 0 5.770315336661724e-09

These O 0 3.345263621667982e-09
assays O 0 1.5290468979856087e-07
should O 0 3.9614284075284445e-10
facilitate O 0 4.143778722931479e-11
screening O 0 1.581517361515239e-09
for O 0 4.866308689344123e-09
A B-Disease 1 0.9999923706054688
- I-Disease 1 0.9999890327453613
T I-Disease 1 0.9999994039535522
heterozygotes O 0 8.217924914788455e-06
in O 0 3.175262830446002e-10
the O 0 8.321490024831846e-11
populations O 0 1.0884888546058846e-09
studied O 0 5.253581125685969e-09
. O 0 2.7441687810991766e-10
. O 0 1.0770990765962551e-09

The O 0 1.3406585139819072e-06
von B-Disease 1 0.9813613295555115
Hippel I-Disease 1 0.9995094537734985
- I-Disease 1 0.9855440258979797
Lindau I-Disease 1 0.9961380362510681
tumor I-Disease 0 0.008488967083394527
suppressor O 0 4.1414943552808836e-05
gene O 0 5.058165584159724e-07
is O 0 9.533872580291813e-10
required O 0 1.3217341110483005e-10
for O 0 1.0395917633687635e-11
cell O 0 5.8400633662358814e-08
cycle O 0 5.105375677771917e-09
exit O 0 2.24317231456439e-09
upon O 0 1.1135303790155149e-09
serum O 0 7.349387374233629e-07
withdrawal O 0 1.5874391579018265e-07
. O 0 5.615142129045125e-09

The O 0 2.2250377540444788e-08
inactivation O 0 6.746531653334387e-07
of O 0 1.5595325031370066e-10
the O 0 2.2468975569012173e-09
von B-Disease 1 0.9988107681274414
Hippel I-Disease 1 0.9999434947967529
- I-Disease 1 0.9996656179428101
Lindau I-Disease 1 0.9996354579925537
( I-Disease 0 1.1871219385284348e-07
VHL I-Disease 0 5.211849929764867e-05
) I-Disease 0 1.0087957552640248e-10
tumor I-Disease 0 2.1878595646285248e-07
suppressor O 0 2.7702460556611186e-06
gene O 0 2.57400557757137e-07
predisposes O 0 6.198355094966246e-06
affected O 0 1.3581008317942178e-08
individuals O 0 1.1543221239973533e-10
to O 0 1.55637377985407e-10
the O 0 1.975218566485637e-08
human O 0 0.014272109605371952
VHL B-Disease 1 0.999996542930603
cancer I-Disease 1 0.9999856948852539
syndrome I-Disease 1 0.99997878074646
and O 0 5.9484367653794834e-08
is O 0 1.7932769713624452e-09
associated O 0 1.1876989169934404e-08
with O 0 4.9055044470946996e-09
sporadic B-Disease 0 0.054669830948114395
renal I-Disease 1 0.9999353885650635
cell I-Disease 1 0.9999849796295166
carcinomas I-Disease 1 1.0
( O 0 5.43413534614956e-06
RCC B-Disease 1 0.8788127899169922
) O 0 4.630286376539061e-09
and O 0 5.259027702209096e-08
brain B-Disease 0 0.004162652883678675
hemangioblastomas I-Disease 0 0.0012735582422465086
. O 0 1.0785802118107313e-07

VHL O 0 0.04549147188663483
- O 0 2.796284570649732e-05
negative O 0 2.234071644124924e-06
786 O 0 7.067283604555996e-06
- O 0 0.00015916423581074923
0 O 0 4.930910080247486e-08
RCC B-Disease 0 7.788916263962165e-05
cells O 0 1.2162006512994594e-08
are O 0 5.2997915084285196e-11
tumorigenic O 0 3.887847412897827e-07
in O 0 2.3948869554146768e-09
nude O 1 0.5734816789627075
mice O 0 0.00013054641021881253
which O 0 5.008271575235312e-09
is O 0 8.215792629551188e-11
suppressed O 0 1.1424510226731854e-09
by O 0 1.5198616670764054e-11
the O 0 2.9224327818822005e-11
reintroduction O 0 5.590743867855963e-09
of O 0 9.015993507333064e-10
VHL B-Disease 0 3.774412834900431e-05
. O 0 1.6914285083657887e-08

Remarkably O 0 3.6907036701450124e-05
, O 0 1.625909545888149e-10
this O 0 2.4351609270722996e-11
occurs O 0 1.762862633647444e-10
without O 0 3.1617118645410613e-11
affecting O 0 8.617322133641636e-11
the O 0 1.0727678294297771e-11
growth O 0 2.1780337533527927e-09
rate O 0 9.67393454232024e-09
and O 0 1.2174381294749459e-11
cell O 0 1.1351534823234033e-08
cycle O 0 2.6935478292244852e-09
profile O 0 7.832203330337961e-09
of O 0 6.112959530929496e-12
these O 0 5.337539091265775e-11
cells O 0 4.2221018348165273e-10
in O 0 1.069287366983751e-10
culture O 0 1.1376743103141962e-08
. O 0 4.156075039674079e-09

The O 0 1.4936430758893948e-08
786 O 0 6.005012664900278e-07
- O 0 6.491050044132862e-06
0 O 0 8.702444098673823e-09
cell O 0 1.0575001851975685e-06
line O 0 4.7351005605378305e-07
, O 0 4.888181005802128e-12
like O 0 8.393508804660499e-11
many O 0 4.489655175410334e-11
cancer B-Disease 0 4.7151331727945944e-08
cells O 0 8.401329631979593e-10
, O 0 1.0426457440482206e-11
fails O 0 1.6432822880219078e-09
to O 0 2.719239980755739e-12
exit O 0 2.913829455497563e-10
the O 0 8.273615126341838e-11
cell O 0 3.608198184679168e-08
cycle O 0 2.7912046007827485e-09
upon O 0 4.1864492428267397e-10
serum O 0 2.808211831961671e-07
withdrawal O 0 8.148681729380769e-08
. O 0 7.943140367672186e-09

Here O 0 6.30408976576291e-07
, O 0 2.67787653163154e-10
it O 0 4.315600654614116e-11
is O 0 2.046305486169686e-11
shown O 0 1.71809899640607e-10
that O 0 4.154436343550838e-12
reintroduction O 0 7.279399999449154e-11
of O 0 7.402972549211406e-13
the O 0 2.0683307497271208e-11
wild O 0 5.716517481602068e-09
- O 0 1.3088680134387687e-05
type O 0 3.332829146529548e-05
VHL B-Disease 0 6.403935003618244e-06
gene O 0 2.086444572668711e-09
restores O 0 3.0989775190448654e-09
the O 0 8.76509888975141e-12
ability O 0 2.718786307198684e-10
of O 0 8.947838997519497e-11
VHL O 0 0.00013800369924865663
- O 0 1.6231841073022224e-05
negative O 0 6.008075433783233e-05
RCC B-Disease 1 0.7228485345840454
cancer I-Disease 0 5.603733370662667e-07
cells O 0 1.6790037415947978e-10
to O 0 2.4105932094203864e-12
exit O 0 3.2984021069992764e-10
the O 0 8.138744539420983e-11
cell O 0 1.0747195489102523e-07
cycle O 0 1.5193297731030952e-09
and O 0 4.439905734732186e-11
enter O 0 6.471669311558514e-10
G0 O 0 3.932802030703897e-07
/ O 0 2.7394337465125318e-08
quiescence O 0 3.8845601579851063e-07
in O 0 4.379437701373945e-09
low O 0 1.8210474763691309e-06
serum O 0 1.1935308066313155e-05
. O 0 2.034570911746414e-08

Both O 0 3.5573714285419555e-07
VHL O 0 0.0007567107095383108
- O 0 8.328158401127439e-06
positive O 0 2.985652614029277e-08
and O 0 2.15488658028562e-08
VHL O 0 0.00010386164649389684
- O 0 1.41839598200022e-06
negative O 0 6.480514116447011e-07
RCC B-Disease 0 1.7662792743067257e-05
cells O 0 8.593084022123776e-10
exit O 0 6.577923206130265e-10
the O 0 3.060610445637657e-11
cell O 0 5.0726285394375736e-08
cycle O 0 1.1078276074272253e-09
by O 0 2.475628382847539e-11
contact O 0 7.343419383687433e-08
inhibition O 0 1.1891410878206443e-07
. O 0 6.557632659109913e-09

The O 0 9.941255996182008e-08
cyclin O 0 0.0006899763247929513
- O 0 7.304190603463212e-06
dependent O 0 1.311485249289035e-07
kinase O 0 2.3010255745248287e-07
inhibitor O 0 4.543520049082872e-08
, O 0 1.6334746055779448e-11
p27 O 0 2.2950714662073324e-09
, O 0 6.029090421355576e-12
accumulates O 0 2.109412644557551e-09
upon O 0 6.535063462598245e-11
serum O 0 5.318868545600708e-08
withdrawal O 0 1.086293099916702e-08
, O 0 5.036734484348271e-12
only O 0 1.2732381338489973e-12
in O 0 1.2676938491995582e-12
the O 0 6.378844067539413e-12
presence O 0 4.4241338370554217e-10
of O 0 4.036462136758345e-11
VHL B-Disease 0 2.819447217916604e-06
, O 0 4.005094433184864e-12
as O 0 1.1655712202698898e-12
a O 0 3.005434096037263e-11
result O 0 3.3149516465158513e-10
of O 0 1.025525584591458e-12
the O 0 1.4354343234879163e-11
stabilization O 0 1.8023880166140316e-09
of O 0 3.668725913341664e-12
the O 0 1.0930800709019195e-10
protein O 0 2.376866259368171e-09
. O 0 1.7978867283829914e-09

We O 0 4.527274555243821e-08
propose O 0 3.9815346575267085e-09
that O 0 5.4793006937225996e-11
the O 0 1.4100567935493302e-11
loss O 0 5.855482765326769e-10
of O 0 4.0003152700085476e-12
wild O 0 2.2088341822268376e-08
- O 0 7.359618757618591e-05
type O 0 0.00021306908456608653
VHL B-Disease 0 1.4019999071024358e-05
gene O 0 6.410834973991086e-09
results O 0 7.632358633991032e-10
in O 0 4.721999700973978e-12
a O 0 1.0917007575717008e-10
specific O 0 2.405498911173254e-09
cellular O 0 1.1649859516182914e-05
defect O 0 1.9918436009902507e-05
in O 0 2.7069901875620417e-09
serum O 0 8.124833584588487e-06
- O 0 7.71639224694809e-06
dependent O 0 7.069738217069244e-07
growth O 0 8.816087415652873e-08
control O 0 3.440780815822109e-08
, O 0 1.6265609692478478e-10
which O 0 2.307584540117702e-10
may O 0 2.0899055819256773e-09
initiate O 0 1.4739513609640653e-08
tumor B-Disease 0 1.0935326827166136e-05
formation O 0 2.0804476719149534e-07
. O 0 1.5471705694380944e-08

This O 0 4.266630782012726e-08
is O 0 1.1098008068088916e-09
corrected O 0 1.3162409828737509e-08
by O 0 1.1711869538424957e-12
the O 0 1.3163388564926826e-12
reintroduction O 0 2.6977728384558475e-10
of O 0 8.968303530365596e-12
wild O 0 9.151098545601144e-09
- O 0 0.000513354258146137
type O 0 0.04769299551844597
VHL B-Disease 0 0.0009294920600950718
, O 0 1.308951835810035e-10
implicating O 0 5.6555877563368995e-06
VHL B-Disease 0 8.120216989482287e-06
as O 0 2.9008741589398035e-11
the O 0 4.005865951450804e-12
first O 0 1.3870372905788741e-10
tumor B-Disease 0 3.1645342346564576e-08
suppressor O 0 6.341637970308511e-08
involved O 0 6.893235982019519e-10
in O 0 1.9954286487045003e-11
the O 0 8.96452443527318e-12
regulation O 0 4.743442860721814e-10
of O 0 2.19282816731059e-12
cell O 0 1.6599857488586167e-08
cycle O 0 6.630438420529572e-10
exit O 0 2.971199064560892e-09
, O 0 5.1900431868867614e-11
which O 0 3.756633337737014e-10
is O 0 1.3301507117979838e-10
consistent O 0 7.3245596254878365e-09
with O 0 9.336613079891087e-12
its O 0 3.4472130011620195e-11
gatekeeper O 0 1.1294216228918685e-08
function O 0 1.1161713775464932e-09
in O 0 1.0878884598719551e-10
the O 0 3.485575161832344e-10
kidney O 0 1.7610169322779257e-07
. O 0 1.8666275192202875e-09
. O 0 5.059581198452179e-09

Piebaldism B-Disease 1 0.9999819993972778
with O 0 0.0002640449383761734
deafness B-Disease 1 0.9999997615814209
: O 0 1.5869147773628356e-08
molecular O 0 3.793463463352964e-07
evidence O 0 4.672961573248813e-09
for O 0 9.903561998259036e-11
an O 0 2.3682726890683625e-09
expanded O 0 0.00014895532513037324
syndrome O 1 0.9992469549179077
. O 0 5.0260158701576074e-08

In O 0 1.7245783467956244e-08
a O 0 4.800486230749357e-09
South O 0 6.858757450878272e-10
African O 0 2.996306258662429e-10
girl O 0 7.60369758268098e-08
of O 0 2.457876610573173e-11
Xhosa O 0 5.897296162515886e-08
stock O 0 1.0427229746312605e-08
with O 0 1.603245314285573e-09
severe O 0 8.775420610618312e-06
piebaldism B-Disease 0 0.0008282764465548098
and O 0 7.068531431286829e-07
profound O 0 0.01825769431889057
congenital O 1 0.9999978542327881
sensorineural B-Disease 1 0.9999982118606567
deafness I-Disease 1 1.0
we O 0 4.638593236450106e-05
identified O 0 7.636734977722881e-08
a O 0 2.2640700425569094e-10
novel O 0 2.040888569254662e-10
missense O 0 5.7626849070402386e-08
substitution O 0 2.675978549859792e-09
at O 0 1.4505899814665213e-09
a O 0 1.2493442391736664e-10
highly O 0 3.850315621889422e-09
conserved O 0 1.4253257241136907e-08
residue O 0 2.6624076099324157e-07
in O 0 3.1402023342730345e-11
the O 0 1.6015321013806982e-11
intracellular O 0 1.842543007057884e-08
kinase O 0 5.7978630785271434e-09
domain O 0 3.59317464670994e-10
of O 0 5.317478228572536e-12
the O 0 2.650836217199526e-10
KIT O 0 0.00022045096557121724
proto O 0 0.0005626356578432024
- O 0 0.0006533887353725731
oncogene O 0 9.37898857955588e-06
, O 0 9.785199317491333e-10
R796G O 0 9.898099051497411e-08
. O 0 4.148266619097285e-09

Though O 0 3.5879330084753747e-07
auditory B-Disease 0 9.395433153258637e-06
anomalies I-Disease 0 0.014172405935823917
have O 0 4.706911482799114e-08
been O 0 1.0145702056263417e-08
observed O 0 1.0271116934745805e-07
in O 0 7.455541184420156e-10
mice O 0 3.637805718881282e-07
with O 0 8.75992722804142e-10
dominant O 0 1.629365442568087e-06
white O 0 3.7918064208497526e-06
spotting O 0 8.090966730378568e-05
( O 0 9.692177060927065e-10
W O 0 0.016577498987317085
) O 0 2.6474190895076077e-11
due O 0 2.334211157695165e-10
to O 0 1.393051118903088e-09
KIT O 1 0.7589874863624573
mutations O 0 0.03918584808707237
, O 0 1.3619901437778026e-06
deafness B-Disease 1 0.9999998807907104
is O 0 3.871806697475222e-08
not O 0 4.14964373973703e-09
typical O 0 2.884183913920424e-08
in O 0 1.3664614995079205e-09
human O 0 1.1679412992293692e-08
piebaldism B-Disease 0 1.4087239833315834e-05
. O 0 2.2077982109180994e-08

Thus O 0 2.5719589302752865e-07
, O 0 1.2646811375915945e-10
the O 0 4.727589500430618e-11
occurrence O 0 3.4984742569577065e-07
of O 0 2.604270354922278e-09
sensorineural B-Disease 1 0.9999804496765137
deafness I-Disease 1 1.0
in O 0 4.6794127683824627e-07
this O 0 6.929121720844478e-09
patient O 0 5.549896187062586e-08
extends O 0 1.3658622011192278e-09
considerably O 0 1.6916406053724131e-09
the O 0 1.0420692087009797e-11
phenotypic O 0 6.435312727148812e-09
range O 0 1.8705763604742742e-09
of O 0 1.970372823234534e-11
piebaldism B-Disease 0 6.195916171236604e-07
due O 0 5.016414506009426e-10
to O 0 3.508839746535486e-11
KIT O 0 1.8660305158846313e-06
gene O 0 2.4383529861893294e-08
mutation O 0 9.21789933272521e-08
in O 0 1.360131729466474e-10
humans O 0 8.665685391484601e-10
and O 0 1.176754665932478e-10
tightens O 0 1.5244719975271437e-07
the O 0 1.2334754051490648e-10
clinical O 0 1.4265053582818155e-09
similarity O 0 6.943939645509545e-09
between O 0 1.0312153353453368e-09
piebaldism B-Disease 0 4.801706836587982e-06
and O 0 6.71285804720867e-10
the O 0 3.642828660249675e-12
various O 0 9.92534179844462e-12
forms O 0 6.740304314689638e-09
of O 0 1.5818852716620313e-06
Waardenburg B-Disease 1 0.999988317489624
syndrome I-Disease 1 0.9998195767402649
. O 0 4.310257928352712e-09
. O 0 9.595209959911699e-09

Cycloheximide O 0 8.73676617629826e-06
facilitates O 0 5.0388969441428344e-08
the O 0 2.1483714807146725e-10
identification O 0 3.587123487136523e-09
of O 0 3.809666471177309e-11
aberrant O 0 8.149039132376856e-08
transcripts O 0 1.589605602703159e-07
resulting O 0 2.7915893596741626e-08
from O 0 8.840186915826109e-11
a O 0 4.691383392874116e-10
novel O 0 1.3626095807239835e-09
splice O 0 5.495405162037059e-07
- O 0 8.217015420086682e-06
site O 0 2.512978767299501e-07
mutation O 0 9.82980168373615e-07
in O 0 6.021431131486565e-10
COL17A1 O 0 5.066999165137531e-06
in O 0 2.705672630387568e-10
a O 0 1.2432813001339582e-08
patient O 0 2.7429348392615793e-07
with O 0 9.14746944857825e-09
generalized O 0 9.222251537721604e-05
atrophic B-Disease 1 0.9983193278312683
benign I-Disease 1 0.9976639747619629
epidermolysis I-Disease 1 0.9966210126876831
bullosa I-Disease 1 0.9879468083381653
. O 0 2.633631766002509e-06

Patients O 0 2.720846350712236e-05
with O 0 4.1390688210185544e-08
generalized O 0 0.00013914270675741136
atrophic B-Disease 1 0.9973057508468628
benign I-Disease 1 0.9926539659500122
epidermolysis I-Disease 1 0.9951477646827698
bullosa I-Disease 1 0.9846975803375244
often O 0 2.1189785002206918e-06
show O 0 1.7708539701288828e-07
decreased O 0 6.36390851127544e-08
expression O 0 3.372542689561442e-09
of O 0 5.7132520936420406e-11
type O 0 3.0674222216475755e-05
XVII O 0 6.1383648244373035e-06
collagen O 0 3.5959695310339157e-07
, O 0 6.60689072895515e-11
a O 0 3.67634367393066e-10
transmembrane O 0 4.774810236085614e-07
hemidesmosomal O 0 1.4791396552027436e-07
protein O 0 3.983537943952342e-10
encoded O 0 1.3871490622818783e-09
by O 0 6.991326406691201e-10
COL17A1 O 0 0.00011065844591939822
. O 0 5.336366726282904e-08

This O 0 2.346175875800327e-08
report O 0 2.438537816118469e-09
documents O 0 7.640238441908309e-10
a O 0 2.250748198928676e-10
novel O 0 8.267767026559625e-10
splice O 0 9.570043175699539e-07
- O 0 2.286171911691781e-05
site O 0 2.2627992279922182e-07
mutation O 0 5.178116566639801e-07
in O 0 2.560536227491639e-10
COL17A1 O 0 1.5980749594746158e-06
in O 0 1.2829123874347204e-10
a O 0 3.795932901340393e-09
patient O 0 1.4447788032612152e-07
with O 0 2.4700792522480697e-09
generalized O 0 1.5422820069943555e-05
atrophic B-Disease 1 0.9934873580932617
benign I-Disease 1 0.8527297377586365
epidermolysis I-Disease 1 0.8672977685928345
bullosa I-Disease 1 0.6553944945335388
, O 0 4.441934375876144e-09
and O 0 1.6619736142864383e-10
applies O 0 1.1236492292177047e-10
a O 0 1.6387610018986365e-11
new O 0 5.432687719825191e-12
methodology O 0 1.1496092272578196e-10
to O 0 4.5328641014308335e-12
define O 0 4.715040802238946e-09
and O 0 6.439004884839505e-10
characterize O 0 1.8519438071962213e-07
the O 0 1.3344352012278904e-10
resulting O 0 1.9071428880579333e-09
mRNA O 0 1.4481849053282758e-09
splice O 0 4.523122854038775e-08
variants O 0 7.130638834951242e-08
. O 0 1.4247223845131884e-08

Mutational O 0 0.00036464008735492826
analysis O 0 7.98039465621514e-08
of O 0 7.902622445321583e-10
COL17A1 O 0 3.592794746509753e-05
identified O 0 1.2356929346424295e-07
a O 0 6.120786100183295e-09
maternally O 0 0.00018785562133416533
inherited O 0 0.005649537779390812
G O 0 0.001409078249707818
- O 0 2.6092097868968267e-06
to O 0 2.1720360621202417e-08
- O 0 0.00010992184252245352
T O 0 2.2080686903791502e-05
transversion O 0 5.867876495813107e-08
at O 0 1.1183402121028863e-10
the O 0 2.055247291798956e-11
- O 0 3.3883924999145165e-08
1 O 0 5.867196312125955e-11
position O 0 5.286114879154979e-10
of O 0 6.833535473593777e-12
exon O 0 1.1838827163046517e-07
32 O 0 4.072798542864575e-09
. O 0 3.980912044454499e-09

This O 0 2.558794509610607e-09
acceptor O 0 1.3318708802501078e-08
splice O 0 1.0456824384164065e-06
- O 0 8.892072401067708e-06
site O 0 1.0881100109827457e-07
mutation O 0 4.580037966661621e-07
led O 0 3.654063718272482e-10
to O 0 1.6720201612141494e-11
the O 0 1.459572393502917e-11
formation O 0 2.172361179830773e-10
of O 0 6.887551726869612e-12
aberrant O 0 7.502920063018337e-09
transcripts O 0 1.1189216664320156e-08
present O 0 1.2754178824181395e-09
at O 0 1.0422098739581998e-08
extremely O 0 2.8328745429462288e-06
low O 0 2.6926998543785885e-05
levels O 0 4.329037324168894e-07
. O 0 4.082575166819424e-09

Based O 0 5.38422462170729e-08
on O 0 2.0090951124984713e-09
our O 0 3.285229865923611e-10
recent O 0 1.1962254797825977e-10
finding O 0 2.2147296496743962e-10
that O 0 1.3675349741504306e-10
cycloheximide O 0 7.688280447837315e-07
stabilized O 0 6.029577889421489e-06
mutant O 0 1.7987176192946208e-08
COL17A1 O 0 2.91996997248134e-07
transcripts O 0 9.22334741915165e-09
in O 0 9.161988528960663e-11
keratinocytes O 0 1.4303558337758204e-08
homozygous O 0 5.868299179923042e-09
for O 0 1.6950430642426184e-11
a O 0 7.0824359710286444e-09
frameshift O 0 0.22719736397266388
mutation O 0 8.087079913821071e-05
, O 0 7.809030505567804e-11
the O 0 3.6051661655989165e-11
effects O 0 1.953614514604851e-08
of O 0 6.803077632483445e-12
the O 0 9.411370988088308e-11
splice O 0 8.311554324791359e-07
- O 0 4.171582986600697e-06
site O 0 1.2946740923780453e-07
mutation O 0 2.9350282204632094e-08
on O 0 3.3944291821796924e-11
splicing O 0 2.512098584706024e-10
of O 0 1.3819717072094395e-11
COL17A1 O 0 3.14454695171662e-07
transcripts O 0 7.707085636354805e-09
were O 0 3.2870597910239496e-10
determined O 0 9.927377808693905e-10
using O 0 1.0793751309412514e-10
reverse O 0 1.2046251107733497e-08
transcriptase O 0 1.578736430474237e-08
polymerase O 0 9.72375246988122e-09
chain O 0 1.9497356618103368e-08
reaction O 0 9.111698062724827e-10
of O 0 2.7798412443463816e-12
total O 0 2.0060144517719536e-11
RNA O 0 4.3186659803851057e-10
from O 0 1.5401431865957882e-11
keratinocytes O 0 1.403712612813024e-08
incubated O 0 5.667943003828668e-09
for O 0 1.482978670419577e-11
2 O 0 4.349981486129195e-10
. O 0 1.1461024351788751e-09

5 O 0 2.6431344224420172e-08
h O 0 7.522841656282253e-07
in O 0 5.7606100445362074e-11
the O 0 1.3344598863429535e-11
presence O 0 6.108537009552606e-10
or O 0 1.0910933267993528e-09
absence O 0 4.504324135901072e-10
of O 0 1.0349699396117185e-11
10 O 0 4.421314009350752e-11
microg O 0 3.445640928134708e-08
cycloheximide O 0 2.2137548683076602e-07
per O 0 1.785169345680515e-08
ml O 0 2.707991370698437e-06
. O 0 1.4920543023322352e-08

Using O 0 1.2255291004237279e-08
this O 0 4.0982781057685713e-10
approach O 0 7.340489549534368e-09
, O 0 4.42994113614148e-11
an O 0 1.3064794038286642e-11
abnormally O 0 1.308868746718872e-07
spliced O 0 1.6764425936344196e-06
transcript O 0 0.00024911589571274817
was O 0 1.7890743038151413e-06
identified O 0 1.3197630543970718e-08
that O 0 6.658274192411495e-12
contains O 0 9.968516897357338e-13
an O 0 1.5150380949791042e-13
extra O 0 8.602291622084035e-12
264 O 0 9.740945897118714e-12
bases O 0 4.797003072543049e-11
upstream O 0 2.257170145236742e-11
from O 0 1.3631950386214231e-12
exon O 0 2.4988717761686985e-09
32 O 0 3.211103258293768e-11
, O 0 2.6086513591622174e-12
resulting O 0 1.471980454192945e-10
in O 0 8.84622583519068e-11
a O 0 9.469721007349108e-09
premature O 0 2.000562972170883e-06
termination O 0 3.140955939784362e-08
codon O 0 5.757781806892126e-09
27 O 0 2.492530071229737e-10
bp O 0 1.2531256921022305e-08
downstream O 0 3.387678471078459e-10
from O 0 3.905362144784874e-11
the O 0 2.905061469160586e-10
cryptic O 0 2.762299970981985e-07
splice O 0 4.997882570023648e-07
site O 0 6.684008440061007e-07
. O 0 2.256480335915967e-08

Three O 0 2.330902360014875e-09
other O 0 4.838593067879593e-11
splice O 0 7.801508417060177e-08
variants O 0 7.775690136213598e-08
, O 0 4.3056194026780403e-11
including O 0 1.1175443383193429e-11
one O 0 5.896881594136261e-11
derived O 0 5.3024709623095134e-11
from O 0 2.720791257224131e-12
the O 0 1.0704698846092375e-12
skipping O 0 8.853179994661176e-11
of O 0 5.080877992641453e-12
exon O 0 4.046474089136609e-08
32 O 0 7.82403253296593e-10
, O 0 6.690013126808836e-11
were O 0 2.1772321723290133e-09
also O 0 4.2550718504230645e-09
identified O 0 7.013931622168457e-07
. O 0 1.7884239866816642e-08

These O 0 4.997517510929583e-09
results O 0 6.816363029571448e-09
indicate O 0 2.8173487987004364e-09
the O 0 1.0386007158469379e-11
usefulness O 0 3.9994951794852796e-10
of O 0 3.5742168773278404e-12
cycloheximide O 0 5.567356993196881e-07
treatment O 0 2.7866402518839095e-09
in O 0 3.915364213402661e-11
evaluating O 0 7.758497733156844e-10
the O 0 3.199469161829782e-11
abnormal O 0 8.347882940462625e-10
processing O 0 3.283787131103111e-11
of O 0 8.769309605728692e-13
mRNA O 0 8.916644506085092e-11
due O 0 4.1316800675206267e-11
to O 0 6.5062686141481585e-12
splice O 0 5.1038885118259714e-08
- O 0 2.565597014836385e-06
site O 0 2.1786587467431673e-07
mutations O 0 3.0527348826581147e-06
, O 0 3.498269729451664e-10
because O 0 2.4042385859956994e-08
( O 0 1.4126309844098017e-10
i O 0 6.766893534404517e-07
) O 0 3.777300520979576e-12
aberrant O 0 7.512754307548164e-10
splicing O 0 1.0995376831246517e-09
often O 0 5.129892621802412e-10
generates O 0 6.266291929790668e-10
a O 0 1.0466757460747544e-09
premature O 0 2.2450831238529645e-07
termination O 0 1.3648524976872523e-08
codon O 0 2.845854440991502e-09
, O 0 3.1228391400572875e-11
( O 0 6.565156838306274e-12
ii O 0 1.0208248113485752e-07
) O 0 1.0392308541495865e-11
transcripts O 0 1.7758498005449042e-09
with O 0 6.954831155425722e-10
premature O 0 1.2993866960187006e-07
termination O 0 2.066341764361823e-09
codons O 0 4.305465706178069e-10
can O 0 1.1581468006838236e-09
occur O 0 2.572771329312218e-09
at O 0 4.795880359509397e-10
low O 0 4.1738644540600944e-07
or O 0 1.5288748045350076e-07
undetectable O 0 1.155668815044919e-05
levels O 0 3.5933428677026313e-08
due O 0 2.204000870698053e-10
to O 0 6.446558564743299e-11
nonsense O 0 1.569516570043561e-07
- O 0 2.8174040878070628e-08
mediated O 0 3.3789827824648455e-08
mRNA O 0 2.3207169519423587e-09
decay O 0 1.1579633962810476e-07
, O 0 7.659885746524875e-12
and O 0 1.884972386512196e-11
( O 0 2.5873238013868205e-12
iii O 0 3.4245155600132193e-09
) O 0 3.348577925360585e-12
the O 0 3.7285705772882594e-11
levels O 0 1.5353754934110952e-09
of O 0 2.370093596208711e-13
these O 0 3.336254883468115e-12
transcripts O 0 7.610814756198181e-10
can O 0 6.404182739672137e-10
be O 0 1.4767244371771682e-10
increased O 0 5.041446426989893e-11
by O 0 8.214194602285119e-11
cycloheximide O 0 2.321822194062406e-06
. O 0 6.3458580612518745e-09

A O 0 1.0379056192277858e-07
deletion O 0 1.1101634299848229e-05
mutation O 0 2.1120900782989338e-05
in O 0 2.9731943573807484e-09
COL17A1 O 0 2.818522261804901e-05
in O 0 7.80861708626901e-10
five O 0 3.602906029076536e-10
Austrian O 0 0.00041668571066111326
families O 0 4.60312987726752e-09
with O 0 3.002337489732554e-09
generalized O 0 6.816042150603607e-05
atrophic B-Disease 1 0.9986968636512756
benign I-Disease 1 0.9967358708381653
epidermolysis I-Disease 1 0.9952098727226257
bullosa I-Disease 1 0.9705132246017456
represents O 0 1.2568464171636151e-06
propagation O 0 3.3854314551717835e-07
of O 0 1.0858569599037082e-10
an O 0 1.2728169906939257e-10
ancestral O 0 1.193876528304827e-06
allele O 0 5.794963271910092e-06
. O 0 2.261896803190666e-08

Patients O 0 3.249993460485712e-05
with O 0 8.141473273326483e-08
generalized O 0 0.0003957436128985137
atrophic B-Disease 1 0.9976038336753845
benign I-Disease 1 0.9974689483642578
epidermolysis I-Disease 1 0.997589111328125
bullosa I-Disease 1 0.9948030114173889
, O 0 1.175986330537171e-08
a O 0 5.924595813944222e-10
usually O 0 3.8664454971026885e-10
nonlethal O 0 4.184862678613399e-09
form O 0 1.8458942152577151e-09
of O 0 2.2158126444793425e-09
junctional B-Disease 0 0.08229339122772217
epidermolysis I-Disease 1 0.8726370930671692
bullosa I-Disease 1 0.5660330057144165
, O 0 4.272133757865504e-09
have O 0 3.0290481234374056e-10
generalized O 0 1.431805252138929e-08
blistering B-Disease 0 9.99836720438907e-06
, O 0 3.8829448101296293e-08
nail B-Disease 1 0.9999756813049316
dystrophy I-Disease 1 0.9997685551643372
, O 0 6.180854228432509e-08
patchy B-Disease 0 0.028280718252062798
alopecia I-Disease 1 0.99957674741745
, O 0 4.975976608534438e-08
and O 0 1.8264775007992284e-06
dental B-Disease 1 0.9967935681343079
abnormalities I-Disease 1 0.9989186525344849
. O 0 3.0288001084954885e-07

Skin B-Disease 1 0.9910584092140198
fragility I-Disease 0 0.011032388545572758
in O 0 5.942990100038514e-09
most O 0 7.457798961718609e-11
cases O 0 5.543500103399879e-10
is O 0 5.30337385118429e-10
due O 0 6.125361329267776e-10
to O 0 1.4483304833223798e-10
mutations O 0 1.7091883819375653e-07
in O 0 5.149928747338883e-11
the O 0 1.8712240090756893e-11
gene O 0 1.5311000245432638e-09
encoding O 0 8.463706180350528e-09
type O 0 6.570549157913774e-05
XVII O 0 2.6547621018835343e-05
collagen O 0 5.940306436968967e-06
( O 0 2.73378453208295e-09
COL17A1 O 0 4.6341006964212283e-05
) O 0 7.828241943563796e-10
. O 0 3.6311242901376772e-09

Recently O 0 1.0812556865857914e-05
, O 0 8.802301110222288e-10
we O 0 1.228214863147059e-09
reported O 0 8.156931241565246e-10
five O 0 2.590633783883245e-11
Austrian O 0 1.5076534509717021e-05
families O 0 1.1303455949018826e-09
with O 0 2.0278365653325636e-09
generalized O 0 2.1742534954682924e-05
atrophic B-Disease 1 0.9880743622779846
benign I-Disease 1 0.9566071033477783
epidermolysis I-Disease 1 0.8792089223861694
bullosa I-Disease 1 0.7225891351699829
who O 0 8.15102936257972e-08
share O 0 3.5356011451881386e-09
the O 0 1.9851421895200616e-10
same O 0 6.6507190865650045e-09
COL17A1 O 0 0.00010983215179294348
mutation O 0 1.1397795788070653e-05
. O 0 1.8700029968954368e-08

Affected O 0 2.0787531411770033e-06
individuals O 0 4.6470614023519374e-09
in O 0 3.680714621978609e-10
three O 0 9.642056597591875e-11
families O 0 8.0880011021911e-11
are O 0 1.2466036883318488e-11
homozygous O 0 4.7538706304806055e-09
for O 0 1.4087073521573679e-11
4003delTC O 0 4.062133740490026e-08
, O 0 2.0580795748181835e-11
whereas O 0 1.372123109577572e-10
those O 0 2.695940172492417e-11
in O 0 3.184310107262611e-11
two O 0 1.0038015557656266e-10
others O 0 2.379887398262781e-09
are O 0 1.8450274641423903e-10
compound O 0 2.9267546608480188e-08
heterozygotes O 0 2.974117705889512e-06
. O 0 1.893342016501265e-08

To O 0 5.996082741432929e-09
determine O 0 6.677630892681918e-08
if O 0 1.6976138272895014e-09
the O 0 1.6154419815728183e-11
occurrence O 0 6.459403234515548e-09
of O 0 7.0415049659156015e-12
4003delTC O 0 9.397733435889677e-08
in O 0 1.0406158573728064e-10
these O 0 3.883960861261748e-11
unrelated O 0 6.175242983630369e-09
families O 0 2.220871958558135e-10
signifies O 0 1.0419668461381093e-09
propagation O 0 3.683875149373961e-10
of O 0 1.0116849849181597e-12
an O 0 1.2956893370719147e-11
ancestral O 0 4.374631146220054e-08
allele O 0 6.737941760093236e-08
or O 0 4.193929925566664e-10
a O 0 6.229254334577661e-10
mutational O 0 1.0851988918147981e-05
hot O 0 3.304682422822225e-06
spot O 0 5.662257990479702e-06
, O 0 1.6692676407803475e-10
haplotypes O 0 3.3664516507769804e-08
were O 0 1.0686503237877787e-08
determined O 0 4.320260416079691e-07
for O 0 1.0103824027440922e-10
polymorphisms O 0 2.8786332677555038e-06
both O 0 5.680569903354638e-10
within O 0 2.355019235178446e-10
and O 0 1.9370354209513607e-09
flanking O 0 6.456892879214138e-05
COL17A1 O 0 0.015403160825371742
. O 0 3.270983484071621e-08

Five O 0 4.010178145108512e-08
intragenic O 0 1.7487340073785163e-06
polymorphisms O 0 1.2944043191964738e-05
were O 0 6.8346932557972195e-09
chosen O 0 9.630481967448645e-10
based O 0 1.3255843644977006e-10
on O 0 1.1587523163214541e-09
their O 0 1.3636911599945734e-09
informativeness O 0 5.1685728976735845e-06
. O 0 9.370792142249229e-09

One O 0 5.148215187489313e-09
of O 0 3.563715295085146e-11
these O 0 6.453276107931671e-11
, O 0 3.0854329508001044e-11
not O 0 2.860109926672294e-10
previously O 0 1.8087565223368074e-08
reported O 0 7.247324873560501e-08
, O 0 1.2573303509455513e-11
was O 0 4.549881027493541e-10
2988 O 0 3.6874692188604286e-09
A O 0 4.241734075094428e-09
or O 0 1.2358433387760215e-08
C O 0 1.5548799581210915e-08
that O 0 1.0175142846347018e-11
introduces O 0 2.7163592555834448e-11
a O 0 2.501692429601743e-11
new O 0 1.0006946660201521e-11
restriction O 0 2.7047268938429347e-11
site O 0 6.566876209479489e-11
for O 0 3.522774086328617e-11
Eco0109 O 0 1.237853695101876e-07
I O 0 1.0750270121206995e-05
. O 0 4.289279598168605e-09

All O 0 1.3828220790657042e-09
the O 0 2.6357666049747763e-10
4003delTC O 0 6.441234035037269e-08
alleles O 0 1.1599558646935293e-08
showed O 0 5.780188416792953e-08
the O 0 1.6214059608832265e-11
same O 0 1.5055057200896726e-10
haplotype O 0 1.2036787566671592e-08
for O 0 4.533037140097562e-12
these O 0 1.430258168844123e-11
five O 0 3.5481562132844147e-11
polymorphic O 0 1.0255357807409382e-07
markers O 0 7.0176843109948095e-06
. O 0 7.777766342087489e-08

Fourteen O 0 7.013088634266751e-07
microsatellite O 0 4.531516970018856e-05
polymorphisms O 0 0.0010954317403957248
were O 0 4.604484260539721e-08
selected O 0 2.371906004938751e-10
based O 0 7.546745173225844e-11
on O 0 6.240242211852376e-10
their O 0 2.3755780675926985e-10
high O 0 2.1301387320704634e-08
heterozygosity O 0 9.026098268805072e-07
and O 0 7.333418872157438e-10
their O 0 1.988384977502644e-11
location O 0 2.434299650744265e-09
within O 0 3.6428582372849405e-11
10q23 O 0 1.991899090114657e-08
- O 0 2.715271136821684e-07
q25 O 0 1.2531428694728675e-07
near O 0 1.5989485291356687e-07
COL17A1 O 0 4.095674739801325e-05
. O 0 1.678656325054817e-08

Three O 0 3.1765562624741506e-08
families O 0 7.45646921984644e-09
shared O 0 1.4434259121287596e-08
microsatellite O 0 4.589637683238834e-05
polymorphisms O 0 0.0017393651651218534
covering O 0 1.8900065015259315e-06
at O 0 7.618139008513936e-09
most O 0 9.66145913272598e-11
19 O 0 1.0400107164354466e-10
cM O 0 2.7477443609313923e-07
, O 0 8.267920376114901e-11
whereas O 0 5.137628100726488e-10
the O 0 3.734712539227303e-11
others O 0 1.591632936559506e-10
shared O 0 1.278198380472162e-10
smaller O 0 4.419191679261303e-10
regions O 0 4.831678945826923e-10
consistent O 0 5.7547328680129795e-08
with O 0 1.0293793595295142e-10
cross O 0 6.627826820704286e-08
- O 0 1.910925675474573e-07
over O 0 2.1299213781578175e-10
events O 0 1.764228346745611e-10
during O 0 5.6537712012083574e-11
passage O 0 1.046838397217309e-11
of O 0 1.2729856231630254e-12
this O 0 1.5740523467977496e-11
mutation O 0 4.72303141041408e-10
through O 0 2.8203769614904006e-12
several O 0 1.9778317872365392e-11
generations O 0 4.75658268328516e-09
. O 0 3.8277923053442464e-09

These O 0 1.3137504417670698e-08
results O 0 1.9090252934006458e-08
indicate O 0 4.676360632061005e-08
that O 0 5.333084529546284e-10
4003delTC O 0 2.3401162252412178e-07
occurs O 0 1.2664970183706714e-09
on O 0 6.8619991633323e-11
a O 0 5.032149696937438e-10
single O 0 9.657010302532854e-09
ancestral O 0 1.5466918057427392e-07
allele O 0 2.403159555797174e-07
. O 0 5.232068667204715e-10
. O 0 3.53017659548982e-09

The O 0 6.755738723995819e-08
haptoglobin O 0 5.763779336120933e-05
- O 0 2.8329068300081417e-06
gene O 0 1.770642796827815e-07
deletion O 0 5.56427835363138e-07
responsible O 0 8.431436526734615e-08
for O 0 2.2467989690966306e-09
anhaptoglobinemia B-Disease 0 4.4144424464320764e-05
. O 0 3.9006707197586366e-08

We O 0 1.309811864302901e-06
have O 0 1.0374929804157773e-09
found O 0 1.1987287551473713e-10
an O 0 6.390315793886048e-12
allelic O 0 1.4721818786256335e-07
deletion O 0 4.19987401301114e-07
of O 0 2.721967096164235e-10
the O 0 6.296074772649263e-10
haptoglobin O 0 6.015392045810586e-06
( O 0 2.5621910842987816e-11
Hp O 0 1.49559142847977e-10
) O 0 2.420074123737903e-12
gene O 0 1.2146417205372018e-10
from O 0 1.1308922548414202e-11
an O 0 1.6491459239875716e-11
individual O 0 9.52936396458881e-10
with O 0 7.655792444438703e-09
anhaptoglobinemia B-Disease 0 0.00013580020458903164
. O 0 3.060317155245684e-08

The O 0 1.5472590320086965e-08
Hp O 0 1.7595924717284106e-08
gene O 0 3.142861615401671e-08
cluster O 0 1.4998381203668032e-08
consists O 0 1.445661784726937e-10
of O 0 3.111346597028941e-11
coding O 0 2.2726091231106693e-07
regions O 0 4.4065159854334013e-10
of O 0 1.6778280154117198e-11
the O 0 1.6641051037158405e-10
alpha O 0 8.390168559913036e-10
chain O 0 4.487632665473029e-08
and O 0 3.563546957519037e-10
beta O 0 2.5445902329668257e-11
chain O 0 1.020282747177248e-09
of O 0 2.7825571707884578e-12
the O 0 4.3794499277050036e-11
haptoglobin O 0 3.1760117735757376e-07
gene O 0 2.972831536496301e-09
( O 0 6.8231813428465404e-12
Hp O 0 6.991670437050956e-11
) O 0 2.0620076826571854e-12
and O 0 1.9538351839210044e-11
of O 0 1.3750323579406198e-12
the O 0 1.2187120757012337e-10
alpha O 0 4.3350892320326295e-10
chain O 0 5.506559119794474e-08
and O 0 2.2289137202591291e-10
beta O 0 3.8059482648789e-11
chain O 0 1.7658586815016974e-09
of O 0 2.9527884044117103e-12
the O 0 1.3250357755456577e-10
haptoglobin O 0 1.0225771802652162e-06
- O 0 8.219399205700029e-07
related O 0 2.704999246816442e-08
gene O 0 2.6430234001395547e-08
( O 0 9.549009499787431e-11
Hpr O 0 9.125445643576313e-08
) O 0 1.855635263503519e-11
, O 0 4.111803779405232e-12
in O 0 6.400784763327394e-11
tandem O 0 5.819591706313076e-07
from O 0 2.516433728061429e-10
the O 0 5.155257887246023e-10
5 O 0 8.384808958261658e-10
side O 0 2.852785883078468e-07
. O 0 2.3058884579540972e-08

Southern O 0 1.1959556900364987e-07
blot O 0 8.545432137907483e-06
and O 0 6.942849628543968e-10
PCR O 0 1.7640390126416605e-07
analyses O 0 2.1599647936909605e-07
have O 0 1.246833303270023e-09
indicated O 0 3.464433406819012e-09
that O 0 1.1947587884308941e-11
the O 0 1.1554047649187105e-12
individual O 0 3.919897826470953e-12
with O 0 2.5608326223447442e-11
anhaptoglobinemia B-Disease 0 2.6220584459224483e-07
was O 0 1.2962294571039479e-09
homozygous O 0 1.0873247857645651e-09
for O 0 3.3514853219063223e-12
the O 0 5.1392306209263605e-12
gene O 0 4.890087779152452e-10
deletion O 0 1.6854158957357868e-08
and O 0 5.13037223814905e-10
that O 0 2.398921339352711e-11
the O 0 2.1300858212697227e-12
gene O 0 5.826539251074792e-10
deletion O 0 3.093374800755555e-08
was O 0 3.2046882925129694e-09
included O 0 2.8059289267079457e-11
at O 0 9.86883352815937e-10
least O 0 1.6074138547983452e-11
from O 0 5.058666159574177e-12
the O 0 4.2506304032130515e-11
promoter O 0 3.861968593810161e-07
region O 0 2.79901879451927e-10
of O 0 8.165578456453826e-12
Hp O 0 1.7433993138027404e-09
to O 0 1.9146134677683335e-10
Hpr O 0 1.2036552732297423e-07
alpha O 0 5.496144650507517e-10
but O 0 1.0183035525912487e-09
not O 0 1.5792557539473506e-10
to O 0 1.0368871733446028e-10
Hpr O 0 5.861891736458347e-07
beta O 0 2.736408655223954e-09
( O 0 1.0187771459779782e-10
Hpdel O 0 2.530862843741488e-07
) O 0 3.589297747907949e-10
. O 0 1.4209710075263615e-09

In O 0 8.493591607816597e-09
addition O 0 9.294317537822394e-10
, O 0 1.2849989128316253e-10
we O 0 3.2348890233180327e-10
found O 0 4.8867104807115425e-11
seven O 0 1.4476276080643835e-12
individuals O 0 1.2958419060016269e-12
with O 0 1.7410415123486622e-11
hypohaptoglobinemia B-Disease 0 7.168439424276585e-07
in O 0 1.2280924888141698e-10
three O 0 3.138124829438205e-11
families O 0 5.490107327088545e-11
, O 0 9.60108988840025e-12
and O 0 2.8351243228086354e-11
the O 0 2.1638538183488265e-11
genotypes O 0 1.0415998730195497e-08
of O 0 4.2894034678331305e-12
six O 0 9.952563946591386e-12
of O 0 1.172152435877094e-12
the O 0 2.355633743622576e-11
seven O 0 4.0954475921672895e-11
individuals O 0 4.355292515523246e-11
were O 0 2.725251802004891e-09
found O 0 2.618815164723287e-09
to O 0 1.1775674879643816e-10
be O 0 3.9739951773754e-08
Hp2 O 0 1.2020671420032158e-05
/ O 0 4.0686242641641e-07
Hpdel O 0 1.2098079196221079e-06
. O 0 4.09212530527725e-09

The O 0 3.325194697367806e-08
phenotypes O 0 1.755213634169195e-05
and O 0 3.868748876811878e-09
genotypes O 0 1.1242868822591845e-06
in O 0 2.9461305617317635e-10
one O 0 4.079667506595719e-11
of O 0 1.5261906322061591e-12
these O 0 6.791824047613915e-12
three O 0 6.960291717983402e-12
families O 0 6.152170439754912e-11
showed O 0 2.8825228426399008e-08
the O 0 4.555488278268349e-11
father O 0 4.002292186555678e-08
to O 0 8.47895087474626e-11
be O 0 1.3294615408554478e-09
hypohaptoglobinemic B-Disease 0 1.6865293162027228e-07
( O 0 8.828118791548434e-12
Hp2 O 0 1.1387076170876753e-08
) O 0 1.2595716570446003e-12
and O 0 3.210282734089631e-11
Hp2 O 0 4.5842590168376773e-08
/ O 0 4.909023854082761e-09
Hpdel O 0 4.63004106165954e-08
, O 0 6.13394751658447e-12
the O 0 1.2455627675100889e-11
mother O 0 2.6554337395623406e-08
to O 0 1.9595564754171235e-11
be O 0 3.3498401275089407e-10
Hp2 O 0 1.9714697430117667e-08
- O 0 7.515009059488875e-09
1 O 0 3.0760546887442786e-11
and O 0 8.653392585822317e-11
Hp1 O 0 1.0640500391900787e-07
/ O 0 6.118288098377889e-09
Hp2 O 0 4.8081489012474776e-08
, O 0 2.21389985337328e-12
one O 0 2.31783819568121e-12
of O 0 1.8893114611846784e-13
the O 0 6.48894306343184e-12
two O 0 3.368335124709354e-11
children O 0 1.727971377096793e-10
to O 0 6.411390862659516e-11
be O 0 1.5066015990328196e-08
hypohaptoglobinemic B-Disease 0 1.5595096556353383e-06
( O 0 2.1505802347276948e-11
Hp2 O 0 1.603502930436207e-08
) O 0 2.257513403644551e-12
and O 0 2.634483603491944e-11
Hp2 O 0 1.35042441229416e-07
/ O 0 1.3686636712861855e-08
Hpdel O 0 1.895691355002782e-07
, O 0 1.9666145448238304e-11
and O 0 7.071667036673279e-12
the O 0 1.8863489329584704e-12
other O 0 4.13554130176963e-12
child O 0 8.617956126499848e-09
to O 0 3.910654439165384e-11
be O 0 1.4302378170683028e-09
Hp1 O 0 8.211465285512531e-08
and O 0 1.1898183549519104e-09
Hp1 O 0 8.636394568384276e-07
/ O 0 6.39816946090832e-08
Hpdel O 0 1.702820355831136e-07
, O 0 1.9166220693866975e-11
showing O 0 5.099983546585918e-09
an O 0 1.1403402527809803e-11
anomalous O 0 3.581532936891563e-08
inheritance O 0 9.61531156917772e-08
of O 0 1.928960324804052e-10
Hp O 0 2.822966038706909e-08
phenotypes O 0 1.3995229437568923e-06
in O 0 7.223663889277532e-10
the O 0 9.983698312510114e-10
child O 0 1.2677636505031842e-06
with O 0 5.825385951396811e-09
Hp1 O 0 2.7224348741583526e-05
. O 0 2.342991933801386e-08

The O 0 2.1424687801641085e-08
Hp2 O 0 4.202713171252981e-06
/ O 0 3.223603073365666e-07
Hpdel O 0 2.0048871647304622e-06
individuals O 0 1.671122684676618e-09
had O 0 3.222685007742143e-09
an O 0 6.085276033074294e-11
extremely O 0 1.613799014421602e-07
low O 0 2.528614402308449e-07
level O 0 2.6884972026408605e-09
of O 0 5.5041539902267456e-12
Hp O 0 3.734786091502684e-10
( O 0 4.635209750747382e-12
mean O 0 1.3573802082333941e-09
+ O 0 9.798175465425274e-11
/ O 0 1.3545455868069212e-09
- O 0 1.8667423162810337e-08
SD O 0 2.817753738781903e-06
= O 0 2.9902746945253966e-08
0 O 0 3.7505172578722323e-11
. O 0 1.6695590222826073e-12
049 O 0 2.0477053386258603e-09
+ O 0 3.0982372223320453e-10
/ O 0 2.2021993117959937e-09
- O 0 1.2196363918803854e-08
0 O 0 1.1936250599031695e-10
. O 0 1.015219072003637e-11
043 O 0 1.6252199586119787e-08
mg O 0 5.70545282130297e-08
/ O 0 5.447055695384506e-09
ml O 0 2.698408430035215e-08
; O 0 3.1717444642920256e-11
n O 0 1.5709655798445965e-08
= O 0 4.179374624158072e-09
6 O 0 7.223422381075206e-12
) O 0 4.591178240538618e-13
, O 0 4.1960838558126323e-13
compared O 0 3.169452547635565e-11
with O 0 1.6018375861848178e-11
the O 0 2.0549424661897575e-10
level O 0 1.5899807692676404e-08
( O 0 4.2573526626808744e-13
1 O 0 1.3681650213800967e-12
. O 0 6.590207437921769e-13
64 O 0 1.6190935311216625e-12
+ O 0 1.4045407198404192e-11
/ O 0 1.451790493378624e-10
- O 0 1.5901558958475448e-09
1 O 0 4.2514172737817546e-11
. O 0 1.5625837429533718e-11
07 O 0 3.469576570491739e-10
mg O 0 1.283714112787493e-08
/ O 0 2.3424633344149015e-09
ml O 0 3.617823596258063e-09
) O 0 5.805187602327122e-13
obtained O 0 1.2397085094595361e-11
from O 0 2.253761630446882e-12
52 O 0 3.515149629707004e-11
healthy O 0 2.4833335388052546e-10
volunteers O 0 7.092756937332467e-11
having O 0 3.0888451796329264e-09
phenotype O 0 1.590131688544716e-07
Hp2 O 0 2.9433364190367683e-08
, O 0 8.184195508798009e-12
whereas O 0 4.534319447691004e-11
the O 0 9.984334539692163e-12
serum O 0 1.1173221459159777e-08
Hp O 0 1.520587267211937e-10
level O 0 2.036043972308832e-10
of O 0 3.896006510028388e-13
an O 0 1.6744318605266262e-12
individual O 0 3.996138142614569e-11
with O 0 3.2717853426511567e-10
Hp1 O 0 1.1143128176627215e-05
/ O 0 2.31677830697663e-07
Hpdel O 0 9.347265290671203e-07
was O 0 3.624206712515843e-08
0 O 0 2.172233948272151e-09
. O 0 1.4551067017976038e-09

50 O 0 2.7854886397449263e-08
mg O 0 7.238296007017198e-07
/ O 0 3.1394768029713305e-07
ml O 0 2.279764657941996e-06
, O 0 9.432882946969201e-11
which O 0 3.336632012351792e-11
was O 0 2.31491548152718e-10
approximately O 0 4.671900344886681e-13
half O 0 1.8685552237440728e-12
the O 0 1.2552018886086147e-12
level O 0 2.230064917452257e-11
of O 0 3.4360893037127527e-13
Hp O 0 2.6796800889350436e-10
in O 0 1.1614866707310156e-10
control O 0 3.984119345545878e-08
sera O 0 1.904243731587485e-07
from O 0 8.900277216616903e-12
the O 0 3.8059482648789e-11
Hp1 O 0 3.482575436919433e-07
phenotype O 0 3.972358086912209e-08
( O 0 1.0407695755568214e-12
1 O 0 7.463829033993452e-12
. O 0 4.1910472488304595e-12
26 O 0 1.1137374876513118e-11
+ O 0 3.279155419422253e-11
/ O 0 3.9129172124674483e-10
- O 0 2.0139907519478584e-09
0 O 0 3.572296625176108e-11
. O 0 2.9656401032834845e-12
33 O 0 1.829691086141505e-11
mg O 0 4.627319860617263e-09
/ O 0 1.383225756157458e-09
ml O 0 1.5466394387431137e-08
; O 0 2.7195527080303705e-11
n O 0 2.079818095523933e-08
= O 0 1.5027703526016012e-08
9 O 0 1.65225975262695e-11
) O 0 3.461295920020868e-13
, O 0 2.2712983837464007e-13
showing O 0 3.3051235082126595e-09
a O 0 1.9445798304928985e-09
gene O 0 2.8429539611352084e-07
- O 0 0.00013560571824200451
dosage O 0 7.771820673951879e-05
effect O 0 4.895024972029205e-07
. O 0 9.258440236692422e-09

The O 0 2.1935218086355235e-09
other O 0 2.413309829751853e-10
allele O 0 9.260333655447539e-08
( O 0 3.414025312453717e-11
Hp2 O 0 4.2164401747868396e-08
) O 0 5.449247823807735e-13
of O 0 2.453097132978227e-13
individuals O 0 4.0281463060953815e-12
with O 0 1.1500346508430681e-10
Hp2 O 0 7.086916866683168e-06
/ O 0 6.996428680849931e-08
Hpdel O 0 3.849973211345059e-07
was O 0 7.536830537446804e-08
found O 0 1.7670716001561004e-09
to O 0 6.533907859207488e-10
have O 0 8.230920833796063e-09
, O 0 9.00464165037862e-12
in O 0 9.310595697198387e-12
all O 0 6.6453834622615116e-12
exons O 0 5.132594349532837e-10
, O 0 3.200360115807044e-11
no O 0 1.0192480193182973e-09
mutation O 0 5.263931956989154e-09
, O 0 6.616670102446709e-13
by O 0 2.3458669902443052e-12
DNA O 0 1.1083523432375841e-08
sequencing O 0 1.1577785841154764e-08
. O 0 5.253761425905168e-09

On O 0 1.3005541532606912e-08
the O 0 1.6992707588259215e-11
basis O 0 2.229656563546012e-11
of O 0 2.1292490340329984e-12
the O 0 2.1867313515500086e-11
present O 0 4.256742180963613e-10
study O 0 1.7060200474539045e-10
, O 0 1.8512118921121257e-12
the O 0 1.3567154127577807e-12
mechanism O 0 5.291287200059891e-11
of O 0 2.2290984162676164e-12
anhaptoglobinemia B-Disease 0 2.0682793433479674e-07
and O 0 2.2405498290023473e-10
the O 0 7.902855453378876e-12
mechanism O 0 1.1918824260881422e-10
of O 0 5.212958103378851e-12
anomalous O 0 1.4373022771962951e-08
inheritance O 0 9.362862840589514e-08
of O 0 4.9145304492626e-10
Hp O 0 7.390984535504685e-08
phenotypes O 0 9.332148692919873e-06
were O 0 4.294897593126734e-08
well O 0 1.995542220356583e-08
explained O 0 4.701841760379466e-07
. O 0 3.740890708314737e-09

However O 0 1.9758937241931562e-07
, O 0 1.0743163303406078e-10
the O 0 9.886608025311272e-12
mechanism O 0 5.327533414423158e-10
of O 0 8.903507792146215e-11
hypohaptoglobinemia B-Disease 0 2.5675437427707948e-05
remains O 0 3.068529679239873e-07
unknown O 0 2.7378202958061593e-06

ATM O 0 0.0008722768980078399
mutations O 0 0.0032249954529106617
and O 0 2.57309494600122e-07
phenotypes O 0 0.004546515177935362
in O 0 2.6383897420600988e-05
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999991655349731
telangiectasia I-Disease 1 0.9999998807907104
families O 0 1.1020809324691072e-05
in O 0 5.884102094455557e-09
the O 0 7.741911556280456e-10
British O 0 7.714442062933813e-07
Isles O 0 1.8127461487438268e-07
: O 0 2.390576278599177e-11
expression O 0 3.5760734651280046e-11
of O 0 2.1751316839260099e-13
mutant O 0 1.6007632719361453e-10
ATM O 0 2.830049972146753e-08
and O 0 1.0717129961257399e-10
the O 0 2.6908131972591676e-11
risk O 0 3.0159242214722326e-08
of O 0 1.3349806815554643e-09
leukemia B-Disease 1 0.9826397895812988
, O 0 9.857769327936694e-06
lymphoma B-Disease 1 1.0
, O 0 3.9898989001585505e-08
and O 0 4.958684712619288e-06
breast B-Disease 1 0.9984219074249268
cancer I-Disease 0 0.0748753696680069
. O 0 2.691218412564922e-07

We O 0 2.144857091934682e-07
report O 0 8.814498575482332e-10
the O 0 1.8078295804802025e-11
spectrum O 0 7.982761673908101e-10
of O 0 6.2636324078824135e-12
59 O 0 7.339641394654706e-11
ATM O 0 2.0010400021419628e-06
mutations O 0 8.817414709483273e-06
observed O 0 9.381841664435342e-06
in O 0 1.3018939171161037e-06
ataxia B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999996423721313
telangiectasia I-Disease 1 1.0
( O 0 0.0001404363283654675
A B-Disease 1 0.9999997615814209
- I-Disease 1 0.9999997615814209
T I-Disease 1 1.0
) O 0 1.6470046659833315e-08
patients O 0 2.5499227174208272e-09
in O 0 1.794418780232121e-10
the O 0 2.2877115757324873e-09
British O 0 3.6813967199123e-06
Isles O 0 1.8650288211574662e-06
. O 0 3.25324478467337e-08

Of O 0 5.454904972168606e-09
51 O 0 6.099109661761304e-09
ATM O 0 8.501442607666831e-06
mutations O 0 4.006633025710471e-05
identified O 0 1.1135859949717997e-06
in O 0 4.88680595989166e-10
families O 0 2.6007743181288845e-10
native O 0 8.112954058558941e-11
to O 0 4.07902982224595e-11
the O 0 9.498727499002158e-11
British O 0 4.171386080997763e-07
Isles O 0 4.580474666227019e-08
, O 0 5.611581685438516e-11
11 O 0 9.227943929823734e-12
were O 0 6.238978084160962e-11
founder O 0 1.8303559778942713e-09
mutations O 0 8.311777577318935e-08
, O 0 1.208367347155237e-11
and O 0 1.808174270034879e-11
2 O 0 3.6265506656724122e-12
of O 0 8.787442344962426e-13
these O 0 3.7039600553345764e-11
11 O 0 1.7394382809121645e-11
conferred O 0 5.380287881884271e-10
a O 0 7.425979275943462e-10
milder O 0 4.691889046171127e-07
clinical O 0 1.312036914669079e-07
phenotype O 0 9.100075430978904e-07
with O 0 2.332213033806596e-10
respect O 0 4.480762427760965e-09
to O 0 2.871161641770925e-10
both O 0 2.1370244240870306e-08
cerebellar B-Disease 0 0.28187090158462524
degeneration I-Disease 0 0.0058719320222735405
and O 0 5.293405180850641e-08
cellular O 0 2.4081591618596576e-06
features O 0 8.990506330519565e-07
. O 0 8.228632708551231e-08

We O 0 9.690130582384882e-07
report O 0 5.158191651588595e-09
, O 0 6.34449307326812e-12
in O 0 1.0147698653595327e-11
two O 0 4.753904492282857e-10
A B-Disease 1 0.9999983310699463
- I-Disease 1 0.9999978542327881
T I-Disease 1 1.0
families O 0 1.2351976330648995e-08
, O 0 9.593145722242014e-12
an O 0 2.9971606793632866e-12
ATM O 0 9.679278036855976e-07
mutation O 0 1.527499193798576e-07
( O 0 3.5150942486600334e-12
7271T O 0 6.136118835264881e-10
- O 0 9.550242907607753e-08
- O 0 1.6894703094294528e-06
> O 0 1.692623357030243e-07
G O 0 2.5613214802433504e-06
) O 0 6.031218059698862e-12
that O 0 7.326959594600169e-10
may O 0 4.2612793293983486e-08
be O 0 9.960055002977697e-10
associated O 0 2.370300622445143e-10
with O 0 1.1326148352530652e-11
an O 0 1.871552218757344e-11
increased O 0 2.911376739689331e-08
risk O 0 1.3607149185190792e-07
of O 0 9.974923109723477e-10
breast B-Disease 1 0.9886789917945862
cancer I-Disease 0 0.00017893666517920792
in O 0 4.6336234849064795e-10
both O 0 6.093385795935546e-10
homozygotes O 0 3.2990651561704e-06
and O 0 1.0088039292810436e-09
heterozygotes O 0 1.1614494610512338e-07
( O 0 2.0746050710673813e-11
relative O 0 3.7063898616906954e-08
risk O 0 3.035945539409113e-08
12 O 0 2.6962590146673016e-11
. O 0 1.147455307853873e-11
7 O 0 1.2798084814136246e-10
; O 0 1.5083223559031467e-10
P O 0 5.551501817535609e-05
= O 0 6.29837444421355e-08
. O 0 3.274774201811326e-11
0025 O 0 1.1693010115720881e-08
) O 0 4.5670398886310526e-12
, O 0 2.2099086883359265e-12
although O 0 2.4223567596237672e-11
there O 0 3.7464278207499646e-11
is O 0 1.4795598773931218e-11
a O 0 5.491303523008639e-10
less O 0 4.0106988308252767e-07
severe O 0 0.10592705011367798
A B-Disease 1 0.9999997615814209
- I-Disease 1 0.9999997615814209
T I-Disease 1 1.0
phenotype O 0 0.00047851091949269176
in O 0 2.066293247615647e-10
terms O 0 7.577413141390821e-10
of O 0 2.2375326418078156e-12
the O 0 6.037021577087742e-11
degree O 0 2.173528024229654e-08
of O 0 1.6186637585846597e-09
cerebellar B-Disease 0 0.25795263051986694
degeneration I-Disease 0 0.01732330396771431
. O 0 6.512526624646853e-07

This O 0 8.565826270512389e-09
mutation O 0 5.958355586699327e-07
( O 0 9.988702226459978e-11
7271T O 0 1.590144549368233e-08
- O 0 2.4808302896417445e-06
- O 0 2.68598560069222e-05
> O 0 4.7068937192307203e-07
G O 0 7.427345281030284e-07
) O 0 8.681107048491565e-13
also O 0 1.2384553018524036e-12
allows O 0 2.6660858850474645e-12
expression O 0 9.946875267896615e-11
of O 0 8.99238203431324e-13
full O 0 1.3316814317931858e-10
- O 0 8.326959566318237e-09
length O 0 1.9632060421770348e-09
ATM O 0 2.981737523555239e-08
protein O 0 1.0192299781941472e-10
at O 0 2.3085562975144747e-11
a O 0 2.224343903511894e-10
level O 0 5.211925113712823e-08
comparable O 0 3.4959660411004734e-07
with O 0 1.1911120700869304e-10
that O 0 1.9674042395223523e-09
in O 0 2.0772676911917642e-09
unaffected O 0 3.610580563417898e-07
individuals O 0 3.748454435736903e-09
. O 0 1.1832558932667325e-08

In O 0 2.3478221589101622e-09
addition O 0 4.952792065360256e-10
, O 0 3.1102728031973115e-11
we O 0 3.808796611437515e-10
have O 0 1.4161163908177343e-10
studied O 0 8.738570755895125e-09
18 O 0 1.027142149112592e-09
A B-Disease 1 0.999963641166687
- I-Disease 1 0.9999979734420776
T I-Disease 1 1.0
patients O 0 3.563350787771924e-07
, O 0 3.519241842386833e-11
in O 0 2.7736564781055684e-11
15 O 0 1.3813128592332635e-11
families O 0 3.1354321916587935e-11
, O 0 4.7905110434065534e-11
who O 0 2.7008336900280483e-08
developed O 0 5.921424235566519e-05
leukemia B-Disease 1 0.9966521859169006
, O 0 1.4099470718065277e-05
lymphoma B-Disease 1 1.0
, O 0 3.3062521609394935e-09
preleukemic O 0 7.233569340314716e-05
T O 0 0.002093448070809245
- O 0 9.769720236363355e-06
cell O 0 3.877323615597561e-05
proliferation O 0 4.792228082806105e-06
, O 0 1.961671269867793e-09
or O 0 0.0004947340348735452
Hodgkin B-Disease 1 0.9999998807907104
lymphoma I-Disease 1 1.0
, O 0 8.42196623551672e-09
mostly O 0 4.757351734774318e-10
in O 0 6.030445032223497e-09
childhood O 0 4.828896635444835e-05
. O 0 1.1042885716960882e-07

A O 0 1.3779079210962664e-07
wide O 0 8.910923554594774e-09
variety O 0 5.731591867785824e-10
of O 0 4.2059199872879205e-11
ATM O 0 3.1937495805323124e-05
mutation O 0 1.0462596947036218e-05
types O 0 5.0795801342928826e-08
, O 0 1.9967765288453343e-11
including O 0 2.6527264759823588e-11
missense O 0 4.8352001613238826e-05
mutations O 0 7.825947250239551e-05
and O 0 4.97815744182617e-09
in O 0 2.1812847084135e-09
- O 0 1.0508676496101543e-05
frame O 0 0.07959446310997009
deletions O 0 4.2681884224293754e-05
, O 0 2.436928880911182e-09
were O 0 5.517111656416773e-09
seen O 0 3.436243218857271e-07
in O 0 2.406755073014466e-10
these O 0 8.715296817563001e-10
patients O 0 7.953024017126609e-09
. O 0 4.501869987905138e-09

We O 0 2.0278380929994455e-07
also O 0 5.2614579360010794e-11
show O 0 2.0457718852284756e-10
that O 0 1.8772689999724257e-11
25 O 0 3.2242045405056485e-12
% O 0 2.822205088983537e-13
of O 0 8.808367446891396e-13
all O 0 2.1419530593647096e-09
A B-Disease 1 0.999996542930603
- I-Disease 1 0.9999971389770508
T I-Disease 1 1.0
patients O 0 2.0979987880309636e-07
carried O 0 1.7705609423046553e-08
in O 0 2.135433080363569e-10
- O 0 2.8511158234323375e-07
frame O 0 1.7789032426662743e-05
deletions O 0 8.64055436977651e-07
or O 0 2.2287755641059448e-08
missense O 0 2.977796975756064e-05
mutations O 0 3.3368426102242665e-06
, O 0 1.3728448065852827e-11
many O 0 1.3571295779876702e-12
of O 0 1.0051306141567462e-11
which O 0 3.653217461874192e-08
were O 0 3.550463389956349e-08
also O 0 4.247547202851365e-09
associated O 0 1.0102828573721467e-09
with O 0 9.29830240581353e-11
expression O 0 4.5402606119182565e-09
of O 0 4.18988212180782e-11
mutant O 0 2.8778918803595843e-08
ATM O 0 1.6703065739420708e-06
protein O 0 7.823666692274855e-08
. O 0 5.784442258516265e-09

The O 0 1.5011144327559123e-08
DMPK O 0 6.458280950027984e-06
gene O 0 9.711189363770245e-08
of O 0 2.369533236290522e-09
severely O 0 0.02449357882142067
affected O 0 0.0008037856314331293
myotonic B-Disease 1 0.9999998807907104
dystrophy I-Disease 1 1.0
patients O 0 0.000806925178039819
is O 0 1.0011829587597276e-08
hypermethylated O 0 8.850885819811083e-07
proximal O 0 1.3123408848514373e-07
to O 0 6.53823384322294e-10
the O 0 1.6278023373672568e-10
largely O 0 1.499122159742683e-09
expanded O 0 4.2527434906958206e-09
CTG O 0 2.132471763616195e-06
repeat O 0 1.0778372825370752e-06
. O 0 1.5598049074583287e-08

Using O 0 1.0884603440786123e-08
methylation O 0 4.66477132476939e-07
- O 0 1.7718450635584304e-06
sensitive O 0 4.40077292296337e-06
restriction O 0 6.6755778682647815e-09
enzymes O 0 1.4349101906674377e-09
, O 0 6.543242076634259e-12
we O 0 3.173856663596375e-11
characterized O 0 4.047519819305734e-10
the O 0 5.262167871583623e-12
methylation O 0 3.041409568638187e-09
pattern O 0 2.512992303138617e-08
on O 0 6.388810591673177e-10
the O 0 3.09847807133945e-11
5 O 0 2.6726192439707752e-11
side O 0 6.902524662955045e-10
of O 0 7.741254685889043e-12
the O 0 9.061242728369834e-11
CTG O 0 7.067824014939106e-08
repeat O 0 7.214648434228366e-09
in O 0 1.55268454343771e-11
the O 0 5.15473167622682e-12
DMPK O 0 4.123585028992238e-08
gene O 0 1.018835363297832e-10
of O 0 2.989242317216756e-12
normal O 0 4.693128108357314e-10
individuals O 0 1.7064813104261667e-11
and O 0 6.00746674628283e-11
of O 0 8.448649418957288e-11
patients O 0 2.0657594745898678e-08
affected O 0 3.198827513983815e-08
with O 0 1.1564802662178408e-05
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 0.9999998807907104
, O 0 2.42392719229656e-08
showing O 0 1.9130391137878178e-07
expansions O 0 2.5859378638415365e-08
of O 0 7.835617571450015e-11
the O 0 5.407065906126718e-10
repetitive O 0 4.369462658360135e-06
sequence O 0 8.083402036618281e-08
. O 0 5.895448129678016e-09

The O 0 5.406625369630547e-09
gene O 0 1.5053721824642707e-08
segment O 0 9.017682600642729e-09
analyzed O 0 3.8801754698170043e-08
corresponds O 0 8.115887517590181e-09
to O 0 2.3586100086903095e-11
the O 0 1.734816283682772e-11
genomic O 0 8.415638852454776e-09
SacI O 0 1.1833956250484334e-06
- O 0 5.380189236348087e-07
HindIII O 0 3.311539842343336e-07
fragment O 0 2.1597214683310995e-08
carrying O 0 1.4208355603173572e-09
exons O 0 1.6083978593428583e-08
11 O 0 7.98949462144094e-10
- O 0 2.6657156126930204e-07
15 O 0 8.583844746112845e-10
. O 0 1.0460531330025447e-09

There O 0 5.54676340414062e-08
is O 0 5.279283676884461e-10
constitutive O 0 2.925581332746674e-09
methylation O 0 6.448803713254847e-09
in O 0 6.547527797717834e-11
intron O 0 4.291270272460679e-07
12 O 0 1.5928659780062304e-10
at O 0 6.148815484552372e-11
restriction O 0 4.5192957015549595e-11
sites O 0 2.655065056700323e-11
of O 0 4.7683931456155015e-12
SacII O 0 9.544142898221253e-08
and O 0 1.635838825508884e-10
HhaI O 0 2.4306540780116848e-08
, O 0 2.0985184076560692e-12
localized O 0 3.864528419494917e-10
1 O 0 9.002017881121205e-11
, O 0 9.878540693786242e-12
159 O 0 5.356243226728452e-11
- O 0 2.4777058627023507e-08
1 O 0 2.508124541389378e-10
, O 0 6.26152992302953e-12
232 O 0 1.2138003276096487e-11
bp O 0 2.6571245204110028e-09
upstream O 0 1.9469604747857083e-11
of O 0 7.734283591180613e-13
the O 0 2.688720079913054e-11
CTG O 0 5.419141047013909e-08
repeat O 0 4.4412168165308685e-08
, O 0 1.1908296397578066e-11
whereas O 0 5.0636501935930056e-11
most O 0 5.2252421139931116e-12
, O 0 1.0795721955281223e-11
if O 0 2.1434487518234846e-09
not O 0 8.006668245075232e-11
all O 0 8.992519185888059e-13
, O 0 2.478361212001484e-13
of O 0 4.844884123880386e-14
the O 0 3.436875892388891e-13
other O 0 1.716268728697845e-13
sites O 0 7.285619156582879e-12
of O 0 1.605752206548794e-12
SacII O 0 1.3551165523040254e-07
, O 0 1.8145381031065e-11
HhaI O 0 1.2225150669564755e-08
, O 0 4.5372759369111115e-12
and O 0 1.554604708853269e-11
HpaII O 0 1.5469757030928122e-08
in O 0 7.647742855665385e-11
this O 0 6.791465306799083e-11
region O 0 1.616342754084954e-10
are O 0 9.160241315475659e-11
unmethylated O 0 3.582024632464709e-08
, O 0 2.2773651020546737e-11
in O 0 4.476725934399184e-11
normal O 0 4.5336731591127943e-10
individuals O 0 2.0081124263438e-11
and O 0 6.701111193718745e-11
most O 0 4.310038003579875e-12
of O 0 5.7820948549947015e-12
the O 0 2.091576467577738e-09
patients O 0 2.3791081105173362e-08
. O 0 9.792448629752926e-09

In O 0 1.6423893356432018e-09
a O 0 1.039165975491585e-10
number O 0 1.1701425418897404e-11
of O 0 9.24050159306633e-12
young O 0 1.0572703601496869e-08
and O 0 4.0572011528183793e-08
severely O 0 0.001860758988186717
affected O 0 1.3154360090084083e-07
patients O 0 1.0690233587240527e-08
, O 0 3.7288904602972295e-11
however O 0 3.009661617148218e-11
, O 0 5.591041952329734e-13
complete O 0 2.5297468113361088e-12
methylation O 0 4.680485513053334e-11
of O 0 1.397561943559597e-13
these O 0 8.035927609104099e-13
restriction O 0 8.884689858823513e-12
sites O 0 5.72522966535427e-11
was O 0 8.806537721284258e-09
found O 0 4.2996470273060083e-10
in O 0 5.359288360318182e-11
the O 0 3.3765829021703553e-10
mutated O 0 6.308990805337089e-07
allele O 0 4.925543066747196e-07
. O 0 2.274295241022628e-08

In O 0 1.0523773852355589e-08
most O 0 6.763464788228646e-11
of O 0 6.707782766735004e-12
these O 0 2.3427304540746263e-10
patients O 0 4.507607342940645e-10
, O 0 4.9189610717981225e-12
the O 0 2.7604148133963946e-11
onset O 0 1.0825988105978013e-08
of O 0 1.446130437621207e-10
the O 0 4.884695385953819e-07
disease O 0 0.0019258216489106417
was O 0 0.0004044722591061145
congenital O 1 0.9999018907546997
. O 0 3.853756993521529e-07

Preliminary O 0 1.1848162557726027e-06
in O 0 9.114101473528535e-09
vivo O 0 2.542761194490595e-06
footprinting O 0 4.3017287680413574e-05
data O 0 3.456104291643669e-09
gave O 0 6.209772973608807e-11
evidence O 0 7.865670614837228e-11
for O 0 4.2029426813861015e-12
protein O 0 1.6612762554490956e-10
- O 0 8.7380755076083e-08
DNA O 0 1.0882386192179183e-07
contact O 0 3.346120820424403e-07
in O 0 1.3248292463075018e-09
normal O 0 7.977956073546011e-09
genes O 0 5.498304589401926e-10
at O 0 6.614556818940187e-11
an O 0 5.153394638107711e-12
Sp1 O 0 2.5908535317142878e-09
consensus O 0 5.1430866510049356e-11
binding O 0 9.314512494640326e-10
site O 0 4.669822861735895e-10
upstream O 0 2.075297746151339e-11
of O 0 7.983115037080157e-13
the O 0 1.2805452011266372e-11
CTG O 0 1.280620978150182e-07
repeat O 0 7.691905068440974e-08
and O 0 6.57069676446298e-11
for O 0 4.706297743010956e-13
a O 0 5.66928578735193e-12
significant O 0 5.104844671977027e-11
reduction O 0 5.87902837523302e-10
of O 0 4.270698920373628e-13
this O 0 3.4293538061364037e-12
interaction O 0 5.430535188200025e-11
in O 0 1.3778665708397142e-10
cells O 0 1.5893848737125182e-10
with O 0 1.533272814269182e-11
a O 0 3.224148281688599e-09
hypermethylated O 0 4.442676072358154e-06
DMPK O 0 2.820560439431574e-06
gene O 0 1.0968319585913378e-08
. O 0 2.8735613888386524e-10
. O 0 2.0685420043520253e-09

The O 0 9.521103265797137e-07
hemochromatosis B-Disease 1 0.9999657869338989
gene O 0 8.476660696032923e-06
product O 0 2.846480029461418e-08
complexes O 0 3.423942729341434e-08
with O 0 6.467915092400744e-11
the O 0 1.1769971108854804e-10
transferrin O 0 1.7464930124333478e-07
receptor O 0 1.0671898031944238e-08
and O 0 6.448431233430085e-10
lowers O 0 1.889680589783893e-07
its O 0 8.616923147242161e-12
affinity O 0 1.2667451809722508e-10
for O 0 6.158284385909818e-12
ligand O 0 4.6141021670109694e-08
binding O 0 2.723897409850906e-07
. O 0 8.026676212580242e-09

We O 0 8.995455118565587e-07
recently O 0 4.2197552119205284e-08
reported O 0 2.5001398729074253e-09
the O 0 6.978982496075314e-12
positional O 0 8.224408709622821e-09
cloning O 0 1.0934599892209462e-09
of O 0 2.3950340408834814e-12
a O 0 1.6699429339350758e-10
candidate O 0 1.2380273517464957e-07
gene O 0 7.164461521824705e-07
for O 0 6.909155558787461e-07
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
called O 1 0.501100480556488
HFE O 1 0.9910486936569214
. O 0 3.074924563861714e-07

The O 0 8.447385013710118e-09
gene O 0 1.0030354502532646e-07
product O 0 1.6553757475890052e-08
, O 0 4.0845257731625395e-11
a O 0 7.800678852865062e-11
member O 0 2.5090709024344626e-11
of O 0 2.320934893926263e-12
the O 0 6.318592177256832e-11
major O 0 1.7918239114678158e-09
histocompatibility O 0 1.750446017467766e-06
complex O 0 4.5158691364122205e-07
class O 0 8.821789521107348e-08
I O 0 8.186634659068659e-06
- O 0 1.4476359666559802e-08
like O 0 2.630007767123743e-09
family O 0 2.232646290067919e-09
, O 0 3.033955378595188e-11
was O 0 2.4180291102737783e-09
found O 0 3.14225923059297e-10
to O 0 3.539254653239787e-11
have O 0 3.572727946821175e-10
a O 0 6.539107033631808e-10
mutation O 0 3.461648034885911e-08
, O 0 4.9586969946835424e-11
Cys O 0 3.2591267995485396e-07
- O 0 1.86620834341511e-08
282 O 0 1.2327068255046925e-09
- O 0 2.5123847535724053e-06
- O 0 2.372290146013256e-05
> O 0 7.369657595290846e-08
Tyr O 0 6.199910984605594e-08
( O 0 4.211513082719165e-12
C282Y O 0 2.1950062600861742e-10
) O 0 6.311045978348029e-13
, O 0 3.815014439339376e-13
in O 0 3.131904024317178e-12
85 O 0 5.696579059161211e-12
% O 0 4.119810829289472e-12
of O 0 4.8662202739579996e-11
patient O 0 6.652308911725413e-06
chromosomes O 0 3.798770421781228e-06
. O 0 2.00040854991812e-08

This O 0 1.1375657749113088e-08
mutation O 0 7.242412038976909e-07
eliminates O 0 7.962074022316301e-08
the O 0 1.9258722394610572e-10
ability O 0 1.4934030678759314e-09
of O 0 3.85599295549266e-11
HFE O 0 6.980551916058175e-06
to O 0 3.2763752821907133e-10
associate O 0 6.822941100992352e-10
with O 0 1.1202338362492625e-10
beta2 O 0 2.5976993129006587e-05
- O 0 1.8620450646267273e-05
microglobulin O 0 1.6045718439272605e-05
( O 0 3.132778064740549e-11
beta2m O 0 2.688478062395916e-08
) O 0 1.948430566195425e-12
and O 0 5.4498532423008506e-12
prevents O 0 2.648824493078905e-10
cell O 0 9.929258339980152e-07
- O 0 8.819637878332287e-05
surface O 0 0.00622818898409605
expression O 0 3.820613528660033e-06
. O 0 8.697996989326384e-09

A O 0 3.0862474886816926e-07
second O 0 4.679341003566151e-08
mutation O 0 6.1537971305369865e-06
that O 0 4.021328159353743e-09
has O 0 4.463751035466146e-10
no O 0 2.6903426708635436e-10
effect O 0 1.847003661126223e-09
on O 0 4.154339539041985e-09
beta2m O 0 3.2463481147715356e-06
association O 0 3.9472639046245206e-10
, O 0 1.2006251028096049e-11
H63D O 0 3.003903259468643e-07
, O 0 2.523189816805438e-11
was O 0 8.335218626420726e-10
found O 0 1.5021525689995485e-10
in O 0 2.308776433923576e-11
eight O 0 5.0973500594075905e-12
out O 0 1.083468904872209e-11
of O 0 4.279670801771163e-12
nine O 0 2.777766350270383e-10
patients O 0 5.296408867039304e-10
heterozygous O 0 8.663421091625878e-10
for O 0 1.194952470306987e-11
the O 0 2.144649874358251e-10
C282Y O 0 2.5644104084676655e-07
mutant O 0 4.106299229533761e-07
. O 0 2.654653918909844e-08

In O 0 8.830859599129326e-09
this O 0 2.3204856092196025e-10
report O 0 1.0426051133549663e-09
, O 0 3.2252627218259944e-12
we O 0 3.810727428055216e-11
demonstrate O 0 1.1765481644498976e-10
in O 0 1.83179998947125e-11
cultured O 0 7.581088645736145e-09
293 O 0 8.434918874478115e-10
cells O 0 2.1777264436195765e-09
overexpressing O 0 2.559501979249035e-07
wild O 0 9.332301154074685e-09
- O 0 3.7357842757046456e-06
type O 0 2.761915311566554e-06
or O 0 4.039593548554876e-09
mutant O 0 5.058744534380821e-08
HFE O 0 6.207436626937124e-07
proteins O 0 1.120890047445755e-10
that O 0 1.1557889194324655e-11
both O 0 5.073276000688853e-12
the O 0 1.6540919675622767e-11
wild O 0 6.823686060641876e-09
- O 0 2.0763893189723603e-05
type O 0 6.66692722006701e-05
and O 0 2.0177676418597912e-08
H63D O 0 3.6165412893751636e-05
HFE O 0 1.0350295269745402e-05
proteins O 0 1.884356004566712e-09
form O 0 2.2519086595451654e-09
stable O 0 1.9925988681279705e-07
complexes O 0 1.4447286922347757e-08
with O 0 6.087574194735268e-11
the O 0 8.3397033723287e-10
transferrin O 0 2.5882059162540827e-06
receptor O 0 2.515822643545107e-07
( O 0 4.160913391615395e-09
TfR O 0 9.825539564189967e-06
) O 0 2.002781274157428e-10
. O 0 8.654420513565242e-10

The O 0 6.402452346065957e-09
C282Y O 0 4.527948362920142e-07
mutation O 0 1.685635083958914e-06
nearly O 0 1.4964939287764878e-09
completely O 0 1.3398892662053186e-08
prevents O 0 2.4622992533807064e-09
the O 0 4.357585819958487e-11
association O 0 7.058501786533222e-12
of O 0 3.657244862856346e-13
the O 0 1.828986094520868e-11
mutant O 0 2.8487285419487307e-08
HFE O 0 1.5362836620624876e-06
protein O 0 9.988059268550842e-10
with O 0 1.5646363371590866e-10
the O 0 1.0426195018453654e-08
TfR O 0 0.00021931799710728228
. O 0 8.914596172360234e-09

Studies O 0 3.739034468708269e-07
on O 0 6.247176997931092e-09
cell O 0 2.8200495307828533e-06
- O 0 2.7880616926267976e-06
associated O 0 1.0370068359577544e-08
transferrin O 0 3.6814274295693394e-08
at O 0 6.123398454960238e-10
37 O 0 6.950451325593576e-11
degrees O 0 4.893841332176407e-09
C O 0 3.7547174258634186e-08
suggest O 0 3.727294473065967e-09
that O 0 8.243764698656619e-11
the O 0 2.651719642476902e-11
overexpressed O 0 6.022211778144992e-07
wild O 0 1.4292512950930814e-08
- O 0 7.67255733080674e-06
type O 0 7.84888743510237e-06
HFE O 0 1.557275390950963e-05
protein O 0 7.76203901153849e-09
decreases O 0 8.072829515981539e-09
the O 0 2.2671142307223446e-12
affinity O 0 2.7298438509681944e-10
of O 0 6.118488528328303e-12
the O 0 1.1408048949945737e-09
TfR O 0 2.2307269773591543e-06
for O 0 1.0781960740890995e-10
transferrin O 0 7.110239721441758e-07
. O 0 5.360245136643016e-09

The O 0 2.538224563863878e-08
overexpressed O 0 1.2199981028970797e-05
H63D O 0 8.62534398038406e-06
protein O 0 1.6013482095900144e-08
does O 0 6.170062682997468e-09
not O 0 2.1360362090216967e-10
have O 0 3.5163833650431187e-11
this O 0 6.14536546650335e-12
effect O 0 1.1056786597407608e-09
, O 0 8.538568073077069e-13
providing O 0 4.166368855820779e-13
the O 0 3.2569864231828116e-13
first O 0 2.9159265063291584e-13
direct O 0 2.8185487797871556e-12
evidence O 0 4.2647224640646186e-10
for O 0 6.8361163084451615e-12
a O 0 2.942031340769091e-10
functional O 0 3.0784288451712882e-09
consequence O 0 1.6162882143788693e-09
of O 0 4.622602214204852e-12
the O 0 3.5642880313879743e-10
H63D O 0 0.00015149514365475625
mutation O 0 3.5192281302443007e-06
. O 0 4.323283508966824e-09

Addition O 0 1.5115897866735395e-08
of O 0 1.039176300565714e-09
soluble O 0 1.149768081631919e-06
wild O 0 5.666097635526057e-08
- O 0 7.085110701154917e-05
type O 0 0.0004928522976115346
HFE O 0 0.0068307435140013695
/ O 0 1.1437400644354057e-06
beta2m O 0 7.146439315874886e-07
heterodimers O 0 4.281092174096557e-07
to O 0 3.6588482243971043e-10
cultured O 0 2.063533059981637e-07
cells O 0 6.584504053108731e-09
also O 0 1.7885758152313969e-10
decreased O 0 1.0493843571879324e-09
the O 0 1.1171026126702288e-12
apparent O 0 7.314880923203759e-10
affinity O 0 5.821495507873919e-10
of O 0 6.964887000471265e-12
the O 0 1.2363843282514608e-10
TfR O 0 4.495917238500624e-08
for O 0 2.2301816426581467e-13
its O 0 4.928979858813409e-13
ligand O 0 1.903507629297252e-10
under O 0 8.45350178746429e-11
steady O 0 3.509400414714037e-08
- O 0 1.693012109171832e-06
state O 0 1.9369034376381933e-08
conditions O 0 2.7761493015532324e-07
, O 0 2.4537440222044404e-12
both O 0 2.2641498051423348e-12
in O 0 2.298946449874606e-11
293 O 0 1.158148507651724e-10
cells O 0 2.5810814596738396e-10
and O 0 4.587761837093751e-10
in O 0 1.2533425408634002e-09
HeLa O 0 1.1646932307485258e-06
cells O 0 9.795068223183989e-08
. O 0 6.017782716583042e-09

Furthermore O 0 6.497649565062602e-07
, O 0 2.0127148558923835e-10
at O 0 5.5459536962843e-10
4 O 0 2.851177349771916e-10
degrees O 0 1.2558862749756372e-07
C O 0 2.2708723008690868e-06
, O 0 4.6704796280439e-11
the O 0 1.8798750056614466e-10
added O 0 2.6968082877942834e-08
soluble O 0 1.1259957233278328e-07
complex O 0 1.0845162545791709e-09
of O 0 2.1055286680837781e-10
HFE O 0 0.00019729825726244599
/ O 0 1.1195689353371563e-07
beta2m O 0 1.7049588052486797e-07
inhibited O 0 5.288538051928526e-09
binding O 0 1.113802383656548e-09
of O 0 9.770624413707463e-12
transferrin O 0 3.4009147498181846e-08
to O 0 5.163386385120816e-10
HeLa O 0 4.3485181322466815e-07
cell O 0 4.068642283527879e-06
TfR O 0 3.037723445231677e-06
in O 0 2.4660615563498745e-11
a O 0 9.385240362647096e-10
concentration O 0 7.175021892180666e-05
- O 0 5.800701546831988e-05
dependent O 0 7.113088429377967e-08
manner O 0 1.551220861983893e-06
. O 0 3.273255444469214e-08

Scatchard O 0 2.7315316401654854e-05
plots O 0 4.428372335496533e-07
of O 0 2.402993914962792e-10
these O 0 3.1122548982409626e-11
data O 0 1.246935554810591e-09
indicate O 0 1.5946032050351278e-08
that O 0 6.789625806025157e-11
the O 0 2.584444637465655e-11
added O 0 4.0037234638745645e-10
heterodimer O 0 2.4735744119652736e-08
substantially O 0 3.8774086164039545e-08
reduced O 0 1.7199645874210745e-10
the O 0 2.7853607007660708e-12
affinity O 0 4.413194532038034e-10
of O 0 1.3004014531858843e-10
TfR O 0 1.232481622537307e-06
for O 0 1.7691717535406326e-10
transferrin O 0 8.374417461709527e-07
. O 0 1.0858413723724425e-08

These O 0 6.012780495723291e-09
results O 0 3.2914280190254885e-09
establish O 0 5.465619068445449e-10
a O 0 5.527451829578922e-10
molecular O 0 1.667647097747249e-06
link O 0 2.8342149107629666e-06
between O 0 3.255615865782602e-08
HFE O 0 0.00820864923298359
and O 0 1.1649283759851414e-09
a O 0 3.090063482868999e-10
key O 0 5.969879035561121e-10
protein O 0 9.635198888746643e-11
involved O 0 1.6682906445186774e-10
in O 0 7.455882578000228e-10
iron O 0 7.760770677123219e-05
transport O 0 8.230359327399128e-08
, O 0 4.6935375724865835e-11
the O 0 8.273504797928766e-11
TfR O 0 6.876406928313372e-07
, O 0 1.6040686574153584e-12
and O 0 1.8291631230515915e-12
raise O 0 3.5966150196964364e-11
the O 0 1.7358150507240655e-12
possibility O 0 9.774562409470278e-11
that O 0 1.553205827842241e-11
alterations O 0 3.9757952485786063e-10
in O 0 8.479060335797595e-12
this O 0 1.958566295257036e-11
regulatory O 0 1.9008130625053354e-09
mechanism O 0 2.3479218569377736e-08
may O 0 2.8230628501546562e-08
play O 0 3.381608534858138e-11
a O 0 2.8687736214338955e-11
role O 0 3.352799426981079e-10
in O 0 5.6307090934293313e-11
the O 0 1.5055343083325567e-10
pathogenesis O 0 9.796581679211158e-08
of O 0 2.4041789004058955e-08
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 1.278443778574001e-05
. O 0 7.081736441705289e-08

Genomic O 0 4.75978913527797e-06
organization O 0 1.1165702140658595e-08
of O 0 1.6194873220243267e-10
the O 0 8.966568598722802e-10
UBE3A O 0 0.0002849047596100718
/ O 0 2.492329258529935e-06
E6 O 0 1.119246007874608e-05
- O 0 0.0007504949462600052
AP O 0 8.150625944836065e-05
gene O 0 6.536568264436937e-08
and O 0 1.0631828750717887e-09
related O 0 2.124713560647251e-08
pseudogenes O 0 2.5217705115210265e-06
. O 0 4.677137255271191e-08

The O 0 4.0958909153232526e-08
UBE3A O 0 1.836090268625412e-05
gene O 0 5.850163731224711e-08
encodes O 0 2.7531784851930752e-08
the O 0 7.543151658850888e-10
E6 O 0 5.539707672141958e-06
- O 0 0.0007547069108113647
AP O 0 1.571650500409305e-05
ubiquitin O 0 5.9530677276598e-08
- O 0 4.934146602408873e-08
protein O 0 2.926349718102017e-10
ligase O 0 2.027326084785841e-09
and O 0 4.136523623632371e-10
has O 0 1.6900499055783058e-10
recently O 0 2.4562294420604758e-09
been O 0 1.6853435313990417e-10
shown O 0 4.1142242390712624e-10
to O 0 1.671605562303391e-11
be O 0 1.1780764808122512e-08
mutated O 0 2.2217944206204265e-05
in O 0 0.018366435542702675
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 0.0001013786531984806
who O 0 2.146403588199064e-08
lack O 0 1.3687733613210185e-08
15q11 O 0 1.8743278928923246e-07
- O 0 3.232401297736942e-07
q13 O 0 5.005122361012582e-08
deletions O 0 8.024182420740544e-07
or O 0 1.5009403853127878e-07
chromosome O 0 2.8386884878273122e-05
15 O 0 7.102917809476139e-09
paternal O 0 2.730263258854393e-05
uniparental B-Disease 0 0.13863955438137054
disomy I-Disease 0 0.005395511630922556
. O 0 1.878042326097784e-07

Previous O 0 6.170830602059141e-07
UBE3A O 0 3.0117509595584124e-05
cDNA O 0 1.4239729750897823e-07
analysis O 0 9.745795637172705e-08
has O 0 9.158778180307081e-10
shown O 0 9.936034217616907e-10
a O 0 2.7016142101210505e-10
coding O 0 5.5565266166013316e-08
region O 0 7.632970366877601e-10
of O 0 2.5498859967942877e-11
approximately O 0 4.569588318847906e-10
2 O 0 2.0559629554384173e-09
. O 0 1.823714868010029e-08

6 O 0 1.4692771799218463e-07
kb O 0 2.2898620954947546e-06
and O 0 2.996753512007899e-09
a O 0 1.0028342600776341e-08
3 O 0 1.6336141328565645e-08
- O 0 0.0012364814756438136
untranslated O 0 0.0017736168811097741
region O 0 1.1225517937418772e-07
( O 0 9.554074198447893e-11
UTR O 0 1.439796371016655e-08
) O 0 9.622957812538413e-13
of O 0 1.088186290208737e-12
< O 0 1.0975099939969368e-08
50 O 0 3.958918609603401e-11
bp O 0 2.6837849276262205e-08
, O 0 2.8982621424339383e-12
whereas O 0 1.8504749815795307e-11
Northern O 0 1.2591831223540684e-11
analysis O 0 1.6117496226542016e-10
has O 0 9.443629905847573e-11
indicated O 0 2.1972515473756005e-10
mRNA O 0 2.4143723478808887e-11
sizes O 0 4.067905734483901e-10
of O 0 3.3781898719359438e-12
5 O 0 1.907571184345258e-10
- O 0 4.856389637097891e-07
8 O 0 2.493610651299605e-09
kb O 0 3.0661474283988355e-06
. O 0 6.113018002906756e-08

We O 0 2.4541662924093544e-07
have O 0 7.500194215692702e-11
analyzed O 0 3.462311271018592e-10
additional O 0 5.638164848192906e-12
cDNA O 0 2.5840912742935984e-10
clones O 0 8.058640976749132e-10
and O 0 1.7422573800329744e-11
provide O 0 6.617064535197059e-12
evidence O 0 7.496876036627853e-11
for O 0 2.0120526338790468e-12
an O 0 3.1049956442791293e-12
additional O 0 6.32134067313217e-11
0 O 0 1.4903127620868872e-09
. O 0 3.774072609985524e-09

5 O 0 1.6022097426571236e-08
kb O 0 2.746827192368073e-07
of O 0 4.189181224134586e-10
5 O 0 2.6667152930315297e-09
- O 0 8.339871783391573e-06
UTR O 0 5.137465450388845e-06
and O 0 4.010235199469747e-10
> O 0 7.793663492350333e-10
2 O 0 1.7020440612469656e-11
kb O 0 1.8099092002898942e-08
of O 0 1.726676579494324e-10
3 O 0 2.1790528492715566e-08
- O 0 0.0002325153909623623
UTR O 0 3.475166886346415e-05
. O 0 2.3129230086738062e-08

We O 0 7.943467039694951e-07
have O 0 3.08904957169176e-10
established O 0 2.6228215779799946e-11
the O 0 6.382738521742981e-12
genomic O 0 1.1627262486157974e-09
organization O 0 1.7181669281773893e-11
of O 0 2.848891261786335e-12
UBE3A O 0 5.932629960625491e-07
and O 0 5.823670018445526e-11
the O 0 3.14439013021639e-12
sequence O 0 7.47873776796304e-11
of O 0 7.329524140398114e-12
intron O 0 3.5082407521258574e-06
- O 0 2.7071908334619366e-05
exon O 0 1.2406761925376486e-05
borders O 0 1.0554730351941544e-06
. O 0 1.8691864056563645e-08

We O 0 7.231417384900851e-07
have O 0 1.507040603421217e-09
also O 0 6.240525457501533e-11
mapped O 0 7.484842257099444e-08
two O 0 3.358096786754139e-11
highly O 0 5.405488279208726e-10
homologous O 0 5.160031957274214e-09
processed O 0 3.1307401116009714e-08
pseudogenes O 0 1.216984344409866e-07
, O 0 7.049975186967927e-11
UBE3AP1 O 0 3.2089477031149727e-07
and O 0 7.627726922310174e-11
UBE3AP2 O 0 2.5749801579877385e-07
, O 0 2.8907098069408388e-12
to O 0 2.1140899360977405e-12
chromosomes O 0 9.611470508374964e-10
2 O 0 1.734319979296295e-11
and O 0 1.8984241956232495e-10
21 O 0 6.428631932342554e-11
, O 0 7.060440340017626e-12
respectively O 0 1.4310836959907647e-09
, O 0 1.1639099406490772e-11
and O 0 2.6434140987241506e-10
determined O 0 3.765905987052065e-08
their O 0 2.265465176565229e-10
genomic O 0 1.5585499113512924e-08
organization O 0 1.422657880389977e-09
. O 0 9.960302582712188e-10

These O 0 1.0067131128721485e-08
results O 0 9.425429325915502e-09
will O 0 2.2371295094192334e-10
form O 0 2.5325918445728846e-11
the O 0 4.130795098339357e-12
basis O 0 1.8353497541201413e-11
for O 0 1.1547746266160619e-12
studies O 0 8.516143519543551e-12
of O 0 3.2326530775145246e-12
mutation O 0 3.583459928790944e-08
and O 0 4.200911007945507e-10
imprinting O 0 2.0983789283945953e-07
of O 0 9.918842414080586e-10
UBE3A O 0 0.00020431532175280154
. O 0 2.5586007978972702e-08

Mutation O 0 0.0011630788212642074
spectrum O 0 2.669830428203568e-05
and O 0 3.164896611451695e-08
genotype O 0 0.004903178662061691
- O 0 0.0013346441555768251
phenotype O 0 7.096673652995378e-05
analyses O 0 1.0898553455263027e-06
in O 0 1.2531711668373191e-08
Cowden B-Disease 1 0.7605627179145813
disease I-Disease 0 0.0005578647251240909
and O 0 4.121089602904249e-07
Bannayan B-Disease 1 0.9989994168281555
- I-Disease 1 0.9999933242797852
Zonana I-Disease 1 0.9999884366989136
syndrome I-Disease 1 0.999985933303833
, O 0 9.714219428857973e-10
two O 0 6.104370342541188e-09
hamartoma B-Disease 1 0.6829782724380493
syndromes I-Disease 0 0.37243151664733887
with O 0 1.0186890619934275e-07
germline O 0 0.12047085165977478
PTEN O 1 0.8525776863098145
mutation O 0 0.0035855250898748636
. O 0 4.936236450703291e-07

The O 0 9.081132930077729e-07
tumour B-Disease 1 0.9998070597648621
suppressor O 0 0.0025744407903403044
gene O 0 9.968058293452486e-05
PTEN O 0 0.002296390710398555
, O 0 1.6121932677748418e-09
which O 0 1.2725791254108998e-10
maps O 0 9.098816811103916e-09
to O 0 2.007084498600875e-09
10q23 O 0 1.6080563227660605e-06
. O 0 2.3697152684576395e-08

3 O 0 2.0704691294781696e-08
and O 0 9.946344442512967e-11
encodes O 0 6.97280233552533e-10
a O 0 3.509958990122186e-10
403 O 0 3.992612629399872e-10
amino O 0 2.4414731347732754e-10
acid O 0 2.310554192419545e-09
dual O 0 1.8472992735496518e-07
specificity O 0 4.998253189114621e-06
phosphatase O 0 0.023667151108384132
( O 0 3.4023517336834175e-10
protein O 0 5.284756632306653e-09
tyrosine O 0 6.04165563800052e-07
phosphatase O 0 0.0013865167275071144
; O 0 2.0289894209213344e-09
PTPase O 0 1.5610480659233872e-06
) O 0 2.381892252878437e-11
, O 0 1.825065792937508e-11
was O 0 9.070434181523979e-09
shown O 0 9.373459164407905e-08
recently O 0 2.1320046172945695e-08
to O 0 2.4525754691029356e-11
play O 0 8.140576407411615e-11
a O 0 5.0150435887408307e-11
broad O 0 1.0232873576265789e-10
role O 0 5.435252803387414e-10
in O 0 7.510619903783322e-10
human O 0 4.240539297484247e-08
malignancy B-Disease 0 0.0001346138451481238
. O 0 2.3632876988699536e-08

Somatic O 0 9.220686479238793e-05
PTEN O 0 0.0006371833151206374
deletions O 0 2.7092002710560337e-05
and O 0 1.475596178579508e-07
mutations O 0 1.1967232239840087e-05
were O 0 3.537199644298994e-09
observed O 0 8.762692971231445e-08
in O 0 2.481231609063883e-10
sporadic B-Disease 0 3.877475319313817e-05
breast I-Disease 1 0.9993990659713745
, I-Disease 0 1.4285830047811032e-06
brain I-Disease 0 0.17343854904174805
, I-Disease 0 2.9691779701579435e-08
prostate I-Disease 0 0.22468356788158417
and I-Disease 0 7.834684220142663e-05
kidney I-Disease 0 0.0869901180267334
cancer I-Disease 0 0.005384200252592564
cell O 0 0.0002214875421486795
lines O 0 6.838092758698622e-06
and O 0 1.2464432819214721e-09
in O 0 2.8583468925091893e-11
several O 0 3.3579430902541674e-11
primary O 0 5.352530934032984e-06
tumours B-Disease 1 0.9999957084655762
such O 0 2.3428713191719908e-08
as O 0 1.6382061858166708e-06
endometrial B-Disease 1 0.9999556541442871
carcinomas I-Disease 1 1.0
, O 1 0.9156444668769836
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 0.9998039603233337
thyroid B-Disease 1 0.9999978542327881
tumours I-Disease 1 0.9999986886978149
. O 0 2.133222324118833e-06

In O 0 1.6456606743986413e-08
addition O 0 3.4913454349805306e-09
, O 0 1.0166947284062644e-09
PTEN O 0 2.9263110263855197e-05
was O 0 9.17161742108874e-08
identified O 0 4.61000082552232e-09
as O 0 9.518146687481632e-12
the O 0 1.2225784620789604e-11
susceptibility O 0 1.157913175120484e-06
gene O 0 1.0000111849706173e-08
for O 0 2.731135595457346e-10
two O 0 6.863854906669076e-08
hamartoma B-Disease 1 0.9997698664665222
syndromes I-Disease 1 0.9999253749847412
Cowden B-Disease 1 0.9998435974121094
disease I-Disease 1 0.9493372440338135
( O 0 2.4217401417558904e-09
CD B-Disease 0 6.150341050670249e-06
; O 0 1.7410334285372642e-09
MIM O 0 1.6595129181951052e-06
158350 O 0 8.797828598972046e-08
) O 0 1.585650534485783e-11
and O 0 8.746070534471073e-10
Bannayan B-Disease 0 0.0003827756445389241
- I-Disease 0 0.06351635605096817
Zonana I-Disease 0 0.016840128228068352
( I-Disease 0 1.0711331821511294e-09
BZS I-Disease 0 6.405966246347816e-07
) I-Disease 0 3.600974032846871e-11
or I-Disease 0 5.324019003438707e-10
Ruvalcaba I-Disease 0 2.1072011804790236e-05
- I-Disease 0 0.0004240262205712497
Riley I-Disease 0 0.0006354794604703784
- I-Disease 1 0.9998552799224854
Smith I-Disease 1 0.7514768242835999
syndrome I-Disease 1 0.9989977478981018
( O 0 2.608804283710242e-09
MIM O 0 2.483614480297547e-05
153480 O 0 2.1985067633067956e-06
) O 0 1.3286883815410988e-09
. O 0 5.4303024299429126e-09

Constitutive O 0 4.008930318377679e-06
DNA O 0 8.019056281227677e-07
from O 0 1.3928386222161748e-09
37 O 0 3.529481429342951e-10
CD B-Disease 0 1.1214005724013987e-07
families O 0 5.408664627282178e-10
and O 0 4.1648501314384134e-10
seven O 0 3.62786883867372e-10
BZS B-Disease 0 2.6753120891953586e-06
families O 0 9.266720724099287e-10
was O 0 1.8000483326119365e-09
screened O 0 6.523080031684003e-08
for O 0 1.829305484868371e-09
germline O 0 0.00023184662859421223
PTEN O 0 0.003402597736567259
mutations O 0 9.231120930053294e-05
. O 0 1.0213077672460713e-07

PTEN O 0 0.006754675880074501
mutations O 0 0.0003888357896357775
were O 0 9.263279032722949e-09
identified O 0 2.0775106079895522e-08
in O 0 2.925756859006867e-11
30 O 0 2.446271917672105e-12
of O 0 1.3158819736971972e-12
37 O 0 4.580161944156558e-11
( O 0 3.5880621390704803e-12
81 O 0 1.3035695786700607e-11
% O 0 1.0072129762173088e-11
) O 0 1.1260875044938334e-12
CD B-Disease 0 1.9682536489540325e-08
families O 0 5.1832860920031365e-11
, O 0 1.0997771703741277e-12
including O 0 9.427788411064952e-12
missense O 0 2.4239679987658747e-06
and O 0 4.539518272395071e-08
nonsense O 0 9.979467904486228e-06
point O 0 9.476713636047407e-09
mutations O 0 4.211231896533718e-08
, O 0 3.865409294728783e-12
deletions O 0 8.674339468939252e-09
, O 0 3.237961634927622e-11
insertions O 0 1.483816021163875e-07
, O 0 5.669872904512374e-11
a O 0 3.8161410143011665e-10
deletion O 0 2.5632709821366007e-06
/ O 0 3.411902582683979e-07
insertion O 0 1.9935562534101336e-08
and O 0 8.095001113872513e-09
splice O 0 4.419155629875604e-06
site O 0 4.785934379469836e-06
mutations O 0 9.826286986935884e-05
. O 0 1.1446921632796148e-07

These O 0 2.4669825293699432e-08
mutations O 0 7.641140769010235e-07
were O 0 7.950730074313128e-10
scattered O 0 1.199127241946485e-09
over O 0 3.1934230260155516e-10
the O 0 2.0056252492128834e-10
entire O 0 1.1016495493620937e-09
length O 0 1.6218166365433717e-08
of O 0 5.768284808138624e-11
PTEN O 0 9.4928827820695e-06
, O 0 1.0224245929058018e-11
with O 0 2.6265348403164968e-12
the O 0 3.492845552718893e-12
exception O 0 5.832317961917965e-11
of O 0 1.6625900959785223e-12
the O 0 4.155659150129054e-11
first O 0 1.1830791901701332e-09
, O 0 1.5620273130512174e-10
fourth O 0 1.1675309607994677e-09
and O 0 1.2117729042415704e-09
last O 0 6.624209181183005e-09
exons O 0 1.2169390117833245e-07
. O 0 1.5977024148128294e-08

A O 0 7.293640464922646e-07
hot O 0 1.7991366121350438e-06
spot O 0 7.733911502327828e-07
for O 0 9.002847356498478e-10
PTEN O 0 0.00016833368863444775
mutation O 0 2.610409410408465e-06
in O 0 9.025163394404956e-10
CD B-Disease 0 3.920013568858849e-06
was O 0 2.061072734704794e-07
identified O 0 3.16633368413477e-08
in O 0 4.3428496909747594e-11
exon O 0 3.524943892330157e-08
5 O 0 9.292823455187005e-11
that O 0 3.986409119471901e-11
contains O 0 2.1501044000782343e-11
the O 0 4.3995598830726124e-11
PTPase O 0 2.9538853141275467e-07
core O 0 1.0954354756620432e-08
motif O 0 2.026194145798854e-08
, O 0 1.2097135359406819e-12
with O 0 1.4538451822629361e-12
13 O 0 1.0756090029068188e-12
of O 0 6.666555870706026e-13
30 O 0 6.851363226756391e-12
( O 0 1.5871354794652626e-12
43 O 0 5.452514741793868e-12
% O 0 5.993375067070428e-12
) O 0 2.4241580964812215e-12
CD B-Disease 0 2.0824266755425924e-07
mutations O 0 2.410157264876034e-07
identified O 0 7.617342845378516e-08
in O 0 2.277070892953148e-10
this O 0 2.859182890446732e-10
exon O 0 1.6669664546498097e-06
. O 0 7.345380481638131e-08

Seven O 0 4.053061442021999e-09
of O 0 5.618928933248668e-11
30 O 0 2.1647381109879404e-10
( O 0 1.2595578226248794e-11
23 O 0 2.083094287341769e-11
% O 0 3.200004714334903e-12
) O 0 1.0109712546280125e-12
were O 0 1.4517267943325862e-10
within O 0 3.8996514351019584e-12
the O 0 2.3606351248761648e-11
core O 0 1.1269104760458504e-08
motif O 0 1.3960202771556851e-08
, O 0 2.132638683705057e-12
the O 0 2.055857871094413e-12
majority O 0 2.129014672891394e-11
( O 0 9.572542411517837e-13
five O 0 5.187899805927931e-13
of O 0 3.469902045815515e-13
seven O 0 3.5102034126599513e-12
) O 0 2.1547741618343358e-13
of O 0 6.709839389835992e-13
which O 0 6.650919259776344e-10
were O 0 6.167827582004293e-09
missense O 0 1.9350007278262638e-05
mutations O 0 4.709332188213011e-06
, O 0 6.64949484363575e-11
possibly O 0 1.1340081096378185e-09
pointing O 0 5.71251987935284e-08
to O 0 6.882355102488802e-11
the O 0 2.0156027888407202e-11
functional O 0 7.187079820170084e-10
significance O 0 4.802178099616583e-10
of O 0 1.1298228845546543e-11
this O 0 2.0241876230731037e-10
region O 0 5.663296054336797e-09
. O 0 1.9292603070653058e-08

Germline O 0 0.012813311070203781
PTEN O 0 0.02478000335395336
mutations O 0 0.0014578826958313584
were O 0 1.3308169677372916e-08
identified O 0 7.915708266637012e-08
in O 0 5.714646811316726e-11
four O 0 7.105440368027072e-12
of O 0 5.312875573509901e-12
seven O 0 1.641715097200347e-10
( O 0 1.6071225947267287e-11
57 O 0 5.186846438465231e-11
% O 0 1.8815312155529007e-11
) O 0 2.3488589545594962e-11
BZS B-Disease 0 7.878848009568173e-07
families O 0 1.4052012886622833e-09
studied O 0 4.84225708419217e-08
. O 0 1.4408237269947222e-08

Interestingly O 0 1.7831154764280654e-05
, O 0 8.195669698451979e-10
none O 0 7.22489013060823e-10
of O 0 1.6988939552028959e-12
these O 0 7.73237446294317e-11
mutations O 0 4.023141286779719e-07
was O 0 7.323166073547327e-08
observed O 0 4.633239214513196e-08
in O 0 4.491796171124385e-11
the O 0 1.6813334058340956e-10
PTPase O 0 2.789191967167426e-06
core O 0 3.083464150677173e-07
motif O 0 6.983376010794018e-07
. O 0 1.8630286646725835e-08

It O 0 4.8230472060595275e-08
is O 0 6.039535538349128e-10
also O 0 5.8141359782215574e-11
worthy O 0 1.2224234957614044e-09
of O 0 7.832311188504804e-12
note O 0 5.802600711035666e-08
that O 0 3.552774741066855e-11
a O 0 1.5595592872674757e-10
single O 0 9.34241661809665e-09
nonsense O 0 2.566323473729426e-07
point O 0 1.6693704196768522e-09
mutation O 0 1.1043555403489336e-08
, O 0 4.961731546460069e-12
R233X O 0 1.2790184467093013e-09
, O 0 1.4768080855431798e-11
was O 0 4.485414262234144e-09
observed O 0 5.210678999389984e-09
in O 0 1.1115006484652135e-11
the O 0 1.8868680923267434e-11
germline O 0 2.22145040140731e-08
DNA O 0 8.115039662470735e-08
from O 0 7.606022062178752e-11
two O 0 5.593778565349261e-11
unrelated O 0 3.070871557042665e-08
CD B-Disease 0 7.392488896584837e-06
families O 0 9.955080093604352e-10
and O 0 1.5755438065312433e-09
one O 0 6.0294098602753365e-09
BZS B-Disease 0 2.7125714041176252e-05
family O 0 8.57884501215267e-08
. O 0 1.7022900422603016e-08

Genotype O 1 0.9349859356880188
- O 0 0.1523086577653885
phenotype O 0 0.015396783128380775
studies O 0 2.05008689135866e-07
were O 0 7.502920063018337e-09
not O 0 6.20325291134094e-10
performed O 0 1.6020683668571678e-09
on O 0 5.951279469229576e-10
this O 0 2.2399120752636392e-11
small O 0 2.5495855426882486e-10
group O 0 5.723267415547184e-10
of O 0 1.5555665089372894e-10
BZS B-Disease 0 1.0637355444487184e-05
families O 0 7.85462894725697e-09
. O 0 1.0718285814448336e-08

However O 0 1.557017412778805e-07
, O 0 6.198438984306165e-10
genotype O 0 8.283799616037868e-06
- O 0 7.950318831717595e-06
phenotype O 0 4.605406957125524e-06
analysis O 0 2.5528861247181567e-09
inthe O 0 1.4269664916355396e-07
group O 0 3.882570376312344e-10
of O 0 9.168730878694742e-12
CD B-Disease 0 1.1641225228231633e-06
families O 0 5.260005209173357e-10
revealed O 0 2.530200760020307e-08
two O 0 4.264327606307017e-12
possible O 0 1.2375735158887124e-10
associations O 0 1.1035432116723864e-11
worthy O 0 2.486907346721523e-10
of O 0 3.723316793768916e-12
follow O 0 1.6040029027220015e-10
- O 0 1.2201115850984934e-07
up O 0 1.7714180122752055e-09
in O 0 5.483221168778307e-11
independent O 0 2.1437664143864055e-10
analyses O 0 6.246678907473324e-08
. O 0 3.1610456474595594e-09

The O 0 1.3712138979826705e-08
first O 0 5.4020588002856584e-09
was O 0 6.687394460413998e-08
an O 0 7.803074852930081e-11
association O 0 2.2265553289990692e-10
noted O 0 8.907810045144515e-10
in O 0 3.638122442195524e-11
the O 0 2.6641810285665812e-11
group O 0 5.5535617771163004e-11
of O 0 3.493505181320633e-12
CD B-Disease 0 1.580910975462757e-06
families O 0 1.7786768724548097e-09
with O 0 2.1942764760751743e-07
breast B-Disease 1 0.9993964433670044
disease I-Disease 0 0.019914347678422928
. O 0 1.2871838350747566e-07

A O 0 1.212745104339774e-07
correlation O 0 5.727450570702786e-06
was O 0 1.3095780104777077e-07
observed O 0 2.2747551398083488e-08
between O 0 3.8459228857146144e-11
the O 0 2.806447955971958e-11
presence O 0 2.9685649494126665e-09
/ O 0 1.1640981512073267e-08
absence O 0 1.7647533434583806e-10
of O 0 1.154516911759662e-12
a O 0 6.268036645273867e-10
PTEN O 0 9.658248927735258e-06
mutation O 0 1.546492569559632e-07
and O 0 3.766511061376043e-11
the O 0 9.043126490693165e-12
type O 0 2.881853333747131e-07
of O 0 8.905889914423426e-10
breast O 0 0.010103035718202591
involvement O 0 3.891103187925182e-05
( O 0 1.1104874353407013e-08
unaffected O 0 3.708098347487976e-06
versus O 0 3.0736002372577786e-05
benign O 0 0.003376307897269726
versus O 0 0.0007399003370665014
malignant O 0 0.0025283535942435265
) O 0 7.54186046947325e-09
. O 0 8.036050935800176e-09

Specifically O 0 9.927783395369261e-08
and O 0 4.975753142844042e-10
more O 0 8.42232360243056e-12
directly O 0 4.0464007144969116e-10
, O 0 5.991469820276762e-11
an O 0 5.778812151024937e-11
association O 0 4.888064397690073e-10
was O 0 3.870108855608123e-08
also O 0 6.492985593631317e-10
observed O 0 1.0148735185566693e-09
between O 0 9.145345071515099e-12
the O 0 4.977086017626808e-12
presence O 0 3.9843715132770186e-11
of O 0 2.7091193871564556e-12
a O 0 4.764436845050568e-09
PTEN O 0 0.00028782058507204056
mutation O 0 1.3185373973101377e-05
and O 0 2.023500428549596e-06
malignant B-Disease 1 0.9998583793640137
breast I-Disease 1 0.9999768733978271
disease I-Disease 1 0.983950138092041
. O 0 8.187253683900053e-07

Secondly O 0 0.00021482033480424434
, O 0 7.255602785249948e-10
there O 0 2.848861702098304e-10
appeared O 0 5.03534947071671e-09
to O 0 1.5512141571250027e-10
be O 0 1.6625640864020852e-09
an O 0 1.2538750593371617e-10
interdependent O 0 0.00016629435413051397
association O 0 2.1072603384464372e-10
between O 0 2.4102278506354935e-10
mutations O 0 5.512654155381824e-08
upstream O 0 4.0819503333011653e-10
and O 0 6.851026690402051e-11
within O 0 1.0720151329135508e-11
the O 0 4.104127454551687e-11
PTPase O 0 4.984088377568696e-07
core O 0 3.9268801543812515e-08
motif O 0 6.795906415391073e-08
, O 0 1.4453715134477019e-11
the O 0 5.97265162674554e-12
core O 0 1.1326850568593727e-09
motif O 0 8.128028805565179e-10
containing O 0 9.531358341474672e-11
the O 0 6.139484320238919e-12
majority O 0 2.2344502983995262e-11
of O 0 2.623181880045955e-11
missense O 0 7.19476884114556e-05
mutations O 0 2.0629126083804294e-05
, O 0 7.20173157220394e-11
and O 0 3.228711048519628e-11
the O 0 9.936308720259746e-12
involvement O 0 7.456166795094532e-10
of O 0 1.2129647980474445e-11
all O 0 4.606523842931587e-11
major O 0 9.179309534701474e-10
organ O 0 7.521150564571144e-06
systems O 0 5.254375992080895e-07
( O 0 3.2590465048887296e-11
central O 0 6.860340628911388e-10
nervous O 0 2.6308377982786624e-06
system O 0 3.2556971518715727e-07
, O 0 2.6394165075771525e-08
thyroid O 0 0.0342475026845932
, O 0 8.938500606348043e-09
breast O 0 0.1033211350440979
, O 0 4.912745339424873e-07
skin O 1 0.9962363839149475
and O 0 0.0031676890794187784
gastrointestinal O 1 0.9990177154541016
tract O 0 0.3482803702354431
) O 0 2.2686329259613558e-08
. O 0 2.5457252306182454e-08

However O 0 9.795329702910749e-08
, O 0 3.6232201267027975e-11
these O 0 1.3729803969089738e-12
observations O 0 2.580329505619261e-09
would O 0 2.852281466569906e-10
need O 0 1.6308354666705327e-10
to O 0 1.7185962722376935e-11
be O 0 1.1764321738994e-09
confirmed O 0 2.7517371714580463e-10
by O 0 2.914215526880759e-12
studying O 0 5.4105601943188475e-11
a O 0 1.529367604780063e-11
larger O 0 1.171436142533011e-10
number O 0 6.518618977935375e-11
of O 0 1.075410593909254e-11
CD B-Disease 0 2.011229753406951e-06
families O 0 3.1767304342622538e-09
. O 0 3.1174327563832094e-09

Molecular O 1 0.9648083448410034
defects O 1 0.9974332451820374
leading O 0 6.173667088660295e-08
to O 0 4.4738432403157447e-10
human O 0 6.735639157540163e-09
complement B-Disease 0 9.56923577177804e-06
component I-Disease 1 0.8869746327400208
C6 I-Disease 1 1.0
deficiency I-Disease 1 0.9999998807907104
in O 0 2.682974953316375e-09
an O 0 1.3970416490316495e-10
African O 0 6.036932620467894e-10
- O 0 1.0304538591299206e-05
American O 0 9.774016263008889e-08
family O 0 5.279993686713169e-08
. O 0 8.390315997530706e-09

Complement B-Disease 0 0.0016855986323207617
component I-Disease 1 0.9755797982215881
C6 I-Disease 1 0.9999992847442627
deficiency I-Disease 1 0.9999992847442627
( O 0 6.6757053218680085e-09
C6D B-Disease 0 0.00012840759882237762
) O 0 9.663343458754525e-10
was O 0 1.826066409194027e-06
diagnosed O 0 0.0001397706218995154
in O 0 1.6787635170878445e-10
a O 0 8.762835457254425e-10
16 O 0 1.5833635791384637e-10
- O 0 8.672423490452275e-08
year O 0 1.5791721263980207e-09
- O 0 9.086333108143663e-08
old O 0 1.2548458983019373e-07
African O 0 1.0606059780426946e-10
- O 0 1.1220787854426817e-07
American O 0 1.0443192088871456e-08
male O 0 8.685169206046339e-08
with O 0 7.259096719280933e-07
meningococcal B-Disease 1 0.9999988079071045
meningitis I-Disease 1 0.9999958276748657
. O 0 2.3330569831614412e-07

The O 0 1.8455453698607016e-07
patients O 0 2.7739312713492836e-07
father O 0 8.010770784494525e-07
and O 0 2.1140609263170518e-09
two O 0 7.134101642769508e-10
brothers O 0 1.470917396773075e-07
also O 0 5.374102829414085e-10
had O 0 3.0919042881549785e-09
C6D B-Disease 0 2.6825241548067424e-06
, O 0 1.455738307676313e-11
but O 0 1.6596033575178026e-11
gave O 0 5.9502999749661e-11
no O 0 4.782689799753825e-10
history O 0 4.839075251616975e-10
of O 0 9.688776447802638e-10
meningitis B-Disease 1 0.9999730587005615
or O 0 7.798024448391061e-09
other O 0 1.3114965780047783e-09
neisserial B-Disease 0 0.0015920063015073538
infection I-Disease 0 0.0014505002181977034
. O 0 6.03875704996426e-08

By O 0 1.7955905651234616e-09
using O 0 8.390936279134564e-10
exon O 0 1.9083451263668394e-07
- O 0 1.728753460383814e-07
specific O 0 6.474114022658739e-10
polymerase O 0 1.3300151202599864e-08
chain O 0 8.478930624278291e-08
reaction O 0 6.7405485637550555e-09
( O 0 5.384398656105294e-12
PCR O 0 5.972023320310882e-09
) O 0 5.692560138548242e-12
/ O 0 3.00431790556388e-10
single O 0 1.5930307073475092e-09
- O 0 4.037014988966803e-08
strand O 0 2.2250887354857696e-08
conformation O 0 1.545439971550877e-07
polymorphism O 0 4.413687193505211e-08
as O 0 2.3281439710115537e-12
a O 0 7.0962580429878575e-12
screening O 0 4.958829180612412e-11
step O 0 1.4392623204351196e-10
and O 0 4.0770672428414034e-12
nucleotide O 0 1.410175014954218e-11
sequencing O 0 2.2573368955308704e-12
of O 0 3.056517712540785e-13
target O 0 7.145390945595409e-10
exons O 0 3.4927110093008196e-09
, O 0 2.93151614094711e-11
we O 0 9.104835774209619e-10
determined O 0 3.3367115737092945e-09
that O 0 8.70021138466015e-11
the O 0 2.2734069834995374e-11
proband O 0 4.898420229437761e-07
was O 0 3.5488909588821116e-09
a O 0 1.636881324929007e-10
compound O 0 4.166631928370634e-09
heterozygote O 0 2.6046890866382455e-08
for O 0 7.55913387440188e-11
two O 0 1.4809167225848796e-09
C6 O 0 0.0001720769505482167
gene O 0 4.319700508403912e-07
mutations O 0 4.4448838707467075e-06
. O 0 1.9552695462721204e-08

The O 0 3.2299340979591307e-09
first O 0 2.9252672506530075e-10
, O 0 8.302777736168832e-12
1195delC O 0 1.6534217328612044e-09
located O 0 1.5677791009860442e-10
in O 0 7.422718689698016e-11
exon O 0 2.1494848567726876e-07
7 O 0 7.524661782554176e-09
, O 0 1.9735886536143e-11
is O 0 1.4866829989301777e-11
a O 0 9.528468292163694e-11
novel O 0 3.0694056185609497e-09
mutation O 0 9.107188958523693e-08
, O 0 4.7645112681571344e-12
while O 0 6.983642830693526e-12
the O 0 3.854578982387391e-12
second O 0 4.6288181621001456e-10
, O 0 4.351055540169346e-12
1936delG O 0 4.171098466621004e-10
in O 0 1.2818696625005455e-11
exon O 0 3.873550014077409e-08
12 O 0 8.751143143470586e-10
, O 0 9.809562884210976e-11
has O 0 9.452428839651361e-10
been O 0 5.956980464461026e-10
described O 0 1.4783915425198302e-08
before O 0 1.8881038399420902e-10
to O 0 6.185574968897711e-11
cause O 0 2.1102911418324766e-08
C6D B-Disease 0 7.048544830468018e-06
in O 0 2.383447883502754e-10
an O 0 8.600979303774459e-12
unrelated O 0 1.3896656270162566e-08
African O 0 2.8770710813752487e-10
- O 0 4.079265920609032e-07
American O 0 1.2709842955871409e-08
individual O 0 3.7547800424420075e-09
. O 0 4.9311332794843565e-09

Both O 0 1.5073567283252487e-07
mutations O 0 3.316798392916098e-05
result O 0 1.1562761415007117e-07
in O 0 1.0712237319410178e-08
premature O 0 8.968464499048423e-06
termination O 0 1.4341961787067703e-06
codons O 0 2.3122576919831772e-07
and O 0 1.0859698917897731e-08
C6 O 0 6.985797517700121e-05
null O 0 1.8021090681941132e-06
alleles O 0 1.8420689684717217e-06
. O 0 7.920390032722935e-08

Allele O 0 2.6204406822216697e-05
- O 0 1.9641026938188588e-07
specific O 0 7.034021698437698e-10
PCR O 0 2.6101753292095964e-07
indicated O 0 1.380021217300964e-07
that O 0 4.778155648921256e-11
the O 0 7.884397128232745e-12
probands O 0 9.038416237672209e-07
two O 0 8.240624849165101e-10
brothers O 0 5.3208573547181004e-08
also O 0 2.0110034470999238e-10
inherited O 0 2.2343172645378218e-08
the O 0 1.0905845670983183e-11
1195delC O 0 2.052554926024186e-08
mutation O 0 1.318678499728776e-08
from O 0 9.238105072584268e-12
their O 0 1.0628457142169978e-10
heterozygous O 0 4.146211551869783e-08
mother O 0 1.4128012537639734e-07
and O 0 8.50379489047981e-11
the O 0 8.060815903654373e-12
1936delG O 0 1.356112822037403e-08
mutation O 0 2.1958795670684594e-08
from O 0 9.465444920919719e-12
their O 0 1.248315201207717e-10
homozygous O 0 1.2080946589776431e-06
father O 0 4.262710433522443e-07
. O 0 2.9930505296427157e-10
. O 0 7.322949469035223e-10

PAX6 O 0 0.08213812112808228
mutations O 0 0.007625304162502289
reviewed O 0 1.306182184634963e-05
. O 0 1.6273438063763024e-07

Mutations O 0 0.0008356752805411816
in O 0 1.016065187542381e-08
PAX6 O 0 4.5911870984127745e-05
are O 0 8.075936031026743e-10
responsible O 0 1.6258546731151569e-09
for O 0 4.3186634823833003e-11
human O 0 1.3077204208400417e-08
aniridia B-Disease 1 0.9999995231628418
and O 0 4.078204085544712e-07
have O 0 2.716902436361579e-08
also O 0 7.467823581741584e-10
been O 0 8.542001550537748e-10
found O 0 5.722623486192902e-10
in O 0 1.8504875409774968e-09
patients O 0 6.795100038203827e-09
with O 0 1.1320662451907992e-07
Peters B-Disease 1 0.9999991655349731
anomaly I-Disease 1 0.9999998807907104
, O 0 1.9059734768234193e-07
with O 0 2.328488881175872e-05
congenital B-Disease 1 0.9999994039535522
cataracts I-Disease 1 0.9998176693916321
, O 0 1.3411855626088709e-08
with O 0 5.4491785306254314e-08
autosomal B-Disease 1 0.9967132806777954
dominant I-Disease 0 0.18580447137355804
keratitis I-Disease 1 0.9983252882957458
, O 0 2.5410242798784566e-08
and O 0 1.3538946630475834e-09
with O 0 4.111012330554331e-08
isolated B-Disease 0 0.046031177043914795
foveal I-Disease 1 0.9999992847442627
hypoplasia I-Disease 1 0.9999992847442627
. O 0 4.767630343849305e-06

No O 0 9.565538761080461e-08
locus O 0 1.7551921871472587e-07
other O 0 1.3474740767627225e-10
than O 0 3.0336619327719916e-10
chromosome O 0 1.705130785012443e-06
11p13 O 0 2.4393676767431316e-07
has O 0 4.684616250472118e-09
been O 0 1.96440463895442e-09
implicated O 0 1.0311488267689128e-06
in O 0 2.31480772328041e-08
aniridia B-Disease 1 0.9999992847442627
, O 0 1.2352487921418742e-09
and O 0 2.691584732872343e-10
PAX6 O 0 1.073891212399758e-06
is O 0 3.381906976684945e-10
clearly O 0 5.265435865098311e-10
the O 0 1.2892250201429478e-12
major O 0 2.172704030578565e-11
, O 0 2.005784947856082e-11
if O 0 7.508614285889337e-10
not O 0 9.84585260543902e-11
only O 0 4.442004056248727e-12
, O 0 7.067176704955713e-12
gene O 0 1.0020612117855876e-09
responsible O 0 3.284218053067889e-08
. O 0 7.371089072449877e-09

Twenty O 0 1.8599278917008633e-07
- O 0 3.033619293546508e-07
eight O 0 7.573858762377483e-10
percent O 0 1.216241884982594e-09
of O 0 2.0467740349805474e-11
identified O 0 2.949451811673498e-07
PAX6 O 0 7.53610220272094e-05
mutations O 0 1.1180574801983312e-05
are O 0 3.803441117611328e-09
C O 0 3.855237991956528e-06
- O 0 7.718128472333774e-05
T O 0 7.916604954516515e-05
changes O 0 6.026635857026008e-10
at O 0 1.208801253538283e-10
CpG O 0 1.0025435592808662e-08
dinucleotides O 0 3.854565022720635e-08
, O 0 5.506190989268411e-12
20 O 0 1.3222977400528801e-12
% O 0 4.0823567399803085e-13
are O 0 7.471744035113248e-13
splicing O 0 4.0422273861473457e-10
errors O 0 1.6728902707541238e-08
, O 0 3.2302617612028905e-12
and O 0 1.4877999006401854e-12
more O 0 4.84431396906293e-13
than O 0 1.5322671950701583e-11
30 O 0 7.878879840217401e-12
% O 0 1.615000776340747e-12
are O 0 5.843494091384294e-12
deletion O 0 1.7739471003253016e-09
or O 0 1.1738411354045297e-09
insertion O 0 2.422271272450871e-09
events O 0 4.0333130613134927e-08
. O 0 2.6398495833745983e-08

There O 0 6.70513458089772e-08
is O 0 8.823245467581842e-10
a O 0 1.050515785472328e-09
noticeably O 0 4.598718135184754e-07
elevated O 0 1.226536824106006e-06
level O 0 1.0890106594274584e-08
of O 0 1.2550014846790525e-11
mutation O 0 4.5495902156744705e-08
in O 0 1.7184946174420013e-11
the O 0 3.255578315611296e-12
paired O 0 4.983515378143011e-09
domain O 0 2.569740420454991e-09
compared O 0 9.788896360163335e-10
with O 0 1.3313430219374922e-11
the O 0 9.204972895027197e-11
rest O 0 5.935519437061387e-11
of O 0 2.2283503167686014e-12
the O 0 1.3435423606988905e-10
gene O 0 3.2129154448057307e-08
. O 0 6.962772136631656e-09

Increased O 0 3.8994329543129425e-07
mutation O 0 1.8231605736218626e-06
in O 0 1.9750545643404394e-10
the O 0 5.509198305886365e-11
homeodomain O 0 1.5470649827875604e-07
is O 0 3.9728390022197857e-10
accounted O 0 2.5475149767473226e-10
for O 0 9.740605674476988e-13
by O 0 1.7161100665519236e-11
the O 0 3.918458890694865e-10
hypermutable O 0 6.806395049352432e-06
CpG O 0 1.0502437817194732e-06
dinucleotide O 0 1.6454731621706742e-07
in O 0 1.1283445289222982e-09
codon O 0 2.8042478561474127e-08
240 O 0 2.9671438639411463e-09
. O 0 3.670102666220032e-09

Very O 0 5.640111666593839e-08
nearly O 0 6.898839832736314e-10
all O 0 3.710104445886486e-11
mutations O 0 4.805252018513784e-08
appear O 0 1.5287749732806333e-08
to O 0 2.698405665579884e-10
cause O 0 5.322227707438287e-07
loss O 0 2.362125073318566e-08
of O 0 2.7989839179037856e-12
function O 0 3.794555503144892e-10
of O 0 6.155427730025753e-13
the O 0 9.939246474466312e-12
mutant O 0 9.388807953314426e-09
allele O 0 5.975121730728006e-09
, O 0 2.3196778699274834e-12
and O 0 3.4804761069734402e-12
more O 0 3.600592588838547e-13
than O 0 7.557342772412934e-12
80 O 0 1.0164469092799333e-12
% O 0 2.7732305926501943e-13
of O 0 9.406390596988778e-13
exonic O 0 5.645945222454429e-08
substitutions O 0 4.011476484322429e-09
result O 0 8.80673933778553e-09
in O 0 1.7278501962536552e-09
nonsense O 0 1.6578867416683352e-06
codons O 0 7.662530521201916e-08
. O 0 3.2883029632557736e-09

In O 0 1.4179367902045215e-08
a O 0 9.49221257151578e-10
gene O 0 2.3702126483726715e-08
with O 0 2.5289051408527996e-10
such O 0 1.4256131830592267e-09
extraordinarily O 0 0.00043199703213758767
high O 0 1.3278352639645163e-08
sequence O 0 5.433542504817979e-10
conservation O 0 5.1661026151395006e-11
throughout O 0 9.231988003927105e-13
evolution O 0 3.686544472469855e-11
, O 0 3.2689185559819922e-12
there O 0 2.565986138847176e-11
are O 0 6.30272847801372e-11
presumed O 0 1.182903702101612e-06
undiscovered O 0 4.917535079584923e-06
missense O 0 1.839113247115165e-05
mutations O 0 1.1478812666609883e-05
, O 0 3.1906328273878515e-11
these O 0 1.1282121938072098e-11
are O 0 1.9528814329539124e-11
hypothesized O 0 4.606976578003241e-09
to O 0 1.7985374300977242e-10
exist O 0 7.88350629221668e-09
in O 0 1.1585903070265857e-10
as O 0 8.082654545660262e-10
- O 0 2.121820580214262e-05
yet O 0 6.67215601879434e-07
unidentified O 0 7.004452072578715e-06
phenotypes O 0 7.150482019824267e-07
. O 0 1.9191177813571159e-10
. O 0 2.212315886040983e-09

Genetic O 0 5.6262386351590976e-05
heterogeneity O 0 2.9442762752296403e-05
and O 0 1.825782192099723e-08
penetrance O 0 5.622589014819823e-06
analysis O 0 2.4701924949965814e-09
of O 0 2.949536448415557e-11
the O 0 7.046335182003816e-10
BRCA1 O 0 0.00010298460256308317
and O 0 9.7147093924832e-08
BRCA2 O 0 6.439159187721089e-05
genes O 0 1.0723439345383667e-06
in O 0 4.946872422806337e-07
breast B-Disease 1 0.9995525479316711
cancer I-Disease 0 0.026536140590906143
families O 0 4.820021786144935e-07
. O 0 7.908661103783743e-08

The O 0 0.0005148277850821614
Breast B-Disease 1 0.9999985694885254
Cancer I-Disease 1 0.9999865293502808
Linkage O 0 0.2522941529750824
Consortium O 0 1.997980689338874e-05
. O 0 1.5921027340937144e-07

The O 0 1.3478500537900118e-09
contribution O 0 2.356193240515836e-09
of O 0 1.0477857470547747e-10
BRCA1 O 0 7.4325989771750756e-06
and O 0 6.470071411968092e-08
BRCA2 O 0 0.021818622946739197
to O 0 0.001142833731137216
inherited B-Disease 1 1.0
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
was O 0 0.0017694849520921707
assessed O 0 1.6565307987548294e-06
by O 0 1.4520341873325293e-10
linkage O 0 3.7941288155707298e-06
and O 0 1.4492846922564695e-09
mutation O 0 1.8235445153891305e-08
analysis O 0 1.4364703870839435e-10
in O 0 4.110408194368809e-12
237 O 0 2.190739083196558e-11
families O 0 3.546749005600702e-11
, O 0 2.6541624800757724e-12
each O 0 3.731093992792589e-12
with O 0 8.25660581571519e-11
at O 0 1.3701779710828532e-09
least O 0 1.518769138231235e-11
four O 0 1.0986854655226086e-11
cases O 0 1.1854459081028779e-10
of O 0 1.1295568924651889e-09
breast B-Disease 1 0.9920706152915955
cancer I-Disease 0 4.046910908073187e-05
, O 0 1.4385314987819253e-11
collected O 0 7.846415878143276e-11
by O 0 2.887924066552472e-10
the O 0 9.823178515944164e-06
Breast B-Disease 1 1.0
Cancer I-Disease 1 0.9999979734420776
Linkage O 0 0.012827546335756779
Consortium O 0 1.5696288073741016e-06
. O 0 2.25156622235545e-08

Families O 0 4.6304739953484386e-07
were O 0 2.088514916565032e-09
included O 0 1.7203714841595996e-10
without O 0 1.270430427524616e-10
regard O 0 1.2477081867690032e-10
to O 0 5.337017286444201e-12
the O 0 2.962029579944847e-11
occurrence O 0 1.9086436964244058e-07
of O 0 1.528135840089817e-09
ovarian B-Disease 0 0.02718680538237095
or I-Disease 0 1.6206824682285514e-07
other I-Disease 0 5.320897500382671e-08
cancers I-Disease 0 0.13672076165676117
. O 0 8.282437136131193e-08

Overall O 0 0.00015564970090053976
, O 0 2.3447987018698768e-07
disease O 0 2.3363631044048816e-05
was O 0 3.8504499144664805e-08
linked O 0 1.8887270698542125e-06
to O 0 8.639560178380634e-10
BRCA1 O 0 1.4637028016295517e-06
in O 0 1.3317094649245576e-10
an O 0 7.1876484798727436e-12
estimated O 0 1.7154500042693144e-10
52 O 0 6.118091710333173e-12
% O 0 4.0129374432804066e-13
of O 0 1.0054676275600416e-12
families O 0 5.6065749265421516e-11
, O 0 2.886588537642787e-12
to O 0 2.49271905200521e-11
BRCA2 O 0 1.3373565366237017e-08
in O 0 5.242964742913081e-11
32 O 0 9.766134081989897e-12
% O 0 5.952881959071787e-13
of O 0 1.3226054366294315e-12
families O 0 7.03243505095763e-11
, O 0 1.6769351532386345e-11
and O 0 5.976232703153173e-11
to O 0 1.9505955878296177e-11
neither O 0 8.054968358983672e-10
gene O 0 1.629383433732201e-10
in O 0 1.2553581438257133e-11
16 O 0 4.219215254952502e-12
% O 0 5.891917813014014e-13
( O 0 4.1854050065147363e-13
95 O 0 4.080000226558411e-12
% O 0 6.663508286819386e-12
confidence O 0 4.41452030486289e-08
interval O 0 8.576898835599422e-08
[ O 0 2.498295126329708e-09
CI O 0 1.828388995761543e-08
] O 0 1.2143358540939175e-10
6 O 0 1.5384570787452256e-12
% O 0 8.576991113867782e-13
- O 0 1.0622185797615202e-08
28 O 0 1.3429787837360152e-10
% O 0 3.572219776926122e-12
) O 0 1.2278149417316309e-12
, O 0 2.0285450836460273e-12
suggesting O 0 3.394685421653776e-09
other O 0 2.884280037029896e-10
predisposition O 0 2.3445622900908347e-06
genes O 0 1.0135376982134403e-07
. O 0 1.2053927633814965e-08

The O 0 5.062168018099555e-09
majority O 0 1.4507310908129512e-09
( O 0 2.8023186202097428e-11
81 O 0 2.589457988311228e-11
% O 0 1.4107769856844254e-12
) O 0 2.8890933157117715e-13
of O 0 1.2064483526780245e-12
the O 0 3.426599448630441e-07
breast B-Disease 1 0.9999983310699463
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
families O 0 7.629279963339286e-08
were O 0 3.741761123166043e-09
due O 0 2.85677481670632e-09
to O 0 1.7218364511961681e-09
BRCA1 O 0 3.9047868085617665e-06
, O 0 5.746574396892079e-11
with O 0 1.9398658027136584e-11
most O 0 6.254025769480975e-11
others O 0 2.169301266397028e-10
( O 0 5.620576486869977e-12
14 O 0 1.3954377584002309e-11
% O 0 2.6910891050280217e-12
) O 0 2.2288815758331193e-12
due O 0 4.6561793309862765e-10
to O 0 1.0749323209324757e-08
BRCA2 O 0 5.7878765801433474e-05
. O 0 5.198392827310272e-08

Conversely O 0 8.751685527386144e-06
, O 0 3.0347557800070035e-10
the O 0 1.0698417846066732e-11
majority O 0 1.7200752974733113e-11
of O 0 1.3216798532347807e-12
families O 0 2.3044604419153458e-11
with O 0 1.8130100198909815e-10
male B-Disease 0 6.332228394967387e-07
and I-Disease 0 3.0721488997187407e-07
female I-Disease 0 0.04133863002061844
breast I-Disease 1 0.9970976114273071
cancer I-Disease 0 0.0017604546155780554
were O 0 1.507403624145809e-08
due O 0 8.598056489006467e-09
to O 0 2.3898765189045434e-09
BRCA2 O 0 4.142405032325769e-06
( O 0 3.297899175969121e-10
76 O 0 5.106035039226242e-10
% O 0 1.5817155918362857e-10
) O 0 1.1057244009293754e-10
. O 0 3.1769242792023533e-09

The O 0 5.813487469197298e-09
largest O 0 5.172477113291052e-09
proportion O 0 1.6258368873423024e-08
( O 0 2.090673120735964e-11
67 O 0 5.942349390331003e-11
% O 0 3.736734446174728e-12
) O 0 2.567422728409763e-13
of O 0 8.774529497088124e-13
families O 0 7.38742192418762e-11
due O 0 1.017868678232503e-09
to O 0 6.895704840470529e-11
other O 0 3.7289546450658406e-11
genes O 0 1.3438864465697975e-09
was O 0 2.0583023285780655e-08
found O 0 2.589668035568593e-09
in O 0 1.7271015173569992e-10
families O 0 3.876160503679671e-11
with O 0 3.1610849354768433e-11
four O 0 2.2705382712873146e-11
or O 0 2.9978841631361774e-10
five O 0 8.302492374157033e-12
cases O 0 6.392025103663102e-11
of O 0 3.13513492944395e-10
female O 0 0.0539822019636631
breast B-Disease 1 0.992409348487854
cancer I-Disease 0 0.000484270800370723
only O 0 6.75617428669284e-09
. O 0 1.4219804000958902e-08

These O 0 5.543555836595715e-09
estimates O 0 9.87817827535764e-09
were O 0 2.2559702717028784e-10
not O 0 1.791788800664662e-10
substantially O 0 1.0908358660799422e-08
affected O 0 1.0036484143771673e-10
either O 0 3.0779795379132224e-11
by O 0 1.370683601342737e-11
changing O 0 1.1702999680451853e-09
the O 0 2.726033981881315e-11
assumed O 0 1.8648064425974553e-08
penetrance O 0 7.549747493840187e-09
model O 0 3.4941485815842555e-10
for O 0 2.968103540723632e-11
BRCA1 O 0 8.03904427471025e-08
or O 0 6.204140534649127e-10
by O 0 3.4481469762814854e-11
including O 0 1.0497921976160285e-10
or O 0 2.032228252346613e-08
excluding O 0 1.3933286879819207e-07
BRCA1 O 0 3.844693492283113e-05
mutation O 0 2.878946361306589e-06
data O 0 3.7765522620247793e-07
. O 0 1.9060383493751942e-08

Among O 0 9.636402786838971e-09
those O 0 5.427969740345873e-10
families O 0 3.203048937194808e-10
with O 0 9.968094127899008e-10
disease O 0 4.884528266302368e-07
due O 0 5.601941577282332e-09
to O 0 3.6974769912490046e-09
BRCA1 O 0 2.8221422326168977e-05
that O 0 4.953212595637524e-08
were O 0 2.8398588369782374e-08
tested O 0 1.7959379761123273e-07
by O 0 1.2274571983827975e-11
one O 0 1.7308238176028112e-11
of O 0 5.233678074256787e-13
the O 0 3.256466494030996e-12
standard O 0 9.864085936950318e-11
screening O 0 2.4563301045943398e-11
methods O 0 3.9198044810007104e-10
, O 0 2.4965349232353162e-11
mutations O 0 4.760821070703969e-09
were O 0 1.1942519195784485e-09
detected O 0 1.329936139882193e-06
in O 0 2.8967271289981333e-11
the O 0 3.4685757738239786e-11
coding O 0 6.744406810810233e-09
sequence O 0 2.1106592862363271e-10
or O 0 2.67019913124944e-11
splice O 0 5.467151731330944e-10
sites O 0 1.1093324869815291e-10
in O 0 1.228415112686232e-11
an O 0 9.634073053210734e-12
estimated O 0 1.6720144713211482e-10
63 O 0 2.2618589293199598e-11
% O 0 2.0744812118111966e-12
( O 0 1.0899186284399343e-12
95 O 0 1.9799522264773994e-12
% O 0 3.2066766776639444e-12
CI O 0 2.7358305842994923e-08
51 O 0 9.047479432311434e-11
% O 0 3.107248833233989e-11
- O 0 8.230956183297167e-08
77 O 0 4.169475875670514e-10
% O 0 3.987793081861035e-11
) O 0 4.343131410067258e-11
. O 0 1.115077696844935e-09

The O 0 4.964881394897702e-09
estimated O 0 4.621806937166184e-09
sensitivity O 0 8.88003739873966e-07
was O 0 3.8726341244910145e-08
identical O 0 4.7914028300510836e-09
for O 0 3.235618424666381e-13
direct O 0 6.024756214750848e-12
sequencing O 0 2.394263259875018e-11
and O 0 2.6579885861743868e-11
other O 0 5.9120148013236395e-12
techniques O 0 1.0203727640600846e-08
. O 0 7.906561627635256e-09

The O 0 2.077597649474683e-08
penetrance O 0 5.251908078207634e-06
of O 0 1.568838725596322e-09
BRCA2 O 0 3.120072142337449e-05
was O 0 3.22186295420579e-08
estimated O 0 1.8265607082401658e-10
by O 0 8.96809883299543e-12
maximizing O 0 5.956937609852275e-09
the O 0 5.63265600828089e-10
LOD O 0 0.0001282651355722919
score O 0 7.956347580773127e-09
in O 0 7.027611825805025e-10
BRCA2 O 0 4.054829332744703e-06
- O 0 2.0193951058899984e-05
mutation O 0 2.6040688680950552e-06
families O 0 3.5912839368990035e-10
, O 0 3.884944015791758e-12
over O 0 2.7321500964405665e-11
all O 0 1.2588852703332432e-11
possible O 0 1.275408845202719e-08
penetrance O 0 1.0901223959081108e-06
functions O 0 7.772854360155179e-09
. O 0 4.845894352456526e-09

The O 0 3.835370687710338e-09
estimated O 0 5.364315658340502e-09
cumulative O 0 6.380255967997073e-08
risk O 0 9.434515391149034e-08
of O 0 8.203238643922361e-10
breast B-Disease 1 0.7687324285507202
cancer I-Disease 0 0.001044272561557591
reached O 0 4.5928185699040114e-08
28 O 0 7.97180307876566e-11
% O 0 1.7591996652813191e-12
( O 0 2.8644949368224204e-13
95 O 0 1.255149196383032e-12
% O 0 2.655276389387784e-12
CI O 0 5.363353761111966e-09
9 O 0 1.3780102926796989e-11
% O 0 1.3088332501132172e-12
- O 0 5.462742480588645e-10
44 O 0 4.773889616949134e-12
% O 0 2.2080537539440753e-13
) O 0 1.5025420889588047e-14
by O 0 1.886625838193323e-12
age O 0 9.571109876871375e-11
50 O 0 1.7966087602003245e-12
years O 0 5.685930025423058e-12
and O 0 6.755622970755493e-12
84 O 0 2.7399558316654193e-12
% O 0 4.2376093411199134e-13
( O 0 2.503814213253297e-13
95 O 0 1.0994269730724149e-12
% O 0 1.3810435000455312e-12
CI O 0 3.454087904586345e-09
43 O 0 6.582384810827069e-12
% O 0 1.2650995702412349e-12
- O 0 6.251703044135581e-10
95 O 0 2.191048210919977e-11
% O 0 2.7701022899118133e-12
) O 0 4.144999502051633e-13
by O 0 2.0207840609187677e-11
age O 0 1.314827802190166e-09
70 O 0 3.1176852766101604e-11
years O 0 1.0862800658983929e-09
. O 0 2.909410268259194e-09

The O 0 1.0599860615911894e-06
corresponding O 1 0.93163001537323
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
risks O 1 0.8299939036369324
were O 0 2.7063236984758987e-07
0 O 0 4.7878604192419516e-08
. O 0 5.907154765338873e-09

4 O 0 2.1975470332336045e-08
% O 0 3.130593839717477e-10
( O 0 6.079738709002802e-12
95 O 0 1.1022621183853776e-11
% O 0 3.7196894869806485e-12
CI O 0 1.1605865601893584e-08
0 O 0 5.1533777245538204e-11
% O 0 1.864507246512881e-12
- O 0 5.858722396112626e-10
1 O 0 1.3332488758843741e-11
% O 0 4.545016977792332e-13
) O 0 3.588222655202117e-14
by O 0 2.1805992341666913e-12
age O 0 1.5318060708757741e-10
50 O 0 9.84250116305152e-13
years O 0 8.970254226914331e-12
and O 0 1.7702880827918932e-11
27 O 0 5.1702010728238434e-12
% O 0 1.7377353896119718e-13
( O 0 6.301805187706663e-14
95 O 0 5.591852393453667e-13
% O 0 1.0356191815566462e-12
CI O 0 3.771561285503822e-09
0 O 0 1.5441582040809365e-11
% O 0 1.3269565567880504e-12
- O 0 1.3797606390753003e-09
47 O 0 5.4654288039746035e-11
% O 0 2.1172738041974615e-12
) O 0 2.901153167526871e-13
by O 0 2.077658010912753e-11
age O 0 5.88459592165691e-09
70 O 0 4.0292470748770626e-11
years O 0 7.32452820617624e-10
. O 0 2.1691040075211276e-09

The O 0 1.4932613368046077e-08
lifetime O 0 7.082425099724787e-07
risk O 0 3.1616295359526703e-07
of O 0 3.0975948472899972e-09
breast B-Disease 1 0.9981217980384827
cancer I-Disease 0 0.008317328058183193
appears O 0 1.206550166443776e-07
similar O 0 5.94059634817512e-10
to O 0 5.4219243678099716e-11
the O 0 2.772885809854131e-10
risk O 0 1.2414027139584505e-07
in O 0 1.1844609737465817e-09
BRCA1 O 0 1.3280982784635853e-06
carriers O 0 1.4202970355370326e-08
, O 0 8.302560722261987e-11
but O 0 1.5154747456946893e-09
there O 0 1.6419250681298792e-10
was O 0 1.555723744273152e-10
some O 0 6.28670225144394e-14
suggestion O 0 1.1873557692609893e-10
of O 0 7.429424371714621e-13
a O 0 4.979911483182775e-10
lower O 0 6.084042780685195e-08
risk O 0 3.066177356458866e-08
in O 0 2.995997616661583e-10
BRCA2 O 0 1.0564482977315492e-07
carriers O 0 2.3409536531460162e-09
< O 0 9.50475431693576e-09
50 O 0 1.580056398220453e-11
years O 0 3.6601166542027386e-11
of O 0 2.7252020085022366e-11
age O 0 2.486359740316857e-08
. O 0 3.0763687153267938e-09

Eye B-Disease 1 0.7283201813697815
movement I-Disease 0 1.892276486614719e-05
abnormalities I-Disease 1 0.7675467729568481
correlate O 0 2.8931846827617846e-05
with O 0 5.529693325456719e-08
genotype O 0 0.103737972676754
in O 0 2.793046576243796e-07
autosomal O 1 0.9994716048240662
dominant O 1 0.9288070201873779
cerebellar B-Disease 1 0.9996820688247681
ataxia I-Disease 1 0.9999551773071289
type I-Disease 1 0.9998430013656616
I I-Disease 1 0.7291878461837769
. O 0 1.5075191583946435e-07

We O 0 3.946169613300299e-07
compared O 0 1.1583168912920883e-07
horizontal O 0 0.0007281822036020458
eye O 0 0.02921389229595661
movements O 0 9.821230378292967e-06
( O 0 4.0809616796977366e-10
visually O 0 1.214009870409427e-07
guided O 0 6.352799886144567e-08
saccades O 0 2.3940807295730338e-05
, O 0 1.1401126570609321e-10
antisaccades O 0 3.854021102256411e-08
, O 0 7.036899275086883e-12
and O 0 6.598952721065254e-12
smooth O 0 2.989640313089126e-09
pursuit O 0 1.5737665393089628e-08
) O 0 3.005082944637638e-12
in O 0 8.357306166550948e-12
control O 0 1.3871842341472984e-08
subjects O 0 7.288286951734335e-07
( O 0 1.08205423787755e-11
n O 0 3.45188979622435e-08
= O 0 1.6831446458809296e-08
14 O 0 7.420817432768345e-12
) O 0 7.826229356418246e-13
and O 0 1.702691043714566e-10
patients O 0 1.2404519078579312e-10
with O 0 2.0104118023112072e-11
three O 0 4.461229649588283e-11
forms O 0 1.6000987201891803e-09
of O 0 1.3682689425920103e-09
autosomal O 0 0.14296913146972656
dominant O 0 0.0009527388610877097
cerebellar B-Disease 0 0.3037339448928833
ataxias I-Disease 0 0.07503896951675415
type I-Disease 0 0.40448030829429626
I I-Disease 0 0.002986198989674449
spinocerebellar B-Disease 0 0.0003754128119908273
ataxias I-Disease 0 1.4927016309229657e-05
1 I-Disease 0 1.9005848006514725e-09
and I-Disease 0 2.4528107323007475e-10
2 I-Disease 0 3.505403189940637e-10
( O 0 1.7338372057529305e-11
SCA1 B-Disease 0 1.5811824596312363e-06
, O 0 3.05566960623338e-11
n O 0 5.436471539610466e-08
= O 0 3.905748258148378e-08
11 O 0 2.1469244784744212e-11
; O 0 4.805664113177732e-12
SCA2 B-Disease 0 1.764321666541946e-07
, O 0 1.7581339162298093e-11
n O 0 1.9430160591582535e-08
= O 0 6.593678492095023e-09
10 O 0 3.9273142030116226e-12
) O 0 1.0145855509902102e-12
and O 0 1.3935719245239397e-09
SCA3 B-Disease 1 0.9999991655349731
/ O 0 5.520900231203996e-06
Machado B-Disease 0 4.900480234937277e-06
- I-Disease 0 0.001732376404106617
Joseph I-Disease 0 0.006192121189087629
disease I-Disease 0 0.000609778449870646
( O 0 1.5546567366797603e-09
MJD B-Disease 1 0.9999988079071045
) O 0 4.992208313403523e-10
( O 0 3.73311763446349e-11
n O 0 4.3498408786035725e-07
= O 0 1.4786149904466583e-07
16 O 0 1.9070253709507767e-10
) O 0 1.0235295250238252e-10
. O 0 1.4157012229176758e-09

In O 0 4.242456697056696e-08
SCA1 B-Disease 0 4.6163918341335375e-06
, O 0 1.2005044180973812e-10
saccade O 0 8.693788089431109e-08
amplitude O 0 4.473642718494375e-07
was O 0 5.374679812319982e-09
significantly O 0 2.7376929612188405e-09
increased O 0 6.862617696334894e-10
, O 0 1.0455334514825054e-11
resulting O 0 7.196599427494732e-10
in O 0 8.294634423755554e-10
hypermetria B-Disease 0 8.964223525254056e-06
. O 0 6.995998891312638e-09

The O 0 8.014162666825086e-09
smooth O 0 1.0958872564970079e-07
pursuit O 0 2.260853761981707e-07
gain O 0 6.424982643693511e-07
was O 0 8.382064606848871e-07
decreased O 0 5.77006971980154e-07
. O 0 5.111397083368274e-09

In O 0 1.3069042381630425e-07
SCA2 B-Disease 0 1.2882568626082502e-05
, O 0 8.674201912306501e-10
saccade O 0 1.1567045703486656e-06
velocity O 0 9.478612810198683e-07
was O 0 7.428111103990886e-08
markedly O 0 8.984600867734116e-07
decreased O 0 2.8707520982607093e-07
. O 0 1.0946709316783654e-08

The O 0 4.536659492515582e-09
percentage O 0 1.404888561040707e-08
of O 0 8.522333880267574e-12
errors O 0 2.932956100210049e-09
in O 0 4.807701459164093e-11
antisaccades O 0 1.1515205642353976e-06
was O 0 3.526127301256565e-08
greatly O 0 3.828799943761396e-09
increased O 0 5.017218307479254e-10
and O 0 1.8970959525521636e-10
was O 0 4.8329069635144606e-09
significantly O 0 1.5472022552032172e-09
correlated O 0 1.8575997629000085e-08
with O 0 6.895918835958526e-10
age O 0 1.5893311910986085e-07
at O 0 1.3118604158535163e-07
disease O 0 1.3266513860799023e-06
onset O 0 8.388989840568684e-07
. O 0 2.7262252899618034e-08

In O 0 1.6197144958596255e-08
addition O 0 4.719968860200652e-10
, O 0 1.2900595522391534e-11
a O 0 3.806362169900268e-11
correlation O 0 2.9004246115960086e-08
between O 0 2.3270053939317137e-10
smooth O 0 1.2769952206781454e-07
pursuit O 0 2.1259910454318742e-07
gain O 0 3.5015908395052975e-08
and O 0 5.639135339241541e-11
the O 0 2.186488403527198e-12
number O 0 7.74255399377255e-12
of O 0 1.1947474259921265e-11
trinucleotide O 0 2.3879699710960267e-06
repeats O 0 3.268050079441309e-07
was O 0 3.062319819946424e-08
found O 0 9.62618962319084e-09
. O 0 3.1782210196951155e-09

In O 0 7.478405450456194e-07
SCA3 B-Disease 1 0.999974250793457
, O 0 1.7883968084220214e-08
gaze B-Disease 0 0.00034590583527460694
- I-Disease 0 6.450295040849596e-05
evoked I-Disease 0 0.00018098459986504167
nystagmus I-Disease 0 2.684438914002385e-05
was O 0 1.1898580254410263e-07
often O 0 9.696170533146642e-10
present O 0 2.4376006421689134e-11
as O 0 1.2442187904970758e-11
was O 0 4.188414337580326e-10
saccade O 0 1.3840287138577878e-08
hypometria O 0 2.997921555447647e-08
and O 0 2.6013784876210977e-11
smooth O 0 2.655381914351551e-09
pursuit O 0 2.672404342263235e-08
gain O 0 4.769021444417376e-08
was O 0 3.3456166192991077e-07
markedly O 0 1.9259130112914136e-06
decreased O 0 2.2929293663764838e-07
. O 0 8.915208127291407e-09

Three O 0 3.973743112339889e-09
major O 0 4.654974183893046e-09
criteria O 0 3.7678149489295265e-09
, O 0 1.4623392774471e-11
saccade O 0 4.9592436823786556e-08
amplitude O 0 8.772442328108809e-08
, O 0 1.8649993008268417e-11
saccade O 0 2.1057717347616745e-08
velocity O 0 2.6031791833247553e-08
, O 0 5.301032616339407e-12
and O 0 4.0607539032733175e-12
presence O 0 5.41888443839067e-11
of O 0 2.2849881708975062e-11
gaze B-Disease 0 0.0002262306516058743
- I-Disease 0 8.032183359318879e-06
evoked I-Disease 0 4.190606887277681e-06
nystagmus I-Disease 0 1.1544724998202582e-07
, O 0 3.651914274455104e-12
permitted O 0 7.528181203420026e-12
the O 0 2.4897811676943826e-12
correct O 0 1.7854137057682351e-09
assignment O 0 3.844984053369416e-11
of O 0 5.99467239628497e-14
90 O 0 3.321250067502002e-13
% O 0 1.5182577688555715e-13
of O 0 1.6883814225182592e-13
the O 0 1.734717057499946e-11
SCA1 B-Disease 0 2.3385145198062673e-07
, O 0 2.035513901529895e-12
90 O 0 2.9816727971192225e-13
% O 0 9.893540657947633e-14
of O 0 1.8025803018208858e-13
the O 0 2.146674504821533e-11
SCA2 B-Disease 0 2.3898951440060046e-06
, O 0 6.348330281596981e-12
and O 0 8.02749099831912e-12
93 O 0 1.588958999099166e-12
% O 0 8.273555587379536e-14
of O 0 2.2057973936978614e-13
the O 0 3.0521646321446383e-10
patients O 0 3.6055067820228714e-09
with O 0 5.244960465944359e-09
SCA3 B-Disease 1 0.9999994039535522
to O 0 1.9260126826736723e-09
their O 0 4.216741678053637e-10
genetically O 0 1.0806142647368233e-08
confirmed O 0 1.7090789583562582e-07
patient O 0 5.719988394048414e-08
group O 0 3.4451441699445695e-10
and O 0 4.630910932501564e-10
, O 0 3.611807727899041e-11
therefore O 0 3.114809798976381e-10
, O 0 3.2135970967628325e-11
may O 0 7.708302329767491e-10
help O 0 8.963690900642973e-11
orient O 0 6.362573401474947e-08
diagnoses O 0 5.235987714513612e-07
of O 0 4.5842173806986963e-11
SCA1 B-Disease 0 2.4524315449525602e-05
, O 0 7.501453624936261e-11
SCA2 B-Disease 0 1.1015670224878704e-06
, O 0 5.5376637303483633e-11
and O 0 2.155386980007279e-09
SCA3 B-Disease 1 0.9999957084655762
at O 0 2.32814745260157e-09
early O 0 2.543523724973795e-10
clinical O 0 5.954776671757145e-10
stages O 0 2.4483994831570044e-09
of O 0 1.6742963959703872e-10
the O 0 8.430584585994438e-08
diseases O 0 1.7887768990476616e-05
. O 0 5.042333772742325e-10
. O 0 5.2758433177757524e-09

Genetic O 0 6.212960670382017e-06
basis O 0 2.9974067672355886e-08
and O 0 1.6322927454126557e-09
molecular O 0 2.698542630241718e-06
mechanism O 0 1.2149554322604672e-06
for O 0 1.9064621028519468e-06
idiopathic B-Disease 1 0.9999997615814209
ventricular I-Disease 1 0.9999773502349854
fibrillation I-Disease 1 0.9999990463256836
. O 0 0.00012953458644915372

Ventricular B-Disease 0 0.27310290932655334
fibrillation I-Disease 0 0.1330738365650177
causes O 0 7.218240625661565e-06
more O 0 1.471163746380455e-10
than O 0 6.30782717725431e-11
300 O 0 7.531215234779509e-11
, O 0 7.576076051230007e-12
000 O 0 5.965277577457684e-11
sudden O 0 1.2328110088333233e-08
deaths O 0 1.8267854784426163e-08
each O 0 3.9838723986385105e-10
year O 0 9.339810036479435e-10
in O 0 1.5084231086426314e-10
the O 0 8.472197943198978e-10
USA O 0 7.521478551097971e-07
alone O 0 1.3342295801521686e-07
. O 0 2.7573603400554703e-09

In O 0 3.425665529022126e-09
approximately O 0 2.997272430249609e-10
5 O 0 3.281633298435338e-11
- O 0 1.4147193638791578e-08
12 O 0 5.2576755449340595e-11
% O 0 1.576244777062863e-12
of O 0 1.0082099001149092e-12
these O 0 9.087897795412303e-11
cases O 0 5.424471427595279e-10
, O 0 3.8147415781786265e-11
there O 0 2.1243509729096388e-10
are O 0 4.736307873676182e-11
no O 0 3.787868685378726e-09
demonstrable O 0 0.0009720585076138377
cardiac O 0 2.199821210524533e-05
or O 0 7.119169254110602e-08
non O 0 3.7506950434362807e-07
- O 0 0.014727816917002201
cardiac O 0 0.00014374851889442652
causes O 0 1.090473915610346e-06
to O 0 3.0506805415164706e-10
account O 0 8.623887159942001e-10
for O 0 9.670599390720902e-12
the O 0 3.049591135173557e-11
episode O 0 2.429995937802687e-08
, O 0 1.1275329281357216e-10
which O 0 1.8453299999166006e-10
is O 0 2.1520994708534857e-10
therefore O 0 9.176998605475717e-10
classified O 0 9.547784429742023e-08
as O 0 1.670535993980593e-06
idiopathic B-Disease 1 0.9999996423721313
ventricular I-Disease 1 0.9999833106994629
fibrillation I-Disease 1 0.9999997615814209
( O 0 6.59509387332946e-05
IVF B-Disease 1 0.9999934434890747
) O 0 5.379502709956796e-08
. O 0 1.9228277636784696e-08

A O 0 1.659850141777497e-07
distinct O 0 1.7593844603425168e-08
group O 0 2.302332102743776e-09
of O 0 9.579516069280203e-10
IVF B-Disease 1 0.9999991655349731
patients O 0 2.8014230338158086e-05
has O 0 5.3928889798271484e-08
been O 0 5.755783405447801e-09
found O 0 6.014578279867067e-10
to O 0 2.0932306235565967e-11
present O 0 7.622723285916067e-11
with O 0 1.2460767140343165e-10
a O 0 5.110031953137195e-09
characteristic O 0 1.009621519187931e-05
electrocardiographic O 0 6.229630525922403e-05
pattern O 0 1.023203458316857e-05
. O 0 1.8391055789379607e-08

Because O 0 4.991603930193378e-08
of O 0 1.2493650211609086e-11
the O 0 4.4522337205865625e-12
small O 0 5.400683025791331e-11
size O 0 2.0382296739285266e-08
of O 0 1.4812541818121083e-11
most O 0 3.762612096891438e-11
pedigrees O 0 1.2126248805088835e-07
and O 0 9.623132152247749e-11
the O 0 7.350331454603065e-11
high O 0 2.172446400550143e-08
incidence O 0 4.502638148551341e-06
of O 0 5.0452655941946034e-11
sudden B-Disease 0 1.4759017403775943e-06
death I-Disease 0 2.661483620158833e-07
, O 0 1.7718488135032295e-11
however O 0 3.639115050968478e-11
, O 0 1.7516796390129596e-12
molecular O 0 1.4695994421387581e-09
genetic O 0 2.3705910567883848e-09
studies O 0 5.673756256485696e-11
of O 0 1.0340470840697336e-10
IVF B-Disease 1 0.9999971389770508
have O 0 3.7719055967500026e-07
not O 0 6.164299293232034e-09
yet O 0 1.0607568157183778e-08
been O 0 2.5903692524309463e-09
done O 0 5.5215538807829034e-09
. O 0 1.71994252173846e-09

Because O 0 6.528627272928134e-05
IVF B-Disease 1 0.9999629259109497
causes O 0 0.022411201149225235
cardiac O 0 0.23250935971736908
rhythm O 0 0.00028843453037552536
disturbance O 0 2.5667911813798128e-06
, O 0 2.0383286725156324e-10
we O 0 3.6087657862005074e-10
investigated O 0 1.844234098768993e-08
whether O 0 8.124684924837311e-09
malfunction O 0 1.2396606052789139e-06
of O 0 6.822699957081957e-12
ion O 0 1.2689927189057926e-06
channels O 0 3.676400126551016e-07
could O 0 4.8055271690827794e-06
cause O 0 7.827120498404838e-07
the O 0 2.836966217500958e-09
disorder O 0 1.105447267946147e-06
by O 0 6.401957436397154e-11
studying O 0 2.988357561406474e-09
mutations O 0 3.0285828955811667e-08
in O 0 4.502475475787193e-11
the O 0 2.3784976765917065e-10
cardiac O 0 1.3081941006021225e-06
sodium O 0 1.9983271215551213e-07
channel O 0 1.1916806386125245e-07
gene O 0 4.746606805383635e-07
SCN5A O 0 6.088470763643272e-05
. O 0 2.1667975858008504e-08

We O 0 1.3098307363179629e-06
have O 0 1.3796738196347746e-09
now O 0 2.1598220434349003e-10
identified O 0 1.1455735249299437e-09
a O 0 8.09058264827911e-10
missense O 0 0.00012468619388528168
mutation O 0 8.226252248277888e-06
, O 0 2.3694856840505985e-11
a O 0 1.181993669607806e-10
splice O 0 5.762552746091387e-07
- O 0 1.667541619099211e-05
donor O 0 1.2781164286934654e-06
mutation O 0 0.00013934943126514554
, O 0 5.687853313340874e-11
and O 0 6.439922206613602e-11
a O 0 7.96380117407125e-09
frameshift O 0 0.010780451819300652
mutation O 0 4.0591239667264745e-06
in O 0 1.9709939236278728e-10
the O 0 4.894228772256426e-11
coding O 0 7.133033363970753e-08
region O 0 6.66049104758315e-10
of O 0 5.797094054793561e-11
SCN5A O 0 2.9492111934814602e-05
in O 0 2.038290869421644e-09
three O 0 5.674530623167584e-09
IVF B-Disease 1 0.999954342842102
families O 0 5.2767315850132945e-08
. O 0 9.296236669342761e-09

We O 0 9.029010783478952e-08
show O 0 3.6148990467665953e-09
that O 0 4.602387568275468e-11
sodium O 0 1.3666119624833328e-10
channels O 0 5.668661373636752e-11
with O 0 8.810708239381793e-12
the O 0 2.70692530890404e-11
missense O 0 3.4452380077709677e-06
mutation O 0 1.1164177067257697e-06
recover O 0 8.005488894013979e-08
from O 0 1.7928271714429123e-11
inactivation O 0 2.75343072786427e-08
more O 0 3.1242792641189565e-12
rapidly O 0 2.1622664769793687e-10
than O 0 2.8834259632737336e-11
normal O 0 1.9623214164710134e-10
and O 0 1.7755363151961134e-11
that O 0 4.436519554507079e-11
the O 0 3.6683496518197245e-11
frameshift O 0 4.4523945689434186e-05
mutation O 0 1.916197902573913e-07
causes O 0 3.3525069387252415e-09
the O 0 9.188759128586632e-12
sodium O 0 6.569422783542223e-10
channel O 0 1.2183594133574616e-09
to O 0 4.246054619017059e-10
be O 0 9.915932963622254e-09
non O 0 8.478603596984158e-09
- O 0 2.638828391354764e-06
functional O 0 1.4722043317760836e-07
. O 0 1.6488970189243446e-08

Our O 0 2.4986141511362803e-07
results O 0 1.6277668990483107e-08
indicate O 0 1.661024384702614e-08
that O 0 3.517485469561876e-10
mutations O 0 6.419255527134737e-08
in O 0 5.993781582169788e-10
cardiac O 0 1.6803786593300174e-06
ion O 0 5.0318943976890296e-05
- O 0 9.87439852906391e-05
channel O 0 1.0517496917827884e-07
genes O 0 1.529331439265036e-09
contribute O 0 4.181132870484383e-11
to O 0 2.325083355014801e-11
the O 0 6.402591651299971e-11
risk O 0 5.557286630875069e-09
of O 0 4.150256874280167e-11
developing O 0 1.565360285837869e-08
IVF B-Disease 1 0.9997108578681946
. O 0 4.162294509058029e-09
. O 0 6.202475422156795e-09

Molecular O 0 4.32356819146662e-06
heterogeneity O 0 1.9709243588295067e-06
in O 0 7.162805903959679e-09
mucopolysaccharidosis B-Disease 0 8.922685992729384e-06
IVA I-Disease 0 0.0002890352043323219
in O 0 7.222265452355714e-08
Australia O 0 6.148141551420849e-09
and O 0 1.6334544827856234e-09
Northern O 0 2.1686075157845153e-09
Ireland O 0 5.634219064631907e-07
: O 0 4.645656082047367e-11
nine O 0 5.453346975381468e-12
novel O 0 1.2688514128278428e-10
mutations O 0 2.2659416565318224e-09
including O 0 1.1017618241349059e-11
T312S O 0 1.6587511808552335e-08
, O 0 1.555945650100199e-11
a O 0 2.1550324025287892e-10
common O 0 1.6834585947478331e-09
allele O 0 1.385372971896004e-08
that O 0 1.1359557738899184e-10
confers O 0 3.890847466436753e-08
a O 0 2.508356722330518e-08
mild O 0 0.00015580070612486452
phenotype O 0 0.00012587961100507528
. O 0 8.48401029429624e-08

Mucopolysaccharidosis B-Disease 0 0.013685029931366444
IVA I-Disease 1 0.8251029253005981
( O 0 4.096862994629191e-06
MPS B-Disease 1 0.9999384880065918
IVA I-Disease 1 0.9999953508377075
) O 0 4.610161141727076e-08
is O 0 2.785333075294716e-09
an O 0 3.2546891848284076e-09
autosomal B-Disease 1 0.999931812286377
recessive I-Disease 1 0.9999856948852539
lysosomal I-Disease 1 0.9999876022338867
storage I-Disease 1 0.9999960660934448
disorder I-Disease 1 0.9999750852584839
caused O 0 9.51729543885449e-06
by O 0 3.954357286062304e-09
a O 0 2.2842237740405835e-05
genetic B-Disease 1 0.9999996423721313
defect I-Disease 1 0.9999996423721313
in O 0 1.2483704381338612e-07
N O 0 0.0005445272545330226
- O 0 2.7802245313068852e-05
acetylgalactosamine O 0 0.002096563344821334
- O 0 0.000689677253831178
6 O 0 2.202436206744096e-07
- O 0 0.009965808130800724
sulfate O 0 0.02262316830456257
sulfatase O 0 0.00013819833111483604
( O 0 1.140737504456979e-09
GALNS O 0 1.4861544741506805e-06
) O 0 7.438056282005334e-10
. O 0 2.5592044039512984e-09

Previous O 0 7.378716304629052e-08
studies O 0 1.897621615398748e-09
of O 0 1.653353669250901e-11
patients O 0 3.410564330952326e-10
from O 0 1.3042186254585975e-11
a O 0 1.0159871832726708e-09
British O 0 9.494553978584008e-07
- O 0 7.66255379858194e-06
Irish O 0 5.895141725886788e-07
population O 0 7.013668118505123e-11
showed O 0 7.947307700817419e-09
that O 0 5.61196445217349e-12
the O 0 3.9027166914840095e-12
I113F O 0 3.4653586666877345e-09
mutation O 0 1.8268970336521306e-08
is O 0 1.268570058027274e-11
the O 0 1.1735930153036755e-12
most O 0 5.783308294066147e-12
common O 0 6.084730636013447e-11
single O 0 8.529307038429579e-09
mutation O 0 1.0105966339324368e-06
among O 0 9.680801049682941e-09
MPS B-Disease 1 0.999927282333374
IVA I-Disease 1 0.9999992847442627
patients O 0 4.908212213194929e-05
and O 0 2.7648505707134063e-08
produces O 0 6.149480924477757e-08
a O 0 1.5590292434808362e-07
severe O 0 0.0006124177598394454
clinical O 0 2.0844443497480825e-05
phenotype O 0 0.0008071605698205531
. O 0 1.9837557374557946e-07

We O 0 8.25839492790692e-07
studied O 0 9.440798010018625e-08
mutations O 0 1.3236204665645346e-07
in O 0 4.8402084423804226e-11
the O 0 2.566862347674892e-11
GALNS O 0 8.423093049714225e-07
gene O 0 2.072973570577119e-09
from O 0 7.243942251600188e-11
23 O 0 9.948905588252899e-11
additional O 0 2.944113841607532e-10
MPS B-Disease 1 0.9998297691345215
IVA I-Disease 1 0.9999964237213135
patients O 0 1.8143309716833755e-05
( O 0 1.999918286532676e-10
15 O 0 1.3569878727637263e-11
from O 0 1.134448264494825e-11
Australia O 0 7.408573754474901e-11
, O 0 3.760687507931015e-12
8 O 0 3.1666713522227052e-12
from O 0 6.27935030361737e-12
Northern O 0 2.102683305249542e-10
Ireland O 0 2.7663221047191655e-08
) O 0 2.641375182813044e-12
, O 0 2.78792126103683e-13
with O 0 1.0323709118478797e-12
various O 0 9.068643752607741e-11
clinical O 0 3.5926171904065995e-07
phenotypes O 0 1.7957503587240353e-05
( O 0 1.0095700941903374e-09
severe O 0 1.9373454051674344e-05
, O 0 4.258853547600694e-10
16 O 0 1.757517048561752e-11
cases O 0 1.8339264828970414e-10
; O 0 4.279289422814969e-11
intermediate O 0 6.253003115297417e-10
, O 0 1.3108774482573082e-11
4 O 0 5.876536757210005e-11
cases O 0 1.4026065864314319e-09
; O 0 3.1136233591411155e-09
mild O 0 2.380752448516432e-06
, O 0 7.269677082533121e-10
3 O 0 5.277632220135331e-10
cases O 0 6.824180776021649e-09
) O 0 3.099998591160613e-10
. O 0 3.3602336468874228e-09

We O 0 4.1529165173415095e-07
found O 0 6.455162515628388e-10
two O 0 2.3549237213038587e-11
common O 0 1.1884462303157761e-09
mutations O 0 5.6581054508342277e-08
that O 0 1.2683264161150731e-10
together O 0 3.5547675913960575e-11
accounted O 0 1.5959404631171736e-10
for O 0 9.38848499811018e-13
32 O 0 1.4341282068147665e-12
% O 0 2.0633954343329125e-13
of O 0 2.3090383771684486e-13
the O 0 2.071453772400922e-11
44 O 0 1.8090333051001828e-11
unrelated O 0 8.313799648718145e-10
alleles O 0 9.891107932702425e-10
in O 0 2.655714537169729e-10
these O 0 1.938802451917354e-09
patients O 0 1.8160090320407107e-08
. O 0 1.5792151586424552e-08

One O 0 1.075408118111909e-08
is O 0 1.0743163303406078e-10
the O 0 1.7163916121720746e-11
T312S O 0 4.078802362528222e-08
mutation O 0 4.0297189229931973e-07
, O 0 1.2767163194704612e-11
a O 0 9.983978227490198e-11
novel O 0 1.3355893058175639e-09
mutation O 0 7.938069757074118e-08
found O 0 8.432908260580518e-10
exclusively O 0 2.1677803996311695e-09
in O 0 4.244478102322091e-09
milder O 0 6.602965186175425e-06
patients O 0 2.462789723267633e-07
. O 0 3.874540155379691e-08

The O 0 4.876361536787499e-09
other O 0 1.0646920844958885e-10
is O 0 7.855759792674277e-11
the O 0 3.189987857199483e-11
previously O 0 4.6900434647056954e-09
described O 0 2.337251814310548e-08
I113F O 0 1.58029695995765e-08
that O 0 2.270340304644236e-10
produces O 0 1.5743062409256936e-09
a O 0 1.289453877006963e-08
severe O 0 0.00016416260041296482
phenotype O 0 0.000266773538896814
. O 0 1.1138053679360382e-07

The O 0 2.155111644697172e-09
I113F O 0 4.895636607216147e-08
and O 0 1.109552588696161e-10
T312S O 0 5.636624500482412e-09
mutations O 0 1.1079253070533923e-08
accounted O 0 9.281668211791327e-10
for O 0 1.4786790498641511e-12
8 O 0 9.13039088779044e-12
( O 0 7.970730737764942e-13
18 O 0 5.082437942727225e-12
% O 0 7.38193577445867e-13
) O 0 3.884579290180934e-13
and O 0 1.0858031140870139e-10
6 O 0 9.204796647122038e-11
( O 0 2.065837952092142e-12
14 O 0 2.5348716181650133e-12
% O 0 7.54659410049513e-13
) O 0 2.8004774063963844e-13
of O 0 8.974835848454821e-13
44 O 0 1.8574908972057713e-11
unrelated O 0 5.686926041192919e-09
alleles O 0 1.5958628196699465e-08
, O 0 5.400346281270174e-10
respectively O 0 6.977425215382027e-08
. O 0 8.435759646374663e-09

The O 0 7.595302164986606e-09
relatively O 0 1.2793266002120163e-08
high O 0 7.650610811538172e-09
residual O 0 2.899600758610177e-06
GALNS O 0 2.0162680812063627e-05
activity O 0 1.1108834740980456e-08
seen O 0 1.1381040110336471e-08
when O 0 2.050145643528456e-11
the O 0 1.9453076302577976e-12
T312S O 0 3.5679201260130355e-10
mutant O 0 2.049075492616126e-10
cDNA O 0 5.975757111364999e-10
is O 0 5.969762184587779e-11
overexpressed O 0 4.955196786227134e-08
in O 0 1.0084956481026808e-10
mutant O 0 6.7758030297682126e-09
cells O 0 4.191307023670987e-10
provides O 0 7.312125731295804e-12
an O 0 1.9317197581109058e-12
explanation O 0 1.1696790758186637e-10
for O 0 6.3690207621758255e-12
the O 0 9.900653213934518e-11
mild O 0 1.7074073639378184e-06
phenotype O 0 5.260088983050082e-06
in O 0 2.3525512649058555e-09
patients O 0 2.7061435314834625e-09
with O 0 1.1147283790480245e-10
this O 0 4.718999413455549e-09
mutation O 0 5.656202120007947e-06
. O 0 2.4009390031665134e-08

The O 0 7.256253375942379e-10
distribution O 0 3.4559047290549927e-10
and O 0 7.973323390420006e-11
relative O 0 2.321088876655608e-09
frequencies O 0 1.3877577975662803e-09
of O 0 5.885077581507803e-13
the O 0 4.005522042521692e-12
I113F O 0 6.999439361443649e-10
and O 0 1.3793750863744236e-11
T312S O 0 6.481725156604057e-10
mutations O 0 2.9843987281452655e-09
in O 0 1.274677325496798e-11
Australia O 0 1.2388292648657373e-11
corresponded O 0 3.1811550615934436e-10
to O 0 2.784278710366017e-11
those O 0 4.5021920219712186e-11
observed O 0 2.3203627907975033e-09
in O 0 9.195812861184649e-11
Northern O 0 3.8724159989733664e-10
Ireland O 0 3.715308309892862e-07
and O 0 1.5547545473282298e-09
are O 0 2.474089509652e-11
unique O 0 4.140744691571996e-11
to O 0 5.574497894539343e-12
these O 0 6.357442350335418e-12
two O 0 6.180064706512445e-12
populations O 0 4.3810708533209564e-11
, O 0 2.6804799699298165e-12
suggesting O 0 5.900732680252929e-10
that O 0 7.002760871177571e-11
both O 0 4.829944083573068e-11
mutations O 0 8.747609747672414e-09
were O 0 8.048579580588466e-10
probably O 0 1.9826307262604814e-09
introduced O 0 1.2374318236751947e-10
to O 0 7.770247986704781e-12
Australia O 0 2.5962232363951898e-11
by O 0 1.5927101651436182e-11
Irish O 0 9.388180899350118e-09
migrants O 0 5.272306896619838e-11
during O 0 1.0414021728299971e-10
the O 0 3.0536479594944765e-11
19th O 0 6.274259778393798e-09
century O 0 1.015460693309933e-08
. O 0 1.2142514549395855e-08

Haplotype O 0 0.0001567995350342244
analysis O 0 4.290558308639447e-08
using O 0 3.6609160147804687e-09
6 O 0 1.284475192875334e-09
RFLPs O 0 2.4834969636344795e-08
provides O 0 1.8959483288893964e-11
additional O 0 2.552458678445335e-12
data O 0 4.872919290299649e-10
that O 0 1.7399625143466046e-11
the O 0 8.508268742324354e-12
I113F O 0 2.418500955059244e-08
mutation O 0 2.1591858967440203e-08
originated O 0 3.0525720839946757e-10
from O 0 8.9181205822908e-12
a O 0 3.357804034820333e-10
common O 0 2.2986990089179926e-09
ancestor O 0 2.8063780632692215e-07
. O 0 4.624701688271671e-08

The O 0 2.716745273190213e-09
other O 0 5.625363022621066e-11
9 O 0 1.4119359847963864e-10
novel O 0 2.972688484259578e-10
mutations O 0 3.626973210657525e-08
identified O 0 3.077174426380225e-08
in O 0 1.149837308700441e-10
these O 0 5.4563877721625076e-11
23 O 0 4.798634822833492e-10
patients O 0 1.856755027507262e-10
were O 0 4.529653874207895e-10
each O 0 5.88858684036353e-11
limited O 0 1.30480154458823e-10
to O 0 7.551150676965435e-11
a O 0 3.554960992246947e-09
single O 0 3.006155679941003e-07
family O 0 2.312384950187152e-08
. O 0 4.0089522812536416e-09

These O 0 2.1442339015464995e-09
data O 0 1.975745123061756e-09
provide O 0 1.3165856425911837e-11
further O 0 2.036907968683277e-12
evidence O 0 3.869630657571399e-11
for O 0 2.0068707980158695e-12
extensive O 0 8.443224452925335e-10
allelic O 0 4.946414833284507e-07
heterogeneity O 0 1.1610933370320708e-06
in O 0 6.763655591157658e-08
MPS B-Disease 1 0.9995843768119812
IVA I-Disease 1 0.9999696016311646
in O 0 3.7295720289876044e-07
British O 0 2.1015099264332093e-05
- O 0 0.015760207548737526
Irish O 0 3.469643706921488e-05
patients O 0 4.081819771073469e-09
and O 0 3.0837620651480435e-11
provide O 0 9.717563559386022e-12
evidence O 0 1.565729074171074e-10
for O 0 4.836026110816016e-12
their O 0 5.2177352716231695e-11
transmission O 0 2.6409322728682127e-08
to O 0 8.972701054377197e-12
Australia O 0 1.3199800627528013e-11
by O 0 1.8291116885005287e-11
British O 0 3.579590384106268e-07
- O 0 1.9903209249605425e-06
Irish O 0 5.292738691764498e-08
migrants O 0 1.5966315769500028e-10
. O 0 5.1147464735779025e-11
. O 0 3.920791469269602e-10

Identification O 0 4.206359562886064e-07
of O 0 1.378156366804717e-09
constitutional O 0 1.4566563777407282e-07
WT1 O 0 0.0008299157489091158
mutations O 0 8.553388761356473e-05
, O 0 2.0582846538275135e-10
in O 0 2.812542143626473e-10
patients O 0 1.7952379582908407e-09
with O 0 2.24041851737411e-09
isolated O 0 0.004946168512105942
diffuse B-Disease 1 0.9999003410339355
mesangial I-Disease 1 0.9999998807907104
sclerosis I-Disease 1 0.9999998807907104
, O 0 1.5696297595013675e-08
and O 0 7.226223786016561e-11
analysis O 0 1.1812387179510608e-10
of O 0 7.044301947312093e-11
genotype O 0 0.0006445531034842134
/ O 0 1.8790003650792642e-06
phenotype O 0 2.684750825210358e-06
correlations O 0 1.9490595093429874e-07
by O 0 1.3917118846240584e-10
use O 0 7.226668152782167e-10
of O 0 2.7944082811592885e-11
a O 0 8.293894460109641e-09
computerized O 0 3.963858398492448e-05
mutation O 0 6.730814220645698e-06
database O 0 1.986421125366178e-07
. O 0 8.162693632129958e-09

Constitutional O 0 4.3466457100294065e-06
mutations O 0 2.9860054837627104e-06
of O 0 2.2214141637277862e-10
the O 0 1.7759198278621824e-10
WT1 O 0 1.594365130586084e-06
gene O 0 1.3058883752137262e-08
, O 0 8.935043677160692e-12
encoding O 0 5.370752176325766e-10
a O 0 1.1733336080510526e-08
zinc O 0 0.0247800350189209
- O 0 1.2857492947659921e-05
finger O 0 1.2445276297512464e-05
transcription O 0 9.529150801768083e-09
factor O 0 1.4126532166258698e-09
involved O 0 1.7379709893461381e-09
in O 0 2.830334633330267e-09
renal O 0 6.818759720772505e-05
and O 0 1.2010877981083468e-07
gonadal O 0 0.00011071088374592364
development O 0 1.4191454678069704e-09
, O 0 7.223315695581434e-11
are O 0 1.6694324742050348e-11
found O 0 1.8695091308362777e-10
in O 0 5.533926095147024e-11
most O 0 1.3966899858885995e-10
patients O 0 7.620721276246911e-10
with O 0 3.5880969306845145e-08
Denys B-Disease 1 0.9999924898147583
- I-Disease 1 0.9999982118606567
Drash I-Disease 1 0.9999967813491821
syndrome I-Disease 1 0.9999973773956299
( O 0 1.2464741416806646e-07
DDS B-Disease 1 0.9999973773956299
) O 0 1.8639021437394376e-09
, O 0 1.8240539634284403e-10
or O 0 2.1684311946046364e-07
diffuse B-Disease 1 0.9971302151679993
mesangial I-Disease 1 0.9999997615814209
sclerosis I-Disease 1 0.9999998807907104
( O 0 8.258605703304056e-06
DMS B-Disease 1 0.6054306030273438
) O 0 1.2963549678168818e-10
associated O 0 1.6336445529674393e-09
with O 0 4.817160892400807e-09
pseudohermaphroditism B-Disease 1 0.9999997615814209
and O 0 1.5421022681039176e-06
/ O 0 8.412564966420177e-06
or O 0 2.2406200059776893e-06
Wilms B-Disease 1 0.8875550627708435
tumor I-Disease 0 0.3694950044155121
( O 0 2.4927521735662594e-07
WT B-Disease 1 0.9999806880950928
) O 0 3.2626013002357013e-09
. O 0 1.2772833457574961e-08

Most O 0 1.3160972400783066e-07
mutations O 0 0.00012368636089377105
in O 0 1.2113387128920294e-06
DDS B-Disease 1 0.999998927116394
patients O 0 2.9642111257999204e-05
lie O 0 0.00024102910538204014
in O 0 2.0660184674170523e-09
exon O 0 6.487582027148164e-07
8 O 0 3.183523888949935e-09
or O 0 8.574779220005269e-10
exon O 0 2.441606739012059e-07
9 O 0 7.356941167380171e-10
, O 0 3.983473273461158e-12
encoding O 0 1.934768345535076e-09
zinc O 0 0.0001071859005605802
finger O 0 1.7915253920364194e-05
2 O 0 1.0576853837207523e-09
or O 0 7.775938115628378e-09
zinc O 0 0.00016291416250169277
finger O 0 4.099645229871385e-05
3 O 0 3.0911082582463223e-09
, O 0 8.20530032807909e-11
respectively O 0 7.717291250486369e-10
, O 0 2.212143662694288e-12
with O 0 1.4505774185991083e-11
a O 0 7.680041491653355e-09
hot O 0 1.8071748854708858e-05
spot O 0 3.217529956600629e-05
( O 0 5.4122224063535285e-11
R394W O 0 3.101715106978986e-09
) O 0 2.430426736602098e-12
in O 0 1.8864612996716268e-11
exon O 0 6.658540030457516e-08
9 O 0 2.258594555826221e-08
. O 0 5.769346778095041e-09

We O 0 5.957690873970023e-08
analyzed O 0 1.5320472002144925e-08
a O 0 8.17493225890864e-11
series O 0 1.1337242256104219e-10
of O 0 3.2829357288211014e-11
24 O 0 1.6449757112013685e-09
patients O 0 1.5011250020791067e-09
, O 0 3.1222673751996055e-11
10 O 0 1.3038431445622223e-11
with O 0 5.942341618769831e-10
isolated B-Disease 0 0.000121944016427733
DMS I-Disease 1 0.9973153471946716
( O 0 6.67445787527754e-09
IDMS B-Disease 0 0.0001355330750811845
) O 0 4.885834445356174e-11
, O 0 1.8246097341356737e-11
10 O 0 3.6162746408496815e-11
with O 0 4.138072551285177e-09
DDS B-Disease 1 0.9999998807907104
, O 0 1.961824702689796e-09
and O 0 6.103272887081346e-10
4 O 0 2.3281197802926812e-10
with O 0 9.002285139558808e-09
urogenital B-Disease 0 0.4254324436187744
abnormalities I-Disease 1 0.9997410178184509
and O 0 1.6751050679886248e-06
/ O 0 0.000281475338852033
or O 0 0.00038071966264396906
WT B-Disease 1 0.9999927282333374
. O 0 4.2040335301862797e-07

We O 0 2.631329323321552e-07
report O 0 5.405357050847215e-09
WT1 O 0 2.4848368411767296e-06
heterozygous O 0 5.773906650574645e-07
mutations O 0 1.080686274690379e-06
in O 0 8.650971050627732e-10
16 O 0 1.2018338546582186e-09
patients O 0 5.039663353301194e-09
, O 0 4.8898433913091566e-11
4 O 0 8.381222799114241e-11
of O 0 8.659584160852773e-11
whom O 0 4.2492189322729246e-07
presented O 0 1.4287367378074123e-07
with O 0 2.419122040464572e-07
IDMS B-Disease 0 0.35191765427589417
. O 0 1.3147236188615352e-07

One O 0 8.485240243771841e-08
male O 0 1.3378085839121923e-07
and O 0 8.305542364972496e-10
two O 0 1.3837666568150553e-09
female O 0 9.113636770052835e-05
IDMS B-Disease 1 0.9558604955673218
patients O 0 2.9522237809942453e-07
with O 0 4.337541525956112e-08
WT1 O 0 0.030416669324040413
mutations O 0 0.0009764573769643903
underwent O 0 2.8276326702325605e-05
normal O 0 3.561282255759579e-06
puberty O 0 1.2478836652007885e-05
. O 0 3.8636038368622394e-08

Two O 0 9.04010875046879e-08
mutations O 0 8.594761311542243e-05
associated O 0 1.0133884416063665e-06
with O 0 1.922974490753404e-08
IDMS B-Disease 0 0.45799118280410767
are O 0 2.3197521681339595e-09
different O 0 4.68395044972425e-11
from O 0 1.0427576857541254e-10
those O 0 1.5259689067903537e-09
described O 0 8.824698625176097e-07
in O 0 3.1174855052995554e-07
DDS B-Disease 1 0.9999979734420776
patients O 0 1.1063278861911385e-06
. O 0 3.169227369426153e-08

No O 0 6.319083354355826e-07
WT1 O 0 0.00012161736958660185
mutations O 0 2.2660162358079106e-05
were O 0 4.964020305919803e-09
detected O 0 1.8631444618222304e-06
in O 0 3.3922805536823475e-11
the O 0 2.2033860846981668e-11
six O 0 2.1247235915122786e-10
other O 0 7.627527498499376e-10
IDMS B-Disease 0 0.1622520536184311
patients O 0 3.574012907847646e-08
, O 0 3.8652785833148684e-11
suggesting O 0 9.054462069002511e-09
genetic O 0 1.066022115026044e-08
heterogeneity O 0 4.170322753793698e-08
of O 0 2.639564955497775e-10
this O 0 1.8770397502976266e-07
disease O 0 1.9961260477430187e-05
. O 0 5.477720321778179e-08

We O 0 1.1495312719489448e-06
analyzed O 0 7.952479791129008e-06
genotype O 0 0.003032470354810357
/ O 0 1.4423243555938825e-05
phenotype O 0 1.8043989257421345e-05
correlations O 0 3.528096385707613e-06
, O 0 1.219135209451494e-10
on O 0 1.4422081584530844e-10
the O 0 6.4673691749228546e-12
basis O 0 3.3025488593851904e-11
of O 0 1.3536008251768816e-12
the O 0 4.5190719222265585e-11
constitution O 0 4.066398259783277e-11
of O 0 6.040194386325304e-13
a O 0 4.505501527418687e-10
WT1 O 0 2.0675575740369823e-07
mutation O 0 2.284288758147568e-09
database O 0 1.039013389214638e-10
of O 0 3.425222562178365e-12
84 O 0 2.2995572113160279e-10
germ O 0 0.0002397248026682064
- O 0 0.0003795453521888703
line O 0 4.2063413275172934e-05
mutations O 0 1.6168752381418017e-06
, O 0 5.386781732480417e-12
to O 0 3.301394747856623e-12
compare O 0 4.866752001397856e-10
the O 0 1.8765629241496162e-12
distribution O 0 6.376313973349701e-12
and O 0 6.084394099659107e-11
type O 0 3.088328526246187e-08
of O 0 4.867138983510877e-11
mutations O 0 3.7108114270267833e-07
, O 0 1.6197800045691935e-11
according O 0 1.4940397877194478e-11
to O 0 1.3044873341250263e-11
the O 0 2.3118709724379016e-10
different O 0 9.445729531876168e-09
symptoms O 0 1.5871075902396115e-06
. O 0 9.07801478433612e-09

This O 0 1.743469901782646e-08
demonstrated O 0 6.941532149085106e-08
( O 0 8.330065109918294e-11
1 O 0 6.3822912232947e-11
) O 0 1.7985768039838201e-12
the O 0 5.96357945664705e-12
association O 0 2.49405062574537e-11
between O 0 4.736109074365835e-11
mutations O 0 8.3307405418509e-09
in O 0 4.743196807543981e-11
exons O 0 4.8062949176141956e-09
8 O 0 9.600088085592873e-11
and O 0 2.122131637083413e-10
9 O 0 3.6845357320736127e-10
and O 0 3.939023329735392e-09
DMS B-Disease 0 0.00987299159169197
; O 0 1.5366873051814167e-10
( O 0 2.5688249270794383e-12
2 O 0 7.694354701992534e-12
) O 0 1.91011789718587e-12
among O 0 1.622550531432676e-11
patients O 0 5.929298718676534e-10
with O 0 2.274962218606902e-09
DMS B-Disease 0 0.02355216257274151
, O 0 1.4478022947184144e-11
a O 0 1.1979951752838502e-10
higher O 0 2.4095581085958884e-09
frequency O 0 5.7403468645134126e-09
of O 0 1.4586196833699105e-12
exon O 0 1.3620178762607793e-08
8 O 0 1.2607938304487476e-10
mutations O 0 5.644994693909666e-09
among O 0 2.633960931308632e-11
46 O 0 1.4435538875368081e-10
, O 0 2.431477241771063e-10
XY O 0 6.22213929091231e-06
patients O 0 1.1330999472036751e-09
with O 0 2.895182149575959e-10
female O 0 9.92095692708972e-07
phenotype O 0 3.1336978167928464e-07
than O 0 8.960067410246353e-11
among O 0 2.8532429890981703e-11
46 O 0 1.0234787323204486e-10
, O 0 1.9728671474261716e-10
XY O 0 1.2976822290511336e-05
patients O 0 6.734723889678662e-10
with O 0 6.668241653295937e-11
sexual O 0 2.1428979479765076e-08
ambiguity O 0 2.390579822986183e-08
or O 0 1.3368770090949056e-08
male O 0 9.424925906387216e-07
phenotype O 0 2.6107702524313936e-06
; O 0 2.4648355578804626e-10
and O 0 4.664161834533331e-10
( O 0 9.943721193672594e-12
3 O 0 2.4414765348312883e-11
) O 0 7.061581679644602e-13
statistically O 0 6.022726067866913e-11
significant O 0 1.7792517459369606e-11
evidence O 0 7.254111977772482e-09
that O 0 3.5806568821072915e-09
mutations O 0 2.1099367586430162e-08
in O 0 5.348678097649717e-11
exons O 0 3.447782059851079e-09
8 O 0 3.0761970748471867e-10
and O 0 2.1026631824572206e-10
9 O 0 6.20767937054012e-10
preferentially O 0 1.8115710531674267e-07
affect O 0 2.9308997895327593e-08
amino O 0 1.0568304009694884e-09
acids O 0 2.5715667442693935e-11
with O 0 5.220507728366519e-13
different O 0 2.399281728154845e-12
functions O 0 3.1780664905278755e-11
. O 0 2.9251094602056327e-11
. O 0 5.545383041649643e-10

The O 0 1.0291707042142662e-07
185delAG O 0 2.7477166440803558e-05
BRCA1 O 0 0.00022717849060427397
mutation O 0 6.774036137358053e-06
originated O 0 1.4074524656848553e-08
before O 0 8.510155774521522e-11
the O 0 2.8293426629355523e-12
dispersion O 0 1.923853965024591e-09
of O 0 2.412331836024184e-12
Jews O 0 5.044835105216805e-10
in O 0 2.0404408718199818e-10
the O 0 7.135635832211662e-11
diaspora O 0 6.102364724647202e-10
and O 0 8.407998186577004e-10
is O 0 1.2284064043743825e-10
not O 0 2.6979463801923842e-11
limited O 0 1.3917510373329112e-11
to O 0 2.3195166620748608e-10
Ashkenazim O 0 6.1321816247073e-07
. O 0 1.2395874549042674e-08

The O 0 1.0876386014047057e-08
185delAG O 0 8.315129775837704e-07
mutation O 0 1.313647430833953e-06
in O 0 1.4632279832227368e-09
BRCA1 O 0 2.4345892597921193e-05
is O 0 5.202020147976327e-09
detected O 0 5.921522756580089e-07
in O 0 9.112822996204528e-11
Ashkenazi O 0 1.1873206418044902e-08
Jews O 0 4.522574814647129e-10
both O 0 8.159914410832414e-11
in O 0 1.1916784226073673e-09
familial B-Disease 1 0.938542366027832
breast I-Disease 1 0.9999945163726807
and I-Disease 1 0.9999901056289673
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 1.6462531675642822e-06
in O 0 5.741307429474318e-10
the O 0 4.294112981861886e-11
general O 0 5.015534099150898e-10
population O 0 4.667730091334477e-10
. O 0 5.452772455782906e-09

All O 0 3.760257172302772e-08
tested O 0 2.2735982838639757e-06
Ashkenazi O 0 2.056793391602696e-06
mutation O 0 6.459072778852715e-07
carriers O 0 5.490123022866555e-09
share O 0 5.154677795715656e-10
the O 0 2.916830665888881e-11
same O 0 8.399438922168656e-10
allelic O 0 2.4118105557136005e-07
pattern O 0 1.8539807342676795e-06
at O 0 6.76485267803173e-09
the O 0 9.871506945202668e-10
BRCA1 O 0 3.0661936762044206e-05
locus O 0 1.9165088815498166e-05
. O 0 1.7759377612946992e-07

Our O 0 6.476392400145414e-08
previous O 0 1.9290420372186645e-09
study O 0 5.723442275673563e-10
showed O 0 2.1265908145551293e-08
that O 0 3.6449503137969685e-11
this O 0 1.7516169070752596e-11
Ashkenazi O 0 2.071567273276287e-08
mutation O 0 5.173880879283388e-08
also O 0 1.754041772938919e-10
occurs O 0 8.27019147608965e-11
in O 0 5.450767875253559e-12
Iraqi O 0 1.1507549357858693e-09
Jews O 0 1.8698763371016724e-10
with O 0 1.6776935743423316e-11
a O 0 4.4650624864139843e-10
similar O 0 1.0394860971985054e-08
allelic O 0 2.8471208679548e-06
pattern O 0 1.5092357898538467e-05
. O 0 2.9724249728246832e-08

We O 0 4.007004861250607e-08
extended O 0 4.105444872948283e-10
our O 0 6.253798867650318e-11
analysis O 0 1.1571806880772417e-11
to O 0 1.5405801634393868e-12
other O 0 2.0956383330050787e-12
non O 0 1.2524314918493928e-10
- O 0 9.536896605766287e-09
Ashkenazi O 0 1.2803658133719864e-09
subsets O 0 2.1863738597360793e-10
354 O 0 3.034157994297182e-11
of O 0 1.077504838825627e-11
Moroccan O 0 1.8626845132985181e-07
origin O 0 2.66979460761263e-09
, O 0 1.1141284075866231e-11
200 O 0 1.3335260846958352e-11
Yemenites O 0 5.638366218363444e-09
and O 0 9.292327324272875e-11
150 O 0 6.679672093223843e-11
Iranian O 0 7.238949883969781e-09
Jews O 0 1.0450564857933387e-08
. O 0 1.0213268453185265e-08

Heteroduplex O 0 1.815147879824508e-05
analysis O 0 2.1519374726608476e-08
complemented O 0 2.0526009780752474e-09
by O 0 9.64197818809076e-12
direct O 0 2.9047772867607513e-11
DNA O 0 1.3273484533726787e-09
sequencing O 0 2.2988512482502443e-10
of O 0 2.802772944288101e-11
abnormally O 0 6.155301690569104e-08
migrating O 0 4.362527838974728e-10
bands O 0 4.221861971132057e-09
were O 0 3.2172555730625163e-09
employed O 0 4.3837605545604674e-08
. O 0 5.3415574186033155e-09

Four O 0 4.4039807356455185e-09
of O 0 9.188887151179159e-11
Moroccan O 0 3.149967540139187e-07
origin O 0 2.3622905853670773e-09
( O 0 2.3529787059745066e-12
1 O 0 1.753029904398573e-12
. O 0 1.4588145145003062e-12
1 O 0 5.725314319859898e-12
% O 0 1.979801088694555e-12
) O 0 4.922224737177738e-13
and O 0 3.8120069600910966e-11
none O 0 2.496821915887182e-10
of O 0 4.957169115298032e-13
the O 0 2.94892894825427e-11
Yemenites O 0 1.02755999265014e-08
or O 0 3.725615094207768e-10
Iranians O 0 2.7228341803464673e-10
was O 0 9.190310734652485e-10
a O 0 2.494984496781427e-10
carrier O 0 3.860596287097451e-09
of O 0 5.136133705840873e-12
the O 0 2.855117531286311e-10
185delAG O 0 4.84150859847432e-07
mutation O 0 6.237416414478503e-07
. O 0 1.0539442207857519e-08

BRCA1 O 0 0.005282405763864517
allelic O 0 0.0005450510652735829
patterns O 0 0.0020130311604589224
were O 0 8.232117920670134e-08
determined O 0 2.203478288720362e-07
for O 0 1.0066386960105866e-11
four O 0 9.448993670835293e-12
of O 0 9.853696634684606e-13
these O 0 8.533264372889704e-12
individuals O 0 7.607295869627162e-12
and O 0 1.7011191066895748e-11
for O 0 1.7089167537662209e-12
12 O 0 2.0277945989022328e-12
additional O 0 2.2743775179162595e-12
non O 0 6.176087974374411e-10
- O 0 5.935634703746473e-07
Ashkenazi O 0 8.290292186075021e-08
185delAG O 0 3.8705074700828845e-08
mutation O 0 1.1555111001371188e-07
carriers O 0 2.1900154578702313e-08
who O 0 2.9591877392931565e-08
had O 0 2.3729329768684693e-05
breast B-Disease 1 0.9999641180038452
/ I-Disease 1 0.9999916553497314
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999985694885254
. O 0 6.915550784469815e-06

Six O 0 7.804991497550873e-08
non O 0 3.7213290227100515e-08
- O 0 3.5654995826917e-06
Ashkenazi O 0 5.113906240694632e-07
individuals O 0 2.2609068783818742e-10
shared O 0 6.079072800702079e-10
the O 0 1.0574104786220673e-10
common O 0 1.98031013809441e-09
Ashkenazi O 0 1.2394248471991887e-07
haplotype O 0 5.887237080060004e-07
, O 0 4.4647452401846976e-11
four O 0 2.2979600861061655e-11
had O 0 1.698251761439451e-09
a O 0 3.9276326635473424e-10
closely O 0 7.461365925109931e-08
related O 0 1.4898787092931798e-08
pattern O 0 1.601396206751815e-06
, O 0 2.0580951873294673e-11
and O 0 1.39795796466613e-11
the O 0 9.264325417923658e-12
rest O 0 3.915649748886807e-10
( O 0 1.4072544345100635e-11
n O 0 1.7034471966326237e-07
= O 0 8.465712397764946e-08
6 O 0 8.574808918471177e-11
) O 0 7.709569744759892e-13
displayed O 0 2.3922721581470796e-08
a O 0 2.3320050335229325e-09
distinct O 0 1.9412274809837982e-07
BRCA1 O 0 0.0001021682473947294
allelic O 0 0.00011087751045124605
pattern O 0 0.0009170089615508914
. O 0 3.3370798746545915e-07

We O 0 9.962135294472318e-08
conclude O 0 5.416513459977068e-09
that O 0 4.188108540525981e-11
the O 0 2.696166553906032e-11
185delAG O 0 7.350845976361597e-07
BRCA1 O 0 2.9945444111945108e-05
mutation O 0 5.055598649050808e-06
occurs O 0 3.738622300630823e-09
in O 0 7.55781895400709e-12
some O 0 4.3718279864324305e-12
non O 0 1.1158777235564799e-09
- O 0 1.056409587363305e-06
Ashkenazi O 0 2.418870792553207e-07
populations O 0 1.0527020366524198e-09
at O 0 1.6228555166364345e-09
rates O 0 1.5884961612755433e-07
comparable O 0 6.262423468683664e-09
with O 0 1.3750513748467252e-11
that O 0 9.513450444087468e-11
of O 0 1.1031376506709378e-10
Ashkenazim O 0 9.80510321824113e-07
. O 0 1.4945037207780842e-08

The O 0 3.226067635253571e-09
majority O 0 5.973523897750965e-10
of O 0 4.8266935587237825e-11
Jewish O 0 8.821364971822732e-09
185delAG O 0 5.770152142758889e-07
mutation O 0 1.2147677352913888e-06
carriers O 0 8.102199799964183e-09
have O 0 1.2233418444917987e-10
a O 0 1.216760997513333e-10
common O 0 1.3000325260748014e-09
allelic O 0 7.872876039982657e-07
pattern O 0 1.7192836821777746e-05
, O 0 3.068512804960122e-11
supporting O 0 7.066183055348674e-11
the O 0 1.8319257569232583e-11
founder O 0 4.801362640804996e-10
effect O 0 8.054272526702988e-11
notion O 0 3.472542253746269e-10
, O 0 1.0173629300114229e-11
but O 0 1.7503179461364482e-11
dating O 0 2.7622768516977203e-09
the O 0 3.3147271819716773e-12
mutations O 0 7.187531680941106e-10
origin O 0 2.562406016537455e-11
to O 0 1.8637678206312458e-12
an O 0 6.266739297627888e-12
earlier O 0 9.265890277276867e-10
date O 0 1.0905405467553919e-08
than O 0 1.6260336133111508e-10
currently O 0 1.9667130424227963e-10
estimated O 0 4.549481902316188e-10
. O 0 1.6329778640411519e-09

However O 0 5.3478601103051915e-08
, O 0 3.7123130958161e-11
the O 0 7.295575601973248e-12
different O 0 1.4111705727570811e-11
allelic O 0 2.9869514861502466e-08
pattern O 0 1.0323100241294014e-06
at O 0 7.106328858696997e-10
the O 0 7.792692879871055e-11
BRCA1 O 0 4.011911585166672e-07
locus O 0 8.558154718230071e-08
even O 0 3.1525739796478547e-09
in O 0 9.247625235020429e-12
some O 0 1.1256064439899016e-12
Jewish O 0 1.315868858320357e-09
mutation O 0 6.768726734662778e-08
carriers O 0 1.8308168314717932e-09
, O 0 1.4013884670760479e-11
might O 0 8.297008080582202e-10
suggest O 0 6.402057772803005e-10
that O 0 2.8443808072764476e-11
the O 0 9.447737731038686e-11
mutation O 0 8.126036732392095e-08
arose O 0 3.6246199375256083e-09
independently O 0 8.18789214207527e-09
. O 0 1.406286337379825e-10
. O 0 1.3889493999386104e-09

Crystal O 0 0.0014511095359921455
structure O 0 1.3987141755933408e-06
of O 0 4.384834995097009e-10
the O 0 5.427333604757223e-08
hemochromatosis B-Disease 1 0.9999996423721313
protein O 0 1.3707853213418275e-05
HFE O 0 0.0003486135392449796
and O 0 1.2142993277564074e-09
characterization O 0 3.078277543977492e-08
of O 0 1.150925015014348e-11
its O 0 3.365836775959252e-11
interaction O 0 4.5595591191549545e-10
with O 0 7.049278938353609e-10
transferrin O 0 1.5798425465618493e-06
receptor O 0 1.314307382926927e-07
. O 0 1.1490798534907753e-08

HFE O 0 0.009159088134765625
is O 0 2.1831637297964335e-07
an O 0 3.2246032510840905e-09
MHC O 0 0.00023058803344611079
- O 0 1.0783693142002448e-05
related O 0 5.872433916920272e-08
protein O 0 3.4725704534110946e-09
that O 0 7.181512329257345e-11
is O 0 3.363827966174071e-11
mutated O 0 1.7421792897209798e-09
in O 0 1.2030350327041361e-10
the O 0 5.646545453430463e-09
iron B-Disease 1 0.9993232488632202
- I-Disease 1 0.9999887943267822
overload I-Disease 1 0.9999459981918335
disease I-Disease 1 0.9995735287666321
hereditary B-Disease 1 0.9999998807907104
hemochromatosis I-Disease 1 1.0
. O 0 0.0005281848134472966

HFE O 0 0.0008081448031589389
binds O 0 2.0139973457844462e-06
to O 0 6.937346697100111e-09
transferrin O 0 2.591967813714291e-06
receptor O 0 5.858024110239057e-07
( O 0 2.0408661427495645e-09
TfR O 0 6.075408236938529e-06
) O 0 7.856925179905438e-12
and O 0 4.0685380411908945e-12
reduces O 0 1.945921895840641e-10
its O 0 3.302780575073494e-12
affinity O 0 3.1589164617429333e-10
for O 0 2.385120052850187e-11
iron O 0 2.9239510695333593e-05
- O 0 4.156968316237908e-06
loaded O 0 5.917345902162197e-07
transferrin O 0 4.7327796437457437e-07
, O 0 1.3935766429717944e-10
implicating O 0 5.577609954343643e-06
HFE O 0 0.00019482335483189672
in O 0 1.428150397941863e-08
iron O 0 0.0014321997296065092
metabolism O 0 0.00010767167259473354
. O 0 2.915099628353346e-08

The O 0 9.334510764347215e-08
2 O 0 4.443750256655221e-08
. O 0 2.1481769252318372e-08

6 O 0 1.355490155674488e-07
A O 0 5.86823460935193e-08
crystal O 0 0.0037781386636197567
structure O 0 8.62424167280551e-06
of O 0 3.686841665295759e-10
HFE O 0 0.00023469144070986658
reveals O 0 1.3413946930995735e-07
the O 0 2.1046844822514288e-11
locations O 0 5.546186843119472e-10
of O 0 1.1720155956851386e-09
hemochromatosis B-Disease 1 0.9999998807907104
mutations O 0 0.01965228281915188
and O 0 4.041690093714578e-09
a O 0 8.015996755261767e-09
patch O 0 0.00011160082794958726
of O 0 2.9315452843015066e-10
histidines O 0 2.2073865693528205e-05
that O 0 9.027923297821872e-09
could O 0 2.569261603468931e-08
be O 0 6.289689324923131e-10
involved O 0 9.70027724811473e-10
in O 0 6.9958256965207966e-09
pH O 0 0.007768751122057438
- O 0 2.376737757003866e-05
dependent O 0 3.3218893236153235e-07
interactions O 0 3.1161536639956466e-07
. O 0 2.7064958274536366e-08

We O 0 1.748469458107138e-07
also O 0 9.02719510254002e-10
demonstrate O 0 8.127072348429465e-09
that O 0 3.4566449702566615e-09
soluble O 0 2.451606087561231e-05
TfR O 0 1.177864305645926e-05
and O 0 2.9612060026273923e-10
HFE O 0 7.780672603985295e-07
bind O 0 9.90593296279485e-09
tightly O 0 5.5136219145879295e-08
at O 0 5.203317221535997e-10
the O 0 1.3915041861822797e-11
basic O 0 4.696745770083055e-10
pH O 0 2.0705442693724763e-08
of O 0 5.900880912373951e-13
the O 0 3.4684762006964576e-11
cell O 0 2.2217866444407264e-06
surface O 0 0.0023538756649941206
, O 0 8.255943845236757e-11
but O 0 1.9933679706873875e-10
not O 0 6.712803229946829e-11
at O 0 2.7381392292413764e-11
the O 0 9.03692398690481e-11
acidic O 0 4.242893680839188e-07
pH O 0 9.104841183216195e-07
of O 0 1.4010551052656695e-10
intracellular O 0 3.5352870781935053e-06
vesicles O 0 1.1245924724789802e-05
. O 0 1.5255912089173762e-08

TfR O 1 0.6014955043792725
HFE O 0 0.0022227142471820116
stoichiometry O 0 9.518435399513692e-05
( O 0 2.8870885682152903e-09
2 O 0 3.1590610682918907e-10
1 O 0 1.1106705138930195e-10
) O 0 7.096609758172612e-12
differs O 0 1.7869875579279437e-09
from O 0 2.4443480572955423e-10
TfR O 0 3.382428076292854e-06
transferrin O 0 3.453918395734945e-08
stoichiometry O 0 3.450547225725131e-08
( O 0 1.1046909914602665e-11
2 O 0 2.581922176059237e-11
2 O 0 3.3134835153436626e-11
) O 0 3.059657128351434e-12
, O 0 2.730309684936816e-12
implying O 0 3.165975481778105e-09
a O 0 5.975913514033593e-11
different O 0 1.2365912981093796e-11
mode O 0 2.194194270721539e-10
of O 0 9.943639878509658e-13
binding O 0 8.767181425284321e-10
for O 0 3.6027188177190084e-11
HFE O 0 2.351261628064094e-06
and O 0 1.2917326097650061e-09
transferrin O 0 9.192177685690694e-08
to O 0 4.292667998839761e-09
TfR O 0 3.896557609550655e-05
, O 0 2.0890945223728252e-11
consistent O 0 1.9809223150701882e-09
with O 0 2.6099464603412947e-11
our O 0 2.0406394629635116e-10
demonstration O 0 6.069467706204534e-10
that O 0 2.6815055731432835e-10
HFE O 0 8.761838330428873e-07
, O 0 2.0110408130435964e-11
transferrin O 0 1.6723637585869255e-08
, O 0 2.935919909963225e-11
and O 0 9.342056017658251e-10
TfR O 0 3.0741994123673066e-06
form O 0 3.9625014380817447e-10
a O 0 4.253384311425634e-09
ternary O 0 1.3136699408278218e-06
complex O 0 5.038484118813358e-07
. O 0 3.064452513967808e-08

Identification O 0 3.12542454139475e-07
of O 0 1.087763976115319e-10
three O 0 2.732947548822473e-11
novel O 0 6.30078378360821e-10
mutations O 0 4.010641418972227e-07
and O 0 3.2633090674139e-10
a O 0 1.3437686519068848e-09
high O 0 1.5838576672422278e-08
frequency O 0 4.9693941406303566e-08
of O 0 9.05592929204696e-13
the O 0 1.3498090666030915e-11
Arg778Leu O 0 6.218374437594321e-07
mutation O 0 9.346608464966266e-08
in O 0 6.369707539199965e-10
Korean O 0 6.44920021386497e-07
patients O 0 1.22057661755548e-08
with O 0 2.7907800514981318e-08
Wilson B-Disease 0 0.005236940924078226
disease I-Disease 0 2.8473590646171942e-05
. O 0 1.6066195485109347e-08

Four O 0 9.471676065686552e-08
mutations O 0 8.937956408772152e-06
- O 0 4.171886030235328e-05
- O 0 7.621449185535312e-06
R778L O 0 1.5436737044183246e-07
, O 0 2.2855809259092474e-11
A874V O 0 1.057386733727128e-09
, O 0 2.1476358018357455e-12
L1083F O 0 3.589818164950742e-10
, O 0 1.3457414436285342e-12
and O 0 7.315836304810919e-12
2304delC O 0 2.044442615201092e-09
- O 0 3.370801593405304e-08
- O 0 3.552888472313498e-08
in O 0 3.7023425991655756e-11
the O 0 5.33677546599165e-11
copper O 0 3.6128819829173153e-06
- O 0 5.587066809198404e-09
transporting O 0 4.230178429764919e-10
enzyme O 0 1.9891407965211272e-10
, O 0 1.042168695092327e-11
P O 0 3.598885598421475e-07
- O 0 1.1008859246430802e-07
type O 0 4.331748186814366e-06
ATPase O 0 2.292868884978816e-06
( O 0 1.1573888375471242e-10
ATP7B O 0 1.3545367210099357e-06
) O 0 1.13531623338603e-11
, O 0 1.0078432012561311e-11
were O 0 5.979177153392357e-10
identified O 0 9.253005828213645e-08
in O 0 1.0803211658583223e-09
Korean O 0 1.2324558156251442e-06
Patients O 0 8.265011786079413e-09
with O 0 1.667830851204144e-08
Wilson B-Disease 0 0.0030611050315201283
disease I-Disease 0 1.6174157281056978e-05
. O 0 2.530461529204331e-08

Arg778Leu O 0 7.927203114377335e-05
, O 0 4.596810154744446e-10
the O 0 1.1977957688202867e-11
most O 0 7.832341546165633e-12
frequently O 0 6.046339429133241e-09
reported O 0 1.6024696236627278e-08
mutation O 0 1.0853341336769518e-08
of O 0 3.091486918890829e-12
this O 0 3.90470676625565e-11
enzyme O 0 7.595413742400581e-10
, O 0 1.89366404501623e-11
was O 0 5.464287688994318e-09
found O 0 1.455067843991742e-09
in O 0 6.071480124214546e-11
six O 0 6.0503902235553575e-12
of O 0 3.740720840722522e-12
eight O 0 1.3831538692166134e-10
unrelated O 0 3.877760832438071e-07
patients O 0 1.970334473355706e-08
studied O 0 3.431009432119936e-08
, O 0 7.656292266844389e-12
an O 0 1.4133443547448277e-11
allele O 0 4.99021135524913e-09
frequency O 0 5.74116008067449e-08
of O 0 4.648953791375199e-11
37 O 0 1.198071086783159e-09
. O 0 2.241641094968827e-09

5 O 0 1.9485572266830786e-08
% O 0 6.90478951792528e-10
, O 0 1.8192511733183814e-11
which O 0 3.144283791667313e-11
is O 0 2.5213327953244047e-11
considerably O 0 8.848254351434548e-10
higher O 0 3.854281616089139e-10
than O 0 8.001412032943023e-12
those O 0 3.9616586920698804e-12
in O 0 3.3692649364924776e-12
other O 0 3.2365401591433196e-12
Asian O 0 6.484095899095266e-11
populations O 0 1.653973735749048e-09
. O 0 4.471123915550379e-09

The O 0 5.897472732385722e-09
novel O 0 1.074695998859454e-09
single O 0 1.515367831217418e-09
nucleotide O 0 1.2799318049872e-08
deletion O 0 3.8965662696455183e-08
, O 0 2.9269066337267446e-11
2304delC O 0 2.614639171838462e-08
, O 0 1.4709447548888477e-10
was O 0 6.171215982675449e-09
found O 0 8.03776434299408e-10
in O 0 3.0247293558716137e-10
one O 0 1.815368300128739e-08
patient O 0 7.611764658577158e-07
. O 0 2.7955696424442067e-08

Since O 0 1.8733217643784883e-07
a O 0 3.233928680401732e-09
mutation O 0 5.988633233755536e-08
at O 0 2.9914409838127654e-10
cDNA O 0 7.108081678808276e-09
nucleotide O 0 5.192575827095425e-07
2302 O 0 7.659411494387314e-06
( O 0 4.925375385322894e-11
2302insC O 0 2.409283439419596e-08
) O 0 3.439909468383462e-11
had O 0 1.4924184554843123e-08
been O 0 3.343842536196462e-08
previously O 0 3.06672127692309e-08
described O 0 3.278354370195302e-07
, O 0 1.6447983600120786e-11
this O 0 4.886064643161436e-12
region O 0 1.2499798938969686e-11
of O 0 8.753517116884268e-13
the O 0 7.550776670584014e-11
ATP7B O 0 2.8789736461476423e-06
gene O 0 1.1502683250341761e-08
may O 0 2.592941328316556e-08
be O 0 5.907737632426802e-10
susceptible O 0 2.965471708193945e-07
to O 0 3.7342018366359753e-10
gene O 0 1.8951901665786863e-06
rearrangements O 0 0.03958383947610855
causing O 0 0.03872421383857727
Wilson B-Disease 0 0.4958241581916809
disease I-Disease 0 0.00025615046615712345
. O 0 2.6984958267917136e-08

Disruption O 0 2.0379982288432075e-06
of O 0 1.3455760117242477e-10
splicing O 0 1.691060802500033e-08
regulated O 0 1.6542584191370224e-08
by O 0 3.462870962200881e-11
a O 0 4.829451505372617e-09
CUG O 0 0.00020092369231861085
- O 0 2.1771579667984042e-06
binding O 0 5.125751201262574e-08
protein O 0 5.387768808873261e-08
in O 0 6.197712565381153e-08
myotonic B-Disease 1 0.999998927116394
dystrophy I-Disease 1 0.9999988079071045
. O 0 1.2958840670762584e-05

Myotonic B-Disease 1 0.9999947547912598
dystrophy I-Disease 1 0.9999992847442627
( O 0 0.0013023229548707604
DM B-Disease 1 0.9999997615814209
) O 0 4.590120994407698e-08
is O 0 3.03047120731037e-09
caused O 0 9.83458292580508e-09
by O 0 3.8077922759338634e-11
a O 0 1.614510414249537e-09
CTG O 0 1.6181157036498917e-07
expansion O 0 3.175371632302415e-10
in O 0 2.2938000457384256e-11
the O 0 2.5660643748759426e-11
3 O 0 1.699355794970714e-10
untranslated O 0 1.0830412833229275e-07
region O 0 8.106585402956057e-10
of O 0 6.812794078880913e-11
the O 0 4.8146649334057656e-08
DM B-Disease 1 0.9999957084655762
gene O 0 1.9314086330268765e-06
. O 0 2.526246589695802e-08

One O 0 1.8126591783129697e-08
model O 0 7.883510022566043e-08
of O 0 1.3168085288839393e-08
DM B-Disease 1 0.9999996423721313
pathogenesis O 0 0.0015140647301450372
suggests O 0 5.235802973402315e-07
that O 0 2.1654485149458225e-10
RNAs O 0 2.6665882835175125e-09
from O 0 3.753607234063816e-12
the O 0 2.577197353095806e-12
expanded O 0 3.52524780200536e-11
allele O 0 2.4464935632906304e-10
create O 0 5.523958027109366e-12
a O 0 3.434703910176751e-11
gain O 0 2.343388594283624e-09
- O 0 2.4789395425273142e-08
of O 0 7.964098130974762e-11
- O 0 3.096420186921023e-06
function O 0 1.4244044166389358e-08
mutation O 0 7.2207471113472366e-09
by O 0 5.602680645810931e-12
the O 0 5.214509379847243e-12
inappropriate O 0 6.8019208043779145e-09
binding O 0 6.025279719601428e-10
of O 0 7.279614736531437e-13
proteins O 0 6.009354906050257e-12
to O 0 5.555264581680319e-12
the O 0 2.1316445830699138e-10
CUG O 0 3.232363087590784e-05
repeats O 0 2.751908709797135e-07
. O 0 3.3149534228726907e-09

Data O 0 6.696085961266363e-07
presented O 0 7.67206529417308e-08
here O 0 5.381993517517003e-09
indicate O 0 1.550218975410189e-08
that O 0 3.716308857870665e-11
the O 0 1.9620060784375504e-11
conserved O 0 3.634119138951064e-08
heterogeneous O 0 8.423847930316697e-07
nuclear O 0 2.0011691958643496e-05
ribonucleoprotein O 0 5.45579905519844e-06
, O 0 9.774376447113653e-11
CUG O 0 6.790949669266411e-07
- O 0 2.2303197511064354e-07
binding O 0 2.367320917073812e-08
protein O 0 3.2617053502548288e-09
( O 0 1.278300122004028e-11
CUG O 0 2.4550233774789376e-06
- O 0 1.4565742276317906e-05
BP O 0 7.642071432201192e-05
) O 0 1.0958893514878554e-11
, O 0 6.503489587139644e-12
may O 0 3.1580249526541593e-10
mediate O 0 1.4762246536292878e-08
the O 0 3.960690442283976e-09
trans O 0 1.921090699852357e-07
- O 0 1.706413422652986e-05
dominant O 0 5.975102226329909e-07
effect O 0 4.751450344286923e-09
of O 0 1.8916859398365737e-11
the O 0 1.375660696467662e-10
RNA O 0 2.0093338548576867e-08
. O 0 2.2582058445408393e-09

CUG O 0 0.011299531906843185
- O 0 0.002735935850068927
BP O 0 0.0012740095844492316
was O 0 3.018254801645526e-08
found O 0 1.485498946074415e-10
to O 0 4.3576171317172285e-12
bind O 0 1.0784598769575382e-09
to O 0 2.8449288064225087e-11
the O 0 4.46057635272723e-10
human O 0 1.0844261311149239e-07
cardiac O 0 0.00012530093954410404
troponin O 0 0.14815901219844818
T O 0 5.1840717787854373e-05
( O 0 3.3934258181211874e-11
cTNT O 0 4.922131147111486e-09
) O 0 1.0622412671690284e-11
pre O 0 8.160876063811884e-08
- O 0 1.6891257814677374e-07
messenger O 0 1.48983814174386e-09
RNA O 0 3.8213998632130597e-10
and O 0 6.800690652980501e-12
regulate O 0 1.4552116456290065e-10
its O 0 7.518438129017202e-12
alternative O 0 1.0575476605545475e-10
splicing O 0 1.3196749470978375e-08
. O 0 2.6956448184733972e-09

Splicing O 0 6.963198870835186e-07
of O 0 4.2911616482399495e-09
cTNT O 0 2.2443132365879137e-06
was O 0 1.4772167844512296e-07
disrupted O 0 3.7532181522692554e-06
in O 0 9.03771208982107e-08
DM B-Disease 1 0.9999992847442627
striated O 1 0.8917272090911865
muscle O 0 0.0002852072357200086
and O 0 4.422383526048179e-08
in O 0 9.909008058528457e-10
normal O 0 2.0909393327883663e-08
cells O 0 2.325901693467358e-09
expressing O 0 9.410550116939476e-10
transcripts O 0 4.7983990114630615e-09
that O 0 4.464245084712104e-10
contain O 0 1.4123952674083284e-08
CUG O 0 2.362717168580275e-05
repeats O 0 9.619949423722574e-07
. O 0 1.457952336636481e-08

Altered O 0 2.1766743429907365e-06
expression O 0 5.3587445592029326e-08
of O 0 8.148375030270216e-11
genes O 0 3.4225697831402613e-09
regulated O 0 2.9091232534028677e-08
posttranscriptionally O 0 3.66108622529282e-07
by O 0 6.117631401458823e-10
CUG O 0 0.0008847887511365116
- O 0 9.002145088743418e-05
BP O 0 8.293792780023068e-05
therefore O 0 7.496884002478055e-09
may O 0 8.542033747005462e-10
contribute O 0 1.5174696221809114e-10
to O 0 7.908627530639478e-09
DM B-Disease 1 0.9999969005584717
pathogenesis O 0 2.1667538021574728e-05
. O 0 3.5917928631334917e-09
. O 0 2.9696127779033077e-09

Identification O 0 3.8345248754012573e-07
of O 0 1.8417785352387028e-10
a O 0 7.32243266021726e-10
novel O 0 5.793585167168658e-09
nonsense O 0 2.1208657926763408e-05
mutation O 0 3.944484205931076e-07
and O 0 2.3375516799983842e-11
a O 0 2.536555861187839e-11
missense O 0 1.553445194701908e-08
substitution O 0 5.211283071737682e-10
in O 0 2.156400231989597e-11
the O 0 3.525341824017758e-11
vasopressin O 0 6.70223201382214e-08
- O 0 1.249395154445665e-06
neurophysin O 0 1.9614535631262697e-06
II O 0 2.473804215696873e-06
gene O 0 3.737338882814356e-09
in O 0 4.519623564291919e-11
two O 0 5.634576139001979e-11
Spanish O 0 5.23672394336927e-09
kindreds O 0 1.4812654569595907e-07
with O 0 3.393358261050139e-09
familial B-Disease 0 0.13180238008499146
neurohypophyseal I-Disease 1 0.9988276362419128
diabetes I-Disease 1 0.9972361922264099
insipidus I-Disease 1 0.6422680616378784
. O 0 9.065003609975975e-07

Familial B-Disease 1 0.9986341595649719
neurohypophyseal I-Disease 1 0.9996069073677063
diabetes I-Disease 1 0.9999260902404785
insipidus I-Disease 1 0.9992713332176208
( O 0 9.19070043892134e-06
FNDI B-Disease 1 0.9999980926513672
) O 0 9.760148245163691e-10
is O 0 4.001158293576168e-10
an O 0 2.0508557074805367e-09
autosomal B-Disease 1 0.999972939491272
dominant I-Disease 1 0.9999862909317017
disease I-Disease 1 0.9996247291564941
caused O 0 0.0005255014402791858
by O 0 3.3521234854561044e-06
deficiency O 0 0.49771031737327576
in O 0 1.3569737555840788e-09
the O 0 3.814425664216969e-09
antidiuretic O 0 0.00024315401969943196
hormone O 0 2.414165464870166e-06
arginine O 0 1.105599451989292e-07
vasopressin O 0 1.30868272663065e-07
( O 0 5.889081583498879e-11
AVP O 0 2.15861239993842e-09
) O 0 1.239561296488556e-12
encoded O 0 2.0410353962496686e-11
by O 0 5.769404051725324e-12
the O 0 4.233598541181216e-11
AVP O 0 4.7177870499126584e-08
- O 0 5.157032319402788e-06
neurophysin O 0 2.8434840714908205e-05
II O 0 2.2320558855426498e-05
( O 0 7.007289887228652e-11
AVP O 0 1.60858188991142e-08
- O 0 3.7084978430357296e-06
NPII O 0 1.8236374671687372e-05
) O 0 2.866093647135859e-11
gene O 0 6.408484298781048e-10
on O 0 5.251477031009699e-09
chromosome O 0 1.3828769624524284e-05
20p13 O 0 1.6192038856388535e-06
. O 0 2.173204727284883e-08

In O 0 2.5264972336458413e-08
this O 0 2.6750024417765417e-10
study O 0 1.022763096436563e-09
, O 0 4.7494612409604287e-11
we O 0 4.3797193649552923e-10
analyzed O 0 3.86590137679832e-09
two O 0 1.528495732761037e-11
families O 0 3.7592977342182365e-11
with O 0 3.656455138667525e-10
FNDI B-Disease 1 0.9999045133590698
using O 0 1.6091510068871884e-10
direct O 0 8.43123210136909e-11
automated O 0 6.363787008467625e-08
fluorescent O 0 3.958419370064803e-07
, O 0 1.1377289735325924e-11
solid O 0 1.6234066313458584e-09
phase O 0 6.721864731495941e-10
, O 0 1.1235392824437973e-11
single O 0 1.1660532539536916e-09
- O 0 3.5575808965404576e-08
stranded O 0 1.8924375955187145e-10
DNA O 0 2.0540098788490724e-10
sequencing O 0 4.531967509602275e-11
of O 0 7.172337376792903e-12
PCR O 0 1.2531572224361298e-07
- O 0 6.986253424656752e-07
amplified O 0 8.672125659359153e-06
AVP O 0 6.436911235141451e-07
- O 0 6.394512183760526e-06
NPII O 0 1.2288279322092421e-05
DNA O 0 9.734701507113641e-07
. O 0 1.418859252311222e-08

In O 0 1.6759882370820378e-08
one O 0 3.037188001098201e-10
of O 0 7.266134742500707e-12
the O 0 6.868166452234092e-11
families O 0 3.7416877929352665e-10
, O 0 4.203265513424981e-11
affected O 0 1.774420055333792e-10
individuals O 0 2.3910139493321658e-11
presented O 0 1.3125776021638558e-09
a O 0 2.153603517740521e-09
novel O 0 3.790130875813702e-09
nonsense O 0 6.710636171192164e-07
mutation O 0 2.0702007219597363e-08
in O 0 9.145780487107569e-12
exon O 0 2.361331130629196e-09
3 O 0 3.088529779149418e-11
of O 0 1.652066829692378e-12
the O 0 2.854843618449454e-11
gene O 0 1.7523238415861897e-09
, O 0 3.690355313001881e-12
consisting O 0 9.43773705019968e-12
in O 0 4.624897340099743e-11
a O 0 7.230463339169546e-09
G O 0 2.0806706743314862e-05
to O 0 1.0187017895901818e-09
T O 0 2.707314706640318e-05
transition O 0 1.4629349953665383e-09
at O 0 5.791084833894899e-10
nucleotide O 0 1.3632238449190481e-08
2101 O 0 3.478604782003458e-08
, O 0 3.9719031015572615e-12
which O 0 7.794591361243164e-12
produces O 0 1.919651416992796e-11
a O 0 4.2890132417872096e-11
stop O 0 1.3248292463075018e-09
signal O 0 4.4916660613125714e-08
in O 0 1.9479941271161039e-10
codon O 0 5.7718345658486214e-09
82 O 0 4.610262172022317e-10
( O 0 6.046309980467512e-11
Glu O 0 7.305712301786116e-07
) O 0 5.510049708168374e-11
of O 0 2.025431211638562e-10
NPII O 0 0.0001821693585952744
. O 0 3.6220924926055886e-08

The O 0 3.8886664555093375e-08
premature O 0 7.07693516233121e-07
termination O 0 3.422297467636781e-08
eliminates O 0 2.1842334163579835e-08
part O 0 9.426821823144138e-11
of O 0 8.887147961988973e-12
the O 0 1.1473622052449173e-09
C O 0 1.394571881974116e-06
- O 0 1.7661803042301472e-07
terminal O 0 2.5170301398702577e-09
domain O 0 8.704427456596164e-11
of O 0 2.3217450097895442e-12
NPII O 0 5.110697998134128e-07
, O 0 9.305637857504045e-13
including O 0 2.7301002170770916e-13
a O 0 2.2816826553140324e-11
cysteine O 0 4.228404015815812e-10
residue O 0 3.154686822881558e-08
in O 0 5.324869364886631e-11
position O 0 3.708185758455329e-08
85 O 0 3.63573615658197e-11
, O 0 8.889911376486204e-12
which O 0 4.088534510948705e-10
could O 0 6.672461694279264e-08
be O 0 4.538633024964156e-09
involved O 0 4.3397135884859495e-10
in O 0 1.421214257391057e-10
the O 0 2.7532912061367654e-10
correct O 0 1.7052286693797214e-07
folding O 0 1.0142532147483507e-07
of O 0 7.861605810788319e-11
the O 0 1.2472138877228645e-09
prohormone O 0 1.3523048437491525e-05
. O 0 2.943431987034728e-08

In O 0 6.743583469415171e-09
the O 0 1.4696267813807395e-10
second O 0 1.7448664735297825e-09
family O 0 3.0849947041389214e-09
, O 0 2.547901126193075e-12
a O 0 4.794476447800289e-12
G279A O 0 5.215924567258945e-11
substitution O 0 2.149464634060294e-11
at O 0 3.3658690418159054e-11
position O 0 1.0544985995508682e-09
- O 0 2.5252238078365963e-09
1 O 0 4.284947396904215e-12
of O 0 7.688189277918478e-13
the O 0 1.0936591909871396e-11
signal O 0 2.836762114100111e-08
peptide O 0 6.714064859636437e-09
was O 0 1.6033920857694284e-09
observed O 0 3.1806712819104632e-09
in O 0 2.195097402457602e-11
all O 0 2.3467271528798683e-11
affected O 0 1.117053227694953e-09
individuals O 0 9.448355431374011e-10
. O 0 7.59188356624918e-09

This O 0 6.559536558370382e-08
missense O 0 0.0005445168353617191
mutation O 0 0.0010284073650836945
, O 0 1.4764660605237623e-09
which O 0 3.4494396228268442e-09
replaces O 0 1.35757329644548e-06
Ala O 0 1.072958113468303e-07
with O 0 1.263847360100101e-09
Thr O 0 2.8994159947615117e-05
, O 0 1.1248521558648861e-10
is O 0 1.8811795871043202e-11
frequent O 0 1.1666632993012627e-08
among O 0 7.85471865327736e-09
FNDI B-Disease 1 0.9999998807907104
patients O 0 3.991105756995239e-07
and O 0 2.2739297111940004e-09
is O 0 3.425716099680898e-10
thought O 0 8.574649323911387e-10
to O 0 5.696133668908754e-12
reduce O 0 3.311564633623476e-10
the O 0 1.2520844604180237e-11
efficiency O 0 1.7997394685664858e-09
of O 0 2.5225726455607722e-12
cleavage O 0 4.041098975449131e-07
by O 0 2.9570296211645086e-10
signal O 0 1.9158434838573157e-07
peptidases O 0 3.8622670217591804e-07
. O 0 5.430289551355827e-10
. O 0 8.12097888935881e-10

Genetic O 0 8.836430424707942e-06
heterogeneity O 0 2.875977088478976e-06
of O 0 9.503086317863563e-09
Saethre B-Disease 1 0.8253036737442017
- I-Disease 1 0.9999432563781738
Chotzen I-Disease 1 0.9999786615371704
syndrome I-Disease 1 0.9999908208847046
, O 0 3.7897673887954397e-10
due O 0 6.458191759151077e-10
to O 0 7.875758378794728e-11
TWIST O 0 3.4592103475006297e-06
and O 0 2.5470315634379403e-08
FGFR O 0 0.00023670271912124008
mutations O 0 2.987931111420039e-06
. O 0 1.0258543348129479e-08

Thirty O 0 8.024717885746213e-07
- O 0 1.8995038999491953e-06
two O 0 2.490097017471271e-10
unrelated O 0 2.1081150691770745e-07
patients O 0 2.3575508212303475e-09
with O 0 3.102641407681794e-11
features O 0 8.738838097599455e-09
of O 0 1.330882404282363e-09
Saethre B-Disease 1 0.828117311000824
- I-Disease 1 0.99994957447052
Chotzen I-Disease 1 0.99992835521698
syndrome I-Disease 1 0.9999388456344604
, O 0 7.273182056621863e-11
a O 0 2.0807850997783817e-09
common O 0 2.818915163516067e-07
autosomal B-Disease 1 0.967617392539978
dominant I-Disease 0 0.37913262844085693
condition I-Disease 0 0.0006077621947042644
of O 0 5.229118027472168e-09
craniosynostosis B-Disease 1 0.9847161769866943
and O 0 1.109337858906656e-06
limb B-Disease 0 0.2460728883743286
anomalies I-Disease 0 0.1986011266708374
, O 0 6.452552936409006e-10
were O 0 6.577496880488809e-10
screened O 0 1.332794994368669e-07
for O 0 7.492420017740642e-10
mutations O 0 2.3079439870343776e-07
in O 0 6.050846490524009e-10
TWIST O 0 2.7871310521732084e-06
, O 0 9.472932438470139e-10
FGFR2 O 0 8.076995982264634e-06
, O 0 8.147162111615813e-11
and O 0 1.7552508335683115e-09
FGFR3 O 0 1.8222397557110526e-05
. O 0 1.8240070787101104e-08

Nine O 0 5.196370267412931e-08
novel O 0 5.968311178605745e-09
and O 0 6.96890656293192e-10
three O 0 1.8382480260203948e-10
recurrent O 0 6.4977380134223495e-06
TWIST O 0 0.0003938977897632867
mutations O 0 8.264266944024712e-05
were O 0 2.5901437439301844e-08
found O 0 6.235225225026397e-09
in O 0 5.270701097792596e-10
12 O 0 7.027369797185656e-10
families O 0 1.9631798409136536e-09
. O 0 6.053020307206225e-09

Seven O 0 1.2416177419538599e-08
families O 0 3.7284819676131065e-09
were O 0 8.330228173925036e-10
found O 0 7.504032950578221e-10
to O 0 5.816254075585725e-11
have O 0 1.5205176007171417e-10
the O 0 2.794355025148576e-11
FGFR3 O 0 2.098660161209409e-06
P250R O 0 2.6706411304644462e-08
mutation O 0 1.208441062772181e-07
, O 0 6.3502436815909835e-12
and O 0 7.747487547338228e-12
one O 0 1.8563645412528196e-11
individual O 0 4.140991716194975e-10
was O 0 1.4146080218324641e-07
found O 0 2.268116805481668e-09
to O 0 1.061727233908627e-10
have O 0 4.73945493961736e-10
an O 0 2.490072037453217e-11
FGFR2 O 0 1.5825672790015233e-06
VV269 O 0 9.301309056297669e-09
- O 0 4.784473617291951e-08
270 O 0 1.1602981908609422e-09
deletion O 0 4.5373627699518693e-07
. O 0 2.3356566458687666e-08

To O 0 5.885359311008642e-09
date O 0 2.3643336177769925e-08
, O 0 1.8617543270926795e-11
our O 0 6.134313890182597e-11
detection O 0 7.695159176535071e-09
rate O 0 1.9962378416948923e-09
for O 0 6.268433580362831e-13
TWIST O 0 1.4054191588286358e-08
or O 0 8.525366523848277e-10
FGFR O 0 4.7003175041027134e-07
mutations O 0 5.457486018656255e-09
is O 0 1.863836342208547e-11
68 O 0 7.959841986926453e-12
% O 0 1.1538786419407199e-12
in O 0 3.387043770453069e-11
our O 0 2.1599396049509778e-08
Saethre B-Disease 0 0.001835016068071127
- I-Disease 1 0.9971586465835571
Chotzen I-Disease 1 0.9999277591705322
syndrome I-Disease 1 0.9999781847000122
patients O 0 2.1531855409762102e-08
, O 0 8.55224658452558e-12
including O 0 4.158860322095448e-12
our O 0 1.0854557253026087e-09
five O 0 8.303130405451498e-11
patients O 0 8.271394680292588e-10
elsewhere O 0 8.06802713526622e-09
reported O 0 8.042398746965773e-09
with O 0 8.887732771967194e-10
TWIST O 0 3.954793282900937e-05
mutations O 0 2.803782990667969e-05
. O 0 2.3748917499233357e-08

More O 0 7.666675072570683e-10
than O 0 6.735876439956101e-11
35 O 0 3.914087456924342e-11
different O 0 1.125950548075405e-11
TWIST O 0 1.0045515637102653e-06
mutations O 0 1.972101244973601e-06
are O 0 7.477572450120817e-10
now O 0 8.380619531678235e-10
known O 0 3.014282434765647e-10
in O 0 1.49331103038719e-10
the O 0 1.6999458785083021e-10
literature O 0 4.390460883740843e-09
. O 0 5.116664425486306e-09

The O 0 5.638065569968376e-09
most O 0 9.770051434543348e-11
common O 0 1.3157878953062863e-10
phenotypic O 0 3.802050230206078e-08
features O 0 6.564217187587928e-07
, O 0 2.383256647586762e-10
present O 0 1.4282960925093846e-10
in O 0 1.9744771789786952e-11
more O 0 6.624098405211276e-12
than O 0 3.521121935690097e-11
a O 0 2.0018646462727219e-10
third O 0 4.3450396058908325e-10
of O 0 1.6595589485968176e-11
our O 0 6.813190900345489e-09
patients O 0 8.452034211403614e-11
with O 0 9.240682524724875e-11
TWIST O 0 4.6363343244593125e-06
mutations O 0 3.2523444133403245e-06
, O 0 6.823900472463507e-11
are O 0 1.689339987342997e-11
coronal B-Disease 0 4.4854337488686724e-07
synostosis I-Disease 0 6.197019501996692e-06
, O 0 7.878117602722057e-11
brachycephaly B-Disease 0 4.928352836941485e-07
, O 0 4.312031842701458e-10
low B-Disease 0 4.468989573069848e-05
frontal I-Disease 1 0.9999802112579346
hairline I-Disease 1 0.9999995231628418
, O 0 1.2992186384508386e-06
facial B-Disease 1 0.9989116191864014
asymmetry I-Disease 0 0.20847322046756744
, O 0 9.910907294852223e-08
ptosis B-Disease 1 0.7308453917503357
, O 0 7.258222911588064e-09
hypertelorism B-Disease 0 0.00011398817878216505
, O 0 1.4478176435517298e-09
broad B-Disease 0 1.71350258426628e-08
great I-Disease 0 2.9445209293044172e-06
toes I-Disease 0 0.06697433441877365
, O 0 4.777246931375601e-10
and O 0 1.335209831587747e-09
clinodactyly B-Disease 0 2.548476004449185e-06
. O 0 8.55945714306472e-09

Significant O 0 9.383154520037351e-08
intra O 0 4.998402118872036e-07
- O 0 4.760424417327158e-06
and O 0 4.2589043403040705e-09
interfamilial O 0 3.2625180210743565e-06
phenotypic O 0 7.427539458149113e-06
variability O 0 0.00018741979147307575
is O 0 2.9896058961753624e-09
present O 0 9.798418326711911e-11
for O 0 2.313246122431778e-11
either O 0 4.494011829336841e-09
TWIST O 0 9.940392374119256e-06
mutations O 0 7.202811048045987e-06
or O 0 2.85870580540859e-08
FGFR O 0 0.00022002554032951593
mutations O 0 1.9199791495339014e-05
. O 0 3.858080788177176e-08

The O 0 6.439044852868392e-09
overlap O 0 2.696160450454954e-08
in O 0 4.043229917538582e-10
clinical O 0 5.7052433888316045e-09
features O 0 8.193426026537054e-08
and O 0 2.1016137718987693e-09
the O 0 2.86035934521367e-11
presence O 0 9.69768709779828e-10
, O 0 3.780847163126211e-12
in O 0 1.001964136659872e-12
the O 0 8.371244778100639e-13
same O 0 3.0317168914217874e-11
genes O 0 1.9276056445471923e-11
, O 0 1.3661095095863357e-13
of O 0 9.283048098664495e-14
mutations O 0 1.8753983088704018e-10
for O 0 7.075805327945439e-13
more O 0 1.5153885091212516e-12
than O 0 3.9271214752334416e-11
one O 0 3.878055654382706e-10
craniosynostotic B-Disease 0 1.4600093891203869e-05
condition I-Disease 0 7.92050855125126e-07
- O 0 4.289753885444725e-09
such O 0 5.737516711734614e-11
as O 0 1.7121093431882173e-10
Saethre B-Disease 0 2.1873441369280044e-07
- I-Disease 0 3.345983543567854e-07
Chotzen I-Disease 0 3.5813181398225424e-07
, I-Disease 0 3.242646429146845e-11
Crouzon I-Disease 0 3.931039316285023e-08
, I-Disease 0 1.5505655787118044e-11
and I-Disease 0 1.075666000716069e-09
Pfeiffer I-Disease 0 4.00964891014155e-05
syndromes I-Disease 0 3.2852429285412654e-05
- O 0 5.88765267650615e-08
support O 0 2.6762680960246144e-10
the O 0 1.6317068529669854e-10
hypothesis O 0 7.426648185315798e-09
that O 0 3.281852220538006e-11
TWIST O 0 2.0744062467770163e-08
and O 0 6.962343479521849e-10
FGFRs O 0 1.0518279225379956e-07
are O 0 2.39704610327518e-11
components O 0 1.8123047507145884e-10
of O 0 5.548738551963694e-13
the O 0 1.2176379696193784e-11
same O 0 3.7144046172166156e-10
molecular O 0 1.3299085388496223e-08
pathway O 0 7.427589793218559e-11
involved O 0 6.183110273783043e-11
in O 0 1.1435115875035873e-11
the O 0 2.165393732378451e-11
modulation O 0 7.237655097469542e-08
of O 0 6.786625705856864e-10
craniofacial O 1 0.776511549949646
and O 0 2.866481736418791e-07
limb O 0 4.6116882003843784e-05
development O 0 3.1157426638728225e-10
in O 0 9.945817502909904e-10
humans O 0 3.98230159959212e-09
. O 0 5.583803974751333e-10
. O 0 3.2439240182924323e-09

Mutation O 0 0.00017166367615573108
analysis O 0 2.647681185408146e-07
of O 0 1.788406933656006e-08
UBE3A O 1 0.9964537620544434
in O 0 0.2812432646751404
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 0.0038269804790616035
. O 0 4.914076043860405e-07

Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 0.00019853407866321504
AS B-Disease 1 0.9999465942382812
) O 0 2.5686917037859303e-09
is O 0 9.690734881218077e-10
caused O 0 7.158190040712498e-09
by O 0 5.689635429462214e-10
chromosome O 0 3.6952016671421006e-05
15q11 O 0 6.391424562934844e-07
- O 0 3.5355495242583856e-07
q13 O 0 7.117455957939001e-09
deletions O 0 1.5472737757704635e-08
of O 0 1.3740505955261995e-10
maternal O 0 1.909886805151473e-06
origin O 0 4.178442036817387e-09
, O 0 8.703228242257222e-12
by O 0 1.030852903038948e-10
paternal O 0 1.960828922165092e-05
uniparental B-Disease 0 0.0037271473556756973
disomy I-Disease 0 0.008001486770808697
( O 0 1.1518227260864933e-08
UPD B-Disease 1 0.9999451637268066
) O 0 7.282177638678888e-11
15 O 0 1.3368036712313458e-11
, O 0 1.571258964952471e-12
by O 0 3.54489770870714e-10
imprinting O 1 0.5716243982315063
defects O 1 0.9998563528060913
, O 0 1.955249157026273e-10
and O 0 1.0971782510305061e-10
by O 0 5.027372407262476e-10
mutations O 0 9.157071758636448e-07
in O 0 1.518443260017932e-09
the O 0 3.5820366672822956e-09
UBE3A O 0 0.00012875470565631986
gene O 0 9.368880000693025e-07
. O 0 3.5002486242774467e-08

UBE3A O 0 0.0017201900482177734
encodes O 0 9.744715043780161e-07
a O 0 1.4107501833393599e-08
ubiquitin O 0 8.221390999096911e-07
- O 0 1.996727860387182e-06
protein O 0 2.697496226389262e-09
ligase O 0 1.727159215647589e-08
and O 0 1.2362340040539266e-09
shows O 0 1.1296068578303675e-06
brain O 0 9.197257168125361e-05
- O 0 1.267183392883453e-06
specific O 0 4.673195519444562e-08
imprinting O 0 6.358831888064742e-05
. O 0 2.2780767494623433e-08

Here O 0 1.8251003552904876e-07
we O 0 3.74351705190179e-09
describe O 0 3.5507746076746116e-08
UBE3A O 0 3.3799246011767536e-05
coding O 0 1.6448579117422923e-05
- O 0 3.952334736823104e-05
region O 0 1.5582800472202507e-07
mutations O 0 4.78159154226887e-06
detected O 0 7.905250072326453e-07
by O 0 4.7190487628689937e-11
SSCP O 0 8.389918093598681e-07
analysis O 0 5.51660384040531e-10
in O 0 1.7296794552201789e-10
13 O 0 3.059088538037713e-10
AS B-Disease 1 0.9443874955177307
individuals O 0 1.5457009006070166e-09
or O 0 2.110669328203585e-08
families O 0 3.3619134143236806e-09
. O 0 7.2130941219938904e-09

Two O 0 4.8743554970087644e-08
identical O 0 5.515153588930843e-06
de O 0 4.1546832107997034e-07
novo O 0 2.7781487688116613e-07
5 O 0 2.1572541530900935e-09
- O 0 1.1547576406201188e-07
bp O 0 1.9837708009617927e-07
duplications O 0 1.8089261288878333e-07
in O 0 2.5380864077106935e-10
exon O 0 1.6621501686131523e-07
16 O 0 7.229963294719255e-10
were O 0 1.2288241535429734e-09
found O 0 4.661088937041313e-08
. O 0 2.376223839917202e-08

Among O 0 2.421148836972975e-09
the O 0 3.621713692836259e-11
other O 0 6.031908045961432e-12
11 O 0 1.1376225482473412e-11
unique O 0 3.5166672351927275e-10
mutations O 0 3.255188119055674e-07
, O 0 5.397655239436361e-11
8 O 0 1.7338769309205304e-11
were O 0 2.4899818318324662e-11
small O 0 4.124089958423838e-11
deletions O 0 6.900109639218499e-08
or O 0 2.864976034189226e-09
insertions O 0 1.6594875660302932e-06
predicted O 0 6.593523949049995e-07
to O 0 1.775537217252321e-10
cause O 0 1.2606429322659096e-07
frameshifts O 0 2.0694009435828775e-05
, O 0 1.340470789923387e-10
1 O 0 5.378314460458e-11
was O 0 1.0085576818141817e-09
a O 0 1.1028057356199383e-09
mutation O 0 4.139337406172672e-08
to O 0 2.1044716316809264e-11
a O 0 2.6886290416250347e-10
stop O 0 1.5763493843579113e-09
codon O 0 1.7423679166128636e-10
, O 0 1.0853464394583456e-12
1 O 0 3.2033388528557305e-12
was O 0 7.536130053331647e-11
a O 0 1.807120147967467e-10
missense O 0 3.379906274858513e-06
mutation O 0 2.4261025828309357e-06
, O 0 2.1660794685685048e-11
and O 0 7.02314525979908e-11
1 O 0 2.126690212822524e-10
was O 0 1.0855499255058021e-07
predicted O 0 1.3792082143027073e-07
to O 0 9.059981237458103e-11
cause O 0 5.390438317931512e-09
insertion O 0 1.0076174339346267e-09
of O 0 5.719597712117164e-11
an O 0 7.026472181870247e-10
isoleucine O 0 1.8366979929851368e-05
in O 0 2.1762636137623304e-10
the O 0 2.130858857418705e-11
hect O 0 2.6583018453152363e-08
domain O 0 2.2351547002141814e-10
of O 0 3.141979948786955e-12
the O 0 4.8257453588718136e-11
UBE3A O 0 1.093877813218569e-06
protein O 0 1.576193064956044e-09
, O 0 3.5286229233683075e-12
which O 0 5.4327701191903e-12
functions O 0 7.951328831468096e-12
in O 0 1.0947486840662268e-11
E2 O 0 5.9671609875522336e-09
binding O 0 3.6163194661043008e-09
and O 0 6.181600370469553e-11
ubiquitin O 0 7.207523911034741e-09
transfer O 0 7.20329129677566e-09
. O 0 6.951307085500957e-09

Eight O 0 5.032775973745629e-09
of O 0 4.0630335901292725e-11
the O 0 1.7189216716673172e-10
cases O 0 1.1169849489789385e-09
were O 0 6.707076227741027e-09
familial O 0 0.0006215636967681348
, O 0 7.4350250400812e-09
and O 0 1.108804270621988e-09
five O 0 1.5369922001795544e-10
were O 0 3.0229949654625443e-09
sporadic O 0 6.797940841352101e-07
. O 0 2.87484169803065e-08

In O 0 1.0001580008633937e-08
two O 0 1.8601438445120522e-10
familial O 0 1.5193562830972951e-05
cases O 0 4.0192296069108124e-07
and O 0 2.5837867401179437e-09
one O 0 5.066937980302555e-10
sporadic O 0 8.829364617213287e-08
case O 0 1.600313765948158e-07
, O 0 2.0699371036658754e-11
mosaicism O 0 8.391888428604943e-08
for O 0 1.992083303870018e-10
UBE3A O 0 8.322393841808662e-05
mutations O 0 4.5106235120329075e-06
was O 0 3.561308048460887e-08
detected O 0 5.925494406255893e-07
in O 0 2.4977162699224564e-11
the O 0 8.724123506942405e-11
mother O 0 4.1043767851078883e-07
of O 0 3.8707377580937674e-11
three O 0 4.329794300872436e-09
AS B-Disease 1 0.9999918937683105
sons O 0 9.344822728962754e-07
, O 0 5.7492578406370676e-12
in O 0 4.067823768799661e-12
the O 0 3.021579514372874e-11
maternal O 0 5.268767040433886e-07
grandfather O 0 2.009179098649838e-07
of O 0 6.732558954780643e-12
two O 0 4.3298004070990714e-10
AS B-Disease 1 0.9966027736663818
first O 0 1.5342748183044819e-09
cousins O 0 7.039059823910065e-07
, O 0 4.912062770423553e-11
and O 0 8.766708886609464e-11
in O 0 5.60519582137875e-11
the O 0 3.1838864877897777e-10
mother O 0 2.2281724909589684e-07
of O 0 2.367958606974696e-11
an O 0 2.9135751589137726e-09
AS B-Disease 1 0.9999897480010986
daughter O 0 0.009162724018096924
. O 0 1.4809633341883455e-07

The O 0 1.7658586815016974e-09
frequencies O 0 3.400869630354464e-08
with O 0 9.65703766953041e-11
which O 0 1.1394718502089063e-09
we O 0 2.4149870991863054e-09
detected O 0 9.545307477765164e-08
mutations O 0 1.1980672454114938e-08
were O 0 1.7169687893670016e-10
5 O 0 8.502039350322121e-12
( O 0 3.2286093286718054e-13
14 O 0 5.560222963475747e-13
% O 0 9.50929940801877e-14
) O 0 2.6319080581919084e-14
of O 0 9.007724443730811e-14
35 O 0 1.2211307269180405e-12
in O 0 2.616654289078202e-12
sporadic O 0 7.000857671357608e-09
cases O 0 3.0943352324896978e-09
and O 0 1.8493724329715633e-09
8 O 0 1.2421233486215044e-10
( O 0 9.88219163618187e-13
80 O 0 1.6784736578054349e-12
% O 0 7.40921646952275e-13
) O 0 1.273684526988464e-13
of O 0 4.67554651679275e-13
10 O 0 1.1246627761030137e-11
in O 0 6.727466500544566e-11
familial O 0 6.691000180580886e-06
cases O 0 2.914466961101425e-07
. O 0 4.635446249068309e-09
. O 0 8.765146830569392e-09

The O 0 5.27859924659424e-07
hemochromatosis B-Disease 1 0.9998237490653992
845 O 0 1.1930915206903592e-05
G O 0 0.00011793911107815802
- O 0 9.400686394656077e-06
- O 0 3.3497042295493884e-06
> O 0 1.941826965889959e-08
A O 0 1.4329574193894246e-09
and O 0 1.37333783234439e-10
187 O 0 8.074221846676721e-11
C O 0 4.301109246540591e-09
- O 0 5.484233156494156e-08
- O 0 2.6869713565247366e-06
> O 0 1.4919295665549726e-07
G O 0 5.82059647058486e-06
mutations O 0 2.0619103224817081e-07
: O 0 1.6639907507443041e-10
prevalence O 0 2.2565627944004518e-07
in O 0 7.651774214245677e-10
non O 0 3.265640913241441e-08
- O 0 0.00010000972542911768
Caucasian O 0 3.409435521462001e-05
populations O 0 6.23736866600666e-07
. O 0 1.507409308487695e-08

Hemochromatosis B-Disease 1 0.9867157340049744
, O 0 1.783910619224116e-07
the O 0 1.7252220914087957e-06
inherited B-Disease 1 0.9999996423721313
disorder I-Disease 1 0.9999992847442627
of I-Disease 0 6.086120407644557e-08
iron I-Disease 1 0.8675550818443298
metabolism I-Disease 0 0.0003944357158616185
, O 0 6.319195167137082e-11
leads O 0 6.553491083138852e-10
, O 0 1.2393402970545253e-10
if O 0 4.010476573057531e-08
untreated O 0 1.5510167941101827e-06
, O 0 1.56121331140735e-11
to O 0 7.212852537463732e-11
progressive O 0 3.4713123113760957e-06
iron B-Disease 1 0.9242950677871704
overload I-Disease 0 0.08518417924642563
and O 0 2.215155063822749e-07
premature B-Disease 0 4.358791557024233e-06
death I-Disease 0 1.6544295533549302e-07
. O 0 6.580976208425682e-09

The O 0 8.835014568830957e-07
hemochromatosis B-Disease 1 0.9999921321868896
gene O 0 3.743898923858069e-05
, O 0 3.0965314756770113e-09
HFE O 0 9.211458382196724e-05
, O 0 7.555462921970957e-10
recently O 0 8.710818377721807e-08
has O 0 3.6655696256104875e-09
been O 0 2.292306566786806e-09
identified O 0 1.4421379646023524e-08
, O 0 9.249229854235708e-12
and O 0 6.305646543108834e-12
characterization O 0 2.8014235375906082e-09
of O 0 1.6539269953597113e-12
this O 0 5.207574302334983e-11
gene O 0 3.4990055297612344e-09
has O 0 1.1798343413360612e-09
shown O 0 3.033628681592404e-09
that O 0 6.072545244428795e-11
it O 0 4.19869607831691e-12
contains O 0 7.563092947054928e-13
two O 0 1.0544654559241362e-11
mutations O 0 9.71984004394244e-09
that O 0 3.8338840435692134e-10
result O 0 4.666139030717886e-09
in O 0 1.5179155155031765e-10
amino O 0 2.1499167723870727e-10
acid O 0 5.636382333085166e-11
substitutions O 0 2.6179350354205155e-10
- O 0 6.093269777629473e-10
cDNA O 0 2.7347635267460646e-10
nucleotides O 0 3.0708621756581067e-10
845 O 0 6.179481371049178e-10
G O 0 1.2059818743637152e-07
- O 0 2.0427955860213842e-07
- O 0 1.4618083241657587e-06
> O 0 1.4961637262445038e-08
A O 0 3.2978755282186967e-09
( O 0 5.292202873846685e-12
C282Y O 0 1.1560341572902644e-10
) O 0 1.8680910496889774e-13
and O 0 1.8995163515028723e-12
187 O 0 2.099836624025464e-11
C O 0 5.3565143431910656e-09
- O 0 6.438642685679952e-07
- O 0 5.999573113513179e-05
> O 0 1.4159417105474859e-06
G O 0 2.0232968381606042e-05
( O 0 6.94406476764442e-11
H63D O 0 1.1834058568638284e-06
) O 0 1.569364777020965e-10
. O 0 1.6641757971669335e-09

Although O 0 7.794302655383945e-05
hemochromatosis B-Disease 1 0.9999940395355225
is O 0 4.93153109459854e-08
common O 0 4.333983394388952e-09
in O 0 4.5333356513133083e-10
Caucasians O 0 3.2437895924886107e-08
, O 0 5.695017374351963e-11
affecting O 0 6.132772623068661e-10
> O 0 2.419288769317518e-09
= O 0 2.5288773297660327e-09
1 O 0 2.212288512104532e-11
/ O 0 2.7044702588518987e-10
300 O 0 2.1689598901641904e-12
individuals O 0 1.7236344729970599e-12
of O 0 2.2398597733508385e-12
northern O 0 3.6634428823845155e-10
European O 0 2.5043398466095823e-09
origin O 0 3.794615288654768e-09
, O 0 7.264724932731781e-11
it O 0 3.1651950505029447e-10
has O 0 1.4325419739336098e-09
not O 0 2.2743666672209173e-10
been O 0 3.335144937999246e-10
recognized O 0 9.921163196535687e-11
in O 0 2.4667436496206285e-11
other O 0 4.4647788938201316e-11
populations O 0 2.3906516766203367e-09
. O 0 5.1404045464664705e-09

The O 0 4.578227574825178e-09
present O 0 5.494509291992244e-10
study O 0 1.2153716921758928e-10
used O 0 4.2883755574374405e-11
PCR O 0 1.4298294104264642e-08
and O 0 7.453020839376379e-11
restriction O 0 1.8972225179769708e-10
- O 0 2.873157267657689e-09
enzyme O 0 1.249885195342415e-10
digestion O 0 1.8200087270603404e-10
to O 0 2.80669801636102e-12
analyze O 0 6.275022723656321e-10
the O 0 4.814572785588611e-12
frequency O 0 1.2282992400969306e-09
of O 0 2.4829603976171677e-13
the O 0 1.7859149489124482e-12
845 O 0 4.824771693279217e-10
G O 0 2.7244379907642724e-07
- O 0 5.993386764657771e-08
- O 0 6.8350999526956e-08
> O 0 8.961883457558883e-10
A O 0 2.2769318375193137e-10
and O 0 1.3399920929801912e-11
187 O 0 2.7375804748097643e-11
C O 0 2.032343626723332e-09
- O 0 1.6321253681894632e-08
- O 0 3.1860804483585525e-07
> O 0 1.5806737252432868e-08
G O 0 6.161345709188026e-07
mutations O 0 2.07212060843176e-08
in O 0 1.1556725715289318e-10
HLA O 0 4.502404848949482e-08
- O 0 5.299809657799415e-08
typed O 0 3.448770513614363e-08
samples O 0 1.3503768103717562e-09
from O 0 1.5585713275534374e-11
non O 0 8.182673427725717e-10
- O 0 1.0369137726229383e-06
Caucasian O 0 5.422769504548342e-07
populations O 0 1.4094396760810923e-09
, O 0 3.3677355609079695e-12
comprising O 0 7.006150434113456e-12
Australian O 0 6.411712272225145e-10
Aboriginal O 0 1.515440106736321e-09
, O 0 8.440640547613398e-12
Chinese O 0 6.522383761559114e-12
, O 0 1.398405957003801e-11
and O 0 1.8493892528503864e-10
Pacific O 0 7.824434988812357e-10
Islanders O 0 5.403452618679694e-08
. O 0 4.20011225799044e-09

Results O 0 2.1723835743614472e-06
showed O 0 1.7886530656596733e-07
that O 0 4.3075907424361404e-11
the O 0 1.2292213254216922e-11
845 O 0 2.816698652097216e-09
G O 0 2.792023678921396e-06
- O 0 1.8219681123810005e-06
- O 0 6.892190413054777e-06
> O 0 3.055202313362315e-08
A O 0 1.6941180902563246e-08
mutation O 0 2.513858419206372e-07
was O 0 1.8567063442276321e-09
present O 0 2.2367272964340934e-11
in O 0 9.743583544163936e-12
these O 0 4.539335921038834e-12
populations O 0 1.7640893953951853e-11
( O 0 5.066639924451721e-13
allele O 0 1.0356340091055571e-10
frequency O 0 1.2844506569464897e-09
0 O 0 3.365237992783432e-12
. O 0 1.6735338158671564e-13
32 O 0 9.786304796047252e-13
% O 0 1.3634550303023851e-12
) O 0 7.47870244465626e-13
, O 0 2.5389358584287924e-12
and O 0 1.6021682591738085e-10
, O 0 2.317216037106551e-11
furthermore O 0 1.9523991312553335e-09
, O 0 1.4336832068750915e-11
it O 0 4.2199518879293407e-10
was O 0 6.886343584255883e-08
always O 0 2.0997797278710095e-08
seen O 0 5.349938714260816e-09
in O 0 1.009518857397751e-11
conjunction O 0 7.807272883741945e-11
with O 0 2.24068250065379e-10
HLA O 0 9.143948886958242e-08
haplotypes O 0 4.294545163929797e-08
common O 0 1.2498094781321356e-09
in O 0 2.618214534066965e-10
Caucasians O 0 1.1119180243213123e-08
, O 0 1.68624628149594e-11
suggesting O 0 8.110142557526956e-10
that O 0 4.542785245198466e-11
845 O 0 5.245057721481317e-10
G O 0 9.935927209880902e-07
- O 0 2.051267529168399e-06
- O 0 4.111147427465767e-05
> O 0 1.7657289674843923e-07
A O 0 2.1025384739914443e-06
may O 0 2.8801382541132625e-06
have O 0 4.4602108117963724e-10
been O 0 9.868941081014881e-11
introduced O 0 2.2319287043548464e-11
into O 0 3.07810699672062e-12
these O 0 1.0696540875265725e-11
populations O 0 1.7477691169331955e-11
by O 0 1.3136815246728162e-10
Caucasian O 0 1.5436162925652752e-07
admixture O 0 1.722732918096881e-06
. O 0 6.937720087307753e-08

187 O 0 6.996068009357259e-07
C O 0 3.4627289551281137e-06
- O 0 1.7790749780033366e-06
- O 0 2.1590232790913433e-05
> O 0 2.8748252134391805e-06
G O 0 2.5646242647781037e-05
was O 0 6.177387046335525e-09
present O 0 9.664002931231153e-11
at O 0 1.1235055941138938e-10
an O 0 6.2723836541378475e-12
allele O 0 4.1895025226779126e-09
frequency O 0 3.725341812810257e-08
of O 0 3.976825119211824e-11
2 O 0 3.15047010701619e-09
. O 0 6.3116605275581605e-09

68 O 0 2.0578987403041538e-07
% O 0 2.1150770024291887e-09
in O 0 1.2586987008234019e-10
the O 0 4.2854154252980337e-11
two O 0 1.4331125175459647e-10
populations O 0 1.0767602365291395e-09
analyzed O 0 4.308945023012711e-08
( O 0 2.192724647687161e-11
Australian O 0 4.678562426363442e-09
Aboriginal O 0 5.860916196809285e-09
and O 0 8.33254798493499e-10
Chinese O 0 1.3407366883377847e-10
) O 0 6.070808439284647e-11
. O 0 6.096350646522808e-10

In O 0 6.025742571580395e-09
the O 0 9.167511888508173e-11
Australian O 0 1.2206899935307547e-09
Aboriginal O 0 1.4914018908740445e-09
samples O 0 5.115627366159003e-10
, O 0 2.625172648706986e-12
187 O 0 2.238681982846824e-11
C O 0 2.0381119014700744e-09
- O 0 2.4855728142370026e-08
- O 0 1.678743274169392e-06
> O 0 1.4566799677595554e-07
G O 0 7.751352313789539e-06
was O 0 9.871229167401907e-09
found O 0 8.25694013162348e-10
to O 0 8.078735597161213e-11
be O 0 1.7461347923131143e-09
associated O 0 8.36761770983685e-10
with O 0 1.7271838126386996e-10
HLA O 0 2.64709569819388e-07
haplotypes O 0 8.742242840753534e-08
common O 0 5.06630204455405e-09
in O 0 5.142873904517842e-10
Caucasians O 0 5.89003406048505e-08
, O 0 5.092698138198237e-11
suggesting O 0 5.086929277808849e-08
that O 0 2.1697701413359027e-09
it O 0 4.1196265843090885e-10
was O 0 4.5096457124138567e-10
introduced O 0 1.184727038694433e-10
by O 0 2.0210460041636402e-11
recent O 0 1.3632490691861676e-09
admixture O 0 2.063228237147996e-07
. O 0 1.762857770870596e-08

In O 0 3.867052011941041e-09
the O 0 3.432136519432305e-11
Chinese O 0 1.4831766023681858e-11
samples O 0 2.8214827696437794e-10
analyzed O 0 1.283152806230703e-09
, O 0 1.755007163900535e-12
187 O 0 1.6079781603450805e-11
C O 0 1.1928222853896386e-09
- O 0 2.481167626910974e-08
- O 0 1.0738523315012571e-06
> O 0 1.1020287615792768e-07
G O 0 1.0356831808167044e-05
was O 0 2.2879222072447192e-08
present O 0 1.9104120507762445e-09
in O 0 9.281562185492476e-10
association O 0 2.0284376608947774e-11
with O 0 1.4393219255337542e-11
a O 0 3.573389084632339e-10
wide O 0 2.3969251028432836e-09
variety O 0 4.658808894220101e-10
of O 0 4.4882847438643125e-11
HLA O 0 1.0506188630188262e-07
haplotypes O 0 2.9078972119123137e-08
, O 0 1.174901669009909e-11
showing O 0 5.707637917851116e-09
this O 0 3.375602575239611e-11
mutation O 0 3.2218492318492054e-09
to O 0 2.2619581555027857e-11
be O 0 5.375651035421924e-10
widespread O 0 1.2324671283536759e-09
and O 0 6.757205461838112e-09
likely O 0 5.095151411893539e-09
to O 0 2.3272217486436375e-11
predate O 0 5.676338510340884e-09
the O 0 1.200801437450938e-11
more O 0 4.4397510841343024e-12
genetically O 0 6.910847588637026e-11
restricted O 0 7.492616249660244e-11
845 O 0 8.361252246125161e-10
G O 0 2.2026767965144245e-06
- O 0 6.6764350776793435e-06
- O 0 2.527526521589607e-05
> O 0 1.0730030908234767e-07
A O 0 8.737558232496667e-08
mutation O 0 3.977252163167577e-06
. O 0 8.418497010609372e-09

Genotype O 1 0.9784911870956421
- O 0 0.0728859007358551
phenotype O 0 0.0016600623494014144
correlations O 0 0.00025931396521627903
in O 0 1.0749060493253637e-05
attenuated B-Disease 1 0.9989091157913208
adenomatous I-Disease 1 0.9999909400939941
polyposis I-Disease 1 0.9998910427093506
coli I-Disease 1 0.9999655485153198
. O 0 1.5992984117474407e-05

Germ O 0 0.019691290333867073
- O 0 0.0005064256838522851
line O 0 1.8517966964282095e-06
mutations O 0 1.6945114111877047e-07
of O 0 1.3799882243870076e-11
the O 0 2.3265660231697183e-10
tumor B-Disease 0 1.3202649142840528e-06
suppressor O 0 2.8715373900922714e-06
APC O 0 1.8084914188420953e-07
are O 0 1.959322926126106e-09
implicated O 0 2.7320267690811306e-05
in O 0 1.145792452916794e-06
attenuated B-Disease 1 0.9997206330299377
adenomatous I-Disease 1 0.9999991655349731
polyposis I-Disease 1 0.9999920129776001
coli I-Disease 1 0.9999990463256836
( O 0 0.00015580665785819292
AAPC B-Disease 1 0.9999964237213135
) O 0 3.442459650671026e-09
, O 0 2.468499189778317e-11
a O 0 1.039596631002837e-09
variant O 0 7.472919241990894e-05
of O 0 3.503800598991802e-06
familial B-Disease 1 0.9999998807907104
adenomatous I-Disease 1 0.9999961853027344
polyposis I-Disease 1 0.9999994039535522
( O 0 3.5469242902763654e-06
FAP B-Disease 0 6.813571962993592e-05
) O 0 5.225867738545276e-09
. O 0 1.1629974316917924e-08

AAPC B-Disease 1 0.999935507774353
is O 0 9.096668662778029e-08
recognized O 0 2.7939581759284238e-09
by O 0 5.348484502509798e-11
the O 0 1.3305212487324525e-10
occurrence O 0 1.4570078121778351e-07
of O 0 2.231644591343951e-10
< O 0 3.249195685839368e-07
100 O 0 1.4905508771700937e-10
colonic B-Disease 0 5.271011104923673e-06
adenomas I-Disease 0 7.668172656849492e-07
and O 0 2.1720172882488953e-10
a O 0 2.410880661773973e-10
later O 0 1.1836666757858438e-08
onset O 0 2.7923886136704823e-06
of O 0 0.00017134020163211972
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 5.7722338908661186e-08
age O 0 5.496338673083301e-08
> O 0 1.8182202410343962e-08
40 O 0 8.190664119167579e-11
years O 0 7.856138517503553e-10
) O 0 1.0244591286401317e-10
. O 0 1.3224610295736738e-09

The O 0 3.4055673836519418e-09
aim O 0 4.826311794658977e-09
of O 0 1.6006708111748758e-11
this O 0 3.075597068691316e-11
study O 0 4.343429782505126e-11
was O 0 5.558100091285212e-10
to O 0 2.3071433652432916e-11
assess O 0 3.648197264283226e-07
genotype O 0 0.0027231029234826565
- O 0 0.0007613747729919851
phenotype O 0 3.836709220195189e-05
correlations O 0 2.091975875373464e-05
in O 0 8.552987083021435e-07
AAPC B-Disease 1 0.9999710321426392
families O 0 2.3611525534761313e-07
. O 0 2.250201092124371e-08

By O 0 1.078814371169301e-08
protein O 0 4.299815614672298e-08
- O 0 6.237814318410528e-07
truncation O 0 2.802858034556266e-07
test O 0 7.170217486418551e-08
( O 0 3.907180481932393e-11
PTT O 0 2.480476801736131e-08
) O 0 1.3548793163786765e-12
assay O 0 1.162761664730283e-09
, O 0 8.425917841052566e-13
the O 0 1.4208603911491924e-12
entire O 0 4.7209576525819585e-11
coding O 0 2.0829691305124243e-09
region O 0 2.799508541651008e-11
of O 0 1.649157806843382e-12
the O 0 1.3897881109836696e-11
APC B-Disease 0 2.020670741842423e-09
gene O 0 4.930641450684448e-10
was O 0 1.0598744104584057e-09
screened O 0 2.6784972462223777e-08
in O 0 4.209911030894631e-10
affected O 0 1.1374697850285997e-09
individuals O 0 1.2764539425447197e-10
from O 0 7.410825286768841e-10
11 O 0 9.421908941931179e-08
AAPC B-Disease 1 0.9999845027923584
kindreds O 0 4.69780461571645e-05
, O 0 3.900852973970359e-10
and O 0 6.414644510011058e-11
their O 0 6.563907750667397e-11
phenotypic O 0 7.035328621896042e-07
differences O 0 2.2349870050675236e-05
were O 0 7.433389441757754e-07
examined O 0 1.7579410268808715e-05
. O 0 4.999035496666693e-08

Five O 0 3.411283699961132e-08
novel O 0 1.178438679971805e-07
germ O 0 0.0005068951286375523
- O 0 0.0002064151776721701
line O 0 8.259353307948913e-06
APC B-Disease 0 4.6547458509849093e-07
mutations O 0 7.659840548512875e-07
were O 0 2.662288833832349e-09
identified O 0 4.517087859312596e-08
in O 0 5.265445857105533e-10
seven O 0 1.836150009815185e-09
kindreds O 0 6.014962309563998e-06
. O 0 3.851360830253725e-08

Mutations O 0 0.010631444863975048
were O 0 5.4797475002033025e-08
located O 0 6.246724026937045e-09
in O 0 7.341630081647565e-11
three O 0 1.2673366696358546e-11
different O 0 1.6074508044083835e-11
regions O 0 2.999827469762906e-11
of O 0 1.0348115593583618e-12
the O 0 3.708123738621616e-11
APC B-Disease 0 2.282316113877414e-09
gene O 0 2.6995436441801246e-10
( O 0 1.595954054675608e-12
1 O 0 4.714898610425067e-12
) O 0 3.824894502686693e-13
at O 0 1.435445252245815e-11
the O 0 3.5903693212935295e-12
5 O 0 1.2531883517019615e-11
end O 0 7.416109393254544e-11
spanning O 0 1.507821922874797e-10
exons O 0 4.565789690769151e-10
4 O 0 1.2537453714100977e-11
and O 0 2.1068171512927947e-11
5 O 0 1.676014362017586e-11
, O 0 6.340416473099575e-12
( O 0 6.794542142460336e-13
2 O 0 2.9792184344512584e-12
) O 0 5.817846204791977e-13
within O 0 1.6297456006258981e-12
exon O 0 9.61673851662681e-09
9 O 0 1.189675469248641e-09
, O 0 1.138566931707663e-11
and O 0 1.232447616184018e-10
( O 0 2.5697070339669725e-12
3 O 0 9.713560684965206e-12
) O 0 7.732307632721258e-13
at O 0 7.07697303536925e-11
the O 0 7.230824879828068e-12
3 O 0 3.33682283193415e-11
distal O 0 2.1173052200396114e-09
end O 0 2.147082067693873e-09
of O 0 9.858005904639366e-12
the O 0 3.035548756802342e-10
gene O 0 8.535413797972069e-08
. O 0 7.681374647461325e-09

Variability O 0 0.00034354982199147344
in O 0 2.1103303549097063e-09
the O 0 5.0419661501432955e-11
number O 0 1.1139148492489426e-09
of O 0 9.927648534358013e-07
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
was O 0 0.0003516502329148352
most O 0 1.2531363446921517e-10
apparent O 0 3.173752460838841e-08
in O 0 2.0789990562430916e-10
individuals O 0 3.567700648798855e-11
with O 0 6.386057238572107e-10
mutations O 0 4.502078638779494e-07
in O 0 5.202265285220165e-10
region O 0 2.130560172730611e-09
1 O 0 2.9839490878202923e-09
, O 0 2.408040711276982e-10
and O 0 1.9211194413060184e-08
upper O 0 0.0003530364774633199
- O 1 0.9554898142814636
gastrointestinal O 1 0.769889771938324
manifestations O 0 4.187482409179211e-05
were O 0 4.0595697470280356e-08
more O 0 8.372039728143932e-10
severe O 0 4.829454155697022e-06
in O 0 5.088673482589456e-09
them O 0 3.1087692420328494e-09
. O 0 1.3630470085956858e-08

In O 0 8.042629673354895e-09
individuals O 0 7.360211329299204e-10
with O 0 4.806897657694265e-10
mutations O 0 1.1924722684852895e-06
in O 0 6.649498729416337e-10
either O 0 9.241643894597473e-09
region O 0 1.9380554938663863e-09
2 O 0 1.2674074290064397e-10
or O 0 2.3324946418767922e-09
region O 0 4.932843022942279e-10
3 O 0 6.133284158327257e-11
, O 0 2.1447132264595936e-12
the O 0 3.5570105888504955e-12
average O 0 2.634941986823236e-10
number O 0 1.278604284081497e-12
of O 0 1.192597561504305e-12
adenomas B-Disease 0 1.0568469654970158e-08
tended O 0 3.1949735301850524e-08
to O 0 1.5101357664359938e-10
be O 0 4.276127896218895e-09
lower O 0 8.479149049556156e-10
than O 0 3.124859052072715e-11
those O 0 9.249424143265017e-12
in O 0 2.1701102286691976e-12
individuals O 0 2.47057973037923e-12
with O 0 7.242892396952527e-11
mutations O 0 3.896164812999814e-08
in O 0 1.8005556767786146e-10
region O 0 3.8336500640667737e-10
1 O 0 4.1794681604478967e-10
, O 0 4.081473353734211e-11
although O 0 4.9738102525509476e-09
age O 0 9.207194118232565e-09
at O 0 2.733160364698506e-08
diagnosis O 0 4.777106369147077e-06
was O 0 3.9197036727500745e-08
similar O 0 9.96777682615857e-09
. O 0 1.43575968891696e-08

In O 0 2.676950430213765e-07
all O 0 1.7494192761091654e-08
AAPC B-Disease 1 0.9999146461486816
kindreds O 0 3.728691808646545e-05
, O 0 1.594060300424971e-10
a O 0 1.0976847902854914e-10
predominance O 0 4.831868238852621e-08
of O 0 2.5109978540882594e-09
right O 0 0.24561767280101776
- O 1 0.9998923540115356
sided O 1 0.999993085861206
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999991655349731
and O 0 0.00022565740800928324
rectal B-Disease 1 0.9983944296836853
polyp I-Disease 0 0.21290223300457
sparing O 0 3.327369540784275e-06
was O 0 3.4026805906250956e-07
observed O 0 2.360544755219962e-07
. O 0 4.454448809809719e-09

No O 0 1.4656662642664742e-05
desmoid B-Disease 1 0.9523288011550903
tumors I-Disease 1 0.9999995231628418
were O 0 3.441559499606228e-07
found O 0 1.2168550611590945e-08
in O 0 1.2016229122835398e-09
these O 0 1.5411026899059266e-09
kindreds O 0 2.9751870442851214e-06
. O 0 3.164166173519334e-08

Our O 0 1.0123167015763102e-07
data O 0 1.1729420101858068e-08
suggest O 0 1.792915327314404e-08
that O 0 5.913667333601325e-10
, O 0 4.9119035228084584e-11
in O 0 3.216679145268131e-09
AAPC B-Disease 1 0.9999966621398926
families O 0 9.201435169359229e-09
, O 0 1.638173451057323e-11
the O 0 2.308942533696401e-12
location O 0 1.2830739248848033e-10
of O 0 6.003580878960468e-12
the O 0 5.133847236216127e-10
APC B-Disease 0 1.7114797401518445e-06
mutation O 0 1.1735946827684529e-05
may O 0 1.4260183434089413e-07
partially O 0 2.9548374413934653e-07
predict O 0 9.21847913559759e-08
specific O 0 2.4836095402491765e-09
phenotypic O 0 4.322751919971779e-06
expression O 0 2.6321218683733605e-05
. O 0 7.277411384620791e-08

This O 0 1.9673302986689123e-08
should O 0 2.534904286477513e-09
help O 0 2.383797881311267e-10
in O 0 1.5190152954924763e-11
the O 0 7.233693678776465e-12
design O 0 2.869531723348473e-09
of O 0 7.18268717073145e-12
tailored O 0 9.736187394082663e-07
clinical O 0 2.736749991072429e-07
- O 0 2.3335216610576026e-05
management O 0 5.227961619169719e-09
protocols O 0 2.537321741602483e-10
in O 0 3.9506644483600084e-12
this O 0 1.2820402291863209e-12
subset O 0 7.987509959006545e-11
of O 0 1.215030992485211e-10
FAP B-Disease 0 1.3171196542316466e-06
patients O 0 1.290689155553082e-08
. O 0 4.4188039338699525e-10
. O 0 2.9972624382423874e-09

Wilms B-Disease 0 0.4411691725254059
' I-Disease 0 7.977509085321799e-06
tumor I-Disease 0 2.8356748771329876e-06
1 O 0 9.08873420968348e-10
and O 0 3.7395761487424295e-10
Dax O 0 0.009504108689725399
- O 0 7.243937716339133e-07
1 O 0 2.0574132675310608e-10
modulate O 0 2.5120433733150094e-08
the O 0 1.698338414346523e-10
orphan O 0 2.8560027232060747e-08
nuclear O 0 8.802645368177764e-08
receptor O 0 5.632143196265815e-09
SF O 0 0.0001169481038232334
- O 0 1.785277277122077e-07
1 O 0 2.117247765998087e-10
in O 0 4.5722713809537296e-11
sex O 0 2.3332431098310735e-08
- O 0 2.402299692505494e-08
specific O 0 8.155749409155533e-10
gene O 0 2.935935405901091e-08
expression O 0 1.0857134924435741e-07
. O 0 3.823501959487885e-09

Products O 0 5.388467627653881e-08
of O 0 3.0650809668131274e-10
steroidogenic O 0 2.4916209895309294e-06
factor O 0 1.7199990764993345e-08
1 O 0 1.3987008218308006e-09
( O 0 1.6250724377275816e-10
SF O 0 0.016070837154984474
- O 0 4.78031915918109e-06
1 O 0 1.4904832923434697e-09
) O 0 1.8186962352784164e-11
and O 0 1.8600170292870644e-09
Wilms B-Disease 0 0.001211082562804222
tumor I-Disease 0 4.0333339711651206e-05
1 O 0 4.82289763681365e-09
( O 0 5.427491095444381e-11
WT1 O 0 2.112151946676022e-07
) O 0 8.131044448855818e-12
genes O 0 1.567931479096174e-10
are O 0 3.2511042469263174e-12
essential O 0 7.941022839297318e-12
for O 0 3.2224587581675124e-12
mammalian O 0 3.1012481471748288e-09
gonadogenesis O 0 5.788584189758694e-08
prior O 0 2.828395850862364e-10
to O 0 3.932480729940124e-11
sexual O 0 2.1056351329207246e-08
differentiation O 0 1.7283060316231058e-08
. O 0 7.18297243906818e-09

In O 0 4.796570962639635e-08
males O 0 1.2335429744325666e-07
, O 0 4.718960777694292e-10
SF O 0 0.0016472528222948313
- O 0 1.1369213552825386e-06
1 O 0 2.5386867608112595e-10
participates O 0 2.4125826336707235e-10
in O 0 3.9594324346969856e-11
sexual O 0 1.4342097509612017e-09
development O 0 4.9022799708531295e-12
by O 0 7.752128799998204e-12
regulating O 0 2.679610089373341e-09
expression O 0 1.481399780622894e-09
of O 0 1.302446258483192e-11
the O 0 6.912010963588955e-10
polypeptide O 0 5.747707291448023e-06
hormone O 0 6.91112006734329e-07
Mullerian O 0 2.232082579212147e-06
inhibiting O 0 4.6688390398230695e-07
substance O 0 6.07897927693557e-05
( O 0 3.7756637816244165e-09
MIS O 0 1.2557869013107847e-05
) O 0 3.561433925547419e-10
. O 0 1.2228946744130553e-09

Here O 0 4.197231078251207e-07
, O 0 1.8920982836068134e-10
we O 0 2.2524232479170792e-10
show O 0 2.1709332109765e-09
that O 0 2.75074141242726e-09
WT1 O 0 1.7283809938817285e-05
- O 0 1.0407039553683717e-05
KTS O 0 1.1147081750095822e-05
isoforms O 0 7.4128219118563266e-09
associate O 0 1.1483781703347518e-09
and O 0 6.774646121865402e-11
synergize O 0 3.396708336822485e-07
with O 0 8.753584523901736e-09
SF O 1 0.9004862308502197
- O 0 4.930223440169357e-06
1 O 0 2.6335203462402035e-10
to O 0 5.153406867908217e-11
promote O 0 2.5760513722161704e-09
MIS O 0 5.073539796285331e-05
expression O 0 9.705949111094014e-08
. O 0 2.8316899935987294e-09

In O 0 4.9977771254816616e-08
contrast O 0 5.058782903688552e-07
, O 0 3.0018909580320496e-09
WT1 O 0 3.543712955433875e-05
missense O 0 0.0014690238749608397
mutations O 0 0.00033899411209858954
, O 0 2.877866833728149e-10
associated O 0 2.4643100893229075e-09
with O 0 7.898448006748993e-10
male B-Disease 0 0.0002733388391789049
pseudohermaphroditism I-Disease 1 0.9999994039535522
in O 0 6.012662652210565e-06
Denys B-Disease 1 0.9999771118164062
- I-Disease 1 0.999990701675415
Drash I-Disease 1 0.9999845027923584
syndrome I-Disease 1 0.9999847412109375
, O 0 1.6070292874204029e-09
fail O 0 1.0114057857890657e-07
to O 0 9.120387084449177e-11
synergize O 0 3.916579771612305e-06
with O 0 1.5798997310412233e-07
SF O 1 0.9993792772293091
- O 0 0.0008044947753660381
1 O 0 2.8115580974485965e-08
. O 0 1.4915505275325813e-08

Additionally O 0 7.263987100714075e-08
, O 0 2.2338890459661087e-10
the O 0 4.147202373183667e-11
X O 0 0.00031598680652678013
- O 0 3.8951646274654195e-05
linked O 0 6.732784822816029e-05
, O 0 1.1198130617229296e-10
candidate O 0 1.5821697729734296e-08
dosage O 0 2.993835551023949e-06
- O 0 2.219807413439412e-07
sensitive O 0 2.305846010131063e-06
sex O 0 7.758223574683143e-08
- O 0 1.4379905266537207e-08
reversal O 0 7.506685051339446e-09
gene O 0 7.056300543872851e-10
, O 0 1.0361433065708692e-11
Dax O 0 7.222513522719964e-05
- O 0 1.4293854633251613e-07
1 O 0 9.117413074521963e-11
, O 0 2.7435694775063135e-12
antagonizes O 0 4.496806926823638e-09
synergy O 0 1.3049216152083432e-09
between O 0 2.8979791899530483e-09
SF O 0 0.20786572992801666
- O 0 1.8280841231899103e-06
1 O 0 7.955007763627009e-10
and O 0 3.5541727894106145e-10
WT1 O 0 1.3577516710938653e-07
, O 0 5.5216616869080415e-12
most O 0 2.833900865709116e-12
likely O 0 3.805483358987338e-11
through O 0 3.9471827499235057e-13
a O 0 3.1813460286272965e-12
direct O 0 1.9119959088209626e-11
interaction O 0 6.078504366513471e-10
with O 0 2.2979415703616723e-08
SF O 1 0.9886162877082825
- O 0 0.00010357185237808153
1 O 0 1.2085374478942867e-08
. O 0 1.078295941425722e-08

We O 0 7.117323264083097e-08
propose O 0 2.1027053875855017e-08
that O 0 4.080743798429154e-10
WT1 O 0 5.746999249822693e-07
and O 0 1.2775311919455135e-09
Dax O 0 0.006770549342036247
- O 0 8.326548481818463e-07
1 O 0 2.2198894111813416e-10
functionally O 0 2.0696786506846365e-09
oppose O 0 5.583153939170415e-10
each O 0 3.607841803088263e-11
other O 0 3.5175755537519837e-12
in O 0 2.3009774641202796e-11
testis O 0 5.2469442124447596e-08
development O 0 1.0507011059812665e-11
by O 0 1.1831327584310714e-10
modulating O 0 9.52876598603325e-06
SF O 1 0.6284158825874329
- O 0 1.356154552922817e-05
1 O 0 3.6011766901822284e-09
- O 0 5.685865289706271e-07
mediated O 0 7.965473969306913e-07
transactivation O 0 1.268294272449566e-05
. O 0 1.931818482958647e-09
. O 0 2.3685662320360734e-09

A O 0 2.974529706989415e-07
mouse O 0 2.6513753255130723e-06
model O 0 2.0334709915914573e-06
for O 0 1.2887429647889803e-06
Prader B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999998807907104
Willi I-Disease 1 1.0
syndrome I-Disease 1 0.9999995231628418
imprinting O 1 0.9966817498207092
- O 1 0.7210667729377747
centre O 0 1.7546748495078646e-05
mutations O 0 9.34391500777565e-05
. O 0 5.4958356088263827e-08

Imprinting O 0 4.132703907089308e-05
in O 0 2.2193400450731815e-09
the O 0 2.2082086159613823e-10
15q11 O 0 1.0474116152181523e-07
- O 0 8.675498293087003e-07
q13 O 0 5.484212550754819e-08
region O 0 1.1690551859899756e-09
involves O 0 4.867642955375118e-10
an O 0 2.9721142214000906e-11
imprinting O 0 9.364645734422083e-07
centre O 0 1.8084428177189693e-08
( O 0 1.0707114014851804e-11
IC O 0 2.1938239669339055e-08
) O 0 7.507576157972373e-12
, O 0 2.190645885177811e-12
mapping O 0 1.3864878134484115e-09
in O 0 3.0548539392549756e-11
part O 0 6.671371094446599e-11
to O 0 4.76912329072654e-11
the O 0 3.0691567343144044e-11
promoter O 0 3.269873900535458e-07
and O 0 3.0970259690121793e-10
first O 0 8.693278041871366e-11
exon O 0 1.4737321585300833e-08
of O 0 4.792972130296391e-10
SNRPN O 0 0.00011554876255104318
. O 0 2.5484798271691034e-08

Deletion O 0 1.3635947652801406e-05
of O 0 1.565102714096156e-09
this O 0 9.30989507708091e-10
IC O 0 1.8139581925424864e-06
abolishes O 0 9.541408871882595e-07
local O 0 9.964502556414345e-10
paternally O 0 2.0003253098366258e-07
derived O 0 1.1456369186646498e-09
gene O 0 3.1462665806003542e-09
expression O 0 1.3765282247391042e-08
and O 0 6.033042398989608e-10
results O 0 5.066594610525499e-08
in O 0 1.364011041005142e-05
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 0.9999998807907104
( O 0 0.00010832065891008824
PWS B-Disease 1 0.999994158744812
) O 0 4.565890066032807e-08
. O 0 1.2853532460610495e-08

We O 0 4.882492703472963e-07
have O 0 1.429429768995405e-10
created O 0 4.065398365171724e-11
two O 0 1.9904720233165918e-11
deletion O 0 2.6594031510285276e-07
mutations O 0 2.1991170342516853e-06
in O 0 1.8482052555057749e-09
mice O 0 2.7862436127179535e-06
to O 0 2.682966204758941e-08
understand O 0 0.00023662015155423433
PWS B-Disease 1 0.9999978542327881
and O 0 2.3489295841727653e-08
the O 0 5.86430973226193e-11
mechanism O 0 5.381683432226225e-10
of O 0 1.3745636573414544e-11
this O 0 4.0598213679743367e-10
IC O 0 4.011856162833283e-06
. O 0 1.3214985550291658e-08

Mice O 0 0.0021160508040338755
harbouring O 0 5.3357234719442204e-05
an O 0 1.5930337049496757e-09
intragenic O 0 1.9825615709123667e-06
deletion O 0 1.985922381209093e-06
in O 0 3.6019462967828986e-09
Snrpn O 0 1.3032582501182333e-05
are O 0 3.5590317359890378e-09
phenotypically O 0 1.0476634997758083e-05
normal O 0 4.198424363721642e-08
, O 0 1.2154010436971063e-11
suggesting O 0 3.459678987738357e-09
that O 0 3.168257323160617e-10
mutations O 0 6.718407608019561e-09
of O 0 1.861385004464644e-11
SNRPN O 0 1.91955259651877e-05
are O 0 1.586773906714356e-10
not O 0 1.3621541394837067e-10
sufficient O 0 5.049870521744992e-10
to O 0 1.1669164523553377e-09
induce O 0 8.299424735014327e-06
PWS B-Disease 1 0.9999778270721436
. O 0 2.1890929247092572e-07

Mice O 0 0.00014153883967082947
with O 0 1.0224957547322333e-09
a O 0 7.602167784170888e-10
larger O 0 1.504541824459693e-09
deletion O 0 1.511737508508304e-07
involving O 0 2.35347705768163e-08
both O 0 3.268605608397479e-09
Snrpn O 0 9.61998102866346e-06
and O 0 2.248106589775034e-09
the O 0 1.0402670946874082e-09
putative O 0 0.00014375592581927776
PWS O 1 0.9999914169311523
- O 0 0.00023470891756005585
IC O 0 2.9262384487083182e-05
lack O 0 3.953612548457386e-08
expression O 0 1.0728103738699701e-08
of O 0 1.8272567486876667e-11
the O 0 1.431306739796412e-10
imprinted O 0 1.7481355826021172e-05
genes O 0 2.482417293947492e-08
Zfp127 O 0 4.012841543499235e-07
( O 0 1.5441257647519357e-11
mouse O 0 9.761381924988655e-09
homologue O 0 4.3052480691585515e-08
of O 0 1.879588013009581e-10
ZNF127 O 0 0.00046235250192694366
) O 0 8.272115631369203e-11
, O 0 3.1476560941046117e-11
Ndn O 0 1.443555817104425e-07
and O 0 1.0364051838962496e-09
Ipw O 0 6.97568111718283e-07
, O 0 4.013188670271006e-10
and O 0 5.625644949880382e-10
manifest O 0 4.268004172303108e-09
several O 0 5.222972748741839e-11
phenotypes O 0 1.042531948769465e-06
common O 0 7.895999942775234e-08
to O 0 3.0259268442023313e-06
PWS B-Disease 1 0.9999992847442627
infants O 0 0.3368047773838043
. O 0 8.068768408975302e-08

These O 0 1.0551082230136899e-09
data O 0 3.2785771875154524e-09
demonstrate O 0 6.131418928134735e-09
that O 0 7.040661803570103e-11
both O 0 6.412267852112796e-12
the O 0 1.4421082383808681e-11
position O 0 7.559242121146781e-09
of O 0 1.3451257252147797e-12
the O 0 1.9239988074959413e-11
IC O 0 2.5699771200038413e-08
and O 0 3.457313949017937e-11
its O 0 1.230644709401818e-12
role O 0 2.3359470607831057e-11
in O 0 5.684812863504529e-12
the O 0 2.097005945625452e-12
coordinate O 0 2.0393173816302124e-09
expression O 0 2.1109984871259257e-09
of O 0 3.528448149978103e-12
genes O 0 1.4917511670375916e-10
is O 0 1.0168372220620281e-11
conserved O 0 4.3971462582170773e-10
between O 0 6.497218735246335e-11
mouse O 0 2.933674920768681e-07
and O 0 1.9763868763789105e-08
human O 0 5.193791174917806e-09
, O 0 8.409292706623717e-11
and O 0 5.546419434843131e-10
indicate O 0 7.17783947834505e-08
that O 0 1.766497781385823e-10
the O 0 1.1534434865567711e-11
mouse O 0 1.1108008735050134e-08
is O 0 1.962777163022622e-11
a O 0 2.1596479812813207e-11
suitable O 0 1.2188434261872771e-08
model O 0 6.935232477189857e-08
system O 0 1.542979188862148e-09
in O 0 2.1710303693689426e-11
which O 0 1.584184519676235e-11
to O 0 1.922919289076841e-12
investigate O 0 7.019199110835928e-10
the O 0 3.2173139152824604e-11
molecular O 0 1.684577277671906e-08
mechanisms O 0 1.546549416309162e-10
of O 0 2.068381056707924e-12
imprinting O 0 6.44281925588075e-08
in O 0 3.7114442075214527e-10
this O 0 6.854346951135071e-11
region O 0 7.860091744138487e-11
of O 0 4.909297360994325e-12
the O 0 1.1075692446516072e-10
genome O 0 2.92246893351944e-09
. O 0 2.62640714732143e-10
. O 0 1.2222579615084328e-09

Mutations O 0 2.2385020201909356e-05
of O 0 1.2921583247837987e-10
the O 0 1.2369057167394004e-10
ATM O 0 2.146433871530462e-06
gene O 0 9.309890742770222e-07
detected O 0 9.022573794936761e-05
in O 0 7.636381305076156e-09
Japanese O 0 0.12415818125009537
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999996423721313
telangiectasia I-Disease 1 1.0
patients O 0 0.00021766497229691595
: O 0 4.4098874552034317e-10
possible O 0 6.510271766124731e-10
preponderance O 0 4.72599168688248e-08
of O 0 3.1946639778013264e-11
the O 0 6.359361648389239e-11
two O 0 1.1599612936841197e-10
founder O 0 8.519584149269122e-09
mutations O 0 7.233887089341806e-08
4612del165 O 0 1.9369551296222198e-08
and O 0 1.4747493226607844e-09
7883del5 O 0 3.0544978812940826e-07
. O 0 1.6938821900680523e-08

The O 0 1.6705371308489703e-08
ATM O 0 2.4818482415867038e-05
( O 0 1.9993978028765014e-08
A O 1 0.9999719858169556
- O 1 0.9999986886978149
T O 1 1.0
, O 0 1.3419303002137895e-08
mutated O 0 3.148669591723774e-08
) O 0 2.543608769792205e-12
gene O 0 1.829594115099198e-10
on O 0 1.0152491070059e-09
human O 0 3.6571334849355708e-09
chromosome O 0 6.509118975372985e-06
11q22 O 0 1.1839510989375412e-06
. O 0 8.573476151241266e-09

3 O 0 1.1328524607279178e-07
has O 0 6.547884012775285e-09
recently O 0 1.569824270575282e-08
been O 0 3.4568294893233542e-09
identified O 0 3.567398154658008e-09
as O 0 5.387747539775667e-12
the O 0 2.0134269685528894e-12
gene O 0 6.949085751273287e-11
responsible O 0 3.41854905494543e-10
for O 0 7.79642149451032e-12
the O 0 1.380866421207827e-09
human O 0 5.31231034983648e-06
recessive B-Disease 1 0.9999133348464966
disease I-Disease 1 0.999962329864502
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999997615814209
telangiectasia I-Disease 1 1.0
( O 0 0.003840423421934247
A B-Disease 1 0.9999997615814209
- I-Disease 1 0.9999995231628418
T I-Disease 1 1.0
) O 0 4.437389478084697e-08
. O 0 1.0900289559856446e-08

In O 0 3.1870355243768245e-09
order O 0 1.2788274605934902e-10
to O 0 1.4150625983477827e-11
define O 0 3.152140992668251e-09
the O 0 5.769318703330306e-11
types O 0 1.3212263283435277e-08
of O 0 9.941530931811826e-10
disease O 0 2.754064098553499e-06
- O 0 1.8014355873674504e-06
causing O 0 2.3520954073319444e-07
ATM O 0 1.0585319614619948e-05
mutations O 0 9.57847987592686e-07
in O 0 7.616972053092752e-10
Japanese O 0 3.188665687048342e-06
A B-Disease 1 0.9999958276748657
- I-Disease 1 0.9999985694885254
T I-Disease 1 1.0
patients O 0 7.91877354799908e-08
as O 0 8.050924510394353e-11
well O 0 7.374428151463164e-11
as O 0 4.258508042725984e-12
to O 0 4.188721418330044e-12
look O 0 7.600717832900727e-10
for O 0 1.319949141306842e-12
possible O 0 6.917840189579749e-10
mutational O 0 3.7061570878904604e-07
hotspots O 0 3.511703638992003e-08
, O 0 7.24792240114347e-11
reverse O 0 3.468170817200189e-08
- O 0 5.613667397597055e-08
transcribed O 0 6.809891317516303e-09
RNA O 0 2.993621461833129e-10
derived O 0 4.282357454754582e-12
from O 0 9.400059940503636e-13
ten O 0 2.017133508835922e-11
patients O 0 2.4802271347823535e-11
belonging O 0 3.7173880640395396e-10
to O 0 4.467615860592744e-11
eight O 0 5.6422012895129825e-11
unrelated O 0 1.3762813999562695e-08
Japanese O 0 7.63633488531923e-06
A B-Disease 1 0.9999877214431763
- I-Disease 1 0.999985933303833
T I-Disease 1 0.9999998807907104
families O 0 3.7714340095362786e-08
was O 0 2.3082339595248413e-08
analyzed O 0 4.996821623137748e-09
for O 0 1.0971776438772896e-11
mutations O 0 1.4682826066092503e-09
by O 0 4.2113205284133315e-12
the O 0 1.8473717347533558e-11
restriction O 0 3.8336939178762464e-10
endonuclease O 0 2.1662851068526834e-08
fingerprinting O 0 1.3667176723686225e-08
method O 0 1.437184327102159e-08
. O 0 1.1957409284946152e-08

As O 0 3.12024788229337e-08
has O 0 7.695364345750022e-09
been O 0 1.7868513335628222e-09
reported O 0 2.028285317479117e-09
by O 0 3.462963249489803e-11
others O 0 1.388848702710277e-09
, O 0 8.42716452176262e-11
mutations O 0 7.4196400134951546e-09
that O 0 2.4264999731737902e-11
lead O 0 5.896803184635147e-11
to O 0 1.2417910449924463e-11
exon O 0 3.6073931397595516e-08
skipping O 0 5.4914554681317895e-08
or O 0 3.852977314977579e-08
premature O 0 3.7539152231147455e-08
protein O 0 2.720415004375809e-10
truncation O 0 8.037338794508742e-09
were O 0 8.28693735854813e-09
also O 0 9.554589341931319e-10
predominant O 0 3.5187369462619245e-08
in O 0 5.208212749963081e-10
our O 0 4.6766261974084955e-09
mutants O 0 3.154530503479691e-08
. O 0 2.690420775053326e-09

Six O 0 1.9582255816885663e-08
different O 0 8.551978569748542e-10
mutations O 0 3.5698985811905004e-07
were O 0 3.0932256755988874e-09
identified O 0 6.852709333315943e-08
on O 0 6.482074876856814e-09
12 O 0 1.813642118431158e-11
of O 0 2.0190956111915126e-12
the O 0 1.263403270890251e-10
16 O 0 4.788394680765862e-10
alleles O 0 1.8767384091233907e-08
examined O 0 2.4418518478341866e-06
. O 0 4.6308187506838294e-08

Four O 0 8.489768887898208e-09
were O 0 2.6407837028230574e-10
deletions O 0 3.650528768162076e-08
involving O 0 5.371331468495555e-08
a O 0 7.612056407424461e-08
loss O 0 2.71265719220537e-07
of O 0 7.368968282794874e-12
a O 0 1.618564948735468e-09
single O 0 1.6476205288995516e-08
exon O 0 1.1369870378530322e-07
exon O 0 6.582661171705695e-07
7 O 0 1.7999659540635093e-09
, O 0 1.1138862401893768e-11
exon O 0 2.304793689233975e-08
16 O 0 1.954197637044075e-10
, O 0 3.1574797030448076e-12
exon O 0 1.1046883408027952e-08
33 O 0 2.615918315296284e-10
or O 0 9.564763425728984e-10
exon O 0 5.108120149088791e-07
35 O 0 1.2041817321062354e-08
. O 0 8.690949293566064e-09

The O 0 1.1156526369404673e-08
others O 0 1.650230063710012e-09
were O 0 3.151771552079019e-11
minute O 0 1.3747007698849956e-10
deletions O 0 3.042931240315738e-08
, O 0 1.7657490053446523e-11
4649delA O 0 1.2481990996349168e-09
in O 0 1.4146146060101117e-11
exon O 0 1.3978374013845496e-08
33 O 0 1.552720868547297e-10
and O 0 2.3468168380835763e-11
7883del5 O 0 1.4471246423397588e-09
in O 0 8.880746832362618e-11
exon O 0 2.6651463258531294e-07
55 O 0 6.877060698684545e-09
. O 0 1.0409523021337463e-08

The O 0 1.0545113227067304e-08
mutations O 0 3.3500415952403273e-07
4612del165 O 0 2.996297965296435e-08
and O 0 1.512384245616616e-10
7883del5 O 0 1.1026843438344258e-08
were O 0 2.344473781779044e-10
found O 0 2.3972529517024554e-10
in O 0 3.6083167703759855e-11
more O 0 2.546414468174163e-12
than O 0 1.0155831037250707e-11
two O 0 2.2946653258082428e-12
unrelated O 0 8.543109553116324e-10
families O 0 1.07557877535025e-11
; O 0 9.507780847350933e-13
44 O 0 8.95561619654317e-13
% O 0 6.73217015988159e-13
( O 0 3.222961177454242e-13
7 O 0 3.63978682263455e-12
of O 0 2.590686779685436e-12
16 O 0 2.68263952718506e-11
) O 0 1.3219313881387973e-13
of O 0 1.1839617827802407e-13
the O 0 1.3182062212624412e-11
mutant O 0 4.038569034747752e-09
alleles O 0 2.0943389245076105e-09
had O 0 1.068175503604607e-08
one O 0 2.2612937564114866e-11
of O 0 1.3178410186026612e-12
the O 0 2.2640689670283543e-11
two O 0 3.6916264489761375e-10
mutations O 0 3.6371434930515534e-07
. O 0 1.0940405914539042e-08

The O 0 5.169784600411731e-09
4612del165 O 0 3.34223642539655e-07
mutations O 0 6.18799106177903e-07
in O 0 1.3013914945680938e-10
three O 0 1.1968480026491868e-11
different O 0 2.8869642787476835e-11
families O 0 5.190914018071702e-11
were O 0 1.7227223814142434e-10
all O 0 2.465133782866835e-12
ascribed O 0 6.778190786427274e-10
to O 0 9.735818921885464e-12
the O 0 1.0752956684789705e-11
same O 0 1.7553914988255315e-09
T O 0 1.822510284910095e-06
- O 0 5.988541573742623e-08
- O 0 9.721882321400699e-08
> O 0 2.69458455548488e-10
A O 0 2.05249723467249e-11
substitution O 0 2.674337661046078e-11
at O 0 1.0040001816036259e-11
the O 0 3.751087981895829e-12
splice O 0 3.532385939308824e-09
donor O 0 1.7349636172170335e-09
site O 0 6.874909974641241e-09
in O 0 7.95980392709339e-10
intron O 0 9.58302553044632e-06
33 O 0 3.356475275495541e-08
. O 0 1.0258504268279012e-08

Microsatellite O 0 0.00017044578271452338
genotyping O 0 1.930201324285008e-05
around O 0 2.3773752744205012e-08
the O 0 1.8363276177435495e-10
ATM O 0 1.7958573153009638e-06
locus O 0 9.49004061112646e-06
also O 0 1.9575496779111745e-08
indicated O 0 1.271745020403614e-07
that O 0 1.1774214936366434e-10
a O 0 4.953699117571375e-10
common O 0 3.8498164656175504e-09
haplotype O 0 1.2304475376367918e-06
was O 0 1.4417585347814565e-08
shared O 0 1.27114790915428e-10
by O 0 7.699963062990367e-12
the O 0 1.5445795684132513e-11
mutant O 0 3.777385515491005e-09
alleles O 0 7.743063412668505e-10
in O 0 2.2419992251609955e-10
both O 0 1.6846276595927634e-09
mutations O 0 2.909134309447836e-06
. O 0 1.3866261028283589e-08

This O 0 3.833608097636443e-09
suggests O 0 7.70496910718066e-09
that O 0 7.035681759415269e-11
these O 0 3.0029399106235033e-12
two O 0 8.943039885023207e-12
founder O 0 2.6240265071919566e-08
mutations O 0 1.418374381501053e-06
may O 0 6.973859001391247e-08
be O 0 4.164167066722513e-10
predominant O 0 7.68263497263888e-09
among O 0 5.2879780415571176e-11
Japanese O 0 1.802141369466881e-08
ATM O 0 7.314071126529598e-07
mutant O 0 1.7535626284370665e-07
alleles O 0 2.8342023483673984e-07
. O 0 3.127791359247567e-08

W474C O 0 5.8433051890460774e-06
amino O 0 7.163218640471314e-08
acid O 0 7.229539189523848e-09
substitution O 0 9.97507521027785e-10
affects O 0 6.700590082786562e-10
early O 0 9.145117822739746e-12
processing O 0 1.484116128602775e-11
of O 0 5.520489664359585e-13
the O 0 1.2389845009327938e-12
alpha O 0 1.9415831789548754e-11
- O 0 2.7443991523767863e-10
subunit O 0 2.0572082232162003e-11
of O 0 1.819361284891019e-12
beta O 0 2.1069627986758377e-10
- O 0 4.98106587087932e-08
hexosaminidase O 0 3.64265588359558e-07
A O 0 2.3661112180661803e-08
and O 0 9.190661565128266e-10
is O 0 4.2499115338046067e-10
associated O 0 3.0145828056049595e-09
with O 0 7.578717209355545e-09
subacute O 0 0.18853268027305603
G B-Disease 0 0.04692539572715759
( I-Disease 0 6.257453444291627e-10
M2 I-Disease 0 2.9353835998335853e-05
) I-Disease 0 1.4761168953825177e-09
gangliosidosis I-Disease 0 9.949648301699199e-06
. O 0 3.237225953967027e-08

Mutations O 0 0.0016096101608127356
in O 0 6.551532205634203e-09
the O 0 8.444497323623068e-10
HEXA O 0 7.299077697098255e-05
gene O 0 1.823353201757527e-08
, O 0 6.883769162330244e-12
encoding O 0 2.6155079838052764e-11
the O 0 4.409513119224551e-12
alpha O 0 1.725451032053016e-11
- O 0 1.7478966884976188e-10
subunit O 0 1.5151437396387912e-11
of O 0 3.982766373644697e-12
beta O 0 2.7760713172675366e-10
- O 0 2.0807928535759856e-07
hexosaminidase O 0 1.951229705809965e-06
A O 0 4.6864595759643635e-08
( O 0 2.108992321059322e-11
Hex O 0 1.4420437066675618e-09
A O 0 3.951017291115022e-09
) O 0 3.315568089176657e-12
, O 0 9.160895783275058e-13
that O 0 1.3466665282901857e-11
abolish O 0 2.0641672815457923e-09
Hex O 0 3.3031131163596683e-09
A O 0 1.2223768663943702e-09
enzyme O 0 1.1934896626542013e-08
activity O 0 6.272719019762008e-07
cause O 0 0.04788661003112793
Tay B-Disease 1 1.0
- I-Disease 1 0.9999997615814209
Sachs I-Disease 1 1.0
disease I-Disease 1 0.8699597716331482
( O 0 8.645824611797082e-10
TSD B-Disease 0 3.2802224723127438e-06
) O 0 3.873381823615851e-11
, O 0 1.0289783781980422e-11
the O 0 1.2539205784811713e-10
fatal O 0 0.003354103537276387
infantile B-Disease 0 0.011039829812943935
form I-Disease 0 5.561510008078585e-08
of I-Disease 0 3.6191902808013765e-09
G I-Disease 0 0.010067088529467583
( I-Disease 0 9.61770038609977e-11
M2 I-Disease 0 6.324054083961528e-06
) I-Disease 0 9.266663131279884e-11
gangliosidosis I-Disease 0 5.788307362308842e-07
, I-Disease 0 1.6017895343445332e-10
Type I-Disease 0 8.969823284132872e-07
1 I-Disease 0 5.787156975856078e-09
. O 0 6.607136615599529e-09

Less O 0 3.448722509347135e-06
severe O 0 0.0003499298181850463
, O 0 2.6465750480042516e-08
subacute O 0 0.017299875617027283
( O 0 2.935520804214775e-08
juvenile O 0 0.002253463491797447
- O 1 0.7586569786071777
onset O 0 0.002404885133728385
) O 0 5.958846749365421e-09
and O 0 3.124137037957553e-07
chronic O 0 0.028671666979789734
( O 0 2.221139938640704e-09
adult O 0 2.0373881852719933e-06
- O 0 0.038956135511398315
onset O 0 2.431391658319626e-05
) O 0 7.291336284742655e-11
variants O 0 3.6998051289316436e-09
are O 0 3.978556373240849e-10
characterized O 0 4.316650592528504e-09
by O 0 8.098201796646887e-12
a O 0 4.3512177194671153e-10
broad O 0 2.0730526184564724e-09
spectrum O 0 3.052202757203304e-08
of O 0 3.8517661282710947e-11
clinical O 0 1.4228485056833051e-08
manifestations O 0 1.841675612013205e-07
and O 0 9.839850045878507e-10
are O 0 4.124310615249982e-11
associated O 0 6.60822951914497e-10
with O 0 6.390614148976681e-10
residual O 0 0.0027150500100106
levels O 0 2.067011450890277e-07
of O 0 2.9328078160473225e-11
Hex O 0 1.6304328553928826e-08
A O 0 2.2450041825550215e-09
enzyme O 0 3.3792519893438566e-09
activity O 0 1.402494920199615e-08
. O 0 2.5024873284706928e-09

We O 0 1.6017459358863562e-07
identified O 0 2.2183424874810953e-08
a O 0 2.686754374536804e-09
1422 O 0 5.569726909016026e-06
G O 0 0.00011941328557441011
- O 0 4.7991754399845377e-05
- O 0 0.003041274147108197
> O 0 4.629309387382818e-06
C O 0 2.851515432666929e-07
( O 0 3.620966157122374e-12
amino O 0 1.309952667172265e-11
acid O 0 5.469179796546708e-12
W474C O 0 4.884583189312952e-12
) O 0 2.1007147234307182e-14
substitution O 0 6.172580892596646e-13
in O 0 1.8635936977623446e-12
the O 0 1.9541657788474387e-12
first O 0 4.9246991901119586e-11
position O 0 1.876601540828915e-09
of O 0 3.0901427250373814e-12
exon O 0 9.522918453797047e-09
13 O 0 3.339102258581583e-11
of O 0 7.2276672494209215e-12
HEXA O 0 4.053522843605606e-06
of O 0 2.917420471870713e-11
a O 0 4.809430631524947e-09
non O 0 1.4332752762413747e-08
- O 0 1.029922373163572e-06
Jewish O 0 2.5143298998386854e-08
proband O 0 1.0272903637087438e-05
who O 0 9.498067221613837e-09
manifested O 0 1.3562629241903323e-08
a O 0 1.4240043588742424e-09
subacute O 0 4.2301795474486426e-05
variant O 0 1.900603274407331e-05
of O 0 1.2137072680218353e-08
G B-Disease 0 0.013346311636269093
( I-Disease 0 1.1053096216073754e-09
M2 I-Disease 0 5.223253901931457e-05
) I-Disease 0 1.9574701859426114e-09
gangliosidosis I-Disease 0 5.692903414455941e-06
. O 0 8.234564141673673e-09

On O 0 3.2197249311138876e-08
the O 0 3.366306955410181e-10
second O 0 7.31210825222206e-09
maternally O 0 5.626802158076316e-05
inherited O 0 0.00014110261690802872
allele O 0 2.5472731977060903e-06
, O 0 2.3246145286481834e-10
we O 0 3.3731714643714383e-10
identified O 0 5.645552358934935e-10
the O 0 9.994820249215053e-11
common O 0 1.7022503584485094e-07
infantile O 1 0.9722142815589905
disease O 0 0.08837263286113739
- O 0 9.379159018862993e-05
causing O 0 2.3435695766238496e-06
4 O 0 3.3705618296409057e-09
- O 0 1.4731581359228585e-06
bp O 0 3.1696541213932505e-07
insertion O 0 1.9147752272630214e-09
, O 0 6.128080681788717e-11
+ O 0 3.6493832955564187e-10
TATC O 0 4.3883201783501136e-07
1278 O 0 1.535373996830458e-07
, O 0 3.782255411644009e-11
in O 0 3.7043205308728844e-11
exon O 0 3.6645724321715534e-07
11 O 0 9.808356793428175e-09
. O 0 5.825519622248976e-09

Pulse O 0 0.0003075799613725394
- O 0 4.3721996689782827e-07
chase O 0 1.2612569655345851e-08
analysis O 0 2.3129559378887166e-10
using O 0 2.4074572890775414e-10
proband O 0 1.247808540938422e-07
fibroblasts O 0 6.049084344539324e-09
revealed O 0 6.786179085338517e-08
that O 0 3.287083452652162e-11
the O 0 4.298961794185763e-12
W474C O 0 1.9667965034386725e-09
- O 0 2.39822384173749e-09
containing O 0 2.28302016180848e-10
alpha O 0 2.3666492376950288e-11
- O 0 2.0625290364506554e-10
subunit O 0 4.1142689949369426e-11
precursor O 0 1.0030130198623866e-10
was O 0 1.1013595591080616e-09
normally O 0 1.7511934957692432e-10
synthesized O 0 1.0078480272568413e-09
, O 0 4.429381340875782e-12
but O 0 7.225172283381598e-12
not O 0 6.732725921915206e-12
phosphorylated O 0 8.729333228485459e-11
or O 0 2.0290028338032506e-11
secreted O 0 4.810951081957171e-10
, O 0 1.1978871020112969e-11
and O 0 2.0181724347256846e-11
the O 0 5.858194485064416e-11
mature O 0 2.846342939122337e-09
lysosomal O 0 2.352449435250037e-08
alpha O 0 1.1188736048772796e-10
- O 0 6.177987899036452e-09
subunit O 0 7.134441926126556e-10
was O 0 5.609279440932369e-08
not O 0 1.202068222738717e-08
detected O 0 1.9440080905042123e-06
. O 0 4.465251723928532e-09

When O 0 3.241736123982264e-08
the O 0 1.332385313190798e-10
W474C O 0 2.1193345745018632e-08
- O 0 1.2739792332183697e-08
containing O 0 7.222203390888637e-10
alpha O 0 1.3285585132027933e-10
- O 0 3.1817755097307554e-09
subunit O 0 7.086702891179186e-10
was O 0 1.1731835947159652e-08
transiently O 0 1.1900066709813473e-07
co O 0 2.144842881079967e-07
- O 0 1.7949500374925265e-07
expressed O 0 1.8656369504821413e-10
with O 0 6.535796209794498e-12
the O 0 1.2407919310064575e-11
beta O 0 4.304929676623992e-11
- O 0 5.204459085916824e-10
subunit O 0 5.6712461116159574e-11
to O 0 1.1822299215979992e-11
produce O 0 1.9677937057593908e-10
Hex O 0 6.396507767902904e-09
A O 0 4.0401020307001545e-09
( O 0 1.6141423267446164e-11
alphabeta O 0 1.7753560399569324e-08
) O 0 2.1277062143415515e-12
in O 0 4.0632275322138867e-11
COS O 0 3.0992418942332733e-06
- O 0 7.85329689279024e-07
7 O 0 5.422992610526478e-10
cells O 0 6.201241742331831e-10
, O 0 3.593706061899571e-12
the O 0 6.0433550524985336e-12
mature O 0 1.5821259580217628e-10
alpha O 0 4.878587117618238e-12
- O 0 2.00912481096438e-10
subunit O 0 8.552740460299191e-11
was O 0 2.0659316479765266e-09
present O 0 2.1750051412694482e-11
, O 0 1.6851137455906051e-12
but O 0 4.8191845479494955e-12
its O 0 1.5846461512772358e-12
level O 0 2.5371668654905477e-10
was O 0 5.917571432867419e-10
much O 0 1.6586737539014962e-10
lower O 0 9.324716554459656e-10
than O 0 6.130044388763523e-11
that O 0 3.48330010668807e-11
from O 0 4.339643228101764e-12
normal O 0 3.4063953047169804e-11
alpha O 0 3.189013072710245e-12
- O 0 1.0509241393785729e-10
subunit O 0 2.7921867942759526e-11
transfections O 0 5.603586927804827e-09
, O 0 1.3739234359586017e-12
although O 0 1.1203871164155998e-11
higher O 0 7.575559624051209e-11
than O 0 6.142740396203328e-12
in O 0 2.0710861844963624e-11
those O 0 1.1881078065822948e-10
cells O 0 2.816165356467337e-10
transfected O 0 4.086384564061518e-09
with O 0 1.666530975719116e-11
an O 0 6.36069278844853e-12
alpha O 0 1.104105903926289e-10
- O 0 2.2018390666289633e-08
subunit O 0 9.07347474932152e-10
associated O 0 8.30310664667877e-09
with O 0 1.2857405806698807e-08
infantile O 1 0.7195188999176025
TSD B-Disease 0 0.002800868358463049
. O 0 6.081954495584796e-08

Furthermore O 0 2.4595744889666094e-06
, O 0 1.223596224342316e-10
the O 0 6.6411260171705955e-12
precursor O 0 1.2883659417095572e-10
level O 0 1.7895414317070646e-10
of O 0 3.079514724821375e-13
the O 0 4.772769852945391e-12
W474C O 0 7.643022326142557e-10
alpha O 0 2.149407388185587e-11
- O 0 7.960957448815975e-10
subunit O 0 7.448558436706776e-11
was O 0 1.8653532052326227e-09
found O 0 1.310788144692765e-10
to O 0 7.139652064003243e-11
accumulate O 0 1.077851852215872e-08
in O 0 1.2705533673773584e-11
comparison O 0 3.9502315307693436e-10
to O 0 3.037423784713056e-11
the O 0 5.4053411052690237e-11
normal O 0 4.69797367674829e-10
alpha O 0 2.2187073359103415e-11
- O 0 9.049450633291656e-10
subunit O 0 3.5466288239582866e-10
precursor O 0 3.701767559149971e-09
levels O 0 3.702164619312498e-08
. O 0 2.2467046001395374e-09

We O 0 1.2620299116861133e-07
conclude O 0 5.3044186820727646e-09
that O 0 6.927977636017602e-11
the O 0 3.949965701743885e-11
1422 O 0 4.765102801229659e-07
G O 0 8.76087142387405e-06
- O 0 2.5685199034342077e-06
- O 0 6.039324580342509e-05
> O 0 1.0067391258417047e-06
C O 0 5.110463803248422e-07
mutation O 0 7.537492052733796e-08
is O 0 3.47554901525271e-11
the O 0 1.5271757816681664e-11
cause O 0 3.777255397352519e-09
of O 0 4.894807476008012e-11
Hex B-Disease 0 2.8755055154761067e-06
A I-Disease 0 0.00022408175573218614
enzyme I-Disease 1 0.9999988079071045
deficiency I-Disease 1 0.9999991655349731
in O 0 1.7401003971073692e-09
the O 0 1.1299404745201969e-09
proband O 0 0.00011253749107709154
. O 0 6.043251232767943e-08

The O 0 5.230674560152693e-09
resulting O 0 4.849371126880442e-09
W474C O 0 1.6118866241754404e-08
substitution O 0 3.144478677441498e-09
clearly O 0 5.26468557637827e-09
interferes O 0 6.044321043674472e-09
with O 0 6.6691027700294114e-12
alpha O 0 4.8148322134844435e-11
- O 0 4.916817508693327e-10
subunit O 0 3.378333723880189e-11
processing O 0 1.2438065855047142e-10
, O 0 3.478770440115686e-12
but O 0 1.4904421447026195e-11
because O 0 6.821476543350524e-12
the O 0 5.214824882679436e-13
base O 0 1.699286891754248e-11
substitution O 0 4.336319150977097e-11
falls O 0 4.212836746120274e-09
at O 0 4.0578214399733525e-11
the O 0 3.064563143181931e-12
first O 0 2.977515803359587e-11
position O 0 8.741350976393392e-10
of O 0 1.993905908437288e-12
exon O 0 1.222368251063699e-08
13 O 0 8.534050549569017e-11
, O 0 5.367715386755956e-12
aberrant O 0 4.410747767025214e-09
splicing O 0 1.8917031496812342e-08
may O 0 3.097584411193566e-08
also O 0 4.223871599706719e-11
contribute O 0 3.477976240340297e-11
to O 0 1.0925672172534817e-10
Hex B-Disease 0 1.222841319759027e-06
A I-Disease 0 2.7543988835532218e-05
deficiency I-Disease 0 0.007780374493449926
in O 0 7.754158426465096e-11
this O 0 1.395033949469493e-10
proband O 0 2.0155748643446714e-06
. O 0 7.587059314140276e-10
. O 0 4.423174271295238e-09

Two O 0 3.5530174358200384e-08
frequent O 0 6.1147370615799446e-06
missense O 1 0.5377597808837891
mutations O 1 0.9341004490852356
in O 0 0.0005147026386111975
Pendred B-Disease 1 0.9999995231628418
syndrome I-Disease 1 1.0
. O 0 1.702150075288955e-05

Pendred B-Disease 1 0.999998927116394
syndrome I-Disease 1 1.0
is O 0 0.00012325345596764237
an O 0 0.017804274335503578
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 1 0.99875807762146
by O 0 9.603651278666803e-07
early O 0 0.0004065934626851231
childhood O 1 0.9999444484710693
deafness B-Disease 1 1.0
and O 0 0.49135151505470276
goiter B-Disease 1 0.9999997615814209
. O 0 1.573378176544793e-05

A O 0 6.513109696015817e-08
century O 0 2.2033965763057495e-09
after O 0 2.288321337973187e-10
its O 0 1.5382554605092302e-11
recognition O 0 2.903078333282849e-10
as O 0 4.450879387274398e-10
a O 0 6.483610945906548e-07
syndrome O 0 0.15079306066036224
by O 0 2.210576999228664e-10
Vaughan O 0 3.963427630537808e-08
Pendred O 0 1.0716875067373621e-06
, O 0 8.748802377001041e-11
the O 0 7.759710651811247e-10
disease O 0 4.823681933885382e-07
gene O 0 5.970829164425595e-08
( O 0 3.0605826206731024e-10
PDS O 0 2.05990681934054e-06
) O 0 5.744722406109126e-11
was O 0 9.866071515318708e-09
mapped O 0 7.763604116917122e-06
to O 0 6.0735469986639146e-09
chromosome O 0 3.3928452467080206e-05
7q22 O 0 1.3212663816375425e-06
- O 0 1.4944209397071972e-05
q31 O 0 1.8514647308620624e-06
. O 0 9.929370214933897e-09

1 O 0 4.322427926695127e-08
and O 0 3.2571174646278678e-09
, O 0 1.0651429738217644e-10
recently O 0 2.1306590269887238e-08
, O 0 5.220224252866501e-11
found O 0 9.621407143223237e-11
to O 0 3.9304614250779135e-12
encode O 0 1.6030586857951334e-09
a O 0 1.4396013270356889e-08
putative O 0 5.118750414112583e-05
sulfate O 0 0.0026287096552550793
transporter O 0 5.404045441537164e-05
. O 0 5.068450548151304e-08

We O 0 3.2268201266560936e-07
performed O 0 5.76224223891586e-09
mutation O 0 1.6091771470883032e-08
analysis O 0 1.6019788273702318e-10
of O 0 1.2239428220928161e-12
the O 0 1.6479323114437783e-11
PDS B-Disease 0 2.5114931645475735e-07
gene O 0 2.8780606786682483e-09
in O 0 4.2724082605083424e-10
patients O 0 3.2473024269563666e-10
from O 0 3.8514282041379744e-11
14 O 0 4.04358248273784e-11
Pendred B-Disease 0 2.2199381888299285e-08
families O 0 1.3743906186747257e-11
originating O 0 3.7625833004817366e-11
from O 0 8.696357869930615e-12
seven O 0 7.497215522012102e-12
countries O 0 1.6917025506130168e-12
and O 0 8.492902214829456e-11
identified O 0 1.4066340092711016e-08
all O 0 1.3591280878522127e-10
mutations O 0 2.3262541049007268e-07
. O 0 4.433918565638351e-09

The O 0 2.3034049334569318e-08
mutations O 0 4.772606985170569e-07
include O 0 2.9870281248456365e-10
three O 0 9.305629877776056e-11
single O 0 4.8113761863533e-09
base O 0 1.3640866214359448e-09
deletions O 0 3.146718441371377e-08
, O 0 2.5953916099608065e-11
one O 0 1.2133257940027953e-11
splice O 0 3.0699634834263634e-08
site O 0 6.217224068905125e-08
mutation O 0 2.283191406604601e-06
and O 0 1.6395568236404756e-09
10 O 0 8.795218997548204e-10
missense O 0 0.00010659961117198691
mutations O 0 9.288161527365446e-05
. O 0 1.348069673667851e-07

One O 0 3.4129894288525975e-07
missense O 0 0.0005591278895735741
mutation O 0 0.00015275653277058154
( O 0 4.0021966296599487e-10
L236P O 0 3.013434479726129e-08
) O 0 5.241615128048771e-11
was O 0 2.1092758650809174e-09
found O 0 2.5545895954159903e-10
in O 0 3.044151736242284e-11
a O 0 4.731777192290565e-10
homozygous O 0 7.221837563520239e-07
state O 0 8.648496363505842e-10
in O 0 2.07536987595347e-10
two O 0 8.119610539480959e-11
consanguineous O 0 3.7114239148650086e-06
families O 0 3.050185937159e-10
and O 0 1.612419919805319e-10
in O 0 2.9884168056826255e-11
a O 0 2.232321549833216e-10
heterozygous O 0 1.059559728844306e-08
state O 0 1.2851900099697389e-10
in O 0 3.9844173099767843e-11
five O 0 5.35473922147478e-12
additional O 0 5.7928717378530337e-11
non O 0 6.767549631803149e-09
- O 0 9.56294115894707e-06
consanguineous O 0 0.00016556732589378953
families O 0 6.155418930120504e-08
. O 0 1.1121639609257272e-08

Another O 0 2.810068338021665e-07
missense O 0 0.002045202301815152
mutation O 0 0.00013523781672120094
( O 0 5.650421242009429e-10
T416P O 0 5.896778532132885e-08
) O 0 4.42994113614148e-11
was O 0 1.7405120678049002e-09
found O 0 9.935295919305531e-10
in O 0 1.968543383856769e-11
a O 0 2.5477966958398213e-10
homozygous O 0 5.318158287082042e-07
state O 0 2.2432919966064446e-09
in O 0 7.360983489412831e-10
one O 0 7.408690883003999e-10
family O 0 3.044386742701022e-09
and O 0 8.339766655041103e-10
in O 0 1.3612469658419446e-11
a O 0 5.453061335813914e-10
heterozygous O 0 2.2187148118746336e-08
state O 0 1.3155074807258416e-09
in O 0 5.692066817886143e-10
four O 0 3.253278757497924e-10
families O 0 1.3295985423766865e-09
. O 0 4.855738922060482e-09

Pendred B-Disease 0 0.0017662065802142024
patients O 0 1.9709900698217098e-06
in O 0 9.622549423937699e-10
three O 0 4.6542084075618106e-10
non O 0 4.866262059977089e-09
- O 0 6.080973435018677e-06
consanguineous O 0 0.00025729381013661623
families O 0 1.447550346256321e-08
were O 0 3.0608993117908767e-09
shown O 0 7.3576607029224306e-09
to O 0 2.8217773603844698e-11
be O 0 2.405758925405621e-10
compound O 0 2.22988849607475e-09
heterozygotes O 0 2.110613017691776e-08
for O 0 2.4557680541881233e-11
L236P O 0 1.1004194888641905e-08
and O 0 1.6650203438217659e-09
T416P O 0 3.0796877581451554e-07
. O 0 7.267489721130005e-09

In O 0 3.589217589805571e-09
total O 0 1.5347481618910308e-10
, O 0 2.1978667150146514e-11
one O 0 6.567452137673513e-11
or O 0 1.0584860071771729e-10
both O 0 1.1474684050161166e-11
of O 0 5.637615808212759e-12
these O 0 2.93691820862918e-10
mutations O 0 3.271869530863114e-08
were O 0 1.0888231427585993e-09
found O 0 2.4754467364829225e-09
in O 0 4.705351386302681e-11
nine O 0 6.673607413215654e-12
of O 0 1.4484754541632672e-12
the O 0 8.14051395736648e-11
14 O 0 1.8344932517511126e-10
families O 0 4.048879009843631e-10
analyzed O 0 1.3487112937582424e-07
. O 0 1.8245778221626097e-08

The O 0 2.309950453138754e-09
identification O 0 8.895538528008728e-09
of O 0 1.663488617686948e-11
two O 0 3.459517394777123e-11
frequent O 0 4.849151764574344e-07
PDS B-Disease 0 0.00020260660676285625
mutations O 0 3.1747622415423393e-06
will O 0 2.2621189643690087e-10
facilitate O 0 1.6815386583157732e-10
the O 0 4.279503695858722e-10
molecular O 0 7.760652806609869e-05
diagnosis O 0 0.0175943486392498
of O 0 7.41328722142498e-06
Pendred B-Disease 1 0.9999998807907104
syndrome I-Disease 1 1.0
. O 0 5.190573119762121e-06

Insertional O 0 0.00017903342086356133
mutation O 0 6.804707481933292e-06
by O 0 4.44780740016526e-10
transposable O 0 2.7066512302553747e-06
element O 0 2.712820048600406e-07
, O 0 5.152210880154939e-10
L1 O 0 3.6848036870651413e-06
, O 0 4.1290408592242756e-11
in O 0 5.394876559372541e-11
the O 0 2.0512469500744146e-09
DMD B-Disease 1 0.9999960660934448
gene O 0 2.452680405440333e-07
results O 0 7.254613620943928e-08
in O 0 3.3419869538420244e-08
X B-Disease 1 0.9996910095214844
- I-Disease 1 0.999852180480957
linked I-Disease 1 0.9999765157699585
dilated I-Disease 1 0.9999229907989502
cardiomyopathy I-Disease 1 0.9999996423721313
. O 0 7.151953923312249e-06

X B-Disease 1 0.9988378882408142
- I-Disease 1 0.9994858503341675
linked I-Disease 1 0.9998916387557983
dilated I-Disease 1 0.9999732971191406
cardiomyopathy I-Disease 1 1.0
( O 0 8.822983943446161e-08
XLDCM B-Disease 0 0.0008206476341001689
) O 0 9.338274598036378e-11
is O 0 5.01711970579688e-11
a O 0 5.228337762730462e-10
clinical O 0 6.595971058231953e-08
phenotype O 0 5.749849947278562e-07
of O 0 6.786234074684927e-11
dystrophinopathy B-Disease 0 0.00025451407418586314
which O 0 2.8724244316435943e-08
is O 0 2.0301187120264075e-10
characterized O 0 7.11536218833686e-10
by O 0 1.3068862658727198e-10
preferential O 0 1.5406720876853797e-07
myocardial B-Disease 0 0.043000586330890656
involvement I-Disease 0 3.84942978826075e-07
without O 0 1.971273144718566e-09
any O 0 2.0305292169897626e-10
overt O 0 1.0440820688017993e-06
clinical O 0 1.1613735750870546e-06
signs O 0 1.1440387424954679e-05
of O 0 4.6483313553835615e-07
skeletal B-Disease 1 0.9999996423721313
myopathy I-Disease 1 1.0
. O 0 0.00034007831709459424

To O 0 2.7599016405588372e-09
date O 0 9.154451419135512e-09
, O 0 6.487829370960263e-12
several O 0 6.853140884638398e-12
mutations O 0 4.305437073526264e-08
in O 0 5.431262661836911e-10
the O 0 5.3291856261239445e-08
Duchenne B-Disease 1 0.9999457597732544
muscular I-Disease 1 0.9993535876274109
dystrophy I-Disease 1 0.9983148574829102
gene O 0 0.0002154773974325508
, O 0 6.363204363424302e-08
DMD O 1 0.999998927116394
, O 0 1.9373690207658e-08
have O 0 8.95693297309208e-09
been O 0 1.0026200314428024e-08
identified O 0 2.3581146990636626e-07
in O 0 8.660712147445793e-10
patients O 0 2.383138686390396e-10
with O 0 1.3318465774680988e-10
XLDCM B-Disease 0 0.0001567913277540356
, O 0 1.0153667490131468e-10
but O 0 3.181177543609692e-11
a O 0 3.3528870652110854e-11
pathogenic O 0 1.1804960342587378e-09
correlation O 0 4.0515207855307267e-10
of O 0 6.284259137373516e-13
these O 0 2.9191458278399196e-11
cardiospecific O 0 1.2075188351445831e-06
mutations O 0 6.374757504090667e-07
in O 0 5.750461440356958e-09
DMD O 1 0.9999966621398926
with O 0 1.6969597949056947e-09
the O 0 3.0775717529962776e-09
XLDCM B-Disease 0 0.018298616632819176
phenotype O 0 6.138866592664272e-05
has O 0 1.4296547945491511e-08
remained O 0 9.342986828642097e-09
to O 0 8.560770842214183e-11
be O 0 1.2096398549488185e-08
elucidated O 0 1.1583633749978617e-05
. O 0 1.1846695180395272e-08

We O 0 3.4146887628594413e-07
report O 0 1.7497189253035117e-09
here O 0 3.744284743367743e-11
the O 0 2.3216697661587737e-12
identification O 0 2.4938520692963095e-10
of O 0 2.0793380038630627e-12
a O 0 3.050412977767536e-10
unique O 0 2.8857232159396062e-09
de O 0 3.013595417655779e-08
novo O 0 1.9514990512448094e-08
L1 O 0 8.434926712652668e-08
insertion O 0 9.057463112860376e-10
in O 0 2.0621464605352635e-11
the O 0 1.820813465280846e-11
muscle O 0 9.83662840070565e-09
exon O 0 2.4262521947093774e-07
1 O 0 9.300688219582298e-09
in O 0 7.199255946943595e-08
DMD O 1 0.9999991655349731
in O 0 1.754639100681743e-08
three O 0 1.8901658016545753e-09
XLDCM B-Disease 0 0.016161762177944183
patients O 0 1.5665371222439717e-08
from O 0 4.3772617475124065e-11
two O 0 9.997507682824036e-11
unrelated O 0 1.4169910400596564e-07
Japanese O 0 1.0711909226301941e-06
families O 0 6.241805294848746e-09
. O 0 3.75699382715311e-09

The O 0 2.2226358531440837e-09
insertion O 0 2.6558998555969993e-08
was O 0 1.3884627669824567e-08
a O 0 9.578583481939518e-10
5 O 0 1.6073962993967683e-10
- O 0 9.214027762993737e-09
truncated O 0 4.626099503468595e-10
form O 0 1.0323995824901289e-10
of O 0 5.286220679939779e-12
human O 0 3.3634572904617244e-10
L1 O 0 9.850637638919579e-08
inversely O 0 6.59914221046165e-08
integrated O 0 1.4827149286134045e-08
in O 0 3.8996550433267885e-10
the O 0 9.821281982125285e-11
5 O 0 5.23404541930006e-10
- O 0 8.299070941575337e-07
untranslated O 0 1.4840668427495984e-06
region O 0 1.5959350507799286e-09
in O 0 2.8314062899825743e-11
the O 0 1.1296872291788329e-11
muscle O 0 1.870879673404602e-09
exon O 0 2.2876255556525393e-08
1 O 0 2.738805404689515e-09
, O 0 4.2594365534665e-11
which O 0 9.181476412489786e-11
affected O 0 4.356937727267862e-11
the O 0 3.420671948820009e-12
transcription O 0 1.1467950200572119e-10
or O 0 2.175026964090776e-10
the O 0 1.659242361562452e-11
stability O 0 9.31700050443851e-10
of O 0 1.019946497052282e-12
the O 0 3.84225706806518e-11
muscle O 0 6.6911809426528635e-09
form O 0 8.975084564433189e-11
of O 0 6.139496029622382e-12
dystrophin O 0 3.0689680130535635e-08
transcripts O 0 1.650199443758993e-08
but O 0 3.790723290819642e-09
not O 0 1.4281217874945185e-10
that O 0 3.901302891851088e-12
of O 0 6.69343920567389e-13
the O 0 5.694749116713638e-10
brain O 0 1.3488838703779038e-05
or O 0 3.8977088223646206e-09
Purkinje O 0 1.8573148281575413e-06
cell O 0 1.0108943797604297e-06
form O 0 9.092831376733557e-09
, O 0 1.0325339472316841e-09
probably O 0 2.3022329287414323e-07
due O 0 1.4363450429044633e-09
to O 0 6.009358288761035e-11
its O 0 4.491710822729367e-11
unique O 0 7.662523393570098e-10
site O 0 2.4642443641198497e-09
of O 0 2.246458401244933e-11
integration O 0 5.838489691711857e-09
. O 0 1.2720998476822842e-08

We O 0 1.1832484148044387e-07
speculate O 0 2.5948311943579938e-08
that O 0 1.2492315341894322e-11
this O 0 9.977628532414906e-13
insertion O 0 3.481002291971791e-11
of O 0 2.633949698974125e-12
an O 0 3.2280584455479655e-11
L1 O 0 6.764210411347449e-06
sequence O 0 1.1873596150735466e-07
in O 0 1.5731251323813922e-07
DMD O 1 0.9999995231628418
is O 0 2.113352337573815e-08
responsible O 0 8.657921046761885e-10
for O 0 1.646316763470601e-12
some O 0 1.9696569408030745e-13
of O 0 5.823285647091336e-13
the O 0 3.0263323097523553e-11
population O 0 6.402560773222099e-13
of O 0 2.132077283820144e-12
Japanese O 0 2.7133867774864484e-07
patients O 0 3.176680307692692e-10
with O 0 2.2882777617194705e-10
XLDCM B-Disease 0 2.311924981768243e-05
. O 0 7.586856698438282e-10
. O 0 2.2913184682948895e-09

Severe O 0 0.0022796187549829483
early O 0 8.026518116821535e-06
- O 1 0.9996763467788696
onset O 1 0.9997543692588806
obesity B-Disease 1 0.9999998807907104
, O 0 0.000343157968018204
adrenal B-Disease 1 0.9999996423721313
insufficiency I-Disease 1 0.9999995231628418
and O 0 4.30506952397991e-06
red O 0 0.0011175153777003288
hair O 1 0.9923783540725708
pigmentation O 0 0.04415031895041466
caused O 0 4.4249867414691835e-07
by O 0 2.8241007310469968e-09
POMC O 0 0.0001615849178051576
mutations O 0 7.061395535856718e-06
in O 0 5.784464462976757e-09
humans O 0 8.296556330833482e-08
. O 0 8.728393119383782e-09

Sequential O 0 6.348439569592301e-07
cleavage O 0 8.747397259867284e-06
of O 0 1.4639531253912708e-10
the O 0 1.4113455196196334e-11
precursor O 0 2.0167652270419723e-10
protein O 0 2.3582241714947827e-10
pre O 0 2.5997510419983882e-06
- O 0 0.0003390736528672278
pro O 0 2.684387618501205e-05
- O 0 0.006615026388317347
opiomelanocortin O 0 7.931278378237039e-05
( O 0 3.9169648080594754e-10
POMC O 0 2.75656844905825e-07
) O 0 1.2606321368735518e-11
generates O 0 2.5373941836548397e-10
the O 0 1.3503453910601593e-10
melanocortin O 0 1.3413056194622186e-06
peptides O 0 3.5830569800054946e-07
adrenocorticotrophin O 0 7.30991951058968e-06
( O 0 1.2139474980799037e-09
ACTH O 0 1.2906371011922602e-06
) O 0 2.1502190652999964e-11
, O 0 2.2434267984983158e-11
melanocyte O 0 1.6252008208539337e-05
- O 0 3.799323530984111e-05
stimulating O 0 0.0002891886979341507
hormones O 0 1.5912293747533113e-05
( O 0 9.410330847892112e-11
MSH O 0 1.938770708420634e-07
) O 0 1.82383643777817e-12
alpha O 0 6.825406993066219e-12
, O 0 3.690860551214259e-13
beta O 0 2.725928423957802e-12
and O 0 7.972559244728838e-12
gamma O 0 4.203692394177949e-10
as O 0 5.924386415473437e-12
well O 0 4.85532404212452e-12
as O 0 8.701829404614281e-13
the O 0 1.967116140116909e-12
opioid O 0 4.3160638951711405e-10
- O 0 2.3529955761603105e-09
receptor O 0 4.536622744133467e-10
ligand O 0 2.7075440556245667e-08
beta O 0 9.134254241871531e-09
- O 0 2.458989001752343e-05
endorphin O 0 0.0006472442764788866
. O 0 2.0810205114685232e-08

While O 0 6.31397245598464e-09
a O 0 3.0072419554549867e-10
few O 0 1.0683537388089803e-10
cases O 0 1.3042392166262573e-10
of O 0 4.824201593756072e-10
isolated O 0 0.015028484165668488
ACTH B-Disease 1 0.9999768733978271
deficiency I-Disease 1 0.9984812140464783
have O 0 5.97382481259956e-08
been O 0 1.1970078617196123e-07
reported O 0 5.939377842878457e-07
( O 0 3.0941443851517647e-10
OMIM O 0 5.605814749287674e-06
201400 O 0 4.84532378663971e-08
) O 0 8.04456588149316e-12
, O 0 7.344301382328222e-12
an O 0 1.773205471344852e-10
inherited O 0 0.37275370955467224
POMC O 1 0.73131263256073
defect O 0 0.49840813875198364
has O 0 3.1135425615502754e-07
not O 0 2.305482915687662e-09
been O 0 2.2565740387392452e-09
described O 0 4.197503500336097e-08
so O 0 3.1146452084129805e-09
far O 0 1.8827572834112516e-09
. O 0 1.3410904609045815e-09

Recent O 0 4.87464888010436e-07
studies O 0 2.8842388033467614e-08
in O 0 2.485930350459853e-10
animal O 0 4.2941827871345595e-09
models O 0 1.1943755318100102e-08
elucidated O 0 1.9739914591809793e-07
a O 0 8.043622434783515e-10
central O 0 1.5970061384429357e-10
role O 0 1.5871916281273712e-10
of O 0 8.592387218397946e-12
alpha O 0 4.5562986716873866e-10
- O 0 2.428870402582106e-07
MSH O 0 6.461056614170957e-07
in O 0 1.921233831747582e-11
the O 0 2.1383287935466955e-12
regulation O 0 1.2380126090949517e-10
of O 0 1.1615275798473879e-12
food O 0 8.340653168126266e-11
intake O 0 1.5466378178174978e-10
by O 0 1.6033100411552703e-12
activation O 0 3.525799444070721e-11
of O 0 1.6025182483087042e-12
the O 0 3.610982901580684e-10
brain O 0 5.241900908004027e-06
melanocortin O 0 8.221759344451129e-07
- O 0 8.083878242359788e-07
4 O 0 1.5503955896889465e-09
- O 0 2.2021924905857304e-07
receptor O 0 9.345624718548606e-09
( O 0 1.0904811775791501e-10
MC4 O 0 9.241854058927856e-06
- O 0 1.429714302503271e-06
R O 0 1.283812162000686e-05
; O 0 4.733183636695948e-11
refs O 0 1.2930398085586603e-08
3 O 0 2.118753436586296e-11
- O 0 1.5780468487491817e-08
5 O 0 3.5578880119846445e-11
) O 0 4.746975382219354e-13
and O 0 3.114533587630919e-12
the O 0 2.40492153101568e-12
linkage O 0 1.2452962216968899e-08
of O 0 5.978193634570417e-11
human O 0 5.694721494364785e-07
obesity B-Disease 1 0.9999947547912598
to O 0 3.384967639519232e-09
chromosome O 0 4.33930654253345e-06
2 O 0 3.4045199992505104e-10
in O 0 6.561629711798744e-11
close O 0 1.5903378614012809e-09
proximity O 0 3.3473954719198673e-09
to O 0 3.6061237329576556e-10
the O 0 6.620467507545413e-10
POMC O 0 1.976840849238215e-06
locus O 0 4.507311146539905e-08
, O 0 1.167068872098831e-11
led O 0 1.0431550588607674e-11
to O 0 6.295612035162046e-12
the O 0 9.002889579667883e-12
proposal O 0 8.201971324339752e-10
of O 0 3.5295384236827543e-12
an O 0 1.231531265855068e-10
association O 0 4.691121102684548e-11
of O 0 8.366397852288543e-12
POMC O 0 2.8394472337822663e-06
with O 0 1.1442158331931296e-08
human O 0 1.9849714590236545e-05
obesity B-Disease 1 0.9999847412109375
. O 0 1.0331810784691697e-07

The O 0 3.7682177378428605e-09
dual O 0 4.087166161070854e-08
role O 0 8.108178572996394e-10
of O 0 3.3277974126333376e-11
alpha O 0 3.4059832731969664e-09
- O 0 2.358335677854484e-06
MSH O 0 6.041032065695617e-06
in O 0 1.52653861773544e-10
regulating O 0 1.0606839850879624e-08
food O 0 1.9224306591070217e-09
intake O 0 5.6153348637622e-09
and O 0 7.824804693079557e-11
influencing O 0 6.662516938149565e-08
hair O 0 0.012372557073831558
pigmentation O 0 2.5576948246452957e-05
predicts O 0 1.0935632843711574e-07
that O 0 5.092843508025524e-11
the O 0 5.2104754538762066e-11
phenotype O 0 1.345048303846852e-06
associated O 0 1.6388282952917166e-09
with O 0 2.4305404910940354e-10
a O 0 2.2550526068698673e-07
defect O 0 0.0001992129546124488
in O 0 3.7671394892413446e-09
POMC O 0 1.0818642294907477e-05
function O 0 1.2806343363536143e-07
would O 0 5.89105342285734e-09
include O 0 4.671769815445259e-08
obesity B-Disease 1 0.9999961853027344
, O 0 8.672315643387662e-10
alteration O 0 4.166308826825116e-07
in O 0 7.817043723434836e-08
pigmentation O 1 0.9181234240531921
and O 0 0.0017167706973850727
ACTH B-Disease 1 0.9997473359107971
deficiency I-Disease 1 0.8575607538223267
. O 0 1.0478751732989622e-07

The O 0 5.207897224579483e-09
observation O 0 2.9328905526426752e-08
of O 0 3.6428721150727483e-11
these O 0 5.869348340681313e-10
symptoms O 0 2.9517298827386185e-08
in O 0 1.4659251243442917e-11
two O 0 1.4107992551970483e-11
probands O 0 6.584406264664722e-08
prompted O 0 2.6699459310108864e-10
us O 0 2.1676292705219424e-11
to O 0 1.6394979991674052e-12
search O 0 3.105826706928383e-11
for O 0 4.005997616962631e-11
mutations O 0 2.0863419436523145e-08
within O 0 7.327431023052e-11
their O 0 2.1902899494108397e-09
POMC O 0 9.644967576605268e-06
genes O 0 5.211099818325238e-08
. O 0 5.094286770201961e-09

Patient O 0 0.0004795377899426967
1 O 0 2.105450391809427e-08
was O 0 2.8548097219527335e-08
found O 0 1.3346216354293006e-09
to O 0 5.824714321978064e-11
be O 0 1.86871393359489e-10
a O 0 9.339164858124249e-11
compound O 0 8.176714305641042e-10
heterozygote O 0 4.335703351898701e-09
for O 0 5.259308179933475e-12
two O 0 2.890694628110424e-11
mutations O 0 1.3504135587538713e-08
in O 0 4.3693038770387105e-11
exon O 0 9.172072168439627e-08
3 O 0 1.3266042708792725e-09
( O 0 1.2826767425977437e-11
G7013T O 0 9.584180560295863e-09
, O 0 5.2305198366964234e-11
C7133delta O 0 8.026664488625102e-08
) O 0 1.8798621513604896e-12
which O 0 7.53862684083062e-12
interfere O 0 1.7396682705506095e-10
with O 0 4.072916916925129e-12
appropriate O 0 1.0298565472632859e-10
synthesis O 0 2.501789053699355e-10
of O 0 3.944898574470557e-11
ACTH O 0 3.6836022445640992e-06
and O 0 1.6082222220603626e-09
alpha O 0 4.600355651973587e-09
- O 0 9.826345376495738e-06
MSH O 0 3.80175952159334e-05
. O 0 1.1659647469741685e-08

Patient O 0 6.56375996186398e-05
2 O 0 5.498768995693126e-09
was O 0 2.6270599029487585e-09
homozygous O 0 2.3944130234099248e-08
for O 0 3.7642916561608786e-11
a O 0 2.997085246647657e-09
mutation O 0 3.4854795671890315e-07
in O 0 2.2269545929543e-10
exon O 0 8.304502898681676e-07
2 O 0 1.8234644016956736e-08
( O 0 2.796878562083549e-10
C3804A O 0 6.871189839330327e-08
) O 0 8.192976852505751e-11
which O 0 1.323743115122511e-09
abolishes O 0 1.2104532288503833e-05
POMC O 0 9.92840577964671e-05
translation O 0 2.0210055140523764e-07
. O 0 1.2571740093392236e-08

These O 0 4.431027100793017e-09
findings O 0 5.4856532649694145e-09
represent O 0 1.4613921184292167e-10
the O 0 1.4242093615557394e-11
first O 0 2.2918058076304426e-11
examples O 0 4.534027597813406e-10
of O 0 2.590816623737613e-11
a O 0 1.8391674529993907e-06
genetic B-Disease 1 0.9999994039535522
defect I-Disease 1 0.9999994039535522
within O 0 5.671673797280619e-09
the O 0 9.18566722685199e-10
POMC O 0 2.870486014217022e-06
gene O 0 8.142230889518487e-09
and O 0 1.882271560837978e-10
define O 0 1.1322364379395822e-08
a O 0 5.954847726030721e-09
new O 0 5.6493387745604196e-08
monogenic B-Disease 1 0.8426110744476318
endocrine I-Disease 0 0.2431349754333496
disorder I-Disease 0 0.00126675795763731
resulting O 0 3.172711160459585e-08
in O 0 7.021233594528553e-10
early O 0 2.374348753164668e-07
- O 1 0.9999203681945801
onset O 1 0.9999274015426636
obesity B-Disease 1 1.0
, O 0 0.0004990668967366219
adrenal B-Disease 1 0.9999997615814209
insufficiency I-Disease 1 0.9999995231628418
and O 0 1.220753347297432e-06
red O 0 3.842069781967439e-05
hair O 0 0.2020118087530136
pigmentation O 0 0.00046134827425703406
. O 0 2.8779947314205856e-09
. O 0 5.583444373513657e-09

A O 0 4.102287221030565e-07
European O 0 6.029251409245262e-08
multicenter O 0 0.0003005819453392178
study O 0 4.406667812872911e-07
of O 0 5.638486868519976e-07
phenylalanine B-Disease 1 0.9999996423721313
hydroxylase I-Disease 1 0.9999986886978149
deficiency I-Disease 1 0.9999998807907104
: O 0 3.8977980842958004e-09
classification O 0 1.629413226567067e-08
of O 0 1.5581850046353374e-11
105 O 0 3.271048987230074e-10
mutations O 0 1.070317310336577e-07
and O 0 2.352366357261104e-10
a O 0 5.640558020658659e-10
general O 0 1.0378546633216246e-10
system O 0 4.5028042405803603e-10
for O 0 1.555150452858811e-11
genotype O 0 1.343475560133811e-06
- O 0 3.404082917768392e-07
based O 0 2.820865319108634e-09
prediction O 0 4.8329745538922e-08
of O 0 6.142977793111015e-11
metabolic O 0 0.00011748148244805634
phenotype O 0 2.6061978132929653e-05
. O 0 3.112200275268151e-08

Phenylketonuria B-Disease 1 0.9859622120857239
( O 0 1.671207030540245e-07
PKU B-Disease 0 0.0003327749145682901
) O 0 3.531335224238319e-09
and O 0 1.835331531196971e-08
mild B-Disease 0 0.03648689389228821
hyperphenylalaninemia I-Disease 1 0.9999998807907104
( O 0 1.691096076683607e-05
MHP B-Disease 1 0.9999977350234985
) O 0 1.2340054533765965e-09
are O 0 3.269441384290417e-09
allelic B-Disease 0 0.026854882016777992
disorders I-Disease 1 0.9976497292518616
caused O 0 4.867248208029196e-06
by O 0 2.6601876257359436e-09
mutations O 0 8.619225809525233e-06
in O 0 2.3060049703094165e-10
the O 0 1.7345126723800064e-10
gene O 0 1.1345672135121276e-07
encoding O 0 1.0288405292158131e-06
phenylalanine O 0 0.028573783114552498
hydroxylase O 0 0.3631487786769867
( O 0 1.4938311920786873e-08
PAH O 0 3.901220770785585e-05
) O 0 2.5586174845493304e-10
. O 0 2.229633366823691e-09

Previous O 0 3.5518155527825e-07
studies O 0 2.9389607192342737e-08
have O 0 3.471257725706778e-10
suggested O 0 1.2204851573827113e-09
that O 0 6.185610357256621e-11
the O 0 4.223468796915597e-11
highly O 0 3.156185712782644e-08
variable O 0 1.8623079085955396e-05
metabolic O 0 0.005572865251451731
phenotypes O 0 6.438409764086828e-05
of O 0 4.358282694738591e-07
PAH B-Disease 1 0.999715268611908
deficiency I-Disease 1 0.5269025564193726
correlate O 0 4.339254883234389e-05
with O 0 3.230126992548321e-07
PAH O 0 0.25085437297821045
genotypes O 0 6.561895861523226e-05
. O 0 4.971233025230504e-08

We O 0 2.6142558340325195e-07
identified O 0 1.6461630281128237e-08
both O 0 2.1453126775039522e-10
causative O 0 1.595542471477529e-06
mutations O 0 9.190404739456426e-07
in O 0 5.2218201984644e-10
686 O 0 1.3445671243061952e-07
patients O 0 2.5296603922697614e-08
from O 0 2.428385825758994e-10
seven O 0 3.160013084535507e-10
European O 0 4.688084587201047e-09
centers O 0 3.34790595246659e-09
. O 0 4.902642292137216e-09

On O 0 1.6116468160021213e-08
the O 0 3.7343995951122366e-11
basis O 0 4.963040048377998e-11
of O 0 2.3314102384763835e-12
the O 0 8.669098425229116e-12
phenotypic O 0 7.067541218930273e-08
characteristics O 0 6.854238421283299e-08
of O 0 1.2136868766943198e-11
297 O 0 1.8151077307848595e-09
functionally O 0 4.671983688808723e-08
hemizygous O 0 5.896828497498063e-06
patients O 0 2.0812416234861075e-09
, O 0 1.8004164782300935e-12
105 O 0 6.112408756225873e-13
of O 0 6.809513890260188e-13
the O 0 1.010378586352445e-10
mutations O 0 7.611939878415797e-08
were O 0 2.110346342121261e-09
assigned O 0 1.2268381865965239e-09
to O 0 1.536601575147234e-11
one O 0 1.2677162271323983e-11
of O 0 1.0830675549119984e-12
four O 0 1.720915424052727e-11
arbitrary O 0 3.281700600155091e-08
phenotype O 0 2.8322208436293295e-06
categories O 0 5.0227189518636806e-08
. O 0 3.6325098484724094e-09

We O 0 1.0118457538510484e-07
proposed O 0 1.994118203896278e-09
and O 0 6.992446621723047e-10
tested O 0 3.557221361916163e-08
a O 0 1.648867015147104e-10
simple O 0 2.0551238488764056e-09
model O 0 1.244934599853309e-09
for O 0 5.812832853946404e-13
correlation O 0 2.5134703207640996e-09
between O 0 4.3454287390609636e-10
genotype O 0 2.806318661896512e-06
and O 0 5.354999776940872e-10
phenotypic O 0 3.1996211191653856e-07
outcome O 0 4.533690400876367e-07
. O 0 2.950508459775847e-08

The O 0 1.2307129537703076e-08
observed O 0 1.9551154650798708e-07
phenotype O 0 4.0752064478510874e-07
matched O 0 3.551323501937986e-08
the O 0 2.2905037241893744e-11
predicted O 0 6.913082550852323e-09
phenotype O 0 9.582224791415683e-09
in O 0 1.4021505310990445e-11
79 O 0 1.9238886525552168e-11
% O 0 1.9931721204069497e-12
of O 0 6.428907428114583e-13
the O 0 9.175349369172636e-11
cases O 0 1.6885007836364707e-09
, O 0 6.060026092047366e-11
and O 0 1.2208641042565915e-10
in O 0 1.876420720192673e-11
only O 0 7.521793951581479e-12
5 O 0 8.792857934813991e-13
of O 0 7.008712729107691e-13
184 O 0 9.62862220510452e-11
patients O 0 4.5576287188708875e-10
was O 0 1.62312807638898e-09
the O 0 3.9402967000334854e-11
observed O 0 7.019137626684824e-08
phenotype O 0 1.0276717254953383e-08
more O 0 2.308149981908314e-12
than O 0 1.1090675253178084e-11
one O 0 2.22873386412914e-11
category O 0 8.281813568267182e-10
away O 0 2.7972255067787444e-10
from O 0 4.0172917076253256e-11
that O 0 7.419777570127906e-10
expected O 0 4.8517119211055615e-09
. O 0 3.6106748702025016e-09

Among O 0 1.056633358587078e-08
the O 0 9.102937847949022e-11
seven O 0 4.244125537122834e-11
contributing O 0 3.485388921919963e-10
centers O 0 7.277928260052136e-11
, O 0 2.4385760338113682e-12
the O 0 2.519826578298301e-12
proportion O 0 8.310929722199489e-10
of O 0 7.0857764100651366e-12
patients O 0 9.752216395542135e-11
for O 0 3.5438462060721765e-12
whom O 0 6.53949394635589e-10
the O 0 3.6724661506282175e-11
observed O 0 4.8029246357828015e-08
phenotype O 0 1.9344193447068392e-07
did O 0 4.397231911923427e-09
not O 0 2.701592075049497e-11
match O 0 4.816772536386793e-10
the O 0 1.525321362272347e-11
predicted O 0 8.250096605877388e-09
phenotype O 0 4.635924089058108e-09
was O 0 4.246978047017791e-10
4 O 0 3.512842360747781e-12
% O 0 4.139234528049984e-12
- O 0 1.6960619575456803e-07
23 O 0 3.9749839531033615e-10
% O 0 1.6472724226335167e-11
( O 0 1.2633689233654266e-11
P O 0 7.055431069602491e-06
< O 0 3.5906708717448055e-08
. O 0 3.4465950926598765e-11
0001 O 0 2.4434820833363347e-09
) O 0 6.683259631476424e-13
, O 0 2.262754193000857e-13
suggesting O 0 5.548895232188045e-10
that O 0 2.7527700605101124e-11
differences O 0 1.149631723151856e-09
in O 0 9.027031726283052e-12
methods O 0 5.588745091711367e-11
used O 0 3.797131012395205e-11
for O 0 9.341190147782452e-12
mutation O 0 4.711096934784109e-08
detection O 0 2.636991780491371e-07
or O 0 6.201519653359355e-08
phenotype O 0 1.923861236718949e-05
classification O 0 5.173348540665756e-07
may O 0 1.2658650128116733e-08
account O 0 1.3555064015680074e-10
for O 0 1.9714657423924864e-12
a O 0 6.28704727168028e-11
considerable O 0 1.6904150301755294e-09
proportion O 0 1.8681491908978387e-08
of O 0 1.0276183237678538e-09
genotype O 0 0.08001969009637833
- O 0 0.09142296761274338
phenotype O 0 0.00031982315704226494
inconsistencies O 0 4.1876783143379726e-06
. O 0 7.828607806459331e-08

Our O 0 1.1028109270228015e-07
data O 0 7.822722913886082e-09
indicate O 0 1.6616295894777977e-08
that O 0 1.4236316292493e-10
the O 0 1.8058256001651785e-09
PAH O 0 0.0006998665048740804
- O 0 3.3041451388271526e-05
mutation O 0 7.168663614720572e-06
genotype O 0 5.044002136855852e-06
is O 0 6.861305273941909e-11
the O 0 1.8483294322163557e-12
main O 0 9.934703060210381e-11
determinant O 0 1.4331003050926938e-08
of O 0 2.054323378075651e-10
metabolic O 0 0.0017423672834411263
phenotype O 0 2.264652903249953e-05
in O 0 1.8579392468964784e-09
most O 0 6.567972388182852e-09
patients O 0 5.08460175296932e-07
with O 0 6.520104216178879e-05
PAH B-Disease 1 0.9999234676361084
deficiency I-Disease 1 0.8469485640525818
. O 0 3.464243292228275e-08

In O 0 5.9389453355152e-09
the O 0 1.5920123552781718e-10
present O 0 2.1870577571192484e-10
study O 0 1.5136712716579126e-10
, O 0 4.073740476895349e-12
the O 0 3.2565595185773955e-12
classification O 0 9.24696375026457e-10
of O 0 1.6021003967914282e-11
105 O 0 8.444367982640699e-10
PAH O 0 4.5407323341351e-06
mutations O 0 1.1335148997204669e-07
may O 0 7.307280336377175e-10
allow O 0 1.336543549446123e-11
the O 0 4.6647997964388566e-11
prediction O 0 4.8616697334580294e-09
of O 0 2.34712341793189e-13
the O 0 6.828688656201898e-12
biochemical O 0 1.586119537932973e-07
phenotype O 0 2.716570612903979e-08
in O 0 3.4595305786755404e-11
> O 0 1.2529124404636605e-09
10 O 0 1.265003813505361e-11
, O 0 8.466114961858118e-12
000 O 0 1.387733261637436e-10
genotypes O 0 1.1480243955475089e-07
, O 0 5.126899460528023e-10
which O 0 3.633592626783866e-08
may O 0 7.248956279681806e-08
be O 0 1.1493110629867687e-10
useful O 0 1.0372669390079636e-10
for O 0 3.253858770965734e-12
the O 0 6.67689584177289e-11
management O 0 1.329653609438708e-10
of O 0 1.582082902185089e-11
hyperphenylalaninemia B-Disease 1 0.9999977350234985
in O 0 4.926294536744535e-07
newborns O 0 4.193004861008376e-05
. O 0 1.3310581969960822e-08

Somatic O 0 1.99766054720385e-05
instability O 0 8.975232958619017e-06
of O 0 1.7561574416902204e-10
the O 0 7.103483357084883e-10
CTG O 0 3.052871534237056e-06
repeat O 0 8.493674386045313e-07
in O 0 9.483942520205346e-10
mice O 0 9.384210386542691e-08
transgenic O 0 5.2914135295623055e-09
for O 0 1.5527712449170394e-10
the O 0 7.899253517962279e-08
myotonic B-Disease 1 0.9999998807907104
dystrophy I-Disease 1 0.9999998807907104
region O 0 1.5636076568625867e-05
is O 0 7.665044421401035e-08
age O 0 3.5348795002221323e-09
dependent O 0 1.1458664017638398e-09
but O 0 1.7373934235731525e-10
not O 0 5.2242279946490555e-11
correlated O 0 8.655988703587525e-10
to O 0 3.071796506395885e-12
the O 0 1.345598372309853e-11
relative O 0 5.151289617089105e-09
intertissue O 0 1.0949386819447682e-07
transcription O 0 1.7477249869557454e-08
levels O 0 6.395619323029678e-08
and O 0 2.3412396465971597e-09
proliferative O 0 0.00018612013082019985
capacities O 0 9.685825261840364e-07
. O 0 2.0913541121103663e-08

A O 0 3.910619398084236e-06
( O 0 4.6097716754900375e-09
CTG O 0 5.638363518301048e-07
) O 0 7.308057631272291e-11
nexpansion O 0 5.872064079426309e-08
in O 0 6.9754993448079e-11
the O 0 1.0776821796065761e-10
3 O 0 3.0762279390472713e-09
- O 0 0.00010925001697614789
untranslated O 0 4.3211515730945393e-05
region O 0 2.9707925008892744e-08
( O 0 9.905980202784548e-11
UTR O 0 9.807103573677978e-09
) O 0 6.112420140348684e-13
of O 0 1.3226659351106562e-12
the O 0 4.0534242629064465e-09
DM O 1 0.9999988079071045
protein O 0 1.9984547350304638e-07
kinase O 0 3.2207990443566814e-06
gene O 0 1.691732478548147e-07
( O 0 3.404494186565188e-10
DMPK O 0 8.219218216254376e-06
) O 0 4.8228008392436905e-11
is O 0 8.380328375690027e-11
responsible O 0 4.414560716980986e-09
for O 0 2.9950792956867645e-09
causing O 0 0.11127322167158127
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 0.004515842534601688
DM B-Disease 1 0.9999996423721313
) O 0 1.1886048412179662e-07
. O 0 2.4558184819056805e-08

Major O 0 4.521354810549383e-07
instability O 0 2.178595241275616e-05
, O 0 8.326950934334221e-11
with O 0 9.685107750512234e-12
very O 0 5.0857283662164576e-11
large O 0 6.17509515743464e-11
expansions O 0 8.43514857962191e-09
between O 0 4.156580635239493e-10
generations O 0 6.094133198075724e-09
and O 0 2.0474317796725927e-09
high O 0 4.315292567724782e-09
levels O 0 3.6439998241100113e-10
of O 0 2.317506646656864e-12
somatic O 0 2.3936369331067908e-08
mosaicism O 0 2.444934580125846e-06
, O 0 4.568072031752024e-10
is O 0 2.9892052721969264e-10
observed O 0 1.2989724851308893e-08
in O 0 1.014871520155225e-09
patients O 0 1.1929639498475808e-08
. O 0 8.925127303882618e-09

There O 0 8.85604691802655e-08
is O 0 1.0437128244999982e-10
a O 0 4.4573341545506295e-11
good O 0 5.53600887354122e-10
correlation O 0 7.806849389169201e-09
between O 0 3.2734207011664296e-10
repeat O 0 2.760604047580273e-07
size O 0 1.7132140328612877e-06
( O 0 1.3951291510938546e-11
at O 0 7.72361827272583e-11
least O 0 6.424265199672652e-12
in O 0 2.1776327269185103e-11
leucocytes O 0 2.901903144447715e-07
) O 0 3.2032044117863423e-12
, O 0 4.07959560230764e-12
clinical O 0 3.5751563931540886e-09
severity O 0 6.738006777595729e-05
and O 0 4.0083886432285e-08
age O 0 4.062340241972606e-09
of O 0 2.447272939853917e-10
onset O 0 8.742590580368415e-07
. O 0 3.271938098237115e-08

The O 0 3.532765191494036e-08
trinucleotide O 0 6.427539483411238e-05
repeat O 0 7.70489168644417e-06
instability O 0 3.177592873271351e-07
mechanisms O 0 2.2963336121506472e-08
involved O 0 1.433247920346048e-08
in O 0 4.5786489266674835e-08
DM B-Disease 1 0.9999994039535522
and O 0 7.537578028404823e-08
other O 0 1.5435177580513937e-09
human O 0 7.45399302104488e-06
genetic B-Disease 1 0.9999996423721313
diseases I-Disease 1 0.9999995231628418
are O 0 2.2011091971307906e-07
unknown O 0 3.0135208817227976e-06
. O 0 2.0789139298926784e-08

We O 0 2.5452013119320327e-07
studied O 0 2.9704301240940367e-08
somatic O 0 1.1038127212259496e-07
instability O 0 6.974250936764292e-07
by O 0 4.2697606561503676e-10
measuring O 0 7.537740748375654e-05
the O 0 7.393303746994206e-10
CTG O 0 1.7264763982893783e-06
repeat O 0 2.7539542202248413e-07
length O 0 1.4929424807519354e-08
at O 0 1.173204866589117e-10
several O 0 1.277305778507598e-11
ages O 0 1.6855599138665411e-09
in O 0 1.738983956833806e-11
various O 0 9.402969722294152e-12
tissues O 0 1.546719019529519e-08
of O 0 8.726233277633888e-12
transgenic O 0 1.8990823491549236e-07
mice O 0 2.4790990664769197e-06
carrying O 0 8.104301230105193e-09
a O 0 6.345458825052219e-09
( O 0 1.352747913685448e-10
CTG O 0 2.9647923227571482e-08
) O 0 2.184020759382621e-12
55expansion O 0 1.169229046915632e-09
surrounded O 0 2.8642699323455645e-10
by O 0 6.990305903564753e-12
45 O 0 1.711193361488006e-12
kb O 0 5.957025983605035e-10
of O 0 1.1805601635161977e-11
the O 0 3.3414246924934332e-09
human O 0 4.5123533709556796e-06
DM B-Disease 1 0.9999998807907104
region O 0 1.410873267104762e-07
, O 0 2.449162921080994e-11
using O 0 1.260163917660151e-10
small O 0 4.605518189038094e-09
- O 0 5.002594116376713e-05
pool O 0 2.4468333776894724e-06
PCR O 0 7.487121365556959e-06
. O 0 1.9818752861056055e-08

These O 0 2.4053440128568582e-08
mice O 0 4.378807261673501e-06
have O 0 1.6319877671477911e-09
been O 0 2.4848495483453803e-10
shown O 0 1.0296076213833771e-09
to O 0 1.577768332650109e-10
reproduce O 0 3.1535986977360153e-07
the O 0 2.6679946446561686e-11
intergenerational O 0 2.7862752105534128e-08
and O 0 2.2892032713883737e-10
somatic O 0 7.525938983121705e-09
instability O 0 1.326523957345671e-08
of O 0 4.36052713034818e-12
the O 0 5.22869386676561e-11
55 O 0 7.205056690162692e-11
CTG O 0 5.774590050577899e-08
repeat O 0 7.107257005145584e-08
suggesting O 0 3.739836529348395e-08
that O 0 1.6333850938465844e-10
surrounding O 0 1.0007834561065465e-09
sequences O 0 1.1434937441379134e-08
and O 0 3.9438399768165766e-10
the O 0 2.776610191768114e-11
chromatin O 0 8.936472006837448e-09
environment O 0 6.243486438961554e-08
are O 0 5.437375549810497e-11
involved O 0 4.1742659329102594e-10
in O 0 4.382109397571554e-10
instability O 0 1.222755798835351e-07
mechanisms O 0 1.4728644259776047e-07
. O 0 2.24060787701319e-08

As O 0 5.942004221992647e-09
observed O 0 2.7637591770712788e-08
in O 0 1.2246954318728687e-11
some O 0 5.122209622600293e-13
of O 0 1.3133594689226924e-12
the O 0 1.8343881968974074e-10
tissues O 0 4.6811533138679806e-07
of O 0 1.3154931366443634e-08
DM B-Disease 1 1.0
patients O 0 1.7142600654551643e-06
, O 0 4.696817934579656e-10
there O 0 2.2367072083362416e-10
is O 0 9.732235850545834e-12
a O 0 2.855355535347215e-11
tendency O 0 8.769791004503702e-10
for O 0 1.155724908136202e-11
repeat O 0 5.3651366016538304e-08
length O 0 6.513331207713691e-09
and O 0 4.570876316334349e-11
somatic O 0 1.4512264723265389e-09
mosaicism O 0 8.525960737415517e-08
to O 0 1.501290342043049e-10
increase O 0 7.023216452850534e-10
with O 0 9.797035405156862e-11
the O 0 1.2045876518484988e-09
age O 0 2.1745387712712727e-09
of O 0 2.631328531801924e-12
the O 0 2.993912617821337e-10
mouse O 0 1.0407796935396618e-06
. O 0 1.1699479607329977e-08

Furthermore O 0 6.289986686169868e-06
, O 0 9.547994617165045e-10
we O 0 1.3980179236483536e-09
observed O 0 3.3398188659106154e-09
no O 0 4.1339265344220166e-11
correlation O 0 1.1104465125200136e-09
between O 0 2.131985039899309e-11
the O 0 3.4475682725298995e-11
somatic O 0 1.4028672978838586e-07
mutation O 0 1.6380143279093318e-05
rate O 0 2.7337657684256556e-06
and O 0 2.639636731416317e-09
tissue O 0 2.2012356566847302e-05
proliferation O 0 2.8497884159151e-06
capacity O 0 1.4519303981330722e-08
. O 0 1.0720775378558756e-09

The O 0 9.898415420650508e-09
somatic O 0 1.3203266462369356e-06
mutation O 0 0.00014712661504745483
rates O 0 3.1537056202068925e-06
in O 0 1.0620757051604812e-10
different O 0 1.5636042460798194e-10
tissues O 0 6.295875891737523e-07
were O 0 9.575428450148138e-09
also O 0 5.707830874612796e-10
not O 0 8.297272591217819e-11
correlated O 0 3.882320687154106e-09
to O 0 5.674456998033817e-12
the O 0 8.696226030946441e-12
relative O 0 1.0522569482418476e-08
inter O 0 6.5611862609671334e-09
- O 0 1.8770375618260005e-06
tissue O 0 3.212063120372477e-06
difference O 0 1.9953860785904e-08
in O 0 7.987825678679172e-12
transcriptional O 0 1.5378491813322626e-09
levels O 0 1.3159818790242639e-09
of O 0 9.303029267077045e-13
the O 0 1.1048931734813916e-11
three O 0 3.244824200998586e-11
genes O 0 7.190891770925134e-10
( O 0 9.253270892572996e-12
DMAHP O 0 4.2123409116356925e-07
, O 0 1.9155696126538224e-11
DMPK O 0 4.7017431370477425e-07
and O 0 1.7299005283799573e-10
59 O 0 1.5916473000698872e-11
) O 0 6.219070939651739e-13
surrounding O 0 1.757025219761843e-10
the O 0 7.912334676341004e-10
repeat O 0 3.042310027012718e-06
. O 0 9.7039232205276e-10
. O 0 1.6342178721373557e-09

A O 0 2.030200789704395e-07
novel O 0 3.7534857000309785e-08
missense O 0 0.0003227258857805282
mutation O 0 0.00013822941400576383
in O 0 2.3581906205549785e-08
patients O 0 9.649315124704572e-09
from O 0 8.049388933173418e-11
a O 0 9.366146080935778e-09
retinoblastoma B-Disease 0 6.653767195530236e-05
pedigree O 0 0.0009288639994338155
showing O 0 7.828360139683355e-06
only O 0 2.040601465580494e-09
mild O 0 1.2494757584136096e-07
expression O 0 6.3627045854275366e-09
of O 0 2.777870988790454e-11
the O 0 1.980899444475881e-09
tumor B-Disease 0 3.0711300496477634e-05
phenotype O 0 1.987441282835789e-05
. O 0 1.2827228168532656e-08

We O 0 9.782313554751454e-07
have O 0 3.097652134798068e-10
used O 0 2.431848333817044e-10
single O 0 7.422693570902084e-10
strand O 0 1.9928302563698708e-08
conformation O 0 2.152590639070695e-07
polymorphism O 0 2.730191397404269e-07
analysis O 0 9.230646247360141e-10
to O 0 9.095888105215e-12
study O 0 3.661052017100985e-11
the O 0 2.1232883506971945e-11
27 O 0 5.365384178612764e-11
exons O 0 1.852096809251691e-10
of O 0 5.073082579021282e-12
the O 0 1.4791542990444384e-10
RB1 O 0 3.234550547404069e-07
gene O 0 3.669324011301711e-10
in O 0 2.3446199842735993e-11
individuals O 0 1.8600010420755098e-11
from O 0 5.449416525665773e-12
a O 0 4.355022564794808e-09
family O 0 3.5322127445169826e-08
showing O 0 3.337829184602015e-05
mild O 0 3.7071151837153593e-06
expression O 0 2.6254483032062126e-08
of O 0 6.040661720829732e-11
the O 0 2.7328825868977447e-09
retinoblastoma B-Disease 0 3.8207897887332365e-05
phenotype O 0 4.085843829670921e-05
. O 0 3.727047470647449e-08

In O 0 8.885398194991012e-09
this O 0 1.5353483762137188e-10
family O 0 2.1287283047399796e-09
affected O 0 1.0547480666645015e-09
individuals O 0 1.5132266273365502e-10
developed O 0 5.677987147123531e-08
unilateral B-Disease 0 0.12274286150932312
tumors I-Disease 1 1.0
and O 0 5.051720108895097e-07
, O 0 6.346251302247197e-11
as O 0 6.451844700855469e-12
a O 0 1.199781107796838e-10
result O 0 1.082499201388032e-09
of O 0 2.244136083559556e-12
linkage O 0 1.8646893806817388e-07
analysis O 0 6.851974543309325e-09
, O 0 6.602154239976343e-11
unaffected O 0 7.406917035268634e-08
mutation O 0 2.08163442039222e-07
carriers O 0 1.1049813508634543e-08
were O 0 5.863711738385291e-09
also O 0 1.140032734880947e-09
identified O 0 6.1754077407272234e-09
within O 0 1.6990405610206594e-11
the O 0 3.050243946312037e-10
pedigree O 0 6.239311915123835e-06
. O 0 7.091844000939318e-09

A O 0 7.539820785495976e-07
single O 0 4.376467188649258e-08
band O 0 2.9223576891723724e-09
shift O 0 2.068699656021522e-09
using O 0 5.111628342824304e-10
SSCP O 0 1.1184904906258453e-05
was O 0 6.527894669261514e-09
identified O 0 4.595514635497011e-09
in O 0 2.1414972226074802e-11
exon O 0 2.3470889232157788e-08
21 O 0 1.1911642505690878e-10
which O 0 1.5190385407870544e-11
resulted O 0 1.6044680861693195e-10
in O 0 2.8145423491832133e-11
a O 0 8.244680493874057e-10
missense O 0 4.722315679828171e-06
mutation O 0 1.0123398652694959e-07
converting O 0 7.819258573960042e-10
a O 0 3.0302746978350115e-09
cys O 0 0.00011687630467349663
- O 0 9.269905604014639e-06
- O 0 4.140386408835184e-06
> O 0 1.8413238933590037e-08
arg O 0 3.711630114366926e-09
at O 0 5.642814687734088e-11
nucleotide O 0 3.6597291863671444e-09
position O 0 8.64401528133385e-09
28 O 0 3.7361235633026624e-11
in O 0 6.325944542501238e-12
the O 0 6.293670445911559e-11
exon O 0 1.488016437178885e-06
. O 0 6.119994822029184e-08

The O 0 3.4095076983930994e-08
mutation O 0 3.076140728808241e-06
destroyed O 0 2.464126396262145e-07
an O 0 1.9484920621426483e-10
NdeI O 0 9.54273787101556e-07
restriction O 0 4.007975817899023e-08
enzyme O 0 2.0652393573072914e-08
site O 0 6.778920891292728e-08
. O 0 4.628025962460924e-09

Analysis O 0 1.1690817558474009e-07
of O 0 1.5876791548130598e-10
all O 0 1.7797067639047093e-11
family O 0 2.187733744163367e-10
members O 0 2.503700805706055e-12
demonstrated O 0 9.009907264712069e-10
that O 0 1.448520383501295e-11
the O 0 1.8438164189893413e-11
missense O 0 9.960345778381452e-06
mutation O 0 3.834312337858137e-06
co O 0 4.965609150531236e-07
- O 0 1.1878233863171772e-06
segregated O 0 4.985911239430152e-09
with O 0 6.084632353520192e-09
patients O 0 3.662692193984185e-08
with O 0 1.7012845319186454e-06
tumors B-Disease 1 1.0
or O 0 5.6089775171130896e-05
who O 0 2.5360455424561223e-07
, O 0 5.6008006392438414e-12
as O 0 1.3543575982932765e-12
a O 0 2.2590478099271394e-11
result O 0 5.168776517905371e-10
of O 0 2.0249730711685565e-12
linkage O 0 4.213843851630372e-07
analysis O 0 7.53050812818401e-08
had O 0 4.5518646629716386e-08
been O 0 2.5956909954771845e-09
predicted O 0 1.6296393123838016e-09
to O 0 1.360084354168345e-11
carry O 0 1.1207366146237518e-09
the O 0 1.9312133836546508e-10
predisposing O 0 1.3625380290704925e-07
mutation O 0 1.965217052202206e-06
. O 0 2.1723177923149706e-08

These O 0 1.9574926124477088e-09
observations O 0 3.308878149255179e-08
point O 0 1.8422046110799783e-09
to O 0 1.3830685728632997e-11
another O 0 7.416746383714923e-11
region O 0 9.98245514027829e-11
of O 0 7.638963246681119e-12
the O 0 5.038007788726873e-10
RB1 O 0 4.558903015094984e-07
gene O 0 1.1920626707961901e-09
where O 0 9.242450138557956e-10
mutations O 0 9.344680584888465e-09
only O 0 1.7567058918643852e-11
modify O 0 4.650499152436538e-10
the O 0 8.166169997159134e-12
function O 0 9.597194566834943e-11
of O 0 3.471424536716228e-13
the O 0 5.4736467094973484e-12
gene O 0 4.794956653952909e-10
and O 0 7.261233975208725e-11
raise O 0 2.2559316914527727e-10
important O 0 9.267401082646565e-12
questions O 0 8.921255401084238e-11
for O 0 2.877386696964468e-12
genetic O 0 5.481930021034032e-09
counseling O 0 3.613478849473495e-09
in O 0 2.982138147533675e-10
families O 0 8.461712580620784e-11
with O 0 1.2066474208705102e-10
these O 0 6.976114685919299e-10
distinctive O 0 1.133750060944294e-06
phenotypes O 0 2.4742123514442937e-06
. O 0 9.788411192701574e-10
. O 0 3.0608877654714206e-09

Maternal B-Disease 0 0.009703068062663078
disomy I-Disease 0 0.02645917795598507
and O 0 0.0007328178617171943
Prader B-Disease 1 0.9999998807907104
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 0.9999995231628418
consistent O 0 6.759230745956302e-05
with O 0 1.0212133361164888e-09
gamete O 0 6.418649718398228e-07
complementation O 0 9.34310992306564e-06
in O 0 2.794292575103441e-10
a O 0 1.967902507615804e-10
case O 0 4.504318251719042e-09
of O 0 3.78032223580238e-11
familial O 0 2.9222255761851557e-05
translocation O 0 9.102016338147223e-05
( O 0 4.1360659341904693e-10
3 O 0 3.223789846185099e-10
; O 0 9.461984668002188e-11
15 O 0 2.912738800153747e-11
) O 0 2.0951029539723054e-12
( O 0 4.763282324994622e-13
p25 O 0 2.2317679648775623e-10
; O 0 1.1781240046027097e-11
q11 O 0 6.617361658634024e-10
. O 0 2.019812962716916e-11
2 O 0 4.136821440958727e-11
) O 0 5.554843390820352e-11
. O 0 7.464633355880324e-10

Maternal B-Disease 0 0.10297899693250656
uniparental I-Disease 1 0.850007951259613
disomy I-Disease 0 0.11864235997200012
( I-Disease 0 1.7344657976536837e-07
UPD I-Disease 1 0.9998548030853271
) I-Disease 0 8.258306538611038e-11
for I-Disease 0 4.5663535452877824e-11
chromosome I-Disease 0 2.354546722926898e-06
15 I-Disease 0 2.895391981727613e-10
is O 0 6.949457675986537e-11
responsible O 0 2.9478730567689126e-10
for O 0 2.5933268119754382e-12
an O 0 7.82987650410627e-12
estimated O 0 1.0056086519050211e-10
30 O 0 3.792525755247356e-12
% O 0 4.587125492817867e-13
of O 0 8.397119805048092e-13
cases O 0 1.8120221989548213e-09
of O 0 3.5467653560772305e-06
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 0.9999998807907104
( O 0 4.725311737274751e-05
PWS B-Disease 1 0.999994158744812
) O 0 2.5466139419449974e-08
. O 0 1.942727045900483e-08

We O 0 1.012156189972302e-06
report O 0 1.5700001299023825e-09
on O 0 2.3951495300988945e-11
an O 0 1.8177936369698222e-12
unusual O 0 5.520487955656961e-10
case O 0 9.26779930576771e-10
of O 0 1.1839990793349742e-11
maternal B-Disease 0 2.976814243993431e-07
disomy I-Disease 0 1.9599017377913697e-06
15 I-Disease 0 4.2813325107360356e-10
in O 0 1.9381294347198263e-09
PWS B-Disease 1 0.999997615814209
that O 0 6.613607439476255e-08
is O 0 4.98185936947948e-10
most O 0 9.015812402202172e-12
consistent O 0 1.7803060137211446e-09
with O 0 1.52016316201653e-11
adjacent O 0 3.3818698952359227e-09
- O 0 5.45172440524766e-07
1 O 0 2.1743053191247697e-10
segregation O 0 5.942431546834825e-10
of O 0 2.932828676097121e-12
a O 0 1.16931597737846e-09
paternal O 0 2.77388903668907e-06
t O 0 1.6649756844344665e-06
( O 0 4.512282474750107e-12
3 O 0 1.3474475875352443e-11
; O 0 3.126784942075744e-11
15 O 0 7.538742199941773e-12
) O 0 1.0965830023537682e-12
( O 0 2.976365898535449e-13
p25 O 0 5.219009599488622e-11
; O 0 3.5488177067138915e-12
q11 O 0 3.7663763774453685e-10
. O 0 5.3719142849295576e-12
2 O 0 1.4360908295873998e-12
) O 0 9.022718282149927e-14
with O 0 1.45703208612874e-12
simultaneous O 0 6.129573648649966e-08
maternal O 0 2.7933233468502294e-06
meiotic O 0 3.442909246587078e-06
nondisjunction O 0 1.1467946933407802e-05
for O 0 4.137249709490476e-10
chromosome O 0 6.997815944487229e-06
15 O 0 2.2924464548879087e-09
. O 0 8.217712732516702e-09

The O 0 6.753986525609434e-08
patient O 0 4.294268819649005e-06
( O 0 6.32614405304821e-10
J O 0 0.0008107225876301527
. O 0 1.6948379366610311e-09
B O 0 1.3738035420374217e-07
. O 0 1.698091320334605e-11
) O 0 5.293391593108598e-13
, O 0 3.0519385846652924e-13
a O 0 2.755243949659203e-11
17 O 0 3.6934840602631525e-11
- O 0 4.244544626885727e-08
year O 0 2.6383331075408023e-09
- O 0 5.875099304830655e-07
old O 0 1.2482817055570194e-06
white O 0 1.6719416180421831e-06
male O 0 2.446618339035922e-07
with O 0 1.5312350498675187e-08
PWS B-Disease 1 0.9999961853027344
, O 0 7.854265016149498e-10
was O 0 8.777258919678843e-09
found O 0 6.335755808883903e-10
to O 0 5.5501096773991065e-11
have O 0 1.8263350831659864e-09
47 O 0 5.616036455324824e-11
chromosomes O 0 1.820978479116775e-09
with O 0 6.086947612615745e-11
a O 0 7.92014542838615e-09
supernumerary O 0 4.871994860877749e-06
, O 0 1.1549857736881108e-09
paternal O 0 4.1654011511127464e-06
der O 0 0.01473408192396164
( O 0 5.889665144476197e-11
15 O 0 8.68001850951039e-12
) O 0 1.367105213756492e-13
consisting O 0 1.9371212533342286e-12
of O 0 4.348284753097342e-12
the O 0 5.638923217254899e-10
short O 0 1.1847026826217188e-07
arm O 0 2.0728842287098814e-07
and O 0 1.2578106611815798e-10
the O 0 2.1314523063198365e-11
proximal O 0 6.79696938732377e-08
long O 0 3.842951912247372e-07
arm O 0 5.198313601795235e-07
of O 0 1.4450166063717518e-10
chromosome O 0 1.9617058569565415e-05
15 O 0 7.263481482944201e-10
, O 0 5.615382811519076e-11
and O 0 2.0067361106157477e-09
distal O 0 9.923616016749293e-05
chromosome O 1 0.9405338168144226
arm O 0 0.01341346837580204
3p O 0 0.0010949511779472232
. O 0 1.2569083196467545e-07

The O 0 6.76524223308661e-08
t O 0 5.049411811341997e-06
( O 0 4.271542494715952e-11
3 O 0 2.023919920546291e-11
; O 0 7.913927325964298e-12
15 O 0 1.3838760866413669e-11
) O 0 5.641323996483094e-13
was O 0 5.580673700933403e-10
present O 0 8.133886619798858e-11
in O 0 2.4194384343201314e-11
the O 0 2.0132090439162198e-11
balanced O 0 1.0597294597403106e-08
state O 0 1.0555103319154213e-10
in O 0 9.913918297410618e-11
the O 0 2.90098056687782e-10
patients O 0 4.0272536416807725e-09
father O 0 6.139929098480934e-08
and O 0 1.0622017709849274e-09
a O 0 8.490870229138636e-09
sister O 0 5.579908247455023e-06
. O 0 1.6173560268839537e-08

Fluorescent O 0 5.5177524700411595e-06
in O 0 5.96912741457345e-10
situ O 0 1.1464375226921675e-08
hybridization O 0 2.3650179592493714e-09
analysis O 0 2.890190309301488e-09
demonstrated O 0 6.1711453724910825e-09
that O 0 2.9398886103315647e-10
the O 0 9.903453612736257e-10
PWS B-Disease 1 0.9999916553497314
critical O 0 2.9262411160857482e-08
region O 0 2.0125776600821155e-09
resided O 0 2.4218973493361773e-09
on O 0 1.1958377343912474e-10
the O 0 1.2479549511834609e-11
derivative O 0 2.7889599962804823e-08
chromosome O 0 2.8746120506184525e-07
3 O 0 2.7678395686514534e-10
and O 0 5.772095579281711e-10
that O 0 5.298371963391446e-09
there O 0 1.42272293945922e-09
was O 0 9.126138955650731e-09
no O 0 4.5934972492389647e-10
deletion O 0 2.8676825358786573e-09
of O 0 4.877789491763984e-11
the O 0 2.7122322165951118e-08
PWS B-Disease 1 0.9999978542327881
region O 0 2.8097193904841333e-08
on O 0 3.974705897746844e-09
the O 0 1.77312761695525e-10
normal O 0 9.232512532264536e-10
pair O 0 2.2377366626358253e-09
of O 0 1.165313939094359e-11
15s O 0 4.002107090173013e-09
present O 0 3.105971924100004e-09
in O 0 1.1120537379838424e-08
J O 0 0.0019399399170652032
. O 0 4.21335322187133e-08

B O 0 0.00040412115049548447
. O 0 3.104191250713484e-07

Methylation O 0 3.910115538019454e-06
analysis O 0 4.712489953817567e-08
at O 0 1.104247582262019e-09
exon O 0 2.832361012394813e-08
alpha O 0 2.49408022012787e-10
of O 0 3.886018676985126e-12
the O 0 3.9066663098941135e-11
small O 0 4.3452237363794666e-09
nuclear O 0 0.0003657011839095503
ribonucleoprotein O 0 0.0003005965845659375
- O 0 4.156255818088539e-05
associated O 0 7.934298196232703e-07
polypeptide O 0 1.4158405974740162e-05
N O 0 7.800222192599904e-06
( O 0 2.5752922364064013e-11
SNRPN O 0 3.4935396797664e-07
) O 0 2.030651037945863e-12
gene O 0 4.773220707576797e-10
showed O 0 2.0365121145005105e-08
a O 0 5.765009580827041e-10
pattern O 0 2.800338734232355e-07
characteristic O 0 4.71720191796976e-08
of O 0 4.65808468186335e-12
only O 0 8.034480025731483e-11
the O 0 1.6085219267658601e-10
maternal O 0 5.863071692147059e-06
chromosome O 0 4.139853444939945e-06
15 O 0 4.2171116598765934e-10
in O 0 1.6469535735197383e-09
J O 0 0.015283946879208088
. O 0 6.233872085203984e-08

B O 0 0.0003714582126121968
. O 0 4.0749071672507853e-07

Maternal B-Disease 0 0.003459704341366887
disomy I-Disease 0 0.0006650048308074474
was O 0 7.979207339303684e-08
confirmed O 0 1.6945211900321056e-09
by O 0 9.423724821322477e-12
polymerase O 0 3.662564473927432e-09
chain O 0 1.577764052740349e-08
reaction O 0 3.992506047989508e-10
analysis O 0 2.964233719593423e-11
of O 0 8.364126990838272e-13
microsatellite O 0 1.7515618822017132e-07
repeats O 0 1.1196031834970199e-07
at O 0 1.8457807504645984e-10
the O 0 2.6710854014733165e-11
gamma O 0 8.815549534801903e-08
- O 0 5.306339403432503e-07
aminobutyric O 0 7.129604568945069e-07
acid O 0 7.927566159082744e-09
receptor O 0 2.9868361117735276e-09
beta3 O 0 5.951853054853018e-08
subunit O 0 1.0611372225355353e-08
( O 0 1.9300495923690875e-10
GABRB3 O 0 1.5289565453713294e-06
) O 0 1.2773843094393555e-10
locus O 0 2.7298216309645795e-07
. O 0 2.0786599108646442e-08

A O 0 2.5845231448329287e-06
niece O 0 0.00030333700124174356
( O 0 2.5242752332843565e-09
B O 0 2.1026536956014752e-07
. O 0 5.473607678219139e-11
B O 0 1.7166421617531569e-09
. O 0 1.1507313114542117e-12
) O 0 7.680974047985858e-14
with O 0 1.2225057121131866e-12
45 O 0 4.589297691870442e-12
chromosomes O 0 6.313848333050487e-10
and O 0 2.365854907815379e-11
the O 0 7.711883215355542e-12
derivative O 0 3.9274250518417375e-09
3 O 0 2.6096279651111054e-11
but O 0 1.5139023368249127e-10
without O 0 1.0239883246887516e-10
the O 0 1.0677385364754599e-10
der O 0 7.502058724639937e-05
( O 0 8.493967681988401e-12
15 O 0 2.1271990245652628e-12
) O 0 2.6884096619890496e-13
demonstrated O 0 2.775425445022961e-10
a O 0 2.3514881153374745e-09
phenotype O 0 3.454845455053146e-06
consistent O 0 4.607823029800784e-07
with O 0 2.2388199627521033e-10
that O 0 4.237642237114869e-09
reported O 0 4.04322442193461e-09
for O 0 3.6893279230232334e-12
haploinsufficiency O 0 5.6604370968216244e-08
of O 0 2.2381272182792067e-11
distal O 0 1.0217267032430755e-07
3 O 0 3.29963896206209e-08
p O 0 9.634732850827277e-05
. O 0 2.909794716288161e-08

Uniparental B-Disease 1 0.9999146461486816
disomy I-Disease 1 0.9998764991760254
associated O 0 3.523080886225216e-05
with O 0 5.2258180005537724e-09
unbalanced O 0 2.802416474878555e-06
segregation O 0 9.149637492100737e-08
of O 0 6.946501707183472e-11
non O 0 3.410930649039301e-09
- O 0 7.023878652034909e-07
Robertsonian O 0 2.307130671397317e-06
translocations O 0 3.2983083656290546e-05
has O 0 5.7814780518583575e-08
been O 0 6.87923851216965e-09
reported O 0 2.1964577712196842e-08
previously O 0 8.258282946371764e-09
but O 0 9.008503276675128e-09
has O 0 2.8168007926154814e-09
not O 0 1.0719625187505244e-10
, O 0 9.04070763564635e-13
to O 0 3.022661764981449e-12
our O 0 6.669310242957138e-11
knowledge O 0 6.989176598581892e-11
, O 0 2.9856011326406806e-12
been O 0 7.828312997837372e-11
observed O 0 1.876100608200204e-09
in O 0 2.244299884823775e-11
a O 0 9.595314542920619e-10
case O 0 1.0326078125899585e-07
of O 0 1.0701780794875049e-08
PWS B-Disease 1 0.999971866607666
. O 0 1.2239154045801115e-07

Furthermore O 0 8.752436770009808e-06
, O 0 8.51598902507078e-10
our O 0 1.0936478389567128e-09
findings O 0 5.722568530153183e-10
are O 0 2.8813092536883467e-11
best O 0 1.8868438755870187e-10
interpreted O 0 6.814903086294066e-10
as O 0 3.5397205999654346e-11
true O 0 1.6741598107827826e-09
gamete O 0 5.1412609280987454e-08
complementation O 0 3.7680692344110867e-07
resulting O 0 6.257900508899183e-08
in O 0 4.4080501027110586e-08
maternal B-Disease 0 0.06452850252389908
UPD I-Disease 1 0.9999828338623047
15 I-Disease 0 3.5888024285668507e-07
and O 0 6.519736416521482e-06
PWS B-Disease 1 0.9998718500137329

Schwartz B-Disease 1 0.6639767289161682
- I-Disease 1 0.993399977684021
Jampel I-Disease 1 0.9990371465682983
syndrome I-Disease 1 0.9998792409896851
type I-Disease 0 1.635510488995351e-05
2 I-Disease 0 5.433918648378722e-09
and O 0 3.9676557150869485e-08
Stuve B-Disease 1 0.9890222549438477
- I-Disease 1 0.9999892711639404
Wiedemann I-Disease 1 0.9999959468841553
syndrome I-Disease 1 0.9999874830245972
: O 0 1.5765440342097037e-10
a O 0 6.325757695435641e-10
case O 0 1.421649553634552e-08
for O 0 4.9125217782552966e-11
" O 0 1.5480552395530367e-09
lumping O 0 3.679006397305784e-07
" O 0 5.6574336326775665e-09
. O 0 2.2507409269678647e-09

Recent O 0 3.593686130898277e-07
studies O 0 4.541449527550867e-08
demonstrated O 0 2.4323144387494722e-08
the O 0 5.905863992294869e-11
existence O 0 4.5019540872992536e-10
of O 0 1.4036963865565744e-12
a O 0 3.645626300841087e-10
genetically O 0 1.5847633205723355e-09
distinct O 0 9.607199480399231e-10
, O 0 6.721541379040019e-11
usually O 0 1.7546071540142094e-10
lethal O 0 2.3288748707273044e-10
form O 0 2.9850389521302034e-11
of O 0 5.48922452631162e-12
the O 0 1.7309972344392577e-09
Schwartz B-Disease 0 0.02161570079624653
- I-Disease 1 0.9990191459655762
Jampel I-Disease 1 0.9999072551727295
syndrome I-Disease 1 0.9999649524688721
( O 0 1.022418327778496e-08
SJS B-Disease 0 0.005069032311439514
) O 0 5.725873941653248e-11
of O 0 2.1683747852829782e-10
myotonia B-Disease 0 0.0656718984246254
and O 0 1.4113417137195938e-06
skeletal B-Disease 1 0.9458935856819153
dysplasia I-Disease 1 0.9986207485198975
, O 0 3.822183813895208e-08
which O 0 1.906154700748175e-08
we O 0 1.18062732923363e-08
called O 0 6.116890460816649e-08
SJS B-Disease 0 0.2703718841075897
type I-Disease 0 1.1804012501670513e-05
2 I-Disease 0 1.3081419503180314e-08
. O 0 1.3314060964830787e-08

This O 0 1.0069360314446385e-06
disorder O 0 0.0007858070894144475
is O 0 1.173782848695737e-09
reminiscent O 0 6.80053460655472e-07
of O 0 3.5087925620569393e-11
another O 0 2.066739668293849e-09
rare O 0 2.947600250990945e-06
condition O 0 3.1132065487327054e-05
, O 0 8.832332781816277e-11
the O 0 7.303462834507002e-10
Stuve B-Disease 1 0.7314613461494446
- I-Disease 1 0.999985933303833
Wiedemann I-Disease 1 0.999994158744812
syndrome I-Disease 1 0.9999939203262329
( O 0 1.0637107195066164e-08
SWS B-Disease 0 0.0018066319171339273
) O 0 9.742585904692902e-11
, O 0 6.674867689820951e-12
which O 0 2.65440672914119e-11
comprises O 0 2.358169041982716e-11
campomelia B-Disease 0 5.413979806689895e-07
at O 0 2.963107625930661e-08
birth O 0 9.998776704378542e-07
with O 0 2.1804540395464755e-08
skeletal B-Disease 1 0.8885570764541626
dysplasia I-Disease 1 0.9531733393669128
, O 0 2.9683910440780892e-08
contractures B-Disease 0 0.031490955501794815
, O 0 1.4157282013371741e-09
and O 0 1.53155566007257e-09
early B-Disease 0 1.8907364562892326e-08
death I-Disease 0 1.1818922303064028e-06
. O 0 1.9931418293595016e-08

To O 0 6.772379101960269e-09
test O 0 9.997627170577061e-10
for O 0 4.504474484384735e-12
possible O 0 3.441302243167854e-10
nosologic O 0 9.413939778823988e-07
identity O 0 6.707961119900574e-07
between O 0 3.029176687263657e-09
these O 0 2.6936570307611873e-08
disorders O 0 0.00016725547902751714
, O 0 5.2111912007823946e-11
we O 0 1.383053671588641e-10
reviewed O 0 3.150587082889622e-11
the O 0 1.2186689374651949e-12
literature O 0 6.108018171108176e-12
and O 0 1.3641990098331447e-12
obtained O 0 7.26280927759726e-12
a O 0 9.503615776285113e-12
follow O 0 1.2072132356266696e-11
- O 0 8.258724371046355e-09
up O 0 7.387859074503567e-11
of O 0 4.2852966184239727e-13
the O 0 1.8777657380397716e-12
only O 0 1.093062272639056e-12
two O 0 3.279554145613206e-12
surviving O 0 6.911858463354292e-08
patients O 0 7.472839014255328e-10
, O 0 2.863534930008793e-12
one O 0 4.895869300247657e-12
with O 0 2.4788096575356633e-10
SJS B-Disease 0 4.808026642422192e-05
type I-Disease 0 1.7599306545434956e-07
2 I-Disease 0 4.8376705419350685e-11
at O 0 1.241309277588698e-09
age O 0 1.1020866441668886e-09
10 O 0 6.881117637497214e-12
years O 0 5.0533265072427724e-11
and O 0 1.0342004162777751e-11
another O 0 3.4180647895398764e-11
with O 0 2.0049686355605445e-09
SWS B-Disease 0 0.0001798492157831788
at O 0 2.1367513980408148e-08
age O 0 6.1988090216402725e-09
7 O 0 1.9633322745349346e-10
years O 0 1.0743578249261532e-09
. O 0 1.873754484904566e-09

Patients O 0 4.2240728362230584e-05
reported O 0 3.0630857850155735e-07
as O 0 6.81881662245587e-10
having O 0 6.812115316279233e-08
either O 0 6.64803428662708e-06
neonatal O 1 0.9999698400497437
SJS B-Disease 1 0.9997584223747253
or O 0 7.817087066541717e-07
SWS B-Disease 0 0.00042791300802491605
presented O 0 4.411959242389685e-09
a O 0 3.3135863497513185e-10
combination O 0 2.0428212454959294e-09
of O 0 1.6100711042188465e-11
a O 0 3.991040387063549e-08
severe O 0 6.291517638601363e-05
, O 0 2.3011171634834682e-08
prenatal O 1 0.9718356132507324
- O 1 0.9998456239700317
onset O 1 0.9452449083328247
neuromuscular B-Disease 1 0.9999281167984009
disorder I-Disease 1 0.9998045563697815
( O 0 2.6817792431188536e-08
with O 0 1.363186925118498e-06
congenital B-Disease 1 0.9999915361404419
joint I-Disease 1 0.5412981510162354
contractures I-Disease 1 0.9999946355819702
, O 0 0.0008921448606997728
respiratory O 1 0.9802671670913696
and O 0 6.725640844251757e-08
feeding O 0 1.3302760635269806e-06
difficulties O 0 4.01666994775951e-07
, O 0 3.5023605543527125e-11
tendency O 0 1.2525873671620502e-09
to O 0 1.1633158325530246e-10
hyperthermia B-Disease 0 0.00011382785305613652
, O 0 5.992032425794491e-10
and O 0 2.8024804699100514e-10
frequent O 0 2.389787141510169e-07
death O 0 4.9757568376662675e-06
in O 0 4.318835067351756e-08
infancy O 0 3.938961071980884e-06
) O 0 6.255060271825874e-12
with O 0 2.557942919978462e-11
a O 0 4.297287858889831e-09
distinct O 0 1.1729335369636829e-07
campomelic B-Disease 0 0.0013943325029686093
- I-Disease 0 0.02326906844973564
metaphyseal I-Disease 0 0.12436383217573166
skeletal I-Disease 1 0.8786487579345703
dysplasia I-Disease 1 0.9806112051010132
. O 0 6.751050136699632e-07

The O 0 1.1728206184002943e-09
similarity O 0 4.007262965899372e-09
of O 0 9.706300867218243e-12
the O 0 1.0930133187425639e-10
clinical O 0 9.881570228742476e-09
and O 0 1.8770740517481954e-09
radiographic O 0 0.00011990117491222918
findings O 0 1.0743690381787019e-07
is O 0 3.6852385032482005e-10
so O 0 1.6804099778333637e-10
extensive O 0 1.6144580117227747e-09
that O 0 1.081425011761894e-07
these O 0 3.221322231183876e-08
disorders O 0 1.0821325304277707e-05
appear O 0 1.3713080448951587e-08
to O 0 5.966508953569871e-10
be O 0 5.997867535967316e-09
a O 0 5.464829921919545e-09
single O 0 2.0319033922078233e-07
entity O 0 3.237250894017052e-07
. O 0 2.2591461146248548e-08

The O 0 2.8182303157819888e-09
follow O 0 2.2221779971687283e-09
- O 0 1.287855440068597e-07
up O 0 6.969970156589511e-10
observation O 0 1.2769813650947981e-08
of O 0 5.00049394253077e-12
an O 0 2.1353507503873992e-11
identical O 0 6.509893069051031e-07
and O 0 4.384249352451519e-10
unique O 0 5.831575777826004e-10
pattern O 0 5.83108104024177e-08
of O 0 8.810359386490774e-11
progressive O 0 3.616664116634638e-06
bone B-Disease 1 0.5270524024963379
dysplasia I-Disease 0 0.369637668132782
in O 0 6.893213555514421e-09
the O 0 6.624610304761802e-10
two O 0 1.0024460372903832e-08
patients O 0 1.663008930563592e-08
( O 0 9.106095218147647e-12
one O 0 1.7735740653890275e-10
with O 0 1.7622054926391684e-08
SJS B-Disease 0 0.23909956216812134
type I-Disease 0 3.5862733057001606e-05
2 I-Disease 0 1.9319510435877874e-09
, O 0 1.0014607892960825e-10
one O 0 1.6591610030314285e-10
with O 0 3.0862834510259063e-09
SWS B-Disease 0 0.00026643392629921436
) O 0 1.4910676859880567e-11
surviving O 0 6.600838542425436e-09
beyond O 0 5.523997703704708e-09
infancy O 0 1.679360828177323e-08
adds O 0 1.9490531411037182e-10
to O 0 1.51933337872584e-12
the O 0 1.843635921011666e-12
evidence O 0 7.000453550176644e-10
in O 0 5.511552325643265e-11
favor O 0 6.678933101023077e-11
of O 0 3.32587499207726e-11
identity O 0 6.88799786985328e-07
. O 0 9.761287778076166e-09

The O 0 1.2033575025327536e-08
hypothesis O 0 4.875903982792806e-07
that O 0 6.181571698959942e-09
SWS B-Disease 0 0.00018008241022471339
and O 0 2.6051710122487748e-08
SJS B-Disease 0 0.00396559527143836
type I-Disease 0 4.185003490420058e-06
2 I-Disease 0 2.337677829089557e-10
are O 0 1.798049382994993e-11
the O 0 7.611623831227377e-11
same O 0 3.527150624904607e-07
disorder O 0 2.693604074011091e-05
should O 0 4.866549829785072e-09
be O 0 1.9054620381542264e-10
testable O 0 1.3125976972006015e-09
by O 0 1.0987567626574712e-11
molecular O 0 2.074386529216099e-08
methods O 0 1.6644591482872784e-08
. O 0 2.8048760536414363e-10
. O 0 1.940570815150977e-09

A O 0 2.3756670941565972e-07
mouse O 0 2.537407681302284e-06
model O 0 7.695586532463494e-07
of O 0 4.343999648881436e-08
severe O 1 0.9988258481025696
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 1 0.5203585028648376
defects O 1 0.9999492168426514
in O 0 7.003824862295005e-07
hemostasis O 1 0.9502135515213013
and O 0 1.754186268954072e-05
thrombosis B-Disease 1 0.9241641163825989
. O 0 1.237893116012856e-06

von B-Disease 1 0.5208068490028381
Willebrand I-Disease 1 0.8658415675163269
factor I-Disease 0 1.1389864084776491e-05
( I-Disease 0 4.173155687681174e-08
vWf I-Disease 0 0.000292908342089504
) I-Disease 0 2.29394049711118e-06
deficiency I-Disease 1 0.9992683529853821
causes O 0 0.20838728547096252
severe O 1 0.9999653100967407
von B-Disease 1 1.0
Willebrand I-Disease 1 0.9999998807907104
disease I-Disease 1 1.0
in O 0 4.584200360113755e-05
humans O 0 7.86135296948487e-06
. O 0 1.1574423552929147e-07

We O 0 2.232400397872425e-08
generated O 0 7.758097497756467e-10
a O 0 1.5475408454701522e-10
mouse O 0 2.157543299574627e-08
model O 0 2.7490539622476717e-08
for O 0 4.269033737624994e-11
this O 0 2.133276666427264e-09
disease O 0 1.0954520845984916e-08
by O 0 4.81557372103425e-12
using O 0 2.245835073466651e-09
gene O 0 1.6415226511412584e-08
targeting O 0 1.0175745046581142e-07
. O 0 5.288033566586137e-09

vWf B-Disease 0 0.016169166192412376
- I-Disease 1 0.9469372034072876
deficient I-Disease 1 0.6837642788887024
mice O 0 0.0003166324459016323
appeared O 0 1.4374110435255716e-07
normal O 0 3.150375604832334e-08
at O 0 4.8111465922318075e-09
birth O 0 3.620124289227533e-07
; O 0 1.0914341652679127e-10
they O 0 5.296489358208589e-10
were O 0 5.69776947845213e-10
viable O 0 5.309956030430385e-09
and O 0 3.5286416011359734e-09
fertile O 0 3.6347577747619653e-07
. O 0 3.977134355181988e-08

Neither O 0 4.668917608796619e-05
vWf O 0 0.00026312138652428985
nor O 0 1.2904307368444279e-05
vWf O 0 7.100762013578787e-05
propolypeptide O 0 0.0001745218614814803
( O 0 1.4191813946240472e-08
von B-Disease 0 0.002755948109552264
Willebrand I-Disease 0 0.22566381096839905
antigen O 0 0.0025776310358196497
II O 0 0.007700986694544554
) O 0 3.307707441280172e-10
were O 0 2.0589689952998924e-09
detectable O 0 1.3442876479530241e-05
in O 0 2.9539856671867426e-10
plasma O 0 1.2482828424253967e-06
, O 0 6.772931104848112e-10
platelets O 0 1.84957471560665e-08
, O 0 2.5442311452072985e-11
or O 0 1.2311601738090872e-10
endothelial O 0 1.1686538403665736e-09
cells O 0 8.124025757672015e-11
of O 0 1.1722306068537303e-12
the O 0 1.3725680314546906e-10
homozygous O 0 4.618914772436256e-06
mutant O 0 3.280842292952002e-06
mice O 0 1.9069266272708774e-05
. O 0 1.9524671657222825e-08

The O 0 2.5139176074162606e-08
mutant O 0 1.655066807870753e-05
mice O 0 0.001478528487496078
exhibited O 0 0.02051602676510811
defects O 1 0.9955978989601135
in O 0 7.0541914531929706e-09
hemostasis O 0 9.170136763714254e-05
with O 0 2.554863876014224e-09
a O 0 4.6634191619432386e-08
highly O 0 3.856304374494357e-06
prolonged O 0 0.00228188862092793
bleeding O 1 0.6915035843849182
time O 0 3.8810195945870873e-08
and O 0 2.0736852235359038e-09
spontaneous O 0 3.212199430890905e-07
bleeding O 0 1.788490408216603e-05
events O 0 2.8033690924189614e-09
in O 0 1.0337237316138115e-10
approximately O 0 4.162084218939377e-11
10 O 0 3.184480110163257e-11
% O 0 3.4710442853302936e-11
of O 0 5.419786841542873e-10
neonates O 0 0.0005884323618374765
. O 0 8.610845014800361e-08

As O 0 2.0325374716634315e-09
in O 0 1.568395135986833e-10
the O 0 1.4456341679291995e-10
human O 0 1.723450537838289e-08
disease O 0 1.0137909356444652e-07
, O 0 3.2079490973335734e-12
the O 0 6.10382534446674e-12
factor O 0 2.3148186145682814e-10
VIII O 0 9.85278575171833e-07
level O 0 2.1175486253355302e-08
in O 0 6.870708169071094e-11
these O 0 1.928952969576514e-10
mice O 0 1.5900239702659746e-07
was O 0 1.676023408947458e-08
reduced O 0 1.8031547366348377e-09
strongly O 0 1.2471091936916423e-09
as O 0 8.557680605814078e-12
a O 0 1.2426897011419413e-10
result O 0 8.824928010575661e-10
of O 0 4.224957189657985e-12
the O 0 5.0298633313961005e-11
lack O 0 8.415411145712426e-10
of O 0 4.910758431841966e-12
protection O 0 8.55755910578182e-10
provided O 0 1.0443201164944682e-10
by O 0 2.6796492802461103e-10
vWf O 0 2.467126876126713e-07
. O 0 8.805563389557847e-09

Defective O 1 0.9249289631843567
thrombosis B-Disease 1 0.8277292251586914
in O 0 6.512066619279722e-08
mutant O 0 1.0542926247580908e-05
mice O 0 0.0004175869980826974
was O 0 3.54344166453302e-07
also O 0 5.547617476509004e-09
evident O 0 4.135809916760991e-08
in O 0 2.5563188718602525e-11
an O 0 8.382082354596587e-12
in O 0 2.6412771969575033e-10
vivo O 0 6.54675034184038e-08
model O 0 9.001666967378696e-09
of O 0 1.2141951888366975e-09
vascular B-Disease 0 0.1330990195274353
injury I-Disease 0 0.3721903860569
. O 0 1.03255808880931e-06

In O 0 4.925267749200657e-09
this O 0 8.377706861573131e-11
model O 0 8.026033171404379e-09
, O 0 5.250838392562018e-12
the O 0 1.0207877945700439e-11
exteriorized O 0 5.258386295281525e-07
mesentery O 0 3.919587470591068e-06
was O 0 4.426617739028416e-09
superfused O 0 2.8545104058252946e-08
with O 0 5.504986050341998e-11
ferric O 0 1.7078602354558825e-07
chloride O 0 2.0285420987420366e-07
and O 0 3.459835751229434e-10
the O 0 4.2285466794744764e-11
accumulation O 0 2.828386413966655e-09
of O 0 1.0159706409496039e-11
fluorescently O 0 5.894140940654324e-06
labeled O 0 3.6410001484910026e-05
platelets O 0 4.757996521220775e-06
was O 0 1.4120773883519178e-08
observed O 0 4.274937293047287e-09
by O 0 1.744336342035524e-10
intravital O 0 8.754855684856011e-07
microscopy O 0 5.225113000051351e-07
. O 0 6.025098642226112e-09

We O 0 6.266392915676988e-08
conclude O 0 5.740095065931428e-09
that O 0 4.6571364820113814e-11
these O 0 2.8040935892703622e-11
mice O 0 2.5928027724830827e-08
very O 0 1.2732886967015133e-09
closely O 0 9.636734148443793e-07
mimic O 0 0.01114155538380146
severe O 0 0.05285866931080818
human O 0 0.010079067200422287
von B-Disease 1 1.0
Willebrand I-Disease 1 0.9999996423721313
disease I-Disease 1 1.0
and O 0 0.0010436787270009518
will O 0 3.841680154437199e-06
be O 0 1.9295216091563816e-08
very O 0 1.3211444438443465e-10
useful O 0 3.662665309933644e-11
for O 0 7.646728844741546e-13
investigating O 0 4.0685729785217006e-10
the O 0 6.057780579243888e-12
role O 0 3.45963604986288e-11
of O 0 1.4260570805821327e-12
vWf O 0 3.2749523093400512e-09
in O 0 6.996155321736808e-10
normal O 0 5.392827517880505e-08
physiology O 0 1.631589299222469e-07
and O 0 1.4121575020453747e-09
in O 0 1.225819001859918e-08
disease O 0 8.844853027767385e-07
models O 0 6.573928601483203e-08
. O 0 6.128562657359282e-10
. O 0 3.092954337091669e-09

Oral O 0 0.0003126599476672709
contraceptives O 0 0.009101885370910168
and O 0 7.0275882890769026e-09
the O 0 1.397388871282601e-09
risk O 0 1.1853496744151926e-06
of O 0 8.754891922535535e-08
hereditary B-Disease 1 0.9999986886978149
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999995231628418
. O 0 3.7526420783251524e-05

Hereditary B-Disease 1 0.9999412298202515
Ovarian I-Disease 1 0.9999934434890747
Cancer I-Disease 1 0.9995501637458801
Clinical O 0 0.0015862868167459965
Study O 0 7.148790928113158e-07
Group O 0 1.8327433792819647e-07
. O 0 3.9003062113351916e-08

BACKGROUND O 0 0.001091967336833477
Women O 0 8.655035799165489e-09
with O 0 2.1351644063916098e-10
mutations O 0 3.95037943690113e-07
in O 0 7.268689122819083e-11
either O 0 7.722164574452961e-10
the O 0 2.557622169607754e-10
BRCA1 O 0 2.3995532956178067e-06
or O 0 1.7718303491065512e-09
the O 0 3.052828267957608e-10
BRCA2 O 0 2.689453424409294e-07
gene O 0 1.651392800283702e-08
have O 0 3.6382907797616326e-10
a O 0 5.581025086520697e-10
high O 0 7.2590559341279e-08
lifetime O 0 2.203866188210668e-06
risk O 0 3.651385895864223e-06
of O 0 4.5040424083708785e-06
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999990463256836
. O 0 3.0623368729720823e-06

Oral O 0 0.0010034196311607957
contraceptives O 1 0.7091829180717468
protect O 0 0.00015825306763872504
against O 0 0.28350839018821716
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
in O 0 2.5943165837816196e-08
general O 0 5.78622649793914e-10
, O 0 5.574096392790828e-11
but O 0 3.5509881146644773e-10
it O 0 8.21710963161415e-11
is O 0 4.624623947679929e-11
not O 0 3.7165850258480404e-11
known O 0 1.3888420795360457e-11
whether O 0 9.63706003886955e-10
they O 0 4.809299625208041e-10
also O 0 4.383611529323872e-11
protect O 0 5.992512597252642e-10
against O 0 5.502513999999792e-09
hereditary B-Disease 0 0.00012293150939512998
forms I-Disease 0 3.0463800158031518e-06
of I-Disease 0 0.000770747778005898
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999982118606567
. O 0 1.5898889387244708e-06

METHODS O 0 1.4115678368398221e-06
We O 0 1.1611135164457664e-08
enrolled O 0 1.3939628340509103e-09
207 O 0 3.873636966744698e-09
women O 0 4.5553627536776276e-09
with O 0 1.7028216916514793e-06
hereditary B-Disease 1 0.9999994039535522
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 8.627251446569062e-08
161 O 0 2.3330451459635526e-10
of O 0 5.203761727079481e-11
their O 0 5.146811421496977e-09
sisters O 0 2.061123183239033e-08
as O 0 5.633759778134184e-11
controls O 0 1.3302130064118955e-08
in O 0 1.546514027950252e-10
a O 0 6.364950344561748e-09
case O 0 2.197959702243679e-06
- O 0 0.0002488919999450445
control O 0 1.4887390307194437e-06
study O 0 8.813124452444754e-09
. O 0 4.422988642005521e-09

All O 0 1.5234911110439953e-09
the O 0 6.101061322816292e-10
patients O 0 4.067799430629293e-09
carried O 0 2.582082325730539e-09
a O 0 1.651603076524566e-09
pathogenic O 0 6.986746825532464e-07
mutation O 0 8.695910480582825e-08
in O 0 1.6628295962384243e-10
either O 0 1.1325603566092468e-08
BRCA1 O 0 3.033806706298492e-06
( O 0 8.107602089690857e-11
179 O 0 5.097374744522654e-10
women O 0 2.04512917711952e-09
) O 0 1.1372044972368656e-10
or O 0 2.0649951082418738e-08
BRCA2 O 0 5.523249001271324e-06
( O 0 4.5942158410916534e-10
28 O 0 1.3693367550970947e-09
women O 0 3.764740963418944e-09
) O 0 1.8164089676808715e-10
. O 0 1.8472008367353965e-09

The O 0 8.101520343473112e-09
control O 0 1.8335056495288882e-07
women O 0 4.022655097912775e-09
were O 0 5.611167086527757e-10
enrolled O 0 2.930416187485463e-10
regardless O 0 7.926019840454046e-10
of O 0 8.853103254831407e-13
whether O 0 4.04475730686471e-10
or O 0 2.2279329492391753e-09
not O 0 2.0314716575597913e-09
they O 0 7.852977157440932e-10
had O 0 2.0673625034106635e-09
either O 0 4.697644051532279e-09
mutation O 0 1.0234894034510944e-06
. O 0 3.3589970804825953e-09

Lifetime O 0 2.817189397319453e-06
histories O 0 3.126133947262133e-07
of O 0 2.8756449999001177e-10
oral O 0 1.092864678753358e-07
- O 0 3.6033816286362708e-06
contraceptive O 0 1.0387705060566077e-06
use O 0 4.7032382433087605e-09
were O 0 2.2326716031528804e-09
obtained O 0 3.2564695384706965e-10
by O 0 2.1476943487530598e-11
interview O 0 2.2783721576047355e-08
or O 0 5.554123480577822e-11
by O 0 3.031061729732998e-12
written O 0 4.0413178359344215e-10
questionnaire O 0 1.0016524276679206e-09
and O 0 1.8360394801741897e-11
were O 0 8.130241618831135e-11
compared O 0 4.501507222531842e-10
between O 0 6.294354620850484e-11
patients O 0 2.2688510792345795e-10
and O 0 6.538969921088267e-10
control O 0 2.1695399254895165e-07
women O 0 1.911130143028572e-09
, O 0 3.388198359030592e-12
after O 0 2.5615020521341236e-11
adjustment O 0 6.735790258893815e-10
for O 0 9.879969021728274e-13
year O 0 9.993308264233391e-12
of O 0 7.478535152261045e-12
birth O 0 2.1441535125177325e-07
and O 0 1.9537551576576107e-09
parity O 0 8.653485679133155e-07
. O 0 6.296029919639068e-09

RESULTS O 0 1.449671913178463e-06
The O 0 1.8420815983688499e-09
adjusted O 0 1.1766472198360134e-05
odds O 0 0.00016909409896470606
ratio O 0 7.822246698196977e-05
for O 0 1.9720959244295955e-05
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
associated O 0 9.424994459550362e-06
with O 0 6.826425535955138e-11
any O 0 1.591957815572087e-10
past O 0 3.490098765546179e-10
use O 0 1.8616416741501496e-10
of O 0 1.4555363858637094e-10
oral O 0 2.372574726905441e-06
contraceptives O 0 0.06742404401302338
was O 0 4.771678163706383e-07
0 O 0 4.938889297534388e-09
. O 0 1.775026681194447e-09

5 O 0 1.562860241222097e-08
( O 0 5.597279237323782e-11
95 O 0 9.222018981791535e-11
percent O 0 2.7364870369694927e-09
confidence O 0 6.067691060707148e-08
interval O 0 1.9404755136065432e-08
, O 0 2.899699794514654e-12
0 O 0 6.278308602170046e-12
. O 0 2.2025602370613628e-13
3 O 0 9.182728362422399e-13
to O 0 3.433811178107926e-12
0 O 0 9.555641000691395e-11
. O 0 2.395843939906328e-11
8 O 0 1.1676305755603522e-10
) O 0 1.943702664097824e-11
. O 0 8.149513286426213e-10

The O 0 8.682304297735755e-08
risk O 0 9.317449780610332e-07
decreased O 0 2.6127297658717907e-08
with O 0 3.738019616061905e-11
increasing O 0 4.4701753409981393e-10
duration O 0 9.24982668237817e-09
of O 0 3.589540773993316e-12
use O 0 2.9839306026069323e-10
( O 0 2.554388645048533e-11
P O 0 8.217058677928435e-08
for O 0 4.1098981856668715e-12
trend O 0 1.2984316954955943e-09
, O 0 5.0495467182609666e-12
< O 0 4.0058775740980934e-10
0 O 0 8.202510719257372e-12
. O 0 1.5559803879378054e-12
001 O 0 7.655770462022815e-11
) O 0 7.455639567093691e-14
; O 0 5.5336645503464496e-14
use O 0 1.9335481566545853e-12
for O 0 3.5991730429341118e-12
six O 0 5.5339973055457126e-12
or O 0 1.1548947909112428e-10
more O 0 1.3297518468291525e-11
years O 0 2.32083197104771e-09
was O 0 1.458864762327039e-08
associated O 0 1.3180635749510117e-10
with O 0 2.948235622649009e-12
a O 0 7.345793973101422e-10
60 O 0 2.573962709639943e-10
percent O 0 1.930518189752206e-09
reduction O 0 7.986542982507672e-09
in O 0 4.0481165086703186e-09
risk O 0 1.6818663652884425e-06
. O 0 1.2384932190911968e-08

Oral O 0 1.9777366105699912e-05
- O 0 7.076509973558132e-06
contraceptive O 0 3.2358357202610932e-06
use O 0 9.737394002229394e-09
protected O 0 0.00035008194390684366
against O 1 0.7530364990234375
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999994039535522
both O 0 5.418597792683499e-10
for O 0 3.1313087539563966e-11
carriers O 0 1.0451949722378728e-10
of O 0 2.59518231557343e-12
the O 0 5.348548826056287e-10
BRCA1 O 0 5.533885268960148e-05
mutation O 0 1.104319721889624e-06
( O 0 8.290833991564384e-11
odds O 0 2.4349196792172734e-06
ratio O 0 9.502255693405459e-08
, O 0 1.4895119642907573e-12
0 O 0 5.299485676679705e-12
. O 0 4.1134489477817615e-13
5 O 0 7.803900754776993e-13
; O 0 6.355886953898771e-13
95 O 0 2.71360820099098e-12
percent O 0 6.315871714512866e-10
confidence O 0 1.1023268520204965e-08
interval O 0 4.739673986620119e-09
, O 0 1.2263544129850756e-12
0 O 0 1.3663943023919933e-12
. O 0 5.241217277351072e-14
3 O 0 1.749101216511409e-13
to O 0 8.569550776459101e-13
0 O 0 1.562184409609202e-11
. O 0 4.398265605887186e-12
9 O 0 3.7699104254995675e-11
) O 0 3.969591311474979e-13
and O 0 2.9230220674469898e-12
for O 0 7.463825022445414e-13
carriers O 0 2.0287937996243954e-11
of O 0 1.3629090260883214e-12
the O 0 4.073464898723955e-10
BRCA2 O 0 3.3052813250833424e-06
mutation O 0 6.379403885148349e-07
( O 0 5.09861701469827e-11
odds O 0 2.0653319552366156e-06
ratio O 0 7.368168297716693e-08
, O 0 8.641689794308682e-13
0 O 0 1.4672361632953046e-12
. O 0 1.3872574150617517e-13
4 O 0 8.480948148620326e-13
; O 0 1.1595662581173616e-12
95 O 0 3.0666213925861774e-12
percent O 0 1.0620681001327625e-09
confidence O 0 1.9583936250455736e-08
interval O 0 4.121468055728883e-09
, O 0 1.6174144272171342e-12
0 O 0 1.3827382164613433e-12
. O 0 1.3143261164746262e-13
2 O 0 4.314131246251768e-13
to O 0 4.583847624389792e-12
1 O 0 6.142228392569393e-11
. O 0 4.438449607846451e-11
1 O 0 6.286519915743582e-11
) O 0 3.419290892092697e-11
. O 0 8.681153018663679e-10

CONCLUSIONS O 0 1.6292353393509984e-05
Oral O 0 6.7182186285208445e-06
- O 0 1.592997978150379e-05
contraceptive O 0 3.586476623240742e-06
use O 0 8.48203285386262e-09
may O 0 9.300245018550868e-09
reduce O 0 1.187070997055173e-09
the O 0 2.698194723205205e-10
risk O 0 1.4886480812492664e-06
of O 0 1.0981685818478581e-06
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
in O 0 2.2651700248843554e-07
women O 0 4.864396441206509e-09
with O 0 5.13523779055447e-10
pathogenic O 0 5.679898436028452e-07
mutations O 0 2.2504636376652343e-07
in O 0 2.7800878266148743e-10
the O 0 1.1383813891541195e-09
BRCA1 O 0 4.849626566283405e-05
or O 0 2.9252926196932094e-06
BRCA2 O 0 0.0009861604776233435
gene O 0 0.00011760207416955382

A O 0 4.6110363882689853e-07
Japanese O 0 2.2787857290040847e-07
family O 0 1.4948115634183523e-08
with O 0 6.577073552449519e-09
adrenoleukodystrophy B-Disease 1 0.9999978542327881
with O 0 3.3121221321152916e-09
a O 0 4.276323739560439e-09
codon O 0 5.090148746944578e-09
291 O 0 3.8358735632293417e-10
deletion O 0 4.612395088088306e-08
: O 0 8.073006152464757e-11
a O 0 9.568886794042442e-10
clinical O 0 5.965377170014108e-08
, O 0 3.642012247340176e-10
biochemical O 0 4.1116936699836515e-06
, O 0 3.570098661143106e-10
pathological O 0 1.0874663303184207e-06
, O 0 3.635529932655146e-10
and O 0 4.742043202554669e-09
genetic O 0 2.9747104690613924e-06
report O 0 1.2445524077975278e-07
. O 0 1.0864463995119422e-08

We O 0 2.8058911993866786e-07
report O 0 2.5158877203779184e-09
a O 0 1.480277705967481e-10
Japanese O 0 3.2208983924419954e-08
family O 0 9.167346881611138e-09
with O 0 9.120589083977393e-07
adrenoleukodystrophy B-Disease 1 0.9999998807907104
( O 0 1.0729979294410441e-05
ALD B-Disease 1 0.9999996423721313
) O 0 2.1225121660251034e-10
with O 0 6.248112444096066e-11
a O 0 2.600597071023003e-09
three O 0 1.2877665600541377e-10
base O 0 1.5013140730602004e-09
pair O 0 4.4064950799338476e-08
deletion O 0 9.352849872357183e-08
( O 0 1.888153175477747e-11
delGAG O 0 3.5243370444248967e-09
291 O 0 1.9839307974223175e-10
) O 0 9.86959472482063e-12
in O 0 2.2574164759703308e-10
the O 0 4.638792461264529e-08
ALD B-Disease 1 0.9999977350234985
gene O 0 1.3070445675111841e-05
. O 0 5.353299670218803e-08

A O 0 5.294394611610187e-08
variety O 0 3.2010474271260136e-09
of O 0 5.508612455074058e-10
phenotypes O 0 3.1903280614642426e-05
were O 0 4.780149964744851e-08
observed O 0 8.638728843379795e-08
within O 0 5.1225960973066975e-11
this O 0 1.1432155916368814e-10
family O 0 1.5817533949302742e-08
. O 0 6.531270191345584e-09

While O 0 1.5782665840902155e-08
the O 0 7.53929696450939e-10
proband O 0 3.757834292628104e-06
( O 0 2.547344835068799e-10
patient O 0 7.5033241841993e-08
1 O 0 2.499166151803678e-10
) O 0 2.3132813373183403e-11
was O 0 1.3045515778742356e-08
classified O 0 2.305101354238559e-08
as O 0 1.332390309194409e-10
having O 0 8.496147674286192e-10
a O 0 2.0467748329533464e-10
rare O 0 5.335305530707046e-09
intermediate O 0 1.3385322850112402e-09
type O 0 1.8265277290652193e-08
of O 0 6.742779251611708e-11
adult O 0 3.6031892705068458e-06
cerebral O 0 8.258830348495394e-05
and O 0 1.738734489720173e-08
cerebello O 0 0.0057786982506513596
- O 0 0.24331451952457428
brain O 0 0.012115545570850372
stem O 0 4.250434528785263e-07
forms O 0 3.833461992286402e-09
, O 0 5.052208651434853e-11
his O 0 6.402839369812341e-10
younger O 0 6.5337122379105494e-09
brother O 0 3.2479125167128586e-08
( O 0 1.4146902399536643e-11
patient O 0 9.682721291426333e-09
2 O 0 1.1833201085664768e-10
) O 0 1.1857708391571631e-11
and O 0 5.011671078136715e-10
nephew O 0 4.983683083992219e-06
( O 0 2.482055116992399e-10
patient O 0 7.842790950007839e-08
3 O 0 4.5182638186425095e-10
) O 0 3.7503170707831046e-11
had O 0 2.3814417104972563e-08
a O 0 1.1587925428102608e-06
childhood O 1 0.9693091511726379
ALD B-Disease 1 0.9999990463256836
type O 0 0.24258165061473846
. O 0 2.0757487106948247e-07

Another O 0 1.7738980773174262e-07
nephew O 0 8.497308044752572e-06
( O 0 1.5255178231754485e-09
patient O 0 8.772995130357231e-08
4 O 0 1.3279959076850645e-10
) O 0 2.4116418497616143e-12
of O 0 1.12956432402056e-11
patient O 0 4.541762791632209e-06
1 O 0 9.21745524351536e-09
was O 0 3.3793480724853e-07
classified O 0 6.18462792090213e-08
as O 0 1.9581947174884817e-09
having O 0 1.8540779578302136e-08
an O 0 1.0202360067879113e-09
adolescent O 0 1.0882841706916224e-05
form O 0 4.7909939127066536e-08
. O 0 4.2071697237133776e-08

The O 0 5.407408742996722e-09
tau O 0 1.1212739181587494e-08
level O 0 8.329373635262982e-09
in O 0 1.426341406096654e-10
the O 0 4.9136703594854225e-09
cerebrospinal O 1 0.5924693942070007
fluid O 0 0.004310197662562132
( O 0 2.85599033311712e-09
CSF O 0 5.2059484005440027e-05
) O 0 1.3065291903924248e-11
in O 0 4.105943710031035e-11
patient O 0 4.805994535672653e-08
1 O 0 9.954054247529598e-10
was O 0 1.0965688801434226e-07
as O 0 1.5798341801431803e-10
high O 0 7.451148031911714e-10
as O 0 8.103084175870023e-12
that O 0 2.7929590931674575e-11
of O 0 2.500285395390378e-11
patients O 0 6.999629764692372e-09
with O 0 2.4905043574108277e-06
Alzheimers B-Disease 1 0.9999761581420898
disease I-Disease 0 0.011220802552998066
( O 0 7.498853205056832e-10
AD B-Disease 0 2.7869933205693087e-07
) O 0 4.5534750969800086e-10
. O 0 2.481961525191423e-09

His O 0 1.3398289411270525e-06
brain O 0 6.311973265837878e-05
magnetic O 0 3.7241039535729215e-05
resonance O 0 0.012686236761510372
image O 0 0.23796482384204865
( O 0 1.8026192094566795e-08
MRI O 0 0.14720340073108673
) O 0 5.298260941088984e-09
showed O 0 0.003418424166738987
abnormalities B-Disease 1 0.7325738072395325
in I-Disease 0 8.325526934527261e-10
the I-Disease 0 1.0286144158655475e-09
bilateral I-Disease 0 3.0800500098848715e-05
cerebellar I-Disease 1 0.9959505796432495
hemispheres I-Disease 0 0.23752476274967194
and O 0 7.163600344028964e-07
brain O 0 9.166594099951908e-05
stem O 0 2.652318755735905e-07
, O 0 1.8559971615150772e-10
but O 0 2.9728244865800946e-10
not O 0 1.0061113053794202e-10
in O 0 1.9575429818785572e-11
the O 0 4.5787404423514033e-10
cerebral O 0 0.0011814867611974478
white O 0 4.7107462819440116e-07
matter O 0 6.551221787276518e-08
, O 0 7.294657065892718e-12
where O 0 1.925136786096182e-11
marked O 0 4.03460959086388e-10
reductions O 0 1.2250290559734367e-08
of O 0 3.817258141525226e-12
the O 0 6.234627258905334e-10
cerebral O 0 7.164767157519236e-05
blood O 0 2.7510219524629065e-07
flow O 0 3.153056482574357e-08
and O 0 4.678562426363442e-09
oxygen O 0 7.5098533613982e-08
metabolism O 0 1.9683062291164788e-08
were O 0 1.8897755582614195e-10
clearly O 0 3.5338953985331045e-09
demonstrated O 0 4.389956453909605e-10
by O 0 6.037873673259142e-11
positron O 0 0.0029711369425058365
emission O 0 0.004643657244741917
tomography O 0 0.0024338029325008392
( O 0 2.205515770015154e-09
PET O 0 9.320274330093525e-06
) O 0 5.34528477036389e-10
. O 0 3.3322218317977104e-09

In O 0 5.175124684342336e-08
patients O 0 1.3103594653784967e-08
2 O 0 2.0977360126739342e-10
and O 0 4.480931459216464e-10
3 O 0 2.0711939108242206e-10
, O 0 8.777078022714768e-12
the O 0 2.964934894822413e-11
autopsy O 0 2.7028518161387183e-05
findings O 0 1.5844413780996547e-07
showed O 0 1.3986061730975052e-06
massive O 0 1.2293753570702393e-05
demyelination B-Disease 1 0.9999974966049194
of I-Disease 0 3.4484792799105435e-09
the I-Disease 0 5.8215459119992374e-08
cerebral I-Disease 0 0.11357446759939194
white I-Disease 0 9.085350711757201e-07
matter I-Disease 0 2.7542168545835466e-09
with O 0 3.907558304705461e-12
sparing O 0 1.6690257509388573e-10
of O 0 8.074819458914195e-12
the O 0 2.3693874640073886e-10
U O 0 2.755884679572773e-06
- O 0 1.5437501133419573e-05
fibers O 0 5.836290438310243e-05
, O 0 1.251316411599035e-10
compatible O 0 2.63748134443631e-10
with O 0 4.1858006644135415e-11
the O 0 1.3549272814827873e-10
findings O 0 2.274884280950573e-09
of O 0 2.673055554680559e-09
childhood O 0 0.1803070455789566
ALD B-Disease 1 0.9999967813491821
. O 0 3.064727707169368e-07

Oleic O 0 0.054525431245565414
and O 0 5.37838332093088e-07
erucic O 0 0.00358758051879704
acids O 0 1.2352511191693338e-07
( O 0 6.764600685160715e-11
Lorenzos O 0 7.912432664625157e-08
Oil O 0 8.586927613407624e-09
) O 0 7.357365042724717e-13
were O 0 5.669350839482279e-12
administered O 0 4.263142963645272e-11
to O 0 1.28386704045802e-10
patients O 0 2.0581354676085795e-10
1 O 0 3.510191443067967e-11
and O 0 1.2344426869592695e-10
4 O 0 4.180111812246423e-11
, O 0 6.6833136247446134e-12
but O 0 2.6851224368962257e-11
sufficient O 0 3.709766660531244e-10
effectiveness O 0 4.599425729168161e-09
was O 0 1.870677301951673e-08
not O 0 5.118896972966525e-10
obtained O 0 2.1691495266651373e-09
. O 0 3.4939087734109364e-10

The O 0 8.085897285070587e-09
findings O 0 7.366141918652147e-09
in O 0 8.094221126686563e-11
this O 0 1.0468144580333405e-11
family O 0 1.9815937779554815e-10
suggest O 0 2.1749035905571645e-09
that O 0 1.5802319175417523e-10
delGAG291 O 0 1.531311077940245e-08
is O 0 2.0485549021009852e-11
part O 0 3.463622184202153e-12
of O 0 3.039288222136949e-12
the O 0 1.1686197842752932e-10
cause O 0 1.4723947394656989e-08
of O 0 1.6636989008667058e-10
Japanese O 0 4.9533427954884246e-05
ALD B-Disease 1 0.9999898672103882
with O 0 2.0195263239486394e-09
phenotypic O 0 1.256792529602535e-06
variations O 0 6.509007562272018e-06
. O 0 1.0084700363677257e-07

Moreover O 0 2.2914784949534805e-06
, O 0 1.3238610208077262e-10
although O 0 4.3730810639353024e-11
the O 0 7.359740421264416e-12
scale O 0 1.4777381807107304e-07
of O 0 1.164967254607685e-11
the O 0 1.3176916502377622e-10
study O 0 3.3743813299125236e-10
is O 0 5.0315522581723116e-11
limited O 0 1.256553541773009e-11
, O 0 3.9873803044099265e-12
there O 0 1.486084866275661e-11
is O 0 8.28444431111297e-12
a O 0 1.452069454260796e-11
possibility O 0 7.455072115192252e-10
that O 0 3.327089936888683e-09
PET O 0 1.0439865718581132e-06
can O 0 1.3940857357397363e-08
detect O 0 1.399094890075503e-05
an O 0 5.014596515806602e-10
insidious B-Disease 0 0.0004481143259909004
lesion I-Disease 1 0.852423906326294
which O 0 9.477712126226834e-08
is O 0 7.388665790308835e-10
undetectable O 0 8.729175604571537e-09
by O 0 1.4376756729550522e-11
computed O 0 6.720806595694739e-07
tomogram O 0 3.082748662563972e-06
( O 0 8.296466291746185e-11
CT O 0 1.056067685567541e-05
) O 0 1.0987567626574712e-11
or O 0 8.160926795452994e-11
MRI O 0 6.440659035433782e-06
analysis O 0 1.216732048447966e-08
, O 0 9.087875417479463e-12
and O 0 1.2825837614194313e-11
that O 0 2.0756816404565726e-11
the O 0 1.0229629643365712e-11
higher O 0 2.3756152600640235e-09
level O 0 1.1744967498561465e-10
of O 0 4.229381601883464e-13
tau O 0 2.4606067183796654e-11
reflects O 0 2.2302350938252502e-11
the O 0 5.087032683114001e-13
process O 0 1.4010189492916214e-12
of O 0 5.327690979356481e-12
neuronal B-Disease 0 8.025766646824195e-07
degeneration I-Disease 0 7.839511090423912e-05
in O 0 1.8907689991465304e-06
ALD B-Disease 1 0.9999940395355225
. O 0 7.144585651985835e-07

Lorenzos O 0 0.00017122145800385624
Oil O 0 6.207890692166984e-06
should O 0 6.908547955930544e-09
be O 0 4.235456430023987e-11
given O 0 5.247934899144102e-12
in O 0 4.937920732028811e-12
the O 0 1.4016397417715432e-11
early O 0 3.979376272944535e-10
stage O 0 2.489140449313254e-08
. O 0 5.488811627429868e-10
. O 0 3.2880835831861077e-09

Nonsense O 0 0.0001682646689005196
mutation O 0 1.3414868590189144e-05
in O 0 7.659104461765764e-10
exon O 0 2.1486016521521378e-07
4 O 0 5.394323876473095e-10
of O 0 2.8025536752407376e-11
human O 0 1.456828546686495e-09
complement O 0 3.236262813288704e-08
C9 O 0 1.3338609278434888e-05
gene O 0 5.6751716215330816e-08
is O 0 3.573095708198082e-10
the O 0 7.799410423059427e-12
major O 0 3.957667527032527e-10
cause O 0 4.0871505291306676e-08
of O 0 1.3961892753044935e-10
Japanese O 0 2.172532731492538e-06
complement B-Disease 0 1.834380418586079e-05
C9 I-Disease 1 0.9893613457679749
deficiency I-Disease 0 0.2591434717178345
. O 0 4.247565499326811e-08

Deficiency B-Disease 1 0.9958502054214478
of I-Disease 0 9.251656107878148e-10
the I-Disease 0 2.657062347921624e-10
ninth I-Disease 0 2.00504102210175e-09
component I-Disease 0 1.388512416156118e-09
of I-Disease 0 1.156249661987685e-11
human I-Disease 0 3.495974898459764e-10
complement I-Disease 0 3.4698428574841955e-09
( O 0 5.4260623771895666e-11
C9 O 0 1.2743126376335567e-07
) O 0 4.482208874889704e-12
is O 0 3.316377771359069e-12
the O 0 2.8331334674114306e-12
most O 0 5.443041156683037e-11
common O 0 1.2257504522494855e-07
complement B-Disease 1 0.9999966621398926
deficiency I-Disease 1 0.9999994039535522
in O 0 8.925008287974379e-09
Japan O 0 1.6122316992550623e-07
but O 0 2.2321267056923944e-09
is O 0 1.4949526339069763e-10
rare O 0 9.649862020566502e-10
in O 0 9.072950724053896e-11
other O 0 1.8568887746872598e-11
countries O 0 4.307261838865095e-11
. O 0 2.3788435665750285e-09

We O 0 2.407455781394674e-07
studied O 0 4.8414876552271835e-09
the O 0 9.322395286281981e-12
molecular O 0 2.368715223965978e-09
basis O 0 1.1850795345047516e-10
of O 0 5.339354514077854e-10
C9 B-Disease 1 0.9861413240432739
deficiency I-Disease 0 0.1969781219959259
in O 0 1.274264721518037e-10
four O 0 1.8752337183070011e-10
Japanese O 0 3.4946526739076944e-07
C9 B-Disease 0 0.00045256278826855123
- I-Disease 0 0.04792392998933792
deficient I-Disease 0 0.006634050980210304
patients O 0 7.646703892305595e-08
who O 0 5.8038846617591844e-08
had O 0 3.6584026474884013e-06
suffered O 0 0.05654371157288551
from O 0 8.369432180188596e-06
meningococcal B-Disease 1 0.9999994039535522
meningitis I-Disease 1 0.999997615814209
. O 0 2.697277068364201e-07

Direct O 0 1.810144034664063e-08
sequencing O 0 1.9856818411767563e-08
of O 0 3.72486180788556e-10
amplified O 0 6.920425903444993e-07
C9 O 0 1.093725472856022e-06
cDNA O 0 8.34244406888729e-09
and O 0 7.551097525038131e-10
DNA O 0 8.57452633340472e-08
revealed O 0 1.257932353837532e-07
a O 0 7.634877730033907e-10
nonsense O 0 9.47066425283083e-08
substitution O 0 1.4083539889853114e-09
( O 0 1.7309162783640808e-11
CGA O 0 1.7013876529858862e-08
- O 0 2.0047245925525203e-06
- O 0 2.6249733764416305e-06
> O 0 1.2025268780746501e-08
TGA O 0 1.3761705019987858e-07
) O 0 7.760828438230227e-12
at O 0 2.13347395305874e-11
codon O 0 1.268645744012531e-10
95 O 0 2.7273691118046006e-12
in O 0 3.779873549575319e-12
exon O 0 1.3293252720814053e-08
4 O 0 3.4324265651974883e-10
in O 0 1.142147626476131e-10
the O 0 1.8585477601362754e-10
four O 0 6.742863156716794e-09
C9 B-Disease 0 0.003789804643020034
- I-Disease 0 0.009958256036043167
deficient I-Disease 0 0.00012734626943711191
individuals O 0 9.39235356156587e-09
. O 0 5.577611705831487e-09

An O 0 9.30118471131891e-09
allele O 0 4.300225953102199e-07
- O 0 4.4200220372658805e-08
specific O 0 1.1082502693327e-09
polymerase O 0 1.636989033215741e-08
chain O 0 2.8180605227134947e-07
reaction O 0 1.1811453148879991e-08
system O 0 6.582993594683728e-10
designed O 0 3.087745170660128e-08
to O 0 8.986955624123993e-11
detect O 0 6.490950454463018e-06
exclusively O 0 6.274125108340911e-10
only O 0 7.152341219285319e-11
one O 0 1.3194866206600597e-11
of O 0 3.2317266809682443e-13
the O 0 1.3239891821781313e-11
normal O 0 4.65709470987008e-10
and O 0 2.982188107569783e-11
mutant O 0 4.915383100545512e-10
alleles O 0 2.4240959239918425e-10
indicated O 0 5.015881043846093e-09
that O 0 6.447604256054618e-11
all O 0 7.459426956332726e-13
the O 0 2.6363620488079054e-12
four O 0 9.938000422593518e-11
patients O 0 1.2799573900768024e-10
were O 0 8.390516059719744e-11
homozygous O 0 5.305673678179801e-09
for O 0 7.289760808881773e-12
the O 0 1.9235803921935357e-11
mutation O 0 7.889357611645664e-09
in O 0 2.340880093931741e-11
exon O 0 1.7986970135552838e-08
4 O 0 4.105029649537073e-10
and O 0 7.290908432544541e-10
that O 0 5.41571509860006e-10
the O 0 3.891628339025566e-11
parents O 0 1.599326671097856e-09
of O 0 2.3182724837034208e-11
patient O 0 4.8449912526393746e-08
2 O 0 2.957401823433514e-10
were O 0 1.3620567784755622e-08
heterozygous O 0 1.1051499768655049e-06
. O 0 2.2840199065399247e-08

The O 0 4.61038718313489e-09
common O 0 6.007174757627354e-09
mutation O 0 2.559664835644071e-08
at O 0 1.213722317094934e-10
codon O 0 2.3501328660913146e-10
95 O 0 3.143838271310595e-12
in O 0 3.8421228004681396e-12
exon O 0 1.897781842785662e-08
4 O 0 6.488804160653672e-09
might O 0 1.680319599017821e-07
be O 0 1.9556751773563974e-09
responsible O 0 9.259494837543514e-10
for O 0 1.9448002236410744e-11
most O 0 4.308661205598696e-10
Japanese O 0 1.0445569387229625e-05
C9 B-Disease 1 0.670009970664978
deficiency I-Disease 0 0.005821405444294214
. O 0 4.4737064053279596e-10
. O 0 1.123058313012848e-09

BRCA1 O 0 0.0018971016397699714
required O 0 6.341782921026606e-08
for O 0 3.7070504999014986e-10
transcription O 0 9.004057233141793e-08
- O 0 1.5262865417753346e-05
coupled O 0 1.3128109458193649e-05
repair O 0 7.826956789358519e-06
of O 0 5.580417794526227e-10
oxidative O 0 0.025135543197393417
DNA O 0 0.04468032345175743
damage O 1 0.6242973804473877
. O 0 3.332789333398978e-07

The O 0 1.02991748462955e-06
breast B-Disease 1 0.9993756413459778
and I-Disease 1 0.9949689507484436
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
susceptibility O 1 0.9997280240058899
gene O 0 0.001625249395146966
BRCA1 O 0 0.0004935019533149898
encodes O 0 4.539804194791941e-07
a O 0 3.0768168812755903e-07
zinc O 0 0.40625447034835815
finger O 0 0.00023005486582405865
protein O 0 2.6476655534679594e-08
of O 0 1.489311868274612e-10
unknown O 0 3.816531375377963e-07
function O 0 5.7986952128885605e-08
. O 0 5.606665798296717e-09

Association O 0 7.733609663773677e-08
of O 0 9.922129090567111e-11
the O 0 3.601264009223115e-10
BRCA1 O 0 1.916926748890546e-06
protein O 0 1.4226361200186943e-09
with O 0 2.4505040358002717e-11
the O 0 1.1930219312450419e-10
DNA O 0 3.3024962249328382e-06
repair O 0 9.953426342690364e-06
protein O 0 2.0047592030891792e-08
Rad51 O 0 6.887958079460077e-07
and O 0 7.864965623216591e-11
changes O 0 8.682192464970484e-11
in O 0 2.049319915153891e-12
the O 0 6.710056230270489e-13
phosphorylation O 0 9.495593894515153e-11
and O 0 2.859351644346475e-10
cellular O 0 1.5669554542796504e-08
localization O 0 1.2174882213500382e-09
of O 0 1.929284775556775e-13
the O 0 1.0467859218321607e-12
protein O 0 2.6354635487835232e-11
after O 0 6.891602566394539e-11
exposure O 0 5.334972570381069e-07
to O 0 6.378165356979437e-11
DNA O 0 7.383994784504466e-07
- O 0 1.6140966181410477e-05
damaging O 0 2.994737997141783e-06
agents O 0 8.702265574811463e-08
are O 0 1.9841124576647218e-10
consistent O 0 7.728902851056318e-09
with O 0 5.106828588480328e-12
a O 0 5.065214914168337e-11
role O 0 5.571590411257432e-10
for O 0 1.6543513781108743e-10
BRCA1 O 0 3.8601126561843557e-07
in O 0 8.867447887084268e-10
DNA O 0 3.4366141790087568e-06
repair O 0 0.00016970353317447007
. O 0 6.086387571713203e-08

Here O 0 5.975170438432542e-07
, O 0 1.1219530859918336e-10
it O 0 3.566176520752862e-11
is O 0 1.9085890853864917e-11
shown O 0 3.0350508217757977e-10
that O 0 2.799647319529086e-11
mouse O 0 2.3610258637063453e-08
embryonic O 0 7.843269855811741e-08
stem O 0 4.949250751451473e-07
cells O 0 6.611210778828536e-08
deficient B-Disease 0 6.750154852852575e-07
in I-Disease 0 6.124870055579379e-10
BRCA1 I-Disease 0 4.894833182333969e-06
are O 0 2.239470164866475e-09
defective O 0 3.7314684959710576e-06
in O 0 2.9040364557531007e-10
the O 0 7.728068879275796e-11
ability O 0 9.35632127330166e-10
to O 0 2.6078864762135723e-11
carry O 0 5.312485451547388e-10
out O 0 4.818460908051492e-11
transcription O 0 3.905237799806116e-10
- O 0 1.0179878984217794e-07
coupled O 0 2.601747723929293e-07
repair O 0 1.5868351965764305e-07
of O 0 2.7886581932534682e-11
oxidative O 0 0.00017915091302711517
DNA O 0 0.006115091033279896
damage O 1 0.940824568271637
, O 0 1.6729596596931628e-09
and O 0 6.503818039682585e-10
are O 0 5.737366692848411e-10
hypersensitive O 0 4.092622111784294e-05
to O 0 7.421228076509578e-08
ionizing O 1 0.9999839067459106
radiation O 1 0.9999853372573853
and O 0 6.21160580749347e-08
hydrogen O 0 3.800640342888073e-06
peroxide O 0 9.343131387140602e-05
. O 0 1.141922290059938e-08

These O 0 2.939155363534951e-09
results O 0 3.342113030768701e-09
suggest O 0 6.280797659741211e-09
that O 0 1.8935207568571144e-10
BRCA1 O 0 5.911394964641659e-07
participates O 0 3.3921416786597547e-09
, O 0 1.3594723437260203e-11
directly O 0 5.28054960868829e-11
or O 0 3.664770709121967e-10
indirectly O 0 8.296900944060326e-09
, O 0 6.57282518343183e-12
in O 0 1.2771401124156423e-11
transcription O 0 5.806414238307411e-10
- O 0 6.403022325685015e-07
coupled O 0 9.019679509947309e-07
repair O 0 5.707106538466178e-07
of O 0 4.879222373355141e-11
oxidative O 0 0.0003575080481823534
DNA O 0 0.0005177978309802711
damage O 0 0.06993042677640915
. O 0 9.690721114452572e-09
. O 0 1.6759146959088866e-08

Truncation O 0 1.2334844541328494e-05
mutations O 0 7.404432108160108e-05
in O 0 1.521887837974134e-09
the O 0 2.2314913805665526e-10
transactivation O 0 3.680231202451978e-06
region O 0 7.040897642696109e-09
of O 0 1.1013716327834544e-10
PAX6 O 0 8.159308890753891e-06
result O 0 5.151429860461576e-08
in O 0 8.300347631440275e-10
dominant O 0 3.7161873933655443e-07
- O 0 7.362431915680645e-06
negative O 0 2.2836029529571533e-06
mutants O 0 4.1994172761405935e-07
. O 0 1.0776420644731388e-08

PAX6 O 0 0.005630353465676308
is O 0 2.75720388742684e-08
a O 0 3.340021315079156e-10
transcription O 0 6.995221069061586e-10
factor O 0 6.254800843930042e-11
with O 0 1.869446437929856e-12
two O 0 2.055114065036001e-11
DNA O 0 5.453034646052402e-07
- O 0 1.0042717804026324e-05
binding O 0 9.72590555647912e-07
domains O 0 3.7568089084061285e-08
( O 0 1.972038504716167e-11
paired O 0 2.3370603230432607e-08
box O 0 5.8852606343862135e-06
and O 0 5.107683609395508e-09
homeobox O 0 1.14827800601347e-08
) O 0 5.234279589622082e-12
and O 0 2.175266564097278e-11
a O 0 1.0254410653942614e-09
proline O 0 6.4293672039639205e-06
- O 0 7.986757282196777e-07
serine O 0 2.7440444227977423e-07
- O 0 2.127125981132849e-06
threonine O 0 2.2240072894419427e-07
( O 0 8.967760561917615e-11
PST O 0 1.2294083262531785e-06
) O 0 6.721669054687851e-11
- O 0 8.583592148170283e-08
rich O 0 2.209706728706351e-08
transactivation O 0 2.631294591992628e-06
domain O 0 7.31149825128341e-08
. O 0 9.269995437932721e-09

PAX6 O 0 0.006657969672232866
regulates O 0 8.994559902930632e-05
eye O 0 9.0570974862203e-05
development O 0 1.2123045900480633e-09
in O 0 3.4360159162361015e-10
animals O 0 1.0433948149923822e-09
ranging O 0 6.2668923384023856e-09
from O 0 9.269986861459856e-11
jellyfish O 0 4.565931632782849e-09
to O 0 3.003995663330983e-11
Drosophila O 0 2.860497394507888e-10
to O 0 1.183945441685097e-10
humans O 0 6.042257805205509e-09
. O 0 5.651221712810184e-09

Heterozygous O 0 9.041582234203815e-05
mutations O 0 3.176781683578156e-05
in O 0 1.2580944064310984e-09
the O 0 2.4549823285369143e-10
human O 0 2.1747295075869033e-09
PAX6 O 0 4.506770892476197e-06
gene O 0 9.763247277305709e-08
result O 0 7.198868612334763e-09
in O 0 2.4238356113870374e-11
various O 0 2.4795648173592255e-11
phenotypes O 0 2.978975430778519e-07
, O 0 5.7546360038296385e-11
including O 0 1.9290606889654782e-09
aniridia B-Disease 1 1.0
, O 0 2.9708944566664286e-06
Peters B-Disease 1 0.9999972581863403
anomaly I-Disease 1 0.9999997615814209
, O 0 9.658156585601319e-08
autosomal B-Disease 1 0.6179777383804321
dominant I-Disease 0 0.004365508910268545
keratitis I-Disease 1 0.9836640357971191
, O 0 2.7770115096359405e-08
and O 0 6.378053285516216e-08
familial B-Disease 1 0.7698221206665039
foveal I-Disease 1 0.997271716594696
dysplasia I-Disease 1 0.998974084854126
. O 0 3.270577281000442e-06

It O 0 8.382625793501575e-08
is O 0 8.305700571753505e-10
believed O 0 2.2841537550277735e-09
that O 0 1.9216881558259402e-11
the O 0 1.049033082622941e-11
mutated O 0 2.1837294639226457e-08
allele O 0 1.1582469205961843e-08
of O 0 2.483644886974723e-11
PAX6 O 0 1.203286046802532e-06
produces O 0 9.64474611286903e-10
an O 0 1.382356555612585e-11
inactive O 0 1.9637602655109276e-09
protein O 0 1.978203600927486e-09
and O 0 1.8383691013923453e-08
aniridia B-Disease 1 0.9999997615814209
is O 0 4.4929299747309415e-07
caused O 0 3.6041544149156834e-07
due O 0 3.982385088363571e-09
to O 0 2.058034409557763e-09
genetic O 0 3.618520167947281e-06
haploinsufficiency O 0 0.00024484461755491793
. O 0 2.2050373971183035e-08

However O 0 3.514310265018139e-08
, O 0 1.5620412949224338e-11
several O 0 3.1437246469229185e-12
truncation O 0 1.4608807497040743e-08
mutations O 0 5.540996880881721e-06
have O 0 3.1847688930497497e-09
been O 0 9.299104819504578e-10
found O 0 1.1944158995191856e-09
to O 0 5.556859972166706e-10
occur O 0 1.00544088610377e-08
in O 0 3.9976855159551405e-11
the O 0 4.1049433296969084e-10
C O 0 8.690751656104112e-07
- O 0 3.7881056869082386e-07
terminal O 0 3.3596248005807183e-09
half O 0 1.6975343006264687e-11
of O 0 2.650236800849637e-12
PAX6 O 0 1.7540443764119118e-07
in O 0 5.545361392300663e-10
patients O 0 5.634503974505378e-10
with O 0 8.618032953933152e-10
Aniridia B-Disease 1 0.9999951124191284
resulting O 0 3.87857745920428e-08
in O 0 1.1491619461567737e-10
mutant O 0 7.268636803559048e-10
proteins O 0 2.0953037915827366e-11
that O 0 1.020090956149744e-11
retain O 0 3.0416921759091053e-10
the O 0 1.643365304948574e-11
DNA O 0 2.3845959873369793e-08
- O 0 1.3190009440222639e-07
binding O 0 1.2855566389191608e-08
domains O 0 9.080681984130479e-09
but O 0 3.9580472233069486e-09
have O 0 1.2842693575265685e-09
lost O 0 1.2755743128423092e-08
most O 0 3.698727088496945e-12
of O 0 1.593365630409016e-12
the O 0 1.8818478719762055e-10
transactivation O 0 1.2329707033131854e-06
domain O 0 4.83638658010932e-08
. O 0 5.63790392149599e-09

It O 0 3.2404258831775223e-08
is O 0 1.8851099847783104e-10
not O 0 2.2861214657443618e-11
clear O 0 7.837620830120073e-11
whether O 0 4.529911168393852e-11
such O 0 2.132407965482752e-11
mutants O 0 9.174535797740191e-09
really O 0 3.2528351567862046e-08
behave O 0 1.923039505413726e-09
as O 0 1.526083773240039e-11
loss O 0 1.6474500652563506e-09
- O 0 9.000842737805215e-09
of O 0 5.904107064358399e-11
- O 0 9.792245236894814e-07
function O 0 7.540393198723905e-09
mutants O 0 1.3465806247836554e-09
as O 0 2.952564234770527e-11
predicted O 0 2.6286035570421973e-09
by O 0 3.1037553083201885e-10
haploinsufficiency O 0 1.0122612366103567e-05
. O 0 1.7249995210022462e-08

Contrary O 0 4.0286354874297103e-07
to O 0 1.3904648266116482e-10
this O 0 3.306148063653147e-11
theory O 0 2.977285973315702e-09
, O 0 2.78072161651044e-12
our O 0 1.6074508044083835e-11
data O 0 3.0844635179327895e-10
showed O 0 3.732537390277457e-09
that O 0 6.576298533511604e-12
these O 0 2.1984733911822874e-12
mutants O 0 1.6907558686440893e-10
are O 0 8.807834669943837e-12
dominant O 0 2.48016340798074e-09
- O 0 5.976719563705046e-08
negative O 0 7.967372539496864e-09
in O 0 1.9855804500590324e-11
transient O 0 9.560130465047223e-10
transfection O 0 1.6465374130802957e-07
assays O 0 6.602106736863789e-07
when O 0 9.779458132186392e-09
they O 0 2.2699980783968954e-10
are O 0 4.2306904507460885e-12
coexpressed O 0 6.131325225311457e-09
with O 0 1.0948744688654699e-10
wild O 0 4.235252504258824e-08
- O 0 0.00010544303950155154
type O 0 0.00011182441812707111
PAX6 O 0 0.0002028478484135121
. O 0 6.980499733799661e-08

We O 0 1.2417697803357441e-07
found O 0 2.1521487370002035e-10
that O 0 1.6349458245579207e-11
the O 0 4.537223895206832e-12
dominant O 0 3.110651292104194e-08
- O 0 7.75916930706444e-07
negative O 0 2.2448645609074447e-07
effects O 0 6.503005920421856e-07
result O 0 4.203173364913937e-09
from O 0 4.1211864650059216e-12
the O 0 1.5107681815632046e-12
enhanced O 0 1.325289211706604e-09
DNA O 0 8.308651544552959e-09
binding O 0 3.023070016539009e-09
ability O 0 2.7645366551531936e-10
of O 0 2.239334368978052e-12
these O 0 5.079582240941072e-11
mutants O 0 1.0758902213581223e-08
. O 0 1.6751883213927954e-09

Kinetic O 0 7.762034329061862e-06
studies O 0 8.70514949014023e-09
of O 0 2.7825373949408316e-11
binding O 0 9.122522470761396e-08
and O 0 4.948488285805297e-09
dissociation O 0 1.74463330040453e-05
revealed O 0 3.4429998407858875e-08
that O 0 1.3729541592163996e-12
various O 0 1.8729146651543654e-13
truncation O 0 1.2632352941466252e-09
mutants O 0 4.705167366836349e-09
have O 0 6.300059779418277e-11
3 O 0 5.513799920114915e-12
- O 0 7.292637160816184e-09
5 O 0 4.8905334643079e-11
- O 0 2.054341052826203e-08
fold O 0 7.354363340539294e-09
higher O 0 1.1264795346521694e-10
affinity O 0 1.2504330036688938e-11
to O 0 4.4703303558879526e-13
various O 0 4.88771241362318e-13
DNA O 0 1.179672248774466e-09
- O 0 2.2561521539898877e-09
binding O 0 2.392908649007097e-10
sites O 0 4.773946862823841e-11
when O 0 1.4194588560112464e-10
compared O 0 5.654504295349305e-11
with O 0 4.4023448081409455e-12
the O 0 1.1253328130456097e-10
wild O 0 3.243282264975278e-08
- O 0 7.551885937573388e-05
type O 0 0.0001273899688385427
PAX6 O 0 0.00015438252012245357
. O 0 4.755886351404115e-08

These O 0 9.150226354392998e-09
results O 0 3.504228462958281e-09
provide O 0 6.51942666518579e-11
a O 0 7.924292472205607e-11
new O 0 9.170200189478894e-12
insight O 0 5.0873583123944854e-11
into O 0 5.604045873186525e-13
the O 0 1.2121640496909336e-12
role O 0 2.5539452497280735e-11
of O 0 4.94466924003123e-12
mutant O 0 1.0808739681067436e-08
PAX6 O 0 1.628810878173681e-06
in O 0 2.7852800066341388e-09
causing O 0 1.492982846684754e-06
aniridia B-Disease 1 0.9999914169311523
. O 0 6.62558674591196e-09
. O 0 4.76517270087129e-09

Reversal O 0 6.742448022123426e-05
of O 0 3.6125265978625976e-07
severe O 1 0.9545097947120667
hypertrophic B-Disease 1 0.9999545812606812
cardiomyopathy I-Disease 1 0.9999998807907104
and O 0 6.619790724471386e-07
excellent O 0 4.3120897430526384e-07
neuropsychologic O 0 4.702752903540386e-06
outcome O 0 1.9266609285750746e-07
in O 0 1.6874578401271378e-09
very B-Disease 0 2.91267649998872e-08
- I-Disease 0 2.0953699277015403e-05
long I-Disease 0 2.0180639239697484e-06
- I-Disease 0 2.0921432223985903e-05
chain I-Disease 0 8.114882803056389e-06
acyl I-Disease 0 5.748709099862026e-07
- I-Disease 0 5.800663416266616e-07
coenzyme I-Disease 0 2.3008216487596655e-07
A I-Disease 0 3.0734059919268475e-07
dehydrogenase I-Disease 0 0.0011492124758660793
deficiency I-Disease 0 0.4058361351490021
. O 0 2.458686942929944e-08

Very B-Disease 0 2.5202557480952237e-06
- I-Disease 0 3.2249117793980986e-05
long I-Disease 0 1.2911639259982621e-06
- I-Disease 0 1.3870692782802507e-05
chain I-Disease 0 1.7114507500082254e-05
acyl I-Disease 0 3.577720917746774e-06
- I-Disease 0 1.2957649460076937e-06
coenzyme I-Disease 0 6.695409382473372e-08
A I-Disease 0 6.045024480982875e-09
dehydrogenase I-Disease 0 4.1407989215258567e-07
( I-Disease 0 3.0879441226261406e-09
VLCAD I-Disease 0 0.012891375459730625
) I-Disease 0 3.6714489226596925e-08
deficiency I-Disease 0 0.0007795443525537848
is O 0 1.8216037567242438e-09
a O 0 3.446291998443485e-07
disorder O 0 0.001447271672077477
of O 0 9.457333804974155e-10
fatty O 0 3.7353747757151723e-06
acid O 0 1.2708629704150098e-08
beta O 0 3.004179197074741e-11
oxidation O 0 1.1959455648025141e-09
that O 0 6.277967590229139e-10
reportedly O 0 2.7467226004773693e-07
has O 0 3.2974289965181924e-09
high O 0 9.343557039187544e-09
rates O 0 2.020400415858603e-07
of O 0 2.3264862258898233e-10
morbidity O 0 0.003563626203685999
and O 0 1.5517785811880458e-07
mortality O 0 3.624503005994484e-05
. O 0 9.304076620253454e-09

We O 0 5.679492787180607e-08
describe O 0 4.039247158971193e-09
the O 0 2.3851701863586428e-11
outcome O 0 2.729343973051357e-10
of O 0 1.0539461013994722e-12
a O 0 1.1324382404032107e-10
5 O 0 4.702803077516471e-11
- O 0 9.115147747706942e-08
year O 0 3.807055559690298e-09
- O 0 1.4829123529125354e-06
old O 0 5.719615364796482e-05
girl O 0 0.0004625760193448514
with O 0 1.3599823205368011e-06
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
who O 0 1.9110404991806718e-07
was O 0 1.132944937864977e-08
first O 0 4.347756182854212e-11
seen O 0 1.8299658677278785e-08
at O 0 7.83095602252537e-11
5 O 0 6.944100676420373e-12
months O 0 6.306576094683436e-11
of O 0 1.2106119058608034e-11
age O 0 2.7906095212415494e-08
with O 0 3.862719566427586e-08
severe O 1 0.9942576885223389
hypertrophic B-Disease 1 0.9999955892562866
cardiomyopathy I-Disease 1 1.0
, O 0 0.038514748215675354
hepatomegaly B-Disease 1 0.9999998807907104
, O 0 1.9731793145183474e-05
encephalopathy B-Disease 1 0.5954298973083496
, O 0 6.219925907657853e-09
and O 0 3.29057598946747e-08
hypotonia B-Disease 0 0.0009253530879504979
. O 0 1.0914023818031637e-07

Biochemical O 0 0.0037137994077056646
studies O 0 0.00012391171185299754
indicated O 1 0.9804774522781372
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
caused O 0 3.2202224247157574e-05
by O 0 1.4935339631705347e-09
a O 0 1.481036662198676e-07
stable O 0 3.0465482268482447e-05
yet O 0 3.211470129826921e-07
inactive O 0 2.306271262852988e-08
enzyme O 0 7.005453106501136e-09
. O 0 1.970055452105157e-09

Molecular O 0 5.112998769618571e-05
genetic O 0 5.434218110167421e-06
analysis O 0 6.159105936376363e-08
of O 0 2.4655830155317915e-10
her O 0 6.320836973827682e-07
VLCAD O 0 0.017171710729599
gene O 0 9.48769240949332e-07
revealed O 0 7.201054472716351e-07
a O 0 3.5150728994182145e-09
T1372C O 0 1.856035254377275e-07
( O 0 9.762265995583164e-11
F458L O 0 1.2315090280878849e-08
) O 0 3.619683372479976e-11
missense O 0 4.497286226978758e-06
mutation O 0 9.14260272111278e-06
and O 0 2.3614390443071898e-09
a O 0 4.268177278277108e-08
1668 O 0 0.0011690324172377586
ACAG O 0 0.0005907948943786323
1669 O 0 2.7107637379231164e-06
splice O 0 6.566498996107839e-06
site O 0 5.214328666625079e-06
mutation O 0 0.00011024010018445551
. O 0 7.461508744199818e-08

After O 0 6.374839767175899e-09
initial O 0 6.8811676356972384e-09
treatment O 0 6.6924572550419725e-09
with O 0 1.2083425926512348e-10
intravenous O 0 3.8839152693981305e-07
glucose O 0 1.5249186617438681e-05
and O 0 6.1171214760236126e-09
carnitine O 0 1.3124251836416079e-06
, O 0 2.4427062803034083e-11
the O 0 2.043699931508769e-11
patient O 0 8.557628383698557e-09
has O 0 7.269326807168852e-11
thrived O 0 9.354804708650022e-10
on O 0 9.568280195937362e-11
a O 0 2.5675064296848404e-09
low O 0 2.365898126299726e-06
- O 0 1.1714706715793e-06
fat O 0 8.40027993831427e-08
diet O 0 1.2092603307589656e-10
supplemented O 0 1.027611884474311e-10
with O 0 4.445040169276382e-11
medium O 0 3.8583163330940806e-08
- O 0 8.701715614733985e-07
chain O 0 8.292378197438666e-07
triglyceride O 0 1.2591785889526363e-06
oil O 0 2.251918473916703e-08
and O 0 2.233454393651968e-10
carnitine O 0 2.0471134121180512e-07
and O 0 7.000960922098898e-10
avoidance O 0 3.4382983926661836e-07
of O 0 1.428726581487183e-10
fasting O 0 4.830209832107357e-08
. O 0 4.532300756920904e-09

Her O 0 1.0929269592452329e-05
ventricular O 0 0.00048635643906891346
hypertrophy O 0 0.0006282311514951289
resolved O 0 2.8985280096094357e-06
significantly O 0 1.815593542175975e-08
over O 0 4.3868592092266567e-10
1 O 0 8.191137212953947e-10
year O 0 1.8479374697122353e-09
, O 0 4.245987589301947e-11
and O 0 7.066608187500378e-09
cognitively O 0 2.746650716289878e-05
, O 0 1.1388671949941198e-10
she O 0 5.952601966896509e-08
is O 0 2.6574869041451343e-11
in O 0 3.4273989896194124e-12
the O 0 8.333747754385445e-12
superior O 0 1.2166733176499633e-09
range O 0 2.491651773794956e-09
for O 0 2.694779677181458e-10
age O 0 1.0039404862993706e-08
. O 0 2.058470061072626e-09

Clinical O 0 4.930354862153763e-06
recognition O 0 5.151459276930836e-07
of O 0 3.446243681537453e-06
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 4.229319472415227e-08
important O 0 1.8204332485893815e-09
because O 0 9.41477384941436e-09
it O 0 2.1196477906215705e-10
is O 0 2.0490041954812632e-11
one O 0 1.9447475314154916e-12
of O 0 2.2362642878963335e-13
the O 0 8.42732047340311e-12
few O 0 5.937741409667296e-10
directly O 0 1.8885073131968966e-06
treatable O 1 0.9049694538116455
causes O 0 2.43245438014128e-07
of O 0 2.040423474625186e-08
cardiomyopathy B-Disease 1 0.9999998807907104
in O 0 1.7986805289638141e-07
children O 0 3.424608863156209e-08
. O 0 1.804923432935368e-09
. O 0 4.744268977674437e-09

Cloning O 0 4.446471848496003e-07
of O 0 6.062641499937627e-10
a O 0 9.097909647870495e-10
novel O 0 1.239111702133755e-09
member O 0 3.756617239503157e-11
of O 0 6.808854261658448e-12
the O 0 7.729576978476871e-10
low O 0 1.6964977476163767e-05
- O 0 2.4841048798407428e-05
density O 0 1.5634854833024292e-07
lipoprotein O 0 0.00019760870782192796
receptor O 0 4.659631542835996e-07
family O 0 3.338114424877858e-07
. O 0 3.645108748173698e-08

A O 0 3.450849561659197e-08
gene O 0 6.877979075170515e-09
encoding O 0 3.249522206871802e-09
a O 0 1.6203379749057945e-09
novel O 0 1.0801279870520375e-08
transmembrane O 0 3.865362032229314e-06
protein O 0 1.7901474080872504e-08
was O 0 4.898473626724353e-09
identified O 0 8.042333465851925e-10
by O 0 7.576278146514959e-12
DNA O 0 2.120756903423171e-09
sequence O 0 1.4628422084772552e-10
analysis O 0 7.732312186370383e-12
within O 0 1.468358746224696e-12
the O 0 1.5329197633473512e-10
insulin B-Disease 0 0.003495179582387209
- I-Disease 1 0.9994706511497498
dependent I-Disease 1 0.9987817406654358
diabetes I-Disease 1 0.9999997615814209
mellitus I-Disease 1 0.9999994039535522
( O 0 1.3049999836312054e-07
IDDM B-Disease 0 0.0006075825658626854
) O 0 3.5286670807543885e-10
locus O 0 3.6244910006644204e-07
IDDM4 O 0 4.706391700892709e-05
on O 0 6.367697125142513e-08
chromosome O 0 7.211473712231964e-05
11q13 O 0 4.189927039988106e-06
. O 0 3.4659421999094775e-08

Based O 0 1.945671534997473e-08
on O 0 8.729271194773958e-10
its O 0 1.932701915174917e-10
chromosomal O 0 0.0005404747789725661
position O 0 3.9954567910172045e-05
, O 0 1.3303258494801184e-10
this O 0 1.5984132420432395e-11
gene O 0 4.6495945982272247e-10
is O 0 6.642950078905585e-12
a O 0 1.3121682559957826e-11
candidate O 0 8.056028621972189e-10
for O 0 1.5277583018113994e-11
conferring O 0 3.2032545504989685e-07
susceptibility O 0 0.002604007488116622
to O 0 1.0707782394092646e-06
diabetes B-Disease 0 0.017072735354304314
. O 0 2.1997281862695672e-07

The O 0 6.781893269192096e-09
gene O 0 4.178667367682465e-08
, O 0 2.4667731746141897e-10
termed O 0 1.6467603813907772e-07
low O 0 7.5920911513094325e-06
- O 0 1.3003877938899677e-05
density O 0 1.544879921766551e-07
lipoprotein O 0 4.280951907276176e-05
receptor O 0 4.5006789406443204e-08
related O 0 3.469044074222438e-08
protein O 0 1.4091824596107472e-08
5 O 0 3.475232601690692e-10
( O 0 2.7305716715497752e-11
LRP5 O 0 1.3229849173512775e-05
) O 0 7.828951029131836e-12
, O 0 4.5050134412846776e-13
encodes O 0 2.1259629473524555e-11
a O 0 1.3540436827330637e-10
protein O 0 5.159664917542273e-10
of O 0 2.1476943487530598e-11
1615 O 0 7.78761568653863e-06
amino O 0 7.3207888640069996e-09
acids O 0 3.212630439453079e-10
that O 0 1.070123416962998e-11
contains O 0 2.5815476492607736e-11
conserved O 0 3.309128970840902e-09
modules O 0 1.017706008354935e-08
which O 0 7.356505959954518e-10
are O 0 1.6580023812218236e-11
characteristic O 0 5.483289378105383e-09
of O 0 2.191691966801912e-11
the O 0 1.8956318736940148e-09
low O 0 0.00012373249046504498
- O 0 0.00043524723150767386
density O 0 2.6964719381794566e-06
lipoprotein O 0 0.2863385081291199
( O 0 1.1437009561632294e-08
LDL O 0 0.0002034618955804035
) O 0 9.301671932693267e-11
receptor O 0 7.940217372492953e-09
family O 0 3.225422773311948e-08
. O 0 1.194284404704149e-08

These O 0 8.879299073782931e-09
modules O 0 9.827289204622502e-09
include O 0 1.0629754715330009e-10
a O 0 6.572279942496095e-10
putative O 0 2.1131668859197816e-08
signal O 0 1.6583337369979745e-08
peptide O 0 1.2463292620168431e-09
for O 0 1.0275834003148354e-12
protein O 0 1.1199961097441147e-11
export O 0 1.530021248585811e-11
, O 0 1.6853773151387363e-12
four O 0 6.662084946207347e-12
epidermal O 0 7.708824512064893e-08
growth O 0 1.4610952447924319e-08
factor O 0 1.683176042988066e-09
( O 0 2.40882504914941e-11
EGF O 0 2.1888753920507042e-08
) O 0 3.508302372570715e-12
repeats O 0 1.0439044073606851e-09
with O 0 1.678439331964654e-11
associated O 0 3.0204361234353883e-09
spacer O 0 1.5029013411549386e-07
domains O 0 6.464101431902236e-08
, O 0 5.758149859702577e-11
three O 0 2.2256468890091696e-10
LDL O 0 0.0001511136651970446
- O 0 2.285818936798023e-06
receptor O 0 3.0555927565956154e-08
( O 0 1.799868865060006e-10
LDLR O 0 3.011839908140246e-06
) O 0 1.3459732460530116e-11
repeats O 0 6.399900165376948e-09
, O 0 3.454187890578053e-12
a O 0 5.959113758002843e-11
single O 0 3.1919281440195846e-08
transmembrane O 0 1.2959785067323537e-07
spanning O 0 6.317875556050012e-09
domain O 0 4.1679673046246535e-09
, O 0 4.047926924211076e-11
and O 0 4.05478879639265e-11
a O 0 1.4411886128939955e-09
cytoplasmic O 0 1.2044004904510075e-07
domain O 0 1.4737271669673646e-07
. O 0 2.118894038005692e-08

The O 0 3.458636488318234e-09
encoded O 0 1.75880074948509e-08
protein O 0 1.0853652199216413e-08
has O 0 2.0532892053282126e-10
a O 0 6.097289340090128e-11
unique O 0 8.557755060145666e-10
organization O 0 1.1140264058462357e-11
of O 0 3.3711998036894952e-12
EGF O 0 9.27969452391153e-08
and O 0 4.268319309108648e-10
LDLR O 0 4.234398602420697e-06
repeats O 0 4.75187853510306e-08
; O 0 5.5326805636912724e-11
therefore O 0 6.26234550327176e-11
, O 0 5.450632566822433e-12
LRP5 O 0 4.981137635695632e-07
likely O 0 3.262551784288803e-09
represents O 0 1.060043719469661e-10
a O 0 9.926937050153128e-11
new O 0 4.1446086146423866e-11
category O 0 4.83043494092783e-10
of O 0 2.6638188183047973e-12
the O 0 5.358361532259437e-10
LDLR O 0 0.00023773724387865514
family O 0 7.556695180710449e-08
. O 0 1.0987332821343898e-08

Both O 0 4.426113164868184e-08
human O 0 1.2620173350796904e-08
and O 0 5.075788123143354e-10
mouse O 0 4.36504194567533e-07
LRP5 O 0 4.9922859034268185e-05
cDNAs O 0 1.6596997056694818e-06
have O 0 7.554587178049132e-09
been O 0 3.086518818307127e-09
isolated O 0 1.4570517237189051e-08
and O 0 2.0997856231552703e-10
the O 0 1.484291509146196e-11
encoded O 0 9.566660796878068e-10
mature O 0 3.137725357316157e-10
proteins O 0 1.2958321481820745e-12
are O 0 1.7094154867655642e-12
95 O 0 2.075359849251779e-12
% O 0 1.1299501265216172e-11
identical O 0 1.6867012391230674e-06
, O 0 1.5178634737988972e-10
indicating O 0 4.2675587508256285e-08
a O 0 1.6590225859758334e-09
high O 0 8.36711144813762e-09
degree O 0 9.054423322218952e-10
of O 0 7.264222643549312e-12
evolutionary O 0 2.7336384267329095e-09
conservation O 0 4.793274110959089e-10
. O 0 6.179336903278099e-11
. O 0 1.0397592786759446e-09

The O 0 2.21016609458502e-08
APC B-Disease 0 7.496171861021139e-08
variants O 0 3.490180366938489e-09
I1307K O 0 1.1106674691063745e-08
and O 0 9.74291966548968e-11
E1317Q O 0 8.350276026192205e-09
are O 0 5.323216867303415e-10
associated O 0 2.189783117501065e-06
with O 1 0.9971590042114258
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 0.00010399948223493993
but O 0 2.770071887425729e-07
not O 0 1.789300974053276e-08
always O 0 1.5253702301265548e-08
with O 0 2.6682694248547634e-11
a O 0 4.35161018330632e-09
family O 0 2.4019604083491686e-08
history O 0 3.027156481039128e-08
. O 0 3.3686724520975986e-09

Classical O 1 0.5296648144721985
familial B-Disease 1 0.9999959468841553
adenomatous I-Disease 1 0.9999634027481079
polyposis I-Disease 1 0.9999960660934448
( O 0 7.208508918665757e-07
FAP B-Disease 0 8.736524250707589e-06
) O 0 6.979841704612966e-10
is O 0 2.9751670571620537e-10
a O 0 4.5087791278319855e-09
high O 0 1.2251455700607039e-05
- O 1 0.9947465062141418
penetrance O 1 0.9950729012489319
autosomal B-Disease 1 0.9998354911804199
dominant I-Disease 1 0.9803007245063782
disease I-Disease 0 0.0009810751071199775
that O 0 9.616439866633186e-10
predisposes O 0 7.837825677370347e-08
to O 0 3.093883482740978e-11
hundreds O 0 6.336913632720709e-11
or O 0 6.276507091840244e-10
thousands O 0 7.129000723082868e-10
of O 0 1.44326565987285e-06
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999998807907104
and I-Disease 1 0.9592952132225037
carcinoma I-Disease 1 1.0
and O 0 6.587207508346182e-07
that O 0 6.996345724985531e-09
results O 0 1.0204539435676452e-09
from O 0 2.1214668910474188e-11
truncating O 0 1.0562590091467428e-07
mutations O 0 3.1681099699198967e-07
in O 0 1.675682925750266e-10
the O 0 1.7530049634117972e-10
APC B-Disease 0 1.2242726654676517e-07
gene O 0 6.43332711547373e-08
. O 0 1.0447495313314903e-08

A O 0 2.450842657708563e-07
variant O 0 1.0223158142252942e-06
of O 0 3.626196676265181e-09
FAP B-Disease 0 9.1964153398294e-05
is O 0 9.258025102099054e-07
attenuated B-Disease 1 0.9753984212875366
adenomatous I-Disease 1 0.9999947547912598
polyposis I-Disease 1 0.9999511241912842
coli I-Disease 1 0.9999841451644897
, O 0 1.2132328031100315e-08
which O 0 3.6476710540966906e-10
results O 0 8.106369464577767e-10
from O 0 2.1158347296434954e-10
germ O 0 0.0010453922441229224
- O 0 0.00026862751110456884
line O 0 8.318029358633794e-06
mutations O 0 1.1388872422912755e-07
in O 0 2.545337725312624e-11
the O 0 6.495357203484264e-12
5 O 0 1.4450599571114164e-11
and O 0 2.599235757183571e-11
3 O 0 9.317630868255211e-12
regions O 0 5.151399706110338e-12
of O 0 3.029402900409095e-12
the O 0 3.8425812531883707e-10
APC B-Disease 0 8.509844207083006e-08
gene O 0 4.1010505213989745e-08
. O 0 8.249970484541791e-09

Attenuated B-Disease 1 0.997908353805542
adenomatous I-Disease 1 0.9999661445617676
polyposis I-Disease 1 0.9999321699142456
coli I-Disease 1 0.9999940395355225
patients O 1 0.6040863990783691
have O 0 3.5084840988020005e-07
" O 0 2.3644600943839578e-08
multiple O 0 4.6624768401670735e-06
" O 0 0.09290599077939987
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.999996542930603
( O 0 1.0027233265930136e-08
typically O 0 7.2697776687391524e-09
fewer O 0 1.2509990265918702e-10
than O 0 4.5364472595066374e-11
100 O 0 2.1811701750307222e-11
) O 0 1.7119769143980612e-12
without O 0 2.1285922677249935e-11
the O 0 4.921243967892508e-11
florid O 0 1.0485790880920831e-05
phenotype O 0 4.872571253144997e-07
of O 0 1.804447563591438e-10
classical O 0 2.827455602982809e-07
FAP B-Disease 0 6.210424999153474e-06
. O 0 2.1788077120277194e-08

Another O 0 4.1646792681149236e-08
group O 0 2.505735174906931e-09
of O 0 5.0538372098341e-11
patients O 0 8.773822779417628e-10
with O 0 1.2452593123324363e-10
multiple O 0 1.368343532703875e-06
adenomas B-Disease 0 0.0010110716102644801
has O 0 1.1970672630923218e-07
no O 0 6.495788351656984e-09
mutations O 0 2.2373280117449212e-08
in O 0 3.034759943343346e-11
the O 0 2.9865027117992327e-11
APC B-Disease 0 2.1545853989834995e-09
gene O 0 1.3526866293744888e-09
, O 0 5.146057625166067e-12
and O 0 2.9294424525039275e-11
their O 0 1.7972857924153374e-10
phenotype O 0 1.924176444845216e-07
probably O 0 6.674916175342105e-09
results O 0 1.0528421190425519e-10
from O 0 1.1883197334125462e-12
variation O 0 1.8213849317660902e-09
at O 0 4.508658779656116e-09
a O 0 1.589112952338212e-09
locus O 0 3.0337639600475086e-07
, O 0 7.058881951182983e-11
or O 0 1.1724353432551737e-10
loci O 0 4.84151274626754e-10
, O 0 4.6546856646845214e-11
elsewhere O 0 8.791495864635124e-10
in O 0 9.752960244968634e-11
the O 0 2.970262646950772e-10
genome O 0 2.7085460985176724e-08
. O 0 6.949690156687893e-09

Recently O 0 8.488499588565901e-05
, O 0 5.746084164037768e-10
however O 0 1.1738450489406915e-10
, O 0 3.188866922257394e-12
a O 0 1.2445944275185639e-10
missense O 0 4.733804871648317e-06
variant O 0 4.2588379756125505e-07
of O 0 5.220266441341437e-10
APC B-Disease 0 1.5969946787208755e-07
( O 0 7.607023344569086e-11
I1307K O 0 8.342921020698668e-09
) O 0 2.0475626402727265e-11
was O 0 1.6962543591958479e-09
described O 0 4.331801584100958e-09
that O 0 3.8374449451428205e-11
confers O 0 3.5417768717849185e-09
an O 0 2.414639495296189e-11
increased O 0 7.044339156436763e-08
risk O 0 9.655601024860516e-05
of O 0 0.04878528043627739
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 1.0778583714454726e-07
including O 0 7.264534529483058e-10
multiple O 0 2.9676502322217857e-07
adenomas B-Disease 0 0.0001870381092885509
, O 0 4.176991641458017e-09
in O 0 5.34800026485982e-09
Ashkenazim O 0 9.937851245922502e-06
. O 0 6.857939638393873e-08

We O 0 1.1460175528554828e-06
have O 0 1.3217903438444978e-09
studied O 0 1.1017083911823988e-09
a O 0 1.039540675762396e-10
set O 0 5.262835722774639e-10
of O 0 5.0998107646582636e-12
164 O 0 7.763841791685877e-10
patients O 0 1.3582710511883533e-09
with O 0 1.548732520006979e-08
multiple O 1 0.9995575547218323
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999997615814209
and I-Disease 0 0.04470838978886604
/ I-Disease 0 0.05407235026359558
or I-Disease 0 0.002125895582139492
carcinoma I-Disease 1 1.0
and O 0 1.8232440197607502e-06
analyzed O 0 2.0811905415030196e-05
codons O 0 4.0621341668156674e-07
1263 O 0 1.610406798135955e-05
- O 0 2.9647851988556795e-05
1377 O 0 6.6076836446882226e-06
( O 0 1.871681837295469e-10
exon O 0 1.6187593132599432e-07
15G O 0 1.3497097484105325e-07
) O 0 2.5091077219402402e-12
of O 0 4.451034267723142e-13
the O 0 5.521861613788648e-12
APC B-Disease 0 1.798250326423556e-09
gene O 0 1.075116329296577e-09
for O 0 3.253948777093285e-10
germ O 0 0.00407274067401886
- O 0 4.9199839850189164e-05
line O 0 2.0245465748303104e-06
variants O 0 1.5830246979930962e-07
. O 0 1.1038332914381499e-08

Three O 0 3.346248078628378e-08
patients O 0 7.48591055810266e-09
with O 0 6.474506347720066e-11
the O 0 3.224164824011666e-10
I1307K O 0 1.3236306983799295e-07
allele O 0 4.0427718772662047e-07
were O 0 6.591679646561488e-09
detected O 0 1.3326402950042393e-06
, O 0 4.169082180177641e-12
each O 0 1.3739292689662896e-11
of O 0 1.0617029477799633e-10
Ashkenazi O 0 8.887569720172905e-07
descent O 0 2.7932301236432977e-06
. O 0 4.104736106569362e-08

Four O 0 7.996728612624793e-08
patients O 0 5.76259751028374e-08
had O 0 6.0517155731076855e-09
a O 0 4.5502477341585745e-09
germ O 0 0.028311962261795998
- O 0 0.00012447686458472162
line O 0 3.5129841080561164e-07
E1317Q O 0 3.0576330800613505e-08
missense O 0 1.7676227059837402e-07
variant O 0 1.059115106727404e-08
of O 0 1.0902685004809953e-11
APC O 0 5.438055339368475e-09
that O 0 1.6333516761335432e-09
was O 0 1.2761802281602286e-08
not O 0 1.0426125240936557e-10
present O 0 1.5774185777028826e-11
in O 0 4.590849922436746e-11
controls O 0 1.4610423981764598e-08
; O 0 1.0499818896281266e-11
one O 0 3.424249382308342e-12
of O 0 1.1064913091676787e-12
these O 0 4.0792549893531316e-11
individuals O 0 7.012236624692747e-11
had O 0 1.1510628006305978e-08
an O 0 9.207461182381138e-12
unusually O 0 1.0471195466266181e-08
large O 0 7.080757646882319e-10
number O 0 9.954201352080361e-11
of O 0 1.2265561830093752e-11
metaplastic B-Disease 0 1.06248592146585e-06
polyps I-Disease 0 1.046660713655001e-07
of I-Disease 0 3.699137871016056e-11
the I-Disease 0 1.3769790863094045e-09
colorectum I-Disease 0 1.3237534403742757e-05
. O 0 2.088452077941838e-08

There O 0 2.265273124635314e-08
is O 0 1.5955811671908293e-10
increasing O 0 1.2858004938554046e-10
evidence O 0 1.4547709703549572e-09
that O 0 1.5425994925877262e-09
there O 0 6.451556511244405e-10
exist O 0 2.9355602393366098e-08
germ O 0 2.1603289496852085e-05
- O 0 4.599954763762071e-07
line O 0 5.516238132940998e-09
variants O 0 5.836903183009667e-11
of O 0 5.545183995141201e-13
the O 0 9.010345421167631e-12
APC B-Disease 0 7.08767600166027e-10
gene O 0 1.9295785802508902e-10
that O 0 2.7521400089436376e-11
predispose O 0 3.4857078334837865e-10
to O 0 8.366332800158194e-12
the O 0 1.322202503734049e-11
development O 0 1.094143265573111e-11
of O 0 4.708459733215875e-10
multiple O 1 0.9903895258903503
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9993160963058472
carcinoma I-Disease 1 1.0
, O 0 4.091690186669439e-08
but O 0 3.307007445663146e-10
without O 0 7.867170803699253e-11
the O 0 1.802410304341251e-11
florid O 0 5.627181053569075e-06
phenotype O 0 3.2394243731914685e-08
of O 0 4.0567206711916715e-12
classical O 0 1.0276854034430016e-08
FAP B-Disease 0 6.374404648568088e-08
, O 0 1.517993022948083e-11
and O 0 1.4245896996778473e-11
possibly O 0 1.2849057928754348e-10
with O 0 2.2099435129097067e-11
importance O 0 2.2857636849948904e-07
for O 0 0.10164717584848404
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 0 0.05665474012494087
in O 0 1.7839831001342787e-10
the O 0 6.05699474950927e-12
general O 0 2.9644935811701245e-11
population O 0 1.9641179307972045e-11
. O 0 1.0712879194851865e-10
. O 0 1.5391873331438433e-09

Genomic O 0 3.8411931200244e-06
structure O 0 5.348574632080272e-07
of O 0 2.565488099737223e-10
the O 0 1.5180503964984382e-08
human O 0 0.00026773512945510447
congenital B-Disease 1 0.9999992847442627
chloride I-Disease 1 0.9999973773956299
diarrhea I-Disease 1 1.0
( O 0 4.274093953426927e-06
CLD B-Disease 0 0.059727150946855545
) O 0 3.0115137050756857e-09
gene O 0 1.5099350036962278e-07
. O 0 2.6081192316951274e-08

Congenital B-Disease 1 0.999998927116394
chloride I-Disease 1 0.999985933303833
diarrhea I-Disease 1 0.9999997615814209
( O 0 3.5961586490884656e-06
CLD B-Disease 0 0.4194561243057251
) O 0 2.7438038507909823e-09
is O 0 1.3270092802386557e-09
caused O 0 3.579764040750888e-08
by O 0 7.80708331316049e-10
mutations O 0 4.166211510892026e-06
in O 0 4.841993472837203e-10
a O 0 1.6921439804917782e-09
gene O 0 8.2629147968305e-09
which O 0 2.808141497112615e-10
encodes O 0 1.0459219268454945e-08
an O 0 6.671390551105105e-09
intestinal O 1 0.818327009677887
anion O 0 0.003542725695297122
transporter O 0 0.001731513999402523
. O 0 1.368361495224235e-07

We O 0 1.6711686612325138e-06
report O 0 4.948695675466297e-09
here O 0 1.0514313725229485e-10
the O 0 2.346023549038012e-12
complete O 0 3.2389251003461794e-11
genomic O 0 4.351973226235373e-10
organization O 0 1.1175592569412363e-11
of O 0 5.447636699379421e-13
the O 0 1.8475020124864017e-11
human O 0 6.276818509398652e-10
CLD B-Disease 0 3.430124479564256e-06
gene O 0 9.559406599635167e-09
which O 0 3.8570688309924606e-10
spans O 0 7.48034345576798e-09
approximately O 0 1.4131860959221143e-10
39kb O 0 8.353399607585743e-07
, O 0 7.111966571216044e-11
and O 0 8.485810665259663e-11
comprises O 0 1.0023857438534733e-10
21 O 0 2.7421387382986495e-10
exons O 0 8.824196129353368e-08
. O 0 1.5425619892539544e-08

All O 0 1.0627738689095168e-08
exon O 0 2.3176564809546107e-06
/ O 0 8.887433864401828e-07
intron O 0 1.2571963452501222e-06
boundaries O 0 1.2231425650099936e-08
conform O 0 6.614919811909203e-08
to O 0 1.197323490353952e-10
the O 0 9.594321170869335e-11
GT O 0 4.98128542858467e-07
/ O 0 1.495937453910301e-06
AG O 0 0.00769519479945302
rule O 0 2.0441267167825572e-07
. O 0 1.7028584764489096e-08

An O 0 5.258139479380475e-10
analysis O 0 6.235316707403626e-10
of O 0 4.085427742633874e-12
the O 0 1.785772744955505e-11
putative O 0 3.720221997127737e-08
promoter O 0 1.2328342791079194e-06
region O 0 2.3029116391626303e-09
sequence O 0 5.56701240661539e-10
shows O 0 1.7731148771460425e-09
a O 0 3.9256703443513175e-10
putative O 0 5.494555921359279e-07
TATA O 0 3.5502509945217753e-06
box O 0 1.5284506389434682e-06
and O 0 3.423052952200578e-09
predicts O 0 3.695624783972562e-08
multiple O 0 1.6446651818213809e-09
transcription O 0 1.3118116592991669e-09
factor O 0 6.434375809938331e-10
binding O 0 1.9704772924455938e-08
sites O 0 3.976716911324729e-08
. O 0 1.2856081532675034e-08

The O 0 3.6924872048871293e-09
genomic O 0 2.528382765376591e-07
structure O 0 1.6966522480288404e-06
was O 0 9.43870581693318e-09
determined O 0 1.602918131560216e-09
using O 0 4.7625420968033794e-11
DNA O 0 7.212419994573338e-09
from O 0 3.024114812733014e-12
several O 0 1.0661907554748717e-12
sources O 0 1.273515754657284e-11
including O 0 3.2311245692917545e-12
multiple O 0 8.444271948349069e-10
large O 0 1.387694936738626e-08
- O 0 1.90703576663509e-05
insert O 0 4.5886855559729156e-07
libaries O 0 4.0567761061538476e-07
and O 0 5.033443106761126e-11
genomic O 0 1.2555725348306623e-09
DNA O 0 2.8064736312671812e-08
from O 0 9.762717301242674e-10
Finnish O 0 0.0032642532605677843
CLD B-Disease 0 0.15860512852668762
patients O 0 1.72596784864254e-07
and O 0 5.137160474788516e-09
controls O 0 2.3882432742539095e-06
. O 0 4.417148247171099e-08

Exon O 0 2.7884345399797894e-05
- O 0 4.621042990038404e-06
specific O 0 1.6846993133867727e-08
primers O 0 3.5041748560615815e-06
developed O 0 3.758214006666094e-08
in O 0 1.822662853978585e-10
this O 0 1.929194651251187e-11
study O 0 1.7869039581341895e-11
will O 0 1.4454403819696982e-11
facilitate O 0 2.9733729367542594e-11
mutation O 0 1.7515160877223934e-08
screening O 0 3.9970776688491583e-10
studies O 0 1.1897950680239688e-10
of O 0 1.0853470032434753e-11
patients O 0 7.523853762236854e-10
with O 0 3.0204919121423757e-10
the O 0 1.3214700800290302e-07
disease O 0 3.2820429623825476e-05
. O 0 4.7386645718461295e-08

Genomic O 0 6.649928536717198e-07
sequencing O 0 4.4164323753648205e-08
of O 0 6.282735443008391e-10
a O 0 2.4377300178457517e-08
BAC O 0 0.00020229429355822504
clone O 0 0.00012455570686142892
H O 1 0.9999997615814209
_ O 0 2.5436721173832666e-08
RG364P16 O 0 1.4120289826280441e-08
revealed O 0 4.133670739037143e-09
the O 0 4.474683210770047e-12
presence O 0 2.3225036477336758e-11
of O 0 1.7052666787323312e-12
another O 0 1.1967778157373488e-10
, O 0 6.738224561653183e-12
highly O 0 4.6482265952940693e-11
homologous O 0 7.090948384025353e-10
gene O 0 1.6640108180254742e-09
3 O 0 1.0956739855683129e-11
of O 0 2.232447083097555e-12
the O 0 6.083213377472418e-10
CLD B-Disease 0 2.497304194548633e-05
gene O 0 2.063199922019976e-08
, O 0 9.864005445781032e-12
with O 0 4.138208439113944e-12
a O 0 4.1921704996283893e-10
similar O 0 2.271051791069567e-09
genomic O 0 2.83056831307249e-08
structure O 0 1.5106580804058467e-06
, O 0 6.537394930949958e-11
recently O 0 9.262043576541146e-09
identified O 0 3.348661081759019e-08
as O 0 7.792370082526645e-10
the O 0 2.473504537192639e-06
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
gene O 0 3.36820594384335e-05
( O 0 2.3560493556118445e-09
PDS B-Disease 0 6.290874352998799e-06
) O 0 9.220013641453306e-11
. O 0 1.3836445877934977e-10
. O 0 3.0739815137792448e-09

The O 0 2.3668153659173186e-08
APCI1307K O 0 0.00012111994146835059
allele O 0 4.3761323468061164e-05
and O 0 1.341083901706952e-07
cancer B-Disease 0 3.830578498309478e-05
risk O 0 1.4202585134626133e-06
in O 0 4.319918311956883e-10
a O 0 1.5784373808003238e-09
community O 0 8.014200414407924e-11
- O 0 1.689058137799293e-07
based O 0 7.455726036553756e-10
study O 0 4.660815483559233e-11
of O 0 2.856586495125768e-11
Ashkenazi O 0 1.5399537289795262e-07
Jews O 0 4.438295064801423e-08
. O 0 1.1061917604138216e-08

Mutations O 0 0.002310269745066762
in O 0 4.381444895784625e-08
APC O 0 2.1269208900775993e-06
are O 0 1.594676213301227e-08
classically O 0 0.2607536315917969
associated O 0 1.1737088243535254e-05
with O 0 2.376492921030149e-05
familial B-Disease 1 0.9999998807907104
adenomatous I-Disease 1 0.999996542930603
polyposis I-Disease 1 0.9999994039535522
( O 0 4.917835667583859e-07
FAP B-Disease 0 2.3057623366185e-06
) O 0 1.7507092997526286e-10
, O 0 1.364069707882054e-11
a O 0 2.0235786379885212e-09
highly O 0 0.007854238152503967
penetrant O 1 0.9999876022338867
autosomal B-Disease 1 1.0
dominant I-Disease 1 0.999998927116394
disorder I-Disease 1 1.0
characterized O 0 0.0035692539531737566
by O 0 3.262453773800189e-08
multiple O 0 0.005999945569783449
intestinal O 1 0.9995525479316711
polyps B-Disease 0 0.011228852905333042
and O 0 1.9105952375753077e-08
, O 0 1.5313000867323012e-11
without O 0 7.161281984080503e-11
surgical O 0 9.797156863555756e-09
intervention O 0 2.7353805887031513e-09
, O 0 6.4793461394818674e-12
the O 0 5.243532170962073e-12
development O 0 3.4911507018620114e-10
of O 0 2.1556797946686856e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 1.5010334664111724e-06
CRC B-Disease 0 0.0002791148435790092
) O 0 1.978328167950849e-09
. O 0 4.826928190482249e-09

APC B-Disease 0 3.29165268340148e-05
is O 0 3.2547283979056374e-08
a O 0 1.2060669973834592e-07
tumour O 1 0.9999964237213135
- O 0 0.0015763374976813793
suppressor O 0 0.00017797730106394738
gene O 0 3.336427596423164e-07
, O 0 7.068043372804311e-11
and O 0 9.113292759321823e-11
somatic O 0 1.52587730894993e-07
loss O 0 3.1518295600108104e-06
occurs O 0 8.69488232524418e-08
in O 0 6.787900730387264e-08
tumours B-Disease 1 0.9999947547912598
. O 0 5.579432809099671e-07

The O 0 5.758356280693988e-08
germline O 0 2.7082702217740007e-05
T O 0 0.00018195911252405494
- O 0 1.1062887779189623e-06
to O 0 1.0255936100378449e-09
- O 0 9.433126706426265e-07
A O 0 3.871068443572767e-08
transversion O 0 6.188180350363837e-07
responsible O 0 8.800354334148608e-10
for O 0 2.262228815733125e-12
the O 0 3.099102788631236e-12
APC O 0 7.184311479058181e-10
I1307K O 0 3.99534738626528e-10
allele O 0 2.761121886685203e-10
converts O 0 3.689935162975999e-11
the O 0 6.072147992752797e-12
wild O 0 2.8411561991958934e-10
- O 0 2.7426017012999182e-08
type O 0 3.546808358123599e-08
sequence O 0 3.1942146150321094e-10
to O 0 2.8478604890969095e-11
a O 0 1.1343418648834813e-08
homopolymer O 0 0.010431945323944092
tract O 0 0.00048174060066230595
( O 0 4.958425336987204e-10
A8 O 0 1.7353670500597218e-06
) O 0 2.139203050810501e-11
that O 0 3.1043947967823726e-10
is O 0 2.158620837633407e-09
genetically O 0 2.5860717300929537e-07
unstable O 0 0.0011579032288864255
and O 0 1.6491792109718517e-07
prone O 0 0.00017380744975525886
to O 0 2.919070984930272e-09
somatic O 0 5.799060090794228e-06
mutation O 0 6.768667662981898e-05
. O 0 5.076044828911108e-08

The O 0 2.441671220765329e-08
I1307K O 0 9.19712078939483e-07
allele O 0 6.077193120290758e-06
was O 0 3.345111920793897e-08
found O 0 2.8528106543745935e-09
in O 0 8.048932631510297e-10
6 O 0 8.363569392599857e-09
. O 0 8.632975223576977e-09

1 O 0 3.058916675513501e-08
% O 0 5.814737580323026e-10
of O 0 3.527978950645938e-11
unselected O 0 1.6001769836293533e-05
Ashkenazi O 0 3.840522822429193e-06
Jews O 0 5.1571710457665176e-08
and O 0 1.0392239291334704e-09
higher O 0 6.862516332972746e-09
proportions O 0 1.151127051457479e-07
of O 0 2.1778653533366388e-11
Ashkenazim O 0 2.3020398032258527e-07
with O 0 2.3416937833253826e-10
family O 0 4.627408234370023e-09
or O 0 1.8163268666882004e-09
personal O 0 4.6939209141783067e-07
histories O 0 1.6144809933393844e-07
of O 0 4.684954091338511e-10
CRC B-Disease 0 1.7328338799416088e-05
( O 0 1.7599330326412144e-10
ref O 0 1.3654867871082388e-05
. O 0 9.370461351299042e-11
2 O 0 2.88072843357412e-10
) O 0 1.1330648225227336e-10
. O 0 3.5419254196256134e-09

To O 0 4.271351272677748e-09
evaluate O 0 1.1936467814166463e-08
the O 0 1.0611517740899412e-11
role O 0 3.598461112419571e-11
of O 0 4.526298173074261e-12
I1307K O 0 1.2725754672260337e-08
in O 0 2.9437952075994644e-09
cancer B-Disease 0 3.9055399270182534e-07
, O 0 4.797881536511284e-11
we O 0 4.6182707658104505e-10
genotyped O 0 1.527635440368158e-08
5 O 0 1.5162423400161273e-11
, O 0 3.805576079957129e-12
081 O 0 9.228467767741222e-09
Ashkenazi O 0 6.151378961760656e-09
volunteers O 0 1.9664954387099698e-10
in O 0 9.694057362397146e-11
a O 0 7.630087672794161e-10
community O 0 1.8620677222358495e-10
survey O 0 7.308946692319296e-08
. O 0 4.301716316490456e-09

Risk O 0 2.4843820938258432e-05
of O 0 3.102052614778472e-09
developing O 0 1.6749932001403067e-06
colorectal B-Disease 1 0.9999998807907104
, I-Disease 0 2.9044995244476013e-06
breast I-Disease 0 0.1509760171175003
and I-Disease 0 2.7636070853986894e-07
other I-Disease 0 9.06030184211204e-09
cancers I-Disease 0 0.011539816856384277
were O 0 1.84371007350137e-08
compared O 0 5.247582368639314e-09
between O 0 1.0905789465942561e-10
genotyped O 0 1.2072453614564438e-07
I1307K O 0 7.66983809796784e-09
carriers O 0 6.053917367410122e-10
and O 0 6.352088299799163e-11
non O 0 2.6870911051801727e-10
- O 0 9.801403422216026e-08
carriers O 0 2.8514888228414748e-09
and O 0 3.6308851758537486e-11
their O 0 1.1167452379501341e-11
first O 0 1.0366933700378667e-10
- O 0 2.8419052000572265e-07
degree O 0 5.031617078543604e-08
relatives O 0 2.4513166607675885e-08
. O 0 4.275883647153478e-09

Sperm O 0 6.424230832635658e-06
DNA O 0 2.0847407995461253e-06
analysis O 0 4.228956740348622e-08
in O 0 1.0552310136802134e-09
a O 0 1.1084478046541335e-07
Friedreich B-Disease 1 0.8228651881217957
ataxia I-Disease 1 0.9987829327583313
premutation O 1 0.5543630123138428
carrier O 0 9.267812129110098e-05
suggests O 0 1.678182570685749e-08
both O 0 1.7817242473072703e-11
meiotic O 0 7.990401940105585e-08
and O 0 1.9106589921324968e-10
mitotic O 0 2.5659510072273406e-08
expansion O 0 7.1044214955406915e-09
in O 0 1.3255463393591072e-10
the O 0 1.3434706125359241e-10
FRDA B-Disease 0 1.1593116141739301e-05
gene O 0 1.2765325152486184e-07
. O 0 8.669673867700567e-09

Friedreich B-Disease 1 0.9909690022468567
ataxia I-Disease 1 0.9996055960655212
is O 0 1.78133268491365e-05
usually O 0 3.5404625009505253e-07
caused O 0 8.202839296700404e-08
by O 0 2.3922183678415365e-11
an O 0 4.035582631956025e-12
expansion O 0 4.055958902071666e-10
of O 0 9.3886686619582e-12
a O 0 4.663896824297353e-09
GAA O 0 6.088284408178879e-06
trinucleotide O 0 5.981498816254316e-07
repeat O 0 3.445193996753915e-08
in O 0 5.419380569304799e-11
intron O 0 3.464065301272967e-08
1 O 0 7.984067573740816e-11
of O 0 8.717282971859586e-12
the O 0 4.5717329921757255e-10
FRDA B-Disease 0 2.2901960619492456e-05
gene O 0 1.0104339764893666e-07
. O 0 9.630321429199284e-09

Occasionally O 0 2.4538671823393088e-06
, O 0 2.0483019447237183e-10
a O 0 4.814935117281038e-10
fully O 0 3.811444049262036e-09
expanded O 0 3.943569359954324e-10
allele O 0 2.1814731354652395e-08
has O 0 3.683966465217736e-10
been O 0 2.3272761495718441e-10
found O 0 7.230138709957146e-11
to O 0 2.0774123740685546e-11
arise O 0 6.775373595502288e-10
from O 0 8.059766504371624e-13
a O 0 5.013656850794135e-11
premutation O 0 2.6938574038126717e-08
of O 0 3.73978625844984e-12
100 O 0 5.2685172197142194e-11
or O 0 5.474957154305571e-10
less O 0 6.270515218176342e-09
triplet O 0 0.00037315741064958274
repeats O 0 2.7232531465415377e-06
. O 0 8.697117692690881e-09

We O 0 5.141152996657183e-07
have O 0 6.080660974738805e-10
examined O 0 8.527680783743108e-09
the O 0 1.794739530602829e-11
sperm O 0 8.002157159126e-09
DNA O 0 1.76387686678936e-08
of O 0 3.534282935757638e-11
a O 0 4.520886776049338e-09
premutation O 0 3.517203367664479e-05
carrier O 0 1.0657745406206232e-05
. O 0 3.424857197842357e-08

This O 0 1.4608299014895465e-09
mans O 0 5.747712350512302e-08
leucocyte O 0 8.608337793702958e-07
DNA O 0 8.237377642217325e-07
showed O 0 8.782602094470349e-07
one O 0 3.796568059932781e-10
normal O 0 1.255055392945792e-09
allele O 0 2.0819523882664726e-09
and O 0 2.1924821333452194e-11
one O 0 2.8497515111580718e-11
allele O 0 1.0552572149435946e-09
of O 0 7.341724450604659e-12
approximately O 0 1.9349739865948123e-10
100 O 0 8.883547231164357e-10
repeats O 0 1.3684723398910137e-07
. O 0 5.530133240227997e-09

His O 0 1.4162263539674314e-07
sperm O 0 2.948764176835539e-06
showed O 0 5.124206836626399e-07
an O 0 5.5852707875336804e-11
expanded O 0 7.00868363345819e-10
allele O 0 5.479757803072971e-08
in O 0 1.3481397942438633e-10
a O 0 4.262480146621783e-09
tight O 0 5.2021696319570765e-06
range O 0 1.1273484368246045e-09
centering O 0 1.9239421167327464e-09
on O 0 3.6932179536819376e-10
a O 0 1.5370860140251352e-10
size O 0 1.1992834281215892e-08
of O 0 2.9405488460865215e-11
approximately O 0 2.9791305533599655e-10
320 O 0 3.240621770927987e-09
trinucleotide O 0 2.968141870951513e-06
repeats O 0 6.648045314250339e-07
. O 0 1.1149676737431946e-08

His O 0 4.137964992878551e-07
affected O 0 2.038829052253277e-07
son O 0 1.1737161003111396e-06
has O 0 2.8629276727087927e-09
repeat O 0 9.034317116629609e-08
sizes O 0 5.274256409393274e-08
of O 0 7.727331968743201e-11
1040 O 0 1.2094636758774868e-07
and O 0 4.967354083618147e-09
540 O 0 2.2585645353956352e-08
. O 0 8.751014135555124e-09

These O 0 1.3128905740344976e-09
data O 0 2.176667290854084e-09
suggest O 0 1.0955539808676917e-09
that O 0 1.0567688217555382e-11
expansion O 0 1.73199371511501e-10
occurs O 0 8.073221258175778e-11
in O 0 1.813582378891454e-12
two O 0 3.1313786199443916e-12
stages O 0 9.922852539645532e-10
, O 0 3.941564956366772e-12
the O 0 1.0003735036526185e-12
first O 0 1.2589092962533854e-11
during O 0 8.620856806196286e-11
meiosis O 0 1.1189722481930175e-09
followed O 0 2.3901887413746437e-11
by O 0 7.5331078180918e-12
a O 0 8.657998623595731e-11
second O 0 4.0388212219077957e-10
mitotic O 0 1.5203458758605848e-07
expansion O 0 3.3949461908378e-08
. O 0 1.1455304260721277e-08

We O 0 8.114441811812867e-07
also O 0 6.790588091831751e-10
show O 0 2.811165300542484e-09
that O 0 3.0313352522570725e-11
in O 0 7.023423509444626e-12
all O 0 3.580801670802214e-12
informative O 0 2.5029742722892934e-09
carrier O 0 1.155080369130701e-07
father O 0 1.7405726637775842e-08
to O 0 5.7712230827622335e-11
affected O 0 1.2830011497655391e-09
child O 0 2.7296027838019654e-07
transmissions O 0 1.0734314628280117e-06
, O 0 9.60992049825471e-12
with O 0 2.3239960303400586e-12
the O 0 1.952791010492727e-12
notable O 0 2.6134733266403032e-11
exception O 0 3.5543200327392555e-11
of O 0 1.0132666190473816e-12
the O 0 3.767883574590236e-11
premutation O 0 8.897152952158649e-07
carrier O 0 6.422806819728066e-08
, O 0 1.940582677190106e-12
the O 0 3.207457899539329e-13
expansion O 0 1.934168797346203e-11
size O 0 1.3967900613920392e-08
decreases O 0 4.008465026572594e-08
. O 0 1.21617632631299e-10
. O 0 1.4020020699945235e-09

The O 0 8.882179436398019e-09
R496H O 0 2.0129708389049483e-07
mutation O 0 2.639996239395259e-07
of O 0 4.308527493113168e-11
arylsulfatase O 0 4.340821305959253e-06
A O 0 4.90790341700631e-07
does O 0 1.3626939221467183e-07
not O 0 1.7831341736496142e-08
cause O 0 1.1984659067820758e-05
metachromatic B-Disease 1 0.9999889135360718
leukodystrophy I-Disease 1 0.999990701675415
. O 0 1.687116309767589e-06

Deficiency B-Disease 1 0.9972383975982666
of I-Disease 0 4.811669729321011e-09
arylsulfatase I-Disease 0 9.421451250091195e-05
A I-Disease 0 5.637148206005804e-07
( O 0 2.7931537083247804e-09
ARSA O 0 8.988773333840072e-05
) O 0 1.7054734013921546e-10
enzyme O 0 6.370683092171703e-09
activity O 0 2.0500125685884996e-07
causes O 0 0.0001357524306513369
metachromatic B-Disease 1 0.9999949932098389
leukodystrophy I-Disease 1 0.9999982118606567
( O 0 6.97137729730457e-05
MLD B-Disease 1 0.9999741315841675
) O 0 2.7998758866942808e-08
. O 0 1.3962439204817656e-08

A O 0 9.223156638427099e-08
number O 0 8.762567338393978e-10
of O 0 3.6520431123676644e-10
ARSA O 0 0.0017278263112530112
gene O 0 2.4988787572510773e-06
mutations O 0 8.38358755572699e-06
responsible O 0 2.450263139053277e-07
for O 0 4.0951565694058445e-08
MLD B-Disease 1 0.9999995231628418
have O 0 1.5109677633518004e-06
been O 0 5.617855336481625e-08
identified O 0 8.888824254427163e-07
. O 0 9.106108755929654e-09

Recently O 0 1.0007038326875772e-06
, O 0 1.0105712794361565e-10
the O 0 1.0605184265488621e-11
R496H O 0 6.680341613218843e-09
mutation O 0 2.84031926867101e-08
of O 0 3.939544870878997e-11
ARSA O 0 6.469570507761091e-05
was O 0 8.667756290492434e-09
proposed O 0 5.60524925086181e-11
to O 0 3.60737412163914e-11
be O 0 1.540520710996418e-09
a O 0 1.4499039746596054e-09
cause O 0 7.58627663799416e-07
of O 0 1.1384340581344077e-08
MLD B-Disease 1 0.9999986886978149
( O 0 9.605533035639269e-10
Draghia O 0 1.8815682096828823e-06
et O 0 9.657323971623555e-07
al O 0 1.6026215234887786e-06
. O 0 1.1024960805405826e-10
, O 0 1.2684490610648247e-11
1997 O 0 1.2380267644385157e-10
) O 0 2.483019692633981e-11
. O 0 8.872793610947838e-10

We O 0 2.5336666453767975e-07
have O 0 3.4222416567253333e-10
investigated O 0 3.578431106987523e-09
the O 0 2.751148094060074e-11
R496H O 0 2.200092907855833e-08
mutation O 0 4.653680107935543e-08
and O 0 9.213720064682462e-11
found O 0 1.5066028979937585e-10
this O 0 2.3131843662760332e-11
mutation O 0 6.596848844964143e-09
at O 0 2.388061970393096e-10
a O 0 2.5034313511085315e-10
relatively O 0 9.573327908185547e-09
high O 0 1.1497287566442083e-08
frequency O 0 1.432024276937227e-07
in O 0 5.259187616651895e-12
an O 0 2.3592430092866934e-12
African O 0 2.6685582996816004e-12
American O 0 5.1803113881865315e-11
population O 0 1.9626303620484675e-12
( O 0 1.1995052303856446e-12
f O 0 3.206732301919146e-08
= O 0 1.4565535444432953e-09
0 O 0 1.1866215475497821e-11
. O 0 3.725135217652609e-12
09 O 0 3.625750394364857e-11
, O 0 2.551772378470152e-12
n O 0 3.9029629306241986e-08
= O 0 5.8750661224848955e-08
61 O 0 6.193263124565362e-10
subjects O 0 1.5500421568503953e-07
) O 0 6.689875875487417e-10
. O 0 2.413992561400846e-09

The O 0 4.7528576629929375e-08
ARSA O 0 5.664742275257595e-05
enzyme O 0 6.145354092268462e-08
activity O 0 1.3126259190698875e-08
in O 0 1.2752322808839978e-10
subjects O 0 1.1255099963136672e-08
with O 0 1.639621632909538e-10
and O 0 9.98748750369316e-10
without O 0 8.732947004430613e-11
the O 0 4.139108326917107e-12
R496H O 0 2.318770064846376e-09
mutation O 0 3.2168401276067016e-08
was O 0 8.428314046682317e-09
determined O 0 1.119964139206786e-07
and O 0 4.772529038632456e-10
found O 0 8.714814425658801e-10
to O 0 1.668510191121797e-10
be O 0 6.310095557182649e-09
normal O 0 1.540033700564436e-08
. O 0 5.182292817096368e-09

It O 0 5.14483140534594e-08
is O 0 1.0232878988603034e-09
therefore O 0 5.053791829467968e-10
concluded O 0 1.7485768388780798e-10
that O 0 5.551515410567864e-12
the O 0 3.3527447311498815e-12
R496H O 0 3.73839448286617e-09
mutation O 0 5.410617287537889e-09
of O 0 1.3837837126162711e-11
ARSA O 0 2.5766978069441393e-05
does O 0 7.285588576877444e-09
not O 0 6.803211466399617e-11
negatively O 0 2.3841750795838834e-10
influence O 0 5.792948759575367e-11
the O 0 1.9117041283323033e-11
activity O 0 3.2186658893706976e-10
of O 0 8.355026739903515e-12
ARSA O 0 2.81458196695894e-05
and O 0 4.81741802005331e-09
is O 0 1.716435049647913e-10
not O 0 1.6184097118010499e-10
a O 0 1.062019472364284e-09
cause O 0 3.015766480984894e-07
of O 0 3.285910281647375e-07
MLD B-Disease 1 0.9999788999557495

Down O 0 2.416957613604609e-06
- O 0 1.2609799568963354e-06
regulation O 0 1.912812308546563e-08
of O 0 1.880886280059002e-10
transmembrane O 0 7.461411314579891e-06
carbonic O 0 1.7963747040994349e-06
anhydrases O 0 1.4575552086171228e-05
in O 0 9.407723666754464e-08
renal B-Disease 0 0.42941272258758545
cell I-Disease 1 0.9998000264167786
carcinoma I-Disease 1 1.0
cell O 1 0.9002208709716797
lines O 0 8.554237865610048e-06
by O 0 9.374041542997702e-10
wild O 0 4.1508181425342627e-07
- O 0 0.017581963911652565
type O 0 0.15220853686332703
von B-Disease 1 0.9997032284736633
Hippel I-Disease 1 0.9994138479232788
- I-Disease 1 0.9212073683738708
Lindau I-Disease 1 0.8764413595199585
transgenes O 0 0.0038488716818392277
. O 0 2.0138310219408595e-07

To O 0 3.430158912465231e-08
discover O 0 1.475590636346169e-07
genes O 0 1.1977427050169354e-08
involved O 0 3.730431075155138e-09
in O 0 1.9061763723016156e-08
von B-Disease 1 0.9996250867843628
Hippel I-Disease 1 0.9999665021896362
- I-Disease 1 0.9999262094497681
Lindau I-Disease 1 0.9995558857917786
( O 0 2.532895848617045e-07
VHL B-Disease 0 0.00018229203124064952
) O 0 1.1892868634344467e-10
- O 0 1.9365641890090046e-07
mediated O 0 2.909675458795391e-06
carcinogenesis O 0 0.0018475886899977922
, O 0 1.992722875598929e-09
we O 0 3.149172478345008e-09
used O 0 3.6314523299552093e-07
renal B-Disease 0 0.4290376901626587
cell I-Disease 1 0.9997324347496033
carcinoma I-Disease 1 1.0
cell O 1 0.9813932776451111
lines O 0 0.0006747526349499822
stably O 0 0.00022343744058161974
transfected O 0 6.986945663811639e-06
with O 0 2.4835999923311647e-09
wild O 0 8.265628252956958e-07
- O 0 0.03967699408531189
type O 0 0.41376861929893494
VHL O 0 0.18175604939460754
- O 0 0.0001618819369468838
expressing O 0 1.7531791627334314e-06
transgenes O 0 5.295131995808333e-05
. O 0 6.383798023534837e-08

Large O 0 1.3181521296701249e-07
- O 0 9.39264168664522e-07
scale O 0 6.113582458056044e-06
RNA O 0 9.99931373257823e-08
differential O 0 5.34112245986762e-07
display O 0 5.8966548976968625e-08
technology O 0 5.363650412704146e-09
applied O 0 5.440604633477619e-10
to O 0 2.0608015294243387e-11
these O 0 1.908545370354897e-11
cell O 0 1.5012567189387482e-07
lines O 0 1.9867199441137018e-08
identified O 0 1.2170540131251073e-09
several O 0 5.784874749364954e-12
differentially O 0 2.499102720321389e-07
expressed O 0 1.328825272040035e-09
genes O 0 8.290048092440827e-10
, O 0 2.4570692702674535e-12
including O 0 1.4800192321695604e-12
an O 0 2.3199888191105522e-11
alpha O 0 1.814706274139155e-09
carbonic O 0 6.026606769182763e-08
anhydrase O 0 1.3746961258220836e-07
gene O 0 1.7133261920321274e-08
, O 0 3.186979014024871e-10
termed O 0 8.099947024220455e-08
CA12 O 0 0.00010658497194526717
. O 0 3.4526077996588356e-08

The O 0 1.0663882221706444e-08
deduced O 0 7.812497671011442e-08
protein O 0 4.531557351583615e-09
sequence O 0 1.7969061794076424e-09
was O 0 4.227790895150463e-10
classified O 0 4.586965807185095e-10
as O 0 9.758090169231792e-12
a O 0 8.546678920140494e-10
one O 0 1.870734323006218e-08
- O 0 0.00018915477267000824
pass O 0 2.4437179035885492e-06
transmembrane O 0 0.0003097118460573256
CA O 0 5.328714905772358e-06
possessing O 0 4.044605095288034e-09
an O 0 1.9530675687828847e-11
apparently O 0 4.422754429356246e-08
intact O 0 9.490515928689547e-09
catalytic O 0 3.824763616933069e-09
domain O 0 5.018280235802308e-10
in O 0 4.520701174515196e-11
the O 0 4.5411588378563295e-10
extracellular O 0 1.8382133930572309e-06
CA O 0 0.0027264265809208155
module O 0 3.0517156119458377e-05
. O 0 2.315536207220248e-08

Reintroduced O 0 1.2629256161744706e-05
wild O 0 7.756564741612237e-07
- O 0 0.0008540000999346375
type O 0 0.00023457377392333
VHL B-Disease 0 0.0003456546401139349
strongly O 0 1.6284717574421848e-08
inhibited O 0 7.05241598453199e-09
the O 0 4.992050609692322e-12
overexpression O 0 2.5423502192367664e-10
of O 0 3.437139895617891e-12
the O 0 3.3057064030561634e-11
CA12 O 0 8.025651823118096e-07
gene O 0 5.704524852490067e-09
in O 0 1.6409731906641412e-10
the O 0 2.5449518048503705e-09
parental O 0 0.040085501968860626
renal B-Disease 1 0.9966803789138794
cell I-Disease 1 0.9999539852142334
carcinoma I-Disease 1 1.0
cell O 1 0.9976855516433716
lines O 0 0.007893172092735767
. O 0 1.2637063662168657e-07

Similar O 0 2.91126127649477e-07
results O 0 1.2946591709805944e-07
were O 0 4.871246184201539e-10
obtained O 0 3.6818750270839473e-09
with O 0 7.357586206957478e-10
CA9 O 0 7.880563498474658e-05
, O 0 2.7516204592625826e-11
encoding O 0 7.384665101639598e-10
another O 0 5.8164930649695634e-09
transmembrane O 0 0.0005792347947135568
CA O 0 0.00010978899808833376
with O 0 1.4161541384005716e-10
an O 0 8.77520764386297e-11
intact O 0 2.4773663653832045e-07
catalytic O 0 1.6163512839284522e-07
domain O 0 5.672196223827086e-08
. O 0 1.0417607221313574e-08

Although O 0 4.286566479549947e-08
both O 0 2.3069111898532668e-10
domains O 0 2.183032865588075e-09
of O 0 2.425805910311052e-11
the O 0 8.1747647540098e-10
VHL B-Disease 0 5.791262083221227e-06
protein O 0 4.839371126053038e-10
contribute O 0 4.8453071416210136e-11
to O 0 8.031533771379884e-12
regulation O 0 4.0995212780003953e-10
of O 0 1.0092185767640593e-11
CA12 O 0 8.826130397210363e-06
expression O 0 1.1086863871412334e-08
, O 0 2.400819777356733e-12
the O 0 1.616156319016182e-12
elongin O 0 1.219154999176908e-08
binding O 0 1.48538059629999e-09
domain O 0 2.386205455451318e-09
alone O 0 8.258897565838197e-09
could O 0 2.4509552165596915e-09
effectively O 0 8.581623411885175e-09
regulate O 0 5.540545657822804e-07
CA9 O 0 0.00031145705725066364
expression O 0 3.1384342946694233e-06
. O 0 4.1640756620608954e-08

We O 0 9.676979288997245e-07
mapped O 0 2.6639963834895752e-05
CA12 O 0 0.0002208810328738764
and O 0 1.1561059665154971e-08
CA9 O 0 2.355998549319338e-05
loci O 0 2.063089787895933e-08
to O 0 1.3681410448995734e-09
chromosome O 0 3.098984734606347e-06
bands O 0 9.37488948693499e-08
15q22 O 0 1.256630213219978e-07
and O 0 1.8304187054951626e-09
17q21 O 0 1.314373747618447e-07
. O 0 6.1930065520243716e-09

2 O 0 4.842469181198794e-08
respectively O 0 4.446259538326558e-08
, O 0 2.1899630719968144e-10
regions O 0 5.2548139173325126e-09
prone O 0 3.7607816921081394e-05
to O 0 5.268238623123978e-10
amplification O 0 2.745947256244108e-07
in O 0 1.7166969235038465e-10
some O 0 3.11470155223148e-11
human O 0 9.652889332301129e-08
cancers B-Disease 0 0.0017551725031808019
. O 0 2.6394165075771525e-08

Additional O 0 8.770598469709512e-09
experiments O 0 2.7022102244700363e-07
are O 0 2.2425637735690174e-10
needed O 0 3.9462103029741513e-10
to O 0 1.0333485803148967e-11
define O 0 2.2312585112871375e-09
the O 0 9.649703779091023e-12
role O 0 4.854736057602338e-10
of O 0 2.157812817316085e-10
CA O 0 7.340497541008517e-05
IX O 0 1.9272779354650993e-06
and O 0 5.2009713868983454e-08
CA O 0 5.328338829713175e-06
XII O 0 4.2114088216749224e-08
enzymes O 0 1.6175578931854062e-10
in O 0 5.0630099071580226e-12
the O 0 3.638995355048635e-12
regulation O 0 4.192314273510078e-10
of O 0 5.303965600056415e-12
pH O 0 8.725506859263987e-07
in O 0 1.4490786175158643e-11
the O 0 1.11618735088026e-11
extracellular O 0 6.914938066593379e-10
microenvironment O 0 2.471692539529613e-08
and O 0 3.275348742226569e-11
its O 0 4.446640972100013e-12
potential O 0 3.6844022277549016e-10
impact O 0 3.463443931650545e-08
on O 0 1.5059572433528956e-06
cancer B-Disease 0 1.83989559445763e-05
cell O 0 6.672418294328963e-06
growth O 0 1.9854419974763005e-07
. O 0 6.865396695587833e-09

A O 0 5.939129366083762e-08
gene O 0 2.2515061814942783e-08
encoding O 0 6.010831388181259e-09
a O 0 4.1968450936735735e-09
transmembrane O 0 3.1327494980359916e-06
protein O 0 1.4271972936796828e-08
is O 0 2.4400720333161985e-10
mutated O 0 3.669824977237113e-08
in O 0 3.0299047715232064e-09
patients O 0 2.6046103585031233e-07
with O 0 0.0016883709467947483
diabetes B-Disease 1 1.0
mellitus I-Disease 1 0.9999998807907104
and O 1 0.9336148500442505
optic B-Disease 1 0.9999988079071045
atrophy I-Disease 1 0.9999949932098389
( O 0 0.12525822222232819
Wolfram B-Disease 1 0.9999996423721313
syndrome I-Disease 1 1.0
) O 0 9.561416192127581e-08
. O 0 3.371244972072418e-08

Wolfram B-Disease 1 0.9999923706054688
syndrome I-Disease 1 1.0
( O 0 7.308943622774677e-06
WFS B-Disease 0 0.26740169525146484
; O 0 2.444414235469594e-07
OMIM O 0 0.0018378070089966059
222300 O 0 3.3293313208559994e-06
) O 0 1.8681223235006428e-10
is O 0 1.4277840021392763e-10
an O 0 3.4192810804967166e-09
autosomal B-Disease 1 0.999987006187439
recessive I-Disease 1 0.9999979734420776
neurodegenerative I-Disease 1 0.9999903440475464
disorder I-Disease 1 0.999806821346283
defined O 0 1.1040311619581189e-05
by O 0 4.297714628620497e-09
young O 0 1.1051630366409881e-07
- O 0 1.9712160792551003e-05
onset O 0 8.453370355709922e-06
non O 0 4.774988155986648e-07
- O 0 0.010625647380948067
immune O 0 0.0029879568610340357
insulin B-Disease 0 0.3232813775539398
- I-Disease 1 0.9907851219177246
dependent I-Disease 1 0.9741695523262024
diabetes I-Disease 1 0.9999990463256836
mellitus I-Disease 1 0.9999982118606567
and O 0 3.4767581382766366e-05
progressive O 0 0.09275432676076889
optic B-Disease 1 0.9999687671661377
atrophy I-Disease 1 0.9962916374206543
. O 0 1.1648198778857477e-06

Linkage O 0 1.9292407159809954e-05
to O 0 2.1674246841740796e-09
markers O 0 7.779025281706708e-07
on O 0 2.1023771523687174e-07
chromosome O 0 0.04301467165350914
4p O 0 0.008778528310358524
was O 0 5.931605301157106e-06
confirmed O 0 2.935773864010116e-07
in O 0 3.2812469408227685e-10
five O 0 5.238099398674478e-10
families O 0 6.121673390424576e-09
. O 0 8.817395702465092e-09

On O 0 1.4106183776618764e-08
the O 0 7.55126586260424e-11
basis O 0 4.4498078832777566e-11
of O 0 7.311930574904757e-12
meiotic O 0 3.447854396654293e-06
recombinants O 0 0.0028584387619048357
and O 0 3.178082579324837e-06
disease O 0 0.00014985269808676094
- O 0 4.558971704682335e-05
associated O 0 8.378036682188394e-07
haplotypes O 0 3.4897941532108234e-06
, O 0 2.353847117220198e-10
the O 0 1.0479896811466105e-10
WFS B-Disease 0 1.0600407449601335e-06
gene O 0 9.112867793703572e-09
was O 0 1.8619337183167772e-09
localized O 0 1.9168625797760797e-08
to O 0 1.0525634808189466e-09
a O 0 1.6282271531053993e-07
BAC O 0 9.943280019797385e-05
/ O 0 3.675741027109325e-07
P1 O 0 1.1944153811782598e-05
contig O 0 1.5483225013213087e-07
of O 0 1.7023946488614605e-11
less O 0 1.9471398104986548e-10
than O 0 8.36145666593957e-11
250 O 0 1.9954107810526978e-10
kb O 0 8.757460818742402e-07
. O 0 7.21934512171174e-08

Mutations O 0 0.0009085239144042134
in O 0 5.3844684266834975e-09
a O 0 1.8051162786747454e-09
novel O 0 9.749175688966716e-09
gene O 0 9.257736621748336e-08
( O 0 8.306805243663007e-11
WFS1 O 0 1.332665760855889e-06
) O 0 1.9974839924469245e-12
encoding O 0 2.982870200840537e-11
a O 0 1.0980031467378026e-10
putative O 0 3.868750653168718e-08
transmembrane O 0 1.514447376393946e-07
protein O 0 2.5887789689704732e-09
were O 0 8.057288169993626e-10
found O 0 3.106599866242732e-09
in O 0 4.0057324124376237e-10
all O 0 6.171186478498569e-11
affected O 0 2.0111415310886116e-10
individuals O 0 4.875352205280237e-11
in O 0 1.3308892876651157e-10
six O 0 2.888508043863425e-10
WFS B-Disease 0 7.140029083529953e-07
families O 0 4.045852541878503e-10
, O 0 1.8311362842693413e-11
and O 0 8.411907975736099e-11
these O 0 8.28326296442583e-11
mutations O 0 3.98741875073938e-08
were O 0 1.582386333076613e-09
associated O 0 4.886621773891875e-09
with O 0 4.741969039656624e-10
the O 0 1.3705464141366974e-07
disease O 0 8.535154483979568e-05
phenotype O 0 1.2048261851305142e-05
. O 0 1.3894800865443813e-08

WFS1 O 0 0.0011345407692715526
appears O 0 5.312886628416891e-07
to O 0 2.9857408212485836e-10
function O 0 1.6898862309489004e-09
in O 0 1.4908521639434014e-10
survival O 0 4.345308823872074e-08
of O 0 3.52980283890858e-11
islet O 0 6.660460257990053e-06
beta O 0 1.3606131332721816e-08
- O 0 3.714716967806453e-06
cells O 0 2.99620666055489e-08
and O 0 1.4784415913737803e-09
neurons O 0 3.437002860096072e-08
. O 0 1.2999773479904775e-10
. O 0 6.880652159146905e-10

Stable O 0 7.365388682956109e-06
interaction O 0 1.0330072797160028e-08
between O 0 5.307775885476929e-10
the O 0 1.8643697696774097e-11
products O 0 4.937725922582459e-11
of O 0 2.556439435141833e-12
the O 0 6.843742239581729e-10
BRCA1 O 0 2.7116457204101607e-05
and O 0 1.0137194550452477e-07
BRCA2 O 0 5.000081000616774e-05
tumor B-Disease 0 4.362168056104565e-06
suppressor O 0 8.435825975539046e-07
genes O 0 9.053841232287141e-09
in O 0 1.9322744793104363e-10
mitotic O 0 1.1138632771690027e-06
and O 0 3.986832908253746e-08
meiotic O 0 0.00045612844405695796
cells O 0 1.0278019544784911e-05
. O 0 5.548731962790043e-08

BRCA1 O 0 0.028200946748256683
and O 0 7.416672076487885e-08
BRCA2 O 0 1.3180985661165323e-05
account O 0 2.3627467982123562e-08
for O 0 4.210037179985804e-11
most O 0 2.6644094916483674e-11
cases O 0 6.750448811043697e-11
of O 0 6.999485626518753e-12
familial O 0 1.048057310981676e-05
, O 0 4.720770441224431e-10
early O 0 9.125930233722102e-09
onset O 0 1.9083146980847232e-05
breast B-Disease 0 0.3440488278865814
and I-Disease 0 3.696656858664937e-05
/ I-Disease 0 0.25205156207084656
or I-Disease 1 0.9967291355133057
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
and O 0 5.5056037950862446e-08
encode O 0 1.3179693780784874e-08
products O 0 8.025283548818152e-09
that O 0 1.7285481379580858e-10
each O 0 5.7255575280912296e-11
interact O 0 3.907338619324463e-10
with O 0 4.892280469626087e-10
hRAD51 O 0 2.739120645856019e-06
. O 0 2.775057872383968e-08

Results O 0 6.932963856343122e-07
presented O 0 3.66643853055848e-08
here O 0 1.5866354896587609e-09
show O 0 5.000234892804656e-09
that O 0 8.234198878298571e-10
BRCA1 O 0 5.620434421871323e-06
and O 0 9.018133795279937e-08
BRCA2 O 0 7.250890485011041e-05
coexist O 0 4.749736035591923e-06
in O 0 4.658116115052735e-10
a O 0 1.3560759182240645e-09
biochemical O 0 2.7991607112198835e-06
complex O 0 6.398828844567106e-08
and O 0 3.4287492289841737e-10
colocalize O 0 3.2376027547798003e-07
in O 0 1.755701972694368e-10
subnuclear O 0 2.078629108837049e-07
foci O 0 1.9643593418550154e-07
in O 0 5.930788499197703e-11
somatic O 0 5.774521305568214e-09
cells O 0 6.296005938821736e-09
and O 0 5.0846517968272664e-11
on O 0 9.473379719571184e-11
the O 0 5.830557824743066e-12
axial O 0 1.9539712070582027e-09
elements O 0 4.881831605629827e-10
of O 0 4.4835361118211736e-11
developing O 0 2.095937423618466e-09
synaptonemal O 0 1.1332386975482223e-06
complexes O 0 8.300099807456718e-07
. O 0 1.780904668180483e-08

Like O 0 2.374055156906252e-06
BRCA1 O 0 0.0009106667130254209
and O 0 3.603665987839122e-08
RAD51 O 0 0.000540182227268815
, O 0 1.8225142506267389e-09
BRCA2 O 0 1.3801978866467834e-06
relocates O 0 5.225431820576887e-08
to O 0 4.4554832046017623e-10
PCNA O 0 2.1233904590189923e-06
+ O 0 4.3513756486923683e-10
replication O 0 1.5640574946296226e-10
sites O 0 1.6057906393474042e-10
following O 0 1.9911336468503293e-10
exposure O 0 8.179027872756706e-07
of O 0 4.333697983804896e-11
S O 0 1.7480105043432559e-06
phase O 0 2.594493286878219e-09
cells O 0 4.326597413673028e-10
to O 0 1.3902467718707179e-11
hydroxyurea O 0 1.1415460221542162e-07
or O 0 3.352917943288958e-08
UV O 0 0.008664846420288086
irradiation O 0 7.476704467990203e-06
. O 0 1.802842675147076e-08

Thus O 0 3.143935316529678e-07
, O 0 6.309611166877005e-10
BRCA1 O 0 1.8173606122218189e-06
and O 0 5.981438899738123e-09
BRCA2 O 0 5.054248504166026e-06
participate O 0 3.7525822449424595e-09
, O 0 1.545151784299037e-10
together O 0 2.9175220572774663e-10
, O 0 3.086486621839413e-11
in O 0 1.857597062282501e-11
a O 0 1.3239601637238252e-09
pathway O 0 4.361381922279861e-09
( O 0 1.4674468237774185e-11
s O 0 1.2166722740403202e-07
) O 0 4.037538532675189e-12
associated O 0 3.2405397809576186e-10
with O 0 8.72483509051225e-12
the O 0 7.310103911084553e-12
activation O 0 1.2905204682667204e-10
of O 0 8.515801779018783e-12
double O 0 7.264485475388938e-07
- O 0 2.9895729767304147e-06
strand O 0 1.5200935195025522e-06
break O 0 2.8052324978489196e-06
repair O 0 8.550788334105164e-05
and O 0 1.1992376869329746e-08
/ O 0 1.934348681231768e-08
or O 0 8.619480129645751e-10
homologous O 0 4.9385057820927614e-08
recombination O 0 1.9433593934081728e-06
. O 0 5.2714000275955186e-08

Dysfunction O 0 0.00013974956527817994
of O 0 6.495809445894452e-10
this O 0 1.1173344471870905e-09
pathway O 0 1.895361734227663e-08
may O 0 2.9378959709447372e-08
be O 0 6.958808529411442e-11
a O 0 9.080013824158684e-11
general O 0 3.015235283676532e-11
phenomenon O 0 1.0964172902916403e-09
in O 0 9.083820501354367e-12
the O 0 6.169959074903142e-12
majority O 0 5.203530748648655e-12
of O 0 3.932656880267088e-13
cases O 0 5.0080179586631246e-11
of O 0 6.635811344857245e-11
hereditary B-Disease 1 0.8980849981307983
breast I-Disease 1 0.9992426633834839
and I-Disease 0 0.011249026283621788
/ I-Disease 1 0.9275960326194763
or I-Disease 1 0.9996474981307983
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999994039535522
. O 0 9.050459937043343e-08
. O 0 1.4627990374549427e-08

A O 0 2.0032385350532422e-07
novel O 0 2.3841502994059738e-08
Arg362Ser O 0 3.914955414074939e-06
mutation O 0 9.591359457772342e-07
in O 0 2.13419532046899e-10
the O 0 1.758550666197678e-10
sterol O 0 5.24805836903397e-05
27 O 0 1.5574386225125636e-08
- O 0 3.1457157092518173e-06
hydroxylase O 0 3.390688289073296e-05
gene O 0 1.0406391481865285e-07
( O 0 2.911228202950866e-11
CYP27 O 0 8.398523618780018e-07
) O 0 4.304492092627177e-12
: O 0 1.1232045024969772e-12
its O 0 2.029102363562685e-12
effects O 0 4.043571255607503e-09
on O 0 3.439899698420845e-09
pre O 0 8.862397748998774e-07
- O 0 5.0573454757341096e-08
mRNA O 0 1.0540195799491059e-10
splicing O 0 6.725724421841051e-10
and O 0 1.0790148635697605e-10
enzyme O 0 7.177572425298706e-10
activity O 0 3.3179772263025598e-09
. O 0 1.5767042116365815e-09

A O 0 2.0736395356379944e-07
novel O 0 1.681200423320206e-08
C O 0 3.206083931672765e-08
to O 0 1.0717759145462136e-11
A O 0 3.4686784555759687e-09
mutation O 0 1.8963459069709643e-07
in O 0 1.0178700937668594e-10
the O 0 1.4888290600367782e-10
sterol O 0 3.1330782803706825e-05
27 O 0 7.70748265210841e-09
- O 0 1.2594126701515052e-06
hydroxylase O 0 6.466243576142006e-06
gene O 0 1.5135862341253414e-08
( O 0 2.2961681167554815e-11
CYP27 O 0 7.623838769177382e-07
) O 0 3.571852015549215e-12
was O 0 4.938227604611711e-10
identified O 0 2.07283024078464e-10
by O 0 4.0012233977482214e-12
sequencing O 0 3.209311150165206e-10
amplified O 0 1.4488783506294567e-07
CYP27 O 0 4.0885666408030374e-07
gene O 0 2.492730910574892e-09
products O 0 1.681872141556795e-10
from O 0 9.425397094753318e-12
a O 0 7.987243755280815e-09
patient O 0 1.94840322365053e-06
with O 0 2.15468361375315e-07
cerebrotendinous B-Disease 1 0.9999986886978149
xanthomatosis I-Disease 1 0.9999984502792358
( O 0 1.4526068525810842e-07
CTX B-Disease 0 0.001401960151270032
) O 0 1.098858448678186e-09
. O 0 3.6669889347251683e-09

The O 0 1.7618695835608378e-08
mutation O 0 1.0962087344523752e-06
changed O 0 8.218653313463165e-09
the O 0 4.2287402746143954e-11
adrenodoxin O 0 1.3271111320989348e-08
cofactor O 0 2.7028939086903847e-09
binding O 0 4.562927813367423e-09
residue O 0 1.8656997724519897e-07
362Arg O 0 5.0143434293659084e-08
to O 0 2.7663249468901085e-10
362Ser O 0 2.3028783857625967e-07
( O 0 8.640643756052668e-11
CGT O 0 4.849817614172025e-08
362Arg O 0 1.4967087125228318e-08
to O 0 1.3589959713122823e-10
AGT O 0 6.862263148832426e-07
362Ser O 0 5.1008910872951674e-08
) O 0 8.064629693216308e-12
, O 0 1.2466459071644453e-12
and O 0 3.549537053171292e-11
was O 0 7.141239155572521e-09
responsible O 0 8.560910202959349e-09
for O 0 4.416034204979269e-09
deficiency O 0 1.416879240423441e-05
in O 0 1.4845180640321587e-11
the O 0 8.865075340480644e-11
sterol O 0 2.360280450375285e-05
27 O 0 2.2024724266600515e-09
- O 0 2.8029435839016514e-07
hydroxylase O 0 8.064619578362908e-06
activity O 0 1.5318660118168737e-08
, O 0 3.5352653963982572e-12
as O 0 6.166194724960272e-12
confirmed O 0 1.1973851077318187e-10
by O 0 6.9752294218350386e-12
expression O 0 2.2741628025180205e-10
of O 0 8.163082297792112e-13
mutant O 0 8.81772224681221e-11
cDNA O 0 6.746355557529782e-11
into O 0 7.222034775766772e-11
COS O 0 2.720675411183038e-06
- O 0 5.214967586653074e-07
1 O 0 2.0712820347768e-09
cells O 0 2.548421385029087e-08
. O 0 4.143585030647046e-09

Quantitative O 0 8.510280053997121e-07
analysis O 0 1.5480389947697404e-07
showed O 0 2.2032281776773743e-07
that O 0 8.584135485767419e-11
the O 0 3.822212511772616e-12
expression O 0 1.6891506249283594e-10
of O 0 3.2993425699845425e-12
CYP27 O 0 4.9013731739933064e-08
gene O 0 1.6964023241694548e-10
mRNA O 0 6.456279955102673e-11
in O 0 5.258716205547298e-12
the O 0 2.0253642513123893e-11
patient O 0 1.3996675818361837e-08
represented O 0 4.63852423138178e-09
52 O 0 1.6890162601868042e-09
. O 0 4.337291414913125e-09

5 O 0 9.434818259990152e-09
% O 0 1.1490348256204541e-10
of O 0 1.9636009832013634e-11
the O 0 1.144097372396402e-09
normal O 0 1.2944641980539018e-07
level O 0 1.8450191419105977e-07
. O 0 2.2935846999416754e-08

As O 0 2.676514565536081e-09
the O 0 2.674430954474616e-10
mutation O 0 1.5124557251056103e-07
occurred O 0 4.38119442947027e-08
at O 0 3.3177207509060835e-11
the O 0 1.9776272633387215e-12
penultimate O 0 1.4553946936501916e-10
nucleotide O 0 3.772243073463244e-10
of O 0 1.6193652321860874e-12
exon O 0 1.767635460225847e-08
6 O 0 6.52558840297246e-10
( O 0 2.773105096248729e-12
- O 0 8.955326258330842e-09
2 O 0 3.4763910500279493e-11
position O 0 2.983715718940516e-09
of O 0 5.548604110894306e-12
exon O 0 9.879520490585492e-08
6 O 0 2.308373714399181e-09
- O 0 7.2629205760677e-08
intron O 0 2.6708255518315127e-07
6 O 0 1.756405298980468e-10
splice O 0 1.0600913924463384e-08
site O 0 4.1262500083405484e-09
) O 0 3.3663273991263454e-13
of O 0 1.0164619661376037e-13
the O 0 3.3773910317752565e-12
gene O 0 1.8632624332326486e-09
, O 0 2.4962065400813138e-11
we O 0 1.3514274421755346e-10
hypothesized O 0 3.393304526255747e-10
that O 0 2.144002510251486e-11
the O 0 9.857389904333047e-11
mutation O 0 2.501654307707213e-06
may O 0 8.991563049676188e-08
partially O 0 1.522716814861269e-07
affect O 0 4.89467910647079e-10
the O 0 7.801165963217116e-12
normal O 0 5.889193299690731e-11
splicing O 0 2.8242341798545567e-10
efficiency O 0 6.742165159501212e-10
in O 0 1.1170733608956152e-11
exon O 0 1.349167533248874e-08
6 O 0 5.785310563943824e-10
and O 0 2.7465305030283105e-10
cause O 0 1.8040252625084463e-09
alternative O 0 3.089584491022812e-11
splicing O 0 2.9583850924552735e-09
elsewhere O 0 1.0515066151128849e-08
, O 0 4.883474701011803e-12
which O 0 6.97690603207457e-12
resulted O 0 9.262987599178985e-11
in O 0 9.334481104739112e-11
decreased O 0 1.83250872254348e-08
transcript O 0 2.2810116462324004e-08
in O 0 3.4947350568970137e-10
the O 0 9.713347903783642e-10
patient O 0 2.9678312785108574e-07
. O 0 2.701151746720143e-09

Transfection O 0 0.00015398320101667196
of O 0 9.073911400037105e-09
constructed O 0 3.006092583746067e-07
minigenes O 0 1.5014320524642244e-05
, O 0 3.1234289460391196e-11
with O 0 2.549555185027419e-11
or O 0 2.0425250379929594e-09
without O 0 3.817131055683376e-10
the O 0 2.9821992098000294e-11
mutation O 0 1.810765404286485e-08
, O 0 6.51093328557506e-13
into O 0 6.188486355307443e-12
COS O 0 3.1669318900640064e-07
- O 0 9.818505475323036e-08
1 O 0 8.927042438600097e-11
cells O 0 2.1906398917082015e-10
confirmed O 0 1.777112623724264e-10
that O 0 8.672075210713892e-12
the O 0 5.558932220789403e-12
mutant O 0 4.357058269732761e-09
minigene O 0 9.428396197108668e-07
was O 0 2.208451022056579e-08
responsible O 0 1.2117035153025313e-09
for O 0 4.613547391341122e-12
a O 0 2.05540515163527e-10
mRNA O 0 2.572387303168e-10
species O 0 2.2785164380256795e-11
alternatively O 0 4.182028057186926e-10
spliced O 0 2.1348473921989353e-07
at O 0 2.782557473324232e-08
an O 0 2.704300117173375e-10
activated O 0 4.6626773837488145e-06
cryptic O 0 1.7053099554686924e-07
5 O 0 1.735862321938786e-11
splice O 0 4.682901177943677e-09
site O 0 3.561666517271078e-09
88 O 0 2.1377478953699125e-10
bp O 0 1.0512499315495916e-08
upstream O 0 5.593522520164207e-11
from O 0 2.631368647282306e-12
the O 0 5.586226793641291e-12
3 O 0 1.5256355206938466e-11
end O 0 5.354935592172261e-11
of O 0 6.41772485848735e-12
exon O 0 1.639614595205785e-07
6 O 0 7.865888385083508e-09
. O 0 4.4015284750287265e-09

Our O 0 1.119993982001688e-07
data O 0 7.0403065599577985e-09
suggest O 0 2.9916022992182434e-09
that O 0 3.995985486948683e-11
the O 0 1.756833220567522e-11
C O 0 6.048900047517236e-09
to O 0 1.0622898394263558e-11
A O 0 4.107561846211638e-09
mutation O 0 3.8185334005902405e-08
at O 0 4.0075720519894276e-11
the O 0 2.243519823044715e-12
penultimate O 0 1.7791916551157527e-10
nucleotide O 0 1.217276945908452e-09
of O 0 1.8125449058326026e-12
exon O 0 3.0701610143069047e-09
6 O 0 3.82691239808608e-11
of O 0 7.582172736886328e-13
the O 0 1.4104844896223323e-11
CYP27 O 0 2.2209899270819733e-06
gene O 0 6.013950670791246e-09
not O 0 8.352820102253133e-10
only O 0 5.2223152885444435e-11
causes O 0 2.509763774583007e-08
the O 0 9.827063607303899e-09
deficiency B-Disease 0 0.0003229977155569941
in I-Disease 0 7.677792429605645e-11
the I-Disease 0 4.70359529103348e-10
sterol I-Disease 0 3.876802293234505e-05
27 I-Disease 0 4.8455244261447206e-09
- I-Disease 0 6.310243065854593e-07
hydroxylase I-Disease 0 4.182489647064358e-06
activity I-Disease 0 9.638462472594256e-09
, O 0 1.4513524063120009e-11
but O 0 5.576063916157281e-11
also O 0 3.6280329435145475e-11
partially O 0 4.1868104538878015e-09
leads O 0 4.593538396879815e-11
to O 0 6.3556234927708566e-12
alternative O 0 5.874811054296103e-11
pre O 0 3.076235444154918e-08
- O 0 1.2021462048039666e-08
mRNA O 0 5.3577146191807756e-11
splicing O 0 9.321013405561018e-11
of O 0 1.890754480066148e-12
the O 0 3.502901441132522e-11
gene O 0 7.942897894963608e-09
. O 0 4.748197834913981e-09

To O 0 4.138332787562149e-09
our O 0 1.3019134659231213e-09
knowledge O 0 3.1039332215598847e-10
, O 0 7.695733807155936e-12
this O 0 8.449917848762922e-12
is O 0 7.29482446670815e-12
the O 0 1.0895278819769705e-12
first O 0 6.336647873084189e-11
report O 0 7.997189716002495e-11
regarding O 0 4.78514172730371e-11
effects O 0 4.314864021637277e-09
on O 0 3.3726374470965936e-10
pre O 0 9.388757860051555e-08
- O 0 2.149566391551616e-08
mRNA O 0 1.1262383387000696e-11
splicing O 0 2.1785134460272637e-11
of O 0 1.851511159016786e-13
a O 0 3.0830445835183795e-11
mutation O 0 5.733289398790475e-09
at O 0 1.7391638129637954e-10
the O 0 3.6291126354059955e-11
- O 0 6.365851277223555e-07
2 O 0 4.6556289379218185e-10
position O 0 1.3848657332005132e-08
of O 0 5.70601812327487e-12
a O 0 9.858298621878703e-10
5 O 0 2.7766539067997087e-10
splice O 0 1.2079732414349564e-07
site O 0 6.644331165261974e-07
. O 0 3.1176661252629856e-08

ATM O 0 0.0004450228007044643
germline O 0 0.008281335234642029
mutations O 0 0.008346104063093662
in O 0 6.886776304781961e-07
classical O 0 0.15768368542194366
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999994039535522
telangiectasia I-Disease 1 1.0
patients O 0 0.0031867902725934982
in O 0 1.9722369515307037e-08
the O 0 1.6545227410347252e-09
Dutch O 0 3.8406189560191706e-05
population O 0 1.3277940968947632e-09
. O 0 4.699069133806688e-09

Germline O 0 0.0018284459365531802
mutations O 0 0.0003503637562971562
in O 0 3.275945514857881e-09
the O 0 8.141802509964435e-11
ATM O 0 6.831860446254723e-07
gene O 0 3.137674298159254e-08
are O 0 1.3146339572500665e-10
responsible O 0 2.8090105796962916e-09
for O 0 8.139649509963931e-10
the O 0 0.00904024951159954
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.08258746564388275
A B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999997615814209
T I-Disease 1 1.0
) O 0 6.42463291455897e-08
. O 0 4.4534465004630874e-09

In O 0 1.7853054146144132e-08
our O 0 3.959557126620439e-09
study O 0 2.0719290172444005e-10
, O 0 2.348805178131741e-11
we O 0 7.753700459467439e-11
have O 0 2.399502471717163e-11
determined O 0 4.860990499011564e-10
the O 0 4.149573913647675e-12
ATM O 0 9.45627860460263e-08
mutation O 0 1.0100443148530758e-08
spectrum O 0 6.776772920602525e-09
in O 0 1.232090401925845e-10
19 O 0 1.0328998767406006e-10
classical O 0 8.953140877565602e-07
A B-Disease 1 0.9999991655349731
- I-Disease 1 0.9999997615814209
T I-Disease 1 1.0
patients O 0 1.1186793926754035e-06
, O 0 2.936007773707283e-12
including O 0 2.7376297301144603e-13
some O 0 8.661557799119479e-13
immigrant O 0 4.185229940389945e-09
populations O 0 2.314906738520861e-10
, O 0 5.450414425345329e-12
as O 0 5.2008614428999955e-12
well O 0 5.5967879636353857e-11
as O 0 2.5854211133102822e-11
12 O 0 3.627242386658458e-12
of O 0 4.087844212435909e-12
Dutch O 0 6.048660452506738e-07
ethnic O 0 1.0470072586699075e-09
origin O 0 6.605009872373557e-08
. O 0 9.312599580368897e-09

Both O 0 4.570540834691883e-09
the O 0 1.0343350481667457e-10
protein O 0 8.594460698674311e-10
truncation O 0 3.49128725929404e-08
test O 0 1.827147855237854e-08
( O 0 6.584196382553031e-11
PTT O 0 2.0137581202561705e-07
) O 0 1.50864878315643e-12
and O 0 1.0968632686153557e-12
the O 0 1.96589337690678e-12
restriction O 0 5.410870015931657e-11
endonuclease O 0 7.000537038948096e-09
fingerprinting O 0 1.2183971165313778e-08
( O 0 3.55912313509954e-11
REF O 0 3.301886977169488e-07
) O 0 1.5719326881824536e-13
method O 0 6.8593789502580105e-12
were O 0 5.6795165792600244e-11
used O 0 4.651849572212541e-09
and O 0 1.2462151310899117e-09
compared O 0 9.982916715500778e-10
for O 0 1.351890170989134e-12
their O 0 2.0998406138894588e-11
detection O 0 5.806628067261954e-09
efficiency O 0 2.388385322849018e-10
, O 0 2.9231044668120987e-13
identifying O 0 2.8257198664283223e-11
76 O 0 2.133814609381335e-12
% O 0 3.339034777838368e-13
and O 0 9.488112552580308e-12
60 O 0 9.700822610481108e-12
% O 0 7.380274234629336e-13
of O 0 1.4466531271517535e-12
the O 0 1.5289288723963068e-09
mutations O 0 1.0619055501592811e-06
, O 0 4.910201134578074e-10
respectively O 0 5.4836160501281483e-08
. O 0 7.275645419468901e-09

Most O 0 1.2778224345311173e-07
patients O 0 9.243445475703993e-08
were O 0 6.1470863954582455e-09
found O 0 5.175082140596032e-09
to O 0 2.54913340436147e-10
be O 0 3.5033329570666183e-09
compound O 0 1.0341589984363964e-07
heterozygote O 0 6.701134225295391e-06
. O 0 1.3262533293811885e-08

Seventeen O 0 7.363376539615274e-07
mutations O 0 4.4271282604313456e-06
were O 0 1.5730066138530674e-09
distinct O 0 2.431997714325007e-09
, O 0 5.4033517243867735e-11
of O 0 4.181162794464344e-12
which O 0 4.999014091566778e-09
10 O 0 1.624836931668483e-10
were O 0 1.333271359982291e-08
not O 0 7.52387521174569e-08
reported O 0 3.055537831642141e-07
previously O 0 8.833087150605934e-08
. O 0 8.631510617362892e-09

Mutations O 0 0.0008187632192857563
are O 0 1.2014349515254708e-09
small O 0 4.61341104207591e-10
deletions O 0 3.547472147147346e-07
or O 0 5.259408908386831e-08
point O 0 1.7284220632518554e-07
mutations O 0 1.8282411247128039e-06
frequently O 0 1.690856663572049e-07
affecting O 0 2.2268718424811595e-08
splice O 0 1.6009518049031612e-06
sites O 0 1.186036001854518e-06
. O 0 6.987840350802799e-08

Moreover O 0 6.3685019995318726e-06
, O 0 1.2392747938960724e-09
a O 0 3.352238486797887e-09
16 O 0 2.644509722316002e-09
. O 0 5.15453280058864e-09

7 O 0 1.5494096317070216e-07
- O 0 3.8496426668643835e-07
kb O 0 4.2039613390443265e-07
genomic O 0 5.780342604566613e-08
deletion O 0 7.032753046587459e-07
of O 0 7.926771738997473e-11
the O 0 4.7302772809842963e-11
3 O 0 1.4621609478737696e-11
end O 0 4.7758776100526035e-11
of O 0 6.301808033737366e-13
the O 0 9.00270136217074e-12
gene O 0 1.0261805849509642e-09
, O 0 1.1052704758374166e-11
most O 0 3.981148744003349e-12
likely O 0 7.346434571786631e-11
a O 0 4.2157104196416384e-11
result O 0 1.9165280473742996e-10
of O 0 7.856051421374632e-13
recombination O 0 1.04649611198937e-09
between O 0 1.239667146712975e-09
two O 0 6.269304519967989e-10
LINE O 0 4.817361059394898e-06
elements O 0 3.479520671589853e-08
, O 0 3.5772007578316334e-10
was O 0 3.933589454163666e-08
identified O 0 2.6127702312805923e-07
. O 0 4.2949199752229106e-09

The O 0 4.038938516970347e-09
most O 0 1.600592436368231e-10
frequently O 0 1.2331637044837862e-08
found O 0 5.918319168074504e-09
mutation O 0 2.920499184710934e-07
, O 0 5.1169131431993975e-11
identified O 0 9.069222706159508e-09
in O 0 5.548511650133037e-11
three O 0 3.965244105286203e-11
unrelated O 0 7.417350644800536e-08
Turkish O 0 1.9081764548900537e-05
A B-Disease 1 0.999995231628418
- I-Disease 1 0.9999916553497314
T I-Disease 1 0.9999998807907104
individuals O 0 3.5522585761782466e-08
, O 0 1.197043242306961e-09
was O 0 3.289835603936808e-08
previously O 0 7.298523119203537e-09
described O 0 9.800634082068882e-09
to O 0 6.065090790707828e-11
be O 0 1.5436120159861844e-09
a O 0 9.528678290848802e-09
Turkish O 0 2.6772342607728206e-05
A B-Disease 1 0.9999982118606567
- I-Disease 1 0.999993085861206
T I-Disease 1 0.9999996423721313
founder O 0 1.247596173925558e-06
mutation O 0 3.4821414374164306e-06
. O 0 5.217750231878426e-09

The O 0 2.358918171907476e-09
presence O 0 1.1501120056323089e-09
of O 0 1.604253015152768e-11
a O 0 7.525762235616185e-10
founder O 0 3.693940442417443e-08
mutation O 0 3.5725346947401704e-07
among O 0 2.2739535948668177e-11
relatively O 0 1.7387392914347544e-10
small O 0 3.129368292276169e-11
ethnic O 0 7.82299919288576e-11
population O 0 1.3764001223492972e-11
groups O 0 5.287137914977702e-12
in O 0 1.5772530850832744e-11
Western O 0 1.1924622400627527e-10
Europe O 0 2.2021193757382207e-09
could O 0 2.1056912657968496e-08
indicate O 0 1.3387244202078818e-08
a O 0 9.713571058611592e-10
high O 0 2.660006082066957e-08
carrier O 0 1.2126456283567677e-07
frequency O 0 3.901705838416092e-07
in O 0 1.6928726476184153e-10
such O 0 2.214670530298335e-10
communities O 0 2.707940316426516e-09
. O 0 7.689818559697414e-09

In O 0 3.176150187300664e-08
patients O 0 7.2881318757822555e-09
of O 0 7.802300472370405e-11
Dutch O 0 5.6542176025686786e-06
ethnic O 0 2.671047383273617e-09
origin O 0 6.337224789376705e-08
, O 0 1.0909138870029977e-10
however O 0 7.910731791849201e-11
, O 0 1.59764443428273e-12
no O 0 2.4705574391825635e-11
significant O 0 4.3638238855781e-11
founder O 0 2.9526858735806627e-09
effect O 0 4.198552261414079e-08
could O 0 7.158165260534588e-08
be O 0 5.929991608866203e-09
identified O 0 1.4281563665008434e-07
. O 0 3.112887059231184e-09

The O 0 4.511429008147161e-09
observed O 0 2.900114992598901e-08
genetic O 0 1.1909859765069086e-08
heterogeneity O 0 2.0657042298921624e-08
including O 0 7.209978447608734e-11
the O 0 1.2240328195467498e-10
relative O 0 1.238934828506899e-06
high O 0 4.82132733736762e-08
percentage O 0 1.0518877324727782e-08
of O 0 8.752636636299993e-12
splice O 0 9.889697594189784e-07
- O 0 9.777897503226995e-05
site O 0 5.290606623020722e-06
mutations O 0 6.50040601613e-05
had O 0 5.02705113092361e-08
no O 0 1.355119239043745e-09
reflection O 0 3.001800763513529e-08
on O 0 2.7708886296551327e-09
the O 0 1.4371451806383106e-09
phenotype O 0 2.3176542072178563e-06
. O 0 9.311408533108079e-09

All O 0 6.93435664445019e-09
patients O 0 2.827147405071173e-08
manifested O 0 7.380884170515856e-08
classical O 0 5.726041763409739e-06
A B-Disease 1 0.9999903440475464
- I-Disease 1 0.9999852180480957
T I-Disease 1 0.9999997615814209
and O 0 8.631362291566802e-09
increased O 0 1.960915652077233e-09
cellular O 0 6.09248473892876e-08
radioresistant O 0 8.055943823137568e-08
DNA O 0 2.997829895434734e-08
synthesis O 0 3.909519463718425e-08
. O 0 7.988066208497457e-09

Determination O 0 2.4141195353877265e-06
of O 0 8.223066672030654e-11
the O 0 4.410314474734278e-11
genomic O 0 6.381847494907333e-09
structure O 0 1.576659869328978e-08
of O 0 5.812181465281174e-12
the O 0 3.5233253814492826e-11
COL4A4 O 0 1.5697576145612402e-06
gene O 0 3.5358642680449748e-09
and O 0 1.1580247871734173e-10
of O 0 4.2372098885135046e-11
novel O 0 9.475650841750394e-08
mutations O 0 0.0004590238386299461
causing O 0 0.0017651887610554695
autosomal B-Disease 1 0.9999802112579346
recessive I-Disease 1 0.9999961853027344
Alport I-Disease 1 0.9999984502792358
syndrome I-Disease 1 0.9999955892562866
. O 0 9.272762326872908e-06

Autosomal B-Disease 1 0.9999784231185913
recessive I-Disease 1 0.9999938011169434
Alport I-Disease 1 0.9999982118606567
syndrome I-Disease 1 0.9999994039535522
is O 0 2.6282148155587493e-06
a O 0 5.017682269681245e-08
progressive O 0 0.00023320363834500313
hematuric B-Disease 1 0.9991685152053833
glomerulonephritis I-Disease 1 0.9999985694885254
characterized O 0 0.00442521134391427
by O 0 1.1271119149114384e-07
glomerular B-Disease 1 0.9996528625488281
basement I-Disease 1 0.9999114274978638
membrane I-Disease 1 0.9983956217765808
abnormalities I-Disease 1 0.9998952150344849
and O 0 8.305323540014342e-09
associated O 0 1.4078069376921576e-08
with O 0 3.3172731228603425e-10
mutations O 0 2.7862333240591397e-07
in O 0 1.3477670368633454e-10
either O 0 2.0039285786310757e-09
the O 0 3.3904581919763643e-10
COL4A3 O 0 1.8657243344932795e-05
or O 0 5.404869884984009e-10
the O 0 3.420484381844169e-11
COL4A4 O 0 1.8847362071028329e-06
gene O 0 2.8391424766738282e-09
, O 0 5.0207550790493105e-12
which O 0 1.1642957648341778e-12
encode O 0 2.3496116510757226e-11
the O 0 2.1319930196272985e-11
alpha3 O 0 2.0001975542527362e-07
and O 0 7.158677539642611e-10
alpha4 O 0 3.322733618915663e-06
type O 0 5.3542979003395885e-05
IV O 0 0.0002946796885225922
collagen O 0 2.1860314518562518e-05
chains O 0 1.8234653907711618e-05
, O 0 1.0663347982386995e-09
respectively O 0 3.672709780744299e-08
. O 0 5.615163445327198e-09

To O 0 4.596637293019512e-09
date O 0 1.3129613840590082e-08
, O 0 1.1495428740848634e-11
mutation O 0 7.966213244614551e-10
screening O 0 4.119579399830542e-10
in O 0 4.845187098756476e-11
the O 0 1.9636422696200917e-11
two O 0 2.2268187294116615e-10
genes O 0 1.9852048893653773e-08
has O 0 3.669346826384867e-09
been O 0 2.829487089073268e-09
hampered O 0 4.4867938697734644e-08
by O 0 1.2124636017407653e-10
the O 0 2.599088166910235e-10
lack O 0 1.1886025497176433e-09
of O 0 8.395185588372378e-12
genomic O 0 5.6264526371307966e-09
structure O 0 1.0957931806387933e-07
information O 0 4.0742902385204616e-09
. O 0 1.9668640049985697e-09

We O 0 1.837046170294343e-06
report O 0 1.454072684481389e-08
here O 0 5.7231878958230453e-11
the O 0 8.669872003479184e-13
complete O 0 5.9554063069899854e-12
characterization O 0 1.4573621198721298e-09
of O 0 1.9639071185267865e-12
the O 0 1.6692381851757254e-11
48 O 0 1.015451438213244e-11
exons O 0 1.1897768881219406e-10
of O 0 2.3461174409461494e-12
the O 0 6.703500948779251e-11
COL4A4 O 0 4.83645044369041e-06
gene O 0 1.7335676227858698e-09
, O 0 3.355764451040688e-12
a O 0 2.1215680254260683e-11
comprehensive O 0 5.55715640171428e-10
gene O 0 6.599667923268271e-09
screen O 0 2.0712968762381934e-06
, O 0 4.7494251587121283e-11
and O 0 1.4999100919621533e-11
the O 0 1.9543559479084927e-12
subsequent O 0 2.331269031985439e-11
detection O 0 3.3882747718649853e-09
of O 0 1.9937612758674783e-12
10 O 0 7.226661109804855e-12
novel O 0 1.3271148069371463e-10
mutations O 0 1.5549037613027394e-08
in O 0 7.852108407924163e-10
eight O 0 2.3600309262405972e-08
patients O 0 1.1424971262385952e-06
diagnosed O 0 0.030232498422265053
with O 0 1.4058975466468837e-05
autosomal B-Disease 1 0.9999926090240479
recessive I-Disease 1 0.9999982118606567
Alport I-Disease 1 0.9999990463256836
syndrome I-Disease 1 0.9999943971633911
. O 0 3.3229425753233954e-06

Furthermore O 0 3.736546887012082e-06
, O 0 1.7388596118550481e-09
we O 0 6.357667170497905e-10
identified O 0 4.034278744402542e-10
a O 0 2.41356639535395e-11
glycine O 0 5.384992007861911e-09
to O 0 1.811823434338944e-11
alanine O 0 8.334232748374859e-10
substitution O 0 4.790840293922294e-11
in O 0 9.561179105388451e-12
the O 0 1.147890810182517e-11
collagenous O 0 4.1788430849010183e-07
domain O 0 3.4567637641202964e-09
that O 0 5.077308573575579e-10
is O 0 1.2550116501586217e-10
apparently O 0 3.8464547102989854e-09
silent O 0 3.006006110695125e-08
in O 0 3.458250699694965e-11
the O 0 8.881844044961174e-12
heterozygous O 0 8.986776656172424e-09
carriers O 0 2.5084416765963624e-09
, O 0 3.2428074114854155e-11
in O 0 9.752885998803862e-11
11 O 0 4.944769038672803e-10
. O 0 2.4077664306787483e-09

5 O 0 4.380723783725671e-09
% O 0 7.026508541674303e-11
of O 0 3.927082183746711e-12
all O 0 2.597937143189455e-11
control O 0 1.4084649890833134e-08
individuals O 0 2.376130958658962e-10
, O 0 3.808387979975514e-11
and O 0 1.0977308645410133e-10
in O 0 1.012175759873557e-11
one O 0 2.664551912445745e-11
control O 0 1.0862883925710776e-09
individual O 0 1.0233342645493693e-10
homozygous O 0 5.615849119067207e-09
for O 0 3.740813648428487e-12
this O 0 6.740885193784463e-12
glycine O 0 1.0620403223526864e-08
substitution O 0 1.2238145608023387e-08
. O 0 1.953274431087948e-09

There O 0 7.239967203531705e-07
has O 0 1.3277693611257746e-08
been O 0 8.973480847274118e-10
no O 0 3.601071663084099e-10
previous O 0 6.258023266259016e-11
finding O 0 1.2452586704847501e-11
of O 0 3.360797425945583e-13
a O 0 2.32894016571894e-11
glycine O 0 2.920128805428135e-09
substitution O 0 6.332856461455094e-10
that O 0 1.5360023253307986e-09
is O 0 1.982985164961093e-10
not O 0 6.161671173288141e-11
associated O 0 1.0890054136236671e-10
with O 0 8.355201946974589e-12
any O 0 1.2476277788664447e-09
obvious O 0 1.4790762747907138e-07
phenotype O 0 2.1335428357360797e-07
in O 0 1.900989643477402e-10
homozygous O 0 9.920418051478919e-07
individuals O 0 1.4898191125212179e-08
. O 0 4.537189823849985e-08

Founder O 0 1.636307752050925e-05
BRCA1 O 0 0.0008447839645668864
and O 0 4.546415866002462e-08
BRCA2 O 0 6.638657214352861e-05
mutations O 0 4.173763500148198e-06
in O 0 4.340502179900341e-09
French O 0 4.636288940673694e-05
Canadian O 0 0.15160883963108063
breast B-Disease 1 0.9999713897705078
and I-Disease 1 0.9998041987419128
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
families O 0 1.3892799870518502e-05
. O 0 9.47738598711112e-08

We O 0 3.9332599044428207e-07
have O 0 1.1605106875478555e-09
identified O 0 2.4887307770171674e-09
four O 0 7.592712049364625e-12
mutations O 0 1.430799811963368e-09
in O 0 7.857194062044215e-12
each O 0 8.10657790895064e-12
of O 0 6.394045883040267e-12
the O 0 4.9900140908221147e-08
breast B-Disease 1 0.9993675351142883
cancer I-Disease 0 0.01652194745838642
- O 0 0.0006381581188179553
susceptibility O 0 0.027606280520558357
genes O 0 7.642823902642704e-07
, O 0 4.703200051636713e-10
BRCA1 O 0 1.0106784884555964e-06
and O 0 3.227409228756528e-09
BRCA2 O 0 7.277604368027824e-07
, O 0 4.6506565959392177e-11
in O 0 1.2864800891243533e-10
French O 0 9.889350621961057e-06
Canadian O 0 0.03352546691894531
breast B-Disease 1 0.9999027252197266
cancer I-Disease 1 0.7853726744651794
and O 0 0.004305675625801086
breast B-Disease 1 0.999996542930603
/ I-Disease 1 0.999998927116394
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
families O 0 2.886214815589483e-06
from O 0 2.6197106706149498e-08
Quebec O 0 5.723071353713749e-06
. O 0 3.515704705137068e-08

To O 0 2.5483144483473552e-08
identify O 0 1.1961621737555106e-07
founder O 0 8.073602231206678e-08
effects O 0 1.223893718815816e-06
, O 0 2.794388609395071e-10
we O 0 2.2074182481901516e-09
examined O 0 4.2608888861650485e-08
independently O 0 5.815461445735082e-09
ascertained O 0 4.01451785592144e-07
French O 0 8.311498618240876e-07
Canadian O 0 5.368307483877288e-06
cancer B-Disease 0 5.893146521884773e-07
families O 0 5.177861611693757e-11
for O 0 1.6426843609321229e-12
the O 0 1.9964173543496333e-12
distribution O 0 7.754347511323978e-12
of O 0 1.7832803376333084e-12
these O 0 3.5159944400398047e-11
eight O 0 3.2564570484616695e-10
mutations O 0 3.02702716226122e-07
. O 0 4.426972122217876e-09

Mutations O 0 0.0004937894409522414
were O 0 8.384109406733842e-09
found O 0 1.7567076682212246e-09
in O 0 9.430904668317197e-11
41 O 0 7.692187165009301e-11
of O 0 8.350486968566884e-12
97 O 0 5.168361849605674e-10
families O 0 2.4615198768174196e-09
. O 0 9.018920721359791e-09

Six O 0 5.4803721560858776e-09
of O 0 5.820049650551162e-11
eight O 0 3.8449124439843274e-10
mutations O 0 5.688967803507694e-07
were O 0 1.2000088034369583e-08
observed O 0 2.080620191691196e-07
at O 0 4.6045172119590916e-09
least O 0 2.352850969611353e-10
twice O 0 1.1372234354212196e-07
. O 0 4.841127054788785e-09

The O 0 8.927803918368227e-08
BRCA1 O 0 6.493385444628075e-05
C4446T O 0 1.4684368352391175e-06
mutation O 0 1.456363133911509e-05
was O 0 4.71295491522028e-09
the O 0 1.4263678779768973e-11
most O 0 2.239450812291377e-11
common O 0 2.7729030183110126e-09
mutation O 0 7.451097303601273e-07
found O 0 1.2946735239438567e-08
, O 0 1.0692439988968516e-11
followed O 0 3.317062596819298e-11
by O 0 2.451378336432164e-11
the O 0 2.4042374757726748e-09
BRCA2 O 0 1.5363129932666197e-05
8765delAG O 0 1.9816011445072945e-06
mutation O 0 3.954679414164275e-06
. O 0 1.4398842118623634e-08

Together O 0 3.87470286966618e-08
, O 0 1.2766877832692813e-10
these O 0 1.968543383856769e-11
mutations O 0 9.86180115347679e-09
were O 0 4.426970179327583e-10
found O 0 4.2964665158962134e-10
in O 0 6.499201871124072e-11
28 O 0 1.198714478373164e-11
of O 0 1.9744386247494417e-12
41 O 0 6.818123843288504e-11
families O 0 6.863137835821931e-11
identified O 0 5.7601909020377207e-08
to O 0 6.655804796196207e-10
have O 0 9.077442797433832e-09
a O 0 2.7210305120206613e-08
mutation O 0 1.587836777616758e-05
. O 0 1.699963725343423e-08

The O 0 8.36956992600335e-09
odds O 0 3.888169999299862e-07
of O 0 1.3573683843581819e-11
detection O 0 1.4120504765458008e-08
of O 0 3.368178999596516e-12
any O 0 6.833278387574637e-11
of O 0 3.205062517469548e-12
the O 0 3.4790906267012645e-11
four O 0 1.5631963501405721e-09
BRCA1 O 0 1.8594362700241618e-05
mutations O 0 2.1236598968243925e-06
was O 0 5.564587013395794e-08
18 O 0 1.2674733484985268e-09
. O 0 3.113243440822089e-09

7x O 0 8.324711234308779e-05
greater O 0 9.784121957068237e-09
if O 0 2.315565961197308e-09
one O 0 1.2996569966061688e-11
or O 0 7.574241581154162e-12
more O 0 1.2986304739892596e-12
cases O 0 6.552278719595961e-10
of O 0 1.859315852925647e-05
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 0.00031689307070337236
also O 0 1.1420659973282454e-08
present O 0 7.674590407624748e-10
in O 0 2.7136318192511055e-10
the O 0 2.726024683763484e-10
family O 0 2.2546519318211722e-08
. O 0 1.7899221660400144e-08

The O 0 4.346317972192537e-09
odds O 0 3.2634437729939236e-07
of O 0 2.070047605551295e-11
detection O 0 3.762093925274712e-08
of O 0 7.884065796048834e-12
any O 0 1.6088563814520285e-10
of O 0 2.42613784964818e-12
the O 0 5.1630782982314827e-11
four O 0 1.1098240104701063e-09
BRCA2 O 0 1.0649556315911468e-05
mutations O 0 4.82008590552141e-06
was O 0 5.536669078765044e-08
5 O 0 1.4824624861020652e-09
. O 0 2.763625994717245e-09

3x O 0 3.749844108824618e-05
greater O 0 3.351178889943185e-08
if O 0 2.0549054013940804e-08
there O 0 2.5329893738046394e-10
were O 0 1.9278273422074221e-10
at O 0 1.0357762564305872e-10
least O 0 4.1066854777893624e-12
five O 0 2.0256840909532725e-12
cases O 0 3.450949942473969e-11
of O 0 3.8335914998022247e-10
breast B-Disease 1 0.9931460618972778
cancer I-Disease 0 0.0007779859588481486
in O 0 6.55847109953811e-09
the O 0 9.74076930226886e-10
family O 0 6.165288368720212e-08
. O 0 1.2895301715332153e-08

Interestingly O 0 3.152006911477656e-06
, O 0 1.6601486851897107e-10
the O 0 2.154512462534952e-12
presence O 0 2.8852907910104086e-11
of O 0 1.7971125889498785e-12
a O 0 2.995086845203332e-08
breast B-Disease 1 0.6534847021102905
cancer I-Disease 0 9.890058208839037e-06
case O 0 2.5672138193044702e-08
< O 0 3.779924639957244e-08
36 O 0 1.9542301804564843e-11
years O 0 3.202980242145159e-11
of O 0 6.592939302135781e-12
age O 0 4.498908801053858e-09
was O 0 9.538420053800678e-10
strongly O 0 3.764695777341842e-10
predictive O 0 5.303111283438966e-10
of O 0 8.411529936122597e-13
the O 0 4.465126185460022e-12
presence O 0 4.404295331217334e-11
of O 0 3.1843310540485836e-13
any O 0 1.2610144699276571e-11
of O 0 1.008156123687154e-12
the O 0 2.4246771257452338e-11
eight O 0 2.119801417732603e-10
mutations O 0 8.1519310413114e-08
screened O 0 1.420188027623226e-06
. O 0 4.7120764179453545e-08

Carriers O 0 9.650109689118835e-08
of O 0 3.07147571265709e-11
the O 0 3.153232536190487e-11
same O 0 3.6843528228303057e-10
mutation O 0 3.618432842245056e-08
, O 0 3.493092100292916e-12
from O 0 1.4937767819564463e-12
different O 0 8.592879012503385e-12
families O 0 3.3085072875804755e-11
, O 0 2.374723898426745e-12
shared O 0 2.9359029096731604e-11
similar O 0 2.0704395142789878e-10
haplotypes O 0 2.0222755026111372e-08
, O 0 4.1668977296405174e-11
indicating O 0 2.794123377114488e-09
that O 0 3.186156893875136e-11
the O 0 2.511056250084631e-12
mutant O 0 9.903813324996236e-10
alleles O 0 6.195318702495456e-10
were O 0 2.210725824625115e-09
likely O 0 9.608909223857154e-09
to O 0 3.0952720941890277e-10
be O 0 1.70752567640875e-08
identical O 0 4.1629647284935345e-07
by O 0 3.945005988548189e-10
descent O 0 3.1617890527968484e-08
for O 0 1.5797611482848417e-11
a O 0 2.684766631233515e-09
mutation O 0 2.417270366095181e-07
in O 0 1.996815768290361e-10
the O 0 2.3560570161507144e-10
founder O 0 1.7111251082724266e-08
population O 0 5.216245213546244e-10
. O 0 6.830991328143909e-09

The O 0 2.6367987793207703e-09
identification O 0 4.460978697551354e-09
of O 0 8.535026851941296e-11
common O 0 2.8409097296844266e-08
BRCA1 O 0 0.00025064469082280993
and O 0 1.6410945136158261e-07
BRCA2 O 0 0.00019863764464389533
mutations O 0 2.9001207622059155e-06
will O 0 3.9123204675917123e-10
facilitate O 0 4.2340045358635336e-10
carrier O 0 5.062026176005929e-08
detection O 0 9.502853970388969e-08
in O 0 6.390638573883223e-10
French O 0 2.5337997158203507e-06
Canadian O 0 0.0008797411574050784
breast B-Disease 1 0.9997105002403259
cancer I-Disease 0 0.31641340255737305
and O 0 0.0006963975611142814
breast B-Disease 1 0.9999959468841553
/ I-Disease 1 0.9999988079071045
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
families O 0 1.1833090866275597e-05
. O 0 4.7358092558624776e-08

Are O 0 1.487082279538754e-08
Dp71 O 0 4.746009381051408e-06
and O 0 6.6472951587570606e-09
Dp140 O 0 1.854981860560656e-06
brain O 0 1.6099644199130125e-05
dystrophin O 0 2.313140839760308e-06
isoforms O 0 1.7655395367910387e-08
related O 0 7.561304471437325e-09
to O 0 1.6370476085825203e-09
cognitive B-Disease 0 1.962911119335331e-05
impairment I-Disease 0 0.0010887400712817907
in O 0 1.3805314665660262e-05
Duchenne B-Disease 1 0.9999485015869141
muscular I-Disease 1 0.9999279975891113
dystrophy I-Disease 1 0.9999243021011353
? O 0 0.0029563477728515863

Molecular O 0 0.0008580539142712951
study O 0 2.7639259769784985e-07
and O 0 4.0948187063349906e-09
neuropsychological O 0 1.3519105550585664e-06
analysis O 0 1.6658088242138547e-08
were O 0 2.488938499745075e-10
performed O 0 3.1996416627322333e-10
concurrently O 0 9.57724524686121e-11
on O 0 1.5419523435866722e-09
49 O 0 3.733961584373446e-09
patients O 0 1.0091161684044891e-08
with O 0 9.353971108794212e-07
Duchenne B-Disease 1 0.9999901056289673
muscular I-Disease 1 0.9999755620956421
dystrophy I-Disease 1 0.9999854564666748
( O 0 1.6826572846184717e-06
DMD B-Disease 1 0.9999992847442627
) O 0 4.364575367787893e-10
in O 0 4.4272040894410836e-11
order O 0 4.770142614241024e-11
to O 0 7.93254524567022e-12
find O 0 8.002229434644903e-10
a O 0 1.6947658554311573e-10
molecular O 0 3.656507630012129e-08
explanation O 0 2.766947504451167e-10
for O 0 2.5505023440453023e-12
the O 0 5.05190993205229e-11
cognitive B-Disease 0 7.912251476227539e-08
impairment I-Disease 0 2.1533298877329798e-07
observed O 0 1.7658298645528703e-07
in O 0 1.528485560342574e-09
most O 0 2.554848776981089e-07
DMD B-Disease 1 0.9999988079071045
patients O 0 4.992916728951968e-06
. O 0 7.542410429550728e-08

Complete O 0 3.495191691627042e-08
analysis O 0 3.447446772497642e-09
of O 0 1.0805878761233068e-11
the O 0 9.337455114666326e-11
dystrophin O 0 1.0921912689809687e-06
gene O 0 8.688715524840518e-08
was O 0 2.422739520113737e-08
performed O 0 8.246756610930106e-10
to O 0 1.75730922868933e-11
define O 0 4.81887019176952e-09
the O 0 1.736160173959611e-11
localization O 0 1.1641952957219814e-09
of O 0 4.560004175473142e-13
deletions O 0 8.228519199349194e-09
and O 0 5.133417024794085e-10
duplications O 0 1.0920020798721453e-07
in O 0 2.915580554763153e-10
relation O 0 1.522597159464567e-08
to O 0 8.318728345058091e-11
the O 0 5.079710541089355e-10
different O 0 3.8160870019510185e-08
DMD B-Disease 1 0.9999804496765137
promoters O 0 2.3347436581389047e-05
. O 0 3.916438018336521e-08

Qualitative O 0 2.1593984911305597e-07
analysis O 0 1.6152412740666477e-08
of O 0 3.224661510037308e-11
the O 0 6.002255636960996e-11
Dp71 O 0 2.585987886050134e-07
transcript O 0 7.249425379995955e-07
and O 0 2.100415619210594e-09
testing O 0 1.506516716931472e-10
for O 0 6.166402566516738e-13
the O 0 1.2189013904109758e-12
specific O 0 6.547537251960778e-12
first O 0 3.779340122106456e-12
exon O 0 8.291929365356054e-10
of O 0 3.221059183267094e-11
Dp140 O 0 7.094620713132826e-08
were O 0 1.258073467624854e-08
also O 0 1.0893341784168342e-09
carried O 0 2.0438745806927727e-08
out O 0 1.5589771695800891e-09
. O 0 2.6356219429146677e-09

Neuropsychological O 0 0.0006562027265317738
analysis O 0 2.109284650941845e-06
assessed O 0 1.8187287196269608e-06
verbal O 0 7.6254191299085505e-06
and O 0 7.613112806836853e-09
visuospatial O 0 7.04067133483477e-05
intelligence O 0 1.167477876151679e-06
, O 0 1.111891412275412e-10
verbal O 0 2.58798650065728e-07
memory O 0 0.00016536065959371626
, O 0 2.0874235673318253e-09
and O 0 1.1481109396527245e-09
reading O 0 7.822398373491524e-08
skills O 0 6.951110975705888e-08
. O 0 1.0907276859484227e-08

Comparison O 0 1.4570800033197884e-07
of O 0 2.0930919497619271e-10
molecular O 0 1.255812435374537e-06
and O 0 2.207165561429747e-09
psychometric O 0 1.8202770661446266e-05
findings O 0 5.1089823926986355e-08
demonstrated O 0 9.342024043235142e-09
that O 0 2.993322950617383e-11
deletions O 0 1.5845072809383964e-08
and O 0 7.798436341133197e-10
duplications O 0 3.5300377021485474e-07
that O 0 1.3371524332228546e-08
were O 0 5.01189090229559e-10
localized O 0 6.198681035129994e-08
in O 0 6.318354173195928e-10
the O 0 5.8173861561261475e-11
distal O 0 2.1575916608895795e-09
part O 0 9.817049950733292e-11
of O 0 3.860914626202527e-12
the O 0 4.245995915974632e-11
gene O 0 5.516059164989429e-09
seemed O 0 8.079145352724026e-09
to O 0 1.347108362359517e-11
be O 0 4.1613876233803637e-10
preferentially O 0 4.06730471524952e-08
associated O 0 1.948568417731167e-08
with O 0 4.753707205651381e-09
cognitive B-Disease 0 6.303521331574302e-06
impairment I-Disease 0 1.7679309166851453e-05
. O 0 7.757350317660894e-08

Two O 0 2.5328853681116925e-08
altered O 0 1.1220118949495372e-06
Dp71 O 0 1.2440899581633857e-06
transcripts O 0 1.414647101682931e-07
and O 0 4.158626776273877e-10
two O 0 1.7151939590842602e-11
deleted O 0 2.265220011565816e-09
Dp140 O 0 3.3484170991471274e-09
DNA O 0 1.0027787489264028e-08
sequences O 0 5.993750384902796e-09
were O 0 2.796745335320594e-10
found O 0 4.400384778779909e-10
in O 0 1.1299700064526519e-10
four O 0 1.1300956836990395e-09
patients O 0 6.495751048163356e-09
with O 0 7.506186960881678e-08
severe O 1 0.9113318920135498
cerebral B-Disease 1 0.9996224641799927
dysfunction I-Disease 0 0.46486273407936096
. O 0 4.7237116973519733e-07

These O 0 2.838254298254128e-09
findings O 0 5.065393882119906e-09
suggest O 0 3.548768834349403e-09
that O 0 2.843870972046858e-11
some O 0 3.2095140889594476e-13
sequences O 0 1.638774393963871e-10
located O 0 1.9762037839488045e-10
in O 0 1.9868459308347575e-11
the O 0 5.004272603942317e-12
distal O 0 8.119986905086307e-10
part O 0 3.592021818876745e-11
of O 0 2.3581679144124568e-12
the O 0 2.3107722332826874e-11
gene O 0 1.4958546623589086e-09
and O 0 6.635523797093867e-10
, O 0 5.9687112023698585e-12
in O 0 1.7971202651012597e-11
particular O 0 3.7532385532834667e-10
, O 0 1.326365146187003e-11
some O 0 2.0076374590560775e-11
DMD B-Disease 1 0.9999250173568726
isoforms O 0 4.884693094453496e-09
expressed O 0 1.6881079867303583e-09
in O 0 5.259493951470517e-10
the O 0 1.434785001919181e-08
brain O 0 0.08377048373222351
may O 0 4.7444166284549283e-07
be O 0 1.9572536924528094e-09
related O 0 4.1440256781655194e-10
to O 0 5.978273431850312e-11
the O 0 5.29261434678574e-09
cognitive B-Disease 0 3.155486047035083e-05
impairment I-Disease 0 1.8374863429926336e-05
associated O 0 5.796953246317571e-07
with O 0 7.199420224424102e-07
DMD B-Disease 1 0.9999992847442627
. O 0 4.4082099748266046e-08
. O 0 1.8702349890986625e-08

I1307K O 0 1.0058082807518076e-05
APC O 0 6.034543957866845e-07
and O 0 8.377998295117095e-10
hMLH1 O 0 3.378387418706552e-07
mutations O 0 6.687138807137671e-07
in O 0 1.2825454587250817e-10
a O 0 1.5621770543816638e-09
non O 0 1.5793236940453426e-08
- O 0 4.82806808577152e-06
Jewish O 0 1.8450291960903087e-08
family O 0 2.9420215152953233e-09
with O 0 3.163923123494783e-09
hereditary B-Disease 1 0.7415398955345154
non I-Disease 0 0.07667890936136246
- I-Disease 1 0.9999979734420776
polyposis I-Disease 1 0.999996542930603
colorectal I-Disease 1 1.0
cancer I-Disease 1 0.9999994039535522
. O 0 1.1874555639224127e-05

We O 0 1.160950020562268e-07
describe O 0 4.0178647964239644e-08
a O 0 2.0347405982334976e-09
French O 0 6.734999260515906e-07
Canadian O 0 4.6015479711059015e-06
hereditary B-Disease 1 0.9196664690971375
non I-Disease 1 0.5793727040290833
- I-Disease 1 0.9999990463256836
polyposis I-Disease 1 0.9999994039535522
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 1.9515384337864816e-05
HNPCC B-Disease 1 0.9437600374221802
) O 0 2.2179096337282544e-09
kindred O 0 6.065041588954045e-07
which O 0 1.926732773327444e-09
carries O 0 1.2704697294196876e-09
a O 0 2.1432022823120178e-10
novel O 0 1.8251267164259843e-09
truncating O 0 4.722509174825973e-07
mutation O 0 3.667260898509994e-06
in O 0 2.7683688674784435e-09
hMLH1 O 0 1.743359007377876e-06
. O 0 1.3851457758562447e-08

Interestingly O 0 4.961816102877492e-06
, O 0 2.5073737530689755e-10
the O 0 6.765349391812947e-11
I1307K O 0 3.144780436059591e-08
APC O 0 2.3261025106080524e-08
polymorphism O 0 2.6667021302273497e-06
, O 0 3.05660254051876e-11
associated O 0 8.757617547816565e-11
with O 0 2.6666605121988818e-12
an O 0 1.172879848798658e-11
increased O 0 7.463316364919592e-08
risk O 0 6.134970590210287e-06
of O 0 0.00016583419346716255
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 5.6984481489053e-07
is O 0 4.965734046180614e-09
also O 0 1.4717951857257106e-10
present O 0 5.768438851583291e-11
in O 0 1.8046884819877818e-10
this O 0 3.5729050273936025e-10
family O 0 1.5459256985650427e-08
. O 0 1.1244543074440116e-08

The O 0 1.4010939075603801e-08
I1307K O 0 1.70061966286994e-07
polymorphism O 0 1.7948685126611963e-05
has O 0 1.544393057884008e-08
previously O 0 8.456311761939617e-10
only O 0 2.4870390469278192e-11
been O 0 2.969033352506756e-10
identified O 0 9.04866137574345e-09
in O 0 4.000378153734552e-11
individuals O 0 1.2101894139582292e-11
of O 0 4.3850666153755213e-11
self O 0 0.0029418752528727055
- O 0 0.011093220673501492
reported O 0 3.754352746909717e-06
Ashkenazi O 0 1.5886112691987364e-07
Jewish O 0 9.032779857420792e-09
origins O 0 9.441338022497803e-08
. O 0 9.785018129093714e-09

In O 0 2.973375989867577e-09
addition O 0 3.171026219384032e-10
, O 0 4.1089052299492224e-11
in O 0 1.047961196987135e-11
this O 0 4.160227023985996e-11
family O 0 1.6174909189814457e-09
, O 0 1.7126081802709692e-11
there O 0 8.681910745877985e-11
appears O 0 2.9593276718031802e-09
to O 0 2.1860140433926922e-11
be O 0 2.753324013227143e-09
no O 0 6.019983955773966e-10
relationship O 0 1.3023978562287652e-09
between O 0 1.3616053597120814e-11
the O 0 1.6988558129704678e-11
I1307K O 0 1.5984453760609085e-09
polymorphism O 0 4.402152242732882e-08
and O 0 2.8705249982552417e-11
the O 0 2.7960385742820115e-12
presence O 0 1.327636334202964e-10
or O 0 6.083376025145526e-10
absence O 0 7.607214858040834e-10
of O 0 3.027898487495406e-10
cancer B-Disease 0 7.383065394606092e-07
. O 0 3.981061591495916e-10
. O 0 3.307500939797592e-09

Identification O 0 1.9825452568511537e-07
of O 0 7.47490194741296e-11
a O 0 1.0264821215244524e-09
novel O 0 2.018066824760467e-09
mutation O 0 5.5497054063380347e-08
of O 0 8.11833673203255e-12
the O 0 1.3317373592780513e-10
CPO O 0 3.536659733072156e-06
gene O 0 5.88459592165691e-09
in O 0 1.9221657598933461e-10
a O 0 2.769018347947849e-09
Japanese O 0 6.066793048375985e-06
hereditary B-Disease 0 0.05323630943894386
coproporphyria I-Disease 0 0.0083077447488904
family O 0 5.154428208697936e-07
. O 0 2.2290052470452792e-08

Hereditary B-Disease 1 0.9798952341079712
coproporphyria I-Disease 0 0.34356915950775146
( O 0 3.104291579347773e-08
HCP B-Disease 0 0.0005805065738968551
) O 0 2.7736790642052256e-10
is O 0 3.3811137223338505e-10
an O 0 4.093748895428462e-09
autosomal B-Disease 1 0.9999855756759644
dominant I-Disease 1 0.9999864101409912
disease I-Disease 1 0.9879774451255798
characterized O 0 7.43035934647196e-06
by O 0 4.245862328389194e-09
a O 0 9.595150913810357e-06
deficiency B-Disease 0 0.002463056007400155
of I-Disease 0 1.7348568415176402e-10
coproporphyrinogen I-Disease 0 5.8929494116455317e-05
oxidase I-Disease 0 1.0940519814539584e-06
( O 0 1.6401252578290837e-10
CPO O 0 1.34405593144038e-06
) O 0 3.684203636611372e-11
caused O 0 6.009475694845889e-10
by O 0 1.467329382998095e-11
a O 0 6.742953306826394e-09
mutation O 0 7.616934567522549e-07
in O 0 2.0468998718214948e-10
the O 0 4.5028469841668084e-10
CPO O 0 1.6557662092964165e-05
gene O 0 7.916765554227823e-08
. O 0 7.910211152761804e-09

Only O 0 7.325872797281363e-09
11 O 0 2.409340782438818e-10
mutations O 0 6.272058428180571e-09
of O 0 6.568714322474634e-12
the O 0 9.89257495365159e-11
gene O 0 2.463766257676525e-08
have O 0 1.3688047140192339e-08
been O 0 1.0955277218727133e-07
reported O 0 2.9590702865789353e-07
in O 0 8.720156152719483e-09
HCP B-Disease 0 0.07177750021219254
patients O 0 1.3612729787837452e-07
. O 0 1.730588650161735e-08

We O 0 7.457772994712286e-07
report O 0 4.1761953895047554e-09
another O 0 1.981163011421927e-10
mutation O 0 2.6675358810734906e-08
in O 0 6.170598060295518e-11
a O 0 5.919764678452566e-09
Japanese O 0 3.8295870581350755e-06
family O 0 2.805520793458527e-08
. O 0 1.0866079591664857e-08

Polymerase O 0 1.6112329831230454e-05
chain O 0 6.624295565416105e-06
reaction O 0 5.039627808400837e-07
- O 0 5.762756245530909e-07
single O 0 1.6057310148198667e-08
strand O 0 2.0715444293273322e-07
conformational O 0 2.5760430233390252e-08
polymorphism O 0 2.50179965632924e-07
and O 0 1.116670731576841e-11
direct O 0 2.649773282736856e-11
sequence O 0 8.487952007918409e-10
analyses O 0 5.0310005050846485e-09
demonstrated O 0 9.745824147699977e-10
a O 0 2.0664429889460934e-10
C O 0 1.2535105398114865e-08
to O 0 1.5266543237912877e-11
T O 0 1.2375108937590085e-08
substitution O 0 1.3071373844431022e-11
in O 0 1.9484379387701978e-12
exon O 0 1.0822597262816203e-09
1 O 0 3.068413578777296e-11
of O 0 8.317989851590324e-13
the O 0 2.824340587792573e-11
CPO O 0 2.410966004617876e-08
gene O 0 1.7204435098783222e-10
at O 0 1.0500620338527167e-11
nucleotide O 0 1.239092717320034e-09
position O 0 4.9365724841266e-09
85 O 0 1.9041894797067194e-11
, O 0 4.221227967865504e-12
which O 0 7.309647331865676e-11
lies O 0 2.5515036750078934e-09
in O 0 4.555557667207388e-11
the O 0 2.6544828835017853e-11
putative O 0 1.5421148802374773e-08
presequence O 0 2.99490956479076e-08
for O 0 7.623330786077354e-12
targeting O 0 2.2742552285848205e-09
to O 0 5.061200347711292e-10
mitochondria O 0 4.795556378667243e-07
. O 0 1.3207828608585714e-08

This O 0 1.3023861100691647e-08
mutation O 0 3.744940499927907e-07
changes O 0 8.499907999670597e-10
the O 0 2.361333177602898e-11
codon O 0 6.274519792626165e-10
for O 0 1.9817882144362864e-12
glutamine O 0 4.008078868800169e-10
to O 0 6.731441792862114e-12
a O 0 1.4983839169424584e-10
termination O 0 1.5121319307809244e-08
codon O 0 2.5249395907422922e-09
at O 0 1.7716873801365551e-10
amino O 0 5.353416598907756e-10
acid O 0 1.6004649827650042e-09
position O 0 1.3776785934282998e-08
29 O 0 2.172586111015562e-09
. O 0 1.2410913408089641e-09

MaeI O 0 7.404059942928143e-06
restriction O 0 4.165330480532248e-08
analysis O 0 1.197100996108702e-08
showed O 0 3.431592077163259e-08
two O 0 6.030826879555029e-12
other O 0 3.664320149393552e-12
carriers O 0 4.993960245336382e-10
in O 0 9.634334996455607e-11
the O 0 2.741898097458062e-10
family O 0 4.035236855770563e-08
. O 0 7.473584417994061e-09

The O 0 1.1114773457165938e-07
C O 0 0.00017780598136596382
- O 0 0.07786096632480621
T O 1 0.5684836506843567
mutation O 0 2.716858398343902e-05
is O 0 4.2410525091796103e-10
located O 0 1.4313396301535164e-10
within O 0 3.050993485631537e-11
a O 0 3.9693470732515834e-10
recently O 0 1.7803307272856728e-08
proposed O 0 1.9902603176635836e-10
putative O 0 3.727521846741411e-09
alternative O 0 1.2216956613020358e-10
translation O 0 1.2328191245636333e-10
initiation O 0 5.6158005329320915e-11
codon O 0 1.251200143492781e-09
( O 0 4.8252365644763096e-12
TIC O 0 1.737114274646956e-07
- O 0 2.881886018712976e-07
1 O 0 3.097581358080248e-10
) O 0 3.016361032476267e-12
, O 0 3.0943994653968854e-13
supporting O 0 2.8783432234891215e-11
that O 0 8.756018687883227e-10
TIC O 0 3.4073736969730817e-06
- O 0 1.3231661455392896e-07
1 O 0 1.284107126187095e-10
is O 0 2.4256022537749722e-11
the O 0 4.038524289290413e-12
real O 0 2.4357413508369063e-07
TIC O 0 1.0551801779001835e-06
rather O 0 1.9883972246503845e-10
than O 0 4.089421162811746e-11
TIC O 0 1.9938383388762304e-07
- O 0 2.7017611259338992e-08
2 O 0 1.381661451915761e-10
. O 0 5.606211675446282e-11
. O 0 5.488434706713008e-10

Human B-Disease 0 5.975637122901389e-07
complement I-Disease 0 1.0305158184564789e-06
factor I-Disease 0 7.280828867806122e-05
H I-Disease 1 1.0
deficiency I-Disease 1 0.9999312162399292
associated O 0 9.045005572261289e-05
with O 0 0.00012278858048375696
hemolytic B-Disease 1 0.9999964237213135
uremic I-Disease 1 0.9999996423721313
syndrome I-Disease 1 0.9999971389770508
. O 0 1.7817354091675952e-05

This O 0 6.367791627326369e-09
study O 0 7.680256985942435e-10
reports O 0 2.7902127830436996e-10
on O 0 8.514084576249914e-11
six O 0 2.3241698496323515e-11
cases O 0 1.9826749964035884e-10
of O 0 1.2887131362049331e-09
deficiency B-Disease 0 0.0005430712481029332
in I-Disease 0 6.317942002898036e-11
the I-Disease 0 1.3499788960313897e-11
human I-Disease 0 3.188612915372424e-11
complement I-Disease 0 1.3082704364286712e-10
regulatory I-Disease 0 1.581831110541998e-09
protein I-Disease 0 8.084400704433392e-09
Factor I-Disease 0 2.600816806364037e-08
H I-Disease 1 0.999998927116394
( O 0 1.125674775614982e-09
FH O 0 1.662820864112291e-06
) O 0 2.9041222551762225e-12
in O 0 4.114047210540539e-12
the O 0 2.398421522151195e-12
context O 0 2.0848045512167346e-10
of O 0 4.260525265920023e-11
an O 0 5.529660711545148e-07
acute B-Disease 1 0.9998511075973511
renal I-Disease 1 0.9999998807907104
disease I-Disease 1 0.9999997615814209
. O 0 2.9359965992625803e-05

Five O 0 1.0590135435251113e-09
of O 0 3.039718823871773e-11
the O 0 5.847054090901693e-11
cases O 0 1.623672973849466e-09
were O 0 3.1415055001815517e-09
observed O 0 4.984635211258137e-07
in O 0 4.049851842768959e-10
children O 0 6.497383187031858e-10
presenting O 0 3.021918359991105e-08
with O 0 1.2393896213325206e-05
idiopathic O 1 0.9999895095825195
hemolytic B-Disease 1 0.9999988079071045
uremic I-Disease 1 0.9999998807907104
syndrome I-Disease 1 0.9999997615814209
( O 0 2.3511191102443263e-05
HUS B-Disease 1 0.9997501969337463
) O 0 1.4180265850427531e-07
. O 0 9.054033967004216e-08

Two O 0 1.7538820396012511e-09
of O 0 6.422430642860633e-11
the O 0 3.987521424164697e-10
children O 0 5.308416373139835e-09
exhibited O 0 1.8500951455280301e-06
a O 0 1.0874144891204196e-06
homozygous O 1 0.9994325041770935
deficiency O 1 0.9665798544883728
characterized O 0 1.6127883384342567e-07
by O 0 1.4946104076596356e-10
the O 0 6.995071188953261e-11
absence O 0 4.3015174755467456e-10
of O 0 1.1433802038843255e-12
the O 0 6.287140079386244e-12
150 O 0 9.4080281759501e-12
- O 0 6.2021086044694584e-09
kD O 0 4.477823445370177e-09
form O 0 4.082072527222813e-11
of O 0 9.110959382774286e-12
Factor O 0 6.602714819337052e-09
H O 1 0.9999984502792358
and O 0 1.2616935274323282e-10
the O 0 6.222526834076536e-12
presence O 0 1.7441667554685125e-10
, O 0 1.2238448102164234e-12
upon O 0 3.073308317905199e-12
immunoblotting O 0 2.618750105654044e-09
, O 0 4.173575005560204e-13
of O 0 7.275724348086016e-14
the O 0 2.8832099468328876e-12
42 O 0 1.7250496170406748e-11
- O 0 1.3777496477018758e-08
kD O 0 1.169562366953869e-07
Factor O 0 2.641728258367948e-08
H O 1 0.9999978542327881
- O 0 4.322337474604865e-07
like O 0 4.081866400440504e-09
protein O 0 1.0015644980043703e-09
1 O 0 4.099534947621386e-11
( O 0 7.991102571325293e-12
FHL O 0 2.165012880084305e-08
- O 0 1.3485192518203348e-08
1 O 0 5.460739846419038e-11
) O 0 5.263229088670052e-13
and O 0 9.859528991851274e-12
other O 0 5.865159746765158e-11
FH O 0 4.941534825775307e-06
- O 0 3.2931572491179395e-07
related O 0 8.30439290666618e-08
protein O 0 1.0768901326230207e-08
( O 0 7.332407597759882e-11
FHR O 0 2.044874690909637e-06
) O 0 6.043334582761517e-11
bands O 0 2.532214082862083e-08
. O 0 2.892263983866883e-09

Southern O 0 1.2409658722845052e-07
blot O 0 2.791746737784706e-06
and O 0 3.07300657143017e-10
PCR O 0 2.229651308027769e-08
analysis O 0 1.9743050250209393e-10
of O 0 4.0388149096827475e-13
DNA O 0 2.3168427176756268e-09
of O 0 5.753118901413723e-12
one O 0 1.415280004302133e-09
patient O 0 1.476875866046612e-07
with O 0 2.9635032205987955e-08
homozygous O 1 0.9938170313835144
deficiency O 1 0.8359573483467102
ruled O 0 2.1512562398129376e-08
out O 0 9.588906751956117e-11
the O 0 7.314008773628977e-12
presence O 0 4.9259672729728976e-11
of O 0 5.498485239167905e-13
a O 0 1.761981012482483e-11
large O 0 7.548127400891502e-11
deletion O 0 4.820515986381224e-09
of O 0 1.648303195322942e-11
the O 0 1.3309737756372897e-09
FH O 0 6.703525286866352e-06
gene O 0 1.2038573471429004e-09
as O 0 5.447133022418171e-11
the O 0 1.1372414121524343e-10
underlying O 0 2.69002794084372e-05
defect O 0 6.048710474715335e-06
for O 0 4.1720690791002824e-10
the O 0 1.7860658374502236e-07
deficiency O 0 0.02924168109893799
. O 0 3.285233063365922e-08

The O 0 2.5424677918550742e-09
other O 0 4.6303256368007695e-11
four O 0 3.889469302187365e-11
children O 0 1.875476857149394e-10
presented O 0 8.83540884899503e-09
with O 0 6.795323059805014e-08
heterozygous O 0 0.24993500113487244
deficiency O 0 0.47139737010002136
and O 0 1.774826952072317e-09
exhibited O 0 5.890780698791787e-07
a O 0 5.336974862046873e-09
normal O 0 8.334510681606844e-08
immunoblotting O 0 6.569791253241419e-07
pattern O 0 3.266014658720451e-08
of O 0 3.708263297125258e-12
proteins O 0 8.397188326625393e-12
of O 0 3.5582593729127643e-12
the O 0 4.361556449339332e-09
FH O 0 0.00027946074260398746
family O 0 4.967659705812366e-08
. O 0 6.331217328181538e-09

Factor B-Disease 0 0.07766760140657425
H I-Disease 1 0.9999997615814209
deficiency I-Disease 1 0.9995452761650085
is O 0 2.275873711710119e-09
the O 0 2.418268085779829e-10
only O 0 4.315384671826905e-08
complement B-Disease 1 0.9999986886978149
deficiency I-Disease 1 0.9999998807907104
associated O 0 5.488143870024942e-06
with O 0 3.3747775773917965e-07
HUS B-Disease 1 0.9997360110282898
. O 0 3.996434259079251e-07

These O 0 9.306171833145527e-09
observations O 0 6.218422043957617e-08
suggest O 0 6.300498789357789e-09
a O 0 1.1873987904031935e-10
role O 0 5.290088922471625e-10
for O 0 1.7069377855616352e-10
FH O 0 1.6583973774686456e-05
and O 0 7.555581049700777e-09
/ O 0 1.0828615870650538e-07
or O 0 2.3977218432946756e-08
FH O 0 3.8082523587945616e-06
receptors O 0 7.050358075133545e-09
in O 0 1.4658138591805425e-10
the O 0 1.3760700912079926e-10
pathogenesis O 0 5.672369240983244e-08
of O 0 1.1278818989879369e-09
idiopathic O 1 0.5674479007720947
HUS B-Disease 1 0.9998109936714172
. O 0 1.8238267784909112e-07
. O 0 3.4672247295475245e-08

Further O 0 1.1732143034848264e-09
evidence O 0 7.649701982970214e-10
for O 0 8.14165922180532e-12
a O 0 9.655564542354611e-11
major O 0 3.194872699729956e-10
ancient O 0 1.011672026152155e-07
mutation O 1 0.6479309797286987
underlying O 1 0.9986733198165894
myotonic B-Disease 1 0.9999997615814209
dystrophy I-Disease 1 0.9999997615814209
from O 0 7.210070407381863e-08
linkage O 0 0.00015223684022203088
disequilibrium O 0 0.00047157335211522877
studies O 0 9.47412903684608e-09
in O 0 4.5709110108038686e-11
the O 0 5.885914672321135e-11
Japanese O 0 1.7221731241079397e-07
population O 0 4.1322337218652194e-10
. O 0 3.6534733016679866e-09

The O 0 5.2845891332253814e-05
myotonic B-Disease 1 0.9999964237213135
dystrophy I-Disease 1 0.9999996423721313
( O 0 0.00052481988677755
DM B-Disease 1 0.9999997615814209
) O 0 7.197072449116604e-08
mutation O 0 4.769456427311525e-05
is O 0 1.1203952432481401e-08
an O 0 8.748105573275211e-10
unstable O 0 0.00034167367266491055
( O 0 4.4925785314120503e-10
CTG O 0 4.396764836656075e-07
) O 0 1.4392669347995657e-11
n O 0 2.3258719394902982e-08
repeat O 0 6.728733126237785e-08
, O 0 7.946522780077903e-12
present O 0 1.4571661585693896e-11
at O 0 2.77287359740086e-11
a O 0 1.8406328544662287e-11
copy O 0 1.8797683409843557e-09
number O 0 8.143678439931357e-12
of O 0 8.892229400730978e-13
5 O 0 1.3681553286126746e-11
- O 0 1.9977319354325118e-08
37 O 0 5.4198767002189285e-11
repeats O 0 7.99879606994125e-10
on O 0 1.3491559258671515e-10
normal O 0 3.7753092319015025e-10
chromosomes O 0 6.509899286299969e-10
but O 0 2.18255604561568e-11
amplified O 0 1.1994475412890893e-09
to O 0 1.2192786710829573e-11
50 O 0 1.1598854689209848e-11
- O 0 1.90039983749557e-09
3000 O 0 1.056941201227346e-09
copies O 0 2.0528672095565526e-09
on O 0 1.119935745919065e-06
DM B-Disease 1 0.9999959468841553
chromosomes O 0 1.2624391274584923e-05
. O 0 2.146071942377148e-08

Previous O 0 6.594957540073665e-07
findings O 0 6.773932170744956e-08
in O 0 1.3193621750673401e-09
Caucasian O 0 2.736990154517116e-07
populations O 0 3.5015959021222898e-09
of O 0 5.2225144347994856e-11
a O 0 1.1813017408712767e-06
DM B-Disease 1 0.9999997615814209
founder O 0 8.937087727645121e-07
chromosome O 0 1.599460119905416e-05
raise O 0 1.0656115101426167e-08
a O 0 7.17301495978262e-10
question O 0 4.167482359207497e-09
about O 0 9.27942878786725e-12
the O 0 4.539543654175082e-12
molecular O 0 1.2533336146702823e-08
events O 0 3.066671638851659e-10
involved O 0 9.94769600026757e-10
in O 0 1.4325139685578137e-10
the O 0 2.392657738603532e-10
expansion O 0 4.134437148195502e-08
mutation O 0 8.7806085957709e-07
. O 0 1.460958731769324e-08

To O 0 4.787364726865917e-09
investigate O 0 5.203878572501708e-08
whether O 0 5.731167984635022e-09
a O 0 6.886192727151297e-10
founder O 0 1.0574196629420385e-08
chromosome O 0 2.213811711726521e-07
for O 0 1.5836898459298254e-10
the O 0 2.417292854772768e-08
DM B-Disease 1 0.9999998807907104
mutation O 0 0.00019202947441954166
exists O 0 7.253170952736809e-09
in O 0 2.390001911656281e-11
the O 0 1.404854271108702e-11
Japanese O 0 4.857408697489518e-08
population O 0 1.1184313891687836e-11
, O 0 6.315227420866654e-12
we O 0 2.0067886241648125e-10
genotyped O 0 4.50026504950074e-09
families O 0 1.0174405588869728e-11
using O 0 1.3312979885160559e-10
polymorphic O 0 5.451839868442221e-08
markers O 0 2.5948172606149456e-06
near O 0 2.760967561243888e-07
the O 0 3.1423683655162904e-09
( O 0 1.8208420882181997e-10
CTG O 0 1.0416738405183423e-07
) O 0 1.5154096727476585e-11
n O 0 2.4374228857482194e-08
repeat O 0 4.1986967858065327e-07
region O 0 3.7169223254807093e-09
and O 0 1.4560340710900732e-09
constructed O 0 4.679699031839846e-06
haplotypes O 0 1.610339131730143e-05
. O 0 4.9407855584604476e-08

Six O 0 8.960657993384302e-09
different O 0 2.8604590918135386e-10
haplotypes O 0 1.3160860135030816e-07
were O 0 1.175746344728168e-08
found O 0 1.3853721725354262e-07
and O 0 6.92183220962761e-06
DM B-Disease 1 0.9999995231628418
alleles O 0 9.5926079666242e-06
were O 0 2.139747437013284e-07
always O 0 6.585781875401153e-07
haplotype O 0 1.5227734593281639e-06
A O 0 7.772279531081949e-08
. O 0 1.3930225861713552e-08

To O 0 1.0578775189173939e-08
find O 0 5.58361490377024e-09
an O 0 1.5891052362881908e-11
origin O 0 2.7139993030722565e-10
of O 0 1.0955090133657475e-11
the O 0 2.5136034920159034e-10
( O 0 3.883220481282201e-11
CTG O 0 1.1858586113078218e-08
) O 0 1.5732352486724777e-12
n O 0 2.0111194931615728e-09
repeat O 0 6.939228569535771e-08
mutation O 0 1.091514789663961e-07
and O 0 3.7625260546070294e-11
to O 0 1.0025515140288377e-11
investigate O 0 3.4666014503415e-09
the O 0 2.5211596699215022e-11
mechanism O 0 7.442593763506977e-11
of O 0 3.627240922985525e-13
the O 0 1.8362349401418454e-12
expansion O 0 5.5739263898901825e-11
mutation O 0 4.717395363229571e-10
in O 0 6.556122398443387e-12
the O 0 5.773895684485497e-12
Japanese O 0 5.471400221779277e-09
population O 0 1.9175949023120253e-11
we O 0 5.416696535753829e-10
have O 0 8.749753699355267e-11
studied O 0 6.832043819571254e-10
90 O 0 4.022613145360232e-11
Japanese O 0 2.684958246845781e-07
DM B-Disease 1 0.999971866607666
families O 0 4.0912959131667037e-10
comprising O 0 2.120366382474259e-11
190 O 0 1.1226787555163042e-10
affected O 0 7.201460539008053e-10
and O 0 4.772957029608449e-10
130 O 0 5.664319568943199e-10
unaffected O 0 1.4250625213207968e-07
members O 0 3.787079261297066e-10
. O 0 2.6637769767745567e-09

The O 0 1.4015643756692953e-08
results O 0 4.030544786814971e-08
suggest O 0 7.4107013858792925e-09
that O 0 4.2479561535024857e-11
a O 0 9.912179410598299e-11
few O 0 1.2295080231705668e-10
common O 0 1.9145404706044644e-10
ancestral O 0 1.5068687631014654e-08
mutations O 0 4.763930405715655e-08
in O 0 1.1145838418880061e-10
both O 0 1.432759882957768e-10
Caucasian O 0 6.928132734174142e-08
and O 0 2.855314873428938e-09
Japanese O 0 1.3398336307091085e-07
populations O 0 5.165947669638626e-10
have O 0 8.037392279502953e-11
originated O 0 1.2053863115979446e-11
by O 0 4.903548812655589e-13
expansion O 0 7.2524135134866e-12
of O 0 2.259778193562656e-13
an O 0 2.736717753457074e-12
ancestral O 0 3.776405854694076e-09
n O 0 5.81283607914429e-08
= O 0 3.4259006742587417e-09
5 O 0 6.0248828495645945e-12
repeat O 0 1.6485186549175523e-09
to O 0 5.486129259213435e-11
n O 0 3.086974231791828e-07
= O 0 5.08005477684037e-08
19 O 0 9.291299674085707e-11
- O 0 7.167179294498283e-09
37 O 0 1.654086312363745e-10
copies O 0 3.686561944604705e-09
. O 0 2.5311936990846107e-09

These O 0 2.881784810782051e-09
data O 0 8.230445769363826e-10
support O 0 3.0864099470617745e-11
multistep O 0 2.0147361556865917e-09
models O 0 2.755341510507492e-09
of O 0 1.3711387060466595e-11
triplet O 0 2.038840830209665e-05
repeat O 0 1.6829143589802698e-07
expansion O 0 1.7886312431159013e-09
that O 0 2.82366852122351e-10
have O 0 8.790015937343298e-11
been O 0 2.3970414195217948e-11
proposed O 0 1.1248708561839571e-11
for O 0 1.3065690890323722e-11
both O 0 6.262664697942455e-08
DM B-Disease 1 0.9999997615814209
and O 0 7.695351769143599e-07
Friedreichs B-Disease 0 4.7622841520933434e-05
ataxia I-Disease 0 0.0014208764769136906
. O 0 1.1583882297827586e-08
. O 0 1.4882172827412887e-08

The O 0 5.479985354384098e-09
molecular O 0 3.357535831582936e-07
basis O 0 1.7294205179041455e-08
of O 0 3.7766997138533043e-06
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 1.9984179644438882e-08
the O 0 4.984387347306551e-10
western O 0 1.2581856667637226e-09
Cape O 0 2.6406551612012663e-08
, O 0 8.268992435223055e-11
South O 0 3.7944397623945747e-10
Africa O 0 1.5718338852721558e-09
. O 0 1.5639926020938333e-09

Deficiency B-Disease 1 0.9710408449172974
of I-Disease 0 4.4842229929287214e-10
the I-Disease 0 2.0744596318511555e-10
sixth I-Disease 0 2.456042258458524e-09
component I-Disease 0 1.0622422941253262e-09
of I-Disease 0 1.1663010834883636e-11
human I-Disease 0 1.9923150629264086e-10
complement I-Disease 0 3.7181844270151032e-09
( O 0 5.821526594118609e-11
C6 O 0 1.5044543033582158e-06
) O 0 4.792565216210631e-12
has O 0 5.112915091309844e-10
been O 0 4.555649635307191e-09
reported O 0 1.3918992181061185e-08
in O 0 1.537445865062992e-11
a O 0 2.3468629817280373e-10
number O 0 6.304916311261621e-11
of O 0 2.723101475213263e-12
families O 0 1.8346602015384406e-11
from O 0 5.567548158613711e-12
the O 0 2.398889420440753e-11
western O 0 4.041734169568656e-10
Cape O 0 1.2263895676767333e-08
, O 0 5.79378905962713e-11
South O 0 6.167750338237354e-11
Africa O 0 2.385894815049028e-10
. O 0 8.464186018741771e-10

Meningococcal B-Disease 1 0.9987217783927917
disease I-Disease 0 0.4635438621044159
is O 0 3.4680446958645916e-08
endemic O 0 9.484547547344846e-08
in O 0 2.1594596943952382e-10
the O 0 7.115385364242499e-11
Cape O 0 2.084548178515888e-08
and O 0 1.784214442857035e-10
almost O 0 2.5719443935701136e-11
all O 0 1.0296964019287924e-12
pedigrees O 0 4.997936731143682e-09
of O 0 6.306359601193634e-11
total O 0 8.63489094626857e-06
C6 B-Disease 1 1.0
deficiency I-Disease 1 0.9999997615814209
( O 0 5.823594939613486e-10
C6Q0 O 0 1.4582295989384875e-05
) O 0 3.0425145042256574e-11
have O 0 4.676981024687166e-10
been O 0 2.8716120592520156e-09
ascertained O 0 4.274764648926066e-07
because O 0 1.5580496892653173e-09
of O 0 4.2104647546281626e-10
recurrent O 0 0.25276774168014526
disease O 0 0.0027968701906502247
. O 0 8.100008841438466e-08

We O 0 5.112930807626981e-07
have O 0 4.815798870794197e-10
sequenced O 0 2.080007499571934e-09
the O 0 5.56557360961718e-12
expressed O 0 2.538366045135021e-11
exons O 0 4.5824360972446243e-10
of O 0 3.261153066341782e-12
the O 0 4.923760010822065e-11
C6 O 0 5.901199529034784e-07
gene O 0 5.353529286544756e-10
from O 0 6.881380448103824e-12
selected O 0 2.6078963641373853e-11
cases O 0 2.8057750567356265e-10
and O 0 2.4965756129091687e-09
have O 0 9.314251592229539e-09
found O 0 2.8943443197704255e-09
three O 0 1.1190918192127697e-09
molecular O 0 0.001070191152393818
defects O 0 0.3567824959754944
leading O 0 5.086781218466285e-09
to O 0 8.126649353457083e-10
total O 0 3.5332169545654324e-07
deficiency O 0 0.06307513266801834
879delG O 0 8.787729370851594e-07
, O 0 2.3010052196958952e-10
which O 0 5.063691688178551e-10
is O 0 2.5104315848345493e-10
the O 0 7.293854409340383e-11
common O 0 5.91676219130477e-09
defect O 0 1.4079593029237003e-06
in O 0 7.982300931352881e-11
the O 0 1.2168631380315986e-10
Cape O 0 3.562848904792304e-09
and O 0 2.681172783791652e-10
hitherto O 0 1.5349488791116528e-08
unreported O 0 5.926520163512805e-09
, O 0 6.539537140970442e-12
and O 0 9.749867579955662e-12
1195delC O 0 1.7765272586345304e-09
and O 0 1.2471942922864798e-10
1936delG O 0 2.3946871152702442e-08
, O 0 1.4496260095087088e-11
which O 0 6.134056457218762e-11
have O 0 2.144015798233312e-10
been O 0 6.395796670055631e-10
previously O 0 2.290331257981393e-09
reported O 0 3.4162694895201184e-09
in O 0 2.182955725904545e-11
African O 0 6.357639414922289e-11
- O 0 3.2312409530277364e-06
Americans O 0 4.113639917591172e-08
. O 0 2.9111200117171165e-09

We O 0 1.9038878917854163e-07
also O 0 1.149052381022031e-10
show O 0 4.966375644066545e-10
that O 0 6.894965067644199e-12
the O 0 8.814825605552024e-12
879delG O 0 1.907107929355334e-07
and O 0 1.675086913621726e-08
1195delC O 0 9.559477621223778e-05
defects O 1 0.5795074701309204
are O 0 5.67930313888354e-10
associated O 0 3.69282537882043e-09
with O 0 2.9969364767623574e-09
characteristic O 0 0.07075002789497375
C6 O 1 0.9659994840621948
/ O 0 1.9225186406401917e-05
C7 O 0 0.00015656527830287814
region O 0 1.5418972765246508e-08
DNA O 0 1.6045316897361772e-07
marker O 0 6.691381031487253e-07
haplotypes O 0 1.3832549257131177e-06
, O 0 1.6038684269581438e-10
although O 0 1.3500310591663123e-10
small O 0 3.334152676170987e-10
variations O 0 1.1326515902965184e-07
were O 0 1.1376291553233386e-07
observed O 0 1.8478309584679664e-06
. O 0 1.0094202806953945e-08

The O 0 3.4571808527061876e-08
1936delG O 0 9.281548045692034e-06
defect O 0 0.00022288317268248647
was O 0 4.342574655424869e-08
observed O 0 2.1829091423342106e-08
only O 0 3.474607754294645e-11
once O 0 2.5850781515401877e-09
in O 0 4.7971494832044215e-11
the O 0 6.731342566679288e-11
Cape O 0 8.498922454691638e-09
, O 0 1.4627913463849396e-11
but O 0 2.1515976500463552e-11
its O 0 5.1190774709442e-12
associated O 0 9.990497318312919e-10
haplotype O 0 8.203997481359693e-08
could O 0 2.135447552120695e-08
be O 0 3.721433827763576e-09
deduced O 0 1.6521575219030638e-07
. O 0 3.1179618886767457e-09

The O 0 2.6857245316591616e-09
data O 0 4.065309422429664e-09
from O 0 2.1442070341493036e-11
the O 0 1.8376862531699345e-11
haplotypes O 0 4.50872974511185e-08
indicate O 0 1.8894681375059008e-07
that O 0 4.102648082371374e-11
these O 0 2.3098675749899655e-12
three O 0 4.0274800855444326e-11
molecular O 0 2.171114283555653e-05
defects O 0 0.002050828654319048
account O 0 1.6800968394292681e-09
for O 0 1.5441176115515987e-10
the O 0 1.9985321841886616e-08
defects O 0 0.33516955375671387
in O 0 1.1328358390239046e-10
all O 0 3.771124038043361e-12
the O 0 1.2817669668707676e-11
38 O 0 3.1002159173176835e-11
unrelated O 0 2.5508077872160584e-09
C6Q0 O 0 5.674918156728381e-06
individuals O 0 1.876551358748202e-09
we O 0 1.5398223141005474e-08
have O 0 1.0038480047214193e-09
studied O 0 2.575324398179646e-09
from O 0 2.136768539884315e-11
the O 0 1.8556928216284518e-10
Cape O 0 4.716473611665606e-08
. O 0 7.863443229894074e-09

We O 0 2.2818505840405123e-06
have O 0 2.0678714296451517e-09
also O 0 4.12939508975807e-11
observed O 0 6.933004170761592e-10
the O 0 1.4531416868412972e-11
879delG O 0 1.0518179038854214e-07
defect O 0 7.789136589053669e-07
in O 0 2.3368262880296697e-10
two O 0 1.7112947503505893e-08
Dutch O 1 0.9994542002677917
C6 B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999895095825195
deficient I-Disease 1 0.9999985694885254
kindreds O 0 0.0001343030307907611
, O 0 4.323149060958542e-10
but O 0 4.753729701545417e-11
the O 0 4.615906181587581e-12
879delG O 0 2.1093693902685118e-08
defect O 0 2.1125669036337058e-07
in O 0 2.6466922403711735e-11
the O 0 4.231274011723407e-11
Cape O 0 5.154975557530861e-09
probably O 0 7.612157304492939e-08
did O 0 1.8663068868107757e-09
not O 0 2.133148345462299e-11
come O 0 1.2406688523758369e-11
from O 0 8.059519848377383e-13
The O 0 1.6354261694884187e-11
Netherlands O 0 5.603461872283333e-08
. O 0 1.8075133056960624e-10
. O 0 9.164754510848638e-10

Complement B-Disease 1 0.9950754046440125
C7 I-Disease 1 0.9999978542327881
deficiency I-Disease 1 0.9999995231628418
: O 0 1.4311662965837968e-08
seven O 0 2.968937318215126e-10
further O 0 1.8314455507706384e-09
molecular O 1 0.5287349224090576
defects O 1 0.9998928308486938
and O 0 3.491340549999222e-08
their O 0 3.3854066217031686e-09
associated O 0 8.888165581311114e-08
marker O 0 3.6263757010601694e-06
haplotypes O 0 3.484921035123989e-05
. O 0 6.424571097340959e-08

Seven O 0 8.878215496110897e-09
further O 0 3.909366441678941e-10
molecular O 0 5.914496341574704e-07
bases O 0 3.4331904430473514e-07
of O 0 1.039180801853945e-06
C7 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 1.094897470466094e-06
described O 0 5.224293545325054e-06
. O 0 1.6853869411193045e-08

All O 0 1.0227884095215245e-09
these O 0 2.6931545535346935e-11
new O 0 1.8191514961074517e-10
molecular O 0 2.072994175250642e-05
defects O 0 0.009675231762230396
involve O 0 9.179698778893908e-09
single O 0 1.8089329500980966e-07
- O 0 1.5753815887364908e-06
nucleotide O 0 8.722106059622092e-08
events O 0 4.2343278883194557e-10
, O 0 4.190087946748244e-12
deletions O 0 2.7449345019192606e-09
and O 0 7.681542207871317e-11
substitutions O 0 9.191923888707265e-10
, O 0 1.33996329657049e-12
some O 0 2.4765844756913236e-13
of O 0 3.826253550109904e-12
which O 0 9.564398162353882e-10
alter O 0 6.518578032910227e-08
splice O 0 7.169588656097403e-08
sites O 0 1.7044278877165198e-08
, O 0 2.393634457309446e-10
and O 0 5.699649641144333e-10
others O 0 2.415512456721558e-09
codons O 0 2.7093626897567447e-08
. O 0 1.9238208803784573e-09

They O 0 7.254018186131361e-08
are O 0 9.56012630171088e-11
distributed O 0 4.803595368696456e-11
along O 0 3.0391973659948945e-11
the O 0 6.854085354834893e-11
C7 O 0 4.602974513545632e-06
gene O 0 7.3165447034284625e-09
, O 0 1.7355377551764306e-11
but O 0 8.552230972014296e-12
predominantly O 0 1.1532405889622122e-12
towards O 0 3.890936184358651e-12
the O 0 1.7298402293919324e-11
3 O 0 1.775604940856823e-10
end O 0 4.935273523187789e-09
. O 0 4.725358326851392e-09

All O 0 9.944988832444324e-09
were O 0 1.874637556298353e-09
found O 0 2.4675270715590614e-09
in O 0 2.2629129126094938e-10
compound O 0 1.2443280184015748e-07
heterozygous O 0 9.500631108494417e-07
individuals O 0 9.485845886558764e-09
. O 0 1.3474934057455812e-08

The O 0 3.078588633798063e-06
C6 O 1 0.5849301218986511
/ O 0 0.0005185777554288507
C7 O 0 0.0007284536259248853
marker O 0 1.7185524484375492e-05
haplotypes O 0 6.759147072443739e-05
associated O 0 4.040274177441461e-07
with O 0 8.308936649825682e-09
most O 0 7.1823302505436e-07
C7 B-Disease 1 0.9998605251312256
defects I-Disease 1 0.9999423027038574
are O 0 4.502448192056363e-08
tabulated O 0 0.00015639609773643315
. O 0 2.616623362428072e-09
. O 0 4.587895396923614e-09

A O 0 7.807520319147443e-07
genome O 0 3.2409917594122817e-07
- O 0 3.531209529228363e-07
wide O 0 5.570753636163772e-09
search O 0 2.776210594745976e-09
for O 0 1.667746635236611e-10
chromosomal O 0 4.5288121327757835e-05
loci O 0 2.2677832589579339e-07
linked O 0 0.0013712216168642044
to O 0 2.5705267603370885e-07
mental O 0 0.35680481791496277
health O 0 2.9429011192405596e-06
wellness O 0 2.142877946198496e-07
in O 0 1.3176671975756449e-09
relatives O 0 3.486309907430041e-08
at O 0 1.57891104635155e-08
high O 0 2.2048025982712716e-07
risk O 0 1.2000668903056066e-06
for O 0 3.1902725794452635e-08
bipolar B-Disease 1 0.996465802192688
affective I-Disease 1 0.9900367259979248
disorder I-Disease 1 0.9814062118530273
among O 0 2.227924511544188e-09
the O 0 9.160944225428125e-10
Old O 0 1.0476818488314166e-06
Order O 0 1.98371630233396e-09
Amish O 0 2.1859605112695135e-06
. O 0 1.9320994582017192e-08

Bipolar B-Disease 1 0.9995821118354797
affective I-Disease 1 0.999477207660675
disorder I-Disease 1 0.9998964071273804
( O 0 1.251523553946754e-05
BPAD B-Disease 1 0.9999990463256836
; O 0 6.666177068836987e-05
manic B-Disease 1 0.9999774694442749
- I-Disease 1 0.9999984502792358
depressive I-Disease 1 0.9999995231628418
illness I-Disease 1 0.9999532699584961
) O 0 8.334284373745504e-09
is O 0 1.4756468269538914e-09
characterized O 0 8.82288020420674e-09
by O 0 6.607772662370337e-11
episodes O 0 2.0044408355346377e-09
of O 0 6.43236408581771e-10
mania B-Disease 0 0.0003467482456471771
and O 0 6.133538477115508e-08
/ O 0 8.205403219108121e-07
or O 0 8.908820348096924e-08
hypomania B-Disease 0 5.3464347729459405e-05
interspersed O 0 3.247436382025626e-07
with O 0 1.9556489760930162e-09
periods O 0 1.4350469257351506e-07
of O 0 2.5517470358948913e-09
depression B-Disease 0 1.9747792975977063e-05
. O 0 2.1818642892412754e-08

Compelling O 0 7.461180189238803e-07
evidence O 0 4.913494677794006e-08
supports O 0 1.4158044514545054e-08
a O 0 2.6843863243364297e-10
significant O 0 2.0330714889382762e-10
genetic O 0 1.604892041484618e-08
component O 0 6.78093581285566e-09
in O 0 1.7059419155085465e-10
the O 0 1.9130366735176096e-10
susceptibility O 0 9.26280154089909e-06
to O 0 7.500816856520487e-09
develop O 0 3.352807652845513e-06
BPAD B-Disease 1 0.9999972581863403
. O 0 4.0663820755071356e-07

To O 0 6.309638589385713e-09
date O 0 9.943816081658952e-08
, O 0 3.73081843196843e-11
however O 0 4.093651112535568e-11
, O 0 1.374017761547608e-12
linkage O 0 8.92053186873909e-09
studies O 0 2.582829783381868e-10
have O 0 3.863796782521689e-11
attempted O 0 1.248408709741966e-09
only O 0 6.49404401781295e-12
to O 0 7.685348885067e-12
identify O 0 6.504492056080835e-09
chromosomal O 0 1.0414863027108368e-05
loci O 0 1.879453748188098e-08
that O 0 6.0633849052749156e-09
cause O 0 1.2559868878270208e-07
or O 0 1.2954730621572708e-09
increase O 0 2.976678459276627e-09
the O 0 1.0443784725922e-09
risk O 0 2.8482187985900964e-07
of O 0 3.012672888935697e-10
developing O 0 5.947092063252057e-07
BPAD B-Disease 1 0.9999916553497314
. O 0 2.6898354121840384e-07

To O 0 6.25283913535668e-09
determine O 0 3.852602503684466e-08
whether O 0 5.446494366623256e-09
there O 0 1.822573314491649e-09
could O 0 1.647859271258767e-08
be O 0 4.263283059913192e-10
protective O 0 4.7471498731965767e-08
alleles O 0 5.463596797206094e-10
that O 0 5.22633117339133e-11
prevent O 0 1.1739799132826079e-09
or O 0 1.1583788372959702e-09
reduce O 0 8.552064834077555e-09
the O 0 2.46760140099056e-10
risk O 0 1.3884627669824567e-08
of O 0 6.697682772976998e-12
developing O 0 2.054011893903862e-08
BPAD B-Disease 1 0.999997615814209
, O 0 9.166882530831089e-11
similar O 0 2.322060772830259e-11
to O 0 1.5097319228107864e-11
what O 0 3.74147379744727e-10
is O 0 5.936991176458406e-11
observed O 0 8.64470328654221e-10
in O 0 1.0587424686958613e-10
other O 0 9.044002879932123e-09
genetic B-Disease 1 0.9999995231628418
disorders I-Disease 1 0.9999998807907104
, O 0 2.877546201318637e-08
we O 0 7.189526485262832e-08
used O 0 3.045142875635065e-06
mental O 0 0.050596579909324646
health O 0 2.050264129138668e-06
wellness O 0 1.748362734588227e-07
( O 0 1.830437884597913e-11
absence O 0 4.4096012952188346e-10
of O 0 1.0761861887753632e-11
any O 0 8.175534844667709e-07
psychiatric B-Disease 0 0.4173522889614105
disorder I-Disease 0 0.000111852576083038
) O 0 8.759283229298198e-12
as O 0 3.683198884774086e-11
the O 0 1.473415833785907e-10
phenotype O 0 3.9617503944100463e-07
in O 0 3.4481223432081265e-10
our O 0 1.4409550219696143e-09
genome O 0 9.73731539843925e-10
- O 0 5.748194809029883e-08
wide O 0 1.4966031969265714e-08
linkage O 0 2.2953629468247527e-06
scan O 0 1.697467951089493e-06
of O 0 1.1605532073549751e-12
several O 0 3.2245245969869663e-12
large O 0 1.2646793612347551e-09
multigeneration O 0 6.080010734876851e-06
Old O 0 2.3019431694137893e-07
Order O 0 1.8124983458545074e-10
Amish O 0 3.817615734647006e-08
pedigrees O 0 5.620341312351229e-07
exhibiting O 0 8.591994316020646e-08
an O 0 4.6022408106694e-10
extremely O 0 1.0860546808544314e-06
high O 0 3.5721839140023803e-06
incidence O 0 0.005244209431111813
of O 0 4.163313249705425e-08
BPAD B-Disease 1 0.9999984502792358
. O 0 2.588245422430191e-07

We O 0 1.952646243807976e-06
have O 0 1.3734433590428807e-09
found O 0 1.494678825153528e-10
strong O 0 1.4518569679822235e-10
evidence O 0 4.919528673319462e-10
for O 0 8.734658829556707e-12
a O 0 4.5095510659010074e-10
locus O 0 1.3730975467751705e-07
on O 0 7.195315987473805e-08
chromosome O 0 4.601566615747288e-05
4p O 0 2.2129472654341953e-06
at O 0 2.2707484781392395e-09
D4S2949 O 0 1.3219320749158214e-08
( O 0 1.0898983972273957e-11
maximum O 0 2.93801782902392e-09
GENEHUNTER O 0 6.71851375955157e-06
- O 0 1.604444435088226e-07
PLUS O 0 3.1978191206150086e-09
nonparametric O 0 1.1104386743454597e-08
linkage O 0 6.963970378137674e-08
score O 0 3.663989778246446e-09
= O 0 2.4672541787396085e-09
4 O 0 3.0013539396855915e-12
. O 0 2.8360690532136523e-12
05 O 0 6.296458909815783e-10
, O 0 5.650588070366114e-12
P O 0 4.918633180750476e-07
= O 0 2.592395853540097e-09
5 O 0 2.530296935518428e-12
. O 0 2.4143020482120248e-12
22 O 0 7.004694133755374e-12
x O 0 9.448612559026515e-09
10 O 0 6.170853758535877e-12
( O 0 2.3972230450697296e-12
- O 0 2.193422332652517e-08
4 O 0 7.053552880664782e-11
) O 0 1.0461792022964378e-12
; O 0 1.4576491055851015e-12
SIBPAL O 0 4.443205803283945e-09
Pempirical O 0 1.6136821878731666e-09
value O 0 1.7284888798041464e-10
< O 0 9.903529107901932e-10
3 O 0 2.6786361323472008e-11
x O 0 2.4409729348917608e-08
10 O 0 2.2498201218690284e-11
( O 0 2.640115990409919e-12
- O 0 6.625867143839059e-08
5 O 0 1.9198501122197342e-10
) O 0 3.1562875143359426e-12
) O 0 2.8332669326988635e-13
and O 0 3.723034727731722e-11
suggestive O 0 8.420540353881734e-08
evidence O 0 1.2000150872992776e-09
for O 0 1.89891592033975e-11
a O 0 8.007679519472788e-10
locus O 0 2.1747850098563504e-07
on O 0 4.875806212112366e-07
chromosome O 0 0.0013097154442220926
4q O 0 0.00159503857139498
at O 0 5.018445659032977e-09
D4S397 O 0 1.6947998560112865e-08
( O 0 1.156108628969088e-11
maximum O 0 1.765649737528463e-09
GENEHUNTER O 0 4.334913683123887e-06
- O 0 9.79351781893456e-08
PLUS O 0 2.765503159807281e-09
nonparametric O 0 1.0555939233825029e-08
linkage O 0 5.6184770613754154e-08
score O 0 1.5908961925603649e-09
= O 0 6.755835890714934e-10
3 O 0 2.0899304422478115e-12
. O 0 1.5833983429969223e-12
29 O 0 1.446824951512049e-11
, O 0 1.4774526003666355e-12
P O 0 1.8027195380909689e-07
= O 0 5.375199729762414e-10
2 O 0 1.0921869962252084e-12
. O 0 1.5032086903357667e-12
57 O 0 1.0421368629165428e-11
x O 0 8.848061128219342e-08
10 O 0 1.3322531966508677e-10
( O 0 6.536942862012118e-12
- O 0 7.856190364918803e-08
3 O 0 7.340286017898379e-11
) O 0 1.1805077314991363e-12
; O 0 1.5673648360095549e-12
SIBPAL O 0 3.591504871280904e-09
Pempirical O 0 1.972864316357459e-09
value O 0 2.729500514497829e-10
< O 0 9.518918986373137e-10
1 O 0 1.3909788251775801e-11
x O 0 3.338915988138069e-08
10 O 0 2.4310768675928074e-11
( O 0 2.943678504077618e-12
- O 0 7.602348972568507e-08
3 O 0 2.5734817055145243e-10
) O 0 5.337383746778501e-12
) O 0 8.133025503065383e-13
that O 0 1.4506611190068242e-10
are O 0 5.554041671018695e-10
linked O 0 6.478051091107773e-06
to O 0 2.583522871191235e-07
mental O 0 0.24367712438106537
health O 0 7.634573194081895e-06
wellness O 0 4.964343588653719e-06
. O 0 4.181107016165697e-08

These O 0 1.4581637231003697e-08
findings O 0 1.1352227602401399e-08
are O 0 3.333273587702301e-11
consistent O 0 2.9696523018429843e-09
with O 0 1.3064445358867971e-11
the O 0 1.7681351174858584e-11
hypothesis O 0 1.8706263205103824e-09
that O 0 6.8944524568570476e-12
certain O 0 1.188773645494079e-11
alleles O 0 3.130796455419471e-10
could O 0 2.0534156597307174e-09
prevent O 0 7.417771730189315e-09
or O 0 1.926843129496092e-09
modify O 0 5.449653617262129e-09
the O 0 9.208730999965553e-11
clinical O 0 4.859648683464002e-09
manifestations O 0 2.9171854265541697e-08
of O 0 3.856149566328071e-10
BPAD B-Disease 1 0.9999996423721313
and O 0 5.796439239702522e-08
perhaps O 0 5.177797302025056e-09
other O 0 2.6535779129588377e-10
related O 0 9.016583248921961e-07
affective B-Disease 0 0.24896302819252014
disorders I-Disease 1 0.7033726572990417
. O 0 1.982329678185124e-07

Segregation O 0 0.001565092010423541
distortion O 0 0.28139039874076843
in O 0 9.651347500039265e-05
myotonic B-Disease 1 0.9999933242797852
dystrophy I-Disease 1 0.9999972581863403
. O 0 4.943772728438489e-05

Myotonic B-Disease 1 0.9999940395355225
dystrophy I-Disease 1 0.9999994039535522
( O 0 0.001054015476256609
DM B-Disease 1 0.9999996423721313
) O 0 2.1587535314893103e-08
is O 0 2.7233810762083976e-09
an O 0 2.341168148234374e-09
autosomal B-Disease 1 0.9997199177742004
dominant I-Disease 1 0.9999710321426392
disease I-Disease 1 0.9983603358268738
which O 0 1.9626702396635665e-07
, O 0 1.7268379781665288e-10
in O 0 3.3602624155415484e-11
the O 0 7.735029283750805e-11
typical O 0 6.669903314104886e-07
pedigree O 0 2.5734758310136385e-05
, O 0 2.6202113395656923e-11
shows O 0 2.1693674634448712e-10
a O 0 1.2697545792583753e-10
three O 0 1.0147879064836829e-10
generation O 0 6.583801059889538e-09
anticipation O 0 2.624487116520413e-08
cascade O 0 3.6130126090938575e-07
. O 0 6.942919572594519e-09

This O 0 9.913058818256104e-09
results O 0 4.9224340159526037e-08
in O 0 4.204947501307288e-08
infertility B-Disease 1 0.9908327460289001
and O 1 0.658409059047699
congenital B-Disease 1 0.9999998807907104
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 2.1613755052385386e-06
CDM B-Disease 0 1.3282693544169888e-05
) O 0 4.6598200992287175e-11
with O 0 4.096666408881511e-11
the O 0 2.4480995008957507e-10
disappearance O 0 9.386265560351603e-07
of O 0 1.6528833413076427e-08
DM B-Disease 1 0.9999997615814209
in O 0 1.0113729587146736e-07
that O 0 8.935845130508824e-08
pedigree O 0 0.0001143790505011566
. O 0 1.5881379766824466e-08

The O 0 8.997405598343278e-10
concept O 0 1.3105938556634555e-09
of O 0 1.5206270270740063e-11
segregation O 0 1.9614702750914148e-08
distortion O 0 3.7494653952308e-05
, O 0 5.856507639956376e-11
where O 0 7.36703406611916e-11
there O 0 2.123734001158173e-11
is O 0 5.576390477851634e-12
preferential O 0 1.2723945508330559e-10
transmission O 0 4.930296171323789e-09
of O 0 5.093537896148914e-13
the O 0 3.3096034593449453e-12
larger O 0 4.671195097394332e-10
allele O 0 4.063332781356621e-09
at O 0 3.592935116092377e-10
the O 0 1.3467501558395156e-09
DM B-Disease 1 0.9999983310699463
locus O 0 6.649112037848681e-06
, O 0 9.430674019483831e-10
has O 0 6.804590224618323e-10
been O 0 6.041286360058962e-10
put O 0 1.2962344531075587e-09
forward O 0 8.922246275133716e-10
to O 0 2.804758370000826e-10
explain O 0 4.291368327358214e-08
partially O 0 7.863462059276571e-08
the O 0 7.920997885380032e-11
maintenance O 0 9.124642375013536e-09
of O 0 4.20196072381529e-10
DM B-Disease 1 0.9999985694885254
in O 0 6.976490496413135e-09
the O 0 1.5951681087145175e-09
population O 0 1.000756699731653e-09
. O 0 3.91965704338304e-09

In O 0 1.0994417820597846e-08
a O 0 3.928728897761857e-09
survey O 0 1.1143833944515791e-07
of O 0 1.016944972676015e-09
DM B-Disease 1 0.9999997615814209
in O 0 7.792927192440402e-08
Northern O 0 1.8546296942645313e-08
Ireland O 0 1.62978693651894e-07
, O 0 1.0056221133591947e-10
59 O 0 6.348478687190351e-11
pedigrees O 0 1.0096864144770734e-07
were O 0 1.2497363144348128e-08
ascertained O 0 4.872468707617372e-06
. O 0 1.1093505669634851e-08

Sibships O 0 4.2164258047705516e-05
where O 0 1.4172959694747078e-08
the O 0 8.96988247567343e-11
status O 0 5.668034097627839e-11
of O 0 3.328244526767249e-13
all O 0 1.382933481272608e-12
the O 0 1.463091908911196e-12
members O 0 1.5233318079177494e-12
had O 0 1.943393224124179e-09
been O 0 9.96275395515056e-10
identified O 0 5.171076455923185e-09
were O 0 1.9178809929076834e-10
examined O 0 7.650610811538172e-09
to O 0 3.353475483414137e-11
determine O 0 4.458885705105331e-09
the O 0 7.207310442902681e-11
transmission O 0 2.7955374903854135e-08
of O 0 3.506322402563322e-12
the O 0 1.0796988858530199e-09
DM B-Disease 1 0.9999927282333374
expansion O 0 1.107350100504334e-09
from O 0 5.4523510706339096e-11
affected O 0 3.4644978552655914e-10
parents O 0 4.4767964335612476e-10
to O 0 4.738747588772796e-11
their O 0 1.4280951976530787e-09
offspring O 0 5.4919794933994126e-08
. O 0 2.8037541177639014e-09

Where O 0 1.680577526030902e-07
the O 0 9.990960059269582e-09
transmitting O 0 0.00014701062173116952
parent O 0 1.815207610889047e-06
was O 0 8.931925776778371e-08
male O 0 1.236558091477491e-07
, O 0 1.4165160711065994e-10
58 O 0 8.430656728286579e-10
. O 0 3.875647358597689e-09

3 O 0 5.8880091913238175e-09
% O 0 5.202094310874372e-11
of O 0 4.34568136684077e-12
the O 0 9.786314814075325e-11
offspring O 0 5.191397534076714e-08
were O 0 1.4589315533442004e-08
affected O 0 2.6855144774629025e-09
, O 0 3.222325184459862e-11
and O 0 1.0232600877735365e-10
in O 0 1.8611825622349976e-11
the O 0 2.020549005887773e-11
case O 0 1.7486779801956231e-09
of O 0 7.1945331636680265e-12
a O 0 1.1791734699784229e-08
female O 0 5.363803666114109e-06
transmitting O 0 0.0002818335487972945
parent O 0 8.284854402518249e-08
, O 0 1.2174991570468308e-10
68 O 0 7.933460555165084e-10
. O 0 3.040696139322563e-09

7 O 0 1.384913872470861e-07
% O 0 3.9173402299752524e-09
were O 0 1.0387627646935016e-08
affected O 0 5.968016836277457e-08
. O 0 1.5473327508175316e-08

Studies O 0 2.4348750571334676e-07
on O 0 2.4536916942707876e-09
meiotic O 0 9.6995154308388e-07
drive O 0 3.394418968127866e-07
in O 0 8.76379644410008e-08
DM B-Disease 1 0.9999992847442627
have O 0 1.2762939149979502e-07
shown O 0 1.3432483569886244e-07
increased O 0 1.0084542978461286e-08
transmission O 0 3.262590553276823e-08
of O 0 2.773221539562054e-12
the O 0 1.033502363551042e-11
larger O 0 6.202542923716692e-10
allele O 0 2.146714628281643e-08
at O 0 3.3081429262615814e-10
the O 0 2.3397173087857936e-09
DM B-Disease 1 0.9999936819076538
locus O 0 1.2596661917996244e-06
in O 0 2.7930965984523937e-08
non O 0 3.173765037445264e-07
- O 0 0.3669480085372925
DM O 1 0.9999969005584717
heterozygotes O 0 2.5533521693432704e-05
for O 0 4.80338036012995e-09
CTGn O 0 1.895151763164904e-05
. O 0 1.6681871883861277e-08

This O 0 5.791529922305472e-09
study O 0 4.439789369481417e-10
provides O 0 2.17546571035232e-11
further O 0 7.094728884243784e-12
evidence O 0 2.149203454093751e-10
that O 0 1.3153562961054632e-10
the O 0 6.67272348486847e-10
DM B-Disease 1 0.9999892711639404
expansion O 0 9.521919253074884e-09
tends O 0 2.476250848815198e-08
to O 0 1.8516199684626145e-10
be O 0 3.0817306484465234e-09
transmitted O 0 3.267816168772697e-07
preferentially O 0 1.3759880346242426e-07
. O 0 5.06630204455405e-09

Diagnosis O 1 0.8460546135902405
of O 0 1.4591480521630729e-06
hemochromatosis B-Disease 1 0.9999943971633911
. O 0 1.736820922815241e-05

If O 0 0.00014242697216104716
untreated O 0 0.01801743172109127
, O 0 1.2745617539167142e-07
hemochromatosis B-Disease 1 0.9999994039535522
can O 0 0.009481502696871758
cause O 0 0.0037632037419825792
serious O 0 0.10271047055721283
illness O 0 0.2591093182563782
and O 0 3.271662052384272e-09
early B-Disease 0 4.0239984677725715e-09
death I-Disease 0 1.5422097021655645e-07
, O 0 2.2927328438560046e-11
but O 0 4.611897808093346e-10
the O 0 1.4200552955756507e-09
disease O 0 4.399516626563127e-07
is O 0 5.333389840878056e-10
still O 0 4.591344637816519e-09
substantially O 0 3.3328078075101075e-08
under O 0 7.091468745556995e-08
- O 1 0.8800840377807617
diagnosed O 0 0.14185430109500885
. O 0 5.268243796763272e-08

The O 0 2.4819331034819925e-09
cornerstone O 0 1.1247718312290544e-08
of O 0 4.629378477782886e-12
screening O 0 6.416067122039237e-10
and O 0 1.0300275216090782e-10
case O 0 2.488237171860419e-09
detection O 0 1.7174593835989072e-07
is O 0 5.4011052574853835e-11
the O 0 4.376074155820753e-12
measurement O 0 1.6554514203903636e-08
of O 0 1.3920617263074586e-11
serum O 0 1.0841717568155218e-07
transferrin O 0 4.580483192739848e-08
saturation O 0 1.1973925495567528e-07
and O 0 1.9546075868959178e-10
the O 0 3.3638680729808357e-10
serum O 0 8.913509645935846e-07
ferritin O 0 1.2895769032184035e-05
level O 0 9.958165492207627e-08
. O 0 4.6583670254563e-09

Once O 0 2.364661895626341e-06
the O 0 3.121049862997438e-09
diagnosis O 0 4.780671588378027e-05
is O 0 6.728406720668545e-10
suspected O 0 2.080055949704729e-08
, O 0 3.8682283071134194e-11
physicians O 0 1.2025991313890927e-10
must O 0 6.199811219964602e-10
use O 0 2.502353657618528e-09
serum O 0 2.052167837973684e-05
ferritin O 0 0.0041409749537706375
levels O 0 1.5914514506221167e-06
and O 0 4.477114678991256e-09
hepatic O 0 4.655013071896974e-06
iron O 0 1.7282953194808215e-05
stores O 0 1.617423883715219e-08
on O 0 6.491629278571054e-08
liver O 0 1.0144926818611566e-06
biopsy O 0 8.487406012136489e-05
specimens O 0 4.3887885681215266e-07
to O 0 3.6847605522360993e-10
assess O 0 2.9952471436445194e-07
patients O 0 6.582328571091978e-10
for O 0 3.796643988779325e-12
the O 0 1.4464111332268548e-11
presence O 0 1.0596379329541605e-09
of O 0 4.728574753976034e-10
iron B-Disease 0 0.01412662398070097
overload I-Disease 0 0.0003836227988358587
. O 0 1.7869782098500764e-08

Liver O 1 0.8455336093902588
biopsy O 1 0.9810478687286377
is O 0 9.373512455113087e-08
also O 0 1.1212749478906048e-10
used O 0 1.6466386587588033e-10
to O 0 8.43927271815259e-12
establish O 0 1.6884903197844636e-10
the O 0 2.3504318283351644e-11
presence O 0 5.583249973462046e-10
or O 0 1.8824655723115313e-10
absence O 0 6.964308574275435e-10
of O 0 4.86418752498885e-11
cirrhosis B-Disease 0 2.183535343647236e-06
, O 0 8.167887199928003e-11
which O 0 2.9491624697897123e-09
can O 0 1.432554199709557e-07
affect O 0 9.196085670737375e-07
prognosis O 0 7.429009565385059e-05
and O 0 1.0295336139165556e-08
management O 0 1.718700382014049e-08
. O 0 4.151440524680083e-09

A O 0 1.30886135707442e-07
DNA O 0 1.5917200926196529e-06
- O 0 1.3789735021418892e-05
based O 0 3.095102174555109e-09
test O 0 5.022963156520177e-10
for O 0 3.490601254221848e-12
the O 0 2.6265762134713988e-11
HFE O 0 1.1468747516119038e-06
gene O 0 2.862490910970905e-09
is O 0 1.744658410796074e-11
commercially O 0 1.9045100219106104e-10
available O 0 4.5553144589760564e-11
, O 0 2.5532815878942516e-12
but O 0 7.562159232143983e-12
its O 0 3.068433636517487e-13
place O 0 4.816623142001042e-11
in O 0 4.917199980525311e-11
the O 0 2.509804308825636e-10
diagnosis O 0 1.3085461432638112e-05
of O 0 7.3049433169103395e-09
hemochromatosis B-Disease 1 0.9999998807907104
is O 0 1.4044461750017945e-05
still O 0 2.0045952453529026e-07
being O 0 3.950747640146801e-08
evaluated O 0 1.3610029725441564e-07
. O 0 1.015197348408492e-08

Currently O 0 1.5628519633992255e-07
, O 0 4.737220685169241e-11
the O 0 7.1922147057423835e-12
most O 0 1.2101680334913878e-12
useful O 0 1.5183751825298408e-11
role O 0 1.6905100583275434e-11
for O 0 1.3521170945038352e-12
this O 0 1.2264251246507651e-11
test O 0 9.504309839147851e-11
is O 0 4.331464874274271e-12
in O 0 6.774329361358689e-13
the O 0 1.405298403686639e-12
detection O 0 2.8525182216299072e-08
of O 0 1.6576742756235774e-10
hemochromatosis B-Disease 1 0.9999995231628418
in O 0 9.876181650270155e-09
the O 0 7.707930821387876e-11
family O 0 3.539397941398903e-10
members O 0 1.266265629677743e-12
of O 0 2.5931637479686964e-12
patients O 0 8.388228306399625e-11
with O 0 3.0119243904502824e-11
a O 0 9.751222052045705e-09
proven O 0 2.5990796075348044e-06
case O 0 1.4940468862079115e-09
of O 0 2.3112041794282057e-11
the O 0 2.0724209903733026e-08
disease O 0 5.279110155242961e-06
. O 0 1.6169179772873576e-08

It O 0 1.0568712127678737e-08
is O 0 3.3939390187143204e-10
crucial O 0 1.560732543204324e-09
to O 0 3.9397164641741256e-08
diagnose O 1 0.9998763799667358
hemochromatosis B-Disease 1 0.9999998807907104
before O 0 0.0023232419043779373
hepatic B-Disease 1 0.9822481870651245
cirrhosis I-Disease 0 0.2689332067966461
develops O 0 5.516405963135185e-06
because O 0 3.396506897956897e-08
phlebotomy O 0 0.00018340117821935564
therapy O 0 3.6114539398113266e-05
can O 0 4.5048187757856795e-07
avert O 0 0.002338848076760769
serious O 1 0.9987766146659851
chronic O 1 0.9999940395355225
disease O 1 0.9797525405883789
and O 0 1.948786234606814e-07
can O 0 9.886174012763149e-08
even O 0 1.49509684632676e-08
lead O 0 1.4852955532163037e-09
to O 0 4.36065600295521e-10
normal O 0 4.4902439100269476e-08
life O 0 1.6928558466133836e-07
expectancy O 0 7.641309451855705e-08
. O 0 9.563007330459783e-11
. O 0 9.369143239013056e-10

Prevalence O 0 0.0010891156271100044
of O 0 4.415585397321564e-10
the O 0 6.137008123907606e-10
I1307K O 0 5.792328039433414e-08
APC B-Disease 0 1.924618331372585e-08
gene O 0 7.305696048121035e-09
variant O 0 8.239548066057978e-08
in O 0 3.8495209797595464e-10
Israeli O 0 7.693944326092605e-08
Jews O 0 1.1310745673398515e-09
of O 0 4.925636287733681e-12
differing O 0 8.913877413974092e-10
ethnic O 0 2.5522811641920384e-10
origin O 0 1.2629902457206299e-08
and O 0 2.7310653294421172e-08
risk O 0 1.1354769412719179e-05
for O 0 2.2754356905352324e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999995231628418
. O 0 1.1408442333049607e-05

BACKGROUND O 0 0.00032484810799360275
& O 0 3.597842237468285e-07
AIMS O 0 2.8019165654313838e-08
Israeli O 0 1.5648653572952753e-07
Jews O 0 2.367933849001247e-09
of O 0 1.8100722309899453e-11
European O 0 1.2286045070197815e-08
birth O 0 1.5564874047413468e-06
, O 0 4.889491034276716e-10
i O 0 5.042127426690968e-08
. O 0 2.425800229091668e-12
e O 0 3.5126297703858e-11
. O 0 7.626627736463665e-13
, O 0 4.1759239295668937e-13
Ashkenazim O 0 2.5366103661994543e-10
, O 0 1.4477600975698612e-12
have O 0 3.83819885596548e-11
the O 0 3.4134297610677322e-09
highest O 1 0.9986743927001953
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 1 0.9990455508232117
of O 0 3.6207764564366585e-10
any O 0 6.5134804216882e-09
Israeli O 0 1.2652176337724086e-06
ethnic O 0 8.99466456871778e-09
group O 0 7.922309208652223e-08
. O 0 1.6967566907055698e-08

The O 0 1.7731970558543253e-08
I1307K O 0 5.555816073865572e-07
APC B-Disease 0 1.335651660383519e-07
gene O 0 1.4051904884126998e-07
variant O 0 3.766039071706473e-06
was O 0 1.4046398177924857e-07
found O 0 1.2990169828697162e-08
in O 0 1.4330666653350477e-09
6 O 0 1.925631742949463e-08
. O 0 2.150152766944302e-08

1 O 0 4.5615533572629374e-09
% O 0 5.266909824941379e-11
of O 0 1.4901399341890609e-12
American O 0 1.5395389130201664e-10
Jews O 0 2.39499531318188e-10
, O 0 1.2778125779711047e-11
28 O 0 7.1716534620624994e-12
% O 0 4.902744334643605e-13
of O 0 3.0481183983105398e-12
their O 0 2.451037062201067e-06
familial O 1 0.999998927116394
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 0 0.0002018347877310589
, O 0 2.6509081596515216e-09
but O 0 2.3952706484919872e-09
not O 0 4.783191065449444e-10
in O 0 1.6423196136372553e-10
non O 0 4.676563580829907e-09
- O 0 3.760720346690505e-06
Jews O 0 8.171950582891441e-08
. O 0 1.2105999758205144e-08

We O 0 4.426695809911507e-08
assessed O 0 1.2711272923127126e-08
the O 0 8.31963317682316e-11
I1307K O 0 4.3084025236339585e-08
prevalence O 0 1.8134896606625261e-07
in O 0 9.708842063638201e-11
Israeli O 0 3.959928918106925e-08
Jews O 0 3.25758781061225e-10
of O 0 1.3635226845179482e-12
differing O 0 3.464524223062426e-10
ethnic O 0 4.638342834817344e-11
origin O 0 3.438719087256459e-09
and O 0 8.49764258958885e-09
risk O 0 4.7672392611275427e-07
for O 0 3.4507556847529486e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
. O 0 2.804716132231988e-06

METHODS O 0 5.820368755848904e-07
DNA O 0 2.3294064988022e-07
samples O 0 1.2962549256201328e-08
from O 0 3.545511106928245e-11
500 O 0 6.076646824615395e-11
unrelated O 0 1.5485926985192577e-09
Jews O 0 7.788729661228899e-10
of O 0 2.183347252993073e-11
European O 0 1.6147597703408678e-09
or O 0 1.8833354875624764e-09
non O 0 1.3470532467252383e-09
- O 0 3.138435147320706e-07
European O 0 2.502134055504257e-09
origin O 0 8.116952110448494e-10
, O 0 1.4597245938038905e-12
with O 0 3.114094052070193e-12
or O 0 1.6544524084061152e-10
without O 0 2.5009959381261382e-11
a O 0 3.2607565952913475e-11
personal O 0 8.021262232205117e-08
and O 0 1.5094979488594618e-08
/ O 0 1.4473515719259922e-08
or O 0 1.2381264902217026e-09
family O 0 1.8696311165911084e-09
history O 0 1.8269169510531924e-09
of O 0 1.241900610127189e-10
neoplasia B-Disease 0 2.5690815164125524e-05
, O 0 2.3824386907733697e-10
were O 0 6.870318203233694e-10
examined O 0 3.729073583258469e-08
for O 0 1.1478426716060586e-11
the O 0 3.977583540315521e-11
I1307K O 0 3.1226992103228213e-09
variant O 0 4.9422816950084325e-09
by O 0 3.836427703296508e-11
the O 0 1.0732840310945235e-10
allele O 0 8.692921937836218e-09
- O 0 1.4637619116797396e-08
specific O 0 9.073197748676876e-10
oligonucleotide O 0 2.8214885787747335e-06
( O 0 3.9152764363947767e-10
ASO O 0 7.9722767623025e-06
) O 0 4.4237266627611405e-11
method O 0 1.8141108615310486e-09
. O 0 3.3583691383398673e-09

RESULTS O 0 1.1071057315348298e-06
In O 0 3.7386491125168675e-10
persons O 0 1.8427835646317448e-10
at O 0 2.0088575247712015e-09
average O 0 6.278440309870348e-07
risk O 0 1.8733070419330033e-06
for O 0 0.0003968567762058228
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 2.3472905397170507e-08
I1307K O 0 8.944797258436665e-08
was O 0 1.873719668310514e-08
found O 0 6.706357136287977e-10
in O 0 1.736492200032913e-10
5 O 0 1.0492703372833034e-09
. O 0 7.443878846657981e-09

0 O 0 1.3186433278633558e-08
% O 0 4.937321038123166e-11
of O 0 5.25959917979657e-12
120 O 0 4.804914799372284e-11
European O 0 3.967646211577858e-09
and O 0 2.9445648142001346e-09
1 O 0 2.7112170286613946e-09
. O 0 6.902792115681677e-09

6 O 0 4.132017039637503e-08
% O 0 3.558242589463134e-10
of O 0 2.90068594144266e-11
188 O 0 2.8806293461691723e-10
non O 0 1.399640181531936e-09
- O 0 3.4364791190455435e-07
European O 0 1.9769371917277567e-08
Jews O 0 7.596301365708769e-09
( O 0 7.980154037579013e-11
P O 0 1.3545845831686165e-06
= O 0 1.1920223030870147e-08
0 O 0 1.0972200231718077e-10
. O 0 1.5865975200313187e-11
08 O 0 3.880985810500448e-10
) O 0 1.8912963209438693e-11
. O 0 7.41638195300709e-10

It O 0 7.105386856665064e-08
occurred O 0 7.560731773992302e-08
in O 0 3.026622563684356e-10
15 O 0 8.264156026172031e-10
. O 0 2.934584797387174e-09

4 O 0 7.9209456771423e-09
% O 0 1.9551855967581133e-10
of O 0 1.899198333321639e-11
52 O 0 1.0395609928437466e-09
Ashkenazi O 0 1.193943290900279e-07
Israelis O 0 2.9919689836788166e-08
with O 0 1.1579685654794503e-08
familial O 1 0.9539508819580078
cancer B-Disease 0 0.21127621829509735
( O 0 2.128635046005911e-09
P O 0 8.90216397237964e-05
= O 0 5.1103274500974294e-08
0 O 0 7.837112209196917e-11
. O 0 6.77978766877585e-12
02 O 0 6.211952480184024e-11
) O 0 5.561241029315711e-13
and O 0 6.088851645102977e-11
was O 0 3.627069844469588e-08
not O 0 7.405798196913338e-09
detected O 0 2.732509756242507e-07
in O 0 4.258843624982411e-11
51 O 0 7.673429947008259e-11
non O 0 1.5827386623534778e-10
- O 0 1.508818847639759e-08
European O 0 1.0551746143505625e-09
Jews O 0 6.782109318592688e-10
at O 0 3.2108311565082204e-09
increased O 0 1.3696632095161476e-07
cancer B-Disease 0 1.1629092114162631e-05
risk O 0 8.376933919862495e-07
. O 0 7.78022624103869e-09

Colorectal B-Disease 1 0.9951660633087158
neoplasia I-Disease 1 0.9456550478935242
occurred O 0 0.00016544392565265298
personally O 0 1.0440450751048047e-05
or O 0 1.0324183286058997e-08
in O 0 1.280775485668073e-10
the O 0 2.4920345301215896e-11
families O 0 5.297497510103888e-11
of O 0 3.64595680035773e-12
13 O 0 4.974125712015054e-12
of O 0 2.710096253313865e-12
20 O 0 4.06020599086343e-11
Ashkenazi O 0 2.6107309647471766e-09
I1307K O 0 2.743866689414176e-09
carriers O 0 3.012753380104982e-10
, O 0 1.7978290297454569e-12
8 O 0 1.0429992373245378e-12
of O 0 1.1704321322900113e-12
whom O 0 3.505887846699807e-08
also O 0 1.3709994917121548e-08
had O 0 3.942600912409944e-09
a O 0 4.045868362556604e-10
personal O 0 2.768999138424988e-06
or O 0 2.8301577970069047e-08
family O 0 5.244260137260426e-09
history O 0 3.83296461237137e-09
of O 0 3.001196791085903e-10
noncolonic O 0 0.00010652928904164582
neoplasia B-Disease 0 0.0023111095651984215
. O 0 4.651559493140667e-08

CONCLUSIONS O 0 2.275633050885517e-06
The O 0 2.5014803561873578e-09
I1307K O 0 3.265473651481443e-07
APC O 0 1.887857763449574e-07
variant O 0 1.7059570609490038e-06
may O 0 1.774817803834594e-08
represent O 0 5.644730863285652e-11
a O 0 4.940338138581524e-10
susceptibility O 0 3.1785421015229076e-05
gene O 0 3.3153793310702895e-07
for O 0 7.141391478171499e-08
colorectal B-Disease 1 0.9999998807907104
, I-Disease 0 1.0085543067361868e-08
or I-Disease 0 1.6972317995467279e-09
other I-Disease 0 9.116352117644055e-11
, I-Disease 0 1.141686412076126e-09
cancers I-Disease 0 3.4702723496593535e-05
in O 0 5.835881777827012e-10
Ashkenazi O 0 2.8632439352804795e-07
Jews O 0 2.538573262711452e-08
, O 0 7.552115877107468e-11
and O 0 1.8203698270990998e-10
partially O 0 1.0878402179059776e-07
explains O 0 9.804147715897216e-09
the O 0 5.655874379950632e-11
higher O 0 4.9658314793532554e-08
incidence O 0 0.024213582277297974
of O 0 4.6733901399420574e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
in O 0 3.650550013389875e-07
European O 0 6.411032416053786e-08
Israelis O 0 2.3775527324687573e-07
. O 0 5.802700187018672e-08

Systematic O 0 8.091406584753713e-07
analysis O 0 4.1605979106407176e-08
of O 0 4.4707548774169936e-10
coproporphyrinogen O 0 3.0395720386877656e-05
oxidase O 0 3.013267632923089e-05
gene O 0 0.0004538644279818982
defects O 1 0.9626680016517639
in O 0 1.2955924333368785e-08
hereditary B-Disease 0 0.037566184997558594
coproporphyria I-Disease 0 0.051513832062482834
and O 0 2.117314892302602e-07
mutation O 0 2.928991125372704e-05
update O 0 9.521738206785813e-07
. O 0 1.92217495253999e-08

Hereditary B-Disease 1 0.9789068102836609
coproporphyria I-Disease 0 0.4413242042064667
( O 0 3.381240105682082e-07
HC B-Disease 0 0.35090208053588867
) O 0 2.450604608128515e-09
is O 0 1.0923969506748676e-09
an O 0 8.324831490824636e-09
acute O 1 0.6525920033454895
hepatic B-Disease 1 0.9937697052955627
porphyria I-Disease 1 0.9998822212219238
with O 0 1.67753933055792e-05
autosomal O 1 0.9997982382774353
dominant O 0 0.22151461243629456
inheritance O 1 0.5464065074920654
caused O 0 8.757728937780485e-05
by O 0 7.454676875795485e-09
deficient B-Disease 0 2.633648728078697e-05
activity I-Disease 0 1.4249288859957687e-08
of I-Disease 0 1.6832232829777638e-10
coproporphyrinogen I-Disease 0 5.453178528114222e-05
III I-Disease 0 0.00010947694681817666
oxidase I-Disease 0 3.6580395317287184e-06
( O 0 1.6008007142076508e-09
CPO O 0 2.0147581381024793e-06
) O 0 3.2830121954319225e-10
. O 0 1.5910660566831325e-09

Clinical O 0 2.27510608965531e-05
manifestations O 0 6.926877631485695e-06
of O 0 2.504435547834305e-09
the O 0 2.3092033529792388e-07
disease O 0 1.6264271835098043e-05
are O 0 5.323247398436592e-10
characterized O 0 3.1385579291054455e-07
by O 0 1.655855719207011e-08
acute O 0 0.00035777161247096956
attacks O 0 4.662368155550212e-05
of O 0 2.385474715538294e-07
neurological B-Disease 1 0.9998685121536255
dysfunction I-Disease 0 0.012218385003507137
often O 0 8.153376995778672e-08
precipitated O 0 1.018040407529952e-07
by O 0 7.16230685871011e-11
drugs O 0 2.6845656253549066e-10
, O 0 6.536344382412906e-12
fasting O 0 3.8023509341122974e-10
, O 0 2.3516740638163114e-11
cyclical O 0 2.934743861260358e-07
hormonal O 0 5.825049811392091e-06
changes O 0 5.884932541277976e-09
, O 0 5.037527617268722e-10
or O 0 5.606390232060221e-07
infectious B-Disease 0 0.001157815451733768
diseases I-Disease 0 6.7899341047450434e-06
. O 0 2.0089199637141064e-08

Skin O 1 0.999603807926178
photosensitivity O 1 0.9996668100357056
may O 0 0.0008122586878016591
also O 0 4.041844192670396e-09
be O 0 1.1108914899082833e-09
present O 0 9.282323243375856e-10
. O 0 5.1420130375845474e-09

The O 0 1.1711647651679868e-08
seven O 0 1.0630124558375087e-09
exons O 0 4.699206002101164e-08
, O 0 5.714570830428478e-11
the O 0 2.74852571258144e-11
exon O 0 2.0052608817877626e-07
/ O 0 1.3716068281155458e-07
intron O 0 7.37373454740009e-07
boundaries O 0 4.418553523066748e-09
and O 0 7.414624469959108e-11
part O 0 1.028362291155549e-11
of O 0 2.4596292884371262e-12
3 O 0 1.1275796268916949e-11
noncoding O 0 1.8532496648404617e-09
sequence O 0 2.0878128392798345e-10
of O 0 1.3192645760551347e-12
the O 0 1.659305678969325e-11
CPO O 0 3.4418242478295724e-08
gene O 0 4.009577392327657e-10
were O 0 6.114700412673812e-11
systematically O 0 8.17483059023516e-09
analyzed O 0 4.306567991108068e-09
by O 0 9.149060849200641e-12
an O 0 3.9705625939912e-12
exon O 0 1.8531975953806068e-08
- O 0 1.871537875786089e-07
by O 0 2.355087902472519e-09
- O 0 3.3583826279937057e-06
exon O 0 4.567812084133038e-06
denaturing O 0 4.073953823535703e-05
gradient O 0 4.534317849902436e-05
gel O 0 8.071362390182912e-05
electrophoresis O 0 2.1653161184076453e-06
( O 0 3.9817146801901515e-10
DGGE O 0 2.7564766469367896e-07
) O 0 1.6240173268677882e-12
strategy O 0 3.599579662116881e-11
followed O 0 1.2791287126723283e-12
by O 0 8.840577738183225e-14
direct O 0 2.206951852171124e-12
sequencing O 0 2.064783413691096e-11
in O 0 1.096619062918025e-11
seven O 0 1.597230681049666e-11
unrelated O 0 4.573360001813853e-08
heterozygous O 0 4.8888055061979685e-06
HC B-Disease 1 0.5158425569534302
patients O 0 1.1249289144643626e-07
from O 0 3.4014193683873373e-09
France O 0 4.181935219094157e-05
, O 0 3.338481269210547e-09
Holland O 0 1.4830594636805472e-06
, O 0 6.398200302903945e-10
and O 0 7.427030990214689e-09
Czech O 0 0.00045116504770703614
Republic O 0 4.602350713867054e-07
. O 0 2.655302111520541e-08

Seven O 0 4.0065085471496786e-08
novel O 0 5.067348851639508e-08
mutations O 0 4.565038580039982e-06
and O 0 8.630682835075731e-10
two O 0 8.75244043907486e-11
new O 0 6.103249572397829e-10
polymorphisms O 0 3.768500391743146e-05
were O 0 3.975959259605588e-07
detected O 0 0.00039109494537115097
. O 0 3.83261564707027e-08

Among O 0 6.779021788361206e-09
these O 0 2.1827653573502914e-10
mutations O 0 6.419144682467959e-08
two O 0 1.0437685438180466e-10
are O 0 6.229896043485894e-10
missense O 0 1.0716021279222332e-05
( O 0 1.0063665872861449e-10
G197W O 0 1.2480974476147821e-08
, O 0 2.738520521461396e-11
W427R O 0 2.3598993870166396e-09
) O 0 3.3278150200766188e-12
, O 0 1.8815589277604294e-12
two O 0 4.0930713679498965e-12
are O 0 2.2131588228724297e-10
nonsense O 0 2.5620002475079673e-07
( O 0 4.137529294873099e-12
Q306X O 0 7.61938401261375e-10
, O 0 6.417700572358687e-12
Q385X O 0 1.1075909078783752e-09
) O 0 2.8873372876631054e-12
, O 0 1.4350969414558823e-12
two O 0 3.3566671577694995e-12
are O 0 5.5334061985212735e-12
small O 0 3.7877492808924274e-11
deletions O 0 3.4170082585660566e-07
( O 0 3.568013592913921e-11
662de14bp O 0 2.617302152785328e-09
; O 0 1.0180345282051473e-11
1168del3bp O 0 2.756413763904675e-09
removing O 0 1.6228329791090346e-10
a O 0 5.6249553626042115e-11
glycine O 0 1.3453234082305698e-08
at O 0 1.1079754891341054e-09
position O 0 2.418850231222791e-09
390 O 0 2.5915183193836455e-11
) O 0 1.3499730847077451e-12
, O 0 1.926730042872693e-12
and O 0 2.2411428615698448e-11
one O 0 4.278016135783602e-11
is O 0 8.225133248107586e-12
a O 0 2.1831474128486406e-11
splicing O 0 1.3040365232086515e-08
mutation O 0 5.269354801384907e-07
( O 0 1.7356239709331867e-11
IVS1 O 0 6.31387877092493e-07
- O 0 5.238175049271376e-07
15c O 0 6.600066626560874e-07
- O 0 1.2444198773664539e-06
- O 0 7.027173523965757e-06
> O 0 1.5898920935342176e-07
g O 0 1.540636844765686e-07
) O 0 1.0616492494147645e-12
which O 0 9.868521798350738e-12
creates O 0 1.2709441832292612e-10
a O 0 5.789712459458585e-11
new O 0 5.58286403218311e-11
acceptor O 0 3.866696407506254e-10
splice O 0 9.437700754233447e-08
site O 0 3.080239991959388e-07
. O 0 1.3055796443950385e-08

The O 0 7.940458957023111e-09
pathological O 0 1.8185363614975358e-07
significance O 0 1.059757792631899e-08
of O 0 1.5525128058135884e-11
the O 0 2.985215546980058e-11
point O 0 3.5394405184518973e-09
mutations O 0 3.9927154915631036e-08
G197W O 0 4.551723442602906e-09
, O 0 7.769329450624252e-12
W427R O 0 5.338601227755646e-10
, O 0 1.9050095702299874e-12
and O 0 5.400093133073325e-12
the O 0 2.4646541318257276e-12
in O 0 1.6152332249497192e-10
- O 0 7.342977710322884e-07
frame O 0 0.0012476446572691202
deletion O 0 3.8332118492689915e-06
390delGly O 0 3.158757522214728e-07
were O 0 1.45671741336173e-09
assessed O 0 7.479916241948104e-09
by O 0 1.667971490093567e-11
their O 0 7.53038187362165e-11
respective O 0 1.5998689872898098e-10
expression O 0 1.2290538586867683e-09
in O 0 1.3922634746477147e-11
a O 0 4.5499479184307745e-11
prokaryotic O 0 1.262187021566774e-10
system O 0 1.185066073050578e-10
using O 0 3.3962832546308164e-10
site O 0 2.734907411650056e-08
- O 0 2.1923227677689283e-07
directed O 0 1.617337552772824e-08
mutagenesis O 0 1.240396045432135e-06
. O 0 9.100586950694378e-09

These O 0 1.6416414894138143e-08
mutations O 0 7.599129503432778e-07
resulted O 0 6.803581698022754e-09
in O 0 1.6132381541744678e-10
the O 0 9.955208185585818e-11
absence O 0 2.3242210378526806e-09
or O 0 1.3457994441079535e-10
a O 0 1.173274255528156e-10
dramatic O 0 1.4271039106006356e-07
decrease O 0 1.3059649006663676e-07
of O 0 1.650591191504347e-10
CPO O 0 1.4313062820292544e-05
activity O 0 7.165952098375783e-08
. O 0 2.93843260834592e-09

The O 0 5.513913325927433e-09
two O 0 5.062957275647761e-10
polymorphisms O 0 1.0312531912859413e-06
were O 0 4.937775188729177e-10
localized O 0 8.453577748923635e-08
in O 0 1.64537117264274e-09
noncoding O 0 2.0075435713806655e-07
part O 0 2.3977467233926575e-10
of O 0 1.0081143385354263e-11
the O 0 2.3609322830075996e-11
gene O 0 3.7512848383158826e-10
1 O 0 2.4450462488001534e-11
) O 0 1.0572117183429985e-12
a O 0 1.710744740313075e-10
C O 0 2.391287523551e-07
/ O 0 3.1232847419460086e-08
G O 0 4.464675384951988e-07
polymorphism O 0 2.450047986712889e-07
in O 0 1.6345817754892522e-10
the O 0 2.592503434151183e-10
promotor O 0 7.72852945374325e-06
region O 0 2.048201386273263e-09
, O 0 7.919695281521921e-12
142 O 0 9.344434080682529e-12
bp O 0 3.0975118026077553e-09
upstream O 0 1.6913097658499687e-11
from O 0 6.120096291729882e-13
the O 0 6.975558910875257e-13
transcriptional O 0 9.316641208512166e-11
initiation O 0 1.9468751263906903e-11
site O 0 7.158377224314449e-10
( O 0 7.765862605757512e-12
- O 0 9.805251721672903e-09
142C O 0 4.9747615804562884e-08
/ O 0 9.690558044894715e-08
G O 0 7.728742161816626e-07
) O 0 2.6117480574072705e-12
, O 0 9.635097624263733e-13
and O 0 5.643673028910001e-12
2 O 0 1.0098231278954373e-11
) O 0 2.815054775655995e-13
a O 0 4.8432931276654045e-11
6 O 0 2.9415714308811403e-10
bp O 0 5.018227966502309e-08
deletion O 0 1.644405678291605e-08
polymorphism O 0 5.250361027719919e-06
in O 0 1.6411422221196403e-10
the O 0 2.9525982353506564e-11
3 O 0 5.271251490857054e-11
noncoding O 0 6.778918315575311e-09
part O 0 1.4268611292500566e-10
of O 0 5.052196074689652e-12
the O 0 8.331018513940691e-11
CPO O 0 3.149823442072375e-07
gene O 0 4.5702858164631266e-10
, O 0 6.298290014528085e-12
574 O 0 1.3456556702262645e-10
bp O 0 5.242880352085422e-09
downstream O 0 7.915289257365288e-11
of O 0 1.3108268810679835e-12
the O 0 1.7701158247507287e-11
last O 0 3.532734382805103e-10
base O 0 4.0880333840309646e-11
of O 0 4.881460361795542e-13
the O 0 2.60267883633869e-11
normal O 0 4.530174457784142e-09
termination O 0 4.288461585844061e-09
codon O 0 1.8507346766227784e-09
( O 0 1.2338205977735495e-11
+ O 0 3.767123557540941e-10
574 O 0 2.5149953231107247e-09
delATTCTT O 0 7.45271862001573e-08
) O 0 4.3136855198966373e-10
. O 0 2.2623660722587147e-09

Five O 0 1.5782033457867328e-08
intragenic O 0 1.921541070259991e-06
dimorphisms O 0 6.5128137975989375e-06
are O 0 1.0185600141099371e-09
now O 0 7.291965364863984e-10
well O 0 1.6782449041574665e-10
characterized O 0 1.7340678226673845e-08
and O 0 6.574060185116082e-10
the O 0 4.071536163774425e-11
high O 0 8.900591930149915e-10
degree O 0 2.65691024736725e-10
of O 0 2.4988490009841824e-12
allelic O 0 5.3031872226938503e-08
heterogeneity O 0 9.022569997796381e-07
in O 0 4.5772868162430314e-08
HC B-Disease 0 0.04790060594677925
is O 0 2.430807199971241e-08
demonstrated O 0 1.5489096227838672e-08
with O 0 2.4905232390293186e-11
seven O 0 8.521424017804424e-12
new O 0 2.891933871193575e-12
different O 0 2.3640627216242605e-12
mutations O 0 1.7863323320543856e-10
making O 0 2.8856418123057725e-12
a O 0 7.400608598162606e-11
total O 0 1.0428367371029257e-11
of O 0 6.546925328254627e-12
nineteen O 0 1.7560186194032212e-08
CPO O 0 0.00013031520938966423
gene B-Disease 0 3.530595131451264e-05
defects I-Disease 1 0.9266890287399292
reported O 0 3.692271377531142e-07
so O 0 6.229637694588064e-09
far O 0 2.708487878422261e-09
. O 0 4.610948012295779e-10
. O 0 4.632264793968943e-09

Coincidence O 0 1.5181507251327275e-06
of O 0 2.5462323915981244e-10
two O 0 3.1174174353054696e-11
novel O 0 8.870560397333804e-10
arylsulfatase O 0 2.2963737933423545e-07
A O 0 3.1856863813573e-09
alleles O 0 3.5194736014432237e-09
and O 0 8.905720050300658e-10
mutation O 0 1.2393243764563522e-07
459 O 0 8.483326929820123e-09
+ O 0 7.12086389853539e-09
1G O 0 5.637300546368351e-06
> O 0 7.220130271434755e-08
A O 0 3.054553943115934e-09
within O 0 3.7588678697408895e-11
a O 0 2.608665061742954e-09
family O 0 7.013945690914625e-08
with O 0 6.265377123781946e-07
metachromatic B-Disease 1 0.9999997615814209
leukodystrophy I-Disease 1 0.9999984502792358
: O 0 8.993631395171064e-10
molecular O 0 1.5509189488227548e-09
basis O 0 4.281012003226614e-11
of O 0 3.571458753737211e-11
phenotypic O 0 1.3750870948570082e-06
heterogeneity O 0 0.00010074368037749082
. O 0 2.915748495979642e-07

In O 0 1.313915820588818e-08
a O 0 3.4365552625814644e-09
family O 0 7.48519646265322e-09
with O 0 2.9787669553194007e-10
three O 0 1.496231361031164e-09
siblings O 0 1.4874107137075043e-06
, O 0 3.966506983976714e-11
one O 0 2.1436508818029054e-11
developed O 0 4.842141132499478e-10
classical O 0 7.129605705813447e-08
late O 0 4.950320999341784e-06
infantile O 1 0.9986005425453186
metachromatic B-Disease 1 0.9999971389770508
leukodystrophy I-Disease 1 0.9999964237213135
( O 0 3.7984736422913556e-07
MLD B-Disease 1 0.9999866485595703
) O 0 8.685951957687621e-11
, O 0 3.154664376947558e-11
fatal O 0 2.368781224504346e-06
at O 0 3.9035288779132316e-08
age O 0 3.384039359843882e-08
5 O 0 1.696560947284098e-10
years O 0 1.993262443988897e-09
, O 0 2.2139345912108865e-11
with O 0 2.4418143063087427e-09
deficient O 0 4.373078263597563e-05
arylsulfatase O 0 1.4783408914809115e-05
A O 0 5.988770794829179e-07
( O 0 3.100820433754592e-10
ARSA O 0 1.7607931113161612e-06
) O 0 9.53338970266504e-12
activity O 0 1.6018597559508407e-10
and O 0 2.498040316267769e-11
increased O 0 2.407536836557256e-09
galactosylsulfatide O 0 1.9006991351488978e-05
( O 0 6.250061357349068e-09
GS O 1 0.9999901056289673
) O 0 3.728408692893481e-10
excretion O 0 7.264261192574395e-09
. O 0 2.466002735346251e-09

The O 0 4.675422271560592e-09
two O 0 1.952137479444005e-10
other O 0 2.481884697758119e-10
siblings O 0 3.414018294733978e-07
, O 0 2.5540586312544633e-10
apparently O 0 1.1096175711600154e-07
healthy O 0 1.1691404289138063e-08
at O 0 7.123455159074865e-10
12 O 0 1.5664391658787302e-11
( O 0 1.0390836411786064e-12
1 O 0 1.2079087730043625e-11
/ O 0 3.8633640730978414e-10
2 O 0 4.985294729115131e-12
) O 0 2.2111849298182135e-13
and O 0 1.1401402391642002e-11
15 O 0 6.0759019343548104e-12
years O 0 8.015439006969771e-11
, O 0 7.714840051520344e-12
respectively O 0 1.5248836637837826e-09
, O 0 8.785368266206461e-12
and O 0 1.6110181244588517e-10
their O 0 8.670430484691849e-10
father O 0 6.467122375397594e-07
, O 0 5.813614867289374e-11
apparently O 0 5.761410548643653e-08
healthy O 0 5.514184109323139e-10
as O 0 9.503489141471366e-12
well O 0 8.008348151289368e-11
, O 0 7.076605360728516e-12
presented O 0 1.4446701612769175e-09
ARSA O 0 1.0638267667673063e-05
and O 0 3.7144719300385987e-08
GS O 1 0.9999920129776001
values O 0 6.180618328244236e-08
within O 0 7.822353008390959e-12
the O 0 1.5740705613942474e-11
range O 0 1.958205819718728e-09
of O 0 5.283053106097668e-09
MLD B-Disease 1 0.999993085861206
patients O 0 3.947464506381948e-07
. O 0 1.5540823739002008e-08

Mutation O 0 1.6769090507295914e-05
screening O 0 7.469283502814505e-08
and O 0 3.1494651331342993e-10
sequence O 0 1.6689278847792366e-09
analysis O 0 6.895932713746333e-10
disclosed O 0 2.8410452657112728e-08
the O 0 7.920994589405428e-12
involvement O 0 1.4449511587244501e-09
of O 0 4.600963273565517e-12
three O 0 3.918277854952912e-11
different O 0 2.7544258540679323e-10
ARSA O 0 2.1505302356672473e-05
mutations O 0 2.5046355744962057e-07
being O 0 8.22584778070734e-10
the O 0 4.827141724533801e-12
molecular O 0 1.9890014080203855e-09
basis O 0 3.229511796876139e-11
of O 0 1.7260038884248097e-11
intrafamilial O 0 4.7053225671334076e-07
phenotypic O 0 2.5354047465953045e-06
heterogeneity O 0 8.98638172657229e-05
. O 0 3.542880619988864e-07

The O 0 3.125179404150913e-08
late O 0 8.333834102813853e-07
infantile O 1 0.8990564942359924
patient O 0 0.0024272347800433636
inherited O 0 0.0014131886418908834
from O 0 1.2582456188070523e-09
his O 0 9.049870186572662e-09
mother O 0 1.3218658523328486e-07
the O 0 1.061734814650217e-11
frequent O 0 7.505239096872174e-09
0 O 0 1.2045325847864774e-09
- O 0 1.680745924659277e-07
type O 0 4.2228052734571975e-06
mutation O 0 3.7355596305133076e-07
459 O 0 2.6381166140510004e-09
+ O 0 1.17272214161801e-09
1G O 0 2.9617638119816547e-07
> O 0 6.516438055825802e-09
A O 0 1.3468278048378579e-08
, O 0 4.464268191228804e-11
and O 0 9.700531350409491e-11
from O 0 1.4152352900698162e-11
his O 0 4.566297118202556e-09
father O 0 1.5984332435436954e-07
a O 0 4.575745893298233e-10
novel O 0 2.81500545096236e-10
, O 0 6.11530357602641e-12
single O 0 1.240300501192948e-10
basepair O 0 7.59244844772411e-09
microdeletion O 0 2.614378269427675e-09
of O 0 8.676968648799188e-13
guanine O 0 1.5151596644003007e-09
at O 0 1.8512162289208156e-11
nucleotide O 0 4.40333158824302e-10
7 O 0 9.033438927441573e-12
in O 0 8.564505875330308e-12
exon O 0 9.180543258935359e-08
1 O 0 5.399606983758076e-09
( O 0 9.456968541599053e-11
7delG O 0 1.0698029484501603e-07
) O 0 5.085430410112224e-10
. O 0 2.729158232739337e-09

The O 0 1.5237009876045704e-08
two O 0 4.0839847059714884e-09
clinically O 0 2.451316140650306e-05
unaffected O 0 2.4419321562163532e-05
siblings O 0 7.824664862710051e-07
carried O 0 3.482402277654728e-08
the O 0 5.675176995012521e-10
maternal O 0 8.444270065410819e-07
mutation O 0 1.980455266448189e-07
459 O 0 1.0445422304883323e-08
+ O 0 3.9382417327260555e-09
1G O 0 9.815909152166569e-07
> O 0 4.6583249257992065e-08
A O 0 1.6552684556359054e-08
and O 0 1.5811372211516073e-09
, O 0 1.4089061514677148e-11
on O 0 3.09010456112091e-10
their O 0 3.531683279156539e-10
paternal O 0 6.393637477231096e-07
allele O 0 3.079123089833047e-08
, O 0 2.508538298959251e-12
a O 0 7.079778169966078e-12
novel O 0 1.14672944750982e-10
cytosine O 0 2.640089924454969e-09
to O 0 7.007821406501691e-12
thymidine O 0 4.9929060885745e-09
transition O 0 1.0874451339404345e-09
at O 0 1.779062730467018e-10
nucleotide O 0 3.152730299049722e-09
2435 O 0 1.9403126216843702e-08
in O 0 1.7013916317476507e-11
exon O 0 1.356376611028054e-08
8 O 0 2.6398566665974954e-10
, O 0 2.580975363986049e-12
resulting O 0 5.651474774270859e-11
in O 0 3.1983268030527645e-12
substitution O 0 3.592638339600107e-11
of O 0 8.21190251215631e-12
alanine O 0 2.1228503399584042e-08
464 O 0 8.690861919014026e-10
by O 0 2.254255226930013e-09
valine O 0 7.442488276865333e-05
( O 0 3.573307205684273e-10
A464V O 0 5.7439311973439544e-08
) O 0 2.487154093788746e-10
. O 0 1.8633192766515094e-09

The O 0 1.1877129679760401e-07
fathers O 0 3.2412838208983885e-06
genotype O 0 2.3760894691804424e-05
thus O 0 3.217331112637112e-08
was O 0 9.697248337658948e-09
7delG O 0 8.02251406639698e-07
/ O 0 4.602061096647958e-07
A464V O 0 4.427228077474865e-07
. O 0 9.950150037241201e-09

Mutation O 0 6.441161531256512e-05
A464V O 0 1.1201643701497233e-06
was O 0 1.7129503149249103e-08
not O 0 2.1303642183667648e-10
found O 0 1.617490030803026e-10
in O 0 3.6679875803358186e-10
18 O 0 1.623871259681664e-09
unrelated O 0 2.5984178137150593e-05
MLD B-Disease 1 0.9999995231628418
patients O 0 2.0414246648670087e-07
and O 0 1.6314960493701847e-09
50 O 0 2.509540908413044e-10
controls O 0 7.258502421336743e-08
. O 0 1.4811208259857267e-08

A464V O 0 1.2828561921196524e-05
, O 0 1.839715046969559e-09
although O 0 1.429416918163895e-09
clearly O 0 6.24398399651227e-09
modifying O 0 2.309585944715309e-08
ARSA O 0 0.00010454517178004608
and O 0 7.677202233935532e-07
GS O 1 0.9999996423721313
levels O 0 6.989431767578935e-06
, O 0 1.214604666843755e-10
apparently O 0 2.1074633593798353e-08
bears O 0 7.187193062918595e-09
little O 0 1.4929800451479736e-11
significance O 0 1.2729528542365642e-10
for O 0 1.0420334733973746e-11
clinical O 0 1.3670767851081678e-09
manifestation O 0 8.628370551377884e-08
of O 0 1.563695306572299e-08
MLD B-Disease 1 0.9999990463256836
, O 0 8.099507176062559e-10
mimicking O 0 3.08124185721681e-07
the O 0 3.875563758803935e-10
frequent O 0 1.2626766192624927e-06
ARSA O 0 0.002093438059091568
pseudodeficiency O 0 8.088003960438073e-05
allele O 0 5.570019311562646e-06
. O 0 1.9110510507402978e-08

Our O 0 1.1493280993590815e-07
results O 0 5.1365924846891176e-09
demonstrate O 0 3.26025006991415e-09
that O 0 7.799101642280704e-11
in O 0 9.651545188060773e-12
certain O 0 2.0370771736111237e-10
genetic O 0 7.076604902067629e-07
conditions O 0 3.005828693858348e-05
MLD B-Disease 1 0.999990701675415
- O 0 5.418879482022021e-06
like O 0 1.1662955756719384e-07
ARSA O 0 7.107537385309115e-05
and O 0 1.1420294754316274e-07
GS O 1 0.9999960660934448
values O 0 1.4062927675695391e-06
need O 0 1.3934124964976036e-09
not O 0 5.895914312326056e-11
be O 0 8.21832706054959e-12
paralleled O 0 1.9148618801700934e-10
by O 0 4.3769052271436237e-10
clinical O 0 7.440435638272902e-06
disease O 0 4.641696705220966e-06
, O 0 1.34395689022071e-11
a O 0 2.8859239650791402e-11
finding O 0 1.3149323296879345e-10
with O 0 5.060225571895671e-10
serious O 0 1.2691149322563433e-06
diagnostic O 0 2.2398008070467768e-07
and O 0 1.3859967396001593e-08
prognostic O 0 7.16635940989363e-06
implications O 0 1.8993299590874813e-06
. O 0 2.7294301929714493e-08

Moreover O 0 2.751874490058981e-06
, O 0 5.642172284936464e-10
further O 0 4.824919352941492e-10
ARSA O 0 3.7741825508419424e-05
alleles O 0 6.029296883980351e-08
functionally O 0 4.8559261500713546e-08
similar O 0 9.139965451154808e-10
to O 0 5.679895789811873e-11
A464V O 0 1.06711695480044e-07
might O 0 1.5833266786557942e-07
exist O 0 6.215301162626474e-09
which O 0 1.6706948324785031e-10
, O 0 6.956492131469927e-13
together O 0 1.932386759287419e-12
with O 0 1.909444824477191e-11
0 O 0 1.4172574225312928e-09
- O 0 1.1395643923606258e-05
type O 0 0.009195397607982159
mutations O 0 4.03960766561795e-05
, O 0 1.0903319358490648e-09
may O 0 2.8378822847230367e-08
cause O 0 2.39130510948371e-08
pathological O 0 2.3243012492457638e-06
ARSA O 0 0.019175615161657333
and O 0 1.6178260921151377e-05
GS O 1 0.9999998807907104
levels O 0 1.3448791378323222e-06
, O 0 1.0137794249909238e-11
but O 0 1.295605983608894e-10
not O 0 2.7272833991176526e-10
clinical O 0 8.059470868460039e-10
outbreak O 0 6.068498592526339e-09
of O 0 2.786600290793917e-11
the O 0 2.790130793073331e-08
disease O 0 1.1564085980353411e-05
. O 0 4.331849046135261e-10
. O 0 3.3784399722236458e-09

Human O 0 0.0012183707440271974
MLH1 O 1 0.9979617595672607
deficiency O 1 0.9962010979652405
predisposes O 0 0.00043248734436929226
to O 0 2.5282767524004157e-07
hematological B-Disease 1 0.9955297112464905
malignancy I-Disease 1 0.9990993738174438
and O 0 3.359442644068622e-06
neurofibromatosis B-Disease 1 0.9985132813453674
type I-Disease 0 0.008693786337971687
1 I-Disease 0 2.638428213685984e-07
. O 0 4.1265668215828555e-08

Heterozygous O 0 0.00043731689220294356
germ O 0 0.01665816642343998
- O 0 0.0010392229305580258
line O 0 5.820024853164796e-06
mutations O 0 2.7107432742923265e-07
in O 0 3.452398089631714e-11
the O 0 3.967944722793604e-11
DNA O 0 1.1738191005861154e-06
mismatch O 0 0.00792807899415493
repair O 0 2.4194196157623082e-05
genes O 0 5.8858113050064276e-08
lead O 0 1.924434833711075e-08
to O 0 1.7494168957910006e-07
hereditary B-Disease 1 0.999969482421875
nonpolyposis I-Disease 1 0.9999985694885254
colorectal I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
. O 0 1.3202385162003338e-05

The O 0 5.279923698253697e-07
disease O 0 1.3585973647423089e-05
susceptibility O 0 9.173029866360594e-06
of O 0 2.7930349699722967e-10
individuals O 0 9.18502340852001e-09
who O 0 1.6580828798851144e-07
constitutionally O 0 1.5238732657962828e-06
lack O 0 3.747246513086111e-09
both O 0 1.244129244071246e-10
wild O 0 8.186892941353108e-09
- O 0 7.394258773274487e-06
type O 0 4.955573785991874e-06
alleles O 0 5.749071974037179e-08
is O 0 4.382579632533634e-09
unknown O 0 8.815045049459513e-08
. O 0 2.6624007443132314e-09

We O 0 1.2613695616892073e-06
have O 0 6.61938170942733e-10
identified O 0 1.0923844051546894e-09
three O 0 6.9792756643427545e-12
offspring O 0 6.312860789670083e-10
in O 0 3.0377714232976416e-11
a O 0 1.0986455833972286e-07
hereditary B-Disease 1 0.9999858140945435
nonpolyposis I-Disease 1 0.9999996423721313
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 0.0001704179885564372
who O 0 9.779051879377221e-08
developed O 0 6.986000755659916e-08
hematological B-Disease 0 0.008494025096297264
malignancy I-Disease 0 0.12037920951843262
at O 0 4.4289314438117344e-09
a O 0 7.916274857855399e-10
very O 0 2.0863013538985342e-09
early O 0 9.807402889805417e-09
age O 0 2.157395151414221e-08
, O 0 7.652291994508786e-12
and O 0 2.941906440678821e-11
at O 0 2.4080773486367946e-10
least O 0 5.927890123214041e-12
two O 0 1.6101194813197828e-12
of O 0 2.2286775289842575e-12
them O 0 6.335873492524513e-11
displayed O 0 7.351869157901092e-07
signs O 0 1.1875079763967733e-07
of O 0 2.6163973765314097e-10
neurofibromatosis B-Disease 0 0.04998136684298515
type I-Disease 0 0.00010122641833731905
1 I-Disease 0 5.258305435518196e-08
( O 0 3.4732661191583247e-09
NF1 B-Disease 0 1.0823679076565895e-05
) O 0 5.655812485017009e-10
. O 0 1.841238606026252e-09

DNA O 0 1.0662680551831727e-06
sequence O 0 5.1057870820159224e-08
analysis O 0 4.631134142840665e-09
and O 0 2.429011158877614e-10
allele O 0 2.816055655330274e-08
- O 0 2.3541099736235083e-08
specific O 0 8.110668803240628e-10
amplification O 0 7.539475888052038e-08
in O 0 1.4667815573243814e-10
two O 0 1.078981973212656e-10
siblings O 0 2.3349467426214687e-07
revealed O 0 1.3504978824130376e-07
a O 0 7.662117162965387e-09
homozygous O 0 0.00022320299467537552
MLH1 O 0 0.08588521182537079
mutation O 0 1.0865761396416929e-05
( O 0 1.8513020283439374e-10
C676T O 0 6.770302007907958e-08
- O 0 2.6219104256597348e-05
- O 0 0.00014880528033245355
> O 0 1.354801611341827e-06
Arg226Stop O 0 1.8534275341153261e-06
) O 0 3.302960127626875e-10
. O 0 1.0626840518668246e-09

Thus O 0 2.4400239340138796e-07
, O 0 1.8981563543185587e-10
a O 0 6.174179500995081e-10
homozygous O 0 1.4363931768457405e-05
germ O 1 0.5011769533157349
- O 0 0.0754290446639061
line O 0 0.00029482890386134386
MLH1 O 0 0.0970931351184845
mutation O 0 1.0148856745217927e-05
and O 0 6.282306674876281e-09
consequent O 0 3.489633309072815e-05
mismatch O 1 0.9995400905609131
repair O 1 0.9997877478599548
deficiency O 1 0.999543309211731
results O 0 2.6740212888398673e-07
in O 0 1.5612149351085236e-09
a O 0 8.542531304556178e-08
mutator O 0 0.06086969003081322
phenotype O 0 0.0007273360970430076
characterized O 0 2.4431026304228e-06
by O 0 1.3523073505439243e-07
leukemia B-Disease 1 0.957065224647522
and O 0 3.1724077871331247e-06
/ O 0 0.10944332927465439
or O 1 0.8057142496109009
lymphoma B-Disease 1 1.0
associated O 0 0.0001133363475673832
with O 0 3.920138169632992e-07
neurofibromatosis B-Disease 1 0.9900602102279663
type I-Disease 0 0.001222522696480155
1 I-Disease 0 4.8333983926340807e-08
. O 0 1.9132053719062014e-09
. O 0 7.758412579050855e-09

Missense O 0 0.04664561524987221
mutations O 0 0.002694826340302825
in O 0 2.657094322344733e-09
the O 0 4.406177506188769e-11
most O 0 1.069976399148409e-11
ancient O 0 7.03468880369762e-11
residues O 0 4.738228032152847e-09
of O 0 6.0767133512606986e-12
the O 0 2.0526547128696393e-10
PAX6 O 0 3.5002303775399923e-06
paired O 0 1.5021160493233765e-07
domain O 0 1.6042891459733255e-08
underlie O 0 3.3781554975576e-07
a O 0 1.56543111806684e-09
spectrum O 0 1.1243432851415491e-07
of O 0 2.440706081685562e-09
human O 0 7.041329808998853e-05
congenital B-Disease 1 0.9999949932098389
eye I-Disease 1 0.9995480179786682
malformations I-Disease 1 0.9997417330741882
. O 0 3.0713804335391615e-06

Mutations O 0 4.06443105021026e-05
of O 0 1.4144569959739783e-09
the O 0 5.654884893679935e-10
human O 0 1.4973169371046424e-08
PAX6 O 0 0.0024449771735817194
gene O 0 0.00048062470159493387
underlie O 1 0.9949500560760498
aniridia B-Disease 1 0.9999997615814209
( O 0 4.202216132398462e-06
congenital B-Disease 1 0.999929666519165
absence I-Disease 0 5.018247293264722e-07
of I-Disease 0 7.233311172250012e-11
the I-Disease 0 1.3537603260616038e-09
iris I-Disease 0 0.0024921074509620667
) O 0 4.72121175487672e-10
, O 0 1.839622031096777e-11
a O 0 1.0569229935697422e-09
rare O 0 1.6623815781713347e-06
dominant O 0 0.0022656226065009832
malformation B-Disease 1 0.9894335865974426
of I-Disease 0 1.2295157114650124e-09
the I-Disease 0 4.2675587508256285e-08
eye I-Disease 0 0.002222249051555991
. O 0 1.2179654618194036e-07

The O 0 1.4634715661543396e-08
spectrum O 0 9.017617230711039e-08
of O 0 3.95191213087287e-10
PAX6 O 0 0.00011643380275927484
mutations O 0 2.6264553525834344e-05
in O 0 5.374887379616666e-08
aniridia B-Disease 1 0.9999990463256836
patients O 0 5.870786594641686e-07
is O 0 8.868936141048778e-10
highly O 0 1.0328846666851632e-09
biased O 0 2.7987212547486706e-09
, O 0 2.649751728797667e-12
with O 0 2.1615055665474836e-12
92 O 0 9.69255578575634e-12
% O 0 3.2409120417735415e-13
of O 0 6.90575363820195e-13
all O 0 4.088267224755526e-11
reported O 0 3.486868394020348e-08
mutations O 0 5.949060621901481e-08
leading O 0 9.73308100782333e-10
to O 0 9.57076223828679e-11
premature O 0 4.323778224346597e-09
truncation O 0 9.530308764382767e-10
of O 0 8.34415002370914e-12
the O 0 2.0548679424692295e-10
protein O 0 3.2044926712160304e-09
( O 0 1.8855693048602795e-11
nonsense O 0 1.791258057437517e-07
, O 0 3.1839745683742704e-12
splicing O 0 1.3187224923161267e-10
, O 0 1.934049708579577e-12
insertions O 0 2.4530786291165896e-09
and O 0 7.759277942387399e-11
deletions O 0 1.0045840603822853e-08
) O 0 5.185033825905183e-12
and O 0 1.549040236359378e-11
just O 0 2.5560066216345767e-11
2 O 0 3.169789300830339e-12
% O 0 2.115250384788006e-13
leading O 0 2.953835960550766e-12
to O 0 5.652784013446266e-13
substitution O 0 1.290308051377087e-11
of O 0 1.4145276746799218e-12
one O 0 1.1726053461558195e-10
amino O 0 1.631887125430609e-10
acid O 0 1.5198507730129762e-10
by O 0 1.4474764269134521e-11
another O 0 1.4509330403811305e-09
( O 0 4.788504037733787e-10
missense O 0 1.8864768662751885e-06
) O 0 5.43870615210551e-10
. O 0 2.31444885478993e-09

The O 0 2.8898983206460116e-09
extraordinary O 0 2.1672386107951525e-09
conservation O 0 1.7002020624712344e-10
of O 0 2.7812838837570908e-12
the O 0 2.4814098692482744e-11
PAX6 O 0 2.830099390394025e-07
protein O 0 1.1251102272069602e-09
at O 0 1.3655281072555425e-10
the O 0 1.0888677980103179e-11
amino O 0 1.4750692334253301e-10
acid O 0 2.0357682206650907e-10
level O 0 7.65959726201082e-11
amongst O 0 2.1728696966705208e-11
vertebrates O 0 4.230479078159988e-09
predicts O 0 1.466654442339177e-08
that O 0 7.917977384863661e-11
pathological O 0 2.0336014472377428e-07
missense O 0 3.0413899366976693e-05
mutations O 0 4.008360338048078e-05
should O 0 8.076775515064583e-08
in O 0 5.702520677886014e-10
fact O 0 6.7934022851545706e-09
be O 0 1.9461494638051136e-09
common O 0 2.835774670639779e-10
even O 0 2.875481630582044e-09
though O 0 1.609210098507674e-09
they O 0 6.681255548812715e-10
are O 0 1.4442147477922163e-10
hardly O 0 4.467060321644567e-08
ever O 0 1.1191270488097871e-07
seen O 0 1.8480869812265155e-07
in O 0 2.604699034236546e-08
aniridia B-Disease 1 0.9999904632568359
patients O 0 3.679574547277298e-07
. O 0 1.338578936582735e-08

This O 0 3.247225066616011e-08
indicates O 0 1.528344313328489e-07
that O 0 3.7804542829533716e-10
there O 0 1.0960989754726924e-10
is O 0 1.0336521569231927e-11
a O 0 2.1925112766996158e-11
heavy O 0 9.357578534263666e-08
ascertainment O 0 2.2389986042981036e-06
bias O 0 1.1093339935541735e-07
in O 0 1.7768914811755465e-11
the O 0 1.0756869570430205e-12
selection O 0 2.4032754952774127e-12
of O 0 2.4814655538718533e-12
patients O 0 7.328437162668067e-11
for O 0 1.1200388706777975e-11
PAX6 O 0 3.886693775712047e-06
mutation O 0 2.489881865130883e-07
analysis O 0 1.975790420161161e-09
and O 0 9.951391793938669e-11
that O 0 5.411860889981135e-11
the O 0 5.604714609086514e-11
missing O 0 1.2571720731102687e-07
PAX6 O 0 0.0001634124928386882
missense O 0 0.008145077154040337
mutations O 0 0.0059405225329101086
frequently O 0 4.519718004303286e-06
may O 0 1.0020007721323054e-06
underlie O 0 2.9297398214112036e-05
phenotypes O 0 1.1071943845308851e-05
distinct O 0 5.1050374594296954e-08
from O 0 8.518479255315015e-09
textbook O 0 0.0009320554090663791
aniridia B-Disease 1 0.9999856948852539
. O 0 3.669384227578121e-07

Here O 0 4.937837161378411e-07
we O 0 2.9406077572957656e-09
present O 0 6.610621772207281e-11
four O 0 2.1769018879180813e-11
novel O 0 1.9056083377932964e-09
PAX6 O 0 1.9986859115306288e-05
missense O 0 0.0002801105729304254
mutations O 0 0.000259232911048457
, O 0 1.2480627642474929e-10
two O 0 3.9977847421379664e-11
in O 0 4.934348485363671e-10
association O 0 1.2885428835041068e-10
with O 0 3.1037553083201885e-10
atypical O 0 8.112484124467301e-07
phenotypes O 0 5.87827707931865e-06
ectopia B-Disease 0 1.9827126379823312e-05
pupillae I-Disease 0 4.409249595482834e-05
( O 0 3.369750312121056e-10
displaced B-Disease 0 2.5418327442849886e-09
pupils I-Disease 0 8.087917890975405e-09
) O 0 6.561783894021289e-10
and O 0 4.567367000163358e-07
congenital B-Disease 1 0.9999164342880249
nystagmus I-Disease 0 0.0001272139634238556
( O 0 3.290986927417805e-10
searching B-Disease 0 8.026155740026297e-09
gaze I-Disease 0 0.00021499511785805225
) O 0 1.0687205981296799e-10
, O 0 2.227276349464624e-11
and O 0 2.329967885295048e-10
two O 0 2.0856318061479584e-10
in O 0 1.6293315585613755e-09
association O 0 3.755958391526981e-11
with O 0 2.979527041757635e-11
more O 0 2.1535039029796366e-10
recognizable O 0 5.227120345807634e-05
aniridia B-Disease 1 0.9999850988388062
phenotypes O 0 0.00025635326164774597
. O 0 5.067348851639508e-08

Strikingly O 0 0.0002694966387934983
, O 0 1.877833222252434e-09
all O 0 2.2357208098733317e-11
four O 0 1.4303135065230066e-10
mutations O 0 1.1894064044781771e-07
are O 0 9.526977817753135e-11
located O 0 6.11419873064456e-11
within O 0 1.1908615586697646e-11
the O 0 4.057511965305238e-11
PAX6 O 0 2.1953439954813803e-07
paired O 0 8.595744560579988e-09
domain O 0 2.338543803048765e-09
and O 0 5.002540603982197e-10
affect O 0 1.2320886533245812e-09
amino O 0 2.4442314838779566e-10
acids O 0 8.540530782585876e-11
which O 0 1.9379352289572438e-11
are O 0 1.309612921579495e-11
highly O 0 2.345932059721889e-10
conserved O 0 2.691072698013386e-09
in O 0 9.610494344780562e-11
all O 0 1.7447513919743862e-11
known O 0 2.470101900797772e-10
paired O 0 6.148074049860952e-08
domain O 0 6.1470393220020014e-09
proteins O 0 2.1220678547706484e-09
. O 0 1.6324048779381428e-09

Our O 0 1.1643296460306374e-07
results O 0 2.2721262649127993e-09
support O 0 5.1226349551125594e-11
the O 0 1.609844028915841e-11
hypothesis O 0 1.9304371434714085e-09
that O 0 7.824830193514654e-12
the O 0 1.3687783545490717e-12
under O 0 3.6721018586982623e-11
- O 0 2.591901360204929e-09
representation O 0 6.074714620218913e-10
of O 0 6.276156677698097e-11
missense O 0 8.370083378395066e-05
mutations O 0 5.534933734452352e-06
is O 0 7.735712070910949e-10
caused O 0 5.857764939776189e-09
by O 0 2.057173875691376e-10
ascertainment O 0 1.6149620932992548e-05
bias O 0 3.834619747067336e-06
and O 0 5.296189709014243e-09
suggest O 0 2.184915581793234e-09
that O 0 1.148245647869528e-11
a O 0 2.0127906286138142e-11
substantial O 0 9.908498466160154e-10
burden O 0 3.866110773742548e-07
of O 0 1.1604790739472293e-10
PAX6 B-Disease 0 0.0005830299924127758
- I-Disease 0 0.011862356215715408
related I-Disease 0 9.53629714786075e-05
disease I-Disease 0 0.00010095438483403996
remains O 0 8.652893512817172e-08
to O 0 2.844290081238654e-10
be O 0 1.02811679170145e-08
uncovered O 0 8.376355253858492e-06
. O 0 3.495816747189906e-09
. O 0 5.260067936774249e-09

The O 0 1.3489978023528693e-08
chromosomal O 0 3.12100637529511e-05
order O 0 9.828559077718069e-10
of O 0 3.202460865936452e-11
genes O 0 5.952758286298376e-09
controlling O 0 2.4405677478966936e-08
the O 0 1.8831476655822854e-10
major O 0 3.599933684483858e-09
histocompatibility O 0 5.297938059811713e-06
complex O 0 3.759805622394197e-08
, O 0 1.611352370978203e-11
properdin O 0 4.512532569833638e-08
factor O 0 5.504855238314121e-09
B O 0 9.208444851083186e-08
, O 0 5.723875887153618e-11
and O 0 1.9595706390873602e-08
deficiency B-Disease 0 2.9394259399850853e-06
of I-Disease 0 2.6393609520170003e-12
the I-Disease 0 7.882761110522551e-11
second I-Disease 0 6.82052081479867e-10
component I-Disease 0 1.907437319204064e-09
of I-Disease 0 4.191608865555807e-11
complement I-Disease 0 2.8418853048606252e-08
. O 0 6.773671401560932e-09

The O 0 2.4474844373401083e-09
relationship O 0 3.0531516870269115e-08
of O 0 1.4644103638050687e-11
the O 0 2.6356044083297725e-11
genes O 0 5.643323586213e-10
coding O 0 2.325591053065068e-09
for O 0 8.119111286064573e-12
HLA O 0 4.920741591973865e-09
to O 0 1.4928261751756544e-11
those O 0 6.1933041160811e-12
coding O 0 2.5114085810962195e-10
for O 0 1.2247110877522394e-12
properdin O 0 3.888443700361677e-08
Factor O 0 4.592428659577763e-10
B O 0 1.764538848370023e-09
allotypes O 0 1.438670871323211e-08
and O 0 2.388061970393096e-10
for O 0 5.49939538352362e-10
deficiency B-Disease 0 5.751571734435856e-07
of I-Disease 0 6.115440727601229e-13
the I-Disease 0 2.0549258475388577e-11
second I-Disease 0 2.1315672837918243e-10
component I-Disease 0 2.2151691592142697e-10
of I-Disease 0 2.4588412902981638e-12
complement I-Disease 0 8.476986224081884e-09
( O 0 1.2208198341134846e-10
C2 O 0 1.8461137187841814e-06
) O 0 6.979528066608509e-12
was O 0 2.5432487227305955e-09
studied O 0 3.0005227191765016e-09
in O 0 3.822258135000034e-11
families O 0 1.7002886945616247e-11
of O 0 2.412793229100707e-11
patients O 0 7.122371581402831e-09
with O 0 8.153485708817243e-08
connective O 1 0.9957001209259033
tissue O 1 0.9999665021896362
disorders O 1 0.996505856513977
. O 0 4.0658704847373883e-07

Patients O 0 2.188768348787562e-06
were O 0 2.2589812243012375e-09
selected O 0 4.140944254160672e-10
because O 0 7.357769393756541e-10
they O 0 1.2790324355194116e-10
were O 0 3.464167286360009e-10
heterozygous O 0 1.7245454841940955e-08
or O 0 7.502620746890898e-09
homozygous O 0 0.00014436610217671841
for O 0 9.148744720732793e-05
C2 B-Disease 1 0.9999998807907104
deficiency I-Disease 1 0.999998927116394
. O 0 3.4560736139610526e-07

12 O 0 2.2659126130974983e-08
families O 0 3.5008862475649494e-10
with O 0 7.346490776827252e-11
15 O 0 2.034879209578122e-10
matings O 0 8.772424735070672e-06
informative O 0 0.0006660100189037621
for O 0 0.015562791377305984
C2 B-Disease 1 1.0
deficiency I-Disease 1 0.9999998807907104
were O 0 1.8543697706263629e-06
found O 0 2.7992118134534394e-07
. O 0 1.3933227904772139e-08

Of O 0 6.222892423579651e-09
57 O 0 4.705212219846544e-09
informative O 0 4.5343782062445825e-08
meioses O 0 3.479927045191289e-06
, O 0 2.994430745029142e-11
two O 0 1.942182309075391e-12
crossovers O 0 5.446338491310598e-09
were O 0 1.889589151815585e-09
noted O 0 1.2894679768393758e-09
between O 0 1.0559799701326256e-09
the O 0 7.901836943347007e-05
C2 B-Disease 1 1.0
deficiency I-Disease 1 0.9999992847442627
gene O 0 3.432495532251778e-08
and O 0 2.675032972909719e-10
the O 0 1.1286000606292035e-10
HLA O 0 9.658770068199374e-07
- O 0 2.322248474229127e-05
B O 0 1.213503963981566e-07
gene O 0 6.770773941511266e-10
, O 0 6.227415501672273e-13
with O 0 2.879844800129927e-13
a O 0 5.30111328098104e-12
recombinant O 0 2.8828594025864795e-11
fraction O 0 4.142627074710248e-10
of O 0 5.2336631556348934e-11
0 O 0 8.345913293794638e-09
. O 0 1.6940274960575152e-08

035 O 0 0.019516507163643837
. O 0 3.5372734146221774e-06

A O 0 5.517066483662347e-07
lod O 0 0.0002964213490486145
score O 0 2.5527512548251252e-08
of O 0 1.939702912179264e-11
13 O 0 2.814799955619396e-11
was O 0 8.553870944894015e-10
calculated O 0 1.051867659640493e-08
for O 0 4.004951231761922e-11
linkage O 0 0.00034583182423375547
between O 0 0.026054175570607185
C2 B-Disease 1 1.0
deficiency I-Disease 1 0.9999997615814209
and O 0 3.2948967998436274e-08
HLA O 0 9.993372032113257e-07
- O 0 2.412522235317738e-06
B O 0 6.272874486512592e-08
at O 0 1.831310970923372e-11
a O 0 7.646645469594482e-12
maximum O 0 1.621375811389214e-10
likelihood O 0 2.101376295193802e-10
value O 0 1.638404689696671e-11
of O 0 1.364474126134413e-13
the O 0 3.918094418787349e-13
recombinant O 0 3.790189950086953e-12
fraction O 0 1.388363451981789e-10
of O 0 7.650222816346641e-11
0 O 0 1.2520864345333393e-08
. O 0 4.733702763104475e-09

04 O 0 0.00032498594373464584
. O 0 4.937648441227793e-07

18 O 0 6.098739646631657e-08
families O 0 1.0454187515662738e-09
with O 0 1.197371507499767e-10
21 O 0 1.9562225450631132e-10
informative O 0 6.701219579241524e-09
matings O 0 8.895141263565165e-07
for O 0 7.782385152976801e-11
both O 0 1.3502887696859034e-10
properdin O 0 1.0988651411025785e-06
Factor O 0 3.252709657175501e-09
B O 0 7.152594072579177e-09
allotype O 0 1.889481993089248e-08
and O 0 1.4182794938477628e-09
HLA O 0 1.5478250361411483e-06
- O 0 6.123704224592075e-05
B O 0 1.1923563079108135e-06
were O 0 4.093756889034239e-09
found O 0 1.9519609040230534e-08
. O 0 8.470844470309657e-09

Of O 0 4.9669273138874814e-09
72 O 0 1.1445476566507296e-08
informative O 0 4.4315701330788215e-08
meioses O 0 6.893938916618936e-06
, O 0 1.6145926262645105e-10
three O 0 4.104361989165639e-11
recombinants O 0 1.1005579381162534e-06
were O 0 8.058153255774414e-09
found O 0 4.878212944703364e-09
, O 0 3.783018169556396e-12
giving O 0 2.823488188044565e-12
a O 0 7.491269757298191e-12
recombinant O 0 2.0094688066296662e-11
fraction O 0 4.06666450514237e-10
of O 0 4.014151164244417e-11
0 O 0 9.401190048663466e-09
. O 0 1.0129304506278913e-08

042 O 0 0.00044401473132893443
. O 0 1.6649756844344665e-06

A O 0 2.530476592710329e-07
lod O 0 0.00010519978968659416
score O 0 5.093111266063488e-09
of O 0 9.345717776054752e-12
16 O 0 2.1962114418738743e-11
between O 0 7.528817153046319e-11
HLA O 0 1.3190366416893085e-06
- O 0 2.0544353901641443e-05
B O 0 5.990735019167914e-08
and O 0 5.287655036045891e-11
Factor O 0 1.1748978179237923e-10
B O 0 7.223278641887987e-10
allotypes O 0 7.537459545403635e-09
was O 0 6.669923502400366e-10
calculated O 0 2.617347005795523e-09
at O 0 1.0548235028495778e-11
a O 0 1.5264418201654806e-11
maximum O 0 2.518344699442565e-10
likelihood O 0 3.2679059458473603e-10
value O 0 6.230511245819415e-11
of O 0 1.9923652842552403e-13
the O 0 9.434114730741405e-13
recombinant O 0 1.0969202976496284e-11
fraction O 0 1.4232759415477858e-10
of O 0 5.179708398306282e-11
0 O 0 3.427122807764249e-09
. O 0 6.965919840951074e-09

04 O 0 0.0003965964133385569
. O 0 4.959754846822761e-07

A O 0 3.382277924401933e-08
crossover O 0 1.2426411899468803e-08
was O 0 3.984697016790051e-08
shown O 0 6.698203769417432e-09
to O 0 8.626910297238055e-11
have O 0 9.685597879283137e-10
occurred O 0 1.260816118175967e-09
between O 0 6.66025568030193e-12
genes O 0 3.953304697490445e-11
for O 0 1.364860047897709e-12
Factor O 0 1.2720161035595368e-10
B O 0 1.529331439265036e-09
and O 0 7.126305795468468e-11
HLA O 0 1.6019353665797098e-07
- O 0 1.918236921483185e-05
D O 0 0.0003194221935700625
, O 0 1.3565711921847967e-11
in O 0 1.4935639530699873e-11
which O 0 1.8642426491410902e-10
HLA O 0 3.577317500003119e-07
- O 0 6.043740086170146e-06
D O 0 7.880616612965241e-05
segregared O 0 2.2334208438223868e-07
with O 0 1.6253577650449103e-10
HLA O 0 2.1645428205374628e-07
- O 0 9.96091671368049e-07
A O 0 1.8707456206357165e-07
and O 0 3.3953799771779813e-08
B O 0 1.8271659030233423e-07
. O 0 1.8000210211255308e-09

These O 0 4.510447570993392e-09
studies O 0 2.9370652576687917e-09
suggest O 0 2.6591069346437735e-09
that O 0 3.1530278388203214e-11
the O 0 1.3448229075480045e-12
genes O 0 2.4421844754818345e-11
for O 0 8.508430938969358e-12
Factor O 0 3.466781706151778e-08
B O 0 8.696984878042713e-05
and O 0 0.038296859711408615
C2 B-Disease 1 1.0
deficiency I-Disease 1 0.9999998807907104
are O 0 1.9862416156257723e-09
located O 0 2.348224115156228e-10
outside O 0 2.950708288818049e-10
those O 0 2.3174944602244452e-11
for O 0 6.529316583930855e-12
HLA O 0 2.666660847694402e-08
, O 0 1.8659990219660472e-11
that O 0 1.80515220826738e-11
the O 0 2.623891121739108e-12
order O 0 5.500207927999767e-12
of O 0 7.695260986588515e-13
genese O 0 2.6339751713067017e-08
is O 0 1.9601406608948935e-10
HLA O 0 1.2062575827087585e-08
- O 0 1.3098052420446038e-07
A O 0 1.1260257792855555e-07
, O 0 4.6245823837054445e-10
- O 0 7.474505423488154e-07
B O 0 5.313169992859912e-08
, O 0 2.4158461689460786e-11
- O 0 7.323166073547327e-08
D O 0 1.5085244058354874e-06
, O 0 4.0708508612652405e-12
Factor O 0 2.499647711040609e-10
B O 0 1.1918313447267792e-08
allotype O 0 1.5634286683052778e-05
, O 0 3.841724264930235e-06
C2 B-Disease 1 0.9999998807907104
deficiency I-Disease 1 0.9999994039535522
, O 0 3.4215741351317774e-11
that O 0 6.4293032703277575e-12
the O 0 7.132801727732785e-12
genes O 0 1.1983957159955594e-09
coding O 0 2.565281249644613e-07
for O 0 3.587184664866072e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 0.9999996423721313
and O 0 6.555882503533894e-09
Factor O 0 2.7748552344775135e-09
B O 0 4.232747041754692e-09
allotypes O 0 1.3518697272729696e-08
are O 0 1.4426530282884986e-11
approximately O 0 2.2416033872846297e-12
3 O 0 8.876475075803025e-12
- O 0 4.985628621057003e-08
- O 0 1.7676867969385057e-07
5 O 0 1.845174360526336e-11
centimorgans O 0 2.825119027605183e-09
from O 0 2.0765715535997487e-12
the O 0 6.992146445172764e-12
HLA O 0 3.3582345793092827e-09
- O 0 1.4265441272698354e-08
A O 0 8.150667696327218e-09
and O 0 3.777918422542825e-09
HLA O 0 3.591322013107856e-07
- O 0 5.632650186271349e-07
B O 0 7.159732806627517e-09
loci O 0 1.573831065471154e-10
, O 0 1.0381372844703307e-11
and O 0 1.4202272170804608e-11
that O 0 9.710114656780178e-12
the O 0 2.5886764520172134e-12
apparent O 0 1.477796729432157e-08
lack O 0 2.476111538030068e-10
of O 0 1.3377084813123719e-12
recombinants O 0 1.078370015505925e-08
between O 0 1.578785192857257e-11
the O 0 1.7687119130416207e-11
Factor O 0 1.3000548415575963e-09
B O 0 4.159550570648207e-08
gene O 0 1.9442141763192922e-07
and O 0 0.002514451742172241
C2 B-Disease 1 1.0
deficiency I-Disease 1 0.9999996423721313
gene O 0 1.6886181128938915e-06
suggests O 0 4.9024393433683144e-08
that O 0 4.154200594630453e-11
these O 0 2.326066856489506e-12
two O 0 1.4912893836482866e-11
genes O 0 6.130506768897703e-09
lie O 0 4.540524059848394e-06
in O 0 2.805475296518978e-10
close O 0 3.585112429149717e-09
proximity O 0 8.633799453150459e-09
to O 0 7.788595879354432e-10
one O 0 8.481769731005784e-10
another O 0 3.917063562397516e-09
. O 0 1.4706545314879804e-08

Distribution O 0 3.1574501235809294e-08
of O 0 1.8064655327165724e-10
emerin O 0 1.6263661564153153e-06
and O 0 5.883754372604244e-09
lamins O 0 6.729562301188707e-05
in O 0 5.973181949059381e-10
the O 0 6.472262170653664e-10
heart O 0 3.013251159700303e-07
and O 0 5.528791313658132e-10
implications O 0 3.3776796914963825e-09
for O 0 2.490363193441425e-10
Emery B-Disease 0 0.00015796345542185009
- I-Disease 1 0.9811325669288635
Dreifuss I-Disease 1 0.9997754693031311
muscular I-Disease 1 0.9996150732040405
dystrophy I-Disease 1 0.9994258880615234
. O 0 7.357038498412294e-07

Emerin O 0 0.0002743801160249859
is O 0 7.399119983375613e-09
a O 0 2.590828884763141e-09
nuclear O 0 9.16033798148419e-07
membrane O 0 6.602868296567976e-08
protein O 0 8.52543202700673e-10
which O 0 2.2632884455475732e-10
is O 0 2.9718888461260917e-10
missing O 0 1.1446524617042542e-08
or O 0 8.245801375039719e-09
defective O 0 1.3813427358400077e-05
in O 0 1.90929103638382e-08
Emery B-Disease 0 0.1665734201669693
- I-Disease 1 0.9999691247940063
Dreifuss I-Disease 1 0.9999854564666748
muscular I-Disease 1 0.9999674558639526
dystrophy I-Disease 1 0.9999502897262573
( O 0 2.0871354990958935e-06
EDMD B-Disease 1 0.9999957084655762
) O 0 4.202486181270615e-08
. O 0 1.767881663283788e-08

It O 0 2.4158547162755895e-08
is O 0 3.3956937262047404e-10
one O 0 4.359997085590095e-11
member O 0 8.710069991646474e-12
of O 0 1.0896213402042387e-12
a O 0 3.737608000875525e-10
family O 0 1.4394605507561664e-09
of O 0 8.777517601643581e-11
lamina O 0 0.0021535984706133604
- O 0 0.0009935915004462004
associated O 0 2.739102740179078e-07
proteins O 0 3.2896063650866836e-10
which O 0 1.1055045767704996e-11
includes O 0 2.49204389762836e-11
LAP1 O 0 9.275426009480725e-07
, O 0 1.0347257772824747e-10
LAP2 O 0 1.4296133485913742e-06
and O 0 4.394347996594661e-09
lamin O 0 7.148101576603949e-05
B O 0 1.3734788808505982e-06
receptor O 0 1.7043929290139204e-07
( O 0 4.5693990813333585e-09
LBR O 0 0.04249840974807739
) O 0 1.4946455184627894e-09
. O 0 4.646387274931385e-09

A O 0 8.286656338896137e-08
panel O 0 1.2529272730432695e-08
of O 0 8.318379318694724e-11
16 O 0 2.5727897590144266e-10
monoclonal O 0 1.902689206190189e-08
antibodies O 0 1.535185134571293e-07
( O 0 7.309201160987655e-11
mAbs O 0 3.378512403173772e-08
) O 0 2.7836098009936805e-11
has O 0 2.1761308033330096e-10
been O 0 1.742045535602088e-10
mapped O 0 2.598861215119541e-07
to O 0 5.149869419796005e-11
six O 0 1.2628148526871996e-11
specific O 0 1.558779320898207e-11
sites O 0 3.680586391219265e-11
throughout O 0 8.106160707954668e-12
the O 0 9.530153576020606e-12
emerin O 0 6.520751938410285e-09
molecule O 0 4.0483075225417053e-10
using O 0 1.1592778126345848e-10
phage O 0 1.546114347661387e-08
- O 0 6.665936069794043e-08
displayed O 0 4.12351432999003e-08
peptide O 0 2.3407393801022636e-09
libraries O 0 5.7476159248670555e-11
and O 0 9.687698560023605e-11
has O 0 4.7467987873694995e-11
been O 0 1.1100071382885712e-11
used O 0 5.564578658967534e-11
to O 0 1.11598300045479e-11
localize O 0 1.2873520915945846e-07
emerin O 0 5.1925931074947584e-06
in O 0 1.6080625719894215e-09
human O 0 2.5893616140137965e-09
and O 0 7.364582277347154e-09
rabbit O 0 0.00017458744696341455
heart O 0 3.5591561754699796e-05
. O 0 4.4382783670471326e-08

Several O 0 8.601976908551023e-09
mAbs O 0 3.461430537754495e-07
against O 0 2.891789474546158e-09
different O 0 3.867972331317304e-10
emerin O 0 3.148026507915347e-06
epitopes O 0 3.6758639907930046e-05
did O 0 7.301979110252432e-08
not O 0 6.078064163084207e-10
recognize O 0 2.0211023965543973e-09
intercalated O 0 2.101590723668778e-08
discs O 0 3.2579956155132095e-07
in O 0 3.692541827859941e-10
the O 0 2.6462101399005178e-09
heart O 0 9.717869033920579e-06
, O 0 8.470658202641701e-11
though O 0 4.2993436588645295e-10
they O 0 2.188614289799773e-10
recognized O 0 3.4779379376459474e-10
cardiomyocyte O 0 1.3090446771002462e-07
nuclei O 0 2.663616669451585e-07
strongly O 0 1.346309108640753e-08
, O 0 9.358400339387618e-12
both O 0 1.0707849537605618e-11
at O 0 3.418314520331478e-10
the O 0 1.4824157526516224e-11
rim O 0 1.648971514889297e-09
and O 0 5.200152530804303e-10
in O 0 1.4584849994392357e-10
intranuclear O 0 2.523656519315409e-07
spots O 0 3.6631671918030406e-08
or O 0 2.2454837989016596e-09
channels O 0 1.1200277150180682e-08
. O 0 1.508312230669162e-08

A O 0 2.0832253255775868e-07
polyclonal O 0 4.765884568769252e-06
rabbit O 0 2.455784397170646e-06
antiserum O 0 2.325454033780261e-06
against O 0 9.82957537587481e-09
emerin O 0 1.14264958028798e-05
did O 0 6.141534214521016e-08
recognize O 0 6.2082392560114386e-09
both O 0 1.421431167214493e-10
nuclear O 0 3.8128499113554426e-07
membrane O 0 1.8680673008475424e-08
and O 0 5.916984124887392e-10
intercalated O 0 1.887418044077549e-08
discs O 0 1.47952903262194e-07
but O 0 5.901047983591923e-10
, O 0 8.473881318860066e-13
after O 0 1.4122523680007437e-12
affinity O 0 2.1507441660961746e-11
purification O 0 4.418751128887344e-11
against O 0 4.393430064197901e-11
a O 0 2.0599577599256236e-10
pure O 0 4.1061536393272036e-08
- O 0 1.2609410987352021e-05
emerin O 0 1.561183694320789e-06
band O 0 4.664962305334086e-10
on O 0 3.128455133838415e-11
a O 0 6.252606765677626e-11
western O 0 9.907397124919726e-11
blot O 0 4.971516773366602e-06
, O 0 1.7187412604258157e-10
it O 0 1.8012563662850312e-10
stained O 0 2.6955160137731582e-05
only O 0 3.523844549491173e-10
the O 0 2.6339924685814253e-10
nuclear O 0 2.460951691318769e-06
membrane O 0 1.6451687656626746e-07
. O 0 6.207055314177978e-09

These O 0 4.281547116846696e-09
results O 0 1.2025681783711661e-08
would O 0 1.0798514304966034e-09
not O 0 7.572006216483018e-11
be O 0 6.981674960382378e-11
expected O 0 1.5098421124459804e-10
if O 0 2.70976824312541e-10
immunostaining O 0 3.261657255393402e-08
at O 0 2.6482890880252796e-10
intercalated O 0 6.580135103462226e-09
discs O 0 2.3992049591470277e-07
were O 0 3.0598661382441605e-09
due O 0 3.5427752398398127e-10
to O 0 3.845774393385071e-12
a O 0 4.0712100357609415e-11
product O 0 1.2717420172503324e-10
of O 0 4.836964704636737e-13
the O 0 1.1979328119748889e-11
emerin O 0 1.482999749669034e-07
gene O 0 2.8245157324136017e-09
and O 0 7.270744561971298e-10
, O 0 4.120834923293515e-11
therefore O 0 2.4518939656381633e-10
, O 0 4.625298625007823e-13
cast O 0 1.1804903408962897e-11
some O 0 5.484051797746692e-13
doubt O 0 1.4628616373801862e-10
upon O 0 5.2825413314472325e-12
the O 0 1.5949930612380037e-11
hypothesis O 0 1.124604409596941e-08
that O 0 6.259521789786504e-09
cardiac B-Disease 0 0.0004214470973238349
defects I-Disease 1 0.9949579834938049
in O 0 1.3052156191406539e-06
EDMD B-Disease 1 1.0
are O 0 7.843028129173035e-07
caused O 0 3.6541101167131274e-07
by O 0 3.6654140833647375e-10
absence O 0 8.279100960351116e-09
of O 0 6.589171569482133e-11
emerin O 0 3.2981370168272406e-06
from O 0 1.641828673015766e-09
intercalated O 0 1.6077344753284706e-06
discs O 0 4.934343905915739e-06
. O 0 8.406142448791343e-09

Although O 0 1.64037928129801e-07
emerin O 0 3.7634363252436742e-06
was O 0 3.2775018254938004e-09
abundant O 0 3.3849656411177875e-10
in O 0 3.981287521881427e-11
the O 0 3.2178537612281843e-11
membranes O 0 6.025825172173427e-08
of O 0 2.271365560913008e-11
cardiomyocyte O 0 1.5561073496428435e-06
nuclei O 0 1.8650786159923882e-06
, O 0 9.706898479455717e-11
it O 0 5.885308212993934e-11
was O 0 1.7269375929274133e-09
absent O 0 1.3436968204771915e-09
from O 0 4.600507041291335e-12
many O 0 2.9924767091377147e-12
non O 0 8.871778311991818e-10
- O 0 4.135857807341381e-07
myocyte O 0 6.569516131094133e-07
cells O 0 5.250085255426029e-09
in O 0 1.2960088557889549e-10
the O 0 1.170224028790301e-09
heart O 0 1.6938553244472132e-06
. O 0 1.3938012521919063e-08

This O 0 9.658626121122893e-10
distribution O 0 8.956923397418493e-11
of O 0 8.095297869548101e-12
emerin O 0 1.9512629023665795e-06
was O 0 8.246572313908018e-09
similar O 0 2.8811733554512386e-10
to O 0 3.466954848208026e-11
that O 0 1.1426749130238889e-10
of O 0 5.351604142472821e-12
lamin O 0 1.0198939435213106e-06
A O 0 3.050270436233404e-08
, O 0 1.6135882560663894e-11
a O 0 3.552761210223743e-11
candidate O 0 2.2502730789852876e-09
gene O 0 4.018121391169416e-10
for O 0 9.103055982617736e-12
an O 0 2.1042559361639235e-10
autosomal O 0 0.0005475964862853289
form O 0 1.0655472806320176e-06
of O 0 5.564224920817651e-07
EDMD B-Disease 1 0.9999996423721313
. O 0 1.0526633786867023e-06

In O 0 6.472157565440284e-08
contrast O 0 1.375430656480603e-06
, O 0 5.202417163729933e-09
lamin O 0 0.0007777306018397212
B1 O 1 0.6353558301925659
was O 0 2.2179199277161388e-07
absent O 0 1.4134678316679583e-08
from O 0 4.0498653042231325e-11
cardiomyocyte O 0 1.605943111826491e-07
nuclei O 0 1.7787938588753605e-07
, O 0 1.0592650888374688e-11
showing O 0 2.6902888805580005e-08
that O 0 6.190361112601295e-09
lamin O 0 0.0001661306305322796
B1 O 0 0.06689964234828949
is O 0 2.889633643476941e-09
not O 0 1.1388325005246003e-10
essential O 0 4.282684016448934e-12
for O 0 3.2657264479457604e-13
localization O 0 1.6942229563721156e-10
of O 0 1.1840390863951389e-12
emerin O 0 9.372708120736206e-08
to O 0 1.9409250595625593e-10
the O 0 1.3247433150453958e-09
nuclear O 0 4.6982393541838974e-05
lamina O 0 2.7123021936859004e-05
. O 0 8.352378344511635e-09

Lamin O 1 0.90340256690979
B1 O 1 0.9948260188102722
is O 0 2.977189126340818e-07
also O 0 2.7748869868560178e-09
almost O 0 9.788970745105985e-10
completely O 0 3.4103337043234205e-08
absent O 0 2.353365289309295e-07
from O 0 5.541811454179424e-09
skeletal O 0 0.0009123359341174364
muscle O 0 3.3510652428958565e-05
nuclei O 0 0.00032112805638462305
. O 0 4.913185236432582e-08

In O 0 1.2218924894114025e-06
EDMD B-Disease 1 0.9999697208404541
, O 0 3.6265129788048966e-10
the O 0 6.346926022943178e-12
additional O 0 1.3752742868133883e-11
absence O 0 1.0127174654428472e-09
of O 0 2.544397192938419e-10
lamin O 0 0.002177703892812133
B1 O 0 0.06483324617147446
from O 0 7.402253476840315e-09
heart O 0 2.284589754708577e-05
and O 0 6.23972482571844e-08
skeletal O 0 0.0020663796458393335
muscle O 0 5.983808932796819e-06
nuclei O 0 3.2972453482216224e-05
which O 0 1.7607339586334092e-08
already O 0 8.643684878961722e-09
lack O 0 6.831239129923006e-09
emerin O 0 8.150481335178483e-06
may O 0 7.600823082043462e-09
offer O 0 4.0168934151152413e-11
an O 0 9.73651931648889e-13
alternative O 0 1.471126345742313e-11
explanation O 0 2.1121412951963237e-10
of O 0 2.3014418062267117e-12
why O 0 1.4602782316686103e-09
these O 0 1.9162711348275074e-11
tissues O 0 1.7396100560063132e-08
are O 0 7.18820003520193e-11
particularly O 0 3.39071859478679e-09
affected O 0 1.6372566635780572e-09
. O 0 5.293096516645335e-10
. O 0 2.859053216397456e-09

Genetic O 0 1.2709238944808021e-05
mapping O 0 7.819667189323809e-07
of O 0 1.2692586981444265e-09
the O 0 7.1059940154327705e-09
copper B-Disease 0 0.008983089588582516
toxicosis I-Disease 0 0.07750009745359421
locus O 0 2.55818690675369e-06
in O 0 2.23713048086438e-09
Bedlington O 0 5.979894922347739e-06
terriers O 0 1.0801940334204119e-05
to O 0 1.3594217973533773e-09
dog O 0 0.00015547778457403183
chromosome O 0 7.039985939627513e-05
10 O 0 1.190644111082051e-10
, O 0 6.517943736822351e-12
in O 0 2.0027268038402823e-11
a O 0 1.7675165775443702e-09
region O 0 3.7030101207591315e-09
syntenic O 0 2.6889965738519095e-06
to O 0 4.2982284398362935e-10
human O 0 1.3590465641755145e-08
chromosome O 0 8.80146944837179e-06
region O 0 4.312463985911563e-08
2p13 O 0 1.4333155604617787e-06
- O 0 9.742961083247792e-06
p16 O 0 7.800435355420632e-07
. O 0 1.0544589201799681e-08

Abnormal O 1 0.9632904529571533
hepatic B-Disease 1 0.9722930192947388
copper I-Disease 0 0.04180312901735306
accumulation I-Disease 0 5.6335778936045244e-05
is O 0 2.6576314482440466e-09
recognized O 0 9.257304922627441e-10
as O 0 1.404169142071865e-10
an O 0 1.9900693359886645e-07
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 0 1.8295510244570323e-06
man O 0 0.0005658417358063161
, O 0 1.467469895599649e-10
mouse O 0 1.589337159657589e-07
, O 0 1.9879421719881663e-10
rat O 0 7.787125468894374e-06
and O 0 1.0000569261592318e-08
dog O 0 4.748942592414096e-05
. O 0 1.4779516277485527e-08

The O 0 1.1553520806728557e-08
major O 0 1.3043972124648917e-08
cause O 0 1.7661837148352788e-07
of O 0 4.04832306566405e-10
hepatic B-Disease 0 0.0029054482001811266
copper I-Disease 0 0.40598970651626587
accumulation I-Disease 0 7.407405064441264e-05
in O 0 7.3489085927747055e-09
man O 0 8.02792601461988e-06
is O 0 4.421864263637332e-10
a O 0 2.666059373268581e-09
dysfunctional O 0 2.0453817342058755e-06
ATP7B O 0 5.593898458755575e-05
gene O 0 4.266777580141934e-07
, O 0 2.9103537357855203e-09
causing O 0 6.150857643660856e-06
Wilson B-Disease 0 0.1134653314948082
disease I-Disease 0 0.0004867530078627169
( O 0 1.1023394641540563e-08
WD B-Disease 0 0.3895217478275299
) O 0 1.0976565434361873e-08
. O 0 7.514149302778605e-09

Mutations O 0 0.0004135200579185039
in O 0 6.499518701019724e-09
the O 0 3.6277719717148216e-10
ATP7B O 0 6.22765946900472e-05
genes O 0 1.0048947984842016e-07
have O 0 7.069695495687256e-09
also O 0 4.723328395073167e-10
been O 0 9.738799766623174e-10
demonstrated O 0 1.2746451893974609e-08
in O 0 2.6049248869064456e-10
mouse O 0 9.987360272134538e-07
and O 0 8.412593643924993e-08
rat O 0 0.00029776192968711257
. O 0 3.25864775163609e-08

The O 0 1.1595200355429824e-08
ATP7B O 0 6.133484930614941e-06
gene O 0 6.813531427951602e-08
has O 0 1.9101134007826204e-09
been O 0 1.64766283949902e-10
excluded O 0 5.090864951817764e-10
in O 0 7.294657065892718e-12
the O 0 3.878140863999846e-12
much O 0 7.980417993103117e-10
rarer O 0 2.4757582650636323e-06
human O 0 2.050274616749448e-07
copper B-Disease 0 0.4414251744747162
overload I-Disease 0 0.08313582837581635
disease O 0 5.001275894755963e-06
non B-Disease 0 3.1776288267337804e-08
- I-Disease 0 0.00014582573203369975
Indian I-Disease 0 4.4861007353347304e-08
childhood I-Disease 0 0.0005940103437751532
cirrhosis I-Disease 0 2.0896568457828835e-05
, O 0 3.743915177878421e-10
indicating O 0 6.481064218633037e-08
genetic O 0 3.7611832226502884e-07
heterogeneity O 0 4.559860371955438e-06
. O 0 8.11473057638068e-08

By O 0 4.089947935881355e-09
investigating O 0 3.863824460381693e-08
the O 0 8.651268035286819e-10
common O 0 2.2483784789528727e-07
autosomal O 1 0.998451828956604
recessive O 1 0.9997956156730652
copper B-Disease 1 0.9997566342353821
toxicosis I-Disease 1 0.9995187520980835
( O 0 7.706556282016663e-09
CT B-Disease 0 0.0005830205045640469
) O 0 5.987117052130841e-11
in O 0 6.278083608535212e-11
Bedlington O 0 2.6539912596490467e-06
terriers O 0 0.00048448293819092214
, O 0 5.5263162934693355e-09
we O 0 6.694793608374994e-09
have O 0 9.852127447196324e-11
identified O 0 2.9505226040171806e-10
a O 0 3.1308785425343544e-11
new O 0 2.1154382065513566e-11
locus O 0 1.6621717335851827e-08
involved O 0 3.276296922649635e-08
in O 0 2.1831719720921683e-07
progressive O 1 0.991295576095581
liver B-Disease 1 0.9999998807907104
disease I-Disease 1 0.9999988079071045
. O 0 1.0532468195378897e-06

We O 0 2.0391246380313532e-07
examined O 0 1.5422273236254114e-07
whether O 0 1.5890310178789946e-09
the O 0 3.611382581869549e-10
WD B-Disease 0 0.000597603851929307
gene O 0 4.616461524165061e-07
ATP7B O 0 0.00013213670172262937
was O 0 2.1621655577064303e-08
also O 0 6.630168636334588e-11
causative O 0 1.2905118751405098e-08
for O 0 1.1778903373504956e-11
CT B-Disease 0 1.897647416626569e-05
by O 0 4.1329903388565015e-10
investigating O 0 1.399349116582016e-07
the O 0 1.5376849793469205e-09
chromosomal O 0 0.0010629567550495267
co O 0 1.159736257250188e-05
- O 0 1.691508032308775e-06
localization O 0 1.2956202510849835e-07
of O 0 1.3608213514371137e-11
ATP7B O 0 3.021883912879275e-06
and O 0 1.0054398980052781e-10
C04107 O 0 6.795900509004582e-10
, O 0 5.332954130382594e-13
using O 0 1.2580068063650085e-11
fluorescence O 0 4.6632145256353397e-08
in O 0 1.4744729048832284e-10
situ O 0 1.5862731572724442e-08
hybridization O 0 6.699967247669747e-09
( O 0 6.553649983809251e-11
FISH O 0 9.391333044561634e-09
) O 0 1.4107838508525816e-10
. O 0 1.61512325735913e-09

C04107 O 0 1.420593343937071e-05
is O 0 5.34272937002811e-09
an O 0 5.67355086522614e-11
anonymous O 0 3.0367084402627142e-09
microsatellite O 0 1.1838870705105364e-05
marker O 0 1.571194843563717e-05
closely O 0 2.023716433541267e-06
linked O 0 1.0308097444067243e-05
to O 0 2.3217454625523715e-08
CT B-Disease 1 0.8538438677787781
. O 0 1.8260544720760663e-07

However O 0 3.2199343991123897e-07
, O 0 8.93859875006342e-10
BAC O 0 3.737084739441343e-07
clones O 0 3.428779038472385e-08
containing O 0 3.6507934453311464e-08
ATP7B O 0 1.3450327060127165e-05
and O 0 7.078704844509787e-10
C04107 O 0 5.031710603731199e-09
mapped O 0 3.127392176338617e-07
to O 0 7.811249563838274e-11
the O 0 1.9349002955415529e-10
canine O 0 1.1028904737031553e-05
chromosome O 0 1.4392945558938663e-05
regions O 0 6.862175716548791e-09
CFA22q11 O 0 2.201744337071432e-06
and O 0 2.8623707848396407e-09
CFA10q26 O 0 1.4497464917440084e-06
, O 0 6.4082364414908e-11
respectively O 0 6.066875335442035e-10
, O 0 4.043125643310441e-12
demonstrating O 0 1.8103217536147298e-10
that O 0 5.073513276165897e-10
WD B-Disease 0 0.0007845896761864424
cannot O 0 2.092124731234435e-07
be O 0 1.2034251373194138e-10
homologous O 0 2.5457480568036317e-09
to O 0 2.5463018360483147e-09
CT B-Disease 0 0.04007071629166603
. O 0 1.0555499585507278e-07

The O 0 1.0448416531971816e-07
copper O 0 6.021326043992303e-06
transport O 0 9.022843805439607e-09
genes O 0 4.72945149709858e-09
CTR1 O 0 2.2643976080871653e-06
and O 0 3.812752780163464e-09
CTR2 O 0 3.0669656553072855e-05
were O 0 3.311730445432204e-09
also O 0 6.395549367876896e-11
excluded O 0 1.0040236697594906e-10
as O 0 4.838461228895419e-12
candidate O 0 2.028663348419002e-10
genes O 0 7.885091884984874e-11
for O 0 8.787664172726917e-12
CT B-Disease 0 0.0002812119200825691
since O 0 4.381344709258883e-08
they O 0 7.486987418925395e-11
both O 0 1.0085104626411656e-11
mapped O 0 1.5016491943242727e-06
to O 0 2.051802505675937e-09
canine O 0 0.0005394767504185438
chromosome O 0 0.0005428243312053382
region O 0 3.0960728736317833e-07
CFA11q22 O 0 7.063583325361833e-05
. O 0 1.0314109744058442e-07

2 O 0 5.700144356524106e-07
- O 0 3.3943277230719104e-05
22 O 0 1.4670740178246433e-08
. O 0 5.833180605208099e-09

5 O 0 1.1106292276963359e-06
. O 0 1.684785075894979e-07

A O 0 5.1305828918657426e-08
transcribed O 0 1.4427178030018695e-07
sequence O 0 8.45205860855458e-09
identified O 0 7.721299155605266e-09
from O 0 1.8839255242625308e-12
the O 0 1.1232478488998332e-11
C04107 O 0 1.6336764829816275e-08
- O 0 2.0388834798268363e-07
containing O 0 8.291177522323778e-08
BAC O 0 3.7843935842829524e-06
was O 0 1.3631717976636537e-08
found O 0 3.638471191003134e-10
to O 0 1.1536810569368061e-11
be O 0 1.116858758254402e-10
homologous O 0 1.7810930508233014e-10
to O 0 2.2709887789740257e-11
a O 0 3.3191149828581956e-10
gene O 0 3.124868142023729e-09
expressed O 0 1.2748871403012174e-10
from O 0 1.2367374485622307e-11
human O 0 4.866677616455206e-10
chromosome O 0 3.711862746058614e-07
2p13 O 0 4.110604834295373e-08
- O 0 7.987016488186782e-07
p16 O 0 1.9902016035189263e-08
, O 0 2.2940187943687462e-11
a O 0 2.1881342571195006e-10
region O 0 7.099907328722566e-10
devoid O 0 3.4428815354203834e-08
of O 0 1.6692182575397951e-12
any O 0 7.735560803023844e-11
positional O 0 4.8878735725566e-08
candidate O 0 1.8178012339831184e-07
genes O 0 6.713951705705767e-08
. O 0 1.2546562899728997e-08

Molecular O 0 1.0407058653072454e-05
analysis O 0 4.7824936899587556e-08
of O 0 2.3812288946212234e-11
the O 0 3.778729065762043e-11
APC B-Disease 0 4.5973735929294435e-09
gene O 0 7.111318756081175e-10
in O 0 4.776825462959877e-11
205 O 0 7.834272813811438e-11
families O 0 8.91033705152644e-11
: O 0 4.2628664487232015e-11
extended O 0 1.751351508261223e-09
genotype O 0 0.00023344169312622398
- O 0 4.719398566521704e-05
phenotype O 0 4.325976988184266e-06
correlations O 0 6.019048441885388e-07
in O 0 5.073745867889556e-10
FAP B-Disease 0 1.4657707048115753e-08
and O 0 1.1262776822285048e-10
evidence O 0 3.128611814062765e-10
for O 0 3.385104262870753e-12
the O 0 2.0736110311475597e-12
role O 0 2.955359221235021e-11
of O 0 4.262506146657241e-12
APC B-Disease 0 3.244437607463624e-09
amino O 0 1.5446979806377215e-10
acid O 0 4.832388378339658e-10
changes O 0 1.4703958051143218e-09
in O 0 3.26359695463907e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
predisposition O 1 0.9910616874694824
. O 0 5.119829893374117e-07

BACKGROUND O 0 0.0002131493529304862
/ O 0 5.563609875025577e-07
AIMS O 0 1.6657326185054444e-08
The O 0 5.991812601635615e-11
development O 0 2.429289269745283e-10
of O 0 1.5945201994327363e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 2.352194172772215e-07
a O 0 1.009027617016045e-08
variable O 0 3.765637188735127e-07
range O 0 1.3708210122587161e-09
of O 0 5.3171664987639033e-11
extracolonic O 0 3.7219062505755574e-05
manifestations O 0 6.668936839560047e-05
in O 0 2.813980700011598e-06
familial B-Disease 1 0.9999997615814209
adenomatous I-Disease 1 0.9999949932098389
polyposis I-Disease 1 0.9999996423721313
( O 0 2.971513026750472e-07
FAP B-Disease 0 3.688196557050105e-06
) O 0 2.648733732346642e-10
is O 0 3.646194804418634e-11
the O 0 3.648753174601005e-12
result O 0 4.76505279678463e-10
of O 0 2.6403577674943834e-12
the O 0 3.36263655809077e-10
dominant O 0 1.4949275737308199e-06
inheritance O 0 0.00010441157064633444
of O 0 3.3254598292842275e-06
adenomatous B-Disease 1 0.9999983310699463
polyposis I-Disease 1 0.9999827146530151
coli I-Disease 1 0.9999947547912598
( O 0 1.3869122028609127e-07
APC B-Disease 0 6.768352136532485e-07
) O 0 8.702141229832705e-10
gene O 0 1.875901460834939e-07
mutations O 0 1.0300942449248396e-05
. O 0 7.287273717793141e-08

In O 0 1.1128855170738916e-08
this O 0 1.2561277018541261e-10
study O 0 8.367135456710528e-11
, O 0 1.2346579921634904e-12
direct O 0 2.906090819376761e-11
mutation O 0 1.548690953256937e-08
analysis O 0 9.604739920066052e-11
of O 0 9.89379043102312e-13
the O 0 2.7622319362374803e-11
APC B-Disease 0 1.9947001828057864e-09
gene O 0 8.765409509337019e-10
was O 0 2.078571759156489e-09
performed O 0 3.5592948033347227e-10
to O 0 1.7287683437561263e-11
determine O 0 2.2467752103239036e-07
genotype O 0 0.0025223870761692524
- O 0 2.5172383175231516e-05
phenotype O 0 1.334139597020112e-06
correlations O 0 3.7913906680842047e-08
for O 0 3.223788250239501e-11
nine O 0 1.1752047945901012e-10
extracolonic O 0 2.7302434091325267e-07
manifestations O 0 1.780056351208259e-07
and O 0 2.4169213852509586e-10
to O 0 1.9445927507133476e-11
investigate O 0 3.813254600970595e-09
the O 0 2.951464184164365e-09
incidence O 0 1.4653308426204603e-05
of O 0 7.573854737819019e-11
APC B-Disease 0 7.194327622528363e-08
mutations O 0 2.903414610955224e-07
in O 0 2.8336026858255536e-09
non O 0 4.5174083425081335e-06
- O 1 0.999876856803894
FAP O 1 0.9999431371688843
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999995231628418
. O 0 4.630245257430943e-06

METHODS O 0 4.5850592300666904e-07
The O 0 1.01393127227567e-09
APC B-Disease 0 2.168294166438045e-08
gene O 0 9.983379456457442e-09
was O 0 8.223008385321862e-10
analysed O 0 3.778538371079776e-09
in O 0 3.964979386483769e-11
190 O 0 2.91936891327893e-11
unrelated O 0 3.739877740827069e-09
FAP B-Disease 0 8.633276138425572e-08
and O 0 1.5057591840061946e-09
15 O 0 8.293574160767037e-10
non O 0 1.0682165907383023e-07
- O 1 0.9972148537635803
FAP O 1 0.9997959733009338
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999995231628418
patients O 0 4.6589826752096997e-07
using O 0 2.25540475184971e-08
denaturing O 0 3.4195232728961855e-05
gradient O 0 2.5881125111482106e-05
gel O 0 2.7054667953052558e-05
electrophoresis O 0 6.16500756223104e-07
, O 0 7.190256723355049e-11
the O 0 6.331497826028709e-12
protein O 0 1.531257065590097e-10
truncation O 0 7.082895159271629e-09
test O 0 8.77066508309099e-09
, O 0 7.137810308088799e-12
and O 0 3.717618660831201e-12
direct O 0 1.2105294544539902e-10
sequencing O 0 1.0839211306290508e-08
. O 0 4.421824684186504e-09

RESULTS O 0 2.14008196053328e-05
Chain O 0 6.994153523010027e-07
terminating O 0 1.8280019276062376e-08
signals O 0 6.480692604782234e-08
were O 0 1.9980690713072846e-10
only O 0 3.2994326021329456e-11
identified O 0 1.4809795167991524e-08
in O 0 4.768225259077497e-10
patients O 0 3.2300367935889085e-10
belonging O 0 2.3008264182777793e-09
to O 0 1.549593509064806e-10
the O 0 3.816308657977885e-10
FAP B-Disease 0 7.449464334285949e-08
group O 0 8.21072043688531e-10
( O 0 1.278300122004028e-11
105 O 0 1.7454912515368903e-10
patients O 0 1.427411633336817e-09
) O 0 3.087954059122211e-10
. O 0 4.578733836524407e-09

Amino O 0 7.140682782846852e-07
acid O 0 2.3979321639444606e-08
changes O 0 1.311726727237783e-09
were O 0 3.8289149628667474e-10
identified O 0 1.6723223694725675e-08
in O 0 8.349089475334637e-11
four O 0 4.123273944500738e-10
patients O 0 1.2390549697371966e-09
, O 0 4.36806840697912e-12
three O 0 8.110269725768171e-13
of O 0 1.841432605356741e-12
whom O 0 2.3360564593843947e-09
belonged O 0 1.2422383122157044e-08
to O 0 4.959926566683315e-11
the O 0 8.298175341314717e-11
non O 0 1.5446045553701993e-09
- O 0 7.703031883465883e-07
FAP O 0 1.9732404155092809e-07
group O 0 7.950991864902335e-09
of O 0 1.3885920679967967e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
patients O 0 0.0001981849636649713
. O 0 1.4890044042203954e-07

Genotype O 1 0.990818440914154
- O 0 0.08937227725982666
phenotype O 0 0.0036948639899492264
correlations O 0 4.2610517994035035e-05
identified O 0 2.797815795929637e-06
significant O 0 1.9955269436877643e-08
differences O 0 4.975814135832479e-06
in O 0 1.2906908875010004e-09
the O 0 1.600409249569168e-10
nature O 0 1.8188089923043549e-09
of O 0 2.4617226659917613e-12
certain O 0 1.41906361661448e-10
extracolonic O 0 8.32940031614271e-07
manifestations O 0 2.3196523102342326e-07
in O 0 1.3326604264563002e-09
FAP B-Disease 0 2.9191289740992943e-07
patients O 0 7.465819074070623e-09
belonging O 0 1.0513602433093183e-08
to O 0 3.9745898239296196e-10
three O 0 1.2090302092815364e-09
mutation O 0 1.6968496083791251e-06
subgroups O 0 4.205212462693453e-07
. O 0 2.4800463904739445e-08

CONCLUSIONS O 0 9.930196938512381e-06
Extended O 0 1.9369041126537923e-07
genotype O 0 0.0008819594513624907
- O 0 4.471466309041716e-05
phenotype O 0 4.842514499614481e-06
correlations O 0 3.464508608885808e-07
made O 0 7.694597181640006e-10
in O 0 1.3679575527891785e-10
this O 0 7.889845721198441e-11
study O 0 4.6297185529731166e-10
may O 0 4.132141295798419e-09
have O 0 6.94321379904328e-12
the O 0 5.301444504744734e-13
potential O 0 3.9333585000189686e-11
to O 0 7.891829550965568e-12
determine O 0 1.7173724664587553e-09
the O 0 2.6776235308861862e-12
most O 0 8.002399741122157e-13
appropriate O 0 8.394369400976931e-12
surveillance O 0 1.5559857846625391e-09
and O 0 7.876344021440218e-11
prophylactic O 0 1.1404023325667367e-07
treatment O 0 3.3479314875961563e-09
regimens O 0 4.410958265310683e-09
for O 0 5.800409198092327e-12
those O 0 9.956973440194972e-11
patients O 0 2.2459753501458124e-10
with O 0 4.237979689403204e-10
mutations O 0 1.0742378435679711e-05
associated O 0 5.175015971303765e-08
with O 0 5.177441586567966e-09
life O 0 3.4923011753562605e-06
threatening O 0 0.0001412517885910347
conditions O 0 1.5625763580828789e-06
. O 0 1.3860812941857148e-08

This O 0 1.3455055736244503e-08
study O 0 1.4288527028227804e-09
also O 0 6.550438663710523e-11
provided O 0 1.3524014373655913e-11
evidence O 0 7.191052614485827e-11
for O 0 4.2021251929480474e-12
the O 0 1.872702166949569e-11
pathological O 0 9.158664227015834e-08
nature O 0 2.5611137655090488e-09
of O 0 8.653058304608496e-12
amino O 0 3.499844858367851e-10
acid O 0 1.2684110706207008e-10
changes O 0 3.217509939035246e-11
in O 0 3.803117890055496e-11
APC O 0 1.6438654881767434e-09
associated O 0 2.413604593964891e-10
with O 0 1.0939054349845545e-11
both O 0 4.606201253753994e-10
FAP B-Disease 0 1.9335766410222277e-07
and O 0 2.3658675019078146e-08
non O 0 3.4429126571922097e-06
- O 1 0.9999130964279175
FAP O 1 0.999944806098938
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
patients O 0 6.548586679855362e-05
. O 0 6.398789942352323e-09
. O 0 6.967900478827005e-09

Inherited B-Disease 1 0.9999064207077026
colorectal I-Disease 1 0.9999996423721313
polyposis I-Disease 1 0.9999403953552246
and O 0 0.002730343723669648
cancer B-Disease 1 0.8619632124900818
risk O 0 1.0805217243614607e-05
of O 0 1.731897958379136e-10
the O 0 8.038132381926744e-10
APC O 0 2.645656991262513e-07
I1307K O 0 3.758852358259901e-07
polymorphism O 0 2.3505208446295e-05
. O 0 3.670328752036767e-08

Germ O 0 0.41142162680625916
- O 0 0.0004895896418020129
line O 0 4.7055740992618666e-07
and O 0 8.04273314614079e-10
somatic O 0 6.532044238838353e-08
truncating O 0 1.0675317980712862e-06
mutations O 0 5.401386147241283e-07
of O 0 1.2084110621868316e-11
the O 0 1.0298861069513165e-10
APC B-Disease 0 5.823219684231162e-09
gene O 0 1.7394468088127724e-09
are O 0 5.20684953486672e-11
thought O 0 8.068761214730102e-10
to O 0 1.8033877169365553e-10
initiate O 0 9.423058509128168e-05
colorectal B-Disease 1 0.9999998807907104
tumor I-Disease 1 0.9901526570320129
formation O 0 6.073607437429018e-05
in O 0 2.8793889214284718e-05
familial B-Disease 1 0.9999998807907104
adenomatous I-Disease 1 0.9999983310699463
polyposis I-Disease 1 1.0
syndrome I-Disease 1 0.9999990463256836
and O 0 4.708896085503511e-06
sporadic O 1 0.5833490490913391
colorectal O 1 0.9999997615814209
carcinogenesis O 1 0.999739944934845
, O 0 3.898685463354923e-07
respectively O 0 1.0817875590873882e-06
. O 0 2.693513145857196e-08

Recently O 0 7.768181603751145e-06
, O 0 4.0697836767300544e-10
an O 0 9.541544637725607e-11
isoleucine O 0 8.312971476698294e-05
- O 0 0.000608121685218066
- O 0 0.0002651886024978012
> O 0 6.277110742303194e-07
lysine O 0 1.3776660523490136e-07
polymorphism O 0 1.7624596466703224e-06
at O 0 3.669018200369578e-09
codon O 0 1.327845389198501e-08
1307 O 0 1.294372822258083e-07
( O 0 6.952967281786959e-12
I1307K O 0 8.651565575057418e-10
) O 0 5.83346847389532e-13
of O 0 4.1479734686107606e-13
the O 0 1.9239988074959413e-11
APC B-Disease 0 2.61768140497054e-09
gene O 0 2.228893514200081e-09
has O 0 5.921251822194051e-10
been O 0 1.4326614894422107e-10
identified O 0 6.110797423630743e-10
in O 0 2.3004992008579528e-11
6 O 0 4.1275368539706037e-11
% O 0 1.2231289765740616e-11
- O 0 6.00107412651596e-08
7 O 0 7.421136483110047e-10
% O 0 2.0655187629725624e-12
of O 0 1.6397638455400987e-12
the O 0 2.3517202074607724e-10
Ashkenazi O 0 8.511190685567271e-08
Jewish O 0 1.4548411364501135e-08
population O 0 5.581759499051486e-10
. O 0 7.654536560153247e-09

To O 0 5.7087263805044586e-09
assess O 0 2.56909061135957e-07
the O 0 5.999214458540791e-10
risk O 0 1.917151415398166e-08
of O 0 3.238040478109605e-12
this O 0 3.473004175913452e-11
common O 0 1.1316377834802438e-09
APC B-Disease 0 1.1911722275215197e-08
allelic O 0 3.466723228484625e-07
variant O 0 1.9944325686083175e-05
in O 0 1.960628878805437e-06
colorectal O 1 0.9999995231628418
carcinogenesis O 1 0.977552056312561
, O 0 1.0218377610726748e-07
we O 0 1.827203632842611e-08
have O 0 1.492206358477688e-10
analyzed O 0 1.2247526326447655e-09
a O 0 7.464572709947603e-11
large O 0 5.286255877479107e-10
cohort O 0 1.7191005952099658e-08
of O 0 7.378368055421802e-11
unselected O 0 3.521769713188405e-06
Ashkenazi O 0 5.043132773607795e-07
Jewish O 0 2.396363996126638e-08
subjects O 0 1.324787461953747e-07
with O 0 3.7581977530010136e-09
adenomatous B-Disease 0 0.0001187494708574377
polyps I-Disease 0 8.053072087932378e-05
and O 0 1.029686735876112e-08
. O 0 7.374463706355527e-09
or O 0 0.1760702282190323
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, I-Disease 0 2.806397114696324e-09
for O 0 1.2266309495911898e-11
the O 0 1.835151197671081e-10
APC O 0 8.272647988860626e-08
I1307K O 0 6.777266037261143e-08
polymorphism O 0 9.100492206925992e-06
. O 0 2.950064192930313e-08

The O 0 1.2688624373424773e-08
APC O 0 2.0036625869579439e-07
I1307K O 0 1.822602797574291e-07
allele O 0 4.683886061229714e-07
was O 0 3.065012244007903e-09
identified O 0 3.6237419731577347e-09
in O 0 2.283079801601584e-11
48 O 0 2.8978324947970258e-11
( O 0 8.472217068525301e-13
10 O 0 1.100425523273274e-12
. O 0 4.4650557123188106e-13
1 O 0 7.687548514434539e-12
% O 0 3.0827547545936307e-12
) O 0 9.746070053426314e-13
of O 0 7.50123487630594e-12
476 O 0 1.8214832309126905e-08
patients O 0 3.806766812886053e-08
. O 0 2.553335498589604e-08

Compared O 0 8.141846308262757e-08
with O 0 9.739204581693528e-11
the O 0 1.4167322870406451e-10
frequency O 0 2.5764759925550607e-07
in O 0 1.8304240068101052e-11
two O 0 2.918259167303261e-12
separate O 0 1.5514448059583685e-10
population O 0 2.3153780975837535e-11
control O 0 1.5310824830194747e-09
groups O 0 1.4432529824026652e-11
, O 0 1.5484722878933432e-12
the O 0 4.255032957922733e-12
APC O 0 1.3119694219909661e-09
I1307K O 0 2.0004458090028265e-09
allele O 0 9.145934676269007e-09
is O 0 2.338452521899459e-11
associated O 0 4.373639991839262e-11
with O 0 6.760779436287834e-12
an O 0 4.313098836417062e-11
estimated O 0 1.5640404527061946e-09
relative O 0 2.3574941110382497e-07
risk O 0 5.747690678958861e-08
of O 0 5.1302521258955736e-11
1 O 0 9.771067510655485e-09
. O 0 1.5958354637746197e-08

5 O 0 3.0876159939907666e-07
- O 0 6.798940830776701e-06
1 O 0 5.135380476417595e-08
. O 0 5.808480452174081e-08

7 O 0 4.002647813194926e-07
for O 0 9.318963378746048e-08
colorectal B-Disease 1 0.9999988079071045
neoplasia I-Disease 1 0.9980733394622803
( O 0 8.165496723222532e-09
both O 0 1.0171627096156044e-08
P O 0 0.2562457025051117
= O 0 3.460959305812139e-06
. O 0 3.337473630793397e-10
01 O 0 1.3097448459120642e-08
) O 0 3.5208263388097905e-11
. O 0 8.044973021092972e-10

Furthermore O 0 1.0914602626144188e-06
, O 0 1.615270278643166e-10
compared O 0 4.2211675821413053e-10
with O 0 3.7144662345944823e-11
noncarriers O 0 2.491050963726593e-06
, O 0 4.8600609647841964e-11
APC O 0 4.422834598560854e-10
I1307K O 0 1.2909887603385073e-09
carriers O 0 3.9016492814347714e-10
had O 0 3.6530464764261694e-10
increased O 0 4.073043291530354e-11
numbers O 0 6.073703345821357e-11
of O 0 5.2613048466543244e-12
adenomas B-Disease 0 3.51966127709602e-06
and O 0 1.2777099982486106e-05
colorectal B-Disease 1 0.9999998807907104
cancers I-Disease 1 0.9997637867927551
per O 0 1.7749247263054713e-06
patient O 0 1.1860500308102928e-05
( O 0 7.742265717425312e-10
P O 0 0.0001954798208316788
= O 0 2.44497130097443e-07
. O 0 3.177502705398183e-11
03 O 0 6.193239809881845e-10
) O 0 2.0596098611325164e-12
, O 0 2.0505162238310115e-12
as O 0 4.673150755252209e-12
well O 0 4.277739273916836e-11
as O 0 7.288871763100335e-12
a O 0 2.919214314722751e-10
younger O 0 6.482794390194613e-08
age O 0 3.925425318129783e-09
at O 0 2.820628841604389e-09
diagnosis O 0 9.657858299760846e-07
. O 0 9.368468667503294e-09

We O 0 1.4348896115734533e-07
conclude O 0 9.011269064274074e-09
that O 0 4.006303622183793e-11
the O 0 1.941413002581882e-11
APC O 0 4.400151798478191e-09
I1307K O 0 4.144399490257911e-09
variant O 0 1.1609850858462778e-08
leads O 0 6.728136936473561e-10
to O 0 2.0421890567501322e-10
increased O 0 1.8049935590624955e-07
adenoma B-Disease 1 0.9999945163726807
formation O 0 6.96545754408362e-08
and O 0 2.1152858631356963e-10
directly O 0 1.3156323253049607e-10
contributes O 0 9.785811050377902e-11
to O 0 2.4972862319727618e-12
3 O 0 1.204457800857428e-11
% O 0 5.979673353695425e-12
- O 0 6.932425744565762e-09
4 O 0 4.9274802987886446e-11
% O 0 2.9079137101734043e-12
of O 0 6.078173554746602e-12
all O 0 5.166413075130549e-09
Ashkenazi O 0 0.0003250284353271127
Jewish O 1 0.749404788017273
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999988079071045
. O 0 3.30498505718424e-06

The O 0 1.001389282606624e-08
estimated O 0 6.045347333838436e-09
relative O 0 1.363564905432213e-07
risk O 0 7.096420517882507e-08
for O 0 5.5164116330441715e-11
carriers O 0 2.0989148197259055e-08
may O 0 2.176820945720692e-09
justify O 0 1.9121619843076587e-09
specific O 0 1.2114163838727876e-10
clinical O 0 2.420621481036278e-10
screening O 0 3.2940247751689355e-11
for O 0 1.7930483486860993e-12
the O 0 1.9535510362156394e-12
360 O 0 3.817025254898576e-12
, O 0 5.967205353972493e-13
000 O 0 7.999291333493641e-12
Americans O 0 1.7283331016360037e-11
expected O 0 3.089289934976591e-11
to O 0 5.075821707389849e-12
harbor O 0 2.7535655977573015e-09
this O 0 2.00575042685891e-11
allele O 0 1.5488881288661105e-09
, O 0 1.7923029596925155e-12
and O 0 1.8390747258401063e-11
genetic O 0 2.3052146858049127e-09
testing O 0 1.381414427292782e-09
in O 0 2.4299829509688564e-11
the O 0 9.204265821738389e-12
setting O 0 1.3167525958479587e-09
of O 0 2.9531276729555245e-11
long O 0 3.065574816218941e-08
- O 0 8.81085725268349e-07
term O 0 5.405617642395555e-08
- O 0 1.7874630486858223e-07
outcome O 0 2.930618858698608e-09
studies O 0 1.5167289646456084e-10
may O 0 2.356695394389874e-10
impact O 0 3.2308580255602237e-09
significantly O 0 6.203939051374618e-07
on O 1 0.9285494089126587
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
prevention O 0 0.005117490887641907
in O 0 4.412251397578615e-10
this O 0 3.1625396745837975e-10
population O 0 5.060795116307304e-10
. O 0 2.541250987420085e-09

Localization O 0 4.731132776214508e-06
of O 0 1.34667821338752e-09
human O 0 1.8131814272237534e-08
BRCA1 O 0 1.789046473277267e-05
and O 0 1.678866823340286e-09
its O 0 2.4208246518497845e-10
loss O 0 2.6336536507187702e-08
in O 0 3.4721450714592095e-10
high O 0 2.4104562612592417e-07
- O 0 1.0088477210956626e-05
grade O 0 1.8294724668521667e-06
, O 0 3.4237565560424343e-10
non B-Disease 0 1.2221351042285278e-08
- I-Disease 0 0.11402943730354309
inherited I-Disease 1 0.9993791580200195
breast I-Disease 1 0.9999229907989502
carcinomas I-Disease 1 0.9999997615814209
. O 0 1.1149675628985278e-05

Although O 0 4.4492374229321285e-08
the O 0 1.3301203194426847e-10
link O 0 2.0172212344959917e-08
between O 0 8.223039471566551e-10
the O 0 1.1012781797603566e-08
BRCA1 O 1 0.7795030474662781
tumour B-Disease 1 0.9999982118606567
- O 0 1.0730767826316878e-05
suppressor O 0 3.707815267262049e-06
gene O 0 1.4434141348829144e-07
and O 0 3.9685261299382546e-08
hereditary B-Disease 1 0.9998862743377686
breast I-Disease 1 0.9999990463256836
and I-Disease 1 0.9999977350234985
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 0 1.2266725661902456e-06
established O 0 2.687972899817481e-10
, O 0 3.31952933023405e-12
the O 0 1.045728282612901e-12
role O 0 1.7210212421847615e-10
, O 0 8.40370915217159e-12
if O 0 3.400793188723661e-11
any O 0 7.972194085437145e-12
, O 0 8.453831168084291e-13
of O 0 1.0021324048370417e-12
BRCA1 O 0 1.591729272831799e-07
in O 0 2.338463644946387e-09
non B-Disease 0 1.2327855358762463e-07
- I-Disease 0 0.04050712659955025
familial I-Disease 1 0.9936522245407104
cancers I-Disease 1 0.9996194839477539
is O 0 8.219958402833072e-08
unclear O 0 1.198858541329173e-07
. O 0 9.23558207688302e-09

BRCA1 O 1 0.7326548099517822
mutations O 0 0.0020294575951993465
are O 0 1.281000860942072e-09
rare O 0 2.6537881225863202e-08
in O 0 1.920341663463887e-09
sporadic B-Disease 0 0.0014060121029615402
cancers I-Disease 1 0.9998699426651001
, O 0 5.947866643651878e-09
but O 0 1.994342468947252e-09
loss O 0 6.4079497263946905e-09
of O 0 2.8853239242287998e-11
BRCA1 O 0 4.769949555338826e-06
resulting O 0 2.406114774089474e-08
from O 0 2.0966441083292153e-10
reduced O 0 9.314695681439389e-09
expression O 0 8.353863734100742e-08
or O 0 2.62132382466973e-09
incorrect O 0 5.8315922757401495e-08
subcellular O 0 4.3928378090640763e-07
localization O 0 4.7368754252374856e-08
is O 0 5.563623173276966e-11
postulated O 0 1.5457656266093522e-09
to O 0 1.1662432304604398e-11
be O 0 6.328892965257182e-11
important O 0 1.775773278422932e-11
in O 0 1.0407469330786512e-10
non B-Disease 0 1.1735282967606508e-08
- I-Disease 0 0.0020794798620045185
familial I-Disease 1 0.998900294303894
breast I-Disease 1 0.9999958276748657
and I-Disease 1 0.9999744892120361
ovarian I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 7.202550477813929e-06

Epigenetic O 0 0.0004712133959401399
loss O 0 0.00026500559761188924
, O 0 2.732085224721459e-09
however O 0 9.789007382465797e-10
, O 0 2.2185506903804608e-11
has O 0 7.362538356758819e-11
not O 0 4.975966687303934e-12
received O 0 8.203585922551826e-13
general O 0 9.41929910805439e-13
acceptance O 0 4.5236078771715427e-11
due O 0 1.0426145363728878e-10
to O 0 4.302005366524364e-12
controversy O 0 1.3491797679066053e-09
regarding O 0 2.7747268371847156e-10
the O 0 3.211054686036441e-11
subcellular O 0 3.8231242172059865e-08
localization O 0 7.093873932717543e-09
of O 0 8.034016160674007e-12
BRCA1 O 0 1.5287393750895717e-07
proteins O 0 1.859030152040475e-10
, O 0 4.595105112387143e-12
reports O 0 5.223171894996881e-11
of O 0 2.436228302427068e-12
which O 0 2.5436791561972427e-10
have O 0 6.880626068905826e-10
ranged O 0 3.1741155481768146e-08
from O 0 3.8242780470154614e-11
exclusively O 0 1.0075655865193767e-09
nuclear O 0 2.3558495740871876e-06
, O 0 2.3161765474316587e-12
to O 0 3.393495337164487e-12
conditionally O 0 2.4808930021436026e-08
nuclear O 0 4.646864226742764e-07
, O 0 7.473027188384385e-13
to O 0 4.834577616713576e-12
the O 0 3.2967292784569224e-10
ER O 0 2.3115949261409696e-06
/ O 0 2.8252713946130825e-08
golgi O 0 1.3017248079449928e-07
, O 0 1.951924386012216e-11
to O 0 3.4347019586128402e-12
cytoplasmic O 0 1.3167376078371262e-09
invaginations O 0 2.698562973080243e-08
into O 0 1.0360212687743342e-10
the O 0 4.1543138373789645e-10
nucleus O 0 2.3433806006778468e-08
. O 0 5.713170825316638e-09

In O 0 1.9168726606011433e-09
an O 0 1.3273116113154959e-11
attempt O 0 2.5687800775386904e-09
to O 0 7.490391085163139e-10
resolve O 0 2.247248716003014e-07
this O 0 4.780965623396582e-10
issue O 0 6.261730689516298e-09
, O 0 3.684266780545897e-11
we O 0 3.803598824791976e-10
have O 0 9.620636232110513e-11
comprehensively O 0 4.3882741351808363e-07
characterized O 0 8.396931860943369e-08
19 O 0 3.683650329211474e-10
anti O 0 4.662725245907495e-07
- O 0 0.0020706651266664267
BRCA1 O 0 0.0002814527542795986
antibodies O 0 1.2976818197785178e-06
. O 0 1.4768019696020929e-08

These O 0 1.2643810443080383e-08
reagents O 0 1.7014502873280435e-07
detect O 0 1.993700834646006e-06
a O 0 2.238428109535562e-09
220 O 0 4.270306330766971e-10
- O 0 1.1752064210668323e-07
kD O 0 1.4778763102185621e-07
protein O 0 5.27674626216168e-10
localized O 0 1.0035996922397317e-08
in O 0 4.4985438985012394e-11
discrete O 0 5.917487300166613e-08
nuclear O 0 5.536559910979122e-06
foci O 0 8.065950396485277e-07
in O 0 4.3906092650480844e-10
all O 0 3.1262537697474e-11
epithelial O 0 3.967800239479402e-07
cell O 0 6.08519667366636e-06
lines O 0 4.565011124668672e-07
, O 0 6.106270437206129e-12
including O 0 2.0931138766666635e-12
those O 0 8.418292105072389e-12
derived O 0 2.4132501552642793e-10
from O 0 1.527150961244672e-09
breast B-Disease 0 0.003834974952042103
malignancies I-Disease 0 0.0041395509615540504
. O 0 6.78935094811095e-08

Immunohistochemical O 0 0.0005789077840745449
staining O 0 2.0636958652175963e-05
of O 0 3.3187808057277834e-09
human O 0 1.767649564499152e-07
breast O 0 0.1728399097919464
specimens O 0 9.427687473362312e-05
also O 0 3.227989608944881e-08
revealed O 0 7.490678399335593e-06
BRCA1 O 0 9.080013842321932e-05
nuclear O 0 9.562594641465694e-06
foci O 0 2.274197140650358e-05
in O 0 9.404311107630292e-09
benign O 0 0.013171900063753128
breast O 1 0.5611156225204468
, O 0 9.119982280481054e-08
invasive B-Disease 0 0.0032451520673930645
lobular I-Disease 1 0.9998094439506531
cancers I-Disease 1 0.999983549118042
and O 0 1.184456232294906e-05
low B-Disease 0 0.23541057109832764
- I-Disease 1 0.9389411211013794
grade I-Disease 0 0.10701245814561844
ductal I-Disease 1 0.9972233772277832
carcinomas I-Disease 1 0.9999974966049194
. O 0 8.673250704305246e-06

Conversely O 0 1.477283876738511e-05
, O 0 2.1846573439177064e-09
BRCA1 O 0 4.786573299497832e-06
expression O 0 1.2654602414841065e-06
was O 0 8.634741277546709e-08
reduced O 0 3.2314129150279314e-09
or O 0 5.875556485790412e-09
undetectable O 0 3.7707005162701535e-07
in O 0 5.503442840337769e-11
the O 0 1.133673883935149e-11
majority O 0 6.796129631281289e-11
of O 0 6.76821376721648e-11
high O 0 8.018995458769496e-07
- O 0 0.00014287256635725498
grade O 0 1.222222294927633e-06
, O 0 1.6158719917669373e-09
ductal B-Disease 0 0.00023417957709170878
carcinomas I-Disease 1 0.9999995231628418
, O 0 3.6443839057653804e-09
suggesting O 0 5.0977689625142375e-08
that O 0 2.7747479314221835e-10
absence O 0 5.863596830302242e-10
of O 0 6.561354237710759e-11
BRCA1 O 0 1.8137357983505353e-05
may O 0 4.853028201523557e-08
contribute O 0 2.1288328044821725e-10
to O 0 5.497882357707873e-11
the O 0 1.1603949745531139e-10
pathogenesis O 0 4.395236619103571e-09
of O 0 8.440185399541389e-13
a O 0 1.9377577667456514e-11
significant O 0 1.895978096744244e-10
percentage O 0 2.1472226663377114e-08
of O 0 6.279257669383753e-11
sporadic B-Disease 0 0.0011144611053168774
breast I-Disease 1 0.9999819993972778
cancers I-Disease 1 0.999876856803894
. O 0 6.350837367108397e-08
. O 0 3.731457454136944e-08

